0001654954-24-003785.txt : 20240328 0001654954-24-003785.hdr.sgml : 20240328 20240328092914 ACCESSION NUMBER: 0001654954-24-003785 CONFORMED SUBMISSION TYPE: 10-K PUBLIC DOCUMENT COUNT: 91 CONFORMED PERIOD OF REPORT: 20231231 FILED AS OF DATE: 20240328 DATE AS OF CHANGE: 20240328 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Lowell Farms Inc. CENTRAL INDEX KEY: 0001838128 STANDARD INDUSTRIAL CLASSIFICATION: AGRICULTURE PRODUCTION - CROPS [0100] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 000000000 STATE OF INCORPORATION: A1 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-56254 FILM NUMBER: 24794005 BUSINESS ADDRESS: STREET 1: 19 QUAIL RUN CIRCLE - SUITE B CITY: SALINAS STATE: CA ZIP: 93907 BUSINESS PHONE: (831) 998-8214 MAIL ADDRESS: STREET 1: 19 QUAIL RUN CIRCLE - SUITE B CITY: SALINAS STATE: CA ZIP: 93907 FORMER COMPANY: FORMER CONFORMED NAME: Indus Holdings, Inc. DATE OF NAME CHANGE: 20201228 10-K 1 lowlf_10k.htm FORM 10-K lowlf_10k.htm

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 10-K

 

     ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the year ended December 31, 2023

 

or

 

     TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the transition period from ________ to ________

 

Commission File Number 000-56254

 

LOWELL FARMS INC.

(Exact name of Registrant as Specified in its Charter)

 

British Columbia, Canada

 

N/A

(State or Other Jurisdiction of Incorporation or Organization)

 

(I.R.S. Employer Identification No.)

 

 

 

19 Quail Run Circle - Suite B, Salinas, California.

 

93907

(Address of Principal Executive Offices)

 

(Zip Code)

 

Registrant’s telephone number, including area code: (831) 998-8214

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class

Trading Symbol(s)

Name of each exchange on which registered

NONE

NONE

NONE

 

Securities registered pursuant to Section 12(g) of the Act:

 

Subordinate Voting Shares

 

(Title of class)

 

Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes ☐     No

 

Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act. Yes ☐     No

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒     No ☐

 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒     No ☐

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer

Accelerated filer

Non-accelerated filer

Smaller reporting company

 

 

Emerging growth company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. 

 

Indicate by check mark whether the registrant has filed a report on and attestation to its management’s assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report.

 

If securities are registered pursuant to Section 12(b) of the Act, indicate by check mark whether the financial statements of the registrant included in the filing reflect the correction of an error to previously issued financial statements. ☐

 

Indicate by check mark whether any of those error corrections are restatements that required a recovery analysis of incentive-based compensation received by any of the registrant’s executive officers during the relevant recovery period pursuant to § 240.10D-1(b). ☐

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act). Yes      No ☒

 

The aggregate market value of subordinate voting shares held by non-affiliates of the registrant, as of June 30, 2023, the last business day of the registrant’s second quarter, was $3,069,255 (based on the closing price for the registrant's subordinate voting shares as reported by the OTCQX on that date). Shares of subordinate voting shares held by each executive officer, director, and holder of 5% or more of the registrant’s outstanding subordinate voting shares have been excluded in that such persons may be deemed to be affiliates. This determination of affiliate status is not necessarily a conclusive determination for other purposes.

 

 There were 18,130,566 shares of the Registrant’s Subordinate Voting Shares outstanding as of March 26, 2024.

 

DOCUMENTS INCORPORATED BY REFERENCE

 

None

 

 

 

 

LOWELL FARMS INC.

ANNUAL REPORT ON FORM 10-K

For the Year Ended December 31, 2023

 

Table of Contents

 

 

 

 

Page

 

 

 

 

 

 

Part I

 

 

 

 

 

Item 1.

Business

 

3

 

Item 1A.

Risk Factors

 

20

 

Item 1B.

Unresolved Staff Comments

 

34

 

Item 1C.

Cybersecurity

 

34

 

Item 2.

Properties

 

34

 

Item 3.

Legal Proceedings

 

37

 

Item 4.

Mine Safety Disclosures

 

37

 

 

 

 

 

 

Part II

 

 

 

 

 

Item 5.

Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities

 

38

 

Item 6.

[Reserved]

 

38

 

Item 7.

Management’s Discussion and Analysis of Financial Condition and Results of Operations

 

39

 

Item 7A.

Quantitative and Qualitative Disclosures about Market Risk

 

50

 

Item 8.

Financial Statements and Supplementary Data

 

53

 

Item 9.

Changes in and Disagreements with Accountants on Accounting and Financial Disclosure

 

78

 

Item 9A.

Controls and Procedures

 

78

 

Item 9B.

Other Information

 

79

 

Item 9C.

Disclosure Regarding Foreign Jurisdictions that Prevent Inspections

 

79

 

Part III

 

 

 

 

 

Item 10.

Directors, Executive Officers and Corporate Governance

 

80

 

Item 11.

Executive Compensation

 

85

 

Item 12.

Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters

 

96

 

Item 13.

Certain Relationships and Related Transactions, and Director Independence

 

99

 

Item 14.

Principal Accountant Fees and Services

 

100

 

 

 

 

 

 

Part IV

 

 

 

 

 

Item 15.

Exhibits and Financial Statement Schedules

 

101

 

Item 16.

Form 10-K Summary

 

 102

 

 

Exhibit Index

 

102

 

 

Signatures

 

103

 

 

 
2

Table of Contents

 

Part I

 

Lowell Farms Inc. and its wholly owned subsidiaries are collectively referred to in this Annual Report on Form 10-K as the “Company,” “Corporation,” “Lowell Farms,” “we,” “us” or “our.”

 

ITEM 1. Business

 

General

 

We are governed by the laws of British Columbia, Canada. On April 26, 2019, we completed a reverse takeover transaction (the “Business Combination” or the “RTO”) with Indus Holding Company, a Delaware corporation. On February 25, 2021, we completed the Lowell Acquisition. Effective March 1, 2021, in connection with the Lowell Acquisition, we changed our name to Lowell Farms Inc.

 

We are a California-based cannabis company with vertically integrated operations including large scale cultivation, extraction, processing, manufacturing, branding, packaging and wholesale distribution to retail dispensaries. We manufacture and distribute proprietary and select third-party brands throughout the State of California, the largest cannabis market in the world. We also provide manufacturing, extraction and distribution services to select third-party cannabis and cannabis branding companies and sell proprietary bulk flower and broker third-party bulk flower to licensed distribution and manufacturing companies in California.

 

During 2023, we operated an approximately 250,000 square foot greenhouse cultivation facility in Monterey County, a 40,000 square foot processing facility that provides drying, bucking, trimming, sorting, grading, and packaging operations of cannabis flower in Monterey County, a 15,000 square foot manufacturing and laboratory facility in Salinas, California, a separate 21,000 square foot distribution facility in Salinas, California and a warehouse depot in Los Angeles, California.  In January 2024 we surrendered possession of the greenhouse cultivation facility.  See “Legal Proceedings.”

 

We sell our products under owned and licensed third-party brands.

 

Product Offerings

 

Our product offerings include flower, vape pens, oils, extracts, chocolate edibles, mints, gummies, tinctures and pre-rolls. We sell our products under owned and third-party brands.

 

Brands we own include the following:

 

 

o

House Weed - a value driven flower, vape and concentrates offering, delivering a flavorful and potent experience with dependable quality.

 

 

 

 

o

Moon - offers a range of cannabis bars, bites and fruit chews in a variety of flavors, focusing on high-quality and high-value.

 

 

 

 

o

Original Pot Company - infuses its quality baked edibles with cannabis extract.

 

 

 

 

o

Cypress Cannabis - a premium flower brand reserved for the Company’s highest potency harvests from its greenhouses.

 

 

 

 

o

Humble Flower - a product line of topicals, pre-rolls and functional pressed sublingual tablets.

 

 

 

 

o

Flavor Extracts - provides a value line of concentrates like crumble and terp sugar (which is a cannabis product with isolated and enhanced flavor and aromas) products that are hand-selected for optimum flavor and premium color.

 

 
3

Table of Contents

 

We exclusively manufacture and distribute Lowell Smokes and Lowell Herb Co. brands as well as other third-party brands in California and provide third-party extraction processing and distribution services and bulk extraction concentrates and flower to licensed manufacturers and distributors.

 

Debt Settlement, Asset Sale and Licensing

 

In October 2023, the Company repurchased (the “Debenture Repurchase”) all of the $22,157 aggregate principal amount of outstanding Senior Secured Convertible Debentures together with the related warrants to purchase 10,627,483 subordinate voting shares of the Company and 4,324,845 common shares of Indus. Share amounts reflect the 1 for 10 reverse stock split effective August 31, 2023. Each holder of debentures and warrants received as the purchase price therefor such holder’s pro rata share, based on the proportion of the outstanding debentures held by such holder, of (x) membership interests (the “Membership Interests”) in LF Brandco LLC (“Brandco”), an entity formed to hold the Company’s intellectual property relating to its “Lowell Smokes” and “Lowell Herb Co.” brands (including trademarks, logos and additional identifying marks, domain names and social media accounts), and (y) 6,849,572 Subordinate Voting Shares, representing approximately 36% of the Company’s consolidated, undiluted equity interests on the date of the transaction. During the year ended December 31, 2023, the Company recognized $13,245 of impairment on the intangible brand assets.

  

In addition, the Company has entered into a license agreement with Brandco for the “Lowell” trademarks, logos, and related intellectual property on an exclusive basis in the State of California for a five-year license term, with up to three five-year extensions. The Company’s exercise of the extension terms is subject to mutual agreement on certain sales performance criteria for each extension term. The Company received a $1 million credit whereby the Company does not have to pay the first $1 million of royalty expense.

 

Cultivation

 

Throughout 2023, we conducted cannabis cultivation operations located in Monterey County, California. We  operated a cultivation facility which includes four greenhouses totaling approximately 255,000 square feet sited on 10 acres located on Zabala Road. Farming cannabis at this scale enabled us to curate specialized strains and maintain control over the quantity and quality of cannabis available for our products, preserving the consistency of our flower and cannabis feedstocks facilitating a predictable output yield of pesticide-free products for our extraction laboratory and product manufacturing operations.

 

The first harvest was in the third quarter of calendar year 2017. In 2021 we completed a series of facility upgrades to our greenhouses and supporting infrastructure, which increased facility output approximately four times from that generated in 2019. These facility improvements include separate grow rooms configured with drop-shades, supplemental lighting, upgraded electrical capability with environmental controls and automated fertigation, and raised gutter height in two of the greenhouses. We harvested approximately 32,000, 34,000 and 23,000 pounds of flower in 2021, 2022 and 2023, respectively. We invested approximately $8.8 million in our greenhouse renovations through 2023.

 

In January 2024, we surrendered possession of the cultivation facility.  See Legal Proceedings.  We have developed relationships with local cannabis growers whereby flower and biomass quantities are readily available at competitive prices, including local growers that utilize the services of our processing facilities. 

 

Extraction

 

Extraction operations were first launched by us in the third quarter of 2017 with the commissioning of our 5,000 square foot licensed laboratory within our Salinas manufacturing facility. The hydrocarbon lab contains six separate rooms that can each house one independent closed loop volatile extraction machine (meaning that the machine does not expose the products to open air), which are designed to process the cannabis through the application of hydrocarbon or ethanol solvents, to extract certain concentrated resins and oils from the dried cannabis. This process is known as volatile extraction, which is an efficient and rapid method of extracting cannabis. These resins, oils and concentrates are sold as inhalable products known as “shatter,” "rosin," "wax," "sugar," "diamonds," “caviar,” and “crumble”.

 

 
4

Table of Contents

 

We currently own and operate five closed loop volatile extraction machines, each housed in a separate room, and each having the capacity to process approximately 100 pounds of dry product per day yielding approximately 5 kilograms of cannabis concentrates. We also currently own and operate 14 purge ovens to work in conjunction with the 5 extraction units in the laboratory. Purge ovens, also known as vacuum ovens, are used after the processing by the extraction units to remove the solvents from the end-product in a low pressure and high heat environment.

 

In 2021, we commenced solventless extraction activities with the capacity to process approximately 120 pounds of biomass daily yielding approximately 4 kilograms of cannabis concentrates. We currently own and operate one extraction unit which works in conjunction with 5 freeze dryers, 2 ice machines, 3 water filtration systems, 1 UV sterilizer, 2 rosin presses and an 80 square foot walk-in freezer. The solventless process yields a superior product to the volatile extraction process and is the fastest growing category in concentrates. 

 

The extraction operations utilize cannabis feedstocks from our cultivation site, supplemented with feedstock acquired from multiple third-party cultivations at competitive prices. Commencing in 2024, all feedstock will be sourced from third-party cultivations.  Concentrate production is packaged as branded extracts, such as crumble, shatter, wax and sugar for distribution, incorporated into its manufactured edible products and sold in bulk to other licensed enterprises. In addition, extraction is provided on a fee-based service on third-party material.

 

Manufacturing

 

Our manufacturing facility is located in Salinas, California and houses our edible product operations and extraction and distillation operations. The edible product operations utilize internally produced and externally supplied cannabis oil, which can be supplied from multiple competitively priced external sources. Our manufacturing operations produce a wide variety of cannabis-infused products and occupies 10,000 square feet in our 15,000 square foot manufacturing facility in Salinas. Our production capabilities include chocolate confections, baked goods, hard and soft non-chocolate confections, and topical lotions and balms. Lowell Farms utilizes modern commercial production equipment and employs food grade manufacturing protocols, including industry-leading standard operating procedures designed so that its products meet stringent quality standards. We have implemented updated compliance, packaging and labeling standards to meet all regulatory requirements, including the California Medicinal and Adult-Use Cannabis Regulation and Safety Act.

 

In 2022, we acquired advanced automated pre-roll production equipment to launch our automated pre-roll line, Lowell 35s. The equipment consists of an automated filler that is capable and producing 180 pre-rolls per minute and an automated packaging machine capable of packaging 50 packs of pre-rolls per minute, with each pack containing 10 pre-rolls per pack. Production began during the third quarter of 2022.

 

We also operate an automated flower filling and packaging line and two automated pre-roll assembly lines for making finished goods in those respective categories with cannabis grown by our cultivation operations as well as cannabis sourced from external cultivators.

 

Processing

 

In June 2021, we acquired real property and related assets of a cannabis drying and midstream processing facility located in Monterey County, nearby our flagship cultivation operation. The 40,000 square foot processing facility provides drying, bucking, trimming, sorting, grading, and packaging operations for up to 250,000 pounds of wholesale cannabis flower annually. The facility processes nearly all the cannabis that we grow at our existing cultivation operations. Additionally, in the third quarter of 2021, we launched our business unit named Lowell Farm Services (“LFS”), which provides fee-based processing services for regional growers from primarily the Salinas Valley area, one of the largest and fastest growing cannabis cultivation regions in the country, as well as throughout California.

 

In May 2023, we announced the closing of a sale and leaseback transaction of our drying and midstream processing facility.  Concurrent with the sale ,we entered into a 10-year lease and we will continue our permitted drying and processing operations at this facility.

 

Distribution and Distribution Services

 

We have a primary distribution center, warehouse and packing facility located in Salinas, California and a warehouse depot in Los Angeles, California. We provide physical warehousing and delivery to retail dispensary customers throughout the State of California for our manufactured products as well as third party branded products distributed on behalf of other licensed product manufacturers. Deliveries are made daily to approximately 80% of the licensed dispensaries in California utilizing a fleet of 20 owned and leased vehicles. We provide warehousing, delivery, customer service and collection services for select third-party brands.

 

 
5

Table of Contents

 

Technology Platform

 

We maintain an automated, on-demand supply chain logistics platform, utilizing e-commerce, enterprise resource planning and other technology to manage product movement, order taking and logistics needs.

 

Inventory Management

 

We have comprehensive inventory management procedures, which we believe are compliant with the rules set forth by the California Department of Cannabis Control (formerly the California Department of Consumer Affairs’ Bureau of Cannabis Control) and all other applicable state and local laws, regulations, ordinances, and other requirements. These procedures ensure strict control over Lowell Farms’ cannabis and cannabis product inventory from cultivation or manufacture to sale and delivery to a licensed dispensary, distributor or manufacturer, or disposal as cannabis waste. Such inventory management procedures also include measures to prevent contamination and maintain the quality of the products cultivated, manufactured or distributed.

 

Sources, Pricing and Availability of Raw Materials, Component Parts or Finished Products

 

During 2023, we sourced flower for sale primarily from our cultivation facility. We have developed relationships with local cannabis growers whereby flower quantities are readily available at competitive prices which will be our primary flower source in 2024. In 2023, we sourced our biomass needs in extraction from our cultivation facility and from third-party suppliers. Biomass material is readily available from multiple sources at competitive prices which will be our primary biomass source in 2024. Lowell Farms manufactures substantially all cannabis oil and distillate needs from its internal extraction operations. Cannabis oil and distillate, including specialized cannabis oil, is procured from multiple external sources at competitive prices. Lowell Farms manufactures all finished goods for its proprietary brands. Third party distributed brand product is sourced directly from third party partners.

 

U.S. Cannabis Market

 

The U.S. cannabis market size was valued at US$21 billion in 2023 and is expected to expand at a compound annual growth rate of 14.2% from 2023 to 2030.3 The increasing legalization of cannabis and rising acceptance of its use for medical purposes are the key factors driving the growth of the market. The increasing research on the use of cannabis and its medicinal properties has led to its increased usage to treat various chronic conditions such as chronic pain and nausea from chemotherapy.

  

An increasing number of companies are entering local markets to cater to the growing demand for cannabis and is one of the factors supporting the market growth. A dynamic startup scene in the U.S. boosts the growth of the market for cannabis.

 

Other factors contributing to the growth include favorable cultivation norms which help cater to the biomass demand in the U.S. States such as Florida, Oregon, Nevada, California, Washington, and Colorado are the major producers of cannabis, owing to favorable climate conditions and the legalization of medical marijuana. Furthermore, the increasing number of companies in cannabis businesses due to the ease with which wholesale procurement of cannabis can be carried out and product development can be achieved is driving the market growth in the U.S.

 

 
6

Table of Contents

 

The COVID-19 pandemic resulted in the reduction in the strategic instances and revenues by various players. The factors responsible for the reduction in revenue include stringent regulation on trade and disruption in the supply chain due to the lockdown in the U.S. In addition, despite the increase in the number of cannabis users during the pandemic, there has also been a significant reduction in the price, leading to an overall decline in total market size based on revenue.

 

However, with the improving situation in the region, there is an upsurge in the strategic developments by key players, and this trend is anticipated to drive growth. In addition, the affirmative guidelines provided by the FDA for the continuation of the R&D activities concerning cannabis is anticipated to boost the growth of the U.S. cannabis market in the forthcoming years.

 

The medical segment accounted for the largest revenue share of 77.0% in 2022. The factors attributing to the largest share of this segment include the growing acceptance of cannabis for the treatment of various chronic conditions such as cancer, depression and anxiety, diabetes, arthritis, and epilepsy. Also, the approval of drugs for treating various conditions is contributing to the growth.

 

Also, the medical application of cannabis has expanded over the years due to the growing amount of scientific literature supporting its benefits in the treatment of various chronic diseases. Moreover, the number of U.S. states legalizing medical cannabis is increasing. Thirty seven U.S. states, three territories and the District of Columbia have legalized the use of medical cannabis and the medical conditions for which cannabis is being used are increasing. Twenty-four states and the District of Columbia and Guam in the U.S. have legalized the use of cannabis for adult or recreational use.4

 

California Cannabis Market

 

Annual legal cannabis sales in California decreased for the second year in a row in 2023. Legal sales reached $5.1 billion, according to figures released by the California Department of Tax and Fee Administration, down 4.7% from $5.4 billion in 2022.1

 

Despite the drop, California still represents roughly 25% of the $21 billion industry. Many in the cannabis sector see the state’s high taxes and a limited number of dispensaries as the main culprits for the decrease.

  

The wholesale price in California in 2022 was around $665 a pound, which was down 26% year over year. Since 2017, the year before legal recreational sales began in the state, and through the summer of 2022, the wholesale price of cannabis in California is down over 50%.2  Over the past year wholesale prices have been stable or slightly down.

 

Considering that California-which only has about 1,000 legal dispensaries for its 40 million residents-grows more cannabis than can be legally consumed within its borders, there is a cannabis surplus which has led to a price war in the legal industry and intense competition from the illicit market.

 

There is belief that mature markets like California experienced a revenue boost in 2020 and 2021 thanks to COVID-19. Now with lockdowns and stimulus checks a distant memory, inflation is also adding to the decline.

 

________

1https://www.cdtfa.ca.gov/dataportal/dataset.htm?url=CannabisTaxRevenues

2https://www.forbes.com/sites/willyakowicz/2023/02/28/californias-cannabis-sales-declined-in-2022-the-first-time-since-legalization/?sh=5ddb6fb87af9

3https://www.grandviewresearch.com/industry-analysis/us-cannabis-market

4https://www.disa.com/marijuana-legality-by-state-updated-March 1, 2024

 

Growth Strategy

 

While the legalization of cannabis throughout the United States continues to expand both in the adult use (recreational) and medical markets, and the size of the U.S. cannabis market will continue to provide growth opportunities, management believes that focusing on the substantial California market and becoming profitable and self-sustaining is the appropriate near-term growth strategy for the Company.

 

We plan to capitalize on cannabis consumption in California through the expansion of our proprietary and licensed brands, our robust manufacturing and processing capabilities and leveraging our expansive distribution footprint to provide third party distribution to other licensed manufacturers. We believe this expanded product offering will appeal to a broad customer base and utilize our existing manufacturing and distribution operations. Our processing capabilities will also enable sourcing competitively priced, high quality cannabis flower and biomass. We will selectively seek opportunities to further expand our brands and operations in California through acquisitions or alliances.

 

 
7

Table of Contents

 

We currently have no retail facilities and we do not currently have definitive plans or timelines for expansion into retail or beyond California.

 

Competitive Conditions

 

We compete with other branded licensed cultivators, manufacturers and distributors, offering similar products and services, within California.

 

Currently, the California cannabis industry is largely comprised of small to medium-sized entities. We believe that the vast majority of our competitors are relatively small operations. Over time, it is expected that within California the industry will begin to consolidate as market-share will increasingly favor larger and more sophisticated operators.

 

We expect to face additional competition from new entrants. To remain competitive, we expect to expand strategic relationships with suppliers distribution brands and invest in scale, people, processes and technology to maintain cost and product leadership over our competitors.

 

We may not have sufficient resources to maintain research and development, marketing, sales and support efforts on a competitive basis, which could materially and adversely affect our business, financial condition, results of operations or prospects.

 

We expect to face continued competition from the illicit or “black-market” commercial activities that still operate within the state. Despite state-level legalization of cannabis in the United States, such operations remain abundant and present substantial competition to Lowell Farms. In particular, illicit operations, because they are largely clandestine, are not required to comply with the extensive regulations with which we must comply in order to conduct business, and accordingly may have significantly lower costs of operation. While legal cannabis sales reached $5.1 billion in revenue, it is estimated that roughly 2 out of every 3 cannabis sale within the state of California are in the illegal market.5

 __________________

5 https://www. calmatters.org/commentary/2023/06/california-illicit-cannabis-market-thrive/

 

Intangible Property

 

We own over 100 website domains, including www.lowellfarms.com, and numerous social media accounts across all major platforms. We presently do not hold any federal or state trademark registrations.  Lowell Farms maintains strict standards and operating procedures regarding its intellectual property, including the regular use of nondisclosure, confidentiality, and intellectual property assignment agreements.

 

We have entered into a license agreement with Brandco for the “Lowell” trademarks, logos, and related intellectual property on an exclusive basis in the State of California for a five-year license term, with up to three five-year extensions. The Company’s exercise of the extension terms is subject to mutual agreement on certain sales performance criteria for each extension term.

 

Lowell Farms has developed numerous proprietary technologies and processes. These proprietary technologies and processes include its information system software, cultivation, edible manufacturing and extraction techniques, quality and compliance processes and new product development processes. While actively exploring the patentability of these techniques and processes, Lowell Farms relies on non-disclosure/confidentiality arrangements and trade secret protection. Lowell Farms has invested significant resources towards developing recognizable and unique brands consistent with premium companies in analogous industries.

 

 
8

Table of Contents

   

Employees

 

Lowell Farms employs personnel with a wide range of skill sets, including those with masters’ and bachelors’ degrees in their respective fields.

 

 With regard to extraction, Lowell Farms recruits individuals with extraction and distillation experience for its product lines, and personnel have the practical experience and knowledge necessary to process the raw, dried cannabis product through volatile and solventless extraction processes, thereby generating high yields of cannabis extracts and distillates. In addition, Lowell Farms personnel have the practical experience and knowledge necessary to conduct secondary processing of cannabis biomass into crude cannabis oil, distillate, and concentrates, including shatter, wax and crystals, and to utilize the natural terpenes in cannabis to formulate premium vaporizer oils. Terpenes are the oils that give cannabis plants their smell. They come from the same components as tetrahydrocannabinol (“THC”) and cannabidiol (“CBD”).

 

With regard to product development and manufacturing, Lowell Farms recruits individuals with professional culinary education for edibles product development for its edibles division, and personnel have extensive experience in confectionary product development and manufacturing, particularly with regard to cannabis edibles, including chocolates, candies, cookies, gummies, beverages and tinctures.

 

With regard to sales and distribution, we recruit employees who retain a high degree of industry awareness and knowledge who can interface with dispensaries state-wide and introduce our products with the intention of retaining and potentially increasing shelf-space and the intention of maintaining or increasing market volume and share. Our sales and distribution teams are important conduits for collecting intelligence on consumer behavior and trends. Our distribution capabilities are critical to building trust with dispensaries that they will receive inventory on a timely and consistent basis.

 

Lowell Farms currently possesses all specialized skills and knowledge it requires, but will continue to compete with other cannabis and manufacturing companies to secure and retain such staff.

 

As of March 19, 2024, we had 97 employees, including 96 full-time and 1 part-time employees, substantially all of whom are located in California. Additionally, Lowell Farms utilizes contract employees in security, packaging and warehousing activities, and during 2023 contract employees also worked in cultivation activities. The use of contract employees enables Lowell Farms to manage variable staffing needs and in the case of security personnel, access to experienced, qualified and readily available human resources.

 

In 2018, the manufacturing personnel of Lowell Farms were organized by UFCW Local 5. In 2020, prior to the completion of a collective bargaining agreement, the union workers voted to decertify UFCW Local 5. Under California law, the holder of a cannabis license with 20 or more employees must enter into a “labor peace agreement” with a union or provide a notarized statement to the Department of Cannabis Control that it will do so. A “labor peace agreement” is a private contract between an employer and a union that requires both parties to waive certain rights under federal labor law in connection with union organizing activities. Following the decertification of UFCW Local 5, Lowell Farms provided such a notarized statement to the Department of Cannabis Control. There has been no further union organizing activity of which the Company is aware involving its employees.

 

United States Regulatory Environment

 

Below is a discussion of the federal and state-level U.S. regulatory regimes in those jurisdictions where Lowell Farms is currently involved, directly or through its subsidiaries in the cannabis industry. Lowell Farms is directly engaged in the manufacturing, extraction, cultivation, packaging, sale or distribution of cannabis in the adult-use and/or medical industries in the State of California. The Company derives substantially all of its revenues from the cannabis industry in the State of California, which industry is illegal under U.S. federal law. Management believes the Company’s cannabis-related activities are compliant with applicable State and local law, and the related licensing framework, and the Company is not aware of any material non-compliance with applicable State and local law, and the related licensing framework, by any of the Company’s clients to whom the Company renders services. Nonetheless, such activities remain illegal under U.S. federal law. The enforcement of relevant laws is a significant risk.

 

 
9

Table of Contents

 

The Company evaluates, monitors and reassesses this disclosure, and any related risks, on an ongoing basis, and the same will be supplemented and amended to investors in public filings, including in the event of government policy changes or the introduction of new or amended guidance, laws or regulations regarding marijuana regulation. Any non-compliance, citations or notices of violation which may have an impact on the Company’s licenses, business activities or operations will be promptly disclosed by the Company.

 

United States Federal Overview

 

The United States federal government regulates drugs in large part through the CSA. Marijuana, which is a form of cannabis, is classified as a Schedule I controlled substance. As a Schedule I controlled substance, the federal Drug Enforcement Agency, or DEA, considers marijuana to have a high potential for abuse; no currently accepted medical use in treatment in the United States; and a lack of accepted safety for use of the drug under medical supervision. According to the U.S. federal government, cannabis having a concentration of tetrahydrocannabinol, or THC, greater than 0.3% on a dry weight basis is marijuana. Cannabis with a THC content below 0.3% is classified as hemp. The scheduling of marijuana as a Schedule I controlled substance is inconsistent with what we believe to be widely accepted medical uses for marijuana by physicians, researchers, patients, and others. Moreover, despite the clear conflict with U.S. federal law, currently 37 states, as well as the territories of Guam, the U.S. Virgin Islands, Puerto Rico and the District of Columbia have legalized cannabis in some form, and 24 states, as well as the District of Columbia and Guam, have legalized cannabis for adult or recreational use. As further evidence of the growing conflict between the U.S. federal treatment of cannabis and the societal acceptance of cannabis, the FDA on June 25, 2018 approved Epidiolex. Epidiolex is an oral solution with an active ingredient derived from the cannabis plant for the treatment of seizures associated with two rare and severe forms of epilepsy, Lennox-Gastaut syndrome and Dravet syndrome, as well as for the treatment of tuberous sclerosis complex. This was the first FDA-approved drug that contains a purified substance derived from the cannabis plant. In this case, the substance is cannabidiol, or CBD, a chemical component of marijuana that does not contain the psychoactive properties of THC.  However, within the federal government, particularly between the Department of Health and Human Services (HHS) and the Drug Enforcement Administration (DEA), there is considerable tension. HHS has recommended the reclassification of marijuana, suggesting that it does not pose the same level of abuse risk as other drugs in Schedule I and has some medical benefits. In contrast, the DEA has expressed concerns, emphasizing the need for more research into marijuana’s health effects and potential for abuse, especially given the increasing potency of modern cannabis strains.  In January, 2024, the DEA confirmed it was conducting its own review of marijuana as a Schedule I drug.

 

Unlike in Canada, which uniformly regulates the cultivation, distribution, sale and possession of marijuana at the federal level under the Cannabis Act (Canada), marijuana is largely regulated at the state level in the United States. State laws regulating marijuana are in conflict with the CSA, which makes marijuana use and possession federally illegal. Although certain states and territories of the United States authorize medical or adult-use marijuana production and distribution by licensed or registered entities, under United States federal law, the possession, use, cultivation, and transfer of marijuana and any related drug paraphernalia is illegal. Although our activities are compliant with the applicable state and local laws in California, strict compliance with state and local laws with respect to cannabis may neither absolve us of liability under United States federal law nor provide a defense to any federal criminal action that may be brought against us.

 

In 2013, as more and more states began to legalize medical and/or adult-use marijuana, the federal government attempted to provide clarity on the incongruity between federal law and these State-level regulatory frameworks. Until 2018, the federal government provided guidance to federal agencies and banking institutions through a series of Department of Justice, or DOJ, memoranda. The most notable of this guidance came in the form of a memorandum issued by former U.S. Deputy Attorney General James Cole on August 29, 2013, which we refer to as the Cole Memorandum.

 

 
10

Table of Contents

 

The Cole Memorandum offered guidance to federal agencies on how to prioritize civil enforcement, criminal investigations and prosecutions regarding marijuana in all states and quickly set a standard for marijuana-related businesses to comply with. The Cole Memorandum put forth 8 prosecution priorities:

 

1.

Preventing the distribution of marijuana to minors;

 

 

2.

Preventing revenue from the sale of marijuana from going to criminal enterprises, gang and cartels;

 

 

3.

Preventing the diversion of marijuana from states where it is legal under state law in some form to other states;

 

 

4.

Preventing the state-authorized marijuana activity from being used as a cover or pretext for the trafficking of other illegal drugs or other illegal activity;

 

 

5.

Preventing violence and the use of firearms in the cultivation and distribution of marijuana;

 

 

6.

Preventing drugged driving and the exacerbation of other adverse public health consequences associated with marijuana use;

 

 

7.

Preventing the growing of marijuana on public lands and the attendant public safety and environmental dangers posed by marijuana production on public lands; and

 

 

8.

Preventing marijuana possession or use on federal property.

 

On January 4, 2018, former United States Attorney General Jeff Sessions rescinded the Cole Memorandum by issuing a new memorandum to all United States Attorneys, which we refer to as the Sessions Memo. Rather than establishing national enforcement priorities particular to marijuana-related crimes in jurisdictions where certain marijuana activity was legal under State law, the Sessions Memo simply rescinded the Cole Memorandum and instructed that “[in] deciding which marijuana activities to prosecute... with the [DOJ’s] finite resources, prosecutors should follow the well-established principles that govern all federal prosecutions.” Namely, these include the seriousness of the offense, history of criminal activity, deterrent effect of prosecution, the interests of victims, and other principles.

 

Neither Attorney General William Barr, who succeeded Attorney General Sessions, nor any subsequent Acting Attorney General provided a clear policy directive for the United States as it pertains to State-legal marijuana-related activities. Merrick Garland currently serves as Attorney General and it is not yet known whether the Department of Justice will re-adopt the Cole Memorandum or announce a substantive marijuana enforcement policy. Mr. Garland indicated at a confirmation hearing before the United States Senate that it did not seem to him to be a good use of limited resources to pursue prosecutions in states that have legalized and that are regulating the use of marijuana, either medically or otherwise. In 2022, Attorney General Garland reiterated this position by stating “[w]ith respect to those jurisdictions where marijuana use and sales are lawfully regulated, there is even greater reason to conserve prosecutorial resources so that we can focus our attention on violent crimes and other crimes that cause societal harm and endanger our communities.” 

 

In October 2022, President Biden announced 3 policy initiatives addressing the cannabis industry. First, the President announced that the Federal government would pardon all prior Federal offenses of simple marijuana possession and directed the Attorney General to develop an administrative process for the issuance of these pardons. Second, the President urged all Governors to likewise issue pardons for all state offenses for simple marijuana possession. Third, the President directed the Attorney General and the Secretary of Health and Human Services to initiate an administrative review process of the current scheduling of marijuana under federal law.

 

Nonetheless, there is no guarantee that state laws legalizing and regulating the sale and use of marijuana will not be repealed or overturned, or that local governmental authorities will not limit the applicability of state laws within their respective jurisdictions. Unless and until the United States Congress amends the CSA with respect to marijuana (and as to the timing or scope of any such potential amendments there can be no assurance), there is a risk that federal authorities may enforce current U.S. federal law. Currently, in the absence of uniform federal guidance, as had been established by the Cole Memorandum, enforcement priorities are determined by respective United States Attorneys.

 

 
11

Table of Contents

 

As an industry best practice, despite the recent rescission of the Cole Memorandum, the Company abides by the following standard operating policies and procedures to ensure compliance with the guidance provided by the Cole Memorandum:

 

1.

ensure that its operations are compliant with all licensing requirements as established by the applicable state, county, municipality, town, township, borough, and other political/administrative divisions;

 

 

2.

ensure that its cannabis related activities adhere to the scope of the licensing obtained (for example: in the states where cannabis is permitted only for adult-use, the products are only sold to individuals who meet the requisite age requirements);

 

 

3.

implement policies and procedures to ensure that cannabis products are not distributed to minors;

 

 

4.

implement policies and procedures to ensure that funds are not distributed to criminal enterprises, gangs or cartels;

 

 

5.

implement an inventory tracking system and necessary procedures to ensure that such compliance system is effective in tracking inventory and preventing diversion of cannabis or cannabis products into those states where cannabis is not permitted by state law, or across any state lines in general;

 

 

6.

ensure that its state-authorized cannabis business activity is not used as a cover or pretense for trafficking of other illegal drugs, is engaged in any other illegal activity or any activities that are contrary to any applicable anti-money laundering statutes; and

 

 

7.

ensure that its products comply with applicable regulations and contain necessary disclaimers about the contents of the products to prevent adverse public health consequences from cannabis use and prevent impaired driving.

 

In addition, the Company conducts background checks to ensure that the principals and management of its operating subsidiaries are of good character, have not been involved with other illegal drugs, engaged in illegal activity or activities involving violence, or use of firearms in cultivation, manufacturing or distribution of cannabis. The Company will also conduct ongoing reviews of the activities of its cannabis businesses, the premises on which they operate and the policies and procedures that are related to possession of cannabis or cannabis products outside of the licensed premises, including the cases where such possession is permitted by regulation. See “Risk Factors”.

 

Significantly, companies authorized to operate in states with medical marijuana laws and robust regulatory schemes enjoy additional protection under the Rohrabacher-Blumenauer Amendment (it is also sometimes referred to as the “Rohrabacher-Farr” or “Joyce-Leahy” Amendment) (the “Amendment”). The Amendment was first approved in 2014 and prevents the U.S. Department of Justice from using federal funds to prosecute state-compliant medical marijuana operators in states that have legal (medical) cannabis programs.  Moreover, the Amendment has been included in the federal budget approved by Congress since its introduction. It should be noted; however, that the Amendment must be renewed each fiscal year in order to remain in effect.

 

United States Border Entry

 

The United States Customs and Border Protection (“CBP”) enforces the laws of the United States as they pertain to lawful travel and trade into and out of the U.S. Crossing the border while in violation of the CSA and other related United States federal laws may result in denied admission, seizures, fines, and apprehension. CBP officers determine the admissibility of travelers who are non-U.S. citizens into the United States pursuant to the United States Immigration and Nationality Act. An investment in our Subordinate Voting Shares, if it became known to CBP, could have an impact on a non-U.S. citizen’s admissibility into the United States and could lead to a lifetime ban on admission.

 

 
12

Table of Contents

 

Because marijuana remains illegal under United States federal law, those investing in Canadian companies with operations in the United States cannabis industry could face detention, denial of entry, or lifetime bans from the United States for their business associations with United States marijuana businesses. Entry happens at the sole discretion of CBP officers on duty, and these officers have wide latitude to ask questions to determine the admissibility of a non-US citizen or foreign national. The government of Canada has previously warned travelers that previous use of marijuana, or any substance prohibited by United States federal laws, could mean denial of entry to the United States. Business or financial involvement in the marijuana industry in the United States could also be reason enough for CBP to deny entry. On September 21, 2018, CBP released a statement outlining its current position with respect to enforcement of the laws of the United States. It stated that Canada’s legalization of cannabis will not change CBP enforcement of United States laws regarding controlled substances and because marijuana continues to be a controlled substance under United States law, working in or facilitating the proliferation of the legal marijuana industry in U.S. states where it is deemed legal may affect admissibility to the United States. As a result, CBP has affirmed that, employees, directors, officers, managers and investors of companies involved in business activities related to marijuana in the United States (such as Lowell Farms), who are not United States citizens, face the risk of being barred from entry into the United States.

 

Anti-Money Laundering Laws and Access to Banking

 

The Company is subject to a variety of laws and regulations in the United States that involve anti-money laundering, financial recordkeeping and the proceeds of crime, including the Currency and Foreign Transactions Reporting Act of 1970 (referred to herein as the “Bank Secrecy Act”), as amended by Title III of the Uniting and Strengthening America by Providing Appropriate Tools Required to Intercept and Obstruct Terrorism Act of 2001 (USA PATRIOT Act), and any related or similar rules, regulations or guidelines, issued, administered or enforced by governmental authorities in the United States.

 

Additionally, under United States federal law, it may potentially be a violation of federal anti-money laundering statutes for financial institutions to take any proceeds from the sale of any Schedule I controlled substance. Banks and other financial institutions could potentially be prosecuted and convicted of money laundering under the Bank Secrecy Act for providing services to cannabis businesses. Therefore, under the Bank Secrecy Act, banks or other financial institutions that provide a cannabis business with a checking account, debit or credit card, small business loan, or any other financial service could be charged with money laundering or conspiracy.

 

While there has been no change in U.S. federal banking laws to accommodate businesses in the large and increasing number of U.S. states that have legalized medical or adult-use marijuana, the Financial Crimes Enforcement Network within the U.S. Department of the Treasury (“FinCEN”), in 2014, issued guidance (the “FinCEN Guidance”) to prosecutors of money laundering and other financial crimes. The FinCEN Guidance advised prosecutors not to focus their enforcement efforts on banks and other financial institutions that serve marijuana-related businesses so long as that marijuana-related business activities are legal in their state and none of the federal enforcement priorities referenced in the Cole Memorandum are being violated (such as keeping marijuana out of the hands of organized crime). The FinCEN Guidance also clarifies how financial institutions can provide services to marijuana-related businesses consistent with their Bank Secrecy Act obligations, including thorough customer due diligence, but makes it clear that they are doing so at their own risk. The customer due diligence steps typically include:

 

1.

Verifying with the appropriate State authorities whether the business is duly licensed and registered;

 

 

2.

Reviewing the license application (and related documentation) submitted by the business for obtaining a State license to operate its marijuana-related business;

 

 

3.

Requesting available information about the business and related parties from State licensing and enforcement authorities;

 

 

4.

Developing an understanding of the normal and expected activity for the business, including the types of products to be sold and the type of customers to be served (e.g., medical versus adult-use customers);

 

 

5.

Ongoing monitoring of publicly available sources for adverse information about the business and related parties;

 

 

6.

Ongoing monitoring for suspicious activity, including for any of the red flags described in the FinCEN Guidance; and

 

 

7.

Refreshing information obtained as part of customer due diligence on a periodic basis and commensurate with the risk.

 

 
13

Table of Contents

 

With respect to information regarding State licensure obtained in connection with such customer due diligence, a financial institution may reasonably rely on the accuracy of information provided by state licensing authorities, where States make such information available.

 

While the FinCEN Guidance decreased some risk for banks and financial institutions considering servicing the cannabis industry, in practice it has not increased banks’ willingness to provide services to marijuana-related businesses. This is because current U.S. federal law does not guarantee banks immunity from prosecution, and it also requires banks and other financial institutions to undertake time-consuming and costly due diligence on each marijuana-related business they accept as a customer.

 

Those State-chartered banks and/or credit unions that have agreed to work with marijuana businesses are typically limiting those accounts to small percentages of their total deposits to avoid creating a liquidity risk. Since, theoretically, the federal government could change the banking laws as it relates to marijuana-related businesses at any time and without notice, these banks and credit unions must keep sufficient cash on hand to be able to return the full value of all deposits from marijuana-related businesses in a single day, while also keeping sufficient liquid capital on hand to service their other customers. Those State-chartered banks and credit unions that do have customers in the marijuana industry can charge marijuana businesses high fees to cover the added cost of ensuring compliance with the FinCEN Guidance.

 

As an industry best practice and consistent with its standard operating procedures, Lowell Farms adheres to all customer due diligence steps in the FinCEN Guidance and any additional requirements imposed by those financial institutions it utilizes. However, in the event that any of our operations, or any proceeds thereof, any dividends or distributions therefrom, or any profits or revenues accruing from such operations in the United States were found to be in violation of anti-money laundering legislation or otherwise, such transactions could be viewed as proceeds of crime under one or more of the statutes noted above or any other applicable legislation. This could restrict or otherwise jeopardize our ability to declare or pay dividends or effect other distributions.

 

In the United States, the “SAFE Banking Act” has been put forth which would grant banks and other financial institutions immunity from federal criminal prosecution for servicing marijuana-related businesses if the underlying marijuana business follows State law. The SAFE Banking Act has been adopted by the House of Representatives multiple times since its initial introduction. Furthermore, the House of Representatives has passed other pieces of legislation key to marijuana reforms, such as the Marijuana Opportunity Reinvestment and Expungement (MORE) Act. The MORE Act would remove marijuana from the CSA and eliminate criminal penalties for individuals who manufacture, distribute or possess marijuana. While there is strong support in the public and within Congress for legislation such as the Safe Banking Act and the MORE Act, there can be no assurance that any such legislation will be adopted by both the House of Representatives and Senate. In both Canada and the United States, transactions involving banks and other financial institutions are both difficult and unpredictable under the current legal and regulatory landscape. Legislative changes could help to reduce or eliminate these challenges for companies in the cannabis space and would improve the efficiency of both significant and minor financial transactions.

 

Tax Concerns

 

An additional challenge for marijuana-related businesses is that the provisions of Internal Revenue Code Section 280E are being applied by the Internal Revenue Services (“IRS”) to businesses operating in the medical and adult-use marijuana industry. Section 280E prohibits marijuana businesses from deducting their ordinary and necessary business expenses, forcing them to pay higher effective federal tax rates than similar companies in other industries. The effective tax rate on a marijuana business depends on how large its ratio of non-deductible expenses is to its total revenues. Therefore, businesses in the legal cannabis industry may be less profitable than they would otherwise be. Furthermore, although the IRS issued a clarification allowing the deduction of cost of goods sold, the scope of such eligible cost items is interpreted very narrowly, and the bulk of operating costs and general administrative costs are not permitted to be capitalized as part of inventory cost basis and deducted as part of cost of goods sold, or otherwise deducted from gross profit, in determining taxable income.

 

As noted above, the DEA has confirmed that it is reviewing the HHS recommendation to reschedule marijuana from its classification as a Schedule I drug to a Schedule III drug.  Such a change would favorably impact the taxability of marijuana businesses.

 

 
14

Table of Contents

 

The 2018 Farm Bill

 

CBD is a non-psychoactive chemical found in cannabis and is often derived from hemp, which contains, at most, only trace amounts of THC. On December 20, 2018, the Agriculture Improvement Act of 2018 (popularly known as the 2018 Farm Bill) was signed into law. Until the 2018 Farm Bill became law, hemp fell within the definition of “marijuana” under the CSA and the DEA classified hemp as a Schedule I controlled substance because hemp is part of the cannabis plant.

 

The 2018 Farm Bill defines hemp as the plant Cannabis sativa L. and any part of the plant with a delta-9 THC concentration of not more than 0.3% by dry weight and removes hemp from the CSA. The 2018 Farm Bill requires the U.S. Department of Agriculture, or USDA, to, among other things: (1) evaluate and approve regulatory plans approved by individual states for the cultivation and production of industrial hemp, and (2) promulgate regulations and guidelines to establish and administer a program for the cultivation and production of hemp in the U.S. The regulations promulgated by the USDA will be in lieu of those States not adopting State-specific hemp regulations. Hemp and products derived from it, such as CBD, may then be sold into commerce and transported across State lines provided that the hemp from which any product is derived was cultivated under a license issued by an authorized state program approved by the USDA and otherwise meets the definition of hemp. The 2018 Farm Bill also explicitly preserved the authority of the FDA to regulate hemp-derived products under the U.S. Food, Drug and Cosmetic Act. Many have expected that the FDA will promulgate its own rules for the regulation of hemp-derived products. The 2018 Farm Bill is slated to expire in 2023. It is widely accepted that Congress will re-certify the 2018 Farm Bill

 

State Level Overview and Compliance Summary

 

In the United States, cannabis is largely regulated at the State level. Although California authorizes medical and adult-use marijuana production and distribution by licensed entities, and numerous other states have legalized marijuana in some form, under U.S. federal law, the possession, use, cultivation, and transfer of marijuana and any related drug paraphernalia remains illegal, and any such acts are criminal acts under U.S. federal law. Although we believe that our business activities are compliant with applicable State and local laws, strict compliance with State and local laws with respect to marijuana may neither absolve us of liability under U.S. federal law, nor provide a defense to any federal proceeding which may be brought against us. Any such proceedings brought against us may result in a material adverse effect on our business.

 

California Regulatory Landscape

 

In 1996, California was the first State to legalize medical marijuana through Proposition 215, the Compassionate Use Act of 1996. This provided an affirmative defense for defendants charged with the use, possession and cultivation of medical marijuana by patients with a physician recommendation for treatment of cancer, anorexia, AIDS, chronic pain, spasticity, glaucoma, arthritis, migraine, or any other illness for which marijuana provides relief. In 2003, Senate Bill 420 was signed into law, decriminalizing the use, possession, and collective cultivation of medical marijuana, and establishing an optional identification card system for medical marijuana patients.

 

In September 2015, the California legislature passed three bills collectively known as the “Medical Marijuana Regulation and Safety Act,” or MCRSA. The MCRSA established a licensing and regulatory framework for medical marijuana businesses in California. The system created testing laboratories and distributors. Edible infused product manufacturers would require either volatile solvent or non-volatile solvent manufacturing licenses depending on their specific extraction methodology. Multiple agencies would oversee different aspects of the program and businesses would require a State license and local approval to operate. However, in November 2016, voters in California overwhelmingly passed Proposition 64, the “Adult Use of Marijuana Act,” or AUMA, creating an adult-use marijuana program for adult-use 21 years of age or older. In June 2017, the California State Legislature passed Senate Bill No. 94, known as Medicinal and Adult-Use Marijuana Regulation and Safety Act, or MAUCRSA, which amalgamated MCRSA and AUMA to provide a set of regulations to govern the medical and adult-use licensing regime for marijuana businesses in the State of California. MAUCRSA went into effect on January 1, 2018. In 2021, the three primary licensing agencies that regulated marijuana at the state level were the Bureau of Cannabis Control, or BCC, California Department of Food and Agriculture, or CDFA, and the California Department of Public Health, or CDPH.

 

On January 10, 2020, the three cannabis licensing agencies announced that California Governor Gavin Newsom’s budget proposal for cannabis industry regulation and taxation included plans to consolidate the three licensing entities into a single Department of Cannabis Control by July 2021. With the passage of AB 141 on July 12, 2021, the California Licensing Agencies were consolidated into the Department of Cannabis Control (“DCC”).  On September 8, 2021, the DCC announced proposed emergency regulations to move all cannabis regulations into Title 4 of the California Code of Regulations, with a stated goal of consolidating and improving the regulations. On November 7, 2022 the DCC adopted a new consolidated regulatory package that superseded the emergency regulations. The new package was aimed at streamlining and simplifying regulations for cannabis operators, licensees and consumers. The regulatory changes include changes to simplify the state licensing requirements as well as providing flexibility for cultivators and distributors.

 

 
15

Table of Contents

 

One of the central features of MAUCRSA is known as “local control.” In order to legally operate a medical or adult-use marijuana business in California, an operator must have both a local and State license. This requires license-holders to operate in cities or counties with marijuana licensing programs. Cities and counties in California are allowed to determine the number of licenses they will issue to marijuana operators, or, alternatively, can choose to ban marijuana licenses.

 

Licenses

 

Once an operator obtains local approval, the operator must obtain State licenses before conducting any commercial marijuana activity. There are multiple license categories that cover all commercial activity. Lowell Farms and its subsidiaries are licensed to operate Medical and Adult-Use Manufacturing, Processing and Distribution facilities under applicable California and local jurisdictional law. Lowell Farms’ licenses permit it to possess, process, manufacture and wholesale medical and adult-use cannabis and cannabis goods in the State of California pursuant to the terms of the various licenses issued by the Department of Cannabis Control. The licenses are independently issued for each approved activity for use at the Lowell Farms facilities in California.  Lowell Farms was licensed to operate Medical and Adult-Use Nursery and Cultivation facilities through January 12, 2024 when it surrendered possession of its Zabala Road cultivation facility.

  

The following licenses are held by the Company:

 

Agency

License

City/County

Type of License

DCC

C11-0000816-LIC

City of Salinas

Distributor Provisional (Salinas)

DCC

CDPH-10002196

City of Salinas

Manufacturing Type 7: Volatile Extraction

 

The following license is held by 20800 Spence Road LLC, a wholly owned subsidiary of Lowell SR LLC:

 

Agency

License

City/County

Type of License

DCC

CCL20-0002424

Monterey County

Processor

DCC

C11-0001881

Monterey County

Distributor

 

 
16

Table of Contents

 

In respect of the renewal process, provided that the requisite renewal fees are paid, the renewal application is submitted in a timely manner, and there are no material violations noted against the applicable license, Lowell Farms would expect to receive the applicable renewed license in the ordinary course of business. While Lowell Farms’ compliance controls have been developed to mitigate the risk of any material violations of a license arising, there is no assurance that Lowell Farms’ licenses will be renewed in the future in a timely manner. Any unexpected delays or costs associated with the licensing renewal process could impede the ongoing or planned operations of Lowell Farms and have a material adverse effect on Lowell Farms’ business, financial condition, results of operations or prospects.

 

California License and Regulations

 

The Adult-Use and Medicinal Cultivation licenses that have been granted to Lowell Farms up until surrendering its cultivation facility on January 12, 2024 permitted cannabis cultivation activity, which means any activity involving the planting, growing, harvesting, drying, curing, grading or trimming of cannabis. Such licenses further permit the production of a limited number of non-manufactured cannabis products and the sales of cannabis to certain licensed entities within the State of California for resale or manufacturing purposes.

  

Lowell Farms’ Adult-Use and Medicinal Manufacturing license permits Lowell Farms to extract concentrated cannabis, THC, CBD and other cannabis extracts from cannabis plants, then convert them to cannabis concentrates, edibles, balms, beverages, vapes and a variety of other consumer goods. Lowell Farms also packages and labels these goods, including processed flower (the smokable part of the cannabis plant) for wholesale delivery.

 

The Adult-Use and Medicinal Distribution licenses permit Lowell Farms to complete cannabis related distribution activity which means the procurement, sale, and transportation of cannabis and cannabis products between licensed entities. Distribution activity is permissible to and from certain Lowell Farms and non-Lowell Farms licensees.

 

The Adult-Use and Medicinal Processing license permit Lowell Farms to process cannabis, which means drying, curing, grading or trimming of cannabis. Such license further permit the production of a limited number of non-manufactured cannabis products and the sales of cannabis to certain licensed entities within the State of California for resale or manufacturing purposes. Processing activity is permissible to and from certain Lowell Farms and non-Lowell Farms licensees.

 

In the State of California, only cannabis that is grown in California can be sold in the state. Although California is not a vertically integrated system, Lowell Farms is vertically integrated and has the capabilities to cultivate, harvest, manufacture and wholesale cannabis and cannabis products to licensed retail dispensaries. Under manufacturing, distribution and cultivation licenses, the State of California also allows Lowell Farms to make a wholesale purchase of cannabis from, or a distribution of cannabis and cannabis product to, another licensed entity within the state.

 

California - Local Licensure, Zoning and Land Use Requirements

 

To obtain a State license, cannabis operators must first obtain local authorization, which is a prerequisite to obtaining State licensure. California’s DCC requires confirmation from the applicable locality that an applicant is in compliance with local requirements and has either been granted authorization to, upon State licensure, continue previous cannabis activities or commence cannabis operations. One of the basic aspects of obtaining local authorization is compliance with all local zoning and land use requirements. Local governments are permitted to prohibit or otherwise regulate the types and number of cannabis businesses allowed in their locality. Some localities have limited the number of authorizations an entity may hold in total or for various types of cannabis activity. Others have tiered the authorization process, granting the initial rounds of local authorization to applicants that previously conducted cannabis activity pursuant to the CUA or those that meet the locality’s definition of social equity.

 

California - Record-Keeping and Continuous Reporting Requirements

 

California’s State license application process additionally requires comprehensive criminal history, regulatory history and personal disclosures for all beneficial owners. Any criminal convictions or civil penalties or judgments occurring after licensure must promptly be reported to the regulatory agency from which the licensee holds a license. State licenses must be renewed annually. Disclosure requirements for local authorization may vary, but generally tend to mirror the State’s requirements.

 

 
17

Table of Contents

 

Licensees must also keep detailed records pertaining to various aspects of the business for up to 7 years. Such records must be easily accessible by the regulatory agency from which the licensee holds a license. Additionally, licensees must record all business transactions, which must be uploaded to METRC, the statewide traceability system. Lowell Farms is in compliance in all material respects with these record-keeping and disclosure requirements.

 

Storage and Security

 

To ensure the safety and security of cannabis business premises and to maintain adequate controls against the diversion, theft, and loss of cannabis or cannabis products, Lowell Farms is required to do the following:

 

o

maintain fully operational security alarm systems;

 

 

o

contract for state-certified security guard services;

 

 

o

maintain video surveillance systems that records continuously 24 hours a day and maintains those recordings for at least 90 days;

 

 

o

ensure that the facility’s outdoor premises have sufficient lighting;

 

 

o

store cannabis and cannabis product only in areas per the premises diagram submitted to the State of California during the licensing process;

 

 

o

store all cannabis and cannabis products in a secured, locked room or a vault;

 

 

o

report to local law enforcement within 24 hours after being notified or becoming aware of the theft, diversion, or loss of cannabis; and

 

 

o

ensure the safe transport of cannabis and cannabis products between licensed facilities, maintain a delivery manifest in any vehicle transporting cannabis and cannabis products. Only vehicles registered with the DCC, that meet DCC distribution requirements, are to be used to transport cannabis and cannabis products.

 

Marijuana Taxes in California

 

Several types of taxes are imposed in California for adult use sale.

 

California imposes an excise tax of 15% on all purchasers of cannabis or cannabis products at retail. Prior to January 1, 2023, as a licensed distributor, the Company was required to collect and remit excise tax. As of January 1, 2023, distributors are no longer responsible to collect or remit excise taxes as the responsibility shifted to the retailers. Cities and counties apply their sales tax along with the state’s excise and many cities and counties have also authorized the imposition of special cannabis business taxes which can range from 2% to 10% of gross receipts of the business.

 

The Company has retained legal counsel and other advisors in connection with California’s marijuana regulatory program. The Company has developed and maintains standard operating procedures for licenses that are operational.

 

California - Operating Procedure Requirements

 

License applicants must submit standard operating procedures describing how the operator will, among other requirements, secure the facility, manage inventory, comply with the State’s seed-to-sale tracking requirements, dispense cannabis, and handle waste, as applicable to the license sought. Once the standard operating procedures are determined compliant and approved by the applicable State regulatory agency, the licensee is required to abide by the processes described and seek regulatory agency approval before any changes to such procedures may be made. Licensees are additionally required to train their employees on compliant operations and are only permitted to transact with other legal and licensed businesses.

 

 
18

Table of Contents

 

Lowell Farms complies in all material respects with these operational and training requirements by systematically training employees in various aspects of regulatory requirements, ensuring that operational and business practices are aligned with regulatory requirements, and by conducting internal audits to ensure compliance and identify areas for further training.

 

California - Site-Visits & Inspections

 

As a condition of State licensure, operators must consent to random and unannounced inspections of the commercial cannabis facility as well as the facility’s books and records to monitor and enforce compliance with State law. Many localities have also enacted similar standards for inspections, and the State of California has already commenced site-visits and compliance inspections for operators who have received State temporary or annual licensure.

 

California - Compliance Procedures

 

Lowell Farms utilizes MAX ERP, an integrated enterprise compliance platform, which integrates Lowell Farms’ inventory management program and standard operating procedures with the software’s compliance and quality features to facilitate compliance with State and local requirements. MAX ERP features include a compliance software solution that offers lot and batch control, recall management, document control and quality analysis. Additionally, Lowell Farms utilizes standard operating procedure building tools to facilitate the implementation and maintenance of compliant operations and tracks all required licensing maintenance criteria.

 

 
19

Table of Contents

 

ITEM 1A. Risk Factors

 

Our business is subject to a number of risks and uncertainties, including those highlighted in the section titled “Item 1A. Risk Factors” in this Annual Report on Form 10-K. Some of these principal risks include the following:

 

Risks Related to Our Business and Industry

 

·

We have limited access to capital.

 

·

Dependency on California bulk market prices.

 

·

Cannabis continues to be a controlled substance under the Controlled Substance Act ("CSA") and is illegal under United States federal law.

 

·

Enforcement of U.S. Federal Law could damage the Company’s operations and financial position.

 

·

Federal and State Forfeiture Laws could result in seizure of our assets.

 

·

Future research may lead to findings that vaporizers, electronic cigarettes and related products are not safe for their intended use.

 

·

Anti-money laundering laws and regulations may limit access to traditional banking funds and services.

 

·

Restricted access to banking services could make operating our business and maintaining our finances difficult.

 

·

Heightened scrutiny by securities regulatory authorities in the United States and Canada may impact investors’ ability to transact in the Company’s securities.

 

·

Changes in State or federal political/or regulatory climate could impact the Company’s business.

 

·

Changes in environmental laws and regulations could impact the Company’s business.

 

·

Investors could be disqualified from ownership in the Company.

 

·

Significant licensure requirements and limitations in States where cannabis is legal could impact the Company’s ability to maintain its operations.

 

·

Reclassification of cannabis in the United States could adversely impact the Company’s business and growth strategy.

 

·

Service providers may suspend or withdraw services if an adverse change in cannabis regulation occurs.

 

·

Increasing legalization of cannabis and rapid growth and consolidation in the cannabis industry may further intensify competition.

 

·

The Company may encounter difficulties enforcing its contracts in Federal and some state courts.

 

·

The COVID-19 pandemic may adversely affect our business and financial condition.

 

·

Wildfire risks in certain areas of California could adversely impact the Company’s operations.

 

·

The Company’s business is subject to the risks inherent in agricultural operations.

 

·

The Company may be adversely impacted by rising or volatile energy costs.

 

·

We are dependent on key inputs, suppliers and skilled labor and fluctuations in the cost or availability of materials we use in our products and supply chain could negatively affect our results.

 

·

Our sales are difficult to forecast.

 

Risks Related to the Securities of the Company

 

·

Unpredictability caused by the Company’s capital structure could adversely impact the market for the Company’s securities.

 

·

Investors could be diluted by future financings.

 

·

The market for Subordinate Voting Shares may be illiquid and the market price of the Subordinate Voting Shares is volatile.

 

·

Future sales of Subordinate Voting Shares in the public market, or the perception that such sales may occur, could adversely affect the prevailing market price of the Subordinate Voting Shares.

 

·

Future sales of Subordinate Voting Shares in the public market, or the perception that such sales may occur, could adversely affect the prevailing market price of the Subordinate Voting Shares.

 

·

Loss of foreign private issuer status.

 

Risks Relating to Taxation

 

·

The Company is a tax resident of both the U.S. and Canada and is, therefore, generally subject to both U.S. and Canadian taxation, which may adversely affect its results of operations.

 

·

The Company is subject to audits by the IRS and the results of the audits may result in significant tax assessments related to prior year filings.

 

 
20

Table of Contents

 

Risks Related to Our Business and Industry

 

We Have Limited Access to Capital

 

The Company’s access to capital is and may continue to be extremely limited, as a consequence of the development stage nature of the Company’s business, the Company’s recent operating results, the Company’s business focus on the cultivation, processing and distribution of cannabis products in violation of the CSA, and the dynamics of the capital markets.  This inhibits the ability of the Company to fund operations and investments in growth initiatives. The Company’s financial results, financial condition, business and prospects are and may continue to be materially adversely affected by its limited access to capital. The Company’s inability to access capital required to operate and grow the Company’s business may result in the inability of the Company to meet its obligations to third parties, which in turn could lead to the insolvency of the Company. 

  

Dependency on California Bulk Market Prices

 

The Company derives a significant portion of its revenues and margin from the bulk sale of cannabis that it cultivates in the State of California and the Company’s business overall is substantially affected by the prices for bulk sales of cannabis in California.  In 2022 and 2023, the prices of bulk cannabis sales in California had deteriorated substantially and at times fell below the Company’s marginal cost of cultivating cannabis.  In January 2024 the Company surrendered possession of its cultivation facility. See Legal Proceedings.  The Company expects to periodically source and broker third party bulk cannabis. In the absence of raising external capital, a prolonged continuation of these market conditions may impede the Company’s ability to fund ongoing operations and to meet its financial obligations to third parties, which in turn could lead to the insolvency of the Company.

 

Cannabis Continues to be a Controlled Substance under the CSA and is Illegal Under United States federal law.

 

The Company is engaged directly in the medical and adult-use cannabis industry. Excluding brand licensing revenues, the Company derives all of its revenues from the State of California and conducts its activities in accordance with applicable state and local laws. Even though the Company’s cannabis-related activities are compliant with applicable state and local law, such activities remain illegal under U.S. federal law.

 

In the United States, cannabis is extensively regulated at the state level. The majority of states, as well as the District of Columbia and multiple U.S. territories have legalized medical cannabis in some form. Of these States, 21 States, including California, have legalized cannabis for adult use. Notwithstanding the permissive regulatory environment of cannabis at the state level, cannabis continues to be categorized as a Schedule I controlled substance under the CSA and as such, the cultivation, manufacture, distribution, sale and possession of cannabis violates federal law. Although the Company believes its business is compliant with applicable state and local law, strict compliance with state and local laws with respect to cannabis may not absolve the Company of liability under federal law, nor may it provide a defense to any federal proceeding which may be brought against the Company. Any such proceedings brought against the Company may result in a material adverse effect on the Company.

 

Since the cultivation, manufacture, distribution, sale and possession of cannabis is illegal under federal law, the Company may be deemed to be aiding and abetting illegal activities. Under these circumstances, U.S. law enforcement authorities, in their attempt to regulate the illegal use of cannabis, may seek to bring an action or actions against the Company, including, but not limited to, a claim regarding the possession and sale of cannabis, and/or aiding and abetting another’s criminal activities. The federal law provides that anyone who “commits an offense or aids, abets, counsels, commands, induces or procures its commission, is punishable as a principal.” As a result, the Department of Justice ("DOJ") could allege that Lowell Farms has “aided and abetted” violations of federal law by providing financing and services to its subsidiaries. Under these circumstances, a federal prosecutor could seek to seize the assets of the Company, and to recover any “illicit profits” previously distributed as of such time to shareholders resulting from any of the foregoing. In these circumstances, the Company’s operations would cease, shareholders could lose their entire investment and directors, officers and/or shareholders may be left to defend any criminal charges against them at their own expense and, if convicted, be sent to federal prison. Such potential criminal liability of our shareholders could arise solely by virtue of their activities as shareholders. Such an action would result in a material adverse effect on the Company.

 

 
21

Table of Contents

 

The CBP enforces the laws of the United States. Crossing the border while in violation of the CSA and other related federal laws may result in denied admission, seizures, fines and apprehension. CBP officers administer the Immigration and Nationality Act to determine the admissibility of travelers, who are non-U.S. citizens, into the United States. An investment in the Company, if it became known to CBP, could have an impact on a shareholder’s admissibility into the United States and could lead to a lifetime ban on admission.

 

Enforcement of U.S. Federal Law Could Damage the Company’s Operations and Financial Position.

 

Since 2014, the United States Congress has passed appropriations bills that have included the Rohrabacher-Blumenauer Amendment. For now, the Rohrabacher-Blumenauer Amendment, as discussed above, is the only statutory restraint on enforcement of federal cannabis laws. Courts in the U.S. have construed these appropriations bills to prevent the federal government from prosecuting individuals or businesses when those individuals or businesses operate in strict compliance with state and local medical cannabis regulations; however, this legislation only covers medical cannabis, not adult-use cannabis, and has historically been passed as an amendment to omnibus appropriations bills, which by  their nature expire at the end of a fiscal year or other defined term.

 

The Rohrabacher-Blumenauer Amendment may or may not be included in future omnibus appropriations packages or continuing budget resolutions, and its inclusion or non-inclusion, as applicable, is subject to political changes. Because this conduct continues to violate federal law, U.S. courts have observed that should the Congress at any time choose to appropriate funds to fully prosecute the CSA, any individual or business - even those that have fully complied with State law - could be prosecuted for violations of federal law and if the Congress restores such funding, the federal government will have the authority to prosecute individuals and businesses for violations of the law while it lacked funding, to the extent of the CSA’s five-year statute of limitations applicable to non-capital CSA violations. The Company may be irreparably harmed by any change in enforcement policies by the federal or applicable state governments, which could have a material adverse effect on the Company’s business, revenues, operating results and financial condition as well as the Company’s reputation.

 

Violations of any federal laws and regulations could result in significant fines, penalties, administrative sanctions, convictions or settlements arising from civil proceedings conducted by either the federal government or private citizens, or criminal charges, including, but not limited to, disgorgement of profits, cessation of business activities or divestiture. This could have a material adverse effect on the Company, including its reputation and ability to conduct business, its holding (directly or indirectly) of cannabis licenses in California, the listing of its securities on any stock exchange, its financial position, operating results, profitability or liquidity or the market price of its shares. In addition, it will be difficult for the Company to estimate the time or resources that would be needed in connection with the investigation of any such matters or its final resolution because, in part, the time and resources that may be needed are dependent on the nature and extent of any information requested by the applicable authorities involved, and such time or resources could be substantial.

 

As a result of the conflicting views between states and the federal government regarding cannabis, investments in cannabis businesses in the U.S. are subject to inconsistent legislation and regulation. The response to this inconsistency was addressed in the Cole Memorandum, acknowledging that notwithstanding the designation of cannabis as a controlled substance at the federal level in the United States, several U.S. states had enacted laws relating to cannabis for medical purposes. The Cole Memorandum outlined certain enforcement priorities for the DOJ relating to the prosecution of cannabis offenses. In particular, the Cole Memorandum noted that in jurisdictions that have enacted laws legalizing cannabis in some form and that have also implemented strong and effective regulatory and enforcement systems to control the cultivation, manufacturing, distribution, sale and possession of cannabis, conduct in compliance with those laws and regulations is less likely to be a priority at the federal level. Notably, however, the DOJ did not provide specific guidelines for what regulatory and enforcement systems it deemed sufficient under the Cole Memorandum standard.

 

In light of limited investigative and prosecutorial resources, the Cole Memorandum concluded that the DOJ should be focused on addressing only the most significant threats. States where cannabis had been legalized were not characterized as a high priority. In March 2017, the then newly appointed Attorney General Jeff Sessions again noted limited federal resources and acknowledged that much of the Cole Memorandum had merit; however, he disagreed that it had been implemented effectively. Accordingly, on January 4, 2018, Attorney General Sessions issued the Sessions Memorandum, which rescinded the Cole Memorandum on the basis that the direction provided therein was unnecessary, given the well-established principles governing federal prosecution that are already in place. Those principals are included in chapter 9-27-000 of the United States Attorneys’ Manual and require federal prosecutors deciding which cases to prosecute to weigh all relevant considerations, including federal law enforcement priorities set by the Attorney General, the seriousness of the crime, the deterrent effect of criminal prosecution and the cumulative impact of particular crimes on the community. Due to the ambiguity of the Sessions Memorandum and the lack of clarity provided by the DOJ since then, there can be no assurance that the federal government will not seek to prosecute cases involving cannabis businesses that are otherwise compliant with State law.

 

 
22

Table of Contents

 

The effect of the rescission of the Cole Memorandum remains to be seen. Currently, federal prosecutors are free to utilize their prosecutorial discretion to decide whether to prosecute cannabis activities despite the existence of state-level laws that may be inconsistent with federal prohibitions. No direction was given to federal prosecutors in the Sessions Memorandum as to the priority they should ascribe to such cannabis activities, and resultantly it is uncertain how active federal prosecutors will be in relation to such activities. While some U.S. Attorneys expressed support for the rescission of the Cole Memorandum, numerous government officials, legislators and federal prosecutors in states with medical and adult-use cannabis statutes announced their intention to continue the Cole Memorandum-era status quo.

 

The impact that this lack of uniformity between state and federal authorities could have on individual state cannabis markets and the businesses that operate within them is unclear, and the enforcement of relevant federal laws is a significant risk. Potential federal prosecutions could involve significant restrictions being imposed upon the Company or third parties, while diverting the attention of key executives. Such proceedings could have a material adverse effect on the Company’s business, revenues, operating results and financial condition, as well as the Company’s reputation and prospects, even if such proceedings were concluded successfully in favor of the Company. Such proceedings could involve the prosecution of key executives of the Company or the seizure of corporate assets.

 

With each new administration at the U.S. federal level, it is possible that additional changes (whether positive or negative) could occur. There can be no assurance as to the position any new administration may take on marijuana and a new administration could decide to take a stronger approach to the enforcement of federal laws. Any enforcement of current federal laws could cause significant damage to the Company’s operations and financial position. Further, future presidential administrations may want to treat marijuana differently and potentially enforce the federal laws more aggressively.

 

Federal and State Forfeiture Laws Could Result in Seizure of our Assets.

 

As an entity that conducts business in the cannabis industry, the Company is subject to U. S. federal and state forfeiture laws (criminal and civil) that permit the government to seize the proceeds of criminal activity. Civil forfeiture laws could provide an alternative for the federal government or any state (or local police force) that wants to discourage residents from conducting transactions with cannabis related businesses but believes criminal liability is too difficult to prosecute. Also, an individual can be required to forfeit property considered to be the proceeds of a crime even if the individual is not convicted of the crime, and the standard of proof in a civil forfeiture matter is lower than the standard in a criminal matter. Shareholders of the Company located in jurisdictions where cannabis remains illegal may be at risk of prosecution under federal and/or state conspiracy, aiding and abetting, and money laundering statutes, and be at further risk of losing their investments or proceeds under forfeiture statutes. Many states remain fully able to take action to prevent the proceeds of cannabis businesses from entering their state. Because state legalization is relatively new, it remains to be seen whether these states would take such action and whether a court would approve it. Current and prospective securityholders of the Company or any entity related thereto should be aware of these potentially relevant federal and state laws in considering whether to remain invested or invest in the Company or any entity related thereto.

 

 
23

Table of Contents

 

Future Research may Lead to Findings that Vaporizers, Electronic Cigarettes and Related Products are not Safe for Their Intended Use.

 

Vaporizers, electronic cigarettes and related products were recently developed and therefore the scientific or medical communities have had a limited period of time to study the long-term health effects of their use. Currently, there is limited scientific or medical data on the safety of such products for their intended use and the medical community is still studying the health effects of the use of such products, including the long-term health effects. If the scientific or medical community were to determine conclusively that use of any or all of these products pose long-term health risks, market demand for these products and their use could materially decline. Such a determination could also lead to litigation, reputational harm and significant regulation. Loss of demand for our product, product liability claims and increased regulation stemming from unfavorable scientific studies on cannabis vaporizer products could have a material adverse effect on our business, results of operations and financial condition.

 

Anti-Money Laundering Laws and Regulations May Limit Access to Traditional Banking Funds and Services.

 

The Company is subject to a variety of laws and regulations in the U.S. and Canada that involve money laundering, financial recordkeeping and proceeds of crime, including the Bank Secrecy Act, as amended by Title III of the Uniting and Strengthening America by Providing Appropriate Tools Required to Intercept and Obstruct Terrorism Act of 2001 (USA PATRIOT Act), the U.S. Anti-Money Laundering Laws, 18 U.S.C. §§ 1956, 1957, the Proceeds of Crime (Money Laundering) and Terrorist Financing Act (Canada), as amended and the rules and regulations promulgated thereunder, the Criminal Code (Canada) and any related or similar rules, regulations or guidelines, issued, administered or enforced by governmental authorities in the U.S. and Canada. Further, under federal law, banks or other financial institutions often refuse to provide a checking account, debit or credit card, small business loan, or any banking services that could be found guilty of money-laundering, aiding and abetting or conspiracy to businesses involved in the cannabis industry due to the present state of the laws and regulations governing financial institutions in the U.S. The lack of banking and financial services presents unique and significant challenges to businesses in the U.S. cannabis industry. While Lowell Farms has maintained bank accounts, the loss of such accounts and the potential lack of a secure place in which to deposit and store cash, the inability to pay creditors through the issuance of checks and the inability to secure traditional forms of operational financing, such as lines of credit, are some of the many challenges presented to U.S. cannabis companies, and which could conceivably impact the Company, by the unavailability of traditional banking and financial services.

 

Despite these laws, FinCEN issued the FinCEN Guidance in 2014, which as described above, outlines the pathways for financial institutions to bank state sanctioned cannabis businesses in compliance with federal enforcement priorities. The FinCEN Guidance echoed the enforcement priorities of the Cole Memorandum. Under these guidelines, financial institutions must submit a Suspicious Activity Report (“SAR”) in connection with all cannabis-related banking activities by any client of such financial institution, in accordance with federal money laundering laws. These cannabis-related SARs are divided into three categories - cannabis limited, cannabis priority, and cannabis terminated - based on the financial institution’s belief that the business in question follows state law, is operating outside of compliance with state law, or where the banking relationship has been terminated, respectively.

 

The FinCEN Guidance states that in some circumstances, it is permissible for banks to provide services to cannabis-related businesses without risking prosecution for violation of federal money laundering laws. It refers to supplementary guidance included in the Cole Memorandum. The revocation of the Cole Memorandum has not yet affected the status of the FinCEN Guidance, nor has the United States Department of the Treasury given any indication that it intends to rescind the FinCEN Guidance itself. Although the FinCEN Guidance remains intact, it is unclear whether the current administration or future administrations will continue to follow the guidelines of the FinCEN Guidance. The DOJ continues to have the right and power to prosecute crimes committed by banks and financial institutions, such as money laundering and violations of the Bank Secrecy Act, that occur in any state including states that have in some form legalized the sale of cannabis. Further, the conduct of the DOJ’s enforcement priorities could change for any number of reasons. A change in the DOJ’s priorities could result in the DOJ’s prosecuting banks and financial institutions for crimes that were not previously prosecuted.

 

 
24

Table of Contents

 

In the event that any of the Company’s operations, or any proceeds thereof, any dividends or distributions therefrom, or any profits or revenues accruing from such operations in the United States were found to be in violation of money laundering legislation or otherwise, such transactions may be viewed as proceeds of a crime under one or more of the statutes noted above or any other applicable legislation. Apart from the consequences of any prosecution in connection with such violation, among other things, this could restrict or otherwise jeopardize the Company’s ability to declare or pay dividends, effect other distributions or subsequently repatriate such funds back to Canada.

 

Restricted Access to Banking Services Could Make Operating our Business and Maintaining our Finances Difficult.

 

The FinCEN Guidance, as further described above, remains effective to this day, in spite of the fact that the Cole Memorandum was rescinded and replaced by the Sessions Memorandum. The FinCEN Guidance does not provide any safe harbors or legal defenses from examination or regulatory or criminal enforcement actions by the DOJ, FinCEN or other federal regulators, though. Thus, most banks and other financial institutions in the U.S. do not appear to be comfortable providing banking services to cannabis-related businesses, or relying on this guidance, which can be amended or revoked at any time by the current or future federal administrations. In addition to the foregoing, banks may refuse to process debit card payments and credit card companies generally refuse to process credit card payments for cannabis-related businesses. As a result, the Company may have limited or no access to banking or other financial services in the U.S. The inability or limitation in the Company’s ability to open or maintain bank accounts, obtain other banking services and/or accept credit card and debit card payments may make it difficult for the Company to operate and conduct its business as planned or to operate efficiently.

 

Heightened Scrutiny by Securities Regulatory Authorities in the United States and Canada May Impact Investors’ Ability to Transact in the Company’s Securities.

 

The Company’s existing operations in the United States, and any future operations or investments, may become the subject of heightened scrutiny by regulators, stock exchanges and other authorities in the United States and/or Canada. As a result, the Company may be subject to significant direct and indirect interaction with public officials. It is impossible to determine the extent of the impact of any new laws, regulations or initiatives that may be proposed, or whether any proposals will become law or otherwise be adopted, and there can be no assurance that heightened scrutiny will not in turn lead to the imposition of certain restrictions on the Company’s ability to operate or invest in the United States or any other jurisdiction, in addition to those described herein.

 

The Company’s operations in the United States cannabis market may become the subject of heightened scrutiny by regulators, stock exchanges, clearing agencies and other authorities in Canada. It has been reported by certain publications in Canada that the Canadian Depository for Securities Limited is considering a policy shift that would see its subsidiary, CDS Clearing and Depository Services Inc. (“CDS”), refuse to settle trades for cannabis issuers that have investments in the United States. CDS is Canada’s central securities depository, clearing and settlement hub settling trades in the Canadian equity, fixed income and money markets. CDS or its parent company has not issued any public statement with regard to these reports. On February 8, 2018, following discussions with the Canadian Securities Administrators and recognized Canadian securities exchanges, CDS signed the CDS Memorandum of Understanding (“MOU”) with The Aequitas NEO Exchange Inc., the CSE, the Toronto Stock Exchange, and the TSX Venture Exchange. The MOU outlines the parties’ understanding of Canada’s regulatory framework applicable to the rules and procedures and regulatory oversight of the exchanges and CDS as it relates to issuers with cannabis-related activities in the United States. The MOU confirms, with respect to the clearing of listed securities, that CDS relies on the exchanges to review the conduct of listed issuers. As a result, there currently is no CDS ban on the clearing of securities of issuers with cannabis -related activities in the United States. However, if CDS were to proceed in the manner suggested by these publications, and apply such a ban on the clearing of securities of the Company, it would have a material adverse effect on the ability of the Company’s shareholders to effect trades of shares through the facilities of a stock exchange in Canada, as a result of which such shares could become highly illiquid.

 

 
25

Table of Contents

 

The Depositary Trust Company (“DTC”) is the primary depository for securities in the United States. Several major U.S. securities clearing companies that provide clearance, custody and settlement services in the United States terminated providing clearance services to issuers in the cannabis industry, including those that operate entirely outside the United States, in response to the Sessions Memo. As a result of these decisions, U.S. securityholders may experience difficulties depositing securities of cannabis companies in the DTC system or reselling their securities in open market transactions, including transactions facilitated through the CSE. Many larger U.S. broker-dealers own U.S. securities companies that self-clear transactions. However, some U.S. brokerages have adopted policies precluding their clients from trading securities of cannabis issuers.

 

Changes in State or Federal Political/or Regulatory Climate Could Impact the Company’s Business.

 

The success of the Company’s business strategy depends on the legality of the cannabis industry in the states in which the Company operates, and the lack of federal enforcement of its laws that make cannabis businesses illegal. The political environment surrounding the cannabis industry in general can be volatile and the statutory and regulatory framework remains in flux. Despite widespread state legalization, the risk remains that a shift in the regulatory or political realm could occur and have a drastic impact on the industry as a whole, adversely impacting the Company’s business, results of operations, financial condition or prospects.

 

Delays in enactment of or changes in new state regulations, or changes in federal laws or enforcement priorities, could restrict the Company’s ability to reach strategic growth targets and lower return on investor capital. The strategic growth strategy of the Company will be reliant upon state regulations being implemented to facilitate the operation of medical and adult-use cannabis in California. If such regulations are not timely implemented, or are subsequently repealed or amended, or contain prolonged or problematic phase-in or transition periods or provisions, the Company’s ability to achieve its growth targets, and thus, the return on investor capital, could be adversely affected. The Company is unable to predict with certainty when and how the outcome of these complex regulatory and legislative proceedings will affect its business and growth.

 

Further, there is no guarantee that state laws legalizing and regulating the sale and use of cannabis will not be repealed or overturned, or that local governmental authorities will not limit the applicability of state laws within their respective jurisdictions. If the federal government begins to enforce federal laws relating to cannabis in states where the sale and use of cannabis is currently legal, or if existing applicable state laws are repealed or curtailed, the Company’s business, results of operations, financial condition and prospects would be materially adversely affected. It is also important to note that local and city ordinances may strictly limit and/or restrict cannabis businesses in a manner that will make it extremely difficult or impossible to transact business that is necessary for the continued operation of the cannabis industry, including the Company. Federal actions against individuals or entities engaged in the cannabis industry or a repeal of applicable cannabis related legislation could adversely affect the Company and its business, results of operations, financial condition and prospects.

 

The medical and adult-use cannabis industries are in their infancy and the Company anticipates that the current California regulations will be subject to change as California’s regulation of the cannabis industry matures. The Company’s compliance program emphasizes security and inventory control to ensure strict monitoring of cannabis and other inventory from cultivation to sale or disposal. Additionally, Lowell Farms has created standard operating procedures that include descriptions and instructions for monitoring inventory at all stages of cultivation, processing, manufacturing, distribution, transportation and delivery. The Company will continue to monitor compliance on an ongoing basis in accordance with its compliance program, standard operating procedures, and any changes to applicable regulation.

 

Overall, the medical and adult-use cannabis industry is subject to significant regulatory change at each of the local, state and federal level. The inability of the Company to respond to the changing regulatory landscape may cause it to be unsuccessful in capturing significant market share and could otherwise harm its business, results of operations, financial condition or prospects.

 

Changes in Environmental Laws and Regulations Could Impact the Company’s Business

 

We do not know of any existing environmental law, regulation nor condition that reasonably would be expected to have a material adverse effect on our business, capital expenditures, or operating results. However, future changes to environmental laws or regulations may impact our operations and could result in increased costs.

 

 
26

Table of Contents

 

Investors Could Be Disqualified from Ownership in the Company.

 

The Company’s business is in a highly regulated industry in which many states have enacted extensive rules for ownership of a participant company. Investors in the Company could become disqualified from having an ownership stake in the Company under relevant laws and regulations of applicable state and/or local regulators, if the applicable owner is convicted of a certain type of felony or fails to meet the requirements for owning equity in a company in our industry.

 

Negative Public Opinion and Perception of the Cannabis Industry Could Adversely Impact Our Ability to Operate and Our Growth Strategy.

 

Government policy changes or public opinion may result in a significant influence over the regulation of the cannabis industry in Canada, the United States or elsewhere. The Company believes the medical and adult-use cannabis industry is highly dependent on consumer perception regarding the safety and efficacy of such cannabis. Consumer perceptions regarding legality, morality, consumption, safety, efficacy and quality of cannabis are mixed and evolving. Public opinion and support for medical and adult-use cannabis has traditionally been inconsistent and varied from jurisdiction to jurisdiction. While public opinion and support appears to be rising for legalizing medical and adult-use cannabis, it remains a controversial issue subject to differing opinions surrounding the level of legalization (for example, medical cannabis as opposed to legalization in general). A negative shift in the public’s perception of cannabis in the United States or any other applicable jurisdiction could affect future legislation or regulation. Among other things, such a shift could cause state jurisdictions to abandon initiatives or proposals to legalize medical and/or adult-use cannabis, or could result in adverse regulatory changes in California, thereby limiting the Company’s growth prospects and number of new state jurisdictions into which the Company could expand. Any inability to fully implement the Company’s expansion strategy may have a material adverse effect on its business, results of operations or prospects.

 

Significant Licensure Requirements and Limitations in States Where Cannabis is Legal Could Impact the Company’s Ability to Maintain its Operations.

 

The Company’s business is subject to a variety of laws, regulations and guidelines relating to the cultivation, manufacture, management, transportation, extraction, storage and disposal of cannabis, including laws and regulations relating to health and safety, the conduct of operations and the protection of the environment. Achievement of the Company’s business objectives are contingent, in part, upon compliance with applicable regulatory requirements and obtaining all requisite regulatory approvals. Changes to such laws, regulations and guidelines due to matters beyond the control of the Company may cause adverse effects to the Company.

 

The Company will be required to obtain or renew government permits and licenses for its current and contemplated operations. Obtaining, amending or renewing the necessary governmental permits and licenses can be a time-consuming process involving numerous regulatory agencies, involving public hearings and costly undertakings on the Company’s part. The duration and success of the Company’s efforts to obtain, amend and renew permits and licenses will be contingent upon many variables not within its control, including the interpretation of applicable requirements implemented by the relevant permitting or licensing authority. The Company may not be able to obtain, amend or renew permits or licenses that are necessary to its operations. Any unexpected delays or costs associated with the permitting and licensing process could impede the ongoing or proposed operations of the Company. To the extent permits or licenses are not obtained, amended or renewed, or are subsequently suspended or revoked, the Company may be curtailed or prohibited from proceeding with its ongoing operations or planned renovation, development and commercialization activities. Such curtailment or prohibition may result in a material adverse effect on the Company’s business, financial condition, results of operations or prospects. California state licenses, and some local licenses, are renewed annually. Each year, licensees are required to submit a renewal application per guidelines published by the Department of Cannabis Control (for state licenses) or the applicable local regulatory body (for local licenses). 

 

 
27

Table of Contents

 

Under MAUCRSA, after January 1, 2018, only license holders are permitted to engage in commercial cannabis activities. A prerequisite to obtaining a California state license is obtaining a valid license, permit or authorization from a local municipality. The process associated with acquiring a permanent state license is onerous and there are no assurances that the Company, or any subsidiary or entity to which the Company will provide or intends to provide services, will be granted any licenses or any renewals thereof. Because there are different licenses for different types of commercial cannabis activities, even if the Company, any subsidiary and/or any such entity to which the Company will provide services or intends to provide services is granted one or more licenses, there are no assurances that they will be granted all of the licenses they will need to effectuate the Company’s business plan. Further, as part of the permitting and licensing process in California, state and local officials may conduct both random and scheduled inspections of cannabis operations. The Company is required to comply with both state laws and regulations and applicable local ordinances and codes. Compliance with both state and local laws may be burdensome and failure to do so could result in the loss of licenses, civil penalties and possibly criminal prosecution. While the compliance controls of Lowell Farms have been developed to mitigate the risk of any material violations of any license it holds arising, there is no assurance that the Company’s licenses will be renewed by each applicable regulatory authority in the future in a timely manner. Any unexpected delays or costs associated with the licensing renewal process for any of the licenses held or to be held by the Company could impede the ongoing or planned operations of the Company and have a material adverse effect on the Company’s business, financial condition, results of operations or prospects.

 

The Company may become involved in a number of government or agency proceedings, investigations and audits. The outcome of any regulatory or agency proceedings, investigations, audits, and other contingencies could harm the Company’s reputation, require the Company to take, or refrain from taking, actions that could harm its operations or require the Company to pay substantial amounts of money, harming its financial condition. There can be no assurance that any pending or future regulatory or agency proceedings, investigations and audits will not result in substantial costs or a diversion of management’s attention and resources or have a material adverse impact on the Company’s business, financial condition, results of operations or prospects.

 

Reclassification of Cannabis in the United States Could Adversely Impact the Company’s Business and Growth Strategy.

 

If marijuana is re-categorized as a Schedule II or other controlled substance, and the resulting re-classification would result in the requirement for FDA approval if medical claims are made for the Company’s products such as medical cannabis, then as a result, such products may be subject to a significant degree of regulation by the FDA and United States Drug Enforcement Administration (“DEA”). In that case, the Company may be required to be registered (licensed) to perform these activities and have the security, control, recordkeeping, reporting and inventory mechanisms required by the DEA to prevent drug loss and diversion. Obtaining the necessary registrations may result in delay of the cultivation, manufacturing or distribution of the Company’s anticipated products. The DEA conducts periodic inspections of certain registered establishments that handle controlled substances. Failure to maintain compliance could have a material adverse effect on the Company’s business, financial condition and results of operations. The DEA may seek civil penalties, refuse to renew necessary registrations, or initiate proceedings to restrict, suspend or revoke those registrations. In certain circumstances, violations could lead to criminal proceedings. Furthermore, if the FDA, DEA, or any other regulatory authority determines that the Company’s products may have potential for abuse, it may require the Company to generate more clinical or other data than the Company currently anticipates in order to establish whether or to what extent the substance has an abuse potential, which could increase the cost and/or delay the launch of that product.

 

Service Providers May Suspend or Withdraw Services if an Adverse Change in Cannabis Regulation Occurs.

 

As a result of any adverse change to the approach in enforcement of United States cannabis laws, adverse regulatory or political change, additional scrutiny by regulatory authorities, adverse change in public perception in respect of the consumption of marijuana or otherwise, third party service providers to the Company could suspend or withdraw their services, which may have a material adverse effect on the Company’s business, revenues, operating results, financial condition or prospects.

 

 
28

Table of Contents

 

Increasing Legalization of Cannabis and Rapid Growth and Consolidation in the Cannabis Industry may Further Intensify Competition.

 

The cannabis industry is undergoing rapid growth and substantial change, and the legal landscape for medical and recreational cannabis is rapidly changing internationally. An increasing number of jurisdictions globally are passing legislation allowing for the production and distribution of medical and/or recreational cannabis in some form or another. Entry into the cannabis market by international competitors might lower the demand for our products.

 

The foregoing legalization and growth trends in the cannabis industry has resulted in an increase in competitors, consolidation and formation of strategic relationships. Such acquisitions or other consolidating transactions could harm us in a number of ways, including by losing strategic partners if they are acquired by or enter into relationships with a competitor, losing customers, revenue and market share, or forcing us to expend greater resources to meet new or additional competitive threats, all of which could harm our operating results. As competitors enter the market and become increasingly sophisticated, competition in the cannabis industry may intensify and place downward pressure on retail prices for products and services, which could have a material adverse effect on the Company’s business, revenues, operating results, financial condition or prospects operations.

 

The Company May Encounter Difficulties Enforcing its Contracts in Federal and Some State Courts.

 

Due to the nature of the Company’s business and the fact that its contracts involve cannabis and other activities that are not legal under federal law, the Company may face difficulties in enforcing its contracts in federal and certain state courts. The inability to enforce any of the Company’s contracts could have a material adverse effect on the Company’s business, operating results, financial condition or prospects. California enacted a law that provides that notwithstanding any other law, commercial activity relating to medicinal cannabis or adult-use cannabis conducted in compliance with California law and any applicable local standards, requirements, and regulations shall be deemed to be all of the following: (1) a lawful object of a contract, (2) not contrary to, an express provision of law, any policy of express law, or good morals, and (3) not against public policy.

 

The Company’s articles provide that the Supreme Court of the Province of British Columbia, Canada and the appellate Courts therefrom are the sole and exclusive forum for any derivative action brought on behalf of the Company, which may limit our investors’ flexibility in selecting a forum for any future disputes.

 

However, the Company’s articles do not limit the ability of investors to bring direct actions outside of British Columbia, Canada, including those arising under the Securities Exchange Act of 1934, as amended (the “Exchange Act”) and the Securities Act of 1933, as amended (the “Securities Act”). Section 27 of the Securities Act creates exclusive federal jurisdiction over actions brought to enforce any duty or liability created by the Exchange Act or the rules and regulations thereunder, and Section 22 of the Securities Act creates concurrent jurisdiction for federal and state courts over all suits brought to enforce any duty or liability created by the Securities Act or the rules and regulations thereunder. Neither investors nor the Company may waive compliance with the federal securities laws and the rules and regulations thereunder, and it is therefore uncertain whether the exclusive forum provision of our charter would be enforced by a court as to derivative claims brought under the Exchange Act or the Securities Act. Furthermore, the exclusive forum provision of the Company’s articles may increase the costs to investors in bringing claims, may discourage investors from bringing claims and may limit investors’ ability to bring claims in a judicial forum that they find favorable.

 

 
29

Table of Contents

 

The COVID-19 Pandemic May Adversely Affect Our Business and Financial Condition.

 

The COVID-19 pandemic has adversely impacted commercial and economic activity and contributed to significant volatility in the equity and debt markets in the U.S. and Canada. The pandemic created significant disruption in supply chains and economic conditions. The Company has continuously sought to assess the potential impact of the pandemic on its financial condition and operating results, and any assessment is subject to extreme uncertainty as to probability, severity and duration of the pandemic. Continued spread of the virus globally could result in additional economic downturns and the effects of which could last for some period and our business, financial condition, results of operations and cash flows could be materially adversely affected. While the spread of COVID-19 has become less severe, the continuing impact of COVID-19 could have the effect of heightening many of the other risk factors described herein.

 

Wildfire Risks in Certain Areas of California Could Adversely Impact the Company’s Operations.

 

Certain areas of California, including certain areas nearby the Company’s cultivation facility in Monterey County, can be negatively impacted by wildfires. Wildfires can cause smoke and ash to pass through greenhouse vents and cause cannabis plants to fail testing. As a result, the Company will close the greenhouse vents when needed to prohibit smoke and ash from entering the greenhouses at its cultivation facility. However, closing the greenhouse vents may cause elevated temperatures within the greenhouses and as a result induced plant stress, thereby negatively affecting plant yields. Wildfires can also cause essential sunlight to be blocked out, thereby negatively affecting plant yields in another manner. Overall, such wildfires can materially disrupt the Company’s ability to harvest cannabis crops, significantly diminishing both the size and quality of the crops harvested, the Company’s supply chain, and other operations and as a result can negatively impact the Company’s business, financial position, results of operations and cash flows. While the Company believes that the addition of such systems should mitigate future negative effects of wildfires that may occur nearby the Company’s cultivation facility, there is no guarantee that such negative effects would in fact be mitigated. The extent to which any such future wildfires or any other natural disaster impacts the Company’s results will depend on future developments, which are highly uncertain and cannot be predicted.  The Company experienced no adverse implications from wildfires during 2022 and 2023.

 

The Company’s business is subject to the risks inherent in agricultural operations.

 

The Company’s business involves the growing of cannabis, an agricultural product. The Company’s business is subject to the risks inherent in the agricultural business, such as insects, plant diseases and similar agricultural risks. Although the Company’s cultivation is substantially completed indoors under climate control, some cultivation is completed outdoors, and there can be no assurance that natural elements will not have a material adverse effect on any future production.  Commencing in January 2024, the Company no longer is growing its own cannabis but our cannabis suppliers remain subject to risks inherent in agricultural operations.

 

The Company may be adversely impacted by rising or volatile energy costs.

 

The Company’s cannabis growing suppliers consume considerable energy, which makes them vulnerable to rising energy costs. Accordingly, rising or volatile energy costs may adversely affect the business of the Company and our ability to operate profitably.

 

 
30

Table of Contents

 

We are dependent on key inputs, suppliers and skilled labor and fluctuations in the cost or availability of materials we use in our products and supply chain could negatively affect our results.

 

The cannabis industry is dependent on a number of key inputs and their related costs, including raw materials and supplies related to growing operations, as well as electricity, water and other local utilities. Any significant interruption or negative change in the availability or economics of the supply chain for key inputs, such as the raw material cost and supply of cannabis, materials we use in our products and for the construction and development of our facilities, or natural or other disruptions to power or other utility systems, could materially impact our business, financial condition, results of operations or prospects. Some of these inputs may only be available from a single supplier or a limited group of suppliers, or be sourced abroad. If a sole source supplier was to go out of business, we might be unable to find a replacement for such source in a timely manner, or at all. If a sole source supplier were to be acquired by a competitor, that competitor may elect not to sell to us in the future. Manufacturing delays or unexpected transportation delays, particularly from materials we source abroad, can also cause us to incur significantly increased costs. Any of these fluctuations may increase our cost of products and have an adverse effect on our profit margins, results of operations and financial condition. Any inability to secure required supplies and services, or to do so on appropriate terms, could have a materially adverse impact on our operations.

 

Our ability to compete and grow will be dependent on us having access, at a reasonable cost and in a timely manner, to skilled labor, equipment, parts and components. No assurances can be given that we will be successful in maintaining our required supply of skilled labor, equipment, parts and components. The imposition of health mandates due to COVID-19 or any other similar event may impact our ability to retain current employees and attract new employees.

 

Our sales are difficult to forecast.

 

As a result of recent and ongoing regulatory and policy changes in the medical and adult use cannabis industries and unreliable levels of market supply, the market data available is limited and unreliable. We must rely largely on our own market research to forecast sales, as detailed forecasts are not generally obtainable from other sources in the states in which our business operates. Additionally, any market research and our projections of estimated total retail sales, demographics, demand and similar consumer research, are based on assumptions from limited and unreliable market data. A failure in the demand for our products to materialize as a result of competition, technological change or other factors could have a material adverse effect on our business, results of operations and financial condition.

 

Additionally, the U.S. has imposed and may impose additional quotas, duties, tariffs, retaliatory or trade protection measures or other restrictions or regulations and may adversely adjust prevailing quota, duty or tariff levels, which can affect both the materials that we use to package our products and the sale of finished products. For example, the tariffs imposed by the U.S. on materials from China are impacting materials that we import for use in packaging in the U.S. Measures to reduce the impact of tariff increases or trade restrictions, including geographical diversification of our sources of supply, adjustments in packaging design and fabrication or increased prices, could increase our costs, delay our time to market and/or decrease sales. Other governmental action related to tariffs or international trade agreements has the potential to adversely impact demand for our products and our costs, customers, suppliers and global economic conditions and cause higher volatility in financial markets. While we actively review existing and proposed measures to seek to assess the impact of them on our business, changes in tariff rates, import duties and other new or augmented trade restrictions could have a number of negative impacts on our business, including higher consumer prices and reduced demand for our products and higher input costs.

 

Risks Related to the Securities of the Company

 

Unpredictability caused by the Company’s capital structure could adversely impact the market for the Company’s securities.

 

Although other Canadian-listed companies have dual class or multiple voting and exchangeable share structures, given the other unique features of the capital structure of the Company, including exchangeable securities of Indus Holding Company, which equity securities are redeemable from time to time for Subordinate Voting Shares in accordance with their terms, the Company is not able to predict whether this structure will result in a lower trading price for or greater fluctuations in the trading price of the Subordinate Voting Shares or will result in adverse publicity to the Company or other adverse consequences.

 

 
31

Table of Contents

 

Investors Could be Diluted by Future Financings.

 

The Company may need to raise additional financing in the future through the issuance of additional equity securities or convertible debt securities. If the Company raises additional funding by issuing additional equity securities or convertible debt securities, such financings may substantially dilute the interests of shareholders of the Company and reduce the value of their investment and the value of the Company’s securities.

 

The Market for Subordinate Voting Shares May be Illiquid and the Market Price of the Subordinate Voting Shares is Volatile.

 

There may not be an active, liquid market for the Subordinate Voting Shares. There is no guarantee that an active trading market for the Subordinate Voting Shares will be maintained on the CSE. Investors may not be able to sell their Subordinate Voting Shares quickly or at the latest market price if trading in the Subordinate Voting Shares is not active.

 

The market price of the Subordinate Voting Shares cannot be predicted and has been and may be volatile and subject to wide fluctuations in response to numerous factors, many of which are beyond the Company’s control. This volatility may affect the ability of holders of Subordinate Voting Shares to sell their securities at an advantageous price. Market price fluctuations in the Subordinate Voting Shares may be due to the Company’s operating results failing to meet expectations of securities analysts or investors in any period, downward revision in securities analysts’ estimates, adverse changes in general market conditions or competitive, regulatory or economic trends, adverse changes in the economic performance or market valuations of companies in the industry in which the Company operates, acquisitions, dispositions, strategic partnerships, joint ventures, capital commitments or other material public announcements by the Company or its competitors or government and regulatory authorities, operating and share price performance of the companies that investors deem comparable to the Company, addition or departure of the Company’s executive officers and other key personnel, along with a variety of additional factors. These broad market fluctuations may adversely affect the market price of the Subordinate Voting Shares.

 

Financial markets have at times historically experienced significant price and volume fluctuations that have particularly affected the market prices of equity and convertible securities of companies and that have often been unrelated to the operating performance, underlying asset values or prospects of such companies. Accordingly, the market price of the Subordinate Voting Shares and any other listed securities of the Company, from time to time, may decline even if the Company’s operating results, underlying asset values or prospects have not changed. Additionally, these factors, as well as other related factors, may cause decreases in asset values that are deemed to be other than temporary, which may result in impairment losses. There can be no assurance that continuing fluctuations in price and volume will not occur. If such increased levels of volatility and market turmoil arise or continue, the Company’s operations may be adversely impacted and the trading price of the Subordinate Voting Shares and such other securities may be materially adversely affected.

 

Future sales of Subordinate Voting Shares in the public market, or the perception that such sales may occur, could adversely affect the prevailing market price of the Subordinate Voting Shares.

 

As of March 19, 2024, there were 18,130,566 Subordinate Voting Shares outstanding and the following Subordinate Voting Shares are issuable upon the conversion, redemption, or exercise of derivate securities of Lowell Farms and Indus Holding Company:

 

 

o

893,591 Subordinate Voting Shares are issuable upon the redemption of all of the Class B Common Shares of Indus Holding Company (“Indus Class B Common Shares”);

 

 
32

Table of Contents

 

 

o

900,000 Subordinate Voting Shares are issuable upon the exercise of the warrants (the “PIPE Warrants”) issued by the Company in the PIPE transaction;

 

o

225,652 Subordinate Voting Shares are issuable upon the exercise of warrants issued by Indus Holding Company prior to the RTO to investors in debentures of Indus Holding Company; and

 

o

1,375,600 Subordinate Voting Shares are issuable upon the exercise of options issued pursuant to the Company’s equity incentive plans, of which 1,119,658 shares were vested as of March 19, 2024.

 

The Company has filed resale registration statements under the Securities Act covering the securities issued in the Lowell Acquisition, C Quadrant Acquisition, and PIPE transaction, and such registration statements have been declared effective. Accordingly, such securities may be resold pursuant to such registration statements, as well as any applicable exemption from registration, subject to the trading restrictions and expiration of the escrows noted above.

 

Future sales of Subordinate Voting Shares in the public market, or the perception that such sales may occur, could adversely affect the prevailing market price of the Subordinate Voting Shares.

 

The Company has experienced negative operating cash flows throughout its history and had negative operating cash flows for the years ended December 31, 2023 and 2022. Operating cash flows may decline in certain circumstances, many of which are beyond the Company’s control. As a result, the Company may need to allocate a portion of its existing working capital or a portion of the net proceeds of the Offering or any future securities issuance to fund any such negative operating cash flow in future periods.

 

Loss of Foreign Private Issuer Status

 

As of January 1, 2021, the Company ceased to meet the definition of a “foreign private issuer” set out in Rule 405 of the Securities Act. As of that date, the aggregate number of Super Voting Shares and Subordinate Voting Shares, held of record, directly or indirectly, by U.S. Residents exceeded 50% of the aggregate number of Super Voting Shares and Subordinate Voting Shares issued and outstanding. As a result of the loss of foreign private issuer status and the filing of our Form 10 that became effective on May 8, 2021, we are subject to SEC disclosure rules and other rules and regulations applicable to domestic issuers. These obligations require significant financial and management resources. We are also subject to liability under the Securities Act and the Exchange Act. Liability under these acts can lead to monetary fines, limitations on future financings and, if imposed, may impede our ability to finance our business.

  

 
33

Table of Contents

 

Risk Relating to Taxation

 

The Company is a tax resident of both the U.S. and Canada and is, therefore, generally subject to both U.S. and Canadian taxation, which may adversely affect its results of operations.

 

The Company is treated as a United States company for U.S. Federal income tax purposes under section 7874 of the Code and is subject to United States Federal income tax on its worldwide income. However, for Canadian income tax purposes, the Company is, regardless of any application of section 7874 of the Code, treated as a resident of Canada for purposes of the Income Tax Act (Canada). As a result, the Company is subject to taxation both in Canada and the United States, which could have a material adverse effect on its financial condition and results of operations.

 

The Company is subject to audits by the IRS and the results of the audits may result in significant tax assessments related to prior year filings.

 

The Company is presently being audited by the IRS for the years ended December 31, 2019 and 2020. The results of the audit are not known and the likelihood of any penalties or fees are not able to be estimated.

 

ITEM 1B. Unresolved Staff Comments

 

Not applicable.

 

ITEM 1C. Cybersecurity

 

Risk management and strategy 

 

We depend on our information technology to conduct our business operations. This technology is predominantly operated on third-party platforms and services. Our business servers are owned and managed by an experienced third-party provider that addresses issues promptly in the event of a cybersecurity threat or incident.

  

We have tailored our business applications and hosting services to reduce the impact of cybersecurity incidents. We utilize the Google Cloud Suite for email, office documents, and communication. Our ERP and Financial System operate on RDP and SQL server, which are backed up nightly through a SQL backup. All our servers are backed up to tape and transferred off-site every night. Our third-party provider has the necessary tools to restore and clone servers in a timely manner.

  

Our strategy to mitigate cybersecurity risks includes monitoring and detection efforts, and the deployment of the anti-malware application ESET on all workstations and servers. The management of our Anti-Virus and Anti-Malware is performed by an experienced third party provider. Regarding third parties that manage or utilize our information technology or data, we conduct continuous monitoring of all third-party providers to ensure they adhere to our cybersecurity standards. To date, we have not experienced cybersecurity threats or incidents that have significantly impacted our business.

 

Governance

 

Our Board of Directors delegates the responsibility for cybersecurity oversight to the Audit Committee and our VP of Integration and IT Operations, who also manages our general technology risk.

 

Our VP of Integration and IT Operations collaborates closely with our information technology partners to pinpoint new risks and evaluate our risk management framework. This team includes employees familiar with our products and systems who also possess experience in managing cybersecurity risks.

  

The VP of Integration and IT Operations regularly updates the Audit Committee on cybersecurity-related risks. Our incident response plan involves informing the Management Team and then the Board of Directors about any substantial threats or incidents that occur.

  

ITEM 2. Properties

 

DESCRIPTION OF PROPERTY

 

Lowell Farms presently leases its facilities through its subsidiaries. The following table sets forth information about the current facilities that we use to support our operations. We believe that these facilities are generally suitable to meet our needs.

 

Location

 

Square Feet

 

Purpose

 

Lease Expiration Dates

Salinas

 

15,000

 

Manufacturing

 

June 30, 2028 1

Salinas

 

6,000

 

Administrative

 

December 31, 2025

Salinas

 

21,000

 

Distribution and Flower Packaging

 

December 31, 2024 2

Monterey County

 

255,000

 

Cultivation

 

December 31, 2034 3

Salinas

 

40,000

 

Processing

 

May 31, 2034 4

Total square footage

 

337,000

 

 

 

 

_________________

1 Lowell Farms has two 5-year extension options.

2 Lowell Farms has one 2-year extension option.

3 Facility surrendered to landlord on January 12, 2024.

4 Lowell Farms has two 10-year extension options.

 

CORPORATE INFORMATION

 

General

 

We are governed by the laws of British Columbia, Canada. On April 26, 2019, we completed a reverse takeover transaction (the “Business Combination” or the “RTO”) with Indus Holding Company, a Delaware corporation. On February 25, 2021, we completed the Lowell Acquisition. Effective March 1, 2021, in connection with the Lowell Acquisition, we changed our name to Lowell Farms Inc.

 

The Company was incorporated under the Business Corporations Act (Ontario) on October 27, 2005, under the name Zoolander Corporation and changed its name to “Mezzotin Minerals Inc.” on September 10, 2013.

 

 
34

Table of Contents

 

Prior to the Business Combination, the Company engaged in the acquisition, exploration and development of properties prospective for rare earth metals in Zimbabwe. In October 2018, the Company sold all of its exploration property interests in Zimbabwe and had no commercial operations or operating revenues at the time of the Business Combination.

 

Indus Holding Company was formed as a Delaware corporation on January 2, 2015. Indus Holding Company owns all of our operating subsidiaries.

 

Corporate Structure

 

Set forth below is the organization chart of the Company, setting out all material subsidiaries of the Company and their jurisdiction of incorporation, formation or organization. Each of the subsidiaries of Indus Holding Company is wholly-owned by it. The Company is presently carrying on active business operations solely in California.

 

lowlf_10kimg4.jpg

 

 
35

Table of Contents

 

The primary purpose or main business of each entity is as follows:

 

 

·

Lowell Farms Inc. is the issuer of our shares traded on the CSE and OTCQX. Lowell Farms Inc. is a holding company and does not conduct material business activities.

 

 

 

 

·

Indus Holding Company is the owner of our principal brand intellectual property (other than the Lowell Herb Co. and Lowell Smokes brands acquired in the Lowell Acquisition) and an intermediate holding company for our operating entities.

 

 

 

 

·

Cypress Manufacturing Company conducts the majority of our cannabis operations, including cultivation, extraction, manufacturing and distribution, and holds all manufacturing and distribution licenses. Licensed activities acquired by Indus LF LLC in the Lowell Acquisition are being transitioned to Cypress Manufacturing Company.

 

 

 

 

·

Cypress Holding Company owns the majority of our equipment and is a lessee for facility and equipment leases.

 

 

 

 

·

Wellness Innovation Group Incorporated provides sales, marketing, administrative and managerial services to our other operating entities.

 

 

 

 

·

Indus LF LLC is the owner of the product portfolio and assets acquired in the Lowell Acquisition.

 

 

 

 

·

Lowell SR LLC is the lessee of our drying and midstream processing facility in Monterey County, located at 20800 Spence Road, and has a wholly owned subsidiary, 20800 Spence Road LLC, which holds certain permits related to the processing facility. LFS is operated under Lowell SR LLC.

 

The head office of the Company is located at 19 Quail Run Circle - Suite B, Salinas, California 93907 USA. The registered office of the Company is Suite 2200, HSBC Building, 885 West Georgia Street, Vancouver, BC V6C 3E8 Canada. Our website address is https://www.lowellfarms.com. No information available on or through our website shall be deemed to be incorporated into this Form 10-K.

 

The Business Combination

 

On March 29, 2019, the Company entered into a definitive agreement with Indus Holding Company and certain other parties pursuant to which the Company effected the Business Combination. The Business Combination resulted in a reverse take-over of the Company by the securityholders of Indus Holding Company.

 

In connection with the Business Combination:

 

Mezzotin created (i) the Subordinate Voting Shares as a new class of equity securities and all outstanding common shares of Mezzotin were reclassified as Subordinate Voting Shares at a ratio of one Subordinate Voting Share for every 485.3 common shares and (ii) a new class of non-participating securities of Mezzotin designated super voting shares (“Super Voting Shares”) (collectively, the “Share Terms Amendment”).

 

Indus Holding Company was recapitalized by an amendment and restatement of its certificate of incorporation. Pursuant to the recapitalization, the voting Class A Common Shares (“Indus Class A Common Shares “) and the non-voting Class B Common Shares (“Indus Class B Common Shares “) of Indus Holding Company were created, and all outstanding shares of stock of Indus Holding Company were reclassified as Indus Class B Common Shares on a one-for-one basis. Indus Class B Common Shares are redeemable at the option of the holder for Subordinate Voting Shares on a one-for-one basis or, at Indus Holding Company’s option, for cash.

 

 
36

Table of Contents

 

Simultaneously, the Company subscribed for and became the sole holder of the Indus Class A Common Shares. The purchase price for the Class A Common Shares was paid from the proceeds of a subscription receipts financing conducted in connection with the Business Combination.

 

The Convertible Debenture Offering

 

Effective April 16, 2020, in connection with the completion of a private placement of convertible debentures and warrants (the “Convertible Debenture Offering”), the articles of the Company (at that time named Indus Holdings, Inc.) were amended to create a class of non-voting Class C Common Shares. The debentures issued in the Convertible Debenture Offering are convertible into Indus Class C Common Shares. The Indus Class C Common Shares are redeemable at the option of the holder for Subordinate Voting Shares on a one-for-one basis. 

 

During 2022, in connection with the completion of a private placement of convertible debentures and warrants (the “2022 Convertible Debenture Offering”), the articles of the Company were updated to create a class of non-voting Class D common shares. A portion of the warrants issued in the 2022 Convertible Debenture offering are issuable into Indus Class D commons shares upon exercise of warrants issued in the 2022 Convertible Debenture Offering.

 

Effective October 6, 2023, the Company repurchased all of the $22,157 aggregate principal amount of outstanding Senior Secured Convertible Debentures of its subsidiary, Indus Holding Company (“Indus”), together with the related warrants to purchase 10,627,483 subordinate voting shares of the Company and 4,324,845 common shares of Indus.

 

Each holder received as the purchase price therefor, such holder’s pro rata share, based on the proportion of the outstanding Debentures held by such holder, of (x) membership interests in LF Brandco LLC ("Brandco"), an entity formed to hold the Company’s intellectual property relating to its “Lowell Smokes” and “Lowell Herb Co.” brands (including trademarks, logos and additional identifying marks, domain names and social media accounts), and (y) 6,849,572 Subordinate Voting Shares, representing approximately 36% of the Company’s consolidated, undiluted equity interests.

 

The Company has entered into a license agreement with Brandco for the “Lowell” trademarks, logos, and related intellectual property on an exclusive basis in the State of California for a five-year license term, with up to three five-year extensions. The Company’s exercise of the extension terms is subject to mutual agreement on certain sales performance criteria for each extension term.

 

As of the closing of the Offer, the voting agreement of the Company, pursuant to which the former holders of the Debentures were entitled to nominate three out of seven members of the Company’s board of directors and consent to the nomination of a fourth, and certain contractual operating covenants in favor of the former Debenture holders, was terminated.

 

Name Change

 

Effective March 1, 2021, in connection with the Lowell Acquisition, the Company changed its name from Indus Holdings, Inc. to Lowell Farms Inc. On March 5, 2021, the Subordinate Voting Shares began trading on the CSE under the ticker symbol LOWL and the (“December 2020 Warrants”) issued by the Company (then named Indus Holdings, Inc.) in connection with the December 2020 Unit Offering began trading on the CSE under the ticker symbol LOWL.WT. Also on March 5, 2021, the Subordinate Voting Shares began trading on the OTCQX under the ticker symbol LOWLF.

 

ITEM 3. Legal Proceedings

 

LEGAL PROCEEDINGS

 

Zabala Road Lease

 

On January 12, 2024, Cypress Holding Company, LLC (“Cypress”), a wholly owned subsidiary of the Company, surrendered possession of approximately 10 acres of real property at 139 Zabala Road, Salinas, California (the “Zabala Road Property”) leased by Cypress pursuant to a Lease Agreement dated April 1, 2017 (the “Zabala Road Lease”) with Tinhouse, LLC, dba Tinhouse Partners, LLC, as landlord (the “Landlord”). Prior to vacating the premises on January 12, 2024, the Company had operated a cultivation facility, which includes four greenhouses totaling approximately 255,000 square feet, on the Zabala Road Property.

 

As previously announced, in January 2023, the Company’s Board of Directors formed a strategic alternatives special committee of independent directors to explore, review and evaluate strategic and financial alternatives. As part of these efforts, the Company entered into negotiations with the Landlord to restructure the terms of the Zabala Road Lease, which provided for an expiry date of December 31, 2027, subject to five 5-year extension options exercisable by Cypress.

 

In September 2023, the Company and the Landlord reached a settlement amending the terms of the Zabala Road Lease and reaching agreement on all rent-related issues. The Landlord terminated the Zabala Road Lease via a letter dated October 6, 2023, which was served by its counsel on the Company on October 10, 2023. On October 16, 2023, the Company filed a lawsuit in the Monterey County California Superior Court for breach of contract and specific performance against the Landlord to enforce the settlement terms. The Landlord filed counterclaims and an unlawful detainer action against the Company, claiming damages of more than $36 million, which the Landlord claims are based on an analysis of accelerated rent due through the end of the term of the Zabala Road Lease, along with attorney’s fees, improvements, and other undefined costs.

  

The Company intends to vigorously defend itself against the claims made by the Landlord. However, no assurance can be provided as to whether or not the Company will prevail, and it may be required to pay significant monetary damages.

 

Potency and Labeling

 

A putative class action was filed in the Los Angeles County California Superior Court on behalf of all California consumers who purchased products made by Lowell Farms, Inc. in California. The case alleges that Lowell failed to accurately label its products with the THC% identified by its testing laboratories, and that California consumers were thereby deceived into paying higher prices for Lowell’s products than they otherwise would have.

  

No trial has been scheduled in this matter. The parties are presently engaged in the process by which Plaintiff will bring a motion seeking certification of a class. The class certification motion is scheduled to be heard on August 26, 2024. Plaintiff has served discovery requests limited to class certification issues, but the parties have not engaged in any merits discovery. It is difficult to evaluate any potential outcome at such an early stage of the case where there has been no merits discovery. The Company is prepared to vigorously defend itself at the trial if a class is certified and a settlement is not reached. It is difficult to evaluate the likely outcome of a trial because Plaintiff has not articulated a theory of damages. In addition, due to the early nature of the case, an estimate of a loss cannot be made.

  

There are no other legal proceedings material to the Company to which the Company or a subsidiary thereof is a party or of which any of their respective property is the subject matter, nor are there any such proceedings known to the Company to be contemplated, and there have been no such legal proceedings during the Company’s most recently completed financial year.

 

ITEM 4. Mine Safety Disclosure

 

Not applicable.

 

 
37

Table of Contents

 

Part II

 

ITEM 5. Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities

 

MARKET PRICE AND DIVIDENDS ON COMMON EQUITY AND RELATED STOCKHOLDER MATTERS

 

Market Information

 

The Subordinate Voting Shares are listed for trading on the CSE under the symbol “LOWL” and the warrants are listed on the CSE under the symbol “LOWL.WT.” The Subordinate Voting Shares commenced trading on the CSE effective April 30, 2019. Our shares are also traded over-the-counter in the United States on the OTCQX under the symbol “LOWLF.” Any over-the-counter market quotations reflect inter-dealer prices, without retail mark-up, mark-down, or commission and may not necessarily represent actual transactions.

 

In August 2023, the Company effected reverse stock split consolidating all of its Subordinate Voting Shares on the basis of one post-consolidation Subordinate Voting Share for every ten pre-consolidation Subordinate Voting Shares, effective August 31, 2023. All share and per share data presented herein has been retroactively adjusted to reflect the reverse stock split.

 

The following table sets forth trading information for the Subordinate Voting Shares for the periods indicated, as quoted on the CSE.

 

Period

 

High Trading

Price

C($)

 

 

Low Trading

Price

C($)

 

Q4 2023

 

$0.40

 

 

$0.18

 

Q3 2023

 

$0.61

 

 

$0.26

 

Q2 2023

 

$0.70

 

 

$0.35

 

Q1 2023

 

$1.55

 

 

$0.35

 

Q4 2022

 

$3.00

 

 

$1.00

 

Q3 2022

 

$3.60

 

 

$1.90

 

Q2 2022

 

$5.30

 

 

$2.50

 

Q1 2022

 

$6.40

 

 

$2.90

 

 

The following table sets forth trading information for the Subordinate Voting Shares for the periods indicated, as quoted on the OTCQX.

 

Period

 

High Trading

Price

US ($)

 

 

Low Trading

Price

US($)

 

Q4 2023

 

$0.30

 

 

$0.14

 

Q3 2023

 

$0.45

 

 

$0.15

 

Q2 2023

 

$0.58

 

 

$0.30

 

Q1 2023

 

$1.15

 

 

$0.30

 

Q4 2022

 

$2.20

 

 

$0.70

 

Q3 2022

 

$2.90

 

 

$1.40

 

Q2 2022

 

$4.60

 

 

$1.90

 

Q1 2022

 

$5.30

 

 

$2.30

 

 

Shareholders 

 

We had approximately 379 shareholders of record as of March 19, 2024. This does not include shares held in the name of a broker, bank or other nominees (typically referred to as being held in “street name”).

 

Dividends 

 

The Company has not paid dividends and currently intends to reinvest any future earnings to finance its business. As a result, the Company does not intend to pay dividends on the Subordinate Voting Shares in the foreseeable future. Any future determination to pay distributions will be at the discretion of the Board and will depend on the financial condition, business environment, operating results, capital requirements, any contractual restrictions on the payment of distributions and any other factors that the Board deems relevant.

 

ITEM 6. [Reserved]

 

 
38

Table of Contents

 

ITEM 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations

 

MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS FOR THE YEAR ENDED DECEMBER 31, 2023, COMPARED TO YEAR ENDED DECEMBER 31, 2022

 

This management's discussion and analysis ("MD&A") of the financial condition and results of operations of the Company is for the years ended December 31, 2023 and 2022. All dollar amounts in this MD&A are expressed in thousands of United States dollars ("$" or "US$"), unless otherwise indicated.

 

CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS

 

In addition to historical information, this Annual Report on Form 10-K contains forward-looking statements within the meaning of Section 27A of the Securities Act and Section 21E of the Exchange Act. These forward-looking statements are subject to certain risks and uncertainties that could cause our actual results to differ materially from those reflected in the forward-looking statements. Factors that could cause or contribute to such differences include, but are not limited to, those discussed in this Annual Report on Form 10-K and, in particular, the risks discussed under the heading “Risk Factors” in Part I, Item 1A of this Annual Report on Form 10-K and those discussed in other documents we file with the SEC. We undertake no obligation, and specifically disclaim any obligation, to revise or publicly release the results of any revision to these and any other forward-looking statements. Given these risks and uncertainties, readers are cautioned not to place undue reliance on such forward-looking statements.

 

OVERVIEW OF THE COMPANY

 

We are a California-based cannabis company with vertically integrated operations including large scale cultivation, extraction, processing, manufacturing, branding, packaging and wholesale distribution to retail dispensaries. We manufacture and distribute proprietary and a limited number of third-party brands throughout the State of California, the largest cannabis market in the world. We also provide manufacturing, extraction and distribution services to several third-party cannabis and cannabis branding companies. We operate a 255,000 square foot greenhouse cultivation and warehouse facility and a 40,000 square foot processing facility in Monterey County, a 15,000 square foot manufacturing and laboratory facility in Salinas, California, a separate 21,000 square foot distribution and flower packing facility in Salinas, California and a warehouse depot in Los Angeles, California.  On January 12, 2024, we surrendered possession of the greenhouse facility.  See “Recent Developments.”

 

Our present product offerings include flower, pre-rolls, vape pens, oils, extracts, chocolate edibles, mints, gummies, topicals and tinctures. We sell our products under owned and third-party brands. Brands we own include the following: Cypress Cannabis (a premium flower brand); Flavor Extracts (crumble and terp sugar products): Kaizen (premium brand cannabis concentrates); House Weed (a value driven flower, vapes and concentrates offering delivering a flavorful and potent experience); Moon (a range of high-potency, high-quality and high-value edibles); Humble Flower (a premium brand offering cannabis-infused topicals, pre-rolls, sublingual tablets); and Original Pot Company (baked edibles). We also exclusively manufacture and distribute Lowell Herb Co. and Lowell Smokes (premium packaged flower, pre-roll, concentrates, and vape products); 35s (a line of automated pre-rolls) and products for several other third party brands in California and provide third party extraction processing and distribution services and bulk extraction concentrates and flower to licensed manufacturers and distributors.

 

Since 2017, we have conducted cannabis cultivation operations located in Monterey County, California. We operated a cultivation facility which included four greenhouses totaling approximately 255,000 square feet sited on 10 acres located on Zabala Road. Farming cannabis at this scale enabled us to curate specialized strains and maintain greater control over the quantity and quality of cannabis available for our products, preserving the consistency of our flower and cannabis feedstocks for our extraction laboratory and product manufacturing operations. We maintained a strict quality control process which facilitates a predictable output yield of pesticide-free products.  As noted previously, we surrendered possession of the cultivation facility on January 12, 2024.

 

We operate a 40,000 square foot processing facility in Monterey County in close proximity to our cultivation operations that provides drying, bucking, trimming, sorting, grading, and packaging operations for up to 250,000 pounds of wholesale cannabis flower annually. The facility processes nearly all the cannabis that we grow at our existing cultivation operations as well as processing services for regional growers from primarily the Salinas Valley area.

 

 
39

Table of Contents

 

Our manufacturing facility is located in Salinas, California and houses our edible product operations and extraction and distillation operations. The edible product operations utilize internally produced cannabis oil, which can also be supplied from multiple external sources. Our manufacturing operations produce a wide variety of cannabis-infused products in our 15,000 square foot manufacturing facility in Salinas. Our products include chocolate confections, tinctures, baked goods, hard and soft non-chocolate confections, and topical lotions and balms. Lowell Farms utilizes modern commercial production equipment and employs food grade manufacturing protocols, including industry-leading standard operating procedures designed so that its products meet stringent quality standards. We have implemented updated compliance, packaging and labeling standards to meet the requirements of the California Medical and Adult-Use Cannabis Regulation and Safety Act with the advent of adult use legalization in California.

 

We also operate an automated flower packaging line, an automated pre-roll line and a pre-roll assembly line for making finished goods in those respective categories with feedstock grown at our cultivation operations.

 

Our business is conducted by the following subsidiaries of the Company:

 

 

·

Indus Holding Company is the owner of our principal brand intellectual property (other than the Lowell Herb Co. and Lowell Smokes brands) and an intermediate holding company for our operating entities.

 

 

 

 

·

Cypress Manufacturing Company conducts the majority of our cannabis operations, including cultivation, extraction, manufacturing and distribution, and holds all manufacturing and distribution licenses.

 

 

 

 

·

Cypress Holding Company owns the majority of our equipment and is a lessee for facility and equipment leases.

 

 

 

 

·

Wellness Innovation Group Incorporated provides sales, marketing, administrative and managerial services to our other operating entities.

 

 

 

 

·

Indus LF LLC is the owner of the brands and assets acquired in the Lowell Acquisition. Licensed activities acquired by Indus LF LLC in the Lowell Acquisition have been transitioned to Cypress Manufacturing Company.

 

 

 

 

·

Lowell SR LLC is the lessee of our drying and midstream processing facility located in Monterey County, located at 20800 Spence Road, and through its wholly owned subsidiary 20800 Spence Road LLC, which holds certain permits and licenses related to the processing facility. LFS is operated under Lowell SR LLC.

 

The Company's corporate office and principal place of business is located at 19 Quail Run Circle, Salinas, California. As of December 31, 2023, we had 165 full-time employees, including 163 full-time and 2 part-time, substantially all of whom are located in California. Additionally, Lowell Farms utilizes contract employees in security, cultivation, processing, packaging and warehousing activities. The use of contract employees enables Lowell Farms to manage variable staffing needs and in the case of cultivation and security personnel, access to experienced, qualified and readily available human resources.

 

 
40

Table of Contents

 

Recent Developments

 

Surrender of Cultivation Facility

 

On January 12, 2024, Cypress Holding Company, LLC (“Cypress”), a wholly owned subsidiary of the Company, surrendered possession of approximately 10 acres of real property at 139 Zabala Road, Salinas, California (the “Zabala Road Property”) leased by Cypress pursuant to a Lease Agreement dated April 1, 2017 (the “Zabala Road Lease”) with Tinhouse, LLC, dba Tinhouse Partners, LLC, as landlord (the “Landlord”). Prior to vacating the premises on January 12, 2024, the Company had operated a cultivation facility, which includes four greenhouses totaling approximately 255,000 square feet, on the Zabala Road Property.

 

As previously announced, in January 2023, the Company’s Board of Directors formed a strategic alternatives special committee of independent directors to explore, review and evaluate strategic and financial alternatives. As part of these efforts, the Company entered into negotiations with the Landlord to restructure the terms of the Zabala Road Lease, which provided for an expiry date of December 31, 2027, subject to five 5-year extension options exercisable by Cypress.

 

In September 2023, the Company and the Landlord reached a settlement amending the terms of the Zabala Road Lease and reaching agreement on all rent-related issues. The Landlord terminated the Zabala Road Lease via a letter dated October 6, 2023, which was served by its counsel on the Company on October 10, 2023. In October 2023, the Company filed a lawsuit for breach of contract and specific performance against the Landlord to enforce the settlement terms. The Landlord filed counterclaims and an unlawful detainer action against the Company, claiming damages of more than $36 million, which the Landlord claims are based on an analysis of accelerated rent due through the end of the term of the Zabala Road Lease, along with attorney’s fees, improvements, and other undefined costs.

 

The Company intends to vigorously defend itself against the claims made by the Landlord. However, no assurance can be provided as to whether or not the Company will prevail, and it may be required to pay significant monetary damages.

 

Refer to “Subsequent Events” for more information.

 

Non-GAAP Financial Measures

 

The Company has provided certain supplemental non-GAAP financial measures in this MD&A. Where the Company has provided such non-GAAP financial measures, we have also provided a reconciliation below to the most comparable GAAP financial measure, see “Reconciliations of Non-GAAP Financial and Performance Measures” in this MD&A. These supplemental non-GAAP financial measures should not be considered superior to, as a substitute for or as an alternative to, and should only be considered in conjunction with, the GAAP financial measures presented herein.

 

In this MD&A, reference is made to adjusted EBITDA and working capital which are not measures of financial performance under GAAP. The Company calculates each as follows:

 

 

·

EBITDA is net income (loss), excluding the effects of income taxes (recovery); net interest expense; depreciation and amortization; and adjusted EBITDA also includes non-cash fair value adjustments on investments; unrealized foreign currency gains/losses; share-based compensation expense; and other transactional and special expenses, such as out-of-period insurance recoveries and acquisition costs and expenses related to the markup of acquired finished goods inventory, which are inconsistent in amount and frequency and are not what we consider as typical of our continuing operations. Management believes this measure provides useful information as it is a commonly used measure in the capital markets and as it is a close proxy for repeatable cash generated by operations. We use adjusted EBITDA internally to understand, manage, make operating decisions related to cash flow generated from operations and evaluate our business. In addition, we use adjusted EBITDA to help plan and forecast future periods.

 

 

 

 

·

Working capital is current assets less current liabilities. Management believes the calculation of working capital provides additional information to investors about the Company’s liquidity. We use working capital internally to understand, manage, make operating decisions related to cash flow required to fund operational activity and evaluate our business cash flow needs. In addition, we use working capital to help plan and forecast future periods.

 

These measures are not necessarily comparable to similarly titled measures used by other companies.

 

 
41

Table of Contents

 

The table below reconciles Net loss to Adjusted EBITDA for the periods indicated:

 

 

 

Years Ended

 

 

 

December 31,

 

 

December 31,

 

(in thousands)

 

2023

 

 

2022

 

Net loss

 

$(37,342 )

 

$(24,564 )

Interest expense(2)

 

 

3,837

 

 

 

5,499

 

Provision for income taxes

 

 

161

 

 

 

191

 

Depreciation and amortization in cost of goods sold

 

 

4,696

 

 

 

6,320

 

Depreciation and amortization in operating expenses

 

 

421

 

 

 

448

 

Depreciation and amortization in other income (expense)

 

 

-

 

 

 

608

 

EBITDA(1)

 

 

(28,227 )

 

 

(11,498 )

Investment and currency losses

 

 

30

 

 

 

130

 

Inventory revaluation

 

 

(157 )

 

 

-

 

Impairment Expense

 

 

2,267

 

 

 

3,240

 

Debt Repurchase Charges(3)

 

 

13,477

 

 

 

-

 

Impairment on Cultivation Facility

 

 

6,822

 

 

 

-

 

Share-based compensation

 

 

231

 

 

 

564

 

Other charges(2) (4) (5)

 

 

(2,161 )

 

 

(1,984 )

Adjusted EBITDA(1)

 

$(7,718 )

 

$(9,548 )

 

_____________

(1) Non-GAAP measure

(2) In 2022, net of $864 of financing charges related to the ERC claim, reclassified from interest expense on the Condensed Consolidated Statements of Income (Loss) to transaction and other special charges in the Adjusted EBITDA table.

(3) Comprised of $13,245 of impairment charges on intangible assets and $232 of legal expenses incurred in the year ending December 31, 2023 related to the debt settlement and asset sale. All charges were included in other income (expense) on the Condensed Consolidated Statements of Income (Loss).

(4) For the year ended December 31, 2023, reflects a one time, non-recurring adjustment to prior period yield and processing variances on the Company’s processing facility, included in cost of goods sold on the Condensed Consolidated Statements of Income (Loss).

(5) Includes a $3,884 gain on lease transactions during the year. All charges were included in other income (expense) on the Condensed Consolidated Statements of Income (Loss).

 

RESULTS OF OPERATIONS

 

Year Ended December 31, 2023 Compared to Year Ended December 31, 2022

 

Revenue

 

We derive our revenue from sales of extracts, distillates, branded and packaged cannabis flower, pre-rolls, concentrates and edible products to retail licensed dispensaries and bulk flower, biomass and concentrates to licensed manufacturers and distributors in the state of California. In addition, we distribute proprietary and several third-party brands throughout the state of California, and commencing in the quarter ended September 30, 2021, we began providing fee services for drying and processing third-party product for licensed cultivators in the State of California and we licensed the Lowell Smokes brand in Illinois and Massachusetts in 2021. The Company licensed the Lowell Smokes brand to Schwazze in Colorado and New Mexico in 2022. On October 6, 2023, as part of the Debenture Repurchase, the Company sold the rights to the Lowell Smokes brand.  The Company recognizes revenue upon delivery of goods to customers since at this time performance obligations are satisfied.

 

The Company classifies its revenues into the following major categories: Consumer Packaged Goods (“CPG”) revenue, Bulk revenue, Lowell Farm Services revenue, and Licensing revenue.

 

 

·

CPG products are primarily sales of proprietary brands of the Company.

 

 

 

 

·

Bulk product includes revenue from flower, biomass and distillates sales.

 

 

 

 

·

Lowell Farm Services revenue is related to our processing facility that provides drying, bucking, trimming, sorting, grading, and packaging services.

 

 

 

 

·

Licensing revenue includes fees from licensing the Lowell Smokes brand and sales of packaging and support services associated with non-California based activities.

 

 
42

Table of Contents

 

Revenue by Category

 

Year Ended December 31, 2023 Compared to Year Ended December 31, 2022:

 

 

 

Years Ended

 

 

 

 

 

 

 

 

 

December 31,

 

 

December 31,

 

 

 

 

 

 

 

(in thousands)

 

2023

 

 

2022

 

 

$ Change

 

 

% Change

 

CPG

 

$18,048

 

 

$28,340

 

 

$(10,292 )

 

 

-36%

Bulk

 

 

7,973

 

 

 

9,898

 

 

 

(1,925 )

 

 

-19%

Lowell Farm Services

 

 

1,582

 

 

 

3,700

 

 

 

(2,118 )

 

 

-57%

Licensing

 

 

662

 

 

 

1,597

 

 

 

(935 )

 

 

-59%

Net revenue

 

$28,265

 

 

$43,535

 

 

$(15,270 )

 

 

-35%

 

CPG Revenues decreased to $18.0 million during the year ended December 31, 2023, a decline of $10.3 million compared to the same period in the prior year. While overall revenue declined, Lowell brand revenues continue to make up the largest percentage of sales with approximately $13.8 million for the year ended December 31, 2023, and represented approximately 78% of total CPG revenues. Lowell brand revenues year over year declined 30%, as Lowell brand revenues were $19.6 million and represented approximately 30% of CPG revenues for the year ended December 31, 2022. House Weed brand revenues decreased to $1.2 million in the year ended December 31, 2023 compared to $6.4 million in the same period of the prior year. As a percentage of total CPG revenues, House Weed decreased to 7% for the current period, compared to 23% in the prior year. The Company focused efforts on expanding third party distributed brands in the year ended December 31, 2023 resulting in third party distributed revenue increasing by $2.0 million, from $0.2 million during the year ended December 31, 2022. Revenue from third party distributed brands are included within CPG revenue. The increase in revenue for the year is driven by an expanded brand portfolio when comparing periods.

 

During the year ended December 31, 2023, bulk sales decreased to $8.0 million, a decline of $1.9 million compared to same period in the prior year. Total pounds of self-grown bulk flower sold decreased by approximately 42% during the year, however realized prices per pound on that flower increased by approximately 22% during the same period. Additionally, the Company realized an approximately 39% decrease in bulk flower pricing during the fourth quarter of the year ended December 31, 2023, but that was offset by a 162% increase in pounds sold, compared to the third quarter of the same year.

 

LFS and licensing revenues decreased to $2.2 million for the year ended December 31, 2023, compared to $5.3 million in the same period of the prior year. Licensing revenue was $0.7 million for the year ended December 31, 2023 compared to $1.6 million for the same period in the prior year. The Company sold the out of state licensing agreements during the convertible debt repurchase.

 

 
43

Table of Contents

 

Cost of Sales, Gross Profit and Gross Margin

 

Cost of goods sold consists of direct and indirect costs of production processing and distribution, and includes amounts paid for direct labor, raw materials, packaging, operating supplies, and allocated overhead, which includes allocations of right of use asset depreciation, insurance, managerial salaries, utilities, and other expenses, such as employee training, cultivation taxes and product testing. The Company manufactures for several brands and processes for cultivators that do not have the capability, licensing or capacity to process their own products. The fees earned for these activities absorb fixed overhead in manufacturing and generates service revenue. Our focus in 2024 is expected to be on flower, pre-rolls and on processing third party product at our processing facility. With the exit from the cultivation facility during early 2024, we will be able to react quickly to the demands of the market to better source our production needs and better control spending on third party purchased flower to manage cash outflows on flower and CPG manufacturing. We are focusing on executing smaller, more frequent production runs to lower inventory working capital, optimize efficiencies and expedite product getting to the market faster.

 

Year Ended December 31, 2023 Compared to Year Ended December 31, 2022:

 

 

 

Years Ended

 

 

 

December 31,

 

 

December 31,

 

(in thousands)

 

2023

 

 

2022

 

Net revenue

 

$28,265

 

 

$43,535

 

Cost of goods sold

 

 

35,707

 

 

 

45,376

 

Gross profit

 

$(7,442 )

 

$(1,841 )

Gross margin

 

 

-26.3%

 

 

-4.2%

 

Gross margin was (26.3%) and (4.2%) in the years ended December 31, 2023 and 2022, respectively. During the year ended December 31, 2023, the Company recorded impairment and write downs related to the cultivation facility, which was exited during early 2024. Included in cost of goods sold is $2.6 million of inventory impairment related to existing the cultivation facility, $1.6 million of expense related to the reclassification of leases from finance leases to operating leases, $1.7 million of one-time non-recurring yield and processing variances on the cultivation and processing facilities and approximately $3 million of variances recorded on the cultivation facility prior to lease termination. The variances recorded on the cultivation facility were the result of lower yields harvested during the year from adverse weather conditions and plant health which led to higher costs per pound of production and unfavorable product margins. The cultivation and yield and processing variances are not expected to recur during subsequent periods.

  

We expect to realize improved gross margin in 2024 as a result of exiting our cultivation facility, taking advantage of favorable per pound pricing on purchased flower and increased operating efficiencies. We recognized certain non-routine expenses related to inventory valuation and manufacturing variances that we do not expect to reoccur in 2024 that would favorably impact gross margin in future periods.

 

 
44

Table of Contents

 

Total Operating Expenses

 

Total operating expenses consist primarily of costs incurred at our corporate offices, personnel costs, selling, marketing, and other professional service costs including legal, accounting and licensing costs. Sales and marketing expenses consist of selling costs to support our customer relationships, including investments in marketing and brand activities and corporate infrastructure required to support our ongoing business. Selling costs as a percentage of retail revenue are expected to decrease as our business continues to grow due to efficiencies associated with scaling the business. We expect to incur periodic transaction costs related to expansion efforts and to continue to invest where appropriate in the general and administrative function to support the increasing complexity of the cannabis business.

 

Year Ended December 31, 2023 Compared to Year Ended December 31, 2022:

 

 

 

Years Ended

 

 

 

December 31,

 

 

December 31,

 

(in thousands)

 

2023

 

 

2022

 

Total operating expenses

 

$10,120

 

 

$15,275

 

 

Total operating expenses decreased $5.2 million for the year ended December 31, 2023, compared to the prior year, primarily as a result of lower salaries and wage related expenses, a reduction in professional fees during the year, a reduction in slotting fees which are recognized as a sales discount in 2022 and an overall decline in travel and entertainment expenses incurred, all of which was offset by an increase in legal fees related to the sale leaseback, exiting the cultivation facility and the convertible debt repurchase. Operating expenses increased as a percentage of sales to 36% in the year ended December 31, 2023, from 35% in the year ended December 31, 2022. Stock based compensation expense for the year ended December 31, 2023 decreased compared to the prior year by $0.3 million. Operating expenses in 2024 are expected to be relatively flat year over year as we maintain current headcount, marketing levels and infrastructure expenditures while pursuing revenue generating leads.

 

Other Income (Expense)

 

Year Ended December 31, 2023 Compared to Year Ended December 31, 2022:

 

 

 

Years Ended

 

 

 

December 31,

 

 

December 31,

 

(in thousands)

 

2023

 

 

2022

 

Total other expense

 

$(19,619 )

 

$(7,257 )

 

During the year ended December 31, 2023, the Company incurred approximately $15.2 million of intangible asset impairment related charges, including $13.2 million related to the Lowell brand assets. The Company recorded $8.7 million of impairment related to long lived assets of the cultivation facility, which were primarily leasehold improvements and equipment, as well as a $4.9 million gain on the net right of use assets and liabilities from the cultivation facility. The Company recorded $3.1 million of interest expense related to the right of use liabilities, the mortgage on the processing facility prior to the sale lease back and on the convertible debt prior to the Brandco deal. The results in the year ending December 31, 2022 include recognition of a sale of an Employee Retention Credit of $2.8 million that was earned during the period, net of financing costs of $862 to facilitate the sale of the credit. During the year ended December 31, 2022, the Company recognized $3.2 million of impairment expense on certain capitalized fixed and right-of-use assets related to the Los Angeles distribution facility.

 

 
45

Table of Contents

 

Provision for Income Taxes

 

Year Ended December 31, 2023 Compared to Year Ended December 31, 2022:

 

 

 

Years Ended

 

 

 

December 31,

 

 

December 31,

 

(in thousands)

 

2023

 

 

2022

 

Provision for income taxes

 

$161

 

 

$191

 

Effective Tax Rate

 

 

-0.4%

 

 

-0.8%

 

Provision for income taxes for the year ended December 31, 2023, is comparable to the prior year and primarily reflects state and franchise taxes due to existing net operating losses.

 

Net Loss

 

Year Ended December 31, 2023 Compared to Year Ended December 31, 2022:

 

 

 

Years Ended

 

 

 

December 31,

 

 

December 31,

 

(in thousands)

 

2023

 

 

2022

 

Net loss

 

$(37,342 )

 

$(24,564 )

 

We incurred a net loss of $37.3 million in the year ended December 31, 2023 compared to a net loss of $24.6 million in the prior year, as a result of the factors noted above.

 

 
46

Table of Contents

 

LIQUIDITY AND CAPITAL RESOURCES

 

Our primary need for liquidity is to fund the working capital requirements of our business, capital expenditures, general corporate purposes, and debt service. Our primary source of liquidity is funds generated by financing activities. Our ability to fund our operations, to make planned capital expenditures, to make scheduled debt payments and to repay or refinance indebtedness depends on our future operating performance and cash flows, and ability to obtain equity or debt financing, which are subject to prevailing economic conditions, as well as financial, business and other factors, some of which are beyond our control. Cash generated from ongoing operations were not sufficient to fund operations and, in particular, to fund the Company’s short term capital investments into manufacturing and cultivation expansions or to fund growth initiatives in the long-term. The Company raised additional funds from a $6.6 million convertible debenture and warrant financing in the third quarter of the year ended December 31, 2022, and an additional $9.0 million from a sale leaseback transaction during the quarter ending June 30, 2023 

 

As of December 31, 2023, the Company had $2.3 million of cash and cash equivalents and $3.5 million of working capital, compared to $1.1 million of cash and cash equivalents and ($13.1) million of working capital as of December 31, 2022. As of December 31, 2023, included in working capital is $1.0 million of deposits that are held for future cash management needs. The increase in working capital is due to $21.4 million of convertible debentures that were repurchased by the Company during October, 2023.

 

The Company is focused on improving its balance sheet by improving accounts receivable collections, right-sizing inventories and increasing gross profits. We have taken a number of steps to improve our cash position and to continue to fund operations and capital expenditures including:

 

 

·

Focusing on collection of principal balances only. Effective in 2023, excise tax is assessed to retailers which simplifies accounts receivable management;

 

 

 

 

·

Scaled back our investment in and support for non-core brands;

 

 

 

 

·

Focused marketing and brand development activities on significantly growing Lowell and owned brands;

 

 

 

 

·

Restructured our organization and identified operating, selling and administrative expense cost efficiencies;

 

 

 

 

·

Developed LFS, which commenced operations in the third quarter of 2021 to add revenue and cash flow generation through processing third party flower;

 

 

 

 

·

In 2022 and 2023 we reduced headcount and significantly decreased our seasonal workforce as we focus on necessary infrastructure to support our current operations;

 

 

 

 

·

Re-negotiating leases on facility space, including leasing more economically feasible facilities in Los Angeles and selling and leasing back our processing facility; and

 

 

 

 

·

Exited our cultivation facility to take advantage of profitably sourcing flower from multiple third party sources. Refer to “Recent Developments” and “Subsequent Events.

 

 
47

Table of Contents

 

Cash Flows

 

The following table presents the Company's net cash inflows and outflows from the consolidated financial statements of the Company for the years ended December 31, 2023 and 2022:

 

 

 

Years Ended

 

 

 

 

 

 

 

 

 

December 31,

 

 

December 31,

 

 

Change

 

(in thousands)

 

2023

 

 

2022

 

 

 $

 

 

 %

 

Net cash used in operating activities

 

$(6,041 )

 

$(6,444 )

 

$403

 

 

 

6%

Net cash used in investing activities

 

 

(135 )

 

 

(4,190 )

 

 

4,055

 

 

 

97%

Net cash provided by financing activities

 

 

7,389

 

 

 

3,845

 

 

 

3,544

 

 

 

92%

Change in cash and cash equivalents

 

$1,213

 

 

$(6,789 )

 

$8,002

 

 

 

118%

 

Cash used in operating activities

 

Net cash used in operating activities was $(6.0) million for the year ended December 31, 2023, compared to ($6.4) million or a 6% favorable improvement from the year ended December 31, 2022. The change was primarily driven by operating losses of $37.3 million which included non-cash impairment expenses of $24.3 million, inventory decreasing by $6.0 million, prepaids and other assets decreasing by $2.8 million and offset by accounts receivable decreasing by $0.9 million in the year ended December 31, 2023, reflecting collection efforts. For the year ended December 31, 2023, included in operating activities is $0.4 million of principal payments on operating leases.

  

Cash used in investing activities

 

Net cash used in investing activities was $0.1 million for the year ended December 31, 2023, compared to $4.2 million or a 97% usage reduction from the year ended December 31, 2022. For the year ended December 31, 2022 the Company invested $4.3 million, primarily for manufacturing equipment for the automated pre-roll line while there were no major capital expenditures during the year ended December 31, 2023.

 

Cash  provided by financing activities

 

Net cash provided by financing activities was $7.4 million for the year ended December 31, 2023, compared to net cash provided by financing activities of $3.8 million or a 92% increase from the year ended December 31, 2022. The change was due to funding received from the sale leaseback transaction compared to proceeds from convertible debt issuances in the prior year.

 

Working Capital and Cash on Hand

 

The following table presents the Company's cash on hand and working capital position as of December 31, 2023 and 2022:

 

 

 

Years Ended

 

 

 

 

 

 

 

December 31,

 

 

December 31,

 

 

Change

 

(in thousands)

 

2023

 

 

2022

 

 

$

 

 

%

 

Working capital(1)

 

$

3,475

 

$

(13,088

 

$

16,563

 

127%

 

Cash and cash equivalents

 

$

2,311

 

 

$

1,098

 

 

$

1,213

 

111%

 

_____________

(1) Non-GAAP measure - see Non-GAAP Financial Measures in this MD&A.

 

At December 31, 2023, we had $2.3 million in cash and cash equivalents and $3.5 million of working capital, compared to $1.1 million of cash and cash equivalents and ($13.1) million of working capital at December 31, 2022. The increase in cash and cash equivalents in the year ended December 31, 2023 was primarily due to funding operational losses being offset by proceeds from the $8.9 million sale lease back. The working capital improvement was driving by the convertible debt repurchase during October, 2023.

 

The Company’s future working capital is expected to be significantly impacted by the growth in operations and continuing margin improvement.

 

Refer to “Recent Developments” and “Subsequent Events” for further discussion on exiting cultivation activities in January 2024. Through sourcing competitively priced flower and focusing on current CPG products, third party distribution and processing activities, the Company believes that cash on hand and cash flows from operations will be adequate to meet our operational needs for the next 12 months.  Should market conditions significantly change adversely, there is no guarantee that our cash on hand and cash flows from operations will be adequate to meet our operational needs for the next 12 months.

 

CHANGES IN OR ADOPTION OF ACCOUNTING PRONOUNCEMENTS

 

This MD&A should be read in conjunction with the audited financial statements of the Company for the year ended December 31, 2023. See Note 1 of the notes to our consolidated financial statements in Part II, Item 8 of this Annual Report on Form 10-K for a full description of recently adopted accounting pronouncements.

 

CRITICAL ACCOUNTING POLICIES AND ESTIMATES

 

A description of significant accounting policies are described in Note 1 to our consolidated financial statements included in Part II, Item 8 of this Annual Report on Form 10-K.

 

 
48

Table of Contents

 

The preparation of the Company’s consolidated financial statements requires management to make judgments, estimates and assumptions that affect the application of policies and reported amounts of assets and liabilities, and revenue and expenses. Actual results may differ from these estimates. The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognized in the period in which the estimate is revised if the revision affects only that period or in the period of the revision and future periods if the revision affects both current and future periods.

 

Significant judgments, estimates and assumptions that have the most significant effect on the amounts recognized in the consolidated financial statements are described below.

 

 

·

Estimated Credit Losses - Accounts receivable are recorded at invoiced amounts and when credit terms are extended to customers, management performs a periodic assessment of whether accounts receivable will be collected. A reserve is booked against doubtful accounts and determined based on factors such as credit worthiness of the customer, past performance with the customer, the age of the receivable and the customer’s ability to pay outstanding amounts.

 

 

·

Estimated Useful Lives and Depreciation of Property and Equipment - Depreciation of property and equipment is dependent upon estimates of useful lives which are determined through the exercise of judgment. The assessment of any impairment of these assets is dependent upon estimates of recoverable amounts that take into account factors such as economic and market conditions and the useful lives of assets.

 

 

·

Estimated Useful Lives and Amortization of Intangible Assets - Amortization of intangible assets is recorded on a straight-line basis over their estimated useful lives, which do not exceed the contractual period, if any.

 

 

 

 

·

Identifiable assets acquired and liabilities assumed are recognized at the acquisition date fair values as defined by accounting standards related to fair value measurements.

 

 

 

 

·

Fair Value of Investments in Private Entities - The Company uses discounted cash flow model to determine fair value of its investment in private entities. In estimating fair value, management is required to make certain assumptions and estimates such as discount rate, long term growth rate and, estimated free cash flows.

 

 

 

 

·

Share-Based Compensation - The Company uses the Black-Scholes option-pricing model to determine the fair value of stock options and warrants granted. In estimating fair value, management is required to make certain assumptions and estimates such as the expected life of units, volatility of the Company’s future share price, risk free rates, future dividend yields and estimated forfeitures at the initial grant date. Changes in assumptions used to estimate fair value could result in materially different results.

 

 

 

 

·

Deferred Tax Asset and Valuation Allowance - Deferred tax assets, including those arising from tax loss carry-forwards, requires management to assess the likelihood that the Company will generate sufficient taxable earnings in future periods in order to utilize recognized deferred tax assets. Assumptions about the generation of future taxable profits depend on management’s estimates of future cash flows. In addition, future changes in tax laws could limit the ability of the Company to obtain tax deductions in future periods. To the extent that future cash flows and taxable income differ significantly from estimates, the ability of the Company to realize the net deferred tax assets recorded at the reporting date could be impacted.

 

CONSOLIDATED FINANCIAL POSITION

 

 

 

December 31,

 

 

December 31,

 

Consolidated Financial Position

 

2023

 

 

2022

 

Cash and cash equivalents

 

$2,311

 

 

$1,098

 

Current assets

 

$12,088

 

 

$17,562

 

Property, plant and equipment, net

 

$4,099

 

 

$31,284

 

Right of use assets, net

 

$18,327

 

 

$27,362

 

Total assets

 

$37,613

 

 

$118,823

 

Current liabilities (1)

 

$8,613

 

 

$30,650

 

Working capital (1)

 

$3,474

 

 

$(13,088 )

Long-term notes payable including current portion

 

$3

 

 

$285

 

Lease obligations including current portion

 

$19,512

 

 

$33,999

 

Total stockholders' equity

 

$11,477

 

 

$48,117

 

_____________

(1) During December 31, 2022, includes $21,398 of convertible debentures, net that mature in October 2023

 

 
49

Table of Contents

 

OUTSTANDING SHARE DATA

 

As of March 26, 2024, the Company had the following securities issued and outstanding:

  

 

 

Number of Shares

 

(in thousands)

 

(on an as converted basis)

 

Issued and Outstanding

 

 

 

Subordinate voting shares

 

 

18,131

 

Class B shares (1)

 

 

894

 

Super voting shares

 

 

20

 

Reserved for Issuance

 

 

 

 

Options

 

 

1,376

 

Warrants

 

 

1,126

 

 

 

 

21,547

 

_____________

(1) Class B shares reserved for conversion to Subordinate voting shares.

 

Seasonality, Cyclicality and Quarterly Revenue Trends

 

Our quarterly results reflect a pattern of increased customer buying and processing seasonality at year-end, which has positively impacted revenue activity in the fourth quarter. In the first quarter, we generally experience lower sequential customer buying, followed by an increase in buying in the second quarter. Although these seasonal factors are common in the industry, historical patterns should not be considered a reliable indicator of future revenue activity or performance.

 

Off-Balance Sheet Arrangements

 

During 2023 and 2022, we did not have any relationships with unconsolidated organizations or financial partnerships, such as structured finance or special purpose entities that would have been established for the purpose of facilitating off-balance sheet arrangements or other contractually narrow or limited purposes.

 

ITEM 7A. Quantitative and Qualitative Disclosures about Market Risk

 

Risks include, but are not limited to, those discussed in this Annual Report on Form 10-K and, in particular, the risks discussed under the heading “Risk Factors” in Part I, Item 1A of this Annual Report on Form 10-K and those discussed in other documents we file with the SEC.

 

The Company's financial instruments consist of cash and cash equivalents, accounts receivable, accounts payable and accrued liabilities; current portion of long-term debt; and long-term debt. The carrying values of these financial instruments approximate their fair values.

 

Financial instruments recorded at fair value are classified using a fair value hierarchy that reflects the significance of the inputs used to make the measurements. The hierarchy is summarized as follows:

 

 

·

Level 1 - Quoted prices (unadjusted) that are in active markets for identical assets or liabilities

 

 

 

 

·

Level 2 - Inputs that are observable for the asset or liability, either directly (prices) for similar assets or liabilities in active markets or indirectly (derived from prices) for identical assets or liabilities in markets with insufficient volume or infrequent transactions

 

 

 

 

·

Level 3 - Inputs for assets or liabilities that are not based upon observable market data

 

The Company has exposure to the following risks from its use of financial instruments and other risks to which it is exposed and assess the impact and likelihood of those risks.

 

 
50

Table of Contents

 

These risks include: market, credit, liquidity, asset forfeiture, banking and interest rate risk.

 

Credit Risk

 

 

·

Credit risk is the risk of a potential loss to the Company if a customer or third party to a financial instrument fails to meet its contractual obligations. The maximum credit exposure at December 31, 2023 and December 31, 2022 is the carrying amount of cash and cash equivalents and accounts receivable. All cash and cash equivalents are placed with U.S. and Canadian financial institutions.

 

 

 

 

·

The Company provides credit to its customers in the normal course of business and has established credit evaluation and monitoring processes to mitigate credit risk but has limited risk as a significant portion of its sales are transacted with cash.

 

Liquidity Risk

 

 

·

Liquidity risk is the risk that the Company will not be able to meet its financial obligations associated with financial liabilities. The Company manages liquidity risk through the management of its capital structure. The Company’s approach to managing liquidity is to ensure that it will have sufficient liquidity to settle obligations and liabilities when due.

 

 

 

 

·

In addition to the commitments outlined in Note 15, the Company has the following contractual obligations at December 31, 2023 and 2022:

 

 

 

Maturity: < 1 Year

 

 

Maturity: > 1 Year

 

 

 

December 31,

 

 

December 31,

 

(in thousands)

 

2023

 

 

2022

 

 

2023

 

 

2022

 

Accounts payable and Other accrued liabilities

 

$6,257

 

 

$5,961

 

 

$-

 

 

$-

 

 

Market Risk

 

 

·

Strategic and operational risks arise if the Company fails to carry out business operations and/or to raise sufficient equity and/or debt financing. These strategic opportunities or threats arise from a range of factors that might include changing economic and political circumstances and regulatory approvals and competitor actions. The risk is mitigated by consideration of other potential development opportunities and challenges which management may undertake.

 

Interest Rate Risk

 

 

·

Interest rate risk is the risk that the fair value or the future cash flows of a financial instrument will fluctuate as a result of changes in market interest rates. The Company’s interest-bearing loans and borrowings are all at fixed interest rates; therefore, the Company is not exposed to interest rate risk on these financial liabilities. The Company considers interest rate risk to be immaterial.

 

Price Risk

 

 

·

Price risk is the risk of variability in fair value due to movements in equity or market prices. Cannabis is a developing market and subject to volatile and possibly declining prices year over year, including volatility in bulk flower pricing, as a result of increased competition and other factors. Because adult-use cannabis is a newly commercialized and regulated industry in the State of California, historical price data is either not available or not predictive of future price levels. There may be downward pressure on the average price for cannabis. There can be no assurance that price volatility will be favorable or in line with expectations. Pricing will depend on general factors including, but not limited to, the number of licenses granted by the local and state governments, the supply such licensees are able to generate, activity by unlicensed producers and sellers and consumer demand for cannabis. An adverse change in cannabis prices, or in investors’ beliefs about trends in those prices, could have a material adverse outcome on the Company and its valuation.

 

 
51

Table of Contents

 

Asset Forfeiture Risk

 

 

·

Because the cannabis industry remains illegal under U.S. federal law, any property owned by participants in the cannabis industry which are either used in the course of conducting such business, or are the proceeds of such business, could be subject to seizure by law enforcement and subsequent civil asset forfeiture. Even if the owner of the property were never charged with a crime, the property in question could still be seized and subject to an administrative proceeding by which, with minimal due process, it could be subject to forfeiture.

 

Banking Risk

 

 

·

Notwithstanding that a majority of states have legalized medical marijuana, there has been no change in U.S. federal banking laws related to the deposit and holding of funds derived from activities related to the marijuana industry. Given that U.S. federal law provides that the production and possession of cannabis is illegal, there are arguments that financial institutions cannot accept for deposit funds from businesses involved with the marijuana industry and legislative efforts to provide greater certainty to financial institutions have not been successful. Consequently, businesses involved in the marijuana industry often have difficulty accessing the U.S. banking system and traditional financing sources. The inability to open bank accounts with certain institutions may make it difficult to operate the business of the Company, its subsidiaries and investee companies, and leaves their cash holdings vulnerable.

 

 
52

Table of Contents

 

ITEM 8. Financial Statements and Supplementary Data

 

INDEX TO CONSOLIDATED FINANCIAL STATEMENTS

 

Report of Independent Registered Public Accounting Firm (PCAOB ID 6580)

 

54

 

Consolidated Balance Sheets as of December 31, 2023 and 2022

 

55

 

Consolidated Statements of Income (Loss) for the year ended December 31, 2023, and 2022

 

56

 

Consolidated Statements of Stockholders’ Equity (Deficit) for the year ended December 31, 2023 and 2022

 

57

 

Consolidated Statements of Cash Flows for the year ended December 31, 2023 and, 2022

 

58

 

Notes to Consolidated Financial Statements

 

59

 

 

The supplementary financial information required by this Item 8 is included in Part II, Item 7 of this Annual Report on Form 10-K under the caption “Management’s Discussion and Analysis of Financial Condition and Results of Operations.

 

 
53

table of Contents

 

lowlf_10kimg7.jpg

 

Report of Independent Registered Public Accounting Firm

 

To the Board of Directors and Shareholders

of Lowell Farms, Inc.

 

Opinion on the Financial Statements

 

We have audited the accompanying consolidated balance sheets of Lowell Farms, Inc. (the Company) as of December 31, 2023 and 2022, and the related consolidated statements of income, stockholders’ equity, and cash flows for each of the years in the two-year period ended December 31, 2023, and the related notes (collectively referred to as the “consolidated financial statements”). In our opinion, the financial statements present fairly, in all material respects, the financial position of the Company as of December 31, 2023 and 2022, and the results of its operations and its cash flows for each of the years in the two-year period ended December 31, 2023, in conformity with accounting principles generally accepted in the United States of America.

 

Basis for Opinion

 

These financial statements are the responsibility of the Company’s management. Our responsibility is to express an opinion on the Company’s financial statements based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (PCAOB) and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

 

We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audits, we are required to obtain an understanding of internal control over financial reporting, but not for the purpose of expressing an opinion on the effectiveness of the Company’s internal control over financial reporting. Accordingly, we express no such opinion.

 

Our audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audits provide a reasonable basis for our opinion.

 

GreenGrowth CPAs

 

We have served as the Company’s auditor since 2018.

 

Los Angeles, California

March 26, 2024

 

PCAOB ID Number 6580

      

 
54

table of Contents

 

LOWELL FARMS INC.

CONSOLIDATED BALANCE SHEETS

(in thousands)

 

 

 

December 31,

 

 

December 31,

 

 

 

2023

 

 

2022

 

ASSETS

 

 

 

 

 

 

Current assets:

 

 

 

 

 

 

Cash and cash equivalents

 

$2,311

 

 

$1,098

 

Accounts Receivable - net of allowance for doubtful accounts of $959 and $1,053 at December 31, 2023 and December 31, 2022, respectively

 

 

2,620

 

 

 

4,163

 

Inventory

 

 

4,760

 

 

 

10,779

 

Prepaid expenses and other current assets

 

 

2,397

 

 

 

1,522

 

Total current assets

 

 

12,088

 

 

 

17,562

 

Property and equipment, net

 

 

4,099

 

 

 

31,284

 

Right of use assets, net

 

 

18,327

 

 

 

27,362

 

Other intangibles, net

 

 

2,544

 

 

 

42,202

 

Other assets

 

 

555

 

 

 

413

 

 

 

 

 

 

 

 

 

 

Total assets

 

$37,613

 

 

$118,823

 

 

 

 

 

 

 

 

 

 

LIABILITIES AND STOCKHOLDERS’ EQUITY

 

 

 

 

 

 

 

 

Current liabilities:

 

 

 

 

 

 

 

 

Accounts payable

 

$4,314

 

 

$2,307

 

Accrued payroll and benefits

 

 

363

 

 

 

350

 

Notes payable, current portion

 

 

3

 

 

 

282

 

Lease obligation, current portion

 

 

1,990

 

 

 

2,659

 

Convertible debentures

 

 

-

 

 

 

21,398

 

Other current liabilities

 

 

1,943

 

 

 

3,654

 

Total current liabilities

 

 

8,613

 

 

 

30,650

 

Notes payable

 

 

-

 

 

 

3

 

Lease obligation

 

 

17,522

 

 

 

31,340

 

Convertible debentures

 

 

-

 

 

 

-

 

Mortgage obligation

 

 

-

 

 

 

8,713

 

Total liabilities

 

 

26,135

 

 

 

70,706

 

COMMITMENTS AND CONTINGENCIES

 

 

 

 

 

 

 

 

STOCKHOLDERS' EQUITY

 

 

 

 

 

 

 

 

Share capital

 

 

192,445

 

 

 

191,742

 

Accumulated deficit

 

 

(180,967)

 

 

(143,625 )

Total stockholders' equity

 

 

11,478

 

 

 

48,117

 

 

 

 

 

 

 

 

 

 

Total liabilities and stockholders' equity

 

$37,613

 

 

$118,823

 

 

See Accompanying Notes to Consolidated Financial Statements

 

 
55

table of Contents

 

LOWELL FARMS INC.

CONSOLIDATED STATEMENTS OF INCOME (LOSS)

(in thousands, except per share amounts)

 

 

 

Years Ended

 

 

 

December 31,

 

 

December 31,

 

 

 

2023

 

 

2022

 

Net revenue

 

$28,265

 

 

$43,535

 

Cost of goods sold

 

 

35,707

 

 

 

45,376

 

 

 

 

 

 

 

 

 

 

Gross profit (loss)

 

 

(7,442)

 

 

(1,841

 

 

 

 

 

 

 

 

 

Operating expenses

 

 

 

 

 

 

 

 

General and administrative

 

 

7,302

 

 

 

9,553

 

Sales and marketing

 

 

2,397

 

 

 

5,274

 

Depreciation and amortization

 

 

421

 

 

 

448

 

Total operating expenses

 

 

10,120

 

 

 

15,275

 

 

 

 

 

 

 

 

 

 

Loss from operations

 

 

(17,562)

 

 

(17,116 )

 

 

 

 

 

 

 

 

 

Other income/(expense)

 

 

 

 

 

 

 

 

Other income (expense)

 

 

8,541

 

 

 

2,455

 

Unrealized loss on change in fair value of investment

 

 

(28)

 

 

(109 )

Impairment expense of long-lived assets

 

 

(24,295)

 

 

(3,240

Interest expense

 

 

(3,837)

 

 

(6,363 )

Total other income (expense)

 

 

(19,619)

 

 

(7,257 )

 

 

 

 

 

 

 

 

 

Loss before provision for income taxes

 

 

(37,181)

 

 

(24,373 )

Provision for income taxes

 

 

 161

 

 

 

191

 

Net loss

 

$(37,342 )

 

$(24,564 )

 

 

 

 

 

 

 

 

 

Net loss per share:

 

 

 

 

 

 

 

 

Basic

 

$(2.71)

 

$(2.17 )

Diluted

 

$(2.71)

 

$(2.17 )

Weighted average shares outstanding:

 

 

 

 

 

 

 

 

Basic

 

 

13,790

 

 

 

11,318

 

Diluted

 

 

13,790

 

 

 

11,318

 

 

See Accompanying Notes to Consolidated Financial Statements

 

 
56

table of Contents

 

LOWELL FARMS INC.

CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY (DEFICIT)

(in thousands)

 

 

 

Year Ended December 31, 2022

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Subordinate

Voting

 

 

Super

Voting

 

 

Share

 

 

Accumulated

 

 

Total

Stockholders’

 

 

 

Shares

 

 

Shares

 

 

Capital

 

 

Deficit

 

 

Equity

 

Balance-December 31, 2021

 

 

11,181

 

 

 

20

 

 

$189,368

 

 

$(119,061 )

 

$70,307

 

Net loss

 

 

-

 

 

 

-

 

 

 

-

 

 

 

(24,564 )

 

 

(24,564 )

Shares issued in connection with asset acquisition

 

 

1,000

 

 

 

-

 

 

 

1,800

 

 

 

-

 

 

 

1,800

 

Share re-purchase

 

 

(40)

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

Issuance of vested RSUs

 

 

14

 

 

 

-

 

 

 

10

 

 

 

-

 

 

 

10

 

Share-based compensation expense

 

 

22

 

 

 

-

 

 

 

564

 

 

 

-

 

 

 

564

 

Balance-December 31, 2022

 

 

12,177

 

 

 

20

 

 

$191,742

 

 

$(143,625 )

 

$48,117

 

 

 

 

Year Ended December 31, 2023

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Subordinate

Voting

 

 

Super

Voting

 

 

Share

 

 

Accumulated

 

 

Total Stockholders’

 

 

 

Shares

 

 

Shares

 

 

Capital

 

 

Deficit

 

 

Equity

 

Balance-December 31, 2022

 

 

12,177

 

 

 

20

 

 

$191,742

 

 

$(143,625 )

 

$48,117

 

Net loss

 

 

-

 

 

 

-

 

 

 

-

 

 

 

(37,342 )

 

 

(37,342 )

Shares issued in connection with debenture conversion

 

 

6,843

 

 

 

-

 

 

 

2,027

 

 

 

-

 

 

 

2,027

 

Warrants Cancelled with brand sale

 

 

-

 

 

 

-

 

 

 

(1,555)

 

 

-

 

 

 

(1,555

Issuance of vested RSUs

 

 

4

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

Share-based compensation expense

 

 

-

 

 

 

-

 

 

 

231

 

 

 

-

 

 

 

231

 

Balance-December 31, 2023

 

 

19,024

 

 

 

20

 

 

$192,445

 

 

$(180,967 )

 

$11,478

 

 

See Accompanying Notes to Consolidated Financial Statements

 

 
57

table of Contents

 

LOWELL FARMS INC.

CONSOLIDATED STATEMENTS OF CASH FLOWS

(in thousands)

 

 

 

Years Ended

 

 

 

December 31,

 

 

December 31,

 

 

 

2023

 

 

2022

 

CASH FLOW FROM OPERATING ACTIVITIES

 

 

 

 

 

 

Net loss

 

$(37,342 )

 

$(24,564 )

Adjustments to reconcile net loss to net cash used in operating activities:

 

 

 

 

 

 

 

 

Depreciation and amortization

 

 

5,117

 

 

 

7,376

 

Amortization of debt issuance costs

 

 

712

 

 

 

937

 

Share-based compensation expense

 

 

231

 

 

 

564

 

Provision for doubtful accounts

 

 

616

 

 

 

517

 

Loss on sale of assets

 

 

-

 

 

 

59

 

Gain on sale leaseback

 

 

(3,004 )

 

 

-

 

Gain on lease settlement

 

 

(880 )

 

 

-

 

Unrealized loss (gain) on change in fair value of investments

 

 

28

 

 

 

109 )

Impairment expense

 

 

24,295

 

 

 

3,240

 

Gain on lease termination

 

 

(5,020 )

 

 

 -

 

Changes in operating assets and liabilities:

 

 

 

 

 

 

 

 

Accounts receivable

 

 

927

 

 

 

3,542

Inventory

 

 

6,019

 

 

 

2,564

Prepaid expenses and other current assets

 

 

2,731

 

 

 

454

 

Other assets

 

 

(270 )

 

 

(106

Operating lease liabilities

 

 

 (443

 

 

 -

 

Accounts payable and accrued expenses

 

 

242

 

 

 

(1,136 )

Net cash used in operating activities

 

$(6,041 )

 

$(6,444 )

CASH FLOW FROM INVESTING ACTIVITIES

 

 

 

 

 

 

 

 

Proceeds from asset sales

 

$-

 

 

$60

 

Purchases of property and equipment

 

 

(135 )

 

 

(4,250 )

Acquisition of business assets, net

 

 

-

 

 

-

 

Net cash used in investing activities

 

$(135 )

 

$(4,190 )

CASH FLOW FROM FINANCING ACTIVITIES

 

 

 

 

 

 

 

 

Proceeds from convertible notes, net of financing costs

 

$-

 

 

$6,552

 

Principal payments on finance lease obligations

 

 

(1,527 )

 

 

(2,497 )

Payments on notes payable

 

 

(75 )

 

 

(210 )

Proceeds from sale leaseback

 

 

8,991

 

 

 

-

 

Issuance costs related to subordinate voting share offering

 

 

-

 

 

-

 

Proceeds from exercise of warrants and options

 

 

-

 

 

 

-

 

Net cash provided by financing activities

 

$7,389

 

 

$3,845

 

 

 

 

 

 

 

 

 

 

Change in cash and cash equivalents

 

$1,213

 

$(6,789 )

Cash and cash equivalents-beginning of year

 

 

1,098

 

 

 

7,887

 

Cash, cash equivalents-end of period

 

$2,311

 

 

$1,098

 

 

 

 

 

 

 

 

 

 

SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION

 

 

 

 

 

 

 

 

Cash paid during the period for interest

 

$3,689

 

 

$4,215

 

Cash paid during the period for income taxes

 

$87

 

 

$171

 

 

 

 

 

 

 

 

 

 

OTHER NONCASH INVESTING AND FINANCING ACTIVITIES

 

 

 

 

 

 

 

 

Purchase of property and equipment not yet paid for

 

$7

 

 

$819

 

Issuance of subordinate voting shares to acquire purchase rights

 

$-

 

 

$1,800

 

Issuance of subordinate voting shares in convertible debenture repurchase

 

$

 2,027

 

 

$

  -

 

 

See Accompanying Notes to Consolidated Financial Statements

 

 
58

table of Contents

 

LOWELL FARMS INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

1. BUSINESS, BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

 

Business

 

Lowell Farms Inc. is governed by the laws of British Columbia, Canada. On April 26, 2019, the Company completed a reverse takeover transaction with Indus Holding Company, a Delaware corporation, incorporated in 2014. Effective March 1, 2021, the Company changed its name to Lowell Farms Inc. and is a California-based cannabis company with vertically integrated operations including large scale cultivation, extraction, processing, manufacturing, branding, packaging and wholesale distribution to retail dispensaries. The Company manufactures and distributes proprietary and third-party brands throughout the State of California, the largest cannabis market in the world. The Company also provides manufacturing, extraction and distribution services to third-party cannabis and cannabis branding companies. The Company’s corporate office and principal place of business is located at 19 Quail Run Circle, Salinas, California.

 

Basis of Presentation

 

The consolidated financial statements of Lowell Farms Inc. and its wholly owned subsidiaries (collectively, the “Company,” “we,” “us” or “our”) have been prepared in accordance with generally accepted accounting principles in the United States (“GAAP”). All intercompany transactions and balances have been eliminated in consolidation.

 

All dollar amounts in the consolidated financial statements and notes to consolidated financial statements are expressed in thousands of United States dollars ("$" or "US$"), unless otherwise indicated.

 

Use of Estimates

 

The preparation of financial statements in conformity with generally accepted accounting principles in the United States (“U.S. GAAP”) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Significant estimates in these financial statements include allowance for doubtful accounts and credit losses, carrying value of inventory, revenue recognition, accounting for stock-based compensation expense, and income taxes. Actual results could differ from those estimates.

 

The global COVID-19 pandemic has impacted the operations and purchasing decisions of companies worldwide. It also has created and may continue to create significant uncertainty in the global economy. The Company has undertaken measures to protect its employees, partners, customers, and vendors. In addition, the Company’s personnel are subject to various travel restrictions, which limit the ability of the Company to provide services to customers and affiliates. This impacts the Company's normal operations. To date, the Company has been able to provide uninterrupted access to its products and services, including certain employees that are working remotely, and its pre-existing infrastructure that supports secure access to the Company’s internal systems. If, however, the COVID-19 pandemic has a substantial impact on the productivity of the Company’s employees or its partners’ or customers’ decision to use the Company’s products and services, the results of the Company’s operations and overall financial performance may be adversely impacted. The duration and extent of the impact from the COVID-19 pandemic depends on future developments that cannot be accurately predicted at this time. As of the date of issuance of the financial statements, the Company is not aware of any specific event or circumstance that would require updates to the Company’s estimates and judgments or revisions to the carrying value of its assets or liabilities. These estimates may change, as new events occur and additional information is obtained, and are recognized in the condensed consolidated financial statements as soon as they become known. Actual results could differ from those estimates and any such differences may be material to the financial statements.

 

 
59

table of Contents

 

LOWELL FARMS INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

Significant Accounting Policies

 

Cash and Cash Equivalents

 

Cash and cash equivalents include cash on hand, cash deposits in financial institutions, and other deposits that are readily convertible into cash. The Company considers all short-term, highly liquid investments purchased with maturities of three months or less to be cash equivalents. These investments are carried at cost, which approximates fair value.

 

As of December 31, 2023 and December 31, 2022, the Company’s cash and cash equivalents exceeded FDIC insured limits by $1,974 and $360, respectively.

 

Accounts Receivable

 

Accounts receivables are classified as loans and receivable financial assets. Accounts receivables are recognized initially at fair value and subsequently measured at amortized cost, less any provisions for impairment. When an accounts receivable is uncollectible, it is written off against the provision. Subsequent recoveries of amounts previously written off are credited to the consolidated statements of operations.

 

Inventories

 

Inventories are valued at the lower of cost and net realizable value. Costs related to raw materials and finished goods are determined on the first-in, first-out basis. Specific identification and average cost methods are also used primarily for certain packing materials and operating supplies. The Company reviews inventory for obsolete, redundant and slow-moving goods and any such inventory is written-down to net realizable value.

 

Property and Equipment

 

Property and equipment are stated at cost, net of accumulated depreciation and impairment losses, if any. Depreciation is calculated on a straight-line basis over the estimated useful life of the asset using the following terms and methods:

 

Category

 

Useful Life

Leasehold improvements

 

The lesser of the estimated useful life or length of the lease

Office equipment

 

3-5 years

Furniture and fixtures

 

3-7 years

Vehicles

 

4-5 years

Machinery and equipment

 

3-6 years

Buildings

 

35 years

Construction in progress

 

Not depreciated

 

The assets’ residual values, useful lives and methods of depreciation are reviewed at each financial year-end and adjusted prospectively if appropriate. An item of equipment is derecognized upon disposal or when no future economic benefits are expected from its use. Any gain or loss arising on derecognition of the asset (calculated as the difference between the net disposal proceeds and the carrying value of the asset) is included in the consolidated statements of operations in the year the asset is derecognized.

 

 
60

table of Contents

 

LOWELL FARMS INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

Goodwill

 

Goodwill represents the excess of the purchase price paid for the acquisition of an entity over the fair value of the net tangible and intangible assets acquired. Goodwill that has an indefinite useful life is not subject to amortization and is tested annually for impairment, or more frequently if events or changes in circumstances indicate that goodwill might be impaired. Any goodwill impairment loss is recognized in the consolidated statements of operations in the period in which the impairment is identified. Impairment losses on goodwill are not subsequently reversed.

 

Intangible Assets

 

Intangible assets are recorded at cost, less accumulated amortization and impairment losses, if any. Intangible assets acquired in a business combination are measured at fair value at the acquisition date. Intangible assets acquired in an asset purchase are valued at their purchase price. Amortization is recorded on a straight-line basis over their estimated useful lives, which do not exceed the contractual period, if any. The estimated useful lives, residual values, and amortization methods are reviewed at each year-end, and any changes in estimates are accounted for prospectively.

 

Branding rights are measured at fair value at the time of acquisition and are amortized on a straight-line basis over a period of 15 years. In addition, the Company has certain brand and tradenames with indefinite lives, which are evaluated for impairment on an annual basis.

 

Impairment of Long-lived Assets

 

Long-lived assets, including property, plant and equipment and intangible assets are reviewed for impairment at each statement of financial position date or whenever events or changes in circumstances indicate that the carrying amount of an asset exceeds its recoverable amount. For the purpose of impairment testing, assets that cannot be tested individually are grouped together into the smallest group of assets that generates cash inflows from continuing use that are largely independent of the cash inflows of other assets or groups of assets. The recoverable amount of an asset or an asset group is the higher of its fair value, less costs to sell, and its value in use. If the carrying amount of an asset exceeds its recoverable amount, an impairment charge is recognized immediately in profit or loss equal to the amount by which the carrying amount exceeds the recoverable amount. Where an impairment loss subsequently reverses, the carrying amount of the asset is increased to the lesser of the revised estimate of the recoverable amount, and the carrying amount that would have been recorded had no impairment loss been recognized previously.

 

Leased Assets

 

The Company adopted FASB Topic 842, Leases (“Topic 842”) effective January 1, 2019, using the modified retrospective adoption method which allowed it to initially apply the new standard at the adoption date and recognize a cumulative-effect adjustment to the opening balance of accumulated deficit. In connection with the adoption of the lease pronouncement, the Company recorded a charge to accumulated deficit of $847. A lease of property and equipment is classified as a capital lease if it transfers substantially all the risks and rewards incidental to ownership to the Company. Lease right-of-use assets represent the right to use an underlying asset for the lease term, and lease liabilities represent the obligation to make payments arising from the lease agreement. These assets and liabilities are recognized at the commencement of the lease based upon the present value of the future minimum lease payments over the lease term. The lease term reflects the noncancelable period of the lease together with periods covered by an option to extend or terminate the lease when management is reasonably certain that it will exercise such option. Changes in the lease term assumption could impact the right-of-use assets and lease liabilities recognized on the balance sheet. As our leases typically do not contain a readily determinable implicit rate, we determine the present value of the lease liability using our incremental borrowing rate at the lease commencement date based on the lease term on a collateralized basis.

 

The Company accounts for sales leaseback transactions in accordance with ASC 842-40: Sale and Leaseback Transactions. The Company determines whether the transfer of an asset represents a sale based on requirements from Topic 606, lease classification, and nature of purchase options. If a transfer is deemed a sale and at fair value, the Company derecognizes the asset and records a gain/(loss) in the income statement. If a transfer is deemed a sale and not at fair value, the Company derecognizes the asset and does not recognize a gain/(loss) in the income statement. If a transfer of the asset is not a sale, the Company does not derecognize the asset.

 

 

 
61

table of Contents

 

LOWELL FARMS INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

 Income Taxes

 

The Company is a United States C corporation for income tax purposes. Income tax expense consisting of current and deferred tax expense is recognized in the consolidated statements of operations. Current tax expense is the expected tax payable on the taxable income for the year, using tax rates enacted or substantively enacted at year-end, adjusted for amendments to tax payable with regards to previous years. Deferred tax assets and liabilities and the related deferred income tax expense or recovery are recognized for deferred tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using the enacted or substantively enacted tax rates expected to apply when the asset is realized or the liability settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that substantive enactment occurs. A deferred tax asset is recognized to the extent that it is probable that future taxable income will be available against which the asset can be utilized. Deferred tax assets and liabilities are offset when there is a legally enforceable right to set off current tax assets against current tax liabilities and when they relate to income taxes levied by the same taxation authority and the Company intends to settle its current tax assets and liabilities on a net basis.

 

Revenue Recognition

 

Revenue is recognized upon transfer of control of promised products or services to customers in an amount that reflects the consideration the Company expects to receive in exchange for those products or services. The Company enters contracts that can include various combinations of products and services, which are generally capable of being distinct and accounted for as separate performance obligations Revenue is recognized net of allowances for returns and any taxes collected from customers, which are subsequently remitted to governmental authorities.

 

Branded Products

 

For the Company’s branded products, revenue is recognized when it satisfies a performance obligation by transferring a promised cannabis good to a customer. A contract, whether a verbal or written sales order, is established with customers prior to order fulfillment with agreement upon unit prices, delivery dates, and payment terms. The transaction price is based on market pricing while considering the value of the Company’s brand and quality. Transaction price is allocated to each product sold based upon the negotiated unit sales price associated with each product line scheduled for delivery within the order. Performance obligation satisfaction occurs upon delivery to customer premises. These types of revenues accounted for under ASC Topic 606, generally, do not require significant estimates or judgments based on the nature of the Company’s revenue stream. The sales prices, including discounts, are fixed at the point of sale and all consideration from contracts is included in the transaction price. The Company’s contracts do not include multiple performance obligations or material variable consideration.

 

Third Party Manufactured Products

 

The Company has certain licenses to manufacture and distribute third party products to retail dispensaries and deliveries in return for paying royalty payments to the third parties. The Company is a principal in the arrangement, it assumes primary responsibility for fulfilling the customer promise to retail dispensaries and deliveries, and it holds the inventory risk. Revenue is recognized when it satisfies a performance obligation by transferring a promised cannabis good to a retail dispensary or retail delivery. A contract, whether a verbal or written sales order, is established with customers prior to order fulfillment with agreement upon unit prices, delivery dates, and payment terms. The transaction price is based on market pricing while considering the value of the Company’s brand and quality. Transaction price is allocated to each product sold based upon the negotiated unit sales price associated with each product line scheduled for delivery within the order. Performance obligation satisfaction occurs upon delivery to customer premises. These types of revenues accounted for under ASC Topic 606, generally, do not require significant estimates or judgments based on the nature of the Company’s revenue stream. The sales prices, including discounts, are fixed at the point of sale and all consideration from contracts is included in the transaction price. The Company’s contracts do not include multiple performance obligations or material variable consideration.

 

 
62

table of Contents

 

LOWELL FARMS INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

Licensing

 

The Company has entered into contracts to license the right to utilize the Company’s branding and intellectual property. For all sales utilizing the license, the Company recognizes a percentage based license fee. Revenue is recognized when performance obligations are satisfied by recognizing fees on sales utilizing the licensed property to other companies. Contracts exist that define the property that is licensed, the time period, the fees and payment terms. These types of revenues accounted for under ASC Topic 606, generally, do not require significant estimates or judgments based on the nature of the Company’s revenue stream.

 

Distribution

 

The Company distributes certain third-party brands and bulk flower. The Company is a principal in the arrangement, it assumes primary responsibility for fulfilling the customer promise to retail dispensaries and deliveries and other wholesale customers, and it holds the inventory risk. Revenue is recognized when it satisfies a performance obligation by transferring a promised cannabis good to a customer. A contract, whether a verbal or written sales order, is established with customers prior to order fulfillment with agreement upon unit prices, delivery dates, and payment terms. The transaction price is based on market pricing while considering the value of the Company’s brand and quality. Transaction price is allocated to each product sold based upon the negotiated unit sales price associated with each product line scheduled for delivery within the order. Performance obligation satisfaction occurs upon delivery to customer premises. These types of revenues accounted for under ASC Topic 606, generally, do not require significant estimates or judgments based on the nature of the Company’s revenue stream. The sales prices, including discounts, are fixed at the point of sale and all consideration from contracts is included in the transaction price. The Company’s contracts do not include multiple performance obligations or material variable consideration.

 

Lowell Farms Services

 

The Company performs various processing activities under Lowell Farms Services including drying, bucking, trimming, sorting, grading and packaging operations. Revenue is recognized when it satisfies a performance obligation by completing the agreed upon services that were negotiated with a customer. A contract, whether a verbal or written sales order, is established with customers prior to completing the agreed upon services with the type of services to be performed and with the agreed upon pricing and timing. The transaction price is based on the nature of the services to be performed and market pricing. Performance obligation satisfaction occurs upon completion of the services performed. These types of revenues accounted for under ASC Topic 606, generally, do not require significant estimates or judgments based on the nature of the Company’s revenue stream. The Company’s contracts do not include multiple performance obligations or material variable consideration.

 

Research and Development

 

Research costs are expensed as incurred. For the years ended December 31, 2023 and 2022, research costs are immaterial.

 

For the year ended December 31, 2022, the Company incurred certain development expenditures related to the Lowell 35s product line that launched during the third quarter of the year ended December 31, 2022. Development costs of approximately $78 were expensed during the year ended December 31, 2022 to validate that the product line was commercially and technically feasible and to bring the product to market. Development expenditures are capitalized only if development costs are material, can be measured reliably, future economic benefits are probable, and the Company intends to and has sufficient resources to complete the development to use or sell the asset. To date, no development costs have been capitalized.

 

Share-Based Compensation

 

The Company has a share-based compensation plan. The Company measures equity settled share-based payments based on their fair value at the grant date and recognizes compensation expense over the vesting period based on the Company’s estimate of equity instruments that will eventually vest.

 

For shares granted to non-employees, the compensation expense is measured at the fair value of the goods and services received, except where the fair value cannot be estimated, in which case, it is measured at the fair value of the equity instruments granted. The fair value of share-based compensation to non-employees is periodically re-measured until counterparty performance is complete, and any change therein is recognized over the period and in the same manner as if the Company had paid cash instead of paying with or using equity instruments.

 

Business Combinations

 

A business combination is defined as an acquisition of assets and liabilities that constitute a business. A business consists of inputs, including non-current assets and processes, including operational processes, that when applied to those inputs have the ability to create outputs that provide a return to the Company. Business combinations are accounted for using the acquisition method of accounting. The consideration of each acquisition is measured at the aggregate of the fair values of tangible and intangible assets obtained, liabilities and contingent liabilities incurred or assumed, and equity instruments issued by the Company at the date of acquisition. Key assumptions routinely utilized in allocation of purchase price to intangible assets include projected financial information such as revenue projections for companies acquired. As of the acquisition date, goodwill is measured as the excess of consideration given, generally measured at fair value, and the net of the acquisition date fair values of the identifiable assets acquired and the liabilities assumed.

 

 
63

table of Contents

  

LOWELL FARMS INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

  

Recently Adopted Accounting Standards

 

In December 2019, the FASB issued ASU 2019-12, Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes. This guidance removes certain exceptions to the general principles in Topic 740 and enhances and simplifies various aspects of the income tax accounting guidance, including requirements such as tax basis step-up in goodwill obtained in a transaction that is not a business combination, ownership changes in investments, and interim-period accounting for enacted changes in tax law. This standard is effective for fiscal years and interim periods within those fiscal years beginning after December 15, 2020. This guidance was effective for the Company in our fiscal year and interim periods beginning on January 1, 2021 and did not have a material impact on our consolidated financial statements.

 

In January 2020, the FASB issued ASU 2020-01 Investments-Equity Securities (Topic 321), Investments-Equity Method and Joint Ventures (Topic 323), and Derivatives and Hedging (Topic 815) - Clarifying the Interactions between Topic 321, Topic 323, and Topic 815. This guidance addresses accounting for the transition into and out of the equity method and provides clarification of the interaction of rules for equity securities, the equity method of accounting, and forward contracts and purchase options on certain types of securities. This standard is effective for fiscal years and interim periods within those fiscal years beginning after December 15, 2020. We evaluated the impact of ASU 2020-01 on our Consolidated Financial Statements, which was effective for the Company in our fiscal year and interim periods beginning on January 1, 2021 and it did not have a material impact on our consolidated financial statements.

 

In August 2020, the FASB issued ASU 2020-06, Debt-Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging-Contracts in Entity’s Own Equity (Subtopic 815-40). This update amends the guidance on convertible instruments and the derivatives scope exception for contracts in an entity's own equity and improves and amends the related EPS guidance for both Subtopics. This standard is effective for fiscal years and interim periods within those fiscal years beginning after December 15, 2021, which means it was effective for our fiscal year beginning January 1, 2022 and did not have a material impact on our consolidated financial statements.

 

Accounting standards not yet adopted

 

In October 2021, the FASB issued ASU 2021-08-Business Combinations (“Topic 805”): Accounting for Contract Assets and Contract Liabilities from Contracts with Customers. The amendments in ASU 2021-08 require that an entity recognizes and measures contract assets and contract liabilities acquired in a business combination in accordance with ASC 606, Revenue from Contracts with Customers (“Topic 606”). At the acquisition date, an acquirer should account for the related revenue contracts in accordance with Topic 606 as if it had originated the contracts. The amendments improve comparability for both the recognition and measurement of acquired revenue contracts with customers at the date of and after a business combination. This standard is effective for fiscal years and interim periods within those fiscal years beginning after December 15, 2022, which means it was effective for our fiscal year beginning January 1, 2023 and did not have a material impact on our consolidated financial statements.

 

No other recently issued accounting pronouncements had or are expected to have a material impact on our consolidated financial statements.

 

 

 
65

table of Contents

 

 LOWELL FARMS INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

2. PREPAID AND OTHER CURRENT ASSETS

 

Prepaid and other current assets were comprised of the following items:

 

 

 

December 31,

 

 

December 31,

 

(in thousands)

 

2023

 

 

2022

 

Deposits

 

$1,134

 

 

$595

 

Insurance

 

 

237

 

 

 

235

 

Supplier advances

 

 

26

 

 

 

375

 

Interest and taxes

 

 

26

 

 

 

69

 

Licenses and payments

 

 

106

 

 

 

146

 

Royalty Advance

 

 

853

 

 

 

-

 

Other

 

 

15

 

 

 

102

 

Total prepaid and other current assets

 

$2,397

 

 

$1,522

 

 

3. INVENTORY

 

Inventory, net was comprised of the following items:

 

 

 

December 31,

 

 

December 31,

 

(in thousands)

 

2023

 

 

2022

 

Raw materials

 

$1,400

 

 

$7,431

 

Work in process

 

 

307

 

 

 

940

 

Finished goods

 

 

3,053

 

 

 

2,408

 

Total inventory

 

$4,760

 

 

$10,779

 

 

As a result of the Zabala lease termination, the Company wrote off $2,607 of plant inventory that was in the facility as of the end of the year, which was recorded in cost of goods sold.

 

The Company recorded an inventory reserve of $1,780 and $1,492 for the year ended December 31, 2023 and 2022, respectively.

 

 

4. OTHER CURRENT LIABILITIES

 

Other current liabilities were comprised of the following items:

 

 

 

December 31,

 

 

December 31,

 

(in thousands)

 

2023

 

 

2022

 

Excise and cannabis tax

 

$3

 

 

$948

 

Third party brand distribution accrual

 

 

558

 

 

 

17

 

Insurance and professional fee accrual

 

 

287

 

 

 

158

 

Interest and tax accrual

 

 

109

 

 

 

921

 

Employee Retention Credit financing accrual

 

 

441

 

 

 

441

 

Equipment purchase accrual

 

 

-

 

 

 

724

 

Other

 

 

545

 

 

 

445

 

Total other current liabilities

 

$1,943

 

 

$3,654

 

 

On July 26, 2022, subsidiaries of the Company entered into an agreement with an institutional investor pursuant to which the investor purchased a participation ("Transferred Interests") in all rights to payment from the United States IRS in respect of the Company’s employee retention credits for the first and second quarters of 2021 (the “ERC Claim”). The purchase price paid for the derivative payment rights was $2,446, which was paid in immediately available funds. For the year ended December 31, 2022, the Company recorded net other income of $2,014 and an accrued other liability of $441 to be paid to facilitate the sale of the ERC Claim. Included in interest expense is $864 of financing related charges.

 

 
66

table of Contents

 

LOWELL FARMS INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

5. PROPERTY AND EQUIPMENT AND RIGHT OF USE ASSETS

 

A reconciliation of the beginning and ending balances of property and equipment, right of use assets and accumulated depreciation during the years ended December 31, 2023 and 2022, and property and equipment, net and right of use assets, net as of for the same years are as follows:

 

 

 

Land and

 

 

Leasehold

 

 

Furniture

and

 

 

 

 

 

 

Construction

 

 

Right of

 

 

 

(in thousands)

 

Buildings

 

 

Improvements

 

 

Fixtures

 

 

Equipment

 

 

Vehicles

 

 

in Process

 

 

Use Assets

 

 

Total

 

Costs

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Balance-December 31, 2022

 

$15,719

 

 

$12,437

 

 

$50

 

 

$6,499

 

 

$830

 

 

$35

 

 

$37,081

 

 

$72,651

 

Additions

 

 

-

 

 

 

29

 

 

 

-

 

 

 

106

 

 

 

-

 

 

 

-

 

 

 

17,068

 

 

 

17,203

 

Disposals

 

 

(15,719 )

 

 

(202 )

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

(15,921

Remeasurements

 

 

-

 

 

 

-

 

 

 

 

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

(4,602 )

 

 

(4,602)

Impairments

 

 

-

 

 

 

(10,148 )

 

 

-

 

 

 

(1,310 )

 

 

-

 

 

 

-

 

 

 

(28,230 )

 

 

(39,688

 

Balance-December 31, 2023

 

$-

 

 

$2,116

 

 

$50

 

 

$5,295

 

 

$830

 

 

$35

 

 

$21,317

 

 

$29,643

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Accumulated Depreciation

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Balance-December 31, 2022

 

$(315 )

 

$(1,815 )

 

$(49 )

 

$(1,498 )

 

$(608 )

 

$-

 

 

$(9,719 )

 

$(14,004

Depreciation

 

 

(71 )

 

 

(837 )

 

-

 

 

 

(925 )

 

 

(136 )

 

 

-

 

 

 

(2,742 )

 

 

(4,711

Disposals

 

 

386

 

 

 

55

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

441

 

Remeasurement

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

2,661

 

 

 

2,661

 

Impairments

 

 

-

 

 

 

1,516

 

 

 

-

 

 

 

70

 

 

-

 

 

 

-

 

 

 

6,810

 

 

 

8,396

 

Balance-December 31, 2023

 

$

 -

 

 

$(1,081 )

 

$(49 )

 

$(2,353 )

 

$(744 )

 

$-

 

 

$(2,990 )

 

$(7,217

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net Book Value-December 31, 2023

 

$-

 

 

$1,035

 

 

$1

 

 

$2,942

 

 

$86

 

 

$35

 

 

$18,327

 

 

$22,426

 

 

Construction in process represents assets under construction related to cultivation, manufacturing, and distribution facilities not yet completed or otherwise not placed in service.

 

Depreciation expense of $4,711, and $7,022, were recorded for the years ended December 31, 2023 and 2022 respectively, of which $4,613 and $6,292, respectively, were included in cost of goods sold. Depreciation expense of $608 was also recorded in other expense for the year ended December 31, 2022.

 

As a result of the Zabala lease termination, the Company wrote off $8,632 of leasehold improvements and $151 of equipment resulting in an impairment expense of $8,783, which was recorded in other income and expense.

  

 
67

table of Contents

 

LOWELL FARMS INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

6. INTANGIBLE ASSETS

 

A reconciliation of the beginning and ending balances of intangible assets and accumulated amortization during the years ended December 31, 2023 and 2022 are as follows:

 

 

 

Definite Life Intangibles

 

 

Indefinite Life

 

 

 

 

 

Technology/

 

 

Acquired

Purchase

 

 

Intangibles

Brands &

 

 

 

(in thousands)

 

Know How

 

 

Rights

 

 

Tradenames

 

 

Total

 

Costs

 

 

 

 

 

 

 

 

 

 

 

 

Balance-December 31, 2022

 

$3,258

 

 

$1,800

 

 

$37,707

 

 

$42,765

 

Sale of Brand Assets

 

 

 

 

 

 

 

 

 

 

(24,053 )

 

 

(37,299 )

Impairment

 

 

(258 )

 

 

(1,384

)

 

 

(13,654

 

 

(2,050

Balance-December 31, 2023

 

$3,000

 

 

$416

 

 

$-

 

 

$3,416

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Accumulated Amortization

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Balance-December 31, 2022

 

$(535 )

 

$(28 )

 

$-

 

 

$(563 )

Amortization

 

 

(323 )

 

 

(83 )

 

 

-

 

 

 

(406 )

     Impairment

 

 

 97

 

 

 

 -

 

 

 

 

 

 

 

 97

 

Balance-December 31, 2023

 

$(761 )

 

$(111 )

 

$-

 

 

$(872 )

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net Book Value

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

December 31, 2022

 

$2,723

 

 

$1,772

 

 

$37,707

 

 

$42,202

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net Book Value

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

December 31, 2023

 

$2,239

 

 

$305

 

 

$-

 

 

$2,544

 

 

Intangible assets with finite lives are amortized over their estimated useful lives. Amortization periods of assets with finite lives are based on management's estimates at the date of acquisition. The Company recorded amortization expense of $406, and $354 for the years ended December 31, 2023, and 2022, respectively.

 

During the year ended December 31, 2022, the Company acquired rights to purchase additional manufacturing equipment related to the Lowell 35s automated pre-roll line. Per the terms of the purchase agreement, the Company acquired the rights to acquire eight pre-roll machines and one packaging machine and received 15% of the issued and outstanding shares of the selling company, which have a fair market value of $nil. For the year ended December 31, 2022, one pre-roll machine and the packaging machine were received and in use and the acquired purchase rights are being amortized over the five year useful life of the machines. As consideration for the purchase of the acquisition rights, the Company paid for deposits on a portion of the machines, which are reflected as additions within Property and Equipment and issued 1 million subordinate voting shares with a fair market value of  $1,800 on the issuance date. The Company impaired the remaining purchase rights on the unpurchased machines in the period ending December 31, 2023.

 

On October 6th, 2023 the Company repurchased all of the $22,157 aggregate principal amount of outstanding Senior Secured Convertible Debentures (“Debentures”) together with the related warrants to purchase 10,627,483 subordinate voting shares of the Company and 4,324,845 common shares of Indus which have been cancelled. Share amounts reflect the 1 for 10 reverse stock split effective August 31, 2023. A total of 6,849,572 shares of the Company were issued to holders based on the proportion of the outstanding Debentures held by such holder, of (x) membership interests in LF Brandco LLC (“Brandco”), an entity formed to hold the Company’s intellectual property relating to its “Lowell Smokes” and “Lowell Herb Co.” brands (including trademarks, logos and additional identifying marks, domain names and social media accounts). During the year ended December 31, 2023, and as result of the transaction, the Company recognized $13,245 of impairment on the intangible brand assets.

 

 In addition, the Company has entered into a license agreement with Brandco for the “Lowell” trademarks, logos, and related intellectual property on an exclusive basis in the State of California for a five-year license term, with up to three five-year extensions. The Company’s exercise of the extension terms is subject to mutual agreement on certain sales performance criteria for each extension term. In addition, the Company received a $1 million royalty advance whereby the Company does not have to pay the first $1 million of royalty expense.

 

The transaction is considered to be a “related party transaction” because insiders of the Company hold Debentures and Warrants.

 

 As a result of the transaction, the Company derecognized Lowell brand name intangible ($24.1) million, convertible notes ($22.1) million, accrued interest ($1.49) million and warrants ($1.55) million. Issued shares and royalty advance were recorded at fair value in the amount of $2.03 million or $0.93 million, respectively.

 

The Company estimates that amortization expense for our existing other intangible assets will average approximately $317 annually for the next seven and a half fiscal years. Actual amortization expense to be reported in future periods could differ from these estimates as a result of new intangible asset acquisitions, changes in useful lives or other relevant factors or changes.

 

 
68

table of Contents

 

LOWELL FARMS INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

7. SHAREHOLDERS’ EQUITY

 

Shares Outstanding

 

The table below details the change in Company shares outstanding by class during year ended December 31, 2023:

 

 

 

Subordinate

 

 

Super

 

(in thousands)

 

Voting Shares

 

 

Voting Shares

 

Balance-December 31, 2022

 

 

12,177

 

 

 

20

 

Issuance of vested restricted stock units

 

 

4

 

 

 

-

 

Issuance of shares in convertible debt conversion

 

 

6,843

 

 

 

-

 

Balance-December 31, 2023

 

 

19,024

 

 

 

20

 

 

Warrants

 

A reconciliation of the beginning and ending balances of warrants outstanding is as follows:

 

(in thousands)

 

 

 

Balance-December 31, 2022

 

 

17,343

 

Warrants canceled in conjunction with convertible debt conversion

 

 

(15,052)

Warrants expired

 

 

(1,165 )

Balance-December 31, 2023

 

 

1,126

 

 

 

8. DEBT

 

Debt at December 31, 2023 and 2022, was comprised of the following:

 

 

 

December 31,

 

 

December 31,

 

(in thousands)

 

2023

 

 

2022

 

Current portion of long-term debt

 

 

 

 

 

 

Vehicle loans(1)

 

$3

 

 

$15

 

Mortgage payable(2)

 

 

-

 

 

 

257

 

Note payable

 

 

-

 

 

 

10

 

Convertible debt(3)

 

 

-

 

 

 

21,398

 

Total short-term debt

 

 

3

 

 

 

21,680

 

 

 

 

 

 

 

 

 

 

Long-term debt, net

 

 

 

 

 

 

 

 

Vehicle loans(1)

 

 

-

 

 

 

3

 

Mortgage payable(2)

 

 

-

 

 

 

8,713

 

Convertible debenture(3)

 

 

-

 

 

 

-

 

Total long-term debt

 

 

-

 

 

 

8,716

 

Total Indebtedness

 

$3

 

 

$30,396

 

_____________

(1)

Primarily fixed term loans on transportation vehicles. Weighted average interest rate at December 31, 2023 and December 31, 2022 was 6.4%.

(2)

Mortgage payable associated with the acquired processing facility. Weighted average interest rate at December 31, 2022 was 12.5%. Net of deferred financing costs as December 31, 2022 of $296.As part of sale leaseback transaction, the Company sold the property, and the buyer assumed the mortgage. Refer to Note “Leases” for more information

      

(3)

Net of deferred financing costs at December 31, 2022 of $759.During the year, the Company repurchased the Convertible Notes. Refer to Note “Intangible Assets” for more information.

 

 

 
69

table of Contents

 

LOWELL FARMS INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

Stated maturities of debt obligations are as follows as of December 31, 2023:

 

 

 

December 31,

 

(in thousands)

 

2023

 

2024

 

$3

 

Total debt obligations

 

$3

 

 

9. LEASES

 

A reconciliation of lease obligations for the years ended December 31, 2023 and 2022, is as follows:

 

(in thousands)

 

 

 

 

 

 

Lease obligation

 

 Operating Leases

 

 

Finance Leases 

 

 

Total

 

December 31, 2022

 

$-

 

 

 

33,999

 

 

 

33,999

 

Sale leaseback addition

 

 

17,068

 

 

 

-

 

 

 

17,068

 

Lease principal payments

 

 

(443)

 

 

(1,527)

 

 

(1,970

Lease remeasurement

 

 

(2,064)

 

 

-

 

 

 

(2,064

 

Lease settlement

 

 

-

 

 

 

(1,202)

 

 

(1,202

Lease termination

 

 

-

 

 

 (26,319

)

 

 

(26,319

)

Operating lease remeasurement classification

 

 

4,841

 

 

(4,841

 

 

-

 

December 31, 2023

 

$19,402

 

 

 

110

 

 

 

19,512

 

 

As a result of the Zabala lease termination, The Company derecognized the right of use asset in the amount of $21,423 and lease obligation of $26,319, which resulted in a gain on termination of $4,896, which was recorded in Other Income/(expense).

 

During the year, the Company entered into a sale and leaseback transaction for its Spence Road facility. As part of the transaction, the Company sold the property for $19.4 million including assumption of the underlying mortgage. The Company leased back the facility for a ten-year period with 2 ten-year extension options. The Company accounted for the transaction as a sale recorded a gain of $3.04 million in Other income (expense). The lease back was classified as an operating lease.

 

All extension options that are reasonably certain to be exercised have been included in the measurement of lease obligations. The Company reassesses the likelihood of extension option exercise if there is a significant event or change in circumstances within its control.

 

The components of lease expense for the years ended December 31, 2023, and 2022, are as follows:

 

 

 

Years Ended

 

Finance Leases

 

December 31,

 

 

December 31,

 

(in thousands)

 

2023

 

 

2022

 

Amortization of leased assets (1)

 

$1,651

 

 

$3,755

 

Interest on lease liabilities (2)

 

 

1,651

 

 

 

2,219

 

Total

 

$3,316

 

 

$5,974

 

____________

(1) Included in cost of goods sold, general and administrative expenses and other expenses in the consolidated statement of operations.

(2) Included in interest expense in the consolidated statement of operations.

 

 

 

Years Ended

 

Operating Leases

 

December 31,

 

 

December 31,

 

(in thousands)

 

2023

 

 

2022

 

Amortization of leased assets (1)

 

$

1,091

 

 

$

-

 

Interest on lease liabilities (1)

 

 

1,326

 

 

 

-

 

Total

 

$

2,417

 

 

$

-

 

____________

(1) Included in cost of goods sold, general and administrative expenses and other expenses in the consolidated statement of operations.

 

 
70

table of Contents

 

LOWELL FARMS INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

The key assumptions used in accounting for leases as of December 31, 2023, were a weighted average remaining lease term of 8.9 years and a weighted average discount rate of 10%. The key assumptions used in accounting for leases as of December 31, 2022 were a weighted average remaining lease term of 14.6 years and a weighted average discount rate of 6%.

 

The future lease payments with initial remaining terms in excess of one year as of December 31, 2023 were as follows:

 

 

 

December 31,

 

(in thousands)

 

2023

 

2024

 

 

3,285

 

2025

 

 

3,258

 

2026

 

 

3,240

 

2027

 

 

3,324

 

2028 and beyond

 

 

52,341

 

Total lease payments

 

$65,448

Less imputed interest

 

 

(45,936)

Total

 

$19,512

 

 

 10. SHARE-BASED COMPENSATION

 

During 2019, the Company’s Board of Directors adopted the 2019 Stock and Incentive Plan (the “Plan”), which was amended in April 2020 and March 2021. The Plan permits the issuance of stock options, stock appreciation rights, stock awards, share units, performance shares, performance units and other stock-based awards, and, as of December 31, 2022, 13.2 million shares have been authorized to be issued under the Plan and 3.6 million are available for future grant. The Plan provides for the grant of options as either non-statutory stock options or incentive stock options and restricted stock units to employees, officers, directors, and consultants of the Company to attract and retain persons of ability to perform services for the Company and to reward such individuals who contribute to the achievement by the Company of its economic objectives. The awards granted generally vest in 25% increments over a four-year period and option awards expire 6 years from grant date

The Plan is administered by the Board or a committee appointed by the Board, which determines the persons to whom the awards will be granted, the type of awards to be granted, the number of awards to be granted, and the specific terms of each grant, including the vesting thereof, subject to the provisions of the Plan.

 

During the years December 31, 2023 and 2022, the Company granted shares to certain employees as compensation for services. These shares were accounted for in accordance with ASC 718 - Compensation - Stock Compensation. The Company amortizes awards over the service period and until awards are fully vested.

 

For the years ended December 31, 2023, and 2022 share-based compensation expense was as follows:

 

 

 

Years Ended

 

 

 

December 31,

 

 

December 31,

 

(in thousands)

 

2023

 

 

2022

 

Cost of goods sold

 

$-

 

 

$-

 

General and administrative expense

 

 

231

 

 

 

564

 

Total share-based compensation

 

$231

 

 

$564

 

 

 
71

table of Contents

 

 LOWELL FARMS INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

The following table summarizes the status of stock option grants and unvested awards at and for the year ended December 31, 2023:

 

 

 

 

 

Weighted-

 

 

Weighted-

Average

 

 

 

 

 

 

 

Average

 

 

Remaining

 

 

Aggregate

 

(in thousands except per share amounts)

 

Stock

Options

 

 

Exercise

Price

 

 

Contractual

Life

 

 

Intrinsic

Value

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Outstanding-December 31, 2022

 

 

1,007

 

 

$4.7

 

 

 

4.6

 

 

 

-

 

Granted

 

 

828

 

 

 

0.3

 

 

 

 

 

 

 

-

 

Expired

 

 

(28)

 

 

20.4

 

 

 

 

 

 

 

-

 

Cancelled

 

 

(354)

 

 

4.6

 

 

 

 

 

 

 

-

 

Outstanding-December 31, 2023

 

 

1,453

 

 

 

1.9

 

 

 

5.3

 

 

 

-

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Exercisable-December 31, 2023

 

 

988

 

 

 

2.09

 

 

 

5.2

 

 

 

-

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Vested and expected to vest-December 31, 2023

 

 

1,453

 

 

 

1.91

 

 

 

5.3

 

 

 

-

 

 

The weighted-average fair value of options granted during the year ended December 31, 2023, estimated as of the grant date was $0.30. As of December 31, 2023, there was $191 of total unrecognized compensation cost related to non-vested options, which is expected to be recognized over a remaining weighted-average vesting period of 0.99 years.

 

The following table summarizes the status of restricted stock unit (“RSU”) grants and unvested awards at and for the year ended December 31, 2023:

 

 

 

 

 

Weighted-Average

 

(in thousands except per share amounts)

 

RSUs

 

 

Fair Value

 

 

 

 

 

 

 

 

Outstanding-December 31, 2022

 

 

21

 

 

$1.10

 

Granted

 

 

-

 

 

-

 

Vested

 

(4

)

 

 

-

 

Cancelled

 

 

(17 )

 

 

1.02

 

Outstanding-December 31, 2023

 

 

-

 

 

$-

 

 

As of December 31, 2023, there was no unrecognized compensation cost related to non-vested restricted stock units.

 

The fair value of the stock options and RSUs granted were determined using the Black-Scholes option-pricing model with the following weighted average assumptions at the time of grant. No RSUs were granted for the years ended December 31, 2023 and 2022.

 

Options

 

Years Ended

 

 

 

December 31,

 

 

December 31,

 

 

 

2023

 

 

2022

 

Expected volatility

 

 

50%

 

 

50%

Dividend yield

 

 

0%

 

 

0%

Risk-free interest rate

 

 

4.12%

 

 

2.48%

Expected term in years

 

 

5.58

 

 

 

3.9

 

 

 

 
72

table of Contents

 

 LOWELL FARMS INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

11. INCOME TAXES

 

Coronavirus Aid, Relief and Economic Security Act

 

On March 27, 2020, the Coronavirus Aid, Relief, and Economic Security Act (the “CARES Act”) was enacted and signed into law in response to the market volatility and instability resulting from the COVID-19 pandemic. It includes a significant number of tax provisions and lifts certain deduction limitations originally imposed by the Tax Cuts and Jobs Act of 2017 (the “2017 Act”). The changes mainly related to: (1) the business interest expense disallowance rules for 2019 and 2020; (2) net operating loss rules; (3) charitable contribution limitations; (4) employee retention credit; and (5) the realization of corporate alternative minimum tax credits.

 

The Company continues to assess the impact and future implication of these provisions; however, it does not anticipate any amounts that could give rise to a material impact to the overall consolidated financial statements.

 

The provision for income tax expense for the year ended December 31, 2023, was $161, representing an effective tax rate of (0.4)%, compared to an income tax expense of 191 for the year ended December 31, 2022, representing an effective tax rate of (0.8)%.

 

The provision for income tax expense for the years ended December 31, 2023 and 2022, consisted of the following:

 

 

 

Years Ended

 

(in thousands)

 

2023

 

 

2022

 

Current

 

 

 

 

 

 

Federal

 

$-

 

 

$-

 

State

 

 

161

 

 

 

191

 

Total Current

 

 

191

 

 

 

191

 

 

 

 

 

 

 

 

 

 

Deferred tax benefit

 

 

 

 

 

 

 

 

Federal

 

 

(1,615 )

 

 

(1,987 )

State

 

 

(3,111 )

 

 

(15,293)

Total deferred tax benefit

 

 

(4,726 )

 

 

(17,280 )

 

 

 

 

 

 

 

 

 

Valuation allowance

 

 

4,726

 

 

 

17,280

 

 

 

 

 

 

 

 

 

 

Income tax expense

 

$161

 

 

$191

 

 

As the Company operates in the cannabis industry, it is subject to the limitations of IRC Section 280E, under which the Company is only allowed to deduct expenses directly related to sales of product. This results in permanent differences between ordinary and necessary business expenses deemed non-allowable under IRC Section 280E. Therefore, the effective tax rate can be highly variable and may not necessarily correlate with pre-tax income or loss.

 

In December 2017, the United States (“U.S.”) Congress passed and the President signed into law what is referred to as the 2017 Tax Act, which contains many significant changes to the U.S. tax laws, including, but not limited to, reducing the U.S. federal corporate tax rate from 35% to 21% and utilization limitations of net operating loss carryforwards created in tax years beginning after December 31, 2017 to 80% of taxable income with an indefinite carryforward period. As the Company has a full valuation allowance against its U.S. deferred tax assets, the revaluation of net deferred tax assets resulting from the reduction in the U.S. federal corporate income tax rate did not impact the Company’s effective tax rate. Additional guidance may be issued by the U.S. Treasury Department, the IRS, or other standard-setting bodies, which may result in adjustments to the amounts recorded,

 

 
73

table of Contents

 

 LOWELL FARMS INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

including the valuation allowance. The Company is being audited by the IRS for years 2019 and 2020. Significant components of the Company’s deferred tax assets and liabilities at December 31, 2023 and 2022, are as follows:

 

 

 

Years Ended

 

(in thousands)

 

2023

 

 

2022

 

Deferred tax assets

 

 

 

 

 

 

Net operating loss carryforwards

 

$23,323

 

 

$17,038

 

Accruals and reserves

 

 

-

 

 

 

-

 

Depreciation

 

 

-

 

 

 

-

 

Other

 

 

-

 

 

 

-

 

Valuation allowance

 

 

(23,323 )

 

 

(17,038 )

Total deferred tax assets

 

 

-

 

 

 

-

 

 

 

 

 

 

 

 

 

 

Accruals and reserves

 

 

-

 

 

 

-

 

Share-based compensation

 

 

-

 

 

 

-

 

Total deferred tax liabilities

 

 

-

 

 

 

-

 

 

 

 

 

 

 

 

 

 

Net deferred tax liabilities

 

$-

 

 

$-

 

 

12. NET INCOME (LOSS) PER SHARE

 

Net loss per share represents the net earnings/loss attributable to shareholders divided by the weighted average number of shares outstanding during the period on an as converted basis.

 

 

 

Years Ended

 

 

 

December 31,

 

 

December 31,

 

(in thousands except per share amounts)

 

2023

 

 

2022

 

Net loss

 

$(37,342 )

 

$(24,677 )

 

 

 

 

 

 

 

 

 

Net loss per share:

 

 

 

 

 

 

 

 

Basic

 

$(2.71 )

 

$(2.17 )

Diluted

 

$(2.71 )

 

$(2.17 )

Weighted average shares outstanding:

 

 

 

 

 

 

 

 

Basic

 

 

13,790

 

 

 

11,318

 

Diluted

 

 

13,790

 

 

 

11,318

 

 

 

 

 

 

 

 

 

 

Weighted average potentially diluted shares (1):

 

 

 

 

 

 

 

 

Basic shares

 

 

13,790

 

 

 

11,318

 

Options

 

 

-

 

 

 

-

 

Warrants

 

 

-

 

 

 

-

 

Convertible debentures

 

 

-

 

 

 

-

 

Restricted stock units

 

 

-

 

 

 

-

 

Total weighted average potentially diluted shares:

 

 

13,790

 

 

 

11,318

 

________________

(1) For the above periods, the inclusion of options, warrants, convertible debentures and restricted stock units in the calculation of diluted earnings per share would be anti-dilutive, and accordingly, were excluded from the diluted loss per share calculation.

 

 
74

table of Contents

 

LOWELL FARMS INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

13. FAIR VALUE MEASUREMENTS

 

Accounting standards define fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. The fair value hierarchy prioritizes the inputs to valuation techniques used to measure fair value. An asset’s or liability’s level is based on the lowest level of input that is significant to the fair value measurement. Assets and liabilities carried at fair value are valued and disclosed in one of the following three levels of the valuation hierarchy:

 

Level 1: Quoted market prices in active markets for identical assets or liabilities.

 

Level 2: Observable market-based inputs or unobservable inputs that are corroborated by market data. Level 3: Unobservable inputs reflecting the reporting entity’s own assumptions.

 

At December 31, 2023 and December 31, 2022 the carrying value of cash and cash equivalents, accounts receivable, prepaid expense and other current assets, accounts payable and other current liabilities approximate fair value due to the short-term nature of such instruments.

 

The carrying value of the Company's debt approximates fair value based on current market rates (Level 2).

 

Nonrecurring fair value measurements

 

The Company uses fair value measures when determining assets and liabilities acquired in an acquisition as described above in the Notes to Consolidated Financial Statements, which are considered a Level 3 measurement.

 

14. COMMITMENTS AND CONTINGENCIES

 

Contingencies

 

The Company’s operations are subject to a variety of local and state regulation. Failure to comply with one or more of those regulations could result in fines, restrictions on its operations, or losses of permits that could result in the Company ceasing operations. While management of the Company believes that the Company is in compliance with applicable local and state regulation as of December 31, 2023, cannabis regulations continue to evolve and are subject to differing interpretations. As a result, the Company may be subject to regulatory fines, penalties or restrictions in the future.

 

The Company is being audited by the IRS for years 2019 and 2020 and may be subject to additional taxes, penalties and interest.

 

Litigation and Claims

 

From time to time, the Company may be involved in litigation relating to claims arising out of operations in the normal course of business.

 

On January 12, 2024, Cypress Holding Company, LLC (“Cypress”), a wholly owned subsidiary of the Company, surrendered possession of approximately 10 acres of real property at 139 Zabala Road, Salinas, California (the “Zabala Road Property”) leased by Cypress pursuant to a Lease Agreement dated April 1, 2017 (the “Zabala Road Lease”) with Tinhouse, LLC, dba Tinhouse Partners, LLC, as landlord (the “Landlord”). Prior to vacating the premises on January 12, 2024, the Company had operated a cultivation facility, which includes four greenhouses totaling approximately 255,000 square feet, on the Zabala Road Property.

 

In January 2023, the Company’s Board of Directors formed a strategic alternatives special committee of independent directors to explore, review and evaluate strategic and financial alternatives. As part of these efforts, the Company entered into negotiations with the Landlord to restructure the terms of the Zabala Road Lease, which provided for an expiry date of December 31, 2027, subject to five 5-year extension options exercisable by Cypress.

 

In 2023, the Company and the Landlord reached a settlement amending the terms of the Zabala Road Lease and reaching agreement on all rent-related issues. The Landlord terminated the Zabala Road Lease via a letter, which was served by its counsel on the Company in 2023. In 2023, the Company filed a lawsuit for breach of contract and specific performance against the Landlord to enforce the settlement terms. The Landlord filed counterclaims and an unlawful detainer action against the Company, claiming damages of more than $36 million, which the Landlord claims are based on an analysis of accelerated rent due through the end of the term of the Zabala Road Lease, along with attorney’s fees, improvements, and other undefined costs.

 

The Company intends to vigorously defend itself against the claims made by the Landlord. However, no assurance can be provided as to whether or not the Company will prevail, and it may be required to pay significant monetary damages. It is difficult to evaluate the likely outcome of a trial at such an early stage and with competing claims and cross-claims. In addition, due to the early nature of the case, an estimate on a loss cannot be made.

 

A punitive class action was filed on behalf of all California consumers who purchased products made by Lowell Farms, Inc. in California. The case alleges that Lowell failed to accurately label its products with the THC% identified by its testing laboratories, and that California consumers were thereby deceived into paying higher prices for Lowell’s products than they otherwise would have.

 

No trial has been scheduled in this matter. The parties are presently engaged in the process by which Plaintiff will bring a motion seeking certification of a class. If class certification is denied, then Plaintiff will be relegated to his own damages, which is likely just a few hundred dollars, and the case will likely end. If class certification is granted, then the parties will engage in fact discovery and the Court will set a trial date. The class certification motion is scheduled to be heard on August 26, 2024. Plaintiff has served discovery requests limited to class certification issues, but the parties have not engaged in any merits discovery. It is difficult to evaluate any potential outcome at such an early stage of the case where there has been no merits discovery. The Company is prepared to vigorously defend itself at the trial if a class is certified and a settlement is not reached. It is difficult to evaluate the likely outcome of a trial because Plaintiff has not articulated a theory of damages. In addition, due to the early nature of the case, an estimate of a loss cannot be made.

 

 
75

table of Contents

 

LOWELL FARMS INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

 

15. GENERAL AND ADMINISTRATIVE EXPENSES

 

For the years ended December 31, 2023 and 2022, general and administrative expenses were comprised of:

 

 

 

Years Ended

 

 

 

December 31,

 

 

December 31,

 

(in thousands)

 

2023

 

 

2022

 

Salaries and benefits

 

$3,229

 

 

$5,286

 

Professional fees

 

 

527

 

 

 

465

 

Share-based compensation

 

 

231

 

 

 

564

 

Insurance

 

 

999

 

 

 

1,344

 

Administrative

 

 

2,316

 

 

 

1,894

 

Total general and administrative expenses

 

$7,302

 

 

$9,553

 

 

16. RELATED-PARTY TRANSACTIONS

 

Transactions with related parties are entered into in the normal course of business and are measured at the amount established and agreed to by the parties.

 

In April 2015, Lowell entered into a services agreement with Olympic Management Group (“OMG”), for advisory and technology support services, including the access and use of software licensed to OMG to perform certain data processing and enterprise resource planning (ERP) operational services. OMG is owned by one of the Company’s co-founders. The agreement provides for the dollar-for-dollar reimbursement of expenses incurred by OMG in performance of its services. Amounts paid to OMG for the years ended December 31, 2023 and 2022, were $nil and $36, respectively.

 

During October 2022, Cannaco Research Corporation, an existing customer, became a related party when Ms. Lawrence, a new member joined the Board of Directors. Total sales recognized for Cannaco Research Corporation for the years ended December 31, 2023 and 2022 were $487 and $274, respectively. For the years ended December 31, 2023 and 2022, cash collected from Cannaco Research Corporation was $476 and $223, respectively. In December, 2022, the Company entered into an agreement with Cannaco Research Corporation to lease approximately 2,000 square feet of warehouse space in Los Angeles to facilitate distribution services in the area. The lease was a 12 month storage agreement for the warehouse space. Total payments to Cannaco Research Corporation for the lease were $130 and $10 in the years ended December 31, 2023 and December 31,2022, respectively.

 

 
76

table of Contents

 

LOWELL FARMS INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

17. SEGMENT INFORMATION

 

The Company's operations are comprised of a single reporting operating segment engaged in the production and sale of cannabis products in the United States. As the operations comprise a single reporting segment, amounts disclosed in the financial statements also represent a single reporting segment.

 

18. SUBSEQUENT EVENTS

 

On January 12, 2024, Cypress Holding Company, LLC (“Cypress”), a wholly owned subsidiary of the Company, surrendered possession of approximately 10 acres of real property at 139 Zabala Road, Salinas, California (the “Zabala Road Property”) leased by Cypress pursuant to a Lease Agreement dated April 1, 2017 (the “Zabala Road Lease”) with Tinhouse, LLC, dba Tinhouse Partners, LLC, as landlord (the “Landlord”). Prior to vacating the premises on January 12, 2024, the Company had operated a cultivation facility, which includes four greenhouses totaling approximately 255,000 square feet, on the Zabala Road Property. 

As previously announced, in January 2023, the Company’s Board of Directors formed a strategic alternatives special committee of independent directors to explore, review and evaluate strategic and financial alternatives. As part of these efforts, the Company entered into negotiations with the Landlord to restructure the terms of the Zabala Road Lease, which provided for an expiry date of December 31, 2027, subject to five 5-year extension options exercisable by Cypress.

 

In September 2023, the Company and the Landlord reached a settlement amending the terms of the Zabala Road Lease and reaching agreement on all rent-related issues. The Landlord terminated the Zabala Road Lease via a letter dated October 6, 2023, which was served by its counsel on the Company on October 10, 2023. In October 2023, the Company filed a lawsuit for breach of contract and specific performance against the Landlord to enforce the settlement terms. The Landlord filed counterclaims and an unlawful detainer action against the Company, claiming damages of more than $36 million, which the Landlord claims are based on an analysis of accelerated rent due through the end of the term of the Zabala Road Lease, along with attorney’s fees, improvements, and other undefined costs.

 

The Company has evaluated subsequent events through March 26, 2024, the date the financial statements were available to be issued.

 

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

 

 
77

table of Contents

 

ITEM 9. Changes in and Disagreements with Accountants on Accounting and Financial Disclosure

 

None.

 

ITEM 9A. Controls and Procedures

 

Evaluation of Disclosure Controls and Procedures

 

Disclosure controls and procedures are designed to ensure that information required to be disclosed by us in reports filed or submitted under the Securities Exchange Act of 1934, as amended (the “Exchange Act”), is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed in reports filed or submitted under the Exchange Act is accumulated and communicated to management, including our principal executive officer and principal financial officer, or persons performing similar functions, as appropriate to allow for timely decisions regarding required disclosure. Due to inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Further, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that degree of compliance with the policies and procedures may deteriorate. Accordingly, even effective disclosure controls and procedures can only provide reasonable assurance of achieving their control objectives.

 

Under the supervision and with the participation of our management, including our principal executive and financial officer, we evaluated the effectiveness of the design and operation of our disclosure controls and procedures (as defined in Rule 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934 (“the Exchange Act”) as of December 31, 2023, the end of the period covered by this report. Based upon that evaluation, our principal executive and financial officer concluded that our disclosure controls and procedures were not effective as of December 31, 2023, due to the existence of a material weakness in our internal control over financial reporting described below.

 

Management’s Annual Report on Internal Control over Financial Reporting

 

Our management is responsible for establishing and maintaining adequate internal control over financial reporting, as such term is defined in Exchange Act Rules 13a-15(f) and 15d-15(f). Our internal control over financial reporting is a process designed by or under the supervision of our principal executive and principal financial officer to provide reasonable assurance to our management and board of directors regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Therefore, even those systems determined to be effective can provide only reasonable assurance of achieving their control objectives. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.

 

Our management, including our principal executive and financial officer, conducted an evaluation of the effectiveness of our internal control over financial reporting as of December 31, 2023, based on the framework in Internal Control – Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission. Based on our evaluation under the COSO framework, our management concluded that our internal control over financial reporting was not effective as of December 31, 2023 due to the material weakness described below.

 

A material weakness is a deficiency, or a combination of deficiencies, in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement of our annual or interim financial statements will not be prevented or detected on a timely basis. We identified the following material weakness:

 

We did not maintain effective internal control over financial reporting over the accounting for impairment of our long-lived assets. Specifically, our internal controls with respect to the assessment of impairment indicators were not designed to effectively account for the impairment in our property and equipment and intangible assets.  These control deficiencies resulted in audit adjustments to our property and equipment during the year-ended December 31, 2023. Additionally, these control deficiencies could result in a misstatement of the aforementioned account balances or disclosures that would result in a material misstatement to the annual or interim consolidated financial statements that would not be prevented or detected. Accordingly, we determined that these control deficiencies constitute a material weakness.

 

 
78

Table of Contents

 

Plan for Remediation of Material Weaknesses in Internal Control over Financial Reporting

 

We have taken steps to remediate the material weakness identified above and plan to take additional actions to remediate the underlying cause of these material weaknesses as described below:

 

1.

We will put in place an additional review related to the identification of impairment triggering events.

 

2.

We will put in place the review of an ASC 360 checklist of impairment triggering events.

 

These actions are subject to ongoing review by management, as well as oversight by our board of directors. Although we plan to complete this remediation process as quickly as possible, we cannot, at this time, estimate when such remediation may occur, and our initiatives may not prove successful in remediating these material weaknesses.

 

ITEM 9B. Other Information

 

Appointment and Resignation of Directors

 

Effective December 19, 2023, Brian Shure resigned from the Board of Directors. 

 

Item 9C. Disclosure Regarding Foreign Jurisdictions that Prevent Inspections

 

Not applicable.

 

 
79

Table of Contents

 

Part III

 

ITEM 10. Directors, Executive Officers and Corporate Governance

 

GOVERNANCE

 

Board of Directors

 

Our business and affairs are managed, and all corporate powers are exercised, under the direction of our Board. Our Board establishes fundamental corporate policies and oversees our performance and the performance of our Chief Executive Officer and the other officers to whom our Board has delegated authority to manage day-to-day business operations.

 

The following table provides information with respect to our directors as of March 19, 2024:

 

Name

 

Age

 

Position

Mark Ainsworth

 

49

 

Chief Executive Officer and Director

William Anton

 

82

 

Director

Jeffrey Monat

 

45

 

Director

Summer Frein

 

40

 

Director

Ann Lawrence

 

50

 

Director and Chairperson

 

Biographical Information

 

The biographies of the Board are set out below.

 

Mark Ainsworth

 

Mark Ainsworth serves as Chief Executive Officer of the Company and has also served as a director of the Company since April 2019. Mr. Ainsworth previously served as the Company’s Chief Operating Officer (November 2019 to April 2020) and Executive Vice President (April 2019 to April 2020) and as Executive Vice President of Indus Holding Company (inception to April 2019). In 2006, Mr. Ainsworth founded Pastry Smart, an American Humane Certified and Organic bakery and confectionery manufacturer. He has been a member of the American Culinary Federation since 2013. The Company believes that Mr. Ainsworth’s long history as an entrepreneur and as a co-founder of the Company as well as his executive-level experience qualify him to serve as a member of our Board.

 

William Anton

 

William Anton has served as an independent director of the Company since April 2019. Mr. Anton has served as Chairman and CEO of Anton Enterprises, Inc. since 2005 and Managing Partner of Anton Venture Capital Fund LLC since 2004. Prior to Anton Enterprises, he was Chairman of Anton Airfood, Inc. from 1989 to 2005, the airport foodservice company he founded. Mr. Anton is Chairman Emeritus of the Board of Trustees of the Culinary Institute of America. He also serves on the Board of Trustees of Media Research Corporation, the Board of Directors of QSpex Technologies Inc., and is a member of the Board of Governors of the Thalians Foundation for Mental Health at Cedars-Sinai. Mr. Anton formerly served on the Board of Directors of Air Chef Corporation, a leading private aviation catering firm in North America, the Board of Directors for Morton’s Restaurant Group, the Board of the British Restaurant Association, the Board of Trustees of the William F. Harrah College - University of Nevada in Las Vegas, and the National Restaurant Association Education Foundation. The Company believes that Mr. Anton’s extensive experience as a senior executive and director and his lengthy history of value-creation as a founder and entrepreneur qualify him to serve as a member of our Board.

 

 
80

Table of Contents

 

Jeffrey Monat

 

Jeffrey Monat has served as an independent director of the Company since January 2022. Mr. Monat has been an investor in cannabis companies since 2013, funding both cultivation and ancillary businesses. Since 2018, he has been a Senior Partner at Merida Capital Holdings, a private equity firm targeting fundamental growth drivers underpinning the rapid development of the cannabis industry. He also sits on Merida Capital’s Investment Committee. From 2000 to 2002, he was with Goldman Sachs, where he advised clients on M&A transactions, financial valuation, and corporate governance issues. He worked in the Goldman Sachs Principal Strategies Group from 2002 to 2003, analyzing public-market opportunities for the firm’s proprietary investment fund. From 2003 to 2010, he was an investment analyst at Rockbay Capital, where he helped grow the firm to $1 billion in assets under management. From 2010 to 2012, he was with FrontPoint Rockbay, an event-driven hedge fund in New York where he evaluated prospective investments and helped build the firm’s investment analysis infrastructure. Mr. Monat also served as a Senior Analyst at Seven Locks Capital, a long/short equity hedge fund from 2012 to 2016 and was a Senior Analyst at Sage Rock Capital, an event-driven hedge fund based in New York from 2016 to 2018.  In addition to his professional accomplishments, Mr. Monat serves as treasurer and trustee of the Friends Grow Friends Foundation, Inc., an after-school program that helps children with special needs improve their social skills. Jeff has a Bachelor of Science in Economics from The Wharton School of the University of Pennsylvania. The Company believes that Mr. Monat's extensive experience as an investor in cannabis companies and his business and financial experience at private equity firms and hedge funds qualify him to serve as a member of our Board.

 

Summer Frein

 

Summer Frein has served as an independent director of the Company since October 2022. Ms. Frein currently serves as the Chief Revenue Officer of Turning Point Brands and previously served as the Chief Marketing Officer through November 2022. Her oversight includes sales, brand management, creative services, e-commerce, business intelligence, marketing services, and consumer insights. Prior to joining Turning Point Brands, Summer held a variety of senior leadership roles - across sales, digital strategy, marketing, and strategy and business development - over the course of 15 years at Cronos Group (January 2020 – March 2022) and Altria Group, Inc. (June 2006 – December 2019). As General Manager of Cronos Group, USA, she was responsible for implementing and defining the strategy and execution across all areas of the business including sales strategy, marketing, and operations. She has also held a number of senior level roles at Altria, where she led the cannabis research and investment strategy within the Strategy and Business Development Group. The Company believes that Ms. Frein’s extensive experience with brand management, marketing, digital strategy and the cannabis industry qualifies her to serve as a member of our Board.

 

Ann Lawrence

 

Ann Lawrence has served as an independent director of the Company since October 2022 and Chairperson since March 2023. Ms. Lawrence is a widely respected executive and attorney currently serving as the Co-Founder and Chief Executive Officer of a Southern California collection of cannabis companies comprising a distribution company and two popular retail dispensaries: The Rose Collective and The Farmacy Westwood, both of which are long-term customers of the Company. Her extensive experience in California’s cannabis industry includes leadership in the areas of retail, branding, manufacturing, cultivation, and distribution, along with an expertise with California’s unique regulatory and compliance challenges. Ms. Lawrence has served as the Chief Executive Officer of Cannaco Research Corporation since January 2021.  Prior to that, Ms. Lawrence was a partner with the law firm of DLA Piper from December 2010  through July 2019 and an attorney with Latham & Watkins from November 2000 through April 2007. Throughout her career, Ms. Lawrence has built multiple retail storefronts in Los Angeles’ competitive cannabis space that have consistently outperformed the market and maintained consistent success and excellence. She designed operational efficiencies for boutique cannabis brands, and has personal experience as the owner of various cannabis brands. She is also the Chief Executive Officer of a centralized distribution facility that focuses on growing local brands and managing retail stores in Southern California by providing distribution, logistical, and consulting support to retailers, helping them to compete and succeed. The Company believes that Ms. Lawrence’s extensive legal experience, corporate management and familiarity with the California cannabis industry qualify her to serve as our Chairperson.

 

Code of Conduct

 

The Board has adopted a Code of Conduct for directors, officers, and employees. The Code of Conduct is available on our website at https://ir.lowellfarms.com/corporate-governance/governance-documents. In addition, the Code of Conduct has been filed on, and is accessible through, Canada’s SEDAR+ website (www.sedarplus.ca). The Corporation will, upon request at ir@lowellfarms.com, provide a copy of the Code of Conduct free of charge to any shareholder. The information on our website is not deemed to be incorporated in this Annual Report on Form 10-K or to be part of this Annual Report on Form 10-K.

 

The Board expects its directors, officers, and employees to act ethically at all times and to acknowledge their adherence to the policies comprising the Code of Conduct. Any material issues regarding compliance with the Code of Conduct are required to be brought forward by management at either the Board or appropriate Board committee meetings or are referred to the executive officers of the Company, as may be appropriate in the circumstances. The Board or appropriate committee or executive officers determine what remedial steps, if any, are required. Any waivers from the Code of Conduct that are granted for the benefit of a director or executive officer may be granted only by the Board (or a committee thereof, as designated by the Board). No material waiver has ever been granted under the Code of Conduct.

 

Each director of the Corporation must disclose all actual or potential conflicts of interest and refrain from voting on matters in which such director has a conflict of interest. In addition, the director must excuse themselves from any discussion or decision on any matter in which the director is precluded from voting as a result of a conflict of interest.

 

Our Articles provide that the quorum necessary for the transaction of the business of the Board is a majority of the number of directors in office or such greater number as the directors may determine from time to time.

 

The Canadian Securities Administrators has issued corporate governance guidelines pursuant to Canadian National Policy 58-201-Corporate Governance Guidelines (the “Corporate Governance Guidelines”), together with certain related disclosure requirements pursuant to Canadian National Instrument 58-101-Disclosure of Corporate Governance Practices (“NI 58-101”). The Corporate Governance Guidelines are recommended as “best practices” for issuers to follow. We recognize that good corporate governance plays an important role in our overall success and in enhancing shareholder value. Accordingly, we have adopted certain corporate governance policies and practices that reflect our consideration of the recommended Corporate Governance Guidelines.

 

Role of the Board of Directors

 

Our Board is responsible for the stewardship of the Corporation and managing and supervising the management of our business and affairs, including providing guidance and strategic oversight to management. Our Board has the authority to exercise all such powers of the Corporation as are not, by the Business Corporations Act (British Columbia) or by our Articles, required to be exercised by the shareholders of the Corporation.

 

Board Leadership

 

The positions of Chairman of the Board and Chief Executive Officer are held by different individuals: Ann Lawrence serves as Chairperson and Mark Ainsworth serves as Chief Executive Officer. Our Board has concluded that our current leadership structure is appropriate at this time and takes advantage of these persons’ respective strengths and perspectives. However, our Board will continue to review our leadership structure periodically and may make changes in the future as it deems appropriate.

 

 
81

Table of Contents

 

Risk Oversight

 

Our Board is responsible for the general oversight of risks that affect us and oversees our enterprise risk management. Our Board receives regular reports on our operations from our Chief Executive Officer and other members of management. Our Board reviews these reports and makes inquiries in their business judgment.

 

Our Board also fulfills its oversight role through two committees, the Audit Committee and the Compensation and Corporate Governance Committee. Our Board receives periodic reports on each committee’s activities. Our Audit Committee has responsibility for risk oversight in connection with its review of our financial reports filed with the SEC and the applicable Canadian securities commissions or similar regulatory authorities. Additionally, our Audit Committee receives reports from our Chief Financial Officer and our independent auditors in connection with the review of our quarterly and annual financial statements regarding significant financial transactions, accounting and reporting matters, critical accounting estimates, and management’s exercise of judgment in accounting matters. When reporting on such matters, our independent auditors also provide their assessment of management’s report and conclusions. Our Compensation and Corporate Governance Committee has responsibility for risk oversight in connection with the Company's compensation policies and practices and corporate governance policies and practices.

 

Orientation and Continuing Education

 

Each new director is given an outline of the nature of the Corporation’s business, its corporate strategy and current issues within the Corporation. New directors are also required to meet with management of the Corporation to discuss and better understand the Corporation’s business and are given the opportunity to meet with counsel to the Corporation to discuss their legal obligations as director of the Corporation.

 

In addition, management of the Corporation takes steps to ensure that its directors and officers are continually updated as to the latest corporate and securities policies which may affect the directors, officers and committee members of the Corporation as a whole. The Corporation continually reviews the latest securities rules and stock exchange policies. Any changes or new requirements are then brought to the attention of the Corporation’s directors either by way of director or committee meetings or by direct communications from management to the directors.

 

Ethical Business Conduct

 

The Board has found that the fiduciary duties placed on individual directors by the Corporation’s governing corporate legislation and the common law and the restrictions placed by applicable corporate legislation on an individual director’s participation in decisions of the Board in which the director has an interest have been sufficient to ensure that the Board operates independently of management and in the best interests of the Corporation. Further, the Corporation’s auditor has full and unrestricted access to the Audit Committee at all times to discuss the audit of the Corporation’s financial statements and any related findings as to the integrity of the financial reporting process.

 

Nomination of Directors

 

Please refer to “- Board Committees - Compensation and Corporate Governance Committee” for a description of the process undertaken to identify new candidates for board nomination.

 

Assessments

 

The Board monitors the adequacy of information given to directors, communication between the Board and management and the strategic direction and processes of the Board and committees.

 

Board and Committee Meetings; Executive Sessions

 

At regularly scheduled board and committee meetings, directors review and discuss management reports regarding our performance, prospects, and plans, as well as significant opportunities and immediate issues facing us. At least once a year, our Board also reviews management’s long-term strategic and financial goals. The Chair, in consultation with the committee chairs and other directors, as appropriate, establishes the agenda for meetings of the Board. Committee agendas and schedules are set by or in consultation with the committee chair. During the year ended December 31, 2023, our Board held 6 meetings, and all directors attended at least 75% of all applicable Board and committee meetings during the year.

 

Board Attendance at Annual Meeting of Shareholders

 

The Board’s unwritten policy regarding director attendance at the annual meeting of shareholders is that directors are encouraged to attend. A majority of the Board attended the 2023 annual meeting of shareholders.

 

 
82

Table of Contents

 

Board Committees

 

Audit Committee

 

The Audit Committee is appointed annually by the Board to assist the Board in fulfilling its oversight responsibilities relating to:

 

 

·

the quality and integrity of the Corporation’s financial statements;

 

 

 

 

·

the Corporation’s compliance with legal and regulatory requirements;

 

 

 

 

·

the qualifications and independence of the independent registered public accounting firm (the “Independent Auditors”);

 

 

 

 

·

the oversight and performance of the Corporation’s internal audit function and the Independent Auditors; and

 

 

 

 

·

any other matters delegated to the Committee by the Board.

 

As further described in the Audit Committee Charter, the Committee’s primary duties and responsibilities relate to:

 

 

·

maintenance by management of the reliability and integrity of the accounting policies and financial reporting and financial disclosure practices of the Corporation;

 

 

 

 

·

establishment and maintenance by management of processes to assure that an adequate system of internal controls is functioning within the Corporation; and

 

 

 

 

·

retention and termination of the Independent Auditors.

 

As of the year ended December 31, 2023, our Audit Committee consisted of William Anton, Ann Lawrence and Jeffrey Monat. William Anton serves as the chair of our Audit Committee and has been identified as an “audit committee financial expert” as that term is defined in the rules and regulations established by the SEC. The members of our Audit Committee are “financially literate” within the meaning of the applicable NYSE rules and NI 52-110. William Anton, Ann Lawrence and Jeffrey Monat are “independent” within the meaning of the applicable NYSE rules and NI 52-110. The following chart sets forth the current composition of our Audit Committee:

 

Name of Member

 

Independent(1)

 

Financially Literate(2)

 

William Anton (Chair)

 

Yes

 

Yes

 

Jeff Monat

 

Yes

 

Yes

 

Ann Lawrence

 

Yes

 

Yes

 

_______________

Notes:

 

(1)

A member of the Audit Committee is independent if they have no direct or indirect ‘material relationship’ with the Corporation. A material relationship is a relationship that could, in the view of the Board, reasonably interfere with the exercise of a member’s independent judgment. An executive officer of the Corporation, such as the Chief Executive Officer, is deemed to have a material relationship with the Corporation.

 

(2)

A member of the Audit Committee is financially literate if they have the ability to read and understand a set of financial statements that present a breadth and level of complexity of accounting issues that are generally comparable to the breadth and complexity of the issues that can reasonably be expected to be raised by the Corporation’s financial statements.

 

The education and experience of each member of the Audit Committee that is relevant to the performance of their responsibilities as a member of the Audit Committee is described above under the heading “Board of Directors.”

 

 
83

Table of Contents

 

Our Board has adopted a written charter for the Audit Committee, which sets out the Audit Committee’s responsibilities, consistent with the Canadian National Instrument 52-110 - Audit Committees (“NI 52-110”) a current copy of which is available on our website at https://ir.lowellfarms.com/corporate-governance/board-committees. The Audit Committee has access to all books, records, facilities, and personnel and may request any information about us as it may deem appropriate. It has the authority to retain and compensate special legal, accounting, financial, and other consultants or advisors to advise the Audit Committee.

 

Both our independent auditors and internal financial personnel regularly meet privately with the Audit Committee and have unrestricted access to this committee. At no time since the commencement of the Corporation’s most recently completed fiscal year was a recommendation of the Audit Committee to nominate or compensate an external auditor not adopted by the Board. Our Audit Committee held four (4) meetings during the year ended December 31, 2023.

 

The Corporation is a “venture issuer” as defined in NI 52-110 and as such is exempt from the requirements of Part 3 (Composition of the Audit Committee) and Part 5 (Reporting Obligations) of NI 52-110.

 

Compensation and Corporate Governance Committee

 

The Compensation and Corporate Governance Committee consists of William Anton and Jeffrey Monat. William Anton serves as the Chair of our Compensation and Corporate Governance Committee. The Board has determined that William Anton and Jeffrey Monat are independent as defined by NYSE rules and applicable Canadian securities laws.

 

The Compensation and Corporate Governance Committee is responsible for assisting the Board in fulfilling its oversight responsibilities in relation to:

 

 

·

the Company’s overall approach to corporate governance;

 

 

 

 

·

subject to the requirements of the Voting Agreement, the size, composition, and structure of the Board and its committees;

 

 

 

 

·

executive and director compensation;

 

 

 

 

·

executive compensation disclosure;

 

 

 

 

·

management development and succession;

 

 

 

 

·

orientation and continuing education for directors;

 

 

 

 

·

subject to the requirements of the Voting Agreement, identifying and recommending new director nominees;

 

 

 

 

·

promotion of a culture of integrity throughout the Company;

 

 

 

 

·

related party transactions and other matters involving conflicts of interest; and

 

 

 

 

·

any additional matters delegated to the Compensation and Corporate Governance Committee by the Board.

 

Subject to the requirements of the Voting Agreement, the Compensation and Corporate Governance Committee formulate and administer criteria for identifying, evaluating and recommending director candidates to stand for election at a meeting of shareholders or to fill a vacancy existing on the Board, which will reflect, among other things:

 

 

·

competencies, skills, and personal qualities that the Board considers to be necessary for the Board, as a whole, to possess;

 

 

 

 

·

competencies, skills, and personal qualities that the Board considers each existing director to possess;

 

 

 

 

·

competencies, skills, and personal qualities that each new director would bring to the Board; and

 

 

 

 

·

responsibilities that would materially interfere with or be incompatible with Board membership.

 

The Compensation and Corporate Governance Committee will consider all qualified director candidates identified by various sources, including members of the board of directors, management and shareholders. Candidates for directors recommended by shareholders will be given the same consideration as those identified from other sources.

 

 
84

Table of Contents

 

Subject to the requirements of the Voting Agreement, the Compensation and Corporate Governance Committee will recommend to the Board a list of candidates for nomination for election to the Board at the Company’s annual meeting of shareholders. In addition, as the need arises, it will identify and recommend to the Board new candidates for Board membership. Should the Compensation and Corporate Governance Committee recommend a Lead Director be appointed to the Board, or should a vacancy occur in the role of Lead Director, the Compensation and Corporate Governance Committee will recommend to the Board an Independent Director to fill such role. In making its recommendations to the Board, the Compensation and Corporate Governance Committee will provide an assessment of whether each candidate is or would be: (i) an independent director; and (ii) “financially literate” as defined in NI 52-110.

 

The Board has adopted a written charter setting forth the purpose, composition, authority, and responsibility of our Compensation and Corporate Governance Committee consistent with the guidance of the Canadian Securities Administrators, a current copy of which is available on our website at https://ir.lowellfarms.com/corporate-governance/board-committees.

 

Our Compensation and Corporate Governance Committee held no separate committee meetings during the year ended December 31, 2023, with its business being conducted with the entire Board.

 

Other Board Committees

 

The Board has no committees other than the Audit Committee and the Compensation and Corporate Governance Committee.

 

Communications with the Board of Directors

 

Shareholders and other interested parties may contact any member (or all members) of our Board (including, without limitation, the non-management directors as a group), any committee of our Board, or the chair of any such committee. Written correspondence may be sent to our Board, any committee, or any individual director, c/o Corporate Secretary, Lowell Farms Inc., 440 N Barranca Ave. #1675 Covina, CA 91723.

 

EXECUTIVE OFFICERS

 

The following table provides information concerning our executive officers:

 

Name

 

Age

 

Position

Mark Ainsworth

 

48

 

Chief Executive Officer and Director

Jamie Schniedwind

 

39

 

Chief Financial Officer

 

Biographical Information

 

The biography of Mark Ainsworth is under “Board of Directors.” 

 

Jamie Schniedwind

 

Jamie Schniedwind has served as Director, Financial Planning & Analysis since June 2022 and was appointed Chief Financial Officer in February, 2024. Mr. Schniedwind has served as Senior Financial Analyst at cannabis brand Plus Products where he managed financial reporting for the US and Canada, performed financial audits, and led the forecasting and budgeting processes, and as senior auditor  at Ernst & Young specializing in the audits of public and private companies.

  

Delinquent Section 16(a) Reports

 

Section 16(a) of the Securities Exchange Act of 1934 requires that the Company’s directors, executive officers and persons who beneficially own 10% or more of the Company’s common stock file with the SEC initial reports of ownership and reports of changes in ownership of our stock and our other equity securities. To the Company’s knowledge, based solely on a review of the copies of such reports furnished to the Company, during the year ended December 31, 2023, all such filing requirements applicable to the Company’s directors, executive officers and greater than 10% beneficial owners were complied with.

 

Item 11. Executive Compensation

 

EXECUTIVE COMPENSATION

 

Compensation of Named Executive Officers

 

The Corporation’s compensation practices are intended to retain, motivate and reward its executive officers for their performance and contribution to the Corporation’s success. Executive officers may be compensated through some combination of cash and equity or equity-linked incentives, both short and long-term in nature. To date, compensation of executive officers, including the NEOs, has been determined by way of negotiation with such officers.

 

The Compensation and Corporate Governance Committee, comprised of independent directors, is charged with oversight of compensation practices. The Compensation and Corporate Governance Committee is responsible for developing a compensation philosophy that rewards the achievement of corporate and individual performance objectives, and aligns executive officers’ incentives with shareholder value creation. The Compensation and Corporate Governance Committee will select components of compensation packages and the amounts of such components, as well as corporate and individual goals and objectives to be used in determining the level of certain of these components. The Compensation and Corporate Governance Committee may determine to use different compensation components and approach compensation in a manner that is different than that used by the Corporation to date.

 

We are an “emerging growth company,” as that term is used in the JOBS Act, and have elected to comply with the reduced compensation disclosure requirements available to emerging growth companies under the JOBS Act.

 

 
85

Table of Contents

 

Summary Compensation Table

 

The following table provides the compensation paid to our principal executive officer and other executive officers whose total compensation exceeded $100,000 for the years ended December 31, 2023 and December 31, 2022.

 

 

 

 

 

 

 

 

Stock

 

 

Option

 

 

Nonequity

Incentive

Plan

 

 

Nonqualified

Deferred

Compensation

 

 

 

Name

 

Year

 

Salary

 

 

Bonus

 

 

Awards

 

 

Awards

 

 

Compensation

 

 

Earnings

 

 

Total

 

Mark Ainsworth

 

2023

 

$248,269

 

 

$-

 

 

 -

 

 

$19,753

 

 

$-

 

 

$-

 

 

$268,022

 

Chief Executive Officer

 

2022

 

$223,845

 

 

$-

 

 

$-

 

 

$24,418

 

 

$-

 

 

$-

 

 

$248,263

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Brian Shure (1)

 

2023

 

$24,800

 

 

$-

 

 

$-

 

 

$-

 

 

$-

 

 

$-

 

 

$24,800

 

Former Chief Financial Officer

 

2022

 

$55,095

 

 

$-

 

 

$-

 

 

$32,509

 

 

$-

 

 

$-

 

 

$87,604

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Tessa O’Dowd (2)

 

2023

 

$137,308

 

 

$-

 

 

$-

 

 

$-

 

 

$-

 

 

$-

 

 

$137,308

 

Interim Chief Financial Officer

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

______________

(1)

Departed the Company as of May 11, 2023

 

(2)

Appointed Interim CFO as of May 11, 2023

 

 
86

Table of Contents

 

Narrative Disclosure to Summary Compensation Table

 

Executive Employment Agreements

 

Mark Ainsworth - The Company is a party to an employment agreement with Mark Ainsworth dated as of July 1, 2020. Mr. Ainsworth is entitled to an annual base salary of $250,000. He is also eligible to receive annual bonuses in such amounts and subject to such performance metrics or other criteria determined by the Board or its Compensation and Corporate Governance Committee from time to time, including performance-based bonuses or programs as determined at the discretion of the Board. Mr. Ainsworth is also eligible to receive discretionary grants of options. In 2023, Mr. Ainsworth was granted options to purchase 175,000 Subordinate Voting Shares of the Company, which  vested immediately. In the event of Mr. Ainsworth’s termination without cause, for a period of nine months from the date of such termination, he is entitled to receive continued payment of his base salary and continuation of health insurance benefits. In addition, in the event that, within six months following a “change of control” of the Company, Mr. Ainsworth’s title or responsibilities are materially diminished or Mr. Ainsworth is terminated without cause, he is entitled, upon notice to the Company given not later than thirty (30) days following such material diminishment or termination, to the acceleration of vesting of half of the remaining unvested portion of any stock options or restricted stock awards previously granted to him and any unvested portion shall continue to vest ratably, or be forfeited, in accordance with the terms of such grants.

 

Brian Shure - The Company was a party to an employment agreement with Brian Shure dated as of November 10, 2020. Mr. Shure was entitled to an annual base salary of $250,000 and signed an revised agreement with an updated base salary of $60,000 for 2023. Mr. Shure departed the Company in May, 2023. 

   

 
87

Table of Contents

 

Outstanding Equity Awards at Fiscal Year-End

 

The following table sets forth certain information regarding equity-based awards held by our named executive officers as of December 31, 2023.

 

 

 

 

 

Option Awards

 

 

 

Number of

 

 

Number of

 

 

 

 

 

 

 

 

 

Securities

 

 

Securities

 

 

 

 

 

 

 

 

 

Underlying

 

 

Underlying

 

 

 

 

 

 

 

 

 

Unexercised

 

 

Unexercised

 

 

Option

 

 

Option

 

 

 

Option (#)

 

 

Option (#)

 

 

Exercise

 

 

Expiration

 

Officer

 

Exercisable

 

 

Unexercisable

 

 

Price ($)

 

 

Date

 

Mark Ainsworth

 

 

3,750

 

 

 

1,250

 

 

$8.50

 

 

1/2/2026

 

 

 

 

46,875

 

 

 

3,125

 

 

3.46

 

 

4/15/2026

 

 

 

 

10,625

 

 

 

9,375

 

 

 

3.08

 

 

1/13/2028

 

 

 

 

11,250

 

 

 

11,250

 

 

 

0.82

 

 

12/22/2028

 

 

 

 

175,000

 

 

 

-

 

 

 

0.30

 

 

         8/1/2029

 

Tessa O’Dowd

 

 

6,250

 

 

 

18,750

 

 

$2.31

 

 

8/12/2028

 

 

 

 

2,500

 

 

 

7,500

 

 

 

0.82

 

 

12/22/2028

 

Brian Shure

 

 

7,500

 

 

 

-

 

 

$3.08

 

 

1/13/28

 

 

 

 

7,500

 

 

 

-

 

 

 

0.82

 

 

12/22/28

 

 

Stock Option Plan and Other Incentive Plans

 

Equity Incentive Plan

 

The Corporation has adopted the Equity Incentive Plan, which was approved by its shareholders at the special meeting of shareholders held on January 26, 2019, and amended on April 10, 2020, and again on February 24, 2021, pursuant to approvals by the Board and the holder of all of the Super Voting Shares, and amended on June 22, 2023 at the 2023 annual general meeting. The principal terms of the Equity Incentive Plan are described below.

 

Purpose

 

The purpose of the Equity Incentive Plan is to promote the interests of the Corporation and its Shareholders by aiding the Corporation in attracting and retaining employees, officers, consultants, advisors and nonemployee directors capable of assuring the future success of the Corporation, to offer such persons incentives to put forth maximum efforts for the success of the Corporation’s business and to compensate such persons through various stock and cash-based arrangements and provide them with opportunities for stock ownership in the Corporation, thereby aligning the interests of such persons with the shareholders.

 

The Equity Incentive Plan permits the grant of (i) nonqualified stock options (“NQSOs”) and incentive stock options (“ISOs”) (collectively, “Options”), (ii) restricted stock awards, (iii) restricted stock units (“RSUs”), (iv) stock appreciation rights (“SARs”), (v) performance compensation awards (“Performance Awards”), (vi) payments (in cash, Subordinate Voting Shares, other securities, other awards or other property) equivalent to the amount of cash dividends paid by the Corporation to holders of Subordinate Voting Shares with respect to a number of Shares determined by the Compensation and Corporate Governance Committee (“Dividend Equivalents”), and (vii) other share-based awards, which are referred to herein collectively as “Awards,” as more fully described below.

 

 
88

Table of Contents

 

The Compensation and Corporate Governance Committee may delegate to one or more officers or directors of the Corporation the authority to grant Awards, subject to such terms, conditions and limitations as the Compensation and Corporate Governance Committee may establish in its sole discretion and provided that such delegation of authority would not cause the Equity Incentive Plan to be noncompliant with applicable exchange rules or applicable corporate law.

 

Eligibility

 

Any of the Corporation’s employees, officers, directors, consultants, independent contractors or advisors providing services to the Corporation or any of its affiliates, or any such person to whom an offer of employment or engagement with the Corporation or any of its affiliates is extended, are eligible to participate in the Equity Incentive Plan (the “Participants”). The basis of participation of an individual under the Equity Incentive Plan, and the type and amount of any Award that an individual will be entitled to receive under the Equity Incentive Plan, will be determined by the Compensation and Corporate Governance Committee based on its judgment as to the best interests of the Corporation, and therefore cannot be determined in advance. Notwithstanding the foregoing, an ISO may only be granted to full-time or part-time employees, and an ISO shall not be granted to an employee of an affiliate of the Corporation unless such affiliate is also a “subsidiary corporation” of the Corporation within the meaning of Section 424(f) the United States Internal Revenue Code of 1986, as amended (the “Code”).

 

The maximum number of Subordinate Voting Shares that may be issued under all Awards under the Equity Incentive Plan is 2,322,593 Subordinate Voting Shares. The maximum number of Subordinate Voting Shares that may be issued pursuant to ISOs is 600,000 Subordinate Voting Shares. Any shares subject to an Award under the Equity Incentive Plan that are forfeited, cancelled, expire unexercised, are reacquired by the Corporation, are settled in cash, or are used or withheld to satisfy tax withholding obligations of a Participant shall again be available for Awards under the Equity Incentive Plan.

 

In the event of any dividend (other than a regular cash dividend) or other distribution (whether in the form of cash, Subordinate Voting Shares, other securities or other property), recapitalization, forward or reverse stock split, reorganization, merger, consolidation, split-up, split-off, combination, repurchase or exchange of Subordinate Voting Shares or other securities of the Corporation, issuance of warrants or other rights to acquire Subordinate Voting Shares or other securities of the Corporation, or other similar corporate transaction or event, which affects the Subordinate Voting Shares, the Compensation and Corporate Governance Committee may make such adjustment, which is appropriate in order to prevent dilution or enlargement of the benefits or potential benefits intended to be made available under the Equity Incentive Plan, to any or all of (i) the number and type of shares (or other securities or other property) which may thereafter be made the subject of Awards, (ii) the number and type of shares (or other securities or other property) subject to outstanding Awards, and (iii) the purchase price or exercise price relating to any Award.

 

If and so long as the Corporation is listed on the CSE (as is currently the case), the aggregate number of Subordinate Voting Shares issued or issuable to persons providing investor relations activities (as defined in CSE policies) as compensation within a one-year period, shall not exceed 1% of the total number of Subordinate Voting Shares then outstanding.

 

Awards

 

Options

 

The Compensation and Corporate Governance Committee is authorized to grant Options to purchase Subordinate Voting Shares that are either ISOs, meaning they are intended to satisfy the requirements of Section 422 of the Code, or NQSOs, meaning they are not intended to satisfy the requirements of Section 422 of the Code. Options granted under the Equity Incentive Plan will be subject to the terms and conditions established by the Compensation and Corporate Governance Committee.

 

 
89

Table of Contents

 

Under the terms of the Equity Incentive Plan, unless the Compensation and Corporate Governance Committee determines otherwise in the case of an Option substituted for another Option in connection with a corporate transaction, the exercise price of the Options will not be less than the fair market value (as determined under the Equity Incentive Plan) of the shares at the time of grant. In the event that the Subordinate Voting Shares are listed on the CSE (as is currently the case), the fair market value shall not be lower than the greater of the closing price of the Subordinate Voting Shares on the CSE on (i) the trading day prior to the date of grant of the Options, and (ii) the date of grant of the Options.

 

Options granted under the Equity Incentive Plan will be subject to such terms, including the exercise price and the conditions and timing of exercise, as may be determined by the Compensation and Corporate Governance Committee and specified in the applicable award agreement. The maximum term of an option granted under the Equity Incentive Plan will be ten years from the date of grant. Payment in respect of the exercise of an Option may be made, among other forms, in cash or by check, in Subordinate Voting Shares (actually or by attestation), in other securities, other Awards or other property, or in any combination thereof, having a fair market value on the exercise date equal to the applicable exercise price. or by such other method as the Compensation and Corporate Governance Committee may determine to be appropriate. The Compensation and Corporate Governance Committee may, in its discretion, permit an Option to be exercised by delivering to the Participant a number of Subordinate Voting Shares having an aggregate fair market value (determined as of the date of exercise) equal to the excess, if positive, of the fair market value of the Subordinate Voting Shares underlying the Option being exercised on the date of exercise, over the exercise price of the Option for such Subordinate Voting Shares.

 

Restricted Stock

 

A restricted stock award is a grant of Subordinate Voting Shares, which are subject to such restrictions as the Compensation and Corporate Governance Committee may impose (including, without limitation, any limitation on the right to vote a Subordinate Voting Share underlying the restricted stock award or the right to receive any dividend or right or property with respect thereto), which restrictions may lapse or in combination at such time or times, in such installments or otherwise as the Compensation and Corporate Governance Committee may deem appropriate. The Compensation and Corporate Governance Committee will determine the price, if any, to be paid by the Participant for each Subordinate Voting Share subject to a restricted stock award. Except as otherwise determined by the Compensation and Corporate Governance Committee or as provided in an award agreement, upon a Participant’s termination of employment or service or resignation or removal as a director (in either case, as determined under criteria established by the Compensation and Corporate Governance Committee) during the applicable restriction period, all Subordinate Voting Shares underlying the restricted stock award held by such Participant at such time shall be forfeited and reacquired by the Corporation for cancellation at no cost to the Corporation; provided however, that the Compensation and Corporate Governance Committee may waive in whole or in part any or all remaining restrictions with respect to Subordinate Voting Shares underlying the restricted stock award.

 

RSUs

 

An RSU is a unit evidencing the right to receive a Subordinate Voting Share (or a cash payment equal to the fair market value of a Subordinate Voting Share) at some future date, provided that in the case of Participants who are liable to taxation under the Income Tax Act (Canada) in respect of amounts payable under the Equity Incentive Plan, that such date shall not be later than December 31 of the third calendar year following the year the services were performed in respect of the corresponding RSU awarded. Unless otherwise provided for in an award agreement, no Subordinate Voting Shares shall be issued at the time RSUs are granted. Except as otherwise determined by the Compensation and Corporate Governance Committee or as provided in an award agreement, upon a Participant’s termination of employment or service or resignation or removal as a director (in either case, as determined under criteria established by the Compensation and Corporate Governance Committee) during the applicable restriction period, all Subordinate Voting Shares underlying the RSUs held by such Participant at such time shall be forfeited and reacquired by the Corporation for cancellation at no cost to the Corporation; provided however, that the Compensation and Corporate Governance Committee may waive in whole or in part any or all remaining restrictions with respect to Subordinate Voting Shares underlying the RSUs.

 

 
90

Table of Contents

 

Stock Appreciation Rights

 

An SAR entitles the recipient to receive, upon exercise of the SAR, the excess of (i) the fair market value of one Subordinate Voting Share on the date of exercise over (ii) the grant price of the SAR as specified by the Compensation and Corporate Governance Committee, which price shall not be less than 100% of the fair market value of one Subordinate Voting Share on the date of grant of the SAR, unless the SAR is granted in substitution for a stock appreciation right previously granted by an entity that is acquired by or merged with the Corporation or an affiliate (subject to applicable law and securities exchange rules). Subject to the terms of the Equity Incentive Plan and any applicable award agreement, the grant price, term, methods of exercise, dates of exercise, methods of settlement and any other terms and conditions of any SAR shall be as determined by the Compensation and Corporate Governance Committee, provided that no SAR may be exercised more than ten years from the grant date.

 

Performance Awards

 

Participants may be granted Performance Awards that may be denominated or payable in cash, Subordinate Voting Shares (including, without limitation, restricted stock and RSUs), other securities, other Awards or other property. Performance Awards granted under the Equity Incentive Plan confer on the holder thereof the right to receive payments, in whole or in part, upon the achievement of one or more objective performance goals during such performance periods as the Compensation and Corporate Governance Committee shall establish. Subject to the terms of the Equity Incentive Plan, the performance goals to be achieved during any performance period, the length of any performance period, the amount of any Performance Award granted, the amount of any payment or transfer to be made pursuant to any Performance Award and any other terms and conditions of any Performance Award will be determined by the Compensation and Corporate Governance Committee.

 

Dividend Equivalents

 

The Compensation and Corporate Governance Committee may also grant Dividend Equivalents under which the Participant will be entitled to receive payments (in cash, Subordinate Voting Shares, other securities, other awards or other property) equivalent to the amount of cash dividends paid by the Corporation to holders of Subordinate Voting Shares with respect to a number of Shares determined by the Compensation and Corporate Governance Committee. Subject to the terms of the Equity Incentive Plan and any applicable award agreement, Dividend Equivalents may have such terms and conditions as the Compensation and Corporate Governance Committee determines, provided that (i) the Compensation and Corporate Governance Committee may not grant Dividend Equivalents to Participants in connection with grants of Options, SARs or other Awards the value of which is based solely on an increase in the value of the Subordinate Voting Shares after the date of grant of such Award, and (ii) dividend and Dividend Equivalent amounts may be accrued but shall not be paid unless and until the date on which all conditions or restrictions relating to such Award have been satisfied, waived or lapsed.

 

Other

 

The Compensation and Corporate Governance Committee may also grant other Awards that are denominated or payable in, valued in whole or in part by reference to, or otherwise based on or related to, Subordinate Voting Shares (including, without limitation, securities convertible into Subordinate Voting Shares), as are deemed by the Compensation and Corporate Governance Committee to be consistent with the purpose of the Equity Incentive Plan.

 

General

 

Awards may be granted for no cash consideration or for any cash or other consideration as may be determined by the Compensation and Corporate Governance Committee or required by applicable law.

 

The Compensation and Corporate Governance Committee may impose restrictions on the grant, exercise or payment of an Award as it determines appropriate. Generally, Awards granted under the Equity Incentive Plan shall be non-transferable except by will or by the laws of descent and distribution. No Participant shall have any rights as a shareholder with respect to Subordinate Voting Shares covered by Options, SARs, restricted stock awards, or RSUs, unless and until such Awards are settled in Subordinate Voting Shares.

 

 
91

Table of Contents

 

No Option (or, if applicable, SARs) shall be exercisable, no Subordinate Voting Shares shall be issued, no certificates for Subordinate Voting Shares shall be delivered and no payment shall be made under the Equity Incentive Plan except in compliance with all applicable laws.

 

The Board may amend, alter, suspend, discontinue or terminate the Equity Incentive Plan and the Compensation and Corporate Governance Committee may amend any outstanding Award at any time; provided that (i) such amendment, alteration, suspension, discontinuation, or termination shall be subject to the approval of the Shareholders if such approval is necessary to comply with any tax or regulatory requirement applicable to the Equity Incentive Plan (including, without limitation, as necessary to comply with any rules or requirements of an applicable securities exchange), and (ii) no such amendment or termination may adversely affect Awards then outstanding without the Award holder’s permission.

 

No award agreement may accelerate the exercisability of any Award or the lapse of restrictions relating to any Award in connection with a change in control event, unless such acceleration occurs upon the consummation of (or effective immediately prior to the consummation of, provided that the consummation subsequently occurs) such change in control event.

 

In the event of any reorganization, merger, consolidation, split-up, spin-off, combination, plan of arrangement, take-over bid or tender offer, repurchase or exchange of Subordinate Voting Shares or other securities of the Corporation or any other similar corporate transaction or event involving the Corporation (or the Corporation shall enter into a written agreement to undergo such a transaction or event), the Compensation and Corporate Governance Committee or the Board may, in its sole discretion, provide for any (or a combination) of the following to be effective upon the consummation of the event (or effective immediately prior to the consummation of the event, provided that the consummation of the event subsequently occurs):

 

 

·

termination of the Award, whether or not vested, in exchange for cash and/or other property, if any, equal to the amount that would have been attained upon the exercise of the vested portion of the Award or realization of the Participant’s vested rights,

 

 

 

 

·

replacement of the Award with other rights or property selected by the Compensation and Corporate Governance Committee or the Board, in its sole discretion,

 

 

 

 

·

assumption of the Award by the successor or survivor corporation, or a parent or subsidiary thereof, or shall be substituted for by similar options, rights or awards covering the stock of the successor or survivor corporation, or a parent or subsidiary thereof, with appropriate adjustments as to the number and kind of shares and prices,

 

 

 

 

·

that the Award shall be exercisable or payable or fully vested with respect to all Subordinate Voting Shares covered thereby, notwithstanding anything to the contrary in the applicable award agreement, or

 

 

 

 

·

that the Award cannot vest, be exercised or become payable after a date certain in the future, which may be the effective date of the event.

 

To the full extent permitted by law, the members of the Board, the Compensation and Corporate Governance Committee and each person to whom the Compensation and Corporate Governance Committee delegates authority under the Equity Incentive Plan will not be liable for any action taken or determination made in good faith with respect to the Equity Incentive Plan or any Award made under the Equity Incentive Plan, and will be entitled to indemnification by the Corporation, in addition to such other rights of indemnification they may have by virtue of their position with the Corporation, with regard to such actions and determinations.

 

 
92

Table of Contents

 

Tax Withholding

 

The Corporation may take such action as it deems appropriate to ensure that all applicable federal, state, local and/or foreign payroll, withholding, income or other taxes, which are the sole and absolute responsibility of a Participant, are withheld or collected from such Participant.

 

Legacy Incentive Plan

 

Pursuant to and upon completion of the RTO, the Corporation assumed the obligations under the Options outstanding at such time issued by Indus Holding under its 2016 Stock Incentive Plan (the “Legacy Incentive Plan”) and the obligations under the Legacy Incentive Plan solely with respect to such assumed Options (no further grants were made under the Legacy Incentive Plan following completion of the RTO). The principal terms of the Legacy Incentive Plan, as they relate to the Options issued thereunder, are described below.

 

Purpose

 

The purpose of the Legacy Incentive Plan is to attract, retain, reward and motivate eligible individuals by providing them with an opportunity to acquire or increase a proprietary interest in the Corporation and to incentivize them to expend maximum effort for the growth and success of the Corporation, so as to strengthen the mutuality of the interests between the eligible individuals and the shareholders of Indus.

 

Eligibility

 

If the outstanding Subordinate Voting Shares are increased or decreased or changed into or exchanged for a different number or kind of shares or other securities by reason of any recapitalization, reclassification, reorganization, stock split, reverse split, combination of shares, exchange of shares, stock dividend or other distribution payable in shares of Indus or other increase or decrease in such shares effected without receipt of consideration by Indus, an appropriate and proportionate adjustment shall be made by the Compensation and Corporate Governance Committee to: (i) the aggregate number and kind of shares available under the Legacy Incentive Plan, (ii) the calculation of the reduction of Subordinate Voting Shares available under the Legacy Incentive Plan, (iii) the number and kind of shares issuable pursuant to outstanding awards granted under the Legacy Incentive Plan and/or (iv) the exercise price of outstanding Options granted under the Legacy Incentive Plan. No fractional Subordinate Voting Shares or units or other securities shall be issued pursuant to any such adjustment under the Legacy Incentive Plan, and any fractions resulting from any such adjustment shall be eliminated in each case by rounding downward to the nearest whole share or unit. Any adjustments made under the Legacy Incentive Plan with respect to any incentive stock options must be made in accordance with Section 424 of the Code.

 

Options

 

Each Option granted under the Legacy Incentive Plan may be designated by the Compensation and Corporate Governance Committee, in its sole discretion, as either (i) an ISO, or (ii) an NQSO. Options designated as ISOs that fail to continue to meet the requirements of Section 422 of the Code shall be re-designated as NQSOs automatically on the date of such failure to continue to meet such requirements without further action by the Compensation and Corporate Governance Committee. In the absence of any designation, Options granted under the Legacy Incentive Plan will be deemed to be NQSOs.

 

Subject to the limitations set forth in the Legacy Incentive Plan relating to ISOs, Options granted under the Legacy Incentive Plan and all rights to purchase Subordinate Voting Shares thereunder shall terminate no later than the tenth anniversary of the grant date of such Options, or on such earlier date as may be stated in the award agreement relating to such Option. In the case of Options expiring prior to the tenth anniversary of the grant date, the Compensation and Corporate Governance Committee may in its discretion, at any time prior to the expiration or termination of said Options, extend the term of any such Options for such additional period as it may determine, but in no event beyond the tenth anniversary of the grant date thereof.

 

 
93

Table of Contents

 

No Options may be exercised prior to the satisfaction of the conditions and vesting schedule provided for in the Legacy Incentive Plan and in the award agreement relating thereto. Unless otherwise provided in the award agreement, 25% of the Options shall vest on each anniversary of the grant date, and there shall be no proportionate or partial vesting in the periods between the vesting dates and all vesting shall occur only on the aforementioned vesting dates.

 

Payment of the exercise price for the Subordinate Voting Shares purchased pursuant to the exercise of an Option shall be made by (i) cash, certified or cashier’s check, bank draft or money order or (ii) any other method which the Compensation and Corporate Governance Committee, in its sole and absolute discretion and to the extent permitted by applicable law, may permit.

 

Unless otherwise provided in an award agreement, upon the termination of the employment or other service of a participant with the Corporation for any reason, all of the participant’s outstanding Options (whether vested or unvested) shall be subject to the rules of the Legacy Incentive Plan. Upon such termination, the participant’s unvested Options shall expire. Notwithstanding anything in the Legacy Incentive Plan to the contrary, the Compensation and Corporate Governance Committee may provide, in its sole and absolute discretion, that following the termination of employment or other service of a participant with the Corporation for any reason (i) any unvested Options held by the participant shall vest in whole or in part, at any time subsequent to such termination of employment or other service, and/or (ii) a participant or the participant’s estate, devisee or heir at law (whichever is applicable), may exercise an Option, in whole or in part, at any time subsequent to such termination of employment or other service and prior to the termination of the Option pursuant to its terms that are unrelated to termination of service. Unless otherwise determined by the Compensation and Corporate Governance Committee, temporary absence from employment or other service because of illness, vacation, approved leaves of absence or military service shall not constitute a termination of employment or other service.

 

If a participant’s termination of employment or other service is for any reason other than death, disability, cause or a voluntary termination within ninety (90) days after occurrence of an event which would be grounds for termination of employment or other service by the Corporation for cause, any Option held by such participant may be exercised, to the extent exercisable at termination, by the participant at any time within a period not to exceed ninety (90) days from the date of such termination, but in no event after the termination of the Option pursuant to its terms that are unrelated to termination of service. If a participant dies while in the employment or other service of the Corporation, any Option held by such participant may be exercised, to the extent exercisable at termination, by the participant’s estate or the devisee named in the participant’s valid last will and testament or the participant’s heir at law who inherits the Option, at any time within a period not to exceed one hundred eighty (180) days after the date of such participant’s death, but in no event after the termination of the Option pursuant to its terms that are unrelated to termination of service. In the event the termination is for cause or is a voluntary termination within ninety (90) days after occurrence of an event which would be grounds for termination of employment or other service by the Corporation for cause (without regard to any notice or cure period requirement), any Option held by the participant at the time of such termination shall be deemed to have terminated and expired upon the date of such termination.

 

Change in Control

 

Upon the occurrence of a change in control of the Corporation, the Compensation and Corporate Governance Committee may in its sole and absolute discretion, provide on a case by case basis that (i) that all unvested awards, and all vested awards that are required to be exercised to realize the full benefit thereof that have not been exercised, shall terminate, provided that participants shall have the right, immediately prior to the occurrence of such change in control and during such reasonable period as the Compensation and Corporate Governance Committee in its sole discretion shall determine and designate, to exercise any such vested award, (ii) that all unvested awards, and all vested awards that are required to be exercised to realize the full benefit thereof that have not been exercised, shall terminate, provided that participants shall be entitled to a cash payment equal to the change in control price with respect to shares subject to the vested portion of the award net of the exercise price thereof, if applicable, (iii) provide that, in connection with a liquidation or dissolution of Indus, awards that are required to be exercised to realize the full benefit thereof that have not been exercised, to the extent vested, shall convert into the right to receive liquidation proceeds net of the exercise price (if applicable), (iv) accelerate the vesting of awards and (v) any combination of the foregoing. In the event that the Compensation and Corporate Governance Committee does not terminate or convert an unvested award, or a vested award that is required to be exercised to realize the full benefit thereof that has not been exercised, upon a change in control of Indus, then the award shall be assumed, or substantially equivalent awards shall be substituted, by the acquiring, or succeeding corporation (or an affiliate thereof).

 

 
94

Table of Contents

 

Right of Repurchase

 

Unless otherwise provided in an award agreement, Indus shall have the right to repurchase the Subordinate Voting Shares issued with respect to any participant, following such participant’s termination of employment and service with the Corporation for any reason. The price for repurchasing the Subordinate Voting Shares shall be equal to the fair market value of the Subordinate Voting Shares, as determined on the day of such termination. Should Indus fail to exercise such repurchase right within one hundred and eighty (180) days following the later of (i) the date of such participant’s termination of employment or service; or (ii) the date Subordinate Voting Shares are issued to the participant, Indus shall be deemed to have waived such right.

 

General

 

All awards granted pursuant to the Legacy Incentive Plan are to be evidenced by an award agreement. The terms of each award agreement need not be identical for eligible individuals provided that each award agreement shall comply with the terms of the Legacy Incentive Plan.

 

A participant may not transfer an award other than by will or the laws of descent and distribution. Awards may be exercised during the participant’s lifetime only by the participant. No award shall be liable for or subject to the debts, contracts, or liabilities of any participant, nor shall any award be subject to legal process or attachment for or against such person. Any purported transfer of an award in contravention of the provisions of the Legacy Incentive Plan shall have no force or effect and shall be null and void, and the purported transferee of such award shall not acquire any rights with respect to such award. Notwithstanding anything to the contrary, the Compensation and Corporate Governance Committee may in its sole and absolute discretion permit the transfer of an award to a participant’s family member under such terms and conditions as specified by the Compensation and Corporate Governance Committee. In such case, such award shall be exercisable only by the transferee approved of by the Compensation and Corporate Governance Committee. To the extent that the Compensation and Corporate Governance Committee permits the transfer of an ISO to a family member, so that such Option fails to continue to satisfy the requirements of an incentive stock option under the Code, such Option shall automatically be re-designated as an NQSO.

 

Subject to the terms and conditions of the Legacy Incentive Plan, the Compensation and Corporate Governance Committee may modify outstanding awards, provided that, except as expressly provided in the Legacy Incentive Plan, no modification of an award shall adversely affect any rights or obligations of the participant under the applicable award agreement without the participant’s consent. Nothing in the Legacy Incentive Plan shall limit the right of the Corporation to pay compensation of any kind outside the terms of the Legacy Incentive Plan.

 

Other than the Equity Incentive Plan and the Legacy Incentive Plan, the Corporation does not have any incentive or compensation-based security plans under which awards are granted.

 

DIRECTOR COMPENSATION

 

The following table summarizes the compensation paid to our non-employee directors for the year ended December 31, 2023.

 

Name

 

Option

Awards

 

 

Stock

Awards

 

 

Total

 

William Anton

 

$1,128

 

 

$-

 

 

$1,128

 

Jeffrey Monat

 

$3,386

 

 

$-

 

 

$3,386

 

Summer Frein

 

$3,386

 

 

$-

 

 

$3,386

 

Ann Lawrence

 

$36,119

 

 

$-

 

 

$36,119

 

 

 
95

Table of Contents

 

Compensation of Directors

 

The level of compensation for directors is determined on an ad hoc basis after consideration of various relevant factors, including the expected nature and quantity of duties and responsibilities, past performance, comparison with compensation paid by other issuers of comparable size and stage of development in the cannabis industry, and the availability of financial and other resources of the Corporation. The Compensation and Corporate Governance Committee of the Board is responsible for determining all forms of compensation to be granted to the directors of the Corporation, which compensation is recommended to the Board for approval.

 

 Item 12. SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT

 

The tables below sets forth information with respect to the beneficial ownership of our Super Voting Shares and Subordinate Voting Shares as of March 19, 2024 by:

 

 

·

each person or entity known by us to own beneficially more than 5% of our outstanding Subordinate Voting Shares;

 

 

 

 

·

each of our directors and executive officers individually; and

 

 

 

 

·

all of our executive officers and directors as a group.

 

The Super Voting Shares carry 1,000 votes per share. The Subordinate Voting Shares carry 1 vote per share. As of March 19, 2024, the Subordinate Voting Shares represented approximately 47.2% of the voting power of our outstanding voting securities and approximately 51.9% of the voting power of our voting securities on a fully diluted basis, and the Super Voting Shares represented approximately 52.8% of the voting power of our outstanding voting securities and approximately 48.1% of the voting power of our voting securities on a fully diluted basis. Fully diluted calculations take into account Subordinate Voting Shares issuable upon the conversion of outstanding debentures, the redemption of Class B Common Shares of our subsidiary, Indus Holding Company, and the exercise of outstanding warrants and options and Subordinate Voting Shares subject to unvested restricted stock units.

   

The Super Voting Shares are held by Robert Weakley. Mr. Weakley served as Chairman and Chief Executive Officer of the Company from the date of the reverse takeover transaction with Indus Holding Company (the “RTO”) until April 2020 and thereafter as a member of our board of directors until October 2020. Mr. Weakley is party to an investment agreement with the Company pursuant to which the Super Voting Shares may be transferred only with the Company’s consent. The Company has agreed to grant its consent to a transfer by Mr. Weakley to certain family members, trusts for their benefit, and entities controlled by Mr. Weakley or such family members, in each case subject to the entry by the transferee into an accession agreement with the Company providing for the same restrictions on transfer. The investment agreement prohibits the Company from consenting to a transfer that would result in the Super Voting Shares being acquired pursuant to a change of control transaction, as defined in the investment agreement. Pursuant to the investment agreement, in the event of a non-permitted transfer by Mr. Weakley, or upon a change of control transaction, the Super Voting Shares shall be redeemed by the Company for their original purchase price of $1,000. The holders of Subordinate Voting Shares will not be entitled to participate in any such permitted transfer or redemption under the terms of the Subordinate Voting Shares or under any coattail or similar agreement.

 

 
96

Table of Contents

 

To our knowledge, except as discussed above, none of the shares listed below are held under a voting trust or similar agreement, except as noted. To our knowledge, there is no arrangement, including any pledge by any person of our securities or any of our parents, the operation of which may at a subsequent date result in a change in control of our company. Unless otherwise noted below, the address of each other person listed on the table is c/o Lowell Farms Inc., 440 N Barranca Ave. #1675 Covina, CA 91723.

 

Beneficial ownership is determined in accordance with the rules of the SEC and generally includes voting or investment power with respect to securities. In accordance with the SEC rules, our shares that may be acquired within 60 days of the date of the table below, including but not limited to by reason of any right to acquire such shares (a) through the exercise of any option, warrant or right, (b) through the conversion of a security, (c) pursuant to the power to revoke a trust, discretionary account, or similar arrangement or (d) pursuant to the automatic termination of a trust, discretionary account or similar arrangement, are deemed beneficially owned by the holders of such equity awards and are deemed outstanding for the purpose of computing the percentage of ownership of such person, but are not treated as outstanding for the purpose of computing the percentage of ownership of any other person. As of March 19, 2024, 20,259 Super Voting Shares and 18,130,566 Subordinate Voting Shares were issued and outstanding.

 

Super Voting Shares

 

 

 

Super

Voting

Shares

Beneficially

Owned

 

 

Percentage

of Super

Voting

Shares

Beneficially

Owned (%)

 

 

 

 

 

 

 

 

Robert Weakley

 

 

20,259

 

 

 

100.00%

 

Subordinate Voting Shares

 

 

 

Subordinate

Voting

Shares

Beneficially

Owned

 

 

Percentage

of

Subordinate

Voting

Shares

Beneficially

Owned (%)

 

Directors and Named Executive Officers:

 

 

 

 

 

 

Ann Lawrence (1)

 

 

332,500

 

 

 

1.80%

Mark Ainsworth (2)

 

 

356,976

 

 

 

1.93%

William Anton (3)

 

 

261,144

 

 

 

1.43%

Jeff Monat (4)

 

 

45,000

 

 

*

 

Summer Frein (5)

 

 

42,500

 

 

*

 

Tessa O’Dowd (6)

 

 

8,750

 

 

*

 

All executive officers and directors as a group (6 persons)

 

 

1,041,870

 

 

 

5.47%

 

 

 

 

 

 

 

 

 

5% or Greater Stockholders:

 

 

 

 

 

 

 

 

Arenal Holdings (7)

 

 

1,226,880

 

 

 

6.75%

Hacienda Company

 

 

1,056,033

 

 

 

5.82%

Hannah Ross (8)

 

 

1,101,320

 

 

 

6.07%

Beehouse Entities (9)

 

 

3,915,381

 

 

 

21.02%

Gregory Heyman (10)

 

 

3,920,381

 

 

 

21.04%

Brian Shure (11)

 

 

1,414,558

 

 

 

7.73%

 

 
97

Table of Contents

 

Subordinate Voting Shares 

_______________ 

*

Represents beneficial ownership of less than 1%.

(1)

Consists of Subordinate Voting Shares issuable upon the exercise of options held by Ms. Lawrence.

(2)

Consists of 101,976 Subordinate Voting Shares issuable upon redemption of Indus Redeemable Shares and 255,000 Subordinate Voting Shares issuable upon the exercise of options held by Mr. Ainsworth.

(3)

Includes 46,000 Subordinate Voting Shares issuable upon redemption of Indus Redeemable Shares and 25,000 Subordinate Voting Shares issuable upon the exercise of options held by Mr. Anton; and 53,291 Subordinate Voting Shares issuable upon redemption of Indus Redeemable Shares and 94,353 subordinate voting shares and 10,000 Subordinate Voting Shares issuable upon the exercise of warrants held by Anton Enterprises, Inc. Mr. Anton is the president and sole stockholder of Anton Enterprises, Inc.

(4)

Consists of Subordinate Voting Shares issuable upon the exercise of options held by Mr. Monat.

(5)

Consists of Subordinate Voting Shares issuable upon the exercise of options held by Ms. Frein.

(6)

Consists of Subordinate Voting Shares issuable upon the exercise of options held by Ms. O’Dowd.

(7)

Includes 10,000 Subordinate Voting Shares issuable upon the exercise of warrants.

(8)

Includes 1,056,033 Subordinate Voting Shares held by Hacienda Company, LLC (“Hacienda”). Ms. Ross is the sole manager of Hacienda.

(9)

Consists of 1,056,033 Subordinate Voting Shares held by Hacienda and 2,359,348 outstanding Subordinate Voting Shares and 500,000 Subordinate Voting Shares issuable upon the exercise of warrants held by Beehouse Partners, LP (“Beehouse Partners”). Beehouse, LLC is the investment manager of two SPVs that collectively own a majority interest in Hacienda and is also the investment manager of Beehouse Partners. Beehouse Manager, LLC (together with Beehouse, LLC, the “Beehouse Entities”) is the manager of Beehouse, LLC.

(10)

Consists of the Subordinate Voting Shares beneficially owned by the Beehouse Entities and 5,000 Subordinate Voting Shares held by Mr. Heyman. Mr. Heyman is the sole and managing member of Beehouse Manager, LLC.

(11) 

Consists of 15,000 Subordinate Voting Shares issuable upon the exercise of options held by Mr. Shure; 863,654 outstanding Subordinate Voting Shares and 85,000 Subordinate Voting Shares issuable upon the exercise of warrants held by Ambrose Capital Holdings, LP;  236,966 outstanding Subordinate Voting Shares and 40,000 Subordinate Voting Shares issuable upon the exercise of warrants held by AMTG Holdings, LLLP; 18,480 outstanding Subordinate Voting Shares and 9,240 Subordinate Voting Shares issuable upon the exercise of warrants held by HSK Holdings, LLC; and 122,740 outstanding Subordinate Voting Shares and 15,000 Subordinate Voting Shares issuable upon the exercise of warrants held by the Brian K. Shure Charitable Trust Lead Annuity. Mr. Shure is a former director and CFO of the Company and is the President of Ambrose Capital Partners, LLC, which is the general partner of Ambrose Capital Holdings, LP, President of AMTG Management, Inc., which is the general partner of AMTG Holdings, LLLP, Managing Member of HSK Holdings, LLC and the sole trustee of the Brian K. Shure Charitable Trust Lead Annuity.

 

 
98

Table of Contents

 

EQUITY COMPENSATION PLAN INFORMATION

 

The following table provides information as of December 31, 2023, concerning our compensation plans under which equity securities are authorized for issuance.

 

Plan Category

 

Number of securities

to be

issued

upon

exercise of outstanding

options,

warrants,

and rights

(a)

 

 

Weighted

average

exercise

price of

outstanding

options,

warrants,

and rights

(b)

 

 

Number of securities remaining

available for

future

issuance

under equity compensation

plans

(excluding securities

reflected in

column (a)

(c)

 

Equity compensation plans approved by stockholders (1) 

 

 

1,449,350

 

 

$1.91

 

 

 

3,579,432

 

Equity compensation plans not approved by stockholders 

 

 

-

 

 

 

-

 

 

 

-

 

____________

(1) In connection with the RTO, the Company assumed the 2016 stock incentive plan of Indus Holding Company and outstanding option awards thereunder became exercisable for Subordinate Voting Shares. Of the Company’s 1,449,350 outstanding awards on December 31, 2023, 14,700 were issued under the legacy 2016 stock incentive plan and the remainder were issued under the Company’s 2019 stock incentive plan. No further awards will be made pursuant to the 2016 stock incentive plan.

 

ITEM 13. Certain Relationships and Related Transactions, and Director Independence

 

Certain Relationships and Related Transactions

 

The following includes a summary of transactions during our fiscal years ended December 31, 2023 and 2022 and one currently proposed transaction to which we have been a party, including transactions in which the amount involved in the transaction exceeds the lesser of $120,000 or 1% of the average of our total assets at year-end for the last two completed fiscal years and in which any of our directors, executive officers or, to our knowledge, beneficial owners of more than 5% of our capital stock or any member of the immediate family of any of the foregoing persons had or will have a direct or indirect material interest, other than equity and other compensation, termination, change in control and other arrangements, which are described elsewhere in this Annual Report on Form 10-K. Except as disclosed below, we are not otherwise a party to a current related party transaction and no transaction is currently proposed, in which the amount of the transaction exceeds the lesser of $120,000 or 1% of the average of our total assets at year-end for the last two completed fiscal years and in which a related person had or will have a direct or indirect material interest.

 

Certain officers and directors of the Company purchased an aggregate of 290,000 Units pursuant to the PIPE transaction that closed on August 30, 2021 on the same terms as the other participants in the PIPE transaction.  Participation by such insiders of the Company in the PIPE transaction was approved by the disinterested directors of the Company.

 

Certain officers and directors purchased $2.3 million of convertible debentures during the third quarter of 2022 that converted in October 2023. The terms of the convertible debentures were the same as other participants in the financing round and were approved by disinterested directors of the Company.

 

During October 2022, Cannaco Research Corporation, an existing customer, became a related party when Ms. Lawrence, a new member joined the Board of Directors. Total sales recognized for Cannaco Research Corporation for the years ended December 31, 2023 and 2022 were $487 and $274, respectively. For the years ended December 31, 2023 and 2022, cash collected from Cannaco Research Corporation was $476 and $223, respectively. In December, 2022, the Company entered into an agreement with Cannaco Research Corporation to lease approximately 2,000 square feet of warehouse space in Los Angeles to facilitate distribution services in the area. The lease was a 12 month storage agreement for the warehouse space. Total payments to Cannaco Research Corporation for the lease were $130 and $10 in the years ended December 31, 2023 and December 31, 2022, respectively.

 

 
99

Table of Contents

 

Director Independence

 

Our Board of Directors includes Mark Ainsworth, William Anton, Jeff Monat, Summer Frein and Ann Lawrence, of which all members except Mark Ainsworth, are deemed to be independent. Mark Ainsworth is not considered independent because of his executive position with the Corporation. Although our securities are not listed on any U.S. national securities exchange, we use the definition of independence applied by the New York Stock Exchange (“NYSE”) to determine which directors are “independent.” We also use the definition of independence under NI 58-101.

 

None of the directors are presently directors of other reporting issuers.

 

Item 14. Principal Accountant Fees and Services

 

Aggregate fees billed by GreenGrowth CPAs for the years ended December 31, 2023, and December 31, 2022, are detailed in the table below.

 

 

 

2023 ($)

 

 

2022 ($)

 

Audit Fees(1)         

 

$129,560

 

 

$129,560

 

Audit-Related Fees

 

 

-

 

 

 

-

 

Tax Fees

 

 

-

 

 

 

-

 

All Other Fees

 

 

-

 

 

 

-

 

Total Fees

 

$129,560

 

 

$129,560

 

_______________

(1)

Fees for audit service on an accrual basis.

 

Pre-Approval of Non-Audit Services

 

The Audit Committee will pre-approve the appointment of the independent auditor for any non-audit service to be provided to the Corporation. Before the appointment of the independent auditor for any non-audit service, the Audit Committee will consider the compatibility of the service with the independent auditor’s independence. The Audit Committee may pre-approve the appointment of the independent auditor for any non-audit services by adopting specific policies and procedures, from time to time, for the engagement of the independent auditor for non-audit services. Such policies and procedures will be detailed as to the particular service, and the Audit Committee must be informed of each service, and the procedures may not include delegation of the Audit Committee’s responsibilities to management. In addition, the Audit Committee may delegate to one or more members the authority to pre-approve the appointment of the independent auditor for any non-audit service to the extent permitted by applicable law provided that any pre-approvals granted pursuant to such delegation shall be reported to the Audit Committee at its next scheduled meeting.

 

 
100

Table of Contents

 

Part IV

 

ITEM 15. Exhibits and Financial Statement Schedules

 

(a) The following documents are filed as part of this Annual Report on Form 10-K:

 

1. Financial Statements: The information concerning Lowell Farms Inc. financial statements and the Report of Independent Registered Public Accounting Firm required by this Item 15(a)(1) is incorporated by reference herein to the section of this Annual Report on Form 10-K in Part II, Item 8, titled “Financial Statements and Supplementary Data.”

 

2. Financial Statement Schedule: The following financial statement schedule Lowell Farms, Inc., for the fiscal years ended December 31, 2023 and 2022, is filed as part of this Annual Report on Form 10-K and should be read in conjunction with our consolidated financial statements.

 

SCHEDULE II-VALUATION AND QUALIFYING ACCOUNTS

 

 

 

 

 

Additions

 

 

 

 

 

 

 

Balance

 

 

Charged to

 

 

(Deductions)

 

 

Balance

 

 

 

Beginning

 

 

Costs and

 

 

Recoveries/

 

 

End of

 

(in thousands)

 

of Year

 

 

Expenses

 

 

Other

 

 

Year

 

Allowance for doubtful accounts:

 

 

 

 

 

 

 

 

 

 

 

 

Year Ended December 31, 2023

 

$

1,053

 

 

$

370

 

 

$

(464

)

 

$

959

 

Year Ended December 31, 2022

 

$1,139

 

 

$517

 

 

$(603 )

 

$1,053

 

 

 
101

Table of Contents

 

EXHIBIT INDEX

 

Schedules not listed above have been omitted because they are not applicable or are not required or the information required to be set forth therein is included in the consolidated financial statements or notes thereto.

 

3. Exhibits: See Item 15(b) below. We have filed, or incorporated into this Annual Report on Form 10-K by reference, the exhibits listed on the accompanying Exhibit Index immediately preceding the signature page of this Annual Report on Form 10-K.

 

(b) Exhibits:

 

The exhibits listed on the Exhibit Index immediately preceding the signature page of this Annual Report on Form 10-K is incorporated herein by reference as the list of exhibits required by this Item 15(b).

 

(c) Financial Statement Schedules: See Item 15(a) above.

 

Exhibit No.

 

Exhibit Description

2.1

 

Business Combination Agreement, dated March 29, 2019 between Mezzotin Minerals Inc., Indus Holding Company, 2670995 Ontario Inc. and 2670764 Ontario Inc. (1)

3.1

 

Articles of Incorporation of Indus Holdings, Inc. (1)

3.2

 

Certificate of Name Change of Indus Holdings, Inc. to Lowell Farms Inc., dated March 1, 2021. (1)

3.3

 

Notice of Articles of Lowell Farms Inc. (1)

4.1

 

Description of Securities. (2)

9.1

 

Letter Agreement, dated April 10, 2020, among Indus Holdings, Inc., Edible Management, LLC and Robert Weakley. (1)

10.1

 

Amended and Restated Support Agreement, dated as of April 10, 2020, between Indus Holdings, Inc. and Indus Holding Company. (1)

10.2

 

Investment Agreement, dated as of April 26, 2019, among Indus Holdings, Inc., and Robert Weakley. (1)

10.3

 

Warrant Indenture, dated December 21, 2020, between Indus Holdings, Inc. and Odyssey Trust Company. (1)

10.4

 

Employment Agreement, entered into as of July 1, 2020, by and between Edible Management, LLC and Mark Ainsworth. (1) (3)

10.5

 

Employment Agreement, entered into as of November 10, 2020, by and between Edible Management, LLC and Brian Shure. (1) (3)

10.6

 

Asset Purchase Agreement, dated as of February 25, 2021, by and among The Hacienda Company, LLC, Brand New Concepts, LLC, LFCO, LLC, Lowell Farms LLC, LFHMP, LLC, LFLC, LLC, Indus LF LLC and Indus Holdings, Inc. (1)

10.7

 

Indus Holding Company 2016 Stock Incentive Plan (1) (3)

10.8

 

Indus Holdings, Inc. 2019 Stock and Incentive Plan (1) (3)

10.9

 

Purchase Agreement dated as of June 29, 2021, among Lowell SR LLC, Lowell Farms Inc., Michael Gregory, C Quadrant LLC, AMAG Holdings LLC and Michael Gregory, as representative.(4)

10.10

 

Form of PIPE Subscription Agreement. (5)

10.11

 

Offer to Purchase, Dated September 17, 2023 (6)

10.12

 

Form of Assignment and Assumption of Contracts (6)

10.13

 

Form of Intellectual Property Assignment (6)

10.14

 

Form of License Agreement (6)

21.1

 

Subsidiaries of Lowell Farms Inc. (2)

31.1

 

Certification of Chief Executive Officer filed pursuant to Exchange Act Rules 13a-14(a) and 15d-14(a) of the Securities Exchange Act of 1934 as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. (2)

31.2

 

Certification of Chief Financial Officer filed pursuant to Exchange Act Rules 13a-14(a) and 15d-14(a) of the Securities Exchange Act of 1934 as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. (2)

32.1

 

Certification by Chief Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.(7)

32.2

 

Certification by Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.(7)

101.INS

 

XBRL Instance Document.

104

 

Cover page Interactive Data File (formatted as inline XBRL and contained in Exhibit 101).

 

(1)

Incorporated by reference from the Form 10 filed on March 9, 2021, as amended.

(2)

Filed herewith.

(3)            

Management compensatory plan or arrangement.

(4)

Incorporated by reference from the Form 8-K filed on July 6, 2021.

(5)

Incorporated by reference from the Form 8-K filed on September 3, 2021.

(6)

Incorporated by reference from the Form 8-K filed on October 12, 2023

(7)

Furnished herewith. This certification is deemed not filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (Exchange Act), or otherwise subject to the liability of that section, nor shall it be deemed incorporated by reference into any filing under the Securities Act of 1933, as amended or the Exchange Act.

  

Item 16. Form 10-K Summary.

 

None. 

 

 
102

Table of Contents

  

SIGNATURES

 

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized, on March 26, 2024.

 

 

LOWELL FARMS, INC.

 

 

 

 

 

Date: March 28, 2024

By:

/s/ Mark Ainsworth

 

 

 

Mark Ainsworth

 

 

 

Chief Executive Officer (principal

executive officer) and Director

 

 

 

 

 

Date: March 28, 2024

By:

/s/ Jamie Schniedwind

 

 

 

Jamie Schniedwind

 

 

 

Chief Financial Officer (principal

financial and accounting officer)

 

 

POWER OF ATTORNEY

 

KNOW ALL PERSONS BY THESE PRESENTS, that each person whose signature appears below constitutes and appoints Mark Ainsworth and Brian Shure, jointly and severally, his or her attorney-in-fact, with the power of substitution, for him or her in any and all capacities, to sign any amendments to this Form 10-K and to file the same, with exhibits thereto and other documents in connection therewith, with the Securities and Exchange Commission, hereby ratifying and confirming all that each of said attorneys-in-fact, or his substitute or substitutes, may do or cause to be done by virtue hereof.

 

Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.

 

Date: March 28, 2024

By:

/s/ Ann Lawrence

 

 

 

Ann Lawrence

 

 

 

Chairperson

 

 

 

 

 

Date: March 28, 2024

By:

/s/ William Anton

 

 

 

William Anton

 

 

 

Director

 

 

Date: March 28, 2024

By:

/s/ Summer Frein

 

 

 

Summer Frein

 

 

 

Director

 

 

 

 

 

Date: March 28, 2024

By:

/s/ Jeffrey Monat

 

 

 

Jeffrey Monat

 

 

 

Director

 

 

Date: March 28, 2024

By:

/s/ Mark Ainsworth

 

 

 

Mark Ainsworth

 

 

 

Chief Executive Officer (principal

executive officer) and Director

 

 

 

103

 

EX-4.1 2 lowlf_ex41.htm DESCRIPTION OF SECURITIES lowlf_ex41.htm

 

EXHIBIT 4.1

 

DESCRIPTION OF SECURITIES

 

The authorized capital stock of the Company is comprised of an unlimited number of Subordinate Voting Shares and an unlimited number of Super Voting Shares. As of March 26, 2024, there are 18,130,566 Subordinate Voting Shares and 20,259 Super Voting Shares outstanding. In addition, the following Subordinate Voting Shares are issuable upon conversion, exercise or exchange of outstanding securities of the Company:

  

 

o

893,591 Subordinate Voting Shares are issuable upon the redemption of all of the Class B Common Shares of Indus Holding Company (“Indus Class B Common Shares”);

 

o

900,000 Subordinate Voting Shares are issuable upon the exercise of the warrants (the “PIPE Warrants”) issued by the Company in the PIPE transaction. The warrants have an exercise price of $14.00 and expire on August 30, 2024;

 

o

 221,152 Subordinate Voting Shares are issuable upon the exercise of warrants issued by Indus Holding Company prior to the RTO to investors in debentures of Indus Holding Company. The warrants have an exercise price of $20.35 and expire on December 20, 2026;

o

4,500 Subordinate Voting Shares are issuable upon the exercise of warrants issued by Indus Holding Company prior to the RTO to investors of Indus Holding Company. The warrants have an exercise price of $10.17 and expire on March 15, 2026; and

 

o

1,375,600 Subordinate Voting Shares are issuable upon the exercise of options issued pursuant to the Company’s equity incentive plans, of which 1,119,658 shares were vested as of March 19, 2024.

 

The following is a summary of the rights, privileges, restrictions and conditions attached to the Subordinate Voting Shares.

 

Holders of Subordinate Voting Shares are entitled to receive as and when declared by the Board, dividends in cash or property of the Company. In the event of the liquidation, dissolution or winding-up of the Company, the holders of Subordinate Voting Shares will, subject to the rights of the holders of any shares of the Company ranking in priority to the Subordinate Voting Shares, be entitled to participate ratably along with all other holders of Subordinate Voting Shares. The only outstanding shares ranking in priority to the Subordinate Voting Shares upon liquidation are the Super Voting Shares, which have a liquidation preference equal to their aggregate original issuance price of U.S. $1,000. Holders of Subordinate Voting Shares are entitled to notice of and to attend any meeting of the shareholders of the Company, except a meeting solely of the Super Voting Shares (or any meeting of another particular class or series of shares of the Company as may be created in the future). Holders of Subordinate Voting Shares are entitled to one vote in respect of each Subordinate Voting Share held and holders of Super Voting Shares are entitled to 1,000 votes in respect of each Super Voting Share held. As of March 26, 2024, the Subordinate Voting Shares represented approximately 47.2% of the voting power of our outstanding voting securities and approximately 50.8% of the voting power of our voting securities on a fully diluted basis, and the Super Voting Shares represented approximately 52.8% of the voting power of our outstanding voting securities and approximately 49.2% of the voting power of our voting securities on a fully diluted basis.  

  

 

 

 

As long as any Subordinate Voting Shares remain outstanding, the Company may not, without the consent of the holders of the Subordinate Voting Shares by separate special resolution, prejudice or interfere with any right or special right of the Subordinate Voting Shares. A special resolution means either (a) a resolution approved by at least two-thirds of the votes cast on the resolution at a properly called meeting of the shareholders or (b) a resolution approved in writing by all of the shareholders holding shares that carry the right to vote on the matter at a general shareholders meeting. Special rights and restrictions of the Subordinate Voting Shares consist of the following special rights and restrictions included in Article 27 of our articles of incorporation and summarized herein: (i) voting rights, (ii) alteration to rights of Subordinate Voting Shares, (iii) dividends, (iv) liquidation, dissolution or winding-up, (v) right to subscribe, preemptive rights and (vi) subdivision or consolidation.

 

The Subordinate Voting Shares are not convertible into any other class or series of capital stock of the Company and are not subject to redemption. The Company and certain of its subsidiaries have outstanding securities that are convertible into, exercisable for or redeemable for Subordinate Voting Shares.

 

Holders of Subordinate Voting Shares are not entitled to a right of first refusal to subscribe for, purchase or receive any part of any issue of Subordinate Voting Shares, or bonds, debentures or other securities of the Company now or in the future.

 

No subdivision or consolidation of the Subordinate Voting Shares or Super Voting Shares shall occur unless, simultaneously, the Subordinate Voting Shares and Super Voting Shares are subdivided or consolidated in the same manner or such other adjustment is made so as to maintain and preserve the relative rights (including voting rights) of the holders of the shares of each of the said classes.

 

In connection with the reverse takeover transaction with Indus Holding Company (the “RTO”), the Company and Indus Holding Company entered into a Support Agreement dated as of April 26, 2019, which was amended and restated as of April 10, 2020 in connection with the closing of the Convertible Debenture Offering (the “Support Agreement”). The purpose of the Support Agreement is to ensure that pro rata interest in the Company’s operating subsidiaries of holders of Subordinate Voting Shares relative to holders of Indus Class B Common Shares and any other shares of Indus Holding Company that are redeemable for Subordinate Voting Shares (“Indus Redeemable Shares”) is not diluted as Indus Redeemable Shares are redeemed for Subordinate Voting Shares or as other securities are issued by the Company. In order to avoid such dilution, the Support Agreement provides that upon any redemption of Indus Redeemable Shares for Subordinate Voting Shares, or upon any issuance of additional Subordinate Voting Share by the Company, an equivalent number of Indus Class A Common Shares will be issued to the Company by Indus Holding Company.

 

Pursuant to the Support Agreement, the Company has agreed that, so long as any Indus Redeemable Shares not owned by or its affiliates are outstanding or any Indus Redeemable Shares are issuable pursuant to the exercise, conversion or exchange of any outstanding securities of Indus Holding Company, the Company shall:

 

o

take all actions reasonably necessary or desirable to permit Indus Holding Company to pay and perform its redemption obligations with respect to Indus Redeemable Shares, including by take all actions reasonably necessary or desirable to permit Indus Holding Company to deliver the Subordinate Voting Shares and/or cash due to holders of Indus Redeemable Shares upon such redemption in accordance with the provisions of the articles of incorporation of Indus Holding Company; and

 

o

in the event any Subordinate Voting Shares are issued upon such redemption, subscribe for a number of Indus Class A Common Shares equal to the number of Subordinate Voting Shares so issued.

 

 
2

 

 

The Support Agreement also provides, in connection with a primary issuance of Subordinate Voting Shares by the Company, that the Company will subscribe for an equivalent number of Indus Class A Common Shares in cash using the net proceeds, if any, received by the Company from the issuance of Subordinate Voting Shares.

 

Pursuant to the Support Agreement, the Company has agreed in good faith take all reasonable actions and do all things as are reasonably necessary or desirable to cause Subordinate Voting Shares delivered pursuant to the Support Agreement to be listed, quoted or posted for trading on the stock exchanges and quotation systems on which outstanding Subordinate Voting Shares are listed, quoted or posted for trading.

 

The Support Agreement provides that in the event that a tender offer, share exchange offer, issuer bid, take-over bid, arrangement, business combination, or similar transaction with respect to Subordinate Voting Shares is proposed by the Company or is proposed to the Company or its shareholders and is recommended by the Board, or is otherwise effected or to be effected with the consent or approval of the Board, the Company will use reasonable efforts to take such actions as are necessary or desirable to permit holders of Indus Redeemable Shares (other than the Company and its affiliates) to participate in the offer to the same extent and on an economically equivalent basis as the holders of Subordinate Voting Shares.

 

The Company's articles of incorporation provides that the Supreme Court of the Province of British Columbia, Canada and the appellate Courts therefrom are the sole and exclusive forum for any derivative action brought on behalf of the company. The Company's articles of incorporation do not limit the ability of investors to bring direct actions outside of British Columbia, Canada, including those arising under the Exchange Act and the Securities Act. Section 27 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), creates exclusive federal jurisdiction over actions brought to enforce any duty or liability created by the Exchange Act or the rules and regulations thereunder, and Section 22 of the Securities Act of 1933, as amended (the “Securities Act”), creates concurrent jurisdiction for federal and state courts over all suits brought to enforce any duty or liability created by the Securities Act or the rules and regulations thereunder. Neither an investor nor the Company may waive compliance with the federal securities laws and the rules and regulations thereunder, and it is therefore uncertain whether the exclusive forum provision of the Company's articles would be enforced by a court as to derivative claims brought under the Exchange Act or the Securities Act. Furthermore, the exclusive forum provision of the Company's articles may increase the costs to investors in bringing claims, may discourage investors from bringing claims and may limit investors’ ability to bring claims in a judicial forum that they find favorable.

 

 
3

 

EX-31.1 3 lowlf_ex311.htm CERTIFICATION lowlf_ex311.htm

EXHIBIT 31.1

CERTIFICATION OF CHIEF EXECUTIVE OFFICER

 

I, Mark Ainsworth, certify that:

 

1.

I have reviewed this Annual Report on Form 10-K of Lowell Farms, Inc.;

 

 

2.

Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

 

3.

Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

 

4.

The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

 

(a)

Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

 

 

 

(b)

Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

 

 

 

(c)

Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

 

 

 

(d)

Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5.

The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

 

(a)

All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

 

 

 

(b)

Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Date: March 28, 2024

By:

/s/ Mark Ainsworth

 

 

 

Mark Ainsworth

 

 

 

Chief Executive Officer

 

 

EX-31.2 4 lowlf_ex312.htm CERTIFICATION lowlf_ex312.htm

EXHIBIT 31.2

 

CERTIFICATION OF CHIEF FINANCIAL OFFICER

 

I, Jamie Schniedwind, certify that:

 

1.

I have reviewed this Annual Report on Form 10-K of Lowell Farms, Inc.;

 

 

2.

Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

 

3.

Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

 

4.

The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant have:

 

 

(a)

Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

 

 

 

(b)

Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

 

 

 

(c)

Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

 

 

 

(d)

Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5.

The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

 

(a)

All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

 

 

 

(b)

Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Date: March 28, 2024

By:

/s/ Jamie Schniedwind

 

 

 

Jamie Schniedwind

 

 

 

Chief Financial Officer

 

 

EX-32.1 5 lowlf_ex321.htm CERTIFICATION lowlf_ex321.htm

EXHIBIT 32.1

 

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

In connection with the Annual Report on Form 10-K of Lowell Farms, Inc. (the “Company”) for the period ended December 31, 2023 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Mark Ainsworth, Chief Executive Officer of the Company, hereby certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 that:

 

 

(1)

the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and

 

 

 

 

(2)

the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

/s/ Mark Ainsworth

 

 

 

Mark Ainsworth

 

 

 

Chief Executive Officer

 

 

 

Date: March 28, 2024

 

 

EX-32.2 6 lowlf_ex322.htm CERTIFICATION lowlf_ex322.htm

EXHIBIT 32.2

 

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

In connection with the Annual Report on Form 10-K of Lowell Farms, Inc. (the “Company”) for the period ended December 31, 2023 as filed with the Securities and Exchange Commission on the date hereof (the “Report”),  I,  Jamie Schniedwind, Chief  Financial  Officer  of  the  Company,  hereby certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 that:

 

 

(1)

the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and

 

 

 

 

(2)

the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

/s/ Jamie Schniedwind

 

Jamie Schniedwind

 

Chief Financial Officer

 

Date: March 28, 2024

 

 

EX-101.SCH 7 lowlf-20231231.xsd XBRL TAXONOMY EXTENSION SCHEMA 000001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink 000002 - Statement - CONSOLIDATED BALANCE SHEETS link:presentationLink link:calculationLink link:definitionLink 000003 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 000004 - Statement - CONSOLIDATED STATEMENTS OF INCOME (LOSS) link:presentationLink link:calculationLink link:definitionLink 000005 - Statement - CONSOLIDATED STATEMENTS OF STOCKHOLDERS EQUITY (DEFICIT) link:presentationLink link:calculationLink link:definitionLink 000006 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS link:presentationLink link:calculationLink link:definitionLink 000007 - Disclosure - BUSINESS BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES link:presentationLink link:calculationLink link:definitionLink 000008 - Disclosure - PREPAID AND OTHER CURRENT ASSETS link:presentationLink link:calculationLink link:definitionLink 000009 - Disclosure - INVENTORY link:presentationLink link:calculationLink link:definitionLink 000010 - Disclosure - OTHER CURRENT LIABILITIES link:presentationLink link:calculationLink link:definitionLink 000011 - Disclosure - PROPERTY AND EQUIPMENT AND RIGHT OF USE ASSETS link:presentationLink link:calculationLink link:definitionLink 000012 - Disclosure - INTANGIBLE ASSETS link:presentationLink link:calculationLink link:definitionLink 000013 - Disclosure - SHAREHOLDERS EQUITY link:presentationLink link:calculationLink link:definitionLink 000014 - Disclosure - DEBT link:presentationLink link:calculationLink link:definitionLink 000015 - Disclosure - LEASES link:presentationLink link:calculationLink link:definitionLink 000016 - Disclosure - SHARE BASED COMPENSATION link:presentationLink link:calculationLink link:definitionLink 000017 - Disclosure - INCOME TAXES link:presentationLink link:calculationLink link:definitionLink 000018 - Disclosure - NET INCOME (LOSS) PER SHARE link:presentationLink link:calculationLink link:definitionLink 000019 - Disclosure - FAIR VALUE MEASUREMENTS link:presentationLink link:calculationLink link:definitionLink 000020 - Disclosure - COMMITMENTS AND CONTINGENCIES link:presentationLink link:calculationLink link:definitionLink 000021 - Disclosure - GENERAL AND ADMINISTRATIVE EXPENSES link:presentationLink link:calculationLink link:definitionLink 000022 - Disclosure - RELATED PARTY TRANSACTIONS link:presentationLink link:calculationLink link:definitionLink 000023 - Disclosure - SEGMENT INFORMATION link:presentationLink link:calculationLink link:definitionLink 000024 - Disclosure - SUBSEQUENT EVENTS link:presentationLink link:calculationLink link:definitionLink 000025 - Disclosure - BUSINESS BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) link:presentationLink link:calculationLink link:definitionLink 000026 - Disclosure - BUSINESS BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables) link:presentationLink link:calculationLink link:definitionLink 000027 - Disclosure - PREPAID AND OTHER CURRENT ASSETS (Tables) link:presentationLink link:calculationLink link:definitionLink 000028 - Disclosure - INVENTORY (Tables) link:presentationLink link:calculationLink link:definitionLink 000029 - Disclosure - OTHER CURRENT LIABILITIES (Tables) link:presentationLink link:calculationLink link:definitionLink 000030 - Disclosure - PROPERTY AND EQUIPMENT AND RIGHT OF USE ASSETS (Tables) link:presentationLink link:calculationLink link:definitionLink 000031 - Disclosure - INTANGIBLE ASSETS (Tables) link:presentationLink link:calculationLink link:definitionLink 000032 - Disclosure - SHAREHOLDERS EQUITY (Tables) link:presentationLink link:calculationLink link:definitionLink 000033 - Disclosure - DEBT (Tables) link:presentationLink link:calculationLink link:definitionLink 000034 - Disclosure - LEASES (Tables) link:presentationLink link:calculationLink link:definitionLink 000035 - Disclosure - SHARE BASED COMPENSATION (Tables) link:presentationLink link:calculationLink link:definitionLink 000036 - Disclosure - INCOME TAXES (Tables) link:presentationLink link:calculationLink link:definitionLink 000037 - Disclosure - NET INCOME (LOSS) PER SHARE (Tables) link:presentationLink link:calculationLink link:definitionLink 000038 - Disclosure - GENERAL AND ADMINISTRATIVE EXPENSES (Tables) link:presentationLink link:calculationLink link:definitionLink 000039 - Disclosure - BUSINESS, BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) link:presentationLink link:calculationLink link:definitionLink 000040 - Disclosure - BUSINESS, BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 000041 - Disclosure - PREPAID AND OTHER CURRENT ASSETS (Details) link:presentationLink link:calculationLink link:definitionLink 000042 - Disclosure - INVENTORY (Details) link:presentationLink link:calculationLink link:definitionLink 000043 - Disclosure - INVENTORY (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 000044 - Disclosure - Other current liabilities (Details) link:presentationLink link:calculationLink link:definitionLink 000045 - Disclosure - Other current liabilities (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 000046 - Disclosure - PROPERTY AND EQUIPMENT AND RIGHT OF USE ASSETS (Details) link:presentationLink link:calculationLink link:definitionLink 000047 - Disclosure - PROPERTY AND EQUIPMENT AND RIGHT OF USE ASSETS (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 000048 - Disclosure - INTANGIBLE ASSETS (Details) link:presentationLink link:calculationLink link:definitionLink 000049 - Disclosure - INTANGIBLE ASSETS (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 000050 - Disclosure - SHAREHOLDERS EQUITY (Details) link:presentationLink link:calculationLink link:definitionLink 000051 - Disclosure - SHAREHOLDERS EQUITY (Details 1) link:presentationLink link:calculationLink link:definitionLink 000052 - Disclosure - DEBT (Details) link:presentationLink link:calculationLink link:definitionLink 000053 - Disclosure - DEBT (Details 1) link:presentationLink link:calculationLink link:definitionLink 000054 - Disclosure - DEBT (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 000055 - Disclosure - LEASES (Details) link:presentationLink link:calculationLink link:definitionLink 000056 - Disclosure - LEASES (Details 1) link:presentationLink link:calculationLink link:definitionLink 000057 - Disclosure - LEASES (Details 2) link:presentationLink link:calculationLink link:definitionLink 000058 - Disclosure - LEASES (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 000059 - Disclosure - SHARE BASED COMPENSATION (Details) link:presentationLink link:calculationLink link:definitionLink 000060 - Disclosure - SHARE BASED COMPENSATION (Details 1) link:presentationLink link:calculationLink link:definitionLink 000061 - Disclosure - SHARE BASED COMPENSATION (Details 2) link:presentationLink link:calculationLink link:definitionLink 000062 - Disclosure - SHARE BASED COMPENSATION (Details 3) link:presentationLink link:calculationLink link:definitionLink 000063 - Disclosure - SHARE BASED COMPENSATION (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 000064 - Disclosure - INCOME TAXES (Details) link:presentationLink link:calculationLink link:definitionLink 000065 - Disclosure - INCOME TAXES (Details 1) link:presentationLink link:calculationLink link:definitionLink 000066 - Disclosure - INCOME TAXES (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 000067 - Disclosure - NET INCOME (LOSS) PER SHARE (Details) link:presentationLink link:calculationLink link:definitionLink 000068 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 000069 - Disclosure - GENERAL AND ADMINISTRATIVE EXPENSES (Details) link:presentationLink link:calculationLink link:definitionLink 000070 - Disclosure - RELATED PARTY TRANSACTIONS (Details Narrative) link:presentationLink link:calculationLink link:definitionLink EX-101.LAB 8 lowlf-20231231_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE Cover [Abstract] Entity Registrant Name Entity Central Index Key Document Type Amendment Flag Entity Voluntary Filers Current Fiscal Year End Date Entity Well Known Seasoned Issuer Entity Small Business Entity Shell Company Entity Emerging Growth Company Entity Current Reporting Status Document Period End Date Entity Filer Category Document Fiscal Period Focus Document Fiscal Year Focus Entity Ex Transition Period Entity Common Stock Shares Outstanding Entity Public Float Document Annual Report Document Transition Report Document Fin Stmt Error Correction Flag Entity File Number Entity Incorporation State Country Code Entity Address Address Line 1 Entity Address City Or Town Entity Address State Or Province Entity Address Postal Zip Code City Area Code Icfr Auditor Attestation Flag Auditor Name Auditor Location Auditor Firm Id Local Phone Number Entity Interactive Data Current CONSOLIDATED BALANCE SHEETS ASSETS Current assets: Cash and cash equivalents Accounts Receivable - net of allowance for doubtful accounts of $1,053 and $1,139 at December 31, 2022 and December 31, 2021, respectively Inventory Prepaid expenses and other current assets Total current assets [Assets, Current] Property and equipment, net Right of use assets, net Other intangibles, net Other assets Total assets [Assets] LIABILITIES AND STOCKHOLDERS' EQUITY Current liabilities: Accounts payable Accrued payroll and benefits Notes payable, current portion Lease obligation, current portion Convertible debentures Other current liabilities Total current liabilities [Liabilities, Current] Notes payable Lease obligation Convertible debentures [Convertible Debt, Noncurrent] Mortgage obligation Total liabilities [Liabilities] COMMITMENTS AND CONTINGENCIES STOCKHOLDERS' EQUITY Share capital Accumulated deficit Total stockholders' equity [Stockholders' Equity Attributable to Parent] Total liabilities and stockholders' equity [Liabilities and Equity] Allowance For Doubtful Accounts CONSOLIDATED STATEMENTS OF INCOME (LOSS) Net revenue Cost of goods sold Gross profit (loss) [Gross Profit] Operating expenses General and administrative Sales and marketing Depreciation and amortization Total operating expenses [Operating Expenses] Loss from operations [Operating Income (Loss)] Other income/(expense) Other income (expense) Unrealized loss on change in fair value of investment Impairment Impairment expense of long-lived assets Interest expense [Interest Expense, Other] Total other income (expense) [Nonoperating Income (Expense)] Loss before provision for income taxes [Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest] Provision for income taxes Net loss [Net Income (Loss) Attributable to Parent] Net loss per share: Basic Diluted Weighted average shares outstanding: Basic [Weighted Average Number of Shares Outstanding, Basic] Diluted [Weighted Average Number of Shares Outstanding, Diluted] CONSOLIDATED STATEMENTS OF STOCKHOLDERS EQUITY (DEFICIT) Statement [Table] Statement [Line Items] Equity Components [Axis] Subordinate Voting Shares [Member] Super Voting Shares [Member] Shares Capital [Member] Retained Earnings (Accumulated Deficit) Balance, shares [Shares, Issued] Balance, amount Net Loss Shares issued in connection with asset acquisition, Shares Shares issued in connection with asset acquisition, Amount Share re-purchase, Shares Share re-purchase, Amount Issuance of vested RSUs, Shares Issuance of vested RSUs, Amount Share-based compensation expense, Shares Share-based compensation expense Amount Shares issued in connection with debenture conversion, Shares Shares issued in connection with debenture conversion, Amount Warrants Cancelled with brand sale Balance, shares Balance, amount CONSOLIDATED STATEMENTS OF CASH FLOWS CASH FLOW FROM OPERATING ACTIVITIES Net loss [Net Income (Loss), Including Portion Attributable to Noncontrolling Interest] Adjustments to reconcile net loss to net cash used in operating activities: Depreciation and amortization [Depreciation, Depletion and Amortization] Amortization of debt issuance costs Share-based compensation expense Provision for doubtful accounts Loss on sale of assets [Gain (Loss) on Disposition of Assets for Financial Service Operations] Gain on sale leaseback [Sale and Leaseback Transaction, Gain (Loss), Net] Gain on lease settlement [Gain on lease settlement] Unrealized loss (gain) on change in fair value of investments Impairment expense Gain on lease termination [Gain on lease termination] Changes in operating assets and liabilities: Accounts receivable [Increase (Decrease) in Accounts Receivable] Inventory [Increase (Decrease) in Inventories] Prepaid expenses and other current assets [Increase (Decrease) in Prepaid Expense and Other Assets] Other assets [Increase (Decrease) in Other Operating Assets] Operating lease liabilities Accounts payable and accrued expenses Net cash used in operating activities [Net Cash Provided by (Used in) Operating Activities] CASH FLOW FROM INVESTING ACTIVITIES Proceeds from asset sales Purchases of property and equipment [Payments to Acquire Property, Plant, and Equipment] Acquisition of business assets, net Net cash used in investing activities [Net Cash Provided by (Used in) Investing Activities] CASH FLOW FROM FINANCING ACTIVITIES Proceeds from convertible notes, net of financing costs Principal payments on finance lease obligations [Finance Lease, Principal Payments] Payments on notes payable [Repayments of Notes Payable] Proceeds from sale leaseback Issuance costs related to subordinate voting share offering Proceeds from exercise of warrants and options Net cash provided by financing activities [Net Cash Provided by (Used in) Financing Activities] Change in cash and cash equivalents [Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect] Cash and cash equivalents-beginning of year Cash, cash equivalents-end of period SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION Cash paid during the period for interest Cash paid during the period for income taxes OTHER NONCASH INVESTING AND FINANCING ACTIVITIES Purchase of property and equipment not yet paid for Issuance of subordinate voting shares to acquire purchase rights Issuance of subordinate voting shares in convertible debenture repurchase BUSINESS BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Basis Of Presentation And Summary Of Significant Accounting Policies PREPAID AND OTHER CURRENT ASSETS Prepaid And Other Current Assets INVENTORY Inventory Inventory Disclosure [Text Block] OTHER CURRENT LIABILITIES Other Current Liabilities PROPERTY AND EQUIPMENT AND RIGHT OF USE ASSETS Property And Equipment And Right Of Use Assets INTANGIBLE ASSETS INTANGIBLE ASSETS Intangible Assets Disclosure [Text Block] SHAREHOLDERS EQUITY Shareholders Equity DEBT Debt LEASES Leases SHARE BASED COMPENSATION SHARE BASED COMPENSATION Share-Based Payment Arrangement [Text Block] INCOME TAXES Income Taxes Net Income (loss) Per Share FAIR VALUE MEASUREMENTS Fair Value Measurements Commitments And Contingencies GENERAL AND ADMINISTRATIVE EXPENSES General And Administrative Expenses RELATED PARTY TRANSACTIONS Related-Party Transactions SEGMENT INFORMATION Segment Information SUBSEQUENT EVENTS Subsequent Events Business Basis Of Presentation Use Of Estimates Cash and Cash Equivalents Accounts Receivable Inventories Property and Equipment Goodwill Intangible Assets Impairment of Long-lived Assets Leased Assets Income Taxes Income Tax, Policy [Policy Text Block] Revenue Recognition Branded Products Third Party Manufactured Products Licensing Distribution Lowell Farms Services Research and Development Share-Based Compensation Business Combinations Recently Adopted Accounting Standards Accounting standards not yet adopted Schedule Of Property and equipment estimated useful life Summary Of Prepaid Expenses And Other Current Assets Summary Of Inventory Schedule Of Other Current Liabilities Schedule Of Property And Equipment And Right Of Use Assets INTANGIBLE ASSETS (Tables) Schedule Of Intangible Assets Schedule Of Shares Outstanding Schedule Of Warrants Outstanding Schedule Of Debt Schedule Of Maturities Of Debt Obligations Schedule Of Lease Obligations Schedule Of Lease Expense Schedule of future lease payments Schedule Of Share-based Compensation Expense Schedule Of Stock Option Activity Schedule Of Restricted Stock Unit Activity Schedule Of Weighted Average Assumptions Schedule Of income tax expense Schedule Of deferred tax assets and liabilities Schedule Of Net Earnings/(loss) Per Share Schedule Of General And Administrative Expense Long-Lived Tangible Asset [Axis] Range [Axis] Buildings [Member] Minimum [Member] Office equipment [Member] Furniture and fixtures [Member] Vehicles [Member] Machinery and equipment [Member] Maximum [Member] Leasehold improvements [Member] Construction in Process Estimated useful life Description of useful life Changes in adoption accumulated deficit Development costs Cash FDIC Insured Amount Straight line basis Deposits Insurance Supplier Advances Interest And Taxes Licenses and payments Royalty Advance Other Prepaid Expenses And Other Current Assets Raw Materials Work In Process Finished Goods Inventory Inventory reserve Inventory write off Excise And Cannabis Tax Third Party Brand Distribution Accrual Insurance And Professional Accrual Interest and tax accrual Employee Retention Credit financing accrual Equipment purchase accrual Other [Other Accrued Liabilities, Current] Total Other Current Liabilities Sale of Stock [Axis] Award Date [Axis] E R C Claim [Member] On Twenty Six July Two Thousand Twenty Two [Member] Purchase of derivative payment rights Other income Accrued other liability Interest Expense Leasehold Improvements Land And Buildings [Member] Furniture and fixtures [Member] Equipment [Member] Vehicles [Member] Right of Use Assets Additions Disposal [Disposal] Remeasurements [Remeasurements] Impairments Property And Equipment Cost, Ending [Property, Plant and Equipment, Gross] Accumulated Depreciation, Beginning [Accumulated Depreciation, Beginning] Depreciation [Depreciation] Accumulated amortization disposals Accumulated amortization remeasurement Accumulated amortization impairments Accumulated Depreciation, Ending [Accumulated Depreciation, Ending] Net Book Value [Net Book Value] Property And Equipment Cost, Beginning Remeasurements [Charity Care, Other Measurement Basis, Amount] Net Book Value Remeasurements Remeasurements Concentration Risk Benchmark [Axis] Cost of Goods Sold [Member] Other Income Expense [Member] Depreciation Leasehold improvements Impairment expense [Impairment expense] Finite-Lived Intangible Assets by Major Class [Axis] Indefinite-Lived Intangible Assets [Axis] Technology/KnowHow Acquired Purchase Rights [Member] Brands & Tradenames [Member] Sale of Brand Assets Impairment [Impairment of Leasehold] Definite life intangibles cost, ending [Definite life intangibles cost, ending] Accumulated amortization, beginning [Accumulated amortization, beginning] Accumulated amortization impairment Amortization [Amortization of Intangible Assets] Accumulated amortization, ending [Accumulated amortization, ending] Net book value, beginning balance [Intangible Assets, Net (Excluding Goodwill)] Net book value, ending balance Amortization Definite life intangibles cost, beginning Impairment Definite life intangibles cost, ending Related Party [Axis] Other Intangible Assets [Member] Lowell Brand [Member] Purchase of warrants Descriptions of royalty Amortization [Amortization] Aggregate principal amount Cancelled common shares Impairment of intangible assets Warrants issued Accrued interest Intangible assets Convertible notes Impairment of goodwill Percentage of issued and outstanding shares Subordinate voting shares issued Fair market value of shares Amortization [Amortization 1] Class of Stock [Axis] Subordinate Voting Share [Member] Super Voting Share [Member] Beginning Balance, Shares [Shares, Outstanding] Issuance Of Vested Restricted Stock Units Issuance of shares in convertible debt conversion Ending Balance, Shares Warrants, Beginning Balance [Warrants, Beginning Balance] Warrants issued in conjunction with convertible debenture offering Warrants expired Warrants, Ending Balance [Warrants, Ending Balance] Debt Instrument [Axis] Short-Term Debt, Type [Axis] Vehicle Loans Mortgage Payable [Member] Note Payable Convertible Debenture Total short-term debt Total long-term debt Total Indebtedness 2024 Total Debt Obligations Weighted average interest rate Net Of Deferred Financing Costs Property Subject to or Available for Operating Lease [Axis] Operating Leases [Member] Finance Leases [Member] Lease Liability, Beginning Sale leaseback addition Lease Principal Payments [Operating Lease, Payments] Lease remeasurement Lease Settlement Lease termination Operating lease remeasurement classification Lease Liability, ending Amortization Of Leased Assets - Finance Leases Interest On Lease Liabilities - Finance Leases Total - Finance Leases Amortization Of Leased Assets - Operating Leases Interest On Lease Liabilities - Operating Leases Total Operating Lease Amortization 2024 [Lessee, Operating Lease, Liability, to be Paid, Year One] 2025 2026 2027 2028 - And Beyond Total lease payments Less Imputed Interest [Receivable with Imputed Interest, Discount] Total [Total] Lease right of use assets Lease obligation [Capital Lease Obligations] Sale of property Other Income (expenses) Weighted Average Remaining Lease Term Weighted Average Discount Rate Income Statement Location [Axis] General And Administrative Expense [Member] Share-based compensation expense [Employee Benefits and Share-Based Compensation] Stock Options Outstanding, Beginning [Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number] Stock Options, Granted Stock Options, Exercised [Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period] Stock Options, Cancelled Stock Options Outstanding, Ending Stock Options Exercisable [Stock Options Exercisable] Stock Options Vested and expected [Stock Options Vested and expected] Weighted-average Exercise Price Outstanding, Beginning [Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price] Weighted-average Exercise Price, Granted Weighted-average Exercise Price, Exercised Weighted-average Exercise Price, Cancelled Weighted-average Exercise Price Outstanding, Ending Weighted-average Exercise Price Exercisable [Weighted-average Exercise Price Exercisable] Weighted-average Exercise Price Vested and expected [Weighted-average Exercise Price Vested and expected] Weighted-average Remaining Contactual Life Outstanding, Beginning Balance Weighted-average Remaining Contactual Life Outstanding, Ending Balance Weighted-average Remaining Contactual Life, Exercisable Weighted-average Remaining Contactual Life, Vested And Expected To Vest Aggregate Intrinsic Value Outstanding, Beginning [Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value] Aggregate Intrinsic Value Outstanding, Ending Aggregate Intrinsic Value, Granted Aggregate Intrinsic Value, Exercised Aggregate Intrinsic Value, Expired Aggregate Intrinsic Value, Cancelled Aggregate Intrinsic Value vested and expected RSUs Outstanding, Beginning Balance RSUs Granted [Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period] RSUs Vested [Conversion of Stock, Shares Issued] RSUs Cancelled [Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period] RSUs Outstanding, Ending Balance Weighted-average Fair Value Outstanding, Beginning Balance Weighted-average Fair Value Granted Weighted-average Fair Value Vested Weighted-average Fair Value Cancelled Weighted-average Fair Value Outstanding, Ending Balance Class of Warrant or Right [Axis] Award Type [Axis] Stock Option [Member] Restricted Stock Units (RSUs) [Member] Expected Volatility Dividend Yield Risk-free Interest Rate Expected Term In Years Proceeds From Issuance Of Stock Options Stock Option For Future Grant Vesting Period Descriptions Weighted-average Exercise Price Granted Unrecognized Compensation Cost Related To Nonvested Restricted Stock Units Vesting Period Current Federal State Total Current Deferred tax benefit Federal [Deferred Federal Income Tax Expense (Benefit)] State [Deferred Federal, State and Local, Tax Expense (Benefit)] Total deferred tax benefit Valuation allowance Income tax expense Net operating loss carryforwards Accruals and reserves Depreciation [Depreciation 1] Other [Deferred Tax Assets, Other] Valuation allowance [Deferred Tax Assets, Valuation Allowance] Total deferred tax assets Accruals and reserves [Deferred Tax Liabilities, Prepaid Expenses] Share-based compensation Total deferred tax liabilities Net deferred tax liabilities Provision For Income Taxes Effective Tax Rate Net income (loss) Net Loss Per Share: Basic Diluted Weighted Average Shares Outstanding: Basic Diluted [Diluted] Weighted average potentially diluted shares: Basic Shares Total Weighted Average Potentially Diluted Shares August 2020 [Member] Insurance maturity date Due date of commitment Nature of Expense [Axis] Salaries And Benefits Member Professional Fees Member Sharebased Compensation Member Insurance Member Administrative Member General and administrative OMG Related Party Transactions Related Party Transactions [Related Party Transaction, Amounts of Transaction] Total sales Total payment Lease term EX-101.CAL 9 lowlf-20231231_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE EX-101.PRE 10 lowlf-20231231_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE EX-101.DEF 11 lowlf-20231231_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE GRAPHIC 12 lowlf_10kimg4.jpg begin 644 lowlf_10kimg4.jpg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ʱ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�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end GRAPHIC 13 lowlf_10kimg7.jpg begin 644 lowlf_10kimg7.jpg M_]C_X 02D9)1@ ! 0$ 8 !@ #_VP!# 4$! 0$ P4$! 0&!04&" T(" <' M"! +# D-$Q 4$Q(0$A(4%QT9%!8<%A(2&B,:'!X?(2$A%!DD)R0@)AT@(2#_ MVP!# 04&!@@'" \(" \@%1(5(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @("#_P 1" Z 0@# 2( A$! Q$!_\0 M'P 04! 0$! 0$ $" P0%!@<("0H+_\0 M1 @$# P($ P4% M! 0 %] 0(# 01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D* M%A<8&1HE)B7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7& MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$ P$! 0$! M 0$! 0 $" P0%!@<("0H+_\0 M1$ @$"! 0#! <%! 0 0)W $" M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$ MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4 MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,! (1 Q$ /P#Z^HHHH ** M*ANKJVL;.6\O+A+>WA4O)+(V%4>I- $U%>?'XQ>"%E_X^+W[-NV_:_LC^3_W MUZ>]=[;W$%W:Q75K*LT$RAXY%.0RGD$4 24444 %%%% !1110 4444 %9/B; M6T\.>&+_ %R2W:X2TC\PQ*VTOR!C/;K5N'4["XU*ZTV"Z22\M IFA'WHPW3/ MUKF_B=_R2WQ!_P!>W_LPIHRG.T7*+V3_ .IM9Q=6-O=!=@FC63:3G&1G%35 M1T?_ ) .G?\ 7M%_Z *O4BXNZ3"BN8\1>/\ PEX6D,.KZO&ER/\ EWB'F2#Z M@=/QKFH/CCX!FF$;W%Y #_&]NF450TG6M)UVQ%]H^H0WMN?XXFS@^A M'4?C61XD\=^&?"5W!:Z[?/;RSH9(PL3/E0<=J .FHKSW_A<_P\_Z#$O_ (#/ M6SHGQ"\&^(;E;72]=@>X;[L,F8V;Z ]: .IHHJGJFJ6&BZ9-J>J7*VUI" 7D M;H,G% FTE=ERBLC0/$FB^)K66ZT6\%W%"_ENX4J V,XYK7H%&2DN:+N@HHHH M*"BBB@ HHHH **** "O-/B\1-8^&M-NY#'I=[JT<=X?8]8\0V=I<]XF?++]0,X_&EU&Q\.>/O"DEJ;B+4-.N.5FMY 2C#HP/8B@#. M\9WFIZ#X?V:+X5L=4TN&%S*KN3X*2>+M/ABL;K^SS M<11 ;TB(X P>HXK*D\ >-I-/?16^(\SZ0Z&(K):JTQC(QMW?2NFD\'VP^&S^ M";:[D2#[(;19W 9@/[Q% &?X.NO%;>'G\2^*]5MKJWN+-;F*UMX/+\@8W')[ MDBO,C\6/$MQ:/KT&M6R,)"T>B#3W/>N$A^&FLV,+:3I/CB\L= :0R"U2%3+&"QT6]UJ/Q!9WZL#.E@U MLUM(!D#D%K/Q1X<&CW5Q-"T;))!N>!6O\/_$&K:U8ZK9ZX\4NH:3>M9R3PIL68#D-CL:2.#2Q\9Y[H:DY MU/\ LI5:S\H[1'NX??TSGM6EX;\,KX=N];N%O#&[(*[?+R,;?>@#H:* MXGXHW5U9^!YIK2XDMY13AVM^)PGAW M_DL?C/\ ZXVW_H-7OB=_R2WQ!_U[?^S"J/AW_DL?C/\ ZXVW_H-7OB=_R2WQ M!_U[?^S"JZG+'X)?/\SH='_Y .G?]>T7_H KA/B[XZF\(^'8K/3)-FJZCN6- M^\,8^\X]^PKN]'_Y .G?]>T7_H KYL^/,TDOQ,2"0GRXK*((/0$L34G53^%% MCX=_"6;QA:_\)%XBO)X+"9B8PI_>W)SRQ8]!GOU->C7WP(\$7%HT=F;ZRGQ\ MLPG,G/N&X->B:+;PVGAW3;6V4+#%:Q*@'3&T5?H-#QKX;_"S7O"/C.[U&^U7 M;8PKLB6W;"WF>[KV ]/6N8_:'_Y&?1?^O-__ $.OHROG+]H;_D9]%_Z\W_\ M0Z .GT/X(^#M2\.:;J%Q-J(FN;:.5]LP W,H)QQ7$_$OX3P^#-,CU[1M0GGL MQ*L&-+L;K5)EGM[6..11;.<,% /.*X/XJ? M%73/%6C)X?T"*9K5I5DFN)5VE\=%5>O6@#U'X1^)KOQ-X!BDU"0RWEG(;:25 MNL@ RI/OBN,^._B-G;3_ C9MN9B+FX5>I/2-?YG\JZGX4Z++X/^&;WFLJ;: M2@ .(T_E^55'N>=C)M MQC3AO)V^74ZBW\20_#*]\'>#\J!,OGZJW=6EX7\C^@KV_P#6O#?V@/#!FLK' MQ9;Q'?"?LMR0/X3RC'Z'(_&NZ^%OB?\ X2CP!9SS2;KVS'V6X]2RCAOQ7%2= MT(*$5".R.WI-Z>9Y?F+O_N[AG\J\U^,WBO5/#'A"W71YFM[F_F,)N$^]&H&3 MCT)]:\MTWX4^(-<\+)XFTOQ1%>ZA)'YXMHYF:3/7:7SPW]:"SZ=HKD_A[;>+ M+/P?!;^,)EEOU/R9;=(L?8.>["NLH **** "L3Q=J5QHW@C6]5L_^/BTLY)8 M_9@.#6W45S;PWEI-:7,8D@F0QR(>C*1@B@#S3PCH>D:'\+8/$ T#_A(=3O8% MN;C$:RS7+.>0"W89_2M?X;:GHM]9ZM:Z+X:E\/?9;S;<6TN,F1ADG Z?2LJP M\+?$7P>C:;X2U32]0T<,6MX=3W+); _P@J#D5O\ @7PSJWAT:O>ZY?6]WJ&K M70NIA;(52,[<8&>M &1X9\6>-/$OB2^ABTK3H='TW4)+2XN&=A(X4G&P>HXS M]:L:EXL\4:CXNO\ P[X*TRQF;2U7[9=Z@[*@=AD(H'.:UO!OAR\\.1:TEY-% M*;_4IKV/RL_*CG@'/>L?4O"WBO3/%^H>(O!=]8 ZH%^V6>H!MF]1@.I'\J - M'POXKU#Q%H^KPS:>EEK^E.UO/;%BT?FA25(/=3BN/U#XP75GX*T/5X]-ADU* M\GDCN[8;ML*1'$A'?N*[;P5X6N?#=O?W6IWZW^KZI^/I?BSX@M[I=-9(VM_ML7G2%(8RO!A'J1USW MKIOAOX(N/!6C7L%]=)=WMU/N:5,D>6HVHO// IG_ C?BBP^)M]X@T>ZT]M+ MU7R1>)<;O-0(,'9C@Y H YS7KKQ%;_'EX_#-G:SWTVCHI:\8K%$H8DL<<^U= MGX'\3WGB33;Y=4LX[34]-NFM+E(6)C+#^)<]C4D?AV[3XIS>+/.B^R/IRV8C MYW[@V<^F*9X1\-WGA^]\13W4T4JZI?F[B$>@#,^+7_)/KC_KZM__ M $8*[J/_ %$?^Z/Y5S?CK0;WQ)X2ETG3VB6X::*0&9BJX5P3R :Z5!MC13U" M@?I3Z'.HM5)2Z61P?AW_ )+'XS_ZXVW_ *#5[XG?\DM\0?\ 7M_[,*FTG0;Z MQ\?^(=>F:(VNH1PK"%8EP4&#N&.*L^--'N_$'@G4]&L6C6YN8?+C,K84'(/) MP?2GU(4)>SE&VKO^+-+1_P#D Z=_U[1?^@"O&/C]X7FN(K'Q7:Q%T@3[-=;1 M]U"&ZMI+:YA2:&52CQN,JP/4 M$5)TQTBCRKX4?$K2]6\/VGA_6+R.UU6S00H9FVK<(.%()XW8X(KU"ZU+3[&V M>ZO;^WMX$&6DDE50!^=>+^)O@!:W5T]UX7U1;)6.[[+= LB_[K#D#ZUSL/P" M\83RK'?:UI\<(_B\QY,?08%!1ZOX?^*WA?Q%XKG\/V,SB0?\>TT@VI=$=0O? MZ9ZUY?\ M#_\C/HO_7F__H=>H>!_A?H/@L_:XRVH:H5P;N90-@[A%_A_G6#\ M5_AOX@\;ZSIUYH\UE'';6[1.+B4H22V>, T 5M"^"G@S4?#>FZA<-?\ G7-M M'*^V? W%03CBNOT'X7>"O#MTEY9:3Y]TARLUTYE*GU / KI-#LIM-\.Z;I]P M5,UM;1PN4.1E5 ./:M"@#RGXX>)?[+\)1Z';R8N=3;]Y@\B%>3^9P/SK"\+^ M!_$'_"F9H]":&VU77G6266:0QE(!T (!.2/YU>\8?#+Q3XP^(/\ :UYD M*Z1JGG,9%A!YXVXR>>_>O8XHHX(8X(5"11J$51V & *I[6/-I4YU*TJE162T M7^9\UR?!'XBS1F.;5K.5#U5[V1@?P(J'X/ZU<>%/B1<>&]3S"EZYM9$8\).I M.T_CR/Q%?3E>+_$+X2ZWKWC8>)/#-Q9VSR*DDHGD*$3+T88!ZX%2>D=_X\T_ MPKJ7A=[3Q?=1VEDTB^7,S[&23H"OOS^5>.Z]\%]6\-:9=>(/#GBC?!;1FF^,OA[_ ,)UX;L(]4N5LM;M8Q^^B)>+>1\P(XR">_6O-?\ MA2OQ"EA&F3^*+;^S0<;3<2LN/]S'Z4 =O\%O&&J^*?#E];ZQ,;FXTZ1$6X;[ MTB,"1N]2,'FO4:Y?P/X+L/ ^@'3;25KB:5_,N+AA@R-C'3L!V%=10 4444 % M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44 944 %%%% !1110 4444 %%%% !1110!__V0$! end XML 15 R1.htm IDEA: XBRL DOCUMENT v3.24.1
Cover - USD ($)
12 Months Ended
Dec. 31, 2023
Mar. 26, 2024
Jun. 30, 2023
Cover [Abstract]      
Entity Registrant Name LOWELL FARMS INC.    
Entity Central Index Key 0001838128    
Document Type 10-K    
Amendment Flag false    
Entity Voluntary Filers No    
Current Fiscal Year End Date --12-31    
Entity Well Known Seasoned Issuer No    
Entity Small Business true    
Entity Shell Company false    
Entity Emerging Growth Company true    
Entity Current Reporting Status Yes    
Document Period End Date Dec. 31, 2023    
Entity Filer Category Non-accelerated Filer    
Document Fiscal Period Focus FY    
Document Fiscal Year Focus 2023    
Entity Ex Transition Period false    
Entity Common Stock Shares Outstanding   18,130,566  
Entity Public Float     $ 3,069,255
Document Annual Report true    
Document Transition Report false    
Document Fin Stmt Error Correction Flag false    
Entity File Number 000-56254    
Entity Incorporation State Country Code Z4    
Entity Address Address Line 1 19 Quail Run Circle - Suite B    
Entity Address City Or Town Salinas    
Entity Address State Or Province CA    
Entity Address Postal Zip Code 93907    
City Area Code 831    
Icfr Auditor Attestation Flag false    
Auditor Name GreenGrowth CPAs    
Auditor Location Los Angeles, California    
Auditor Firm Id 6580    
Local Phone Number 998-8214    
Entity Interactive Data Current Yes    

XML 16 R2.htm IDEA: XBRL DOCUMENT v3.24.1
CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Thousands
Dec. 31, 2023
Dec. 31, 2022
Current assets:    
Cash and cash equivalents $ 2,311 $ 1,098
Accounts Receivable - net of allowance for doubtful accounts of $1,053 and $1,139 at December 31, 2022 and December 31, 2021, respectively 2,620 4,163
Inventory 4,760 10,779
Prepaid expenses and other current assets 2,397 1,522
Total current assets 12,088 17,562
Property and equipment, net 4,099 31,284
Right of use assets, net 18,327 27,362
Other intangibles, net 2,544 42,202
Other assets 555 413
Total assets 37,613 118,823
Current liabilities:    
Accounts payable 4,314 2,307
Accrued payroll and benefits 363 350
Notes payable, current portion 3 282
Lease obligation, current portion 1,990 2,659
Convertible debentures 0 21,398
Other current liabilities 1,943 3,654
Total current liabilities 8,613 30,650
Notes payable 0 3
Lease obligation 17,522 31,340
Convertible debentures 0 0
Mortgage obligation 0 8,713
Total liabilities 26,135 70,706
STOCKHOLDERS' EQUITY    
Share capital 192,445 191,742
Accumulated deficit (180,967) (143,625)
Total stockholders' equity 11,478 48,117
Total liabilities and stockholders' equity $ 37,613 $ 118,823
XML 17 R3.htm IDEA: XBRL DOCUMENT v3.24.1
CONSOLIDATED BALANCE SHEETS (Parenthetical) - USD ($)
$ in Thousands
Dec. 31, 2022
Dec. 31, 2021
CONSOLIDATED BALANCE SHEETS    
Allowance For Doubtful Accounts $ 959 $ 1,053
XML 18 R4.htm IDEA: XBRL DOCUMENT v3.24.1
CONSOLIDATED STATEMENTS OF INCOME (LOSS) - USD ($)
shares in Thousands, $ in Thousands
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
CONSOLIDATED STATEMENTS OF INCOME (LOSS)    
Net revenue $ 28,265 $ 43,535
Cost of goods sold 35,707 45,376
Gross profit (loss) (7,442) (1,841)
Operating expenses    
General and administrative 7,302 9,553
Sales and marketing 2,397 5,274
Depreciation and amortization 421 448
Total operating expenses 10,120 15,275
Loss from operations (17,562) (17,116)
Other income/(expense)    
Other income (expense) 8,541 2,455
Unrealized loss on change in fair value of investment (28) (109)
Impairment Impairment expense of long-lived assets (24,295) (3,240)
Interest expense (3,837) (6,363)
Total other income (expense) (19,619) (7,257)
Loss before provision for income taxes (37,181) (24,373)
Provision for income taxes 161 191
Net loss $ (37,342) $ (24,564)
Net loss per share:    
Basic $ (2.71) $ (2.17)
Diluted $ (2.71) $ (2.17)
Weighted average shares outstanding:    
Basic 13,790 11,318
Diluted 13,790 11,318
XML 19 R5.htm IDEA: XBRL DOCUMENT v3.24.1
CONSOLIDATED STATEMENTS OF STOCKHOLDERS EQUITY (DEFICIT) - USD ($)
shares in Thousands, $ in Thousands
Total
Subordinate Voting Shares [Member]
Super Voting Shares [Member]
Shares Capital [Member]
Retained Earnings (Accumulated Deficit)
Balance, shares at Dec. 31, 2021   11,181 20    
Balance, amount at Dec. 31, 2021 $ 70,307     $ 189,368 $ (119,061)
Net Loss (24,564)     0 (24,564)
Shares issued in connection with asset acquisition, Shares   1,000      
Shares issued in connection with asset acquisition, Amount 1,800     1,800 0
Share re-purchase, Shares   (40)      
Share re-purchase, Amount 0     0 0
Issuance of vested RSUs, Shares   14      
Issuance of vested RSUs, Amount 10     10 0
Share-based compensation expense, Shares   22      
Share-based compensation expense Amount 564     564 0
Balance, shares at Dec. 31, 2022   12,177 20    
Balance, amount at Dec. 31, 2022 48,117     191,742 (143,625)
Net Loss (37,342)     0 (37,342)
Issuance of vested RSUs, Shares   4      
Issuance of vested RSUs, Amount 0     0 0
Share-based compensation expense Amount 231     231 0
Shares issued in connection with debenture conversion, Shares   6,843      
Shares issued in connection with debenture conversion, Amount 2,027     2,027 0
Warrants Cancelled with brand sale (1,555)     (1,555) 0
Balance, shares at Dec. 31, 2023   19,024 20    
Balance, amount at Dec. 31, 2023 $ 11,478     $ 192,445 $ (180,967)
XML 20 R6.htm IDEA: XBRL DOCUMENT v3.24.1
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
CASH FLOW FROM OPERATING ACTIVITIES    
Net loss $ (37,342) $ (24,564)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization 5,117 7,376
Amortization of debt issuance costs 712 937
Share-based compensation expense 231 564
Provision for doubtful accounts 616 517
Loss on sale of assets 0 59
Gain on sale leaseback (3,004) 0
Gain on lease settlement (880) 0
Unrealized loss (gain) on change in fair value of investments 28 109
Impairment expense 24,295 3,240
Gain on lease termination (5,020) 0
Changes in operating assets and liabilities:    
Accounts receivable 927 3,542
Inventory 6,019 2,564
Prepaid expenses and other current assets 2,731 454
Other assets (270) (106)
Operating lease liabilities (443) 0
Accounts payable and accrued expenses 242 (1,136)
Net cash used in operating activities (6,041) (6,444)
CASH FLOW FROM INVESTING ACTIVITIES    
Proceeds from asset sales 0 60
Purchases of property and equipment (135) (4,250)
Acquisition of business assets, net 0 0
Net cash used in investing activities (135) (4,190)
CASH FLOW FROM FINANCING ACTIVITIES    
Proceeds from convertible notes, net of financing costs 0 6,552
Principal payments on finance lease obligations (1,527) (2,497)
Payments on notes payable (75) (210)
Proceeds from sale leaseback 8,991 0
Issuance costs related to subordinate voting share offering 0 0
Proceeds from exercise of warrants and options 0 0
Net cash provided by financing activities 7,389 3,845
Change in cash and cash equivalents 1,213 (6,789)
Cash and cash equivalents-beginning of year 1,098 7,887
Cash, cash equivalents-end of period 2,311 1,098
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION    
Cash paid during the period for interest 3,689 4,215
Cash paid during the period for income taxes 87 171
OTHER NONCASH INVESTING AND FINANCING ACTIVITIES    
Purchase of property and equipment not yet paid for 7 819
Issuance of subordinate voting shares to acquire purchase rights 0 1,800
Issuance of subordinate voting shares in convertible debenture repurchase $ 2,027 $ 0
XML 21 R7.htm IDEA: XBRL DOCUMENT v3.24.1
BUSINESS BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
12 Months Ended
Dec. 31, 2023
BUSINESS BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES  
Basis Of Presentation And Summary Of Significant Accounting Policies

1. BUSINESS, BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

 

Business

 

Lowell Farms Inc. is governed by the laws of British Columbia, Canada. On April 26, 2019, the Company completed a reverse takeover transaction with Indus Holding Company, a Delaware corporation, incorporated in 2014. Effective March 1, 2021, the Company changed its name to Lowell Farms Inc. and is a California-based cannabis company with vertically integrated operations including large scale cultivation, extraction, processing, manufacturing, branding, packaging and wholesale distribution to retail dispensaries. The Company manufactures and distributes proprietary and third-party brands throughout the State of California, the largest cannabis market in the world. The Company also provides manufacturing, extraction and distribution services to third-party cannabis and cannabis branding companies. The Company’s corporate office and principal place of business is located at 19 Quail Run Circle, Salinas, California.

 

Basis of Presentation

 

The consolidated financial statements of Lowell Farms Inc. and its wholly owned subsidiaries (collectively, the “Company,” “we,” “us” or “our”) have been prepared in accordance with generally accepted accounting principles in the United States (“GAAP”). All intercompany transactions and balances have been eliminated in consolidation.

 

All dollar amounts in the consolidated financial statements and notes to consolidated financial statements are expressed in thousands of United States dollars ("$" or "US$"), unless otherwise indicated.

 

Use of Estimates

 

The preparation of financial statements in conformity with generally accepted accounting principles in the United States (“U.S. GAAP”) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Significant estimates in these financial statements include allowance for doubtful accounts and credit losses, carrying value of inventory, revenue recognition, accounting for stock-based compensation expense, and income taxes. Actual results could differ from those estimates.

 

The global COVID-19 pandemic has impacted the operations and purchasing decisions of companies worldwide. It also has created and may continue to create significant uncertainty in the global economy. The Company has undertaken measures to protect its employees, partners, customers, and vendors. In addition, the Company’s personnel are subject to various travel restrictions, which limit the ability of the Company to provide services to customers and affiliates. This impacts the Company's normal operations. To date, the Company has been able to provide uninterrupted access to its products and services, including certain employees that are working remotely, and its pre-existing infrastructure that supports secure access to the Company’s internal systems. If, however, the COVID-19 pandemic has a substantial impact on the productivity of the Company’s employees or its partners’ or customers’ decision to use the Company’s products and services, the results of the Company’s operations and overall financial performance may be adversely impacted. The duration and extent of the impact from the COVID-19 pandemic depends on future developments that cannot be accurately predicted at this time. As of the date of issuance of the financial statements, the Company is not aware of any specific event or circumstance that would require updates to the Company’s estimates and judgments or revisions to the carrying value of its assets or liabilities. These estimates may change, as new events occur and additional information is obtained, and are recognized in the condensed consolidated financial statements as soon as they become known. Actual results could differ from those estimates and any such differences may be material to the financial statements.

Significant Accounting Policies

 

Cash and Cash Equivalents

 

Cash and cash equivalents include cash on hand, cash deposits in financial institutions, and other deposits that are readily convertible into cash. The Company considers all short-term, highly liquid investments purchased with maturities of three months or less to be cash equivalents. These investments are carried at cost, which approximates fair value.

 

As of December 31, 2023 and December 31, 2022, the Company’s cash and cash equivalents exceeded FDIC insured limits by $1,974 and $360, respectively.

 

Accounts Receivable

 

Accounts receivables are classified as loans and receivable financial assets. Accounts receivables are recognized initially at fair value and subsequently measured at amortized cost, less any provisions for impairment. When an accounts receivable is uncollectible, it is written off against the provision. Subsequent recoveries of amounts previously written off are credited to the consolidated statements of operations.

 

Inventories

 

Inventories are valued at the lower of cost and net realizable value. Costs related to raw materials and finished goods are determined on the first-in, first-out basis. Specific identification and average cost methods are also used primarily for certain packing materials and operating supplies. The Company reviews inventory for obsolete, redundant and slow-moving goods and any such inventory is written-down to net realizable value.

 

Property and Equipment

 

Property and equipment are stated at cost, net of accumulated depreciation and impairment losses, if any. Depreciation is calculated on a straight-line basis over the estimated useful life of the asset using the following terms and methods:

 

Category

 

Useful Life

Leasehold improvements

 

The lesser of the estimated useful life or length of the lease

Office equipment

 

3-5 years

Furniture and fixtures

 

3-7 years

Vehicles

 

4-5 years

Machinery and equipment

 

3-6 years

Buildings

 

35 years

Construction in progress

 

Not depreciated

 

The assets’ residual values, useful lives and methods of depreciation are reviewed at each financial year-end and adjusted prospectively if appropriate. An item of equipment is derecognized upon disposal or when no future economic benefits are expected from its use. Any gain or loss arising on derecognition of the asset (calculated as the difference between the net disposal proceeds and the carrying value of the asset) is included in the consolidated statements of operations in the year the asset is derecognized.

Goodwill

 

Goodwill represents the excess of the purchase price paid for the acquisition of an entity over the fair value of the net tangible and intangible assets acquired. Goodwill that has an indefinite useful life is not subject to amortization and is tested annually for impairment, or more frequently if events or changes in circumstances indicate that goodwill might be impaired. Any goodwill impairment loss is recognized in the consolidated statements of operations in the period in which the impairment is identified. Impairment losses on goodwill are not subsequently reversed.

 

Intangible Assets

 

Intangible assets are recorded at cost, less accumulated amortization and impairment losses, if any. Intangible assets acquired in a business combination are measured at fair value at the acquisition date. Intangible assets acquired in an asset purchase are valued at their purchase price. Amortization is recorded on a straight-line basis over their estimated useful lives, which do not exceed the contractual period, if any. The estimated useful lives, residual values, and amortization methods are reviewed at each year-end, and any changes in estimates are accounted for prospectively.

 

Branding rights are measured at fair value at the time of acquisition and are amortized on a straight-line basis over a period of 15 years. In addition, the Company has certain brand and tradenames with indefinite lives, which are evaluated for impairment on an annual basis.

 

Impairment of Long-lived Assets

 

Long-lived assets, including property, plant and equipment and intangible assets are reviewed for impairment at each statement of financial position date or whenever events or changes in circumstances indicate that the carrying amount of an asset exceeds its recoverable amount. For the purpose of impairment testing, assets that cannot be tested individually are grouped together into the smallest group of assets that generates cash inflows from continuing use that are largely independent of the cash inflows of other assets or groups of assets. The recoverable amount of an asset or an asset group is the higher of its fair value, less costs to sell, and its value in use. If the carrying amount of an asset exceeds its recoverable amount, an impairment charge is recognized immediately in profit or loss equal to the amount by which the carrying amount exceeds the recoverable amount. Where an impairment loss subsequently reverses, the carrying amount of the asset is increased to the lesser of the revised estimate of the recoverable amount, and the carrying amount that would have been recorded had no impairment loss been recognized previously.

 

Leased Assets

 

The Company adopted FASB Topic 842, Leases (“Topic 842”) effective January 1, 2019, using the modified retrospective adoption method which allowed it to initially apply the new standard at the adoption date and recognize a cumulative-effect adjustment to the opening balance of accumulated deficit. In connection with the adoption of the lease pronouncement, the Company recorded a charge to accumulated deficit of $847. A lease of property and equipment is classified as a capital lease if it transfers substantially all the risks and rewards incidental to ownership to the Company. Lease right-of-use assets represent the right to use an underlying asset for the lease term, and lease liabilities represent the obligation to make payments arising from the lease agreement. These assets and liabilities are recognized at the commencement of the lease based upon the present value of the future minimum lease payments over the lease term. The lease term reflects the noncancelable period of the lease together with periods covered by an option to extend or terminate the lease when management is reasonably certain that it will exercise such option. Changes in the lease term assumption could impact the right-of-use assets and lease liabilities recognized on the balance sheet. As our leases typically do not contain a readily determinable implicit rate, we determine the present value of the lease liability using our incremental borrowing rate at the lease commencement date based on the lease term on a collateralized basis.

 

The Company accounts for sales leaseback transactions in accordance with ASC 842-40: Sale and Leaseback Transactions. The Company determines whether the transfer of an asset represents a sale based on requirements from Topic 606, lease classification, and nature of purchase options. If a transfer is deemed a sale and at fair value, the Company derecognizes the asset and records a gain/(loss) in the income statement. If a transfer is deemed a sale and not at fair value, the Company derecognizes the asset and does not recognize a gain/(loss) in the income statement. If a transfer of the asset is not a sale, the Company does not derecognize the asset.

 Income Taxes

 

The Company is a United States C corporation for income tax purposes. Income tax expense consisting of current and deferred tax expense is recognized in the consolidated statements of operations. Current tax expense is the expected tax payable on the taxable income for the year, using tax rates enacted or substantively enacted at year-end, adjusted for amendments to tax payable with regards to previous years. Deferred tax assets and liabilities and the related deferred income tax expense or recovery are recognized for deferred tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using the enacted or substantively enacted tax rates expected to apply when the asset is realized or the liability settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that substantive enactment occurs. A deferred tax asset is recognized to the extent that it is probable that future taxable income will be available against which the asset can be utilized. Deferred tax assets and liabilities are offset when there is a legally enforceable right to set off current tax assets against current tax liabilities and when they relate to income taxes levied by the same taxation authority and the Company intends to settle its current tax assets and liabilities on a net basis.

 

Revenue Recognition

 

Revenue is recognized upon transfer of control of promised products or services to customers in an amount that reflects the consideration the Company expects to receive in exchange for those products or services. The Company enters contracts that can include various combinations of products and services, which are generally capable of being distinct and accounted for as separate performance obligations Revenue is recognized net of allowances for returns and any taxes collected from customers, which are subsequently remitted to governmental authorities.

 

Branded Products

 

For the Company’s branded products, revenue is recognized when it satisfies a performance obligation by transferring a promised cannabis good to a customer. A contract, whether a verbal or written sales order, is established with customers prior to order fulfillment with agreement upon unit prices, delivery dates, and payment terms. The transaction price is based on market pricing while considering the value of the Company’s brand and quality. Transaction price is allocated to each product sold based upon the negotiated unit sales price associated with each product line scheduled for delivery within the order. Performance obligation satisfaction occurs upon delivery to customer premises. These types of revenues accounted for under ASC Topic 606, generally, do not require significant estimates or judgments based on the nature of the Company’s revenue stream. The sales prices, including discounts, are fixed at the point of sale and all consideration from contracts is included in the transaction price. The Company’s contracts do not include multiple performance obligations or material variable consideration.

 

Third Party Manufactured Products

 

The Company has certain licenses to manufacture and distribute third party products to retail dispensaries and deliveries in return for paying royalty payments to the third parties. The Company is a principal in the arrangement, it assumes primary responsibility for fulfilling the customer promise to retail dispensaries and deliveries, and it holds the inventory risk. Revenue is recognized when it satisfies a performance obligation by transferring a promised cannabis good to a retail dispensary or retail delivery. A contract, whether a verbal or written sales order, is established with customers prior to order fulfillment with agreement upon unit prices, delivery dates, and payment terms. The transaction price is based on market pricing while considering the value of the Company’s brand and quality. Transaction price is allocated to each product sold based upon the negotiated unit sales price associated with each product line scheduled for delivery within the order. Performance obligation satisfaction occurs upon delivery to customer premises. These types of revenues accounted for under ASC Topic 606, generally, do not require significant estimates or judgments based on the nature of the Company’s revenue stream. The sales prices, including discounts, are fixed at the point of sale and all consideration from contracts is included in the transaction price. The Company’s contracts do not include multiple performance obligations or material variable consideration.

Licensing

 

The Company has entered into contracts to license the right to utilize the Company’s branding and intellectual property. For all sales utilizing the license, the Company recognizes a percentage based license fee. Revenue is recognized when performance obligations are satisfied by recognizing fees on sales utilizing the licensed property to other companies. Contracts exist that define the property that is licensed, the time period, the fees and payment terms. These types of revenues accounted for under ASC Topic 606, generally, do not require significant estimates or judgments based on the nature of the Company’s revenue stream.

 

Distribution

 

The Company distributes certain third-party brands and bulk flower. The Company is a principal in the arrangement, it assumes primary responsibility for fulfilling the customer promise to retail dispensaries and deliveries and other wholesale customers, and it holds the inventory risk. Revenue is recognized when it satisfies a performance obligation by transferring a promised cannabis good to a customer. A contract, whether a verbal or written sales order, is established with customers prior to order fulfillment with agreement upon unit prices, delivery dates, and payment terms. The transaction price is based on market pricing while considering the value of the Company’s brand and quality. Transaction price is allocated to each product sold based upon the negotiated unit sales price associated with each product line scheduled for delivery within the order. Performance obligation satisfaction occurs upon delivery to customer premises. These types of revenues accounted for under ASC Topic 606, generally, do not require significant estimates or judgments based on the nature of the Company’s revenue stream. The sales prices, including discounts, are fixed at the point of sale and all consideration from contracts is included in the transaction price. The Company’s contracts do not include multiple performance obligations or material variable consideration.

 

Lowell Farms Services

 

The Company performs various processing activities under Lowell Farms Services including drying, bucking, trimming, sorting, grading and packaging operations. Revenue is recognized when it satisfies a performance obligation by completing the agreed upon services that were negotiated with a customer. A contract, whether a verbal or written sales order, is established with customers prior to completing the agreed upon services with the type of services to be performed and with the agreed upon pricing and timing. The transaction price is based on the nature of the services to be performed and market pricing. Performance obligation satisfaction occurs upon completion of the services performed. These types of revenues accounted for under ASC Topic 606, generally, do not require significant estimates or judgments based on the nature of the Company’s revenue stream. The Company’s contracts do not include multiple performance obligations or material variable consideration.

 

Research and Development

 

Research costs are expensed as incurred. For the years ended December 31, 2023 and 2022, research costs are immaterial.

 

For the year ended December 31, 2022, the Company incurred certain development expenditures related to the Lowell 35s product line that launched during the third quarter of the year ended December 31, 2022. Development costs of approximately $78 were expensed during the year ended December 31, 2022 to validate that the product line was commercially and technically feasible and to bring the product to market. Development expenditures are capitalized only if development costs are material, can be measured reliably, future economic benefits are probable, and the Company intends to and has sufficient resources to complete the development to use or sell the asset. To date, no development costs have been capitalized.

 

Share-Based Compensation

 

The Company has a share-based compensation plan. The Company measures equity settled share-based payments based on their fair value at the grant date and recognizes compensation expense over the vesting period based on the Company’s estimate of equity instruments that will eventually vest.

 

For shares granted to non-employees, the compensation expense is measured at the fair value of the goods and services received, except where the fair value cannot be estimated, in which case, it is measured at the fair value of the equity instruments granted. The fair value of share-based compensation to non-employees is periodically re-measured until counterparty performance is complete, and any change therein is recognized over the period and in the same manner as if the Company had paid cash instead of paying with or using equity instruments.

 

Business Combinations

 

A business combination is defined as an acquisition of assets and liabilities that constitute a business. A business consists of inputs, including non-current assets and processes, including operational processes, that when applied to those inputs have the ability to create outputs that provide a return to the Company. Business combinations are accounted for using the acquisition method of accounting. The consideration of each acquisition is measured at the aggregate of the fair values of tangible and intangible assets obtained, liabilities and contingent liabilities incurred or assumed, and equity instruments issued by the Company at the date of acquisition. Key assumptions routinely utilized in allocation of purchase price to intangible assets include projected financial information such as revenue projections for companies acquired. As of the acquisition date, goodwill is measured as the excess of consideration given, generally measured at fair value, and the net of the acquisition date fair values of the identifiable assets acquired and the liabilities assumed.

Recently Adopted Accounting Standards

 

In December 2019, the FASB issued ASU 2019-12, Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes. This guidance removes certain exceptions to the general principles in Topic 740 and enhances and simplifies various aspects of the income tax accounting guidance, including requirements such as tax basis step-up in goodwill obtained in a transaction that is not a business combination, ownership changes in investments, and interim-period accounting for enacted changes in tax law. This standard is effective for fiscal years and interim periods within those fiscal years beginning after December 15, 2020. This guidance was effective for the Company in our fiscal year and interim periods beginning on January 1, 2021 and did not have a material impact on our consolidated financial statements.

 

In January 2020, the FASB issued ASU 2020-01 Investments-Equity Securities (Topic 321), Investments-Equity Method and Joint Ventures (Topic 323), and Derivatives and Hedging (Topic 815) - Clarifying the Interactions between Topic 321, Topic 323, and Topic 815. This guidance addresses accounting for the transition into and out of the equity method and provides clarification of the interaction of rules for equity securities, the equity method of accounting, and forward contracts and purchase options on certain types of securities. This standard is effective for fiscal years and interim periods within those fiscal years beginning after December 15, 2020. We evaluated the impact of ASU 2020-01 on our Consolidated Financial Statements, which was effective for the Company in our fiscal year and interim periods beginning on January 1, 2021 and it did not have a material impact on our consolidated financial statements.

 

In August 2020, the FASB issued ASU 2020-06, Debt-Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging-Contracts in Entity’s Own Equity (Subtopic 815-40). This update amends the guidance on convertible instruments and the derivatives scope exception for contracts in an entity's own equity and improves and amends the related EPS guidance for both Subtopics. This standard is effective for fiscal years and interim periods within those fiscal years beginning after December 15, 2021, which means it was effective for our fiscal year beginning January 1, 2022 and did not have a material impact on our consolidated financial statements.

 

Accounting standards not yet adopted

 

In October 2021, the FASB issued ASU 2021-08-Business Combinations (“Topic 805”): Accounting for Contract Assets and Contract Liabilities from Contracts with Customers. The amendments in ASU 2021-08 require that an entity recognizes and measures contract assets and contract liabilities acquired in a business combination in accordance with ASC 606, Revenue from Contracts with Customers (“Topic 606”). At the acquisition date, an acquirer should account for the related revenue contracts in accordance with Topic 606 as if it had originated the contracts. The amendments improve comparability for both the recognition and measurement of acquired revenue contracts with customers at the date of and after a business combination. This standard is effective for fiscal years and interim periods within those fiscal years beginning after December 15, 2022, which means it was effective for our fiscal year beginning January 1, 2023 and did not have a material impact on our consolidated financial statements.

 

No other recently issued accounting pronouncements had or are expected to have a material impact on our consolidated financial statements.

XML 22 R8.htm IDEA: XBRL DOCUMENT v3.24.1
PREPAID AND OTHER CURRENT ASSETS
12 Months Ended
Dec. 31, 2023
PREPAID AND OTHER CURRENT ASSETS  
Prepaid And Other Current Assets

2. PREPAID AND OTHER CURRENT ASSETS

 

Prepaid and other current assets were comprised of the following items:

 

 

 

December 31,

 

 

December 31,

 

(in thousands)

 

2023

 

 

2022

 

Deposits

 

$1,134

 

 

$595

 

Insurance

 

 

237

 

 

 

235

 

Supplier advances

 

 

26

 

 

 

375

 

Interest and taxes

 

 

26

 

 

 

69

 

Licenses and payments

 

 

106

 

 

 

146

 

Royalty Advance

 

 

853

 

 

 

-

 

Other

 

 

15

 

 

 

102

 

Total prepaid and other current assets

 

$2,397

 

 

$1,522

 

XML 23 R9.htm IDEA: XBRL DOCUMENT v3.24.1
INVENTORY
12 Months Ended
Dec. 31, 2023
INVENTORY  
Inventory

3. INVENTORY

 

Inventory, net was comprised of the following items:

 

 

 

December 31,

 

 

December 31,

 

(in thousands)

 

2023

 

 

2022

 

Raw materials

 

$1,400

 

 

$7,431

 

Work in process

 

 

307

 

 

 

940

 

Finished goods

 

 

3,053

 

 

 

2,408

 

Total inventory

 

$4,760

 

 

$10,779

 

 

As a result of the Zabala lease termination, the Company wrote off $2,607 of plant inventory that was in the facility as of the end of the year, which was recorded in cost of goods sold.

 

The Company recorded an inventory reserve of $1,780 and $1,492 for the year ended December 31, 2023 and 2022, respectively.

XML 24 R10.htm IDEA: XBRL DOCUMENT v3.24.1
OTHER CURRENT LIABILITIES
12 Months Ended
Dec. 31, 2023
OTHER CURRENT LIABILITIES  
Other Current Liabilities

4. OTHER CURRENT LIABILITIES

 

Other current liabilities were comprised of the following items:

 

 

 

December 31,

 

 

December 31,

 

(in thousands)

 

2023

 

 

2022

 

Excise and cannabis tax

 

$3

 

 

$948

 

Third party brand distribution accrual

 

 

558

 

 

 

17

 

Insurance and professional fee accrual

 

 

287

 

 

 

158

 

Interest and tax accrual

 

 

109

 

 

 

921

 

Employee Retention Credit financing accrual

 

 

441

 

 

 

441

 

Equipment purchase accrual

 

 

-

 

 

 

724

 

Other

 

 

545

 

 

 

445

 

Total other current liabilities

 

$1,943

 

 

$3,654

 

 

On July 26, 2022, subsidiaries of the Company entered into an agreement with an institutional investor pursuant to which the investor purchased a participation ("Transferred Interests") in all rights to payment from the United States IRS in respect of the Company’s employee retention credits for the first and second quarters of 2021 (the “ERC Claim”). The purchase price paid for the derivative payment rights was $2,446, which was paid in immediately available funds. For the year ended December 31, 2022, the Company recorded net other income of $2,014 and an accrued other liability of $441 to be paid to facilitate the sale of the ERC Claim. Included in interest expense is $864 of financing related charges.

XML 25 R11.htm IDEA: XBRL DOCUMENT v3.24.1
PROPERTY AND EQUIPMENT AND RIGHT OF USE ASSETS
12 Months Ended
Dec. 31, 2023
PROPERTY AND EQUIPMENT AND RIGHT OF USE ASSETS  
Property And Equipment And Right Of Use Assets

5. PROPERTY AND EQUIPMENT AND RIGHT OF USE ASSETS

 

A reconciliation of the beginning and ending balances of property and equipment, right of use assets and accumulated depreciation during the years ended December 31, 2023 and 2022, and property and equipment, net and right of use assets, net as of for the same years are as follows:

 

 

 

Land and

 

 

Leasehold

 

 

Furniture

and

 

 

 

 

 

 

Construction

 

 

Right of

 

 

 

(in thousands)

 

Buildings

 

 

Improvements

 

 

Fixtures

 

 

Equipment

 

 

Vehicles

 

 

in Process

 

 

Use Assets

 

 

Total

 

Costs

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Balance-December 31, 2022

 

$15,719

 

 

$12,437

 

 

$50

 

 

$6,499

 

 

$830

 

 

$35

 

 

$37,081

 

 

$72,651

 

Additions

 

 

-

 

 

 

29

 

 

 

-

 

 

 

106

 

 

 

-

 

 

 

-

 

 

 

17,068

 

 

 

17,203

 

Disposals

 

 

(15,719 )

 

 

(202 )

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

(15,921

Remeasurements

 

 

-

 

 

 

-

 

 

 

 

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

(4,602 )

 

 

(4,602)

Impairments

 

 

-

 

 

 

(10,148 )

 

 

-

 

 

 

(1,310 )

 

 

-

 

 

 

-

 

 

 

(28,230 )

 

 

(39,688

 

Balance-December 31, 2023

 

$-

 

 

$2,116

 

 

$50

 

 

$5,295

 

 

$830

 

 

$35

 

 

$21,317

 

 

$29,643

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Accumulated Depreciation

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Balance-December 31, 2022

 

$(315 )

 

$(1,815 )

 

$(49 )

 

$(1,498 )

 

$(608 )

 

$-

 

 

$(9,719 )

 

$(14,004

Depreciation

 

 

(71 )

 

 

(837 )

 

-

 

 

 

(925 )

 

 

(136 )

 

 

-

 

 

 

(2,742 )

 

 

(4,711

Disposals

 

 

386

 

 

 

55

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

441

 

Remeasurement

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

2,661

 

 

 

2,661

 

Impairments

 

 

-

 

 

 

1,516

 

 

 

-

 

 

 

70

 

 

-

 

 

 

-

 

 

 

6,810

 

 

 

8,396

 

Balance-December 31, 2023

 

$

 -

 

 

$(1,081 )

 

$(49 )

 

$(2,353 )

 

$(744 )

 

$-

 

 

$(2,990 )

 

$(7,217

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net Book Value-December 31, 2023

 

$-

 

 

$1,035

 

 

$1

 

 

$2,942

 

 

$86

 

 

$35

 

 

$18,327

 

 

$22,426

 

 

Construction in process represents assets under construction related to cultivation, manufacturing, and distribution facilities not yet completed or otherwise not placed in service.

 

Depreciation expense of $4,711, and $7,022, were recorded for the years ended December 31, 2023 and 2022 respectively, of which $4,613 and $6,292, respectively, were included in cost of goods sold. Depreciation expense of $608 was also recorded in other expense for the year ended December 31, 2022.

 

As a result of the Zabala lease termination, the Company wrote off $8,632 of leasehold improvements and $151 of equipment resulting in an impairment expense of $8,783, which was recorded in other income and expense.

XML 26 R12.htm IDEA: XBRL DOCUMENT v3.24.1
INTANGIBLE ASSETS
12 Months Ended
Dec. 31, 2023
INTANGIBLE ASSETS

6. INTANGIBLE ASSETS

 

A reconciliation of the beginning and ending balances of intangible assets and accumulated amortization during the years ended December 31, 2023 and 2022 are as follows:

 

 

 

Definite Life Intangibles

 

 

Indefinite Life

 

 

 

 

 

Technology/

 

 

Acquired

Purchase

 

 

Intangibles

Brands &

 

 

 

(in thousands)

 

Know How

 

 

Rights

 

 

Tradenames

 

 

Total

 

Costs

 

 

 

 

 

 

 

 

 

 

 

 

Balance-December 31, 2022

 

$3,258

 

 

$1,800

 

 

$37,707

 

 

$42,765

 

Sale of Brand Assets

 

 

 

 

 

 

 

 

 

 

(24,053 )

 

 

(37,299 )

Impairment

 

 

(258 )

 

 

(1,384

)

 

 

(13,654

 

 

(2,050

Balance-December 31, 2023

 

$3,000

 

 

$416

 

 

$-

 

 

$3,416

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Accumulated Amortization

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Balance-December 31, 2022

 

$(535 )

 

$(28 )

 

$-

 

 

$(563 )

Amortization

 

 

(323 )

 

 

(83 )

 

 

-

 

 

 

(406 )

     Impairment

 

 

 97

 

 

 

 -

 

 

 

 

 

 

 

 97

 

Balance-December 31, 2023

 

$(761 )

 

$(111 )

 

$-

 

 

$(872 )

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net Book Value

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

December 31, 2022

 

$2,723

 

 

$1,772

 

 

$37,707

 

 

$42,202

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net Book Value

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

December 31, 2023

 

$2,239

 

 

$305

 

 

$-

 

 

$2,544

 

 

Intangible assets with finite lives are amortized over their estimated useful lives. Amortization periods of assets with finite lives are based on management's estimates at the date of acquisition. The Company recorded amortization expense of $406, and $354 for the years ended December 31, 2023, and 2022, respectively.

 

During the year ended December 31, 2022, the Company acquired rights to purchase additional manufacturing equipment related to the Lowell 35s automated pre-roll line. Per the terms of the purchase agreement, the Company acquired the rights to acquire eight pre-roll machines and one packaging machine and received 15% of the issued and outstanding shares of the selling company, which have a fair market value of $nil. For the year ended December 31, 2022, one pre-roll machine and the packaging machine were received and in use and the acquired purchase rights are being amortized over the five year useful life of the machines. As consideration for the purchase of the acquisition rights, the Company paid for deposits on a portion of the machines, which are reflected as additions within Property and Equipment and issued 1 million subordinate voting shares with a fair market value of  $1,800 on the issuance date. The Company impaired the remaining purchase rights on the unpurchased machines in the period ending December 31, 2023.

 

On October 6th, 2023 the Company repurchased all of the $22,157 aggregate principal amount of outstanding Senior Secured Convertible Debentures (“Debentures”) together with the related warrants to purchase 10,627,483 subordinate voting shares of the Company and 4,324,845 common shares of Indus which have been cancelled. Share amounts reflect the 1 for 10 reverse stock split effective August 31, 2023. A total of 6,849,572 shares of the Company were issued to holders based on the proportion of the outstanding Debentures held by such holder, of (x) membership interests in LF Brandco LLC (“Brandco”), an entity formed to hold the Company’s intellectual property relating to its “Lowell Smokes” and “Lowell Herb Co.” brands (including trademarks, logos and additional identifying marks, domain names and social media accounts). During the year ended December 31, 2023, and as result of the transaction, the Company recognized $13,245 of impairment on the intangible brand assets.

 

 In addition, the Company has entered into a license agreement with Brandco for the “Lowell” trademarks, logos, and related intellectual property on an exclusive basis in the State of California for a five-year license term, with up to three five-year extensions. The Company’s exercise of the extension terms is subject to mutual agreement on certain sales performance criteria for each extension term. In addition, the Company received a $1 million royalty advance whereby the Company does not have to pay the first $1 million of royalty expense.

 

The transaction is considered to be a “related party transaction” because insiders of the Company hold Debentures and Warrants.

 

 As a result of the transaction, the Company derecognized Lowell brand name intangible ($24.1) million, convertible notes ($22.1) million, accrued interest ($1.49) million and warrants ($1.55) million. Issued shares and royalty advance were recorded at fair value in the amount of $2.03 million or $0.93 million, respectively.

 

The Company estimates that amortization expense for our existing other intangible assets will average approximately $317 annually for the next seven and a half fiscal years. Actual amortization expense to be reported in future periods could differ from these estimates as a result of new intangible asset acquisitions, changes in useful lives or other relevant factors or changes.

XML 27 R13.htm IDEA: XBRL DOCUMENT v3.24.1
SHAREHOLDERS EQUITY
12 Months Ended
Dec. 31, 2023
SHAREHOLDERS EQUITY  
Shareholders Equity

7. SHAREHOLDERS’ EQUITY

 

Shares Outstanding

 

The table below details the change in Company shares outstanding by class during year ended December 31, 2023:

 

 

 

Subordinate

 

 

Super

 

(in thousands)

 

Voting Shares

 

 

Voting Shares

 

Balance-December 31, 2022

 

 

12,177

 

 

 

20

 

Issuance of vested restricted stock units

 

 

4

 

 

 

-

 

Issuance of shares in convertible debt conversion

 

 

6,843

 

 

 

-

 

Balance-December 31, 2023

 

 

19,024

 

 

 

20

 

 

Warrants

 

A reconciliation of the beginning and ending balances of warrants outstanding is as follows:

 

(in thousands)

 

 

 

Balance-December 31, 2022

 

 

17,343

 

Warrants canceled in conjunction with convertible debt conversion

 

 

(15,052)

Warrants expired

 

 

(1,165 )

Balance-December 31, 2023

 

 

1,126

 

 

XML 28 R14.htm IDEA: XBRL DOCUMENT v3.24.1
DEBT
12 Months Ended
Dec. 31, 2023
DEBT  
Debt

8. DEBT

 

Debt at December 31, 2023 and 2022, was comprised of the following:

 

 

 

December 31,

 

 

December 31,

 

(in thousands)

 

2023

 

 

2022

 

Current portion of long-term debt

 

 

 

 

 

 

Vehicle loans(1)

 

$3

 

 

$15

 

Mortgage payable(2)

 

 

-

 

 

 

257

 

Note payable

 

 

-

 

 

 

10

 

Convertible debt(3)

 

 

-

 

 

 

21,398

 

Total short-term debt

 

 

3

 

 

 

21,680

 

 

 

 

 

 

 

 

 

 

Long-term debt, net

 

 

 

 

 

 

 

 

Vehicle loans(1)

 

 

-

 

 

 

3

 

Mortgage payable(2)

 

 

-

 

 

 

8,713

 

Convertible debenture(3)

 

 

-

 

 

 

-

 

Total long-term debt

 

 

-

 

 

 

8,716

 

Total Indebtedness

 

$3

 

 

$30,396

 

_____________

(1)

Primarily fixed term loans on transportation vehicles. Weighted average interest rate at December 31, 2023 and December 31, 2022 was 6.4%.

(2)

Mortgage payable associated with the acquired processing facility. Weighted average interest rate at December 31, 2022 was 12.5%. Net of deferred financing costs as December 31, 2022 of $296.As part of sale leaseback transaction, the Company sold the property, and the buyer assumed the mortgage. Refer to Note “Leases” for more information

      

(3)

Net of deferred financing costs at December 31, 2022 of $759.During the year, the Company repurchased the Convertible Notes. Refer to Note “Intangible Assets” for more information.

 

Stated maturities of debt obligations are as follows as of December 31, 2023:

 

 

 

December 31,

 

(in thousands)

 

2023

 

2024

 

$3

 

Total debt obligations

 

$3

 

XML 29 R15.htm IDEA: XBRL DOCUMENT v3.24.1
LEASES
12 Months Ended
Dec. 31, 2023
LEASES  
Leases

9. LEASES

 

A reconciliation of lease obligations for the years ended December 31, 2023 and 2022, is as follows:

 

(in thousands)

 

 

 

 

 

 

Lease obligation

 

 Operating Leases

 

 

Finance Leases 

 

 

Total

 

December 31, 2022

 

$-

 

 

 

33,999

 

 

 

33,999

 

Sale leaseback addition

 

 

17,068

 

 

 

-

 

 

 

17,068

 

Lease principal payments

 

 

(443)

 

 

(1,527)

 

 

(1,970

Lease remeasurement

 

 

(2,064)

 

 

-

 

 

 

(2,064

 

Lease settlement

 

 

-

 

 

 

(1,202)

 

 

(1,202

Lease termination

 

 

-

 

 

 (26,319

)

 

 

(26,319

)

Operating lease remeasurement classification

 

 

4,841

 

 

(4,841

 

 

-

 

December 31, 2023

 

$19,402

 

 

 

110

 

 

 

19,512

 

 

As a result of the Zabala lease termination, The Company derecognized the right of use asset in the amount of $21,423 and lease obligation of $26,319, which resulted in a gain on termination of $4,896, which was recorded in Other Income/(expense).

 

During the year, the Company entered into a sale and leaseback transaction for its Spence Road facility. As part of the transaction, the Company sold the property for $19.4 million including assumption of the underlying mortgage. The Company leased back the facility for a ten-year period with 2 ten-year extension options. The Company accounted for the transaction as a sale recorded a gain of $3.04 million in Other income (expense). The lease back was classified as an operating lease.

 

All extension options that are reasonably certain to be exercised have been included in the measurement of lease obligations. The Company reassesses the likelihood of extension option exercise if there is a significant event or change in circumstances within its control.

 

The components of lease expense for the years ended December 31, 2023, and 2022, are as follows:

 

 

 

Years Ended

 

Finance Leases

 

December 31,

 

 

December 31,

 

(in thousands)

 

2023

 

 

2022

 

Amortization of leased assets (1)

 

$1,651

 

 

$3,755

 

Interest on lease liabilities (2)

 

 

1,651

 

 

 

2,219

 

Total

 

$3,316

 

 

$5,974

 

____________

(1) Included in cost of goods sold, general and administrative expenses and other expenses in the consolidated statement of operations.

(2) Included in interest expense in the consolidated statement of operations.

 

 

 

Years Ended

 

Operating Leases

 

December 31,

 

 

December 31,

 

(in thousands)

 

2023

 

 

2022

 

Amortization of leased assets (1)

 

$

1,091

 

 

$

-

 

Interest on lease liabilities (1)

 

 

1,326

 

 

 

-

 

Total

 

$

2,417

 

 

$

-

 

____________

(1) Included in cost of goods sold, general and administrative expenses and other expenses in the consolidated statement of operations.

The key assumptions used in accounting for leases as of December 31, 2023, were a weighted average remaining lease term of 8.9 years and a weighted average discount rate of 10%. The key assumptions used in accounting for leases as of December 31, 2022 were a weighted average remaining lease term of 14.6 years and a weighted average discount rate of 6%.

 

The future lease payments with initial remaining terms in excess of one year as of December 31, 2023 were as follows:

 

 

 

December 31,

 

(in thousands)

 

2023

 

2024

 

 

3,285

 

2025

 

 

3,258

 

2026

 

 

3,240

 

2027

 

 

3,324

 

2028 and beyond

 

 

52,341

 

Total lease payments

 

$65,448

Less imputed interest

 

 

(45,936)

Total

 

$19,512

 

XML 30 R16.htm IDEA: XBRL DOCUMENT v3.24.1
SHARE BASED COMPENSATION
12 Months Ended
Dec. 31, 2023
SHARE BASED COMPENSATION  
SHARE BASED COMPENSATION

 10. SHARE-BASED COMPENSATION

 

During 2019, the Company’s Board of Directors adopted the 2019 Stock and Incentive Plan (the “Plan”), which was amended in April 2020 and March 2021. The Plan permits the issuance of stock options, stock appreciation rights, stock awards, share units, performance shares, performance units and other stock-based awards, and, as of December 31, 2022, 13.2 million shares have been authorized to be issued under the Plan and 3.6 million are available for future grant. The Plan provides for the grant of options as either non-statutory stock options or incentive stock options and restricted stock units to employees, officers, directors, and consultants of the Company to attract and retain persons of ability to perform services for the Company and to reward such individuals who contribute to the achievement by the Company of its economic objectives. The awards granted generally vest in 25% increments over a four-year period and option awards expire 6 years from grant date. 

The Plan is administered by the Board or a committee appointed by the Board, which determines the persons to whom the awards will be granted, the type of awards to be granted, the number of awards to be granted, and the specific terms of each grant, including the vesting thereof, subject to the provisions of the Plan.

 

During the years December 31, 2023 and 2022, the Company granted shares to certain employees as compensation for services. These shares were accounted for in accordance with ASC 718 - Compensation - Stock Compensation. The Company amortizes awards over the service period and until awards are fully vested.

 

For the years ended December 31, 2023, and 2022 share-based compensation expense was as follows:

 

 

 

Years Ended

 

 

 

December 31,

 

 

December 31,

 

(in thousands)

 

2023

 

 

2022

 

Cost of goods sold

 

$-

 

 

$-

 

General and administrative expense

 

 

231

 

 

 

564

 

Total share-based compensation

 

$231

 

 

$564

 

The following table summarizes the status of stock option grants and unvested awards at and for the year ended December 31, 2023:

 

 

 

 

 

Weighted-

 

 

Weighted-

Average

 

 

 

 

 

 

 

Average

 

 

Remaining

 

 

Aggregate

 

(in thousands except per share amounts)

 

Stock

Options

 

 

Exercise

Price

 

 

Contractual

Life

 

 

Intrinsic

Value

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Outstanding-December 31, 2022

 

 

1,007

 

 

$4.7

 

 

 

4.6

 

 

 

-

 

Granted

 

 

828

 

 

 

0.3

 

 

 

 

 

 

 

-

 

Expired

 

 

(28)

 

 

20.4

 

 

 

 

 

 

 

-

 

Cancelled

 

 

(354)

 

 

4.6

 

 

 

 

 

 

 

-

 

Outstanding-December 31, 2023

 

 

1,453

 

 

 

1.9

 

 

 

5.3

 

 

 

-

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Exercisable-December 31, 2023

 

 

988

 

 

 

2.09

 

 

 

5.2

 

 

 

-

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Vested and expected to vest-December 31, 2023

 

 

1,453

 

 

 

1.91

 

 

 

5.3

 

 

 

-

 

 

The weighted-average fair value of options granted during the year ended December 31, 2023, estimated as of the grant date was $0.30. As of December 31, 2023, there was $191 of total unrecognized compensation cost related to non-vested options, which is expected to be recognized over a remaining weighted-average vesting period of 0.99 years.

 

The following table summarizes the status of restricted stock unit (“RSU”) grants and unvested awards at and for the year ended December 31, 2023:

 

 

 

 

 

Weighted-Average

 

(in thousands except per share amounts)

 

RSUs

 

 

Fair Value

 

 

 

 

 

 

 

 

Outstanding-December 31, 2022

 

 

21

 

 

$1.10

 

Granted

 

 

-

 

 

-

 

Vested

 

(4

)

 

 

-

 

Cancelled

 

 

(17 )

 

 

1.02

 

Outstanding-December 31, 2023

 

 

-

 

 

$-

 

 

As of December 31, 2023, there was no unrecognized compensation cost related to non-vested restricted stock units.

 

The fair value of the stock options and RSUs granted were determined using the Black-Scholes option-pricing model with the following weighted average assumptions at the time of grant. No RSUs were granted for the years ended December 31, 2023 and 2022.

 

Options

 

Years Ended

 

 

 

December 31,

 

 

December 31,

 

 

 

2023

 

 

2022

 

Expected volatility

 

 

50%

 

 

50%

Dividend yield

 

 

0%

 

 

0%

Risk-free interest rate

 

 

4.12%

 

 

2.48%

Expected term in years

 

 

5.58

 

 

 

3.9

 

 

XML 31 R17.htm IDEA: XBRL DOCUMENT v3.24.1
INCOME TAXES
12 Months Ended
Dec. 31, 2023
INCOME TAXES  
Income Taxes

11. INCOME TAXES

 

Coronavirus Aid, Relief and Economic Security Act

 

On March 27, 2020, the Coronavirus Aid, Relief, and Economic Security Act (the “CARES Act”) was enacted and signed into law in response to the market volatility and instability resulting from the COVID-19 pandemic. It includes a significant number of tax provisions and lifts certain deduction limitations originally imposed by the Tax Cuts and Jobs Act of 2017 (the “2017 Act”). The changes mainly related to: (1) the business interest expense disallowance rules for 2019 and 2020; (2) net operating loss rules; (3) charitable contribution limitations; (4) employee retention credit; and (5) the realization of corporate alternative minimum tax credits.

 

The Company continues to assess the impact and future implication of these provisions; however, it does not anticipate any amounts that could give rise to a material impact to the overall consolidated financial statements.

 

The provision for income tax expense for the year ended December 31, 2023, was $161, representing an effective tax rate of (0.4)%, compared to an income tax expense of 191 for the year ended December 31, 2022, representing an effective tax rate of (0.8)%.

 

The provision for income tax expense for the years ended December 31, 2023 and 2022, consisted of the following:

 

 

 

Years Ended

 

(in thousands)

 

2023

 

 

2022

 

Current

 

 

 

 

 

 

Federal

 

$-

 

 

$-

 

State

 

 

161

 

 

 

191

 

Total Current

 

 

191

 

 

 

191

 

 

 

 

 

 

 

 

 

 

Deferred tax benefit

 

 

 

 

 

 

 

 

Federal

 

 

(1,615 )

 

 

(1,987 )

State

 

 

(3,111 )

 

 

(15,293)

Total deferred tax benefit

 

 

(4,726 )

 

 

(17,280 )

 

 

 

 

 

 

 

 

 

Valuation allowance

 

 

4,726

 

 

 

17,280

 

 

 

 

 

 

 

 

 

 

Income tax expense

 

$161

 

 

$191

 

 

As the Company operates in the cannabis industry, it is subject to the limitations of IRC Section 280E, under which the Company is only allowed to deduct expenses directly related to sales of product. This results in permanent differences between ordinary and necessary business expenses deemed non-allowable under IRC Section 280E. Therefore, the effective tax rate can be highly variable and may not necessarily correlate with pre-tax income or loss.

 

In December 2017, the United States (“U.S.”) Congress passed and the President signed into law what is referred to as the 2017 Tax Act, which contains many significant changes to the U.S. tax laws, including, but not limited to, reducing the U.S. federal corporate tax rate from 35% to 21% and utilization limitations of net operating loss carryforwards created in tax years beginning after December 31, 2017 to 80% of taxable income with an indefinite carryforward period. As the Company has a full valuation allowance against its U.S. deferred tax assets, the revaluation of net deferred tax assets resulting from the reduction in the U.S. federal corporate income tax rate did not impact the Company’s effective tax rate. Additional guidance may be issued by the U.S. Treasury Department, the IRS, or other standard-setting bodies, which may result in adjustments to the amounts recorded,

including the valuation allowance. The Company is being audited by the IRS for years 2019 and 2020. Significant components of the Company’s deferred tax assets and liabilities at December 31, 2023 and 2022, are as follows:

 

 

 

Years Ended

 

(in thousands)

 

2023

 

 

2022

 

Deferred tax assets

 

 

 

 

 

 

Net operating loss carryforwards

 

$23,323

 

 

$17,038

 

Accruals and reserves

 

 

-

 

 

 

-

 

Depreciation

 

 

-

 

 

 

-

 

Other

 

 

-

 

 

 

-

 

Valuation allowance

 

 

(23,323 )

 

 

(17,038 )

Total deferred tax assets

 

 

-

 

 

 

-

 

 

 

 

 

 

 

 

 

 

Accruals and reserves

 

 

-

 

 

 

-

 

Share-based compensation

 

 

-

 

 

 

-

 

Total deferred tax liabilities

 

 

-

 

 

 

-

 

 

 

 

 

 

 

 

 

 

Net deferred tax liabilities

 

$-

 

 

$-

 

XML 32 R18.htm IDEA: XBRL DOCUMENT v3.24.1
NET INCOME (LOSS) PER SHARE
12 Months Ended
Dec. 31, 2023
Net loss per share:  
Net Income (loss) Per Share

12. NET INCOME (LOSS) PER SHARE

 

Net loss per share represents the net earnings/loss attributable to shareholders divided by the weighted average number of shares outstanding during the period on an as converted basis.

 

 

 

Years Ended

 

 

 

December 31,

 

 

December 31,

 

(in thousands except per share amounts)

 

2023

 

 

2022

 

Net loss

 

$(37,342 )

 

$(24,677 )

 

 

 

 

 

 

 

 

 

Net loss per share:

 

 

 

 

 

 

 

 

Basic

 

$(2.71 )

 

$(2.17 )

Diluted

 

$(2.71 )

 

$(2.17 )

Weighted average shares outstanding:

 

 

 

 

 

 

 

 

Basic

 

 

13,790

 

 

 

11,318

 

Diluted

 

 

13,790

 

 

 

11,318

 

 

 

 

 

 

 

 

 

 

Weighted average potentially diluted shares (1):

 

 

 

 

 

 

 

 

Basic shares

 

 

13,790

 

 

 

11,318

 

Options

 

 

-

 

 

 

-

 

Warrants

 

 

-

 

 

 

-

 

Convertible debentures

 

 

-

 

 

 

-

 

Restricted stock units

 

 

-

 

 

 

-

 

Total weighted average potentially diluted shares:

 

 

13,790

 

 

 

11,318

 

________________

(1) For the above periods, the inclusion of options, warrants, convertible debentures and restricted stock units in the calculation of diluted earnings per share would be anti-dilutive, and accordingly, were excluded from the diluted loss per share calculation.

XML 33 R19.htm IDEA: XBRL DOCUMENT v3.24.1
FAIR VALUE MEASUREMENTS
12 Months Ended
Dec. 31, 2023
FAIR VALUE MEASUREMENTS  
Fair Value Measurements

13. FAIR VALUE MEASUREMENTS

 

Accounting standards define fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. The fair value hierarchy prioritizes the inputs to valuation techniques used to measure fair value. An asset’s or liability’s level is based on the lowest level of input that is significant to the fair value measurement. Assets and liabilities carried at fair value are valued and disclosed in one of the following three levels of the valuation hierarchy:

 

Level 1: Quoted market prices in active markets for identical assets or liabilities.

 

Level 2: Observable market-based inputs or unobservable inputs that are corroborated by market data. Level 3: Unobservable inputs reflecting the reporting entity’s own assumptions.

 

At December 31, 2023 and December 31, 2022 the carrying value of cash and cash equivalents, accounts receivable, prepaid expense and other current assets, accounts payable and other current liabilities approximate fair value due to the short-term nature of such instruments.

 

The carrying value of the Company's debt approximates fair value based on current market rates (Level 2).

 

Nonrecurring fair value measurements

 

The Company uses fair value measures when determining assets and liabilities acquired in an acquisition as described above in the Notes to Consolidated Financial Statements, which are considered a Level 3 measurement.

XML 34 R20.htm IDEA: XBRL DOCUMENT v3.24.1
COMMITMENTS AND CONTINGENCIES
12 Months Ended
Dec. 31, 2023
Commitments And Contingencies Disclosure Abstract  
Commitments And Contingencies

14. COMMITMENTS AND CONTINGENCIES

 

Contingencies

 

The Company’s operations are subject to a variety of local and state regulation. Failure to comply with one or more of those regulations could result in fines, restrictions on its operations, or losses of permits that could result in the Company ceasing operations. While management of the Company believes that the Company is in compliance with applicable local and state regulation as of December 31, 2023, cannabis regulations continue to evolve and are subject to differing interpretations. As a result, the Company may be subject to regulatory fines, penalties or restrictions in the future.

 

The Company is being audited by the IRS for years 2019 and 2020 and may be subject to additional taxes, penalties and interest.

 

Litigation and Claims

 

From time to time, the Company may be involved in litigation relating to claims arising out of operations in the normal course of business.

 

On January 12, 2024, Cypress Holding Company, LLC (“Cypress”), a wholly owned subsidiary of the Company, surrendered possession of approximately 10 acres of real property at 139 Zabala Road, Salinas, California (the “Zabala Road Property”) leased by Cypress pursuant to a Lease Agreement dated April 1, 2017 (the “Zabala Road Lease”) with Tinhouse, LLC, dba Tinhouse Partners, LLC, as landlord (the “Landlord”). Prior to vacating the premises on January 12, 2024, the Company had operated a cultivation facility, which includes four greenhouses totaling approximately 255,000 square feet, on the Zabala Road Property.

 

In January 2023, the Company’s Board of Directors formed a strategic alternatives special committee of independent directors to explore, review and evaluate strategic and financial alternatives. As part of these efforts, the Company entered into negotiations with the Landlord to restructure the terms of the Zabala Road Lease, which provided for an expiry date of December 31, 2027, subject to five 5-year extension options exercisable by Cypress.

 

In 2023, the Company and the Landlord reached a settlement amending the terms of the Zabala Road Lease and reaching agreement on all rent-related issues. The Landlord terminated the Zabala Road Lease via a letter, which was served by its counsel on the Company in 2023. In 2023, the Company filed a lawsuit for breach of contract and specific performance against the Landlord to enforce the settlement terms. The Landlord filed counterclaims and an unlawful detainer action against the Company, claiming damages of more than $36 million, which the Landlord claims are based on an analysis of accelerated rent due through the end of the term of the Zabala Road Lease, along with attorney’s fees, improvements, and other undefined costs.

 

The Company intends to vigorously defend itself against the claims made by the Landlord. However, no assurance can be provided as to whether or not the Company will prevail, and it may be required to pay significant monetary damages. It is difficult to evaluate the likely outcome of a trial at such an early stage and with competing claims and cross-claims. In addition, due to the early nature of the case, an estimate on a loss cannot be made.

 

A punitive class action was filed on behalf of all California consumers who purchased products made by Lowell Farms, Inc. in California. The case alleges that Lowell failed to accurately label its products with the THC% identified by its testing laboratories, and that California consumers were thereby deceived into paying higher prices for Lowell’s products than they otherwise would have.

 

No trial has been scheduled in this matter. The parties are presently engaged in the process by which Plaintiff will bring a motion seeking certification of a class. If class certification is denied, then Plaintiff will be relegated to his own damages, which is likely just a few hundred dollars, and the case will likely end. If class certification is granted, then the parties will engage in fact discovery and the Court will set a trial date. The class certification motion is scheduled to be heard on August 26, 2024. Plaintiff has served discovery requests limited to class certification issues, but the parties have not engaged in any merits discovery. It is difficult to evaluate any potential outcome at such an early stage of the case where there has been no merits discovery. The Company is prepared to vigorously defend itself at the trial if a class is certified and a settlement is not reached. It is difficult to evaluate the likely outcome of a trial because Plaintiff has not articulated a theory of damages. In addition, due to the early nature of the case, an estimate of a loss cannot be made.

XML 35 R21.htm IDEA: XBRL DOCUMENT v3.24.1
GENERAL AND ADMINISTRATIVE EXPENSES
12 Months Ended
Dec. 31, 2023
GENERAL AND ADMINISTRATIVE EXPENSES  
General And Administrative Expenses

15. GENERAL AND ADMINISTRATIVE EXPENSES

 

For the years ended December 31, 2023 and 2022, general and administrative expenses were comprised of:

 

 

 

Years Ended

 

 

 

December 31,

 

 

December 31,

 

(in thousands)

 

2023

 

 

2022

 

Salaries and benefits

 

$3,229

 

 

$5,286

 

Professional fees

 

 

527

 

 

 

465

 

Share-based compensation

 

 

231

 

 

 

564

 

Insurance

 

 

999

 

 

 

1,344

 

Administrative

 

 

2,316

 

 

 

1,894

 

Total general and administrative expenses

 

$7,302

 

 

$9,553

 

XML 36 R22.htm IDEA: XBRL DOCUMENT v3.24.1
RELATED PARTY TRANSACTIONS
12 Months Ended
Dec. 31, 2023
RELATED PARTY TRANSACTIONS  
Related-Party Transactions

16. RELATED-PARTY TRANSACTIONS

 

Transactions with related parties are entered into in the normal course of business and are measured at the amount established and agreed to by the parties.

 

In April 2015, Lowell entered into a services agreement with Olympic Management Group (“OMG”), for advisory and technology support services, including the access and use of software licensed to OMG to perform certain data processing and enterprise resource planning (ERP) operational services. OMG is owned by one of the Company’s co-founders. The agreement provides for the dollar-for-dollar reimbursement of expenses incurred by OMG in performance of its services. Amounts paid to OMG for the years ended December 31, 2023 and 2022, were $nil and $36, respectively.

 

During October 2022, Cannaco Research Corporation, an existing customer, became a related party when Ms. Lawrence, a new member joined the Board of Directors. Total sales recognized for Cannaco Research Corporation for the years ended December 31, 2023 and 2022 were $487 and $274, respectively. For the years ended December 31, 2023 and 2022, cash collected from Cannaco Research Corporation was $476 and $223, respectively. In December, 2022, the Company entered into an agreement with Cannaco Research Corporation to lease approximately 2,000 square feet of warehouse space in Los Angeles to facilitate distribution services in the area. The lease was a 12 month storage agreement for the warehouse space. Total payments to Cannaco Research Corporation for the lease were $130 and $10 in the years ended December 31, 2023 and December 31,2022, respectively.

XML 37 R23.htm IDEA: XBRL DOCUMENT v3.24.1
SEGMENT INFORMATION
12 Months Ended
Dec. 31, 2023
SEGMENT INFORMATION  
Segment Information

17. SEGMENT INFORMATION

 

The Company's operations are comprised of a single reporting operating segment engaged in the production and sale of cannabis products in the United States. As the operations comprise a single reporting segment, amounts disclosed in the financial statements also represent a single reporting segment.

XML 38 R24.htm IDEA: XBRL DOCUMENT v3.24.1
SUBSEQUENT EVENTS
12 Months Ended
Dec. 31, 2023
SUBSEQUENT EVENTS  
Subsequent Events

18. SUBSEQUENT EVENTS

 

On January 12, 2024, Cypress Holding Company, LLC (“Cypress”), a wholly owned subsidiary of the Company, surrendered possession of approximately 10 acres of real property at 139 Zabala Road, Salinas, California (the “Zabala Road Property”) leased by Cypress pursuant to a Lease Agreement dated April 1, 2017 (the “Zabala Road Lease”) with Tinhouse, LLC, dba Tinhouse Partners, LLC, as landlord (the “Landlord”). Prior to vacating the premises on January 12, 2024, the Company had operated a cultivation facility, which includes four greenhouses totaling approximately 255,000 square feet, on the Zabala Road Property. 

As previously announced, in January 2023, the Company’s Board of Directors formed a strategic alternatives special committee of independent directors to explore, review and evaluate strategic and financial alternatives. As part of these efforts, the Company entered into negotiations with the Landlord to restructure the terms of the Zabala Road Lease, which provided for an expiry date of December 31, 2027, subject to five 5-year extension options exercisable by Cypress.

 

In September 2023, the Company and the Landlord reached a settlement amending the terms of the Zabala Road Lease and reaching agreement on all rent-related issues. The Landlord terminated the Zabala Road Lease via a letter dated October 6, 2023, which was served by its counsel on the Company on October 10, 2023. In October 2023, the Company filed a lawsuit for breach of contract and specific performance against the Landlord to enforce the settlement terms. The Landlord filed counterclaims and an unlawful detainer action against the Company, claiming damages of more than $36 million, which the Landlord claims are based on an analysis of accelerated rent due through the end of the term of the Zabala Road Lease, along with attorney’s fees, improvements, and other undefined costs.

 

The Company has evaluated subsequent events through March 26, 2024, the date the financial statements were available to be issued.

XML 39 R25.htm IDEA: XBRL DOCUMENT v3.24.1
BUSINESS BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)
12 Months Ended
Dec. 31, 2023
BUSINESS BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES  
Business

Lowell Farms Inc. is governed by the laws of British Columbia, Canada. On April 26, 2019, the Company completed a reverse takeover transaction with Indus Holding Company, a Delaware corporation, incorporated in 2014. Effective March 1, 2021, the Company changed its name to Lowell Farms Inc. and is a California-based cannabis company with vertically integrated operations including large scale cultivation, extraction, processing, manufacturing, branding, packaging and wholesale distribution to retail dispensaries. The Company manufactures and distributes proprietary and third-party brands throughout the State of California, the largest cannabis market in the world. The Company also provides manufacturing, extraction and distribution services to third-party cannabis and cannabis branding companies. The Company’s corporate office and principal place of business is located at 19 Quail Run Circle, Salinas, California.

Basis Of Presentation

The consolidated financial statements of Lowell Farms Inc. and its wholly owned subsidiaries (collectively, the “Company,” “we,” “us” or “our”) have been prepared in accordance with generally accepted accounting principles in the United States (“GAAP”). All intercompany transactions and balances have been eliminated in consolidation.

 

All dollar amounts in the consolidated financial statements and notes to consolidated financial statements are expressed in thousands of United States dollars ("$" or "US$"), unless otherwise indicated.

Use Of Estimates

The preparation of financial statements in conformity with generally accepted accounting principles in the United States (“U.S. GAAP”) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Significant estimates in these financial statements include allowance for doubtful accounts and credit losses, carrying value of inventory, revenue recognition, accounting for stock-based compensation expense, and income taxes. Actual results could differ from those estimates.

 

The global COVID-19 pandemic has impacted the operations and purchasing decisions of companies worldwide. It also has created and may continue to create significant uncertainty in the global economy. The Company has undertaken measures to protect its employees, partners, customers, and vendors. In addition, the Company’s personnel are subject to various travel restrictions, which limit the ability of the Company to provide services to customers and affiliates. This impacts the Company's normal operations. To date, the Company has been able to provide uninterrupted access to its products and services, including certain employees that are working remotely, and its pre-existing infrastructure that supports secure access to the Company’s internal systems. If, however, the COVID-19 pandemic has a substantial impact on the productivity of the Company’s employees or its partners’ or customers’ decision to use the Company’s products and services, the results of the Company’s operations and overall financial performance may be adversely impacted. The duration and extent of the impact from the COVID-19 pandemic depends on future developments that cannot be accurately predicted at this time. As of the date of issuance of the financial statements, the Company is not aware of any specific event or circumstance that would require updates to the Company’s estimates and judgments or revisions to the carrying value of its assets or liabilities. These estimates may change, as new events occur and additional information is obtained, and are recognized in the condensed consolidated financial statements as soon as they become known. Actual results could differ from those estimates and any such differences may be material to the financial statements.

Cash and Cash Equivalents

Cash and cash equivalents include cash on hand, cash deposits in financial institutions, and other deposits that are readily convertible into cash. The Company considers all short-term, highly liquid investments purchased with maturities of three months or less to be cash equivalents. These investments are carried at cost, which approximates fair value.

 

As of December 31, 2023 and December 31, 2022, the Company’s cash and cash equivalents exceeded FDIC insured limits by $1,974 and $360, respectively.

Accounts Receivable

Accounts receivables are classified as loans and receivable financial assets. Accounts receivables are recognized initially at fair value and subsequently measured at amortized cost, less any provisions for impairment. When an accounts receivable is uncollectible, it is written off against the provision. Subsequent recoveries of amounts previously written off are credited to the consolidated statements of operations.

Inventories

Inventories are valued at the lower of cost and net realizable value. Costs related to raw materials and finished goods are determined on the first-in, first-out basis. Specific identification and average cost methods are also used primarily for certain packing materials and operating supplies. The Company reviews inventory for obsolete, redundant and slow-moving goods and any such inventory is written-down to net realizable value.

Property and Equipment

Property and equipment are stated at cost, net of accumulated depreciation and impairment losses, if any. Depreciation is calculated on a straight-line basis over the estimated useful life of the asset using the following terms and methods:

 

Category

 

Useful Life

Leasehold improvements

 

The lesser of the estimated useful life or length of the lease

Office equipment

 

3-5 years

Furniture and fixtures

 

3-7 years

Vehicles

 

4-5 years

Machinery and equipment

 

3-6 years

Buildings

 

35 years

Construction in progress

 

Not depreciated

 

The assets’ residual values, useful lives and methods of depreciation are reviewed at each financial year-end and adjusted prospectively if appropriate. An item of equipment is derecognized upon disposal or when no future economic benefits are expected from its use. Any gain or loss arising on derecognition of the asset (calculated as the difference between the net disposal proceeds and the carrying value of the asset) is included in the consolidated statements of operations in the year the asset is derecognized.

Goodwill

Goodwill represents the excess of the purchase price paid for the acquisition of an entity over the fair value of the net tangible and intangible assets acquired. Goodwill that has an indefinite useful life is not subject to amortization and is tested annually for impairment, or more frequently if events or changes in circumstances indicate that goodwill might be impaired. Any goodwill impairment loss is recognized in the consolidated statements of operations in the period in which the impairment is identified. Impairment losses on goodwill are not subsequently reversed.

Intangible Assets

Intangible assets are recorded at cost, less accumulated amortization and impairment losses, if any. Intangible assets acquired in a business combination are measured at fair value at the acquisition date. Intangible assets acquired in an asset purchase are valued at their purchase price. Amortization is recorded on a straight-line basis over their estimated useful lives, which do not exceed the contractual period, if any. The estimated useful lives, residual values, and amortization methods are reviewed at each year-end, and any changes in estimates are accounted for prospectively.

 

Branding rights are measured at fair value at the time of acquisition and are amortized on a straight-line basis over a period of 15 years. In addition, the Company has certain brand and tradenames with indefinite lives, which are evaluated for impairment on an annual basis.

Impairment of Long-lived Assets

Long-lived assets, including property, plant and equipment and intangible assets are reviewed for impairment at each statement of financial position date or whenever events or changes in circumstances indicate that the carrying amount of an asset exceeds its recoverable amount. For the purpose of impairment testing, assets that cannot be tested individually are grouped together into the smallest group of assets that generates cash inflows from continuing use that are largely independent of the cash inflows of other assets or groups of assets. The recoverable amount of an asset or an asset group is the higher of its fair value, less costs to sell, and its value in use. If the carrying amount of an asset exceeds its recoverable amount, an impairment charge is recognized immediately in profit or loss equal to the amount by which the carrying amount exceeds the recoverable amount. Where an impairment loss subsequently reverses, the carrying amount of the asset is increased to the lesser of the revised estimate of the recoverable amount, and the carrying amount that would have been recorded had no impairment loss been recognized previously.

Leased Assets

The Company adopted FASB Topic 842, Leases (“Topic 842”) effective January 1, 2019, using the modified retrospective adoption method which allowed it to initially apply the new standard at the adoption date and recognize a cumulative-effect adjustment to the opening balance of accumulated deficit. In connection with the adoption of the lease pronouncement, the Company recorded a charge to accumulated deficit of $847. A lease of property and equipment is classified as a capital lease if it transfers substantially all the risks and rewards incidental to ownership to the Company. Lease right-of-use assets represent the right to use an underlying asset for the lease term, and lease liabilities represent the obligation to make payments arising from the lease agreement. These assets and liabilities are recognized at the commencement of the lease based upon the present value of the future minimum lease payments over the lease term. The lease term reflects the noncancelable period of the lease together with periods covered by an option to extend or terminate the lease when management is reasonably certain that it will exercise such option. Changes in the lease term assumption could impact the right-of-use assets and lease liabilities recognized on the balance sheet. As our leases typically do not contain a readily determinable implicit rate, we determine the present value of the lease liability using our incremental borrowing rate at the lease commencement date based on the lease term on a collateralized basis.

 

The Company accounts for sales leaseback transactions in accordance with ASC 842-40: Sale and Leaseback Transactions. The Company determines whether the transfer of an asset represents a sale based on requirements from Topic 606, lease classification, and nature of purchase options. If a transfer is deemed a sale and at fair value, the Company derecognizes the asset and records a gain/(loss) in the income statement. If a transfer is deemed a sale and not at fair value, the Company derecognizes the asset and does not recognize a gain/(loss) in the income statement. If a transfer of the asset is not a sale, the Company does not derecognize the asset.

Income Taxes

The Company is a United States C corporation for income tax purposes. Income tax expense consisting of current and deferred tax expense is recognized in the consolidated statements of operations. Current tax expense is the expected tax payable on the taxable income for the year, using tax rates enacted or substantively enacted at year-end, adjusted for amendments to tax payable with regards to previous years. Deferred tax assets and liabilities and the related deferred income tax expense or recovery are recognized for deferred tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using the enacted or substantively enacted tax rates expected to apply when the asset is realized or the liability settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that substantive enactment occurs. A deferred tax asset is recognized to the extent that it is probable that future taxable income will be available against which the asset can be utilized. Deferred tax assets and liabilities are offset when there is a legally enforceable right to set off current tax assets against current tax liabilities and when they relate to income taxes levied by the same taxation authority and the Company intends to settle its current tax assets and liabilities on a net basis.

Revenue Recognition

Revenue is recognized upon transfer of control of promised products or services to customers in an amount that reflects the consideration the Company expects to receive in exchange for those products or services. The Company enters contracts that can include various combinations of products and services, which are generally capable of being distinct and accounted for as separate performance obligations Revenue is recognized net of allowances for returns and any taxes collected from customers, which are subsequently remitted to governmental authorities.

Branded Products

For the Company’s branded products, revenue is recognized when it satisfies a performance obligation by transferring a promised cannabis good to a customer. A contract, whether a verbal or written sales order, is established with customers prior to order fulfillment with agreement upon unit prices, delivery dates, and payment terms. The transaction price is based on market pricing while considering the value of the Company’s brand and quality. Transaction price is allocated to each product sold based upon the negotiated unit sales price associated with each product line scheduled for delivery within the order. Performance obligation satisfaction occurs upon delivery to customer premises. These types of revenues accounted for under ASC Topic 606, generally, do not require significant estimates or judgments based on the nature of the Company’s revenue stream. The sales prices, including discounts, are fixed at the point of sale and all consideration from contracts is included in the transaction price. The Company’s contracts do not include multiple performance obligations or material variable consideration.

Third Party Manufactured Products

The Company has certain licenses to manufacture and distribute third party products to retail dispensaries and deliveries in return for paying royalty payments to the third parties. The Company is a principal in the arrangement, it assumes primary responsibility for fulfilling the customer promise to retail dispensaries and deliveries, and it holds the inventory risk. Revenue is recognized when it satisfies a performance obligation by transferring a promised cannabis good to a retail dispensary or retail delivery. A contract, whether a verbal or written sales order, is established with customers prior to order fulfillment with agreement upon unit prices, delivery dates, and payment terms. The transaction price is based on market pricing while considering the value of the Company’s brand and quality. Transaction price is allocated to each product sold based upon the negotiated unit sales price associated with each product line scheduled for delivery within the order. Performance obligation satisfaction occurs upon delivery to customer premises. These types of revenues accounted for under ASC Topic 606, generally, do not require significant estimates or judgments based on the nature of the Company’s revenue stream. The sales prices, including discounts, are fixed at the point of sale and all consideration from contracts is included in the transaction price. The Company’s contracts do not include multiple performance obligations or material variable consideration.

Licensing

The Company has entered into contracts to license the right to utilize the Company’s branding and intellectual property. For all sales utilizing the license, the Company recognizes a percentage based license fee. Revenue is recognized when performance obligations are satisfied by recognizing fees on sales utilizing the licensed property to other companies. Contracts exist that define the property that is licensed, the time period, the fees and payment terms. These types of revenues accounted for under ASC Topic 606, generally, do not require significant estimates or judgments based on the nature of the Company’s revenue stream.

Distribution

The Company distributes certain third-party brands and bulk flower. The Company is a principal in the arrangement, it assumes primary responsibility for fulfilling the customer promise to retail dispensaries and deliveries and other wholesale customers, and it holds the inventory risk. Revenue is recognized when it satisfies a performance obligation by transferring a promised cannabis good to a customer. A contract, whether a verbal or written sales order, is established with customers prior to order fulfillment with agreement upon unit prices, delivery dates, and payment terms. The transaction price is based on market pricing while considering the value of the Company’s brand and quality. Transaction price is allocated to each product sold based upon the negotiated unit sales price associated with each product line scheduled for delivery within the order. Performance obligation satisfaction occurs upon delivery to customer premises. These types of revenues accounted for under ASC Topic 606, generally, do not require significant estimates or judgments based on the nature of the Company’s revenue stream. The sales prices, including discounts, are fixed at the point of sale and all consideration from contracts is included in the transaction price. The Company’s contracts do not include multiple performance obligations or material variable consideration.

Lowell Farms Services

The Company performs various processing activities under Lowell Farms Services including drying, bucking, trimming, sorting, grading and packaging operations. Revenue is recognized when it satisfies a performance obligation by completing the agreed upon services that were negotiated with a customer. A contract, whether a verbal or written sales order, is established with customers prior to completing the agreed upon services with the type of services to be performed and with the agreed upon pricing and timing. The transaction price is based on the nature of the services to be performed and market pricing. Performance obligation satisfaction occurs upon completion of the services performed. These types of revenues accounted for under ASC Topic 606, generally, do not require significant estimates or judgments based on the nature of the Company’s revenue stream. The Company’s contracts do not include multiple performance obligations or material variable consideration.

Research and Development

Research costs are expensed as incurred. For the years ended December 31, 2023 and 2022, research costs are immaterial.

 

For the year ended December 31, 2022, the Company incurred certain development expenditures related to the Lowell 35s product line that launched during the third quarter of the year ended December 31, 2022. Development costs of approximately $78 were expensed during the year ended December 31, 2022 to validate that the product line was commercially and technically feasible and to bring the product to market. Development expenditures are capitalized only if development costs are material, can be measured reliably, future economic benefits are probable, and the Company intends to and has sufficient resources to complete the development to use or sell the asset. To date, no development costs have been capitalized.

Share-Based Compensation

The Company has a share-based compensation plan. The Company measures equity settled share-based payments based on their fair value at the grant date and recognizes compensation expense over the vesting period based on the Company’s estimate of equity instruments that will eventually vest.

 

For shares granted to non-employees, the compensation expense is measured at the fair value of the goods and services received, except where the fair value cannot be estimated, in which case, it is measured at the fair value of the equity instruments granted. The fair value of share-based compensation to non-employees is periodically re-measured until counterparty performance is complete, and any change therein is recognized over the period and in the same manner as if the Company had paid cash instead of paying with or using equity instruments.

Business Combinations

A business combination is defined as an acquisition of assets and liabilities that constitute a business. A business consists of inputs, including non-current assets and processes, including operational processes, that when applied to those inputs have the ability to create outputs that provide a return to the Company. Business combinations are accounted for using the acquisition method of accounting. The consideration of each acquisition is measured at the aggregate of the fair values of tangible and intangible assets obtained, liabilities and contingent liabilities incurred or assumed, and equity instruments issued by the Company at the date of acquisition. Key assumptions routinely utilized in allocation of purchase price to intangible assets include projected financial information such as revenue projections for companies acquired. As of the acquisition date, goodwill is measured as the excess of consideration given, generally measured at fair value, and the net of the acquisition date fair values of the identifiable assets acquired and the liabilities assumed.

Recently Adopted Accounting Standards

In December 2019, the FASB issued ASU 2019-12, Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes. This guidance removes certain exceptions to the general principles in Topic 740 and enhances and simplifies various aspects of the income tax accounting guidance, including requirements such as tax basis step-up in goodwill obtained in a transaction that is not a business combination, ownership changes in investments, and interim-period accounting for enacted changes in tax law. This standard is effective for fiscal years and interim periods within those fiscal years beginning after December 15, 2020. This guidance was effective for the Company in our fiscal year and interim periods beginning on January 1, 2021 and did not have a material impact on our consolidated financial statements.

 

In January 2020, the FASB issued ASU 2020-01 Investments-Equity Securities (Topic 321), Investments-Equity Method and Joint Ventures (Topic 323), and Derivatives and Hedging (Topic 815) - Clarifying the Interactions between Topic 321, Topic 323, and Topic 815. This guidance addresses accounting for the transition into and out of the equity method and provides clarification of the interaction of rules for equity securities, the equity method of accounting, and forward contracts and purchase options on certain types of securities. This standard is effective for fiscal years and interim periods within those fiscal years beginning after December 15, 2020. We evaluated the impact of ASU 2020-01 on our Consolidated Financial Statements, which was effective for the Company in our fiscal year and interim periods beginning on January 1, 2021 and it did not have a material impact on our consolidated financial statements.

 

In August 2020, the FASB issued ASU 2020-06, Debt-Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging-Contracts in Entity’s Own Equity (Subtopic 815-40). This update amends the guidance on convertible instruments and the derivatives scope exception for contracts in an entity's own equity and improves and amends the related EPS guidance for both Subtopics. This standard is effective for fiscal years and interim periods within those fiscal years beginning after December 15, 2021, which means it was effective for our fiscal year beginning January 1, 2022 and did not have a material impact on our consolidated financial statements.

Accounting standards not yet adopted

In October 2021, the FASB issued ASU 2021-08-Business Combinations (“Topic 805”): Accounting for Contract Assets and Contract Liabilities from Contracts with Customers. The amendments in ASU 2021-08 require that an entity recognizes and measures contract assets and contract liabilities acquired in a business combination in accordance with ASC 606, Revenue from Contracts with Customers (“Topic 606”). At the acquisition date, an acquirer should account for the related revenue contracts in accordance with Topic 606 as if it had originated the contracts. The amendments improve comparability for both the recognition and measurement of acquired revenue contracts with customers at the date of and after a business combination. This standard is effective for fiscal years and interim periods within those fiscal years beginning after December 15, 2022, which means it was effective for our fiscal year beginning January 1, 2023 and did not have a material impact on our consolidated financial statements.

 

No other recently issued accounting pronouncements had or are expected to have a material impact on our consolidated financial statements.

XML 40 R26.htm IDEA: XBRL DOCUMENT v3.24.1
BUSINESS BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)
12 Months Ended
Dec. 31, 2023
BUSINESS BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES  
Schedule Of Property and equipment estimated useful life Category Useful LifeLeasehold improvements The lesser of the estimated useful life or length of the lease Office equipment 3-5 yearsFurniture and fixtures 3-7 yearsVehicles 4-5 yearsMachinery and equipment 3-6 yearsBuildings 35 yearsConstruction in progress Not depreciated
XML 41 R27.htm IDEA: XBRL DOCUMENT v3.24.1
PREPAID AND OTHER CURRENT ASSETS (Tables)
12 Months Ended
Dec. 31, 2023
PREPAID AND OTHER CURRENT ASSETS  
Summary Of Prepaid Expenses And Other Current Assets

 

 

December 31,

 

 

December 31,

 

(in thousands)

 

2023

 

 

2022

 

Deposits

 

$1,134

 

 

$595

 

Insurance

 

 

237

 

 

 

235

 

Supplier advances

 

 

26

 

 

 

375

 

Interest and taxes

 

 

26

 

 

 

69

 

Licenses and payments

 

 

106

 

 

 

146

 

Royalty Advance

 

 

853

 

 

 

-

 

Other

 

 

15

 

 

 

102

 

Total prepaid and other current assets

 

$2,397

 

 

$1,522

 

XML 42 R28.htm IDEA: XBRL DOCUMENT v3.24.1
INVENTORY (Tables)
12 Months Ended
Dec. 31, 2023
INVENTORY  
Summary Of Inventory

 

 

December 31,

 

 

December 31,

 

(in thousands)

 

2023

 

 

2022

 

Raw materials

 

$1,400

 

 

$7,431

 

Work in process

 

 

307

 

 

 

940

 

Finished goods

 

 

3,053

 

 

 

2,408

 

Total inventory

 

$4,760

 

 

$10,779

 

XML 43 R29.htm IDEA: XBRL DOCUMENT v3.24.1
OTHER CURRENT LIABILITIES (Tables)
12 Months Ended
Dec. 31, 2023
OTHER CURRENT LIABILITIES  
Schedule Of Other Current Liabilities

 

 

December 31,

 

 

December 31,

 

(in thousands)

 

2023

 

 

2022

 

Excise and cannabis tax

 

$3

 

 

$948

 

Third party brand distribution accrual

 

 

558

 

 

 

17

 

Insurance and professional fee accrual

 

 

287

 

 

 

158

 

Interest and tax accrual

 

 

109

 

 

 

921

 

Employee Retention Credit financing accrual

 

 

441

 

 

 

441

 

Equipment purchase accrual

 

 

-

 

 

 

724

 

Other

 

 

545

 

 

 

445

 

Total other current liabilities

 

$1,943

 

 

$3,654

 

XML 44 R30.htm IDEA: XBRL DOCUMENT v3.24.1
PROPERTY AND EQUIPMENT AND RIGHT OF USE ASSETS (Tables)
12 Months Ended
Dec. 31, 2023
PROPERTY AND EQUIPMENT AND RIGHT OF USE ASSETS  
Schedule Of Property And Equipment And Right Of Use Assets

 

 

Land and

 

 

Leasehold

 

 

Furniture

and

 

 

 

 

 

 

Construction

 

 

Right of

 

 

 

(in thousands)

 

Buildings

 

 

Improvements

 

 

Fixtures

 

 

Equipment

 

 

Vehicles

 

 

in Process

 

 

Use Assets

 

 

Total

 

Costs

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Balance-December 31, 2022

 

$15,719

 

 

$12,437

 

 

$50

 

 

$6,499

 

 

$830

 

 

$35

 

 

$37,081

 

 

$72,651

 

Additions

 

 

-

 

 

 

29

 

 

 

-

 

 

 

106

 

 

 

-

 

 

 

-

 

 

 

17,068

 

 

 

17,203

 

Disposals

 

 

(15,719 )

 

 

(202 )

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

(15,921

Remeasurements

 

 

-

 

 

 

-

 

 

 

 

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

(4,602 )

 

 

(4,602)

Impairments

 

 

-

 

 

 

(10,148 )

 

 

-

 

 

 

(1,310 )

 

 

-

 

 

 

-

 

 

 

(28,230 )

 

 

(39,688

 

Balance-December 31, 2023

 

$-

 

 

$2,116

 

 

$50

 

 

$5,295

 

 

$830

 

 

$35

 

 

$21,317

 

 

$29,643

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Accumulated Depreciation

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Balance-December 31, 2022

 

$(315 )

 

$(1,815 )

 

$(49 )

 

$(1,498 )

 

$(608 )

 

$-

 

 

$(9,719 )

 

$(14,004

Depreciation

 

 

(71 )

 

 

(837 )

 

-

 

 

 

(925 )

 

 

(136 )

 

 

-

 

 

 

(2,742 )

 

 

(4,711

Disposals

 

 

386

 

 

 

55

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

441

 

Remeasurement

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

2,661

 

 

 

2,661

 

Impairments

 

 

-

 

 

 

1,516

 

 

 

-

 

 

 

70

 

 

-

 

 

 

-

 

 

 

6,810

 

 

 

8,396

 

Balance-December 31, 2023

 

$

 -

 

 

$(1,081 )

 

$(49 )

 

$(2,353 )

 

$(744 )

 

$-

 

 

$(2,990 )

 

$(7,217

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net Book Value-December 31, 2023

 

$-

 

 

$1,035

 

 

$1

 

 

$2,942

 

 

$86

 

 

$35

 

 

$18,327

 

 

$22,426

 

XML 45 R31.htm IDEA: XBRL DOCUMENT v3.24.1
INTANGIBLE ASSETS (Tables)
12 Months Ended
Dec. 31, 2023
INTANGIBLE ASSETS (Tables)  
Schedule Of Intangible Assets

 

 

Definite Life Intangibles

 

 

Indefinite Life

 

 

 

 

 

Technology/

 

 

Acquired

Purchase

 

 

Intangibles

Brands &

 

 

 

(in thousands)

 

Know How

 

 

Rights

 

 

Tradenames

 

 

Total

 

Costs

 

 

 

 

 

 

 

 

 

 

 

 

Balance-December 31, 2022

 

$3,258

 

 

$1,800

 

 

$37,707

 

 

$42,765

 

Sale of Brand Assets

 

 

 

 

 

 

 

 

 

 

(24,053 )

 

 

(37,299 )

Impairment

 

 

(258 )

 

 

(1,384

)

 

 

(13,654

 

 

(2,050

Balance-December 31, 2023

 

$3,000

 

 

$416

 

 

$-

 

 

$3,416

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Accumulated Amortization

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Balance-December 31, 2022

 

$(535 )

 

$(28 )

 

$-

 

 

$(563 )

Amortization

 

 

(323 )

 

 

(83 )

 

 

-

 

 

 

(406 )

     Impairment

 

 

 97

 

 

 

 -

 

 

 

 

 

 

 

 97

 

Balance-December 31, 2023

 

$(761 )

 

$(111 )

 

$-

 

 

$(872 )

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net Book Value

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

December 31, 2022

 

$2,723

 

 

$1,772

 

 

$37,707

 

 

$42,202

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net Book Value

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

December 31, 2023

 

$2,239

 

 

$305

 

 

$-

 

 

$2,544

 

XML 46 R32.htm IDEA: XBRL DOCUMENT v3.24.1
SHAREHOLDERS EQUITY (Tables)
12 Months Ended
Dec. 31, 2023
SHAREHOLDERS EQUITY  
Schedule Of Shares Outstanding

 

 

Subordinate

 

 

Super

 

(in thousands)

 

Voting Shares

 

 

Voting Shares

 

Balance-December 31, 2022

 

 

12,177

 

 

 

20

 

Issuance of vested restricted stock units

 

 

4

 

 

 

-

 

Issuance of shares in convertible debt conversion

 

 

6,843

 

 

 

-

 

Balance-December 31, 2023

 

 

19,024

 

 

 

20

 

Schedule Of Warrants Outstanding

(in thousands)

 

 

 

Balance-December 31, 2022

 

 

17,343

 

Warrants canceled in conjunction with convertible debt conversion

 

 

(15,052)

Warrants expired

 

 

(1,165 )

Balance-December 31, 2023

 

 

1,126

 

XML 47 R33.htm IDEA: XBRL DOCUMENT v3.24.1
DEBT (Tables)
12 Months Ended
Dec. 31, 2023
DEBT  
Schedule Of Debt

 

 

December 31,

 

 

December 31,

 

(in thousands)

 

2023

 

 

2022

 

Current portion of long-term debt

 

 

 

 

 

 

Vehicle loans(1)

 

$3

 

 

$15

 

Mortgage payable(2)

 

 

-

 

 

 

257

 

Note payable

 

 

-

 

 

 

10

 

Convertible debt(3)

 

 

-

 

 

 

21,398

 

Total short-term debt

 

 

3

 

 

 

21,680

 

 

 

 

 

 

 

 

 

 

Long-term debt, net

 

 

 

 

 

 

 

 

Vehicle loans(1)

 

 

-

 

 

 

3

 

Mortgage payable(2)

 

 

-

 

 

 

8,713

 

Convertible debenture(3)

 

 

-

 

 

 

-

 

Total long-term debt

 

 

-

 

 

 

8,716

 

Total Indebtedness

 

$3

 

 

$30,396

 

Schedule Of Maturities Of Debt Obligations

 

 

December 31,

 

(in thousands)

 

2023

 

2024

 

$3

 

Total debt obligations

 

$3

 

XML 48 R34.htm IDEA: XBRL DOCUMENT v3.24.1
LEASES (Tables)
12 Months Ended
Dec. 31, 2023
LEASES  
Schedule Of Lease Obligations

(in thousands)

 

 

 

 

 

 

Lease obligation

 

 Operating Leases

 

 

Finance Leases 

 

 

Total

 

December 31, 2022

 

$-

 

 

 

33,999

 

 

 

33,999

 

Sale leaseback addition

 

 

17,068

 

 

 

-

 

 

 

17,068

 

Lease principal payments

 

 

(443)

 

 

(1,527)

 

 

(1,970

Lease remeasurement

 

 

(2,064)

 

 

-

 

 

 

(2,064

 

Lease settlement

 

 

-

 

 

 

(1,202)

 

 

(1,202

Lease termination

 

 

-

 

 

 (26,319

)

 

 

(26,319

)

Operating lease remeasurement classification

 

 

4,841

 

 

(4,841

 

 

-

 

December 31, 2023

 

$19,402

 

 

 

110

 

 

 

19,512

 

Schedule Of Lease Expense

 

 

Years Ended

 

Finance Leases

 

December 31,

 

 

December 31,

 

(in thousands)

 

2023

 

 

2022

 

Amortization of leased assets (1)

 

$1,651

 

 

$3,755

 

Interest on lease liabilities (2)

 

 

1,651

 

 

 

2,219

 

Total

 

$3,316

 

 

$5,974

 

 

 

Years Ended

 

Operating Leases

 

December 31,

 

 

December 31,

 

(in thousands)

 

2023

 

 

2022

 

Amortization of leased assets (1)

 

$

1,091

 

 

$

-

 

Interest on lease liabilities (1)

 

 

1,326

 

 

 

-

 

Total

 

$

2,417

 

 

$

-

 

____________

Schedule of future lease payments

 

 

December 31,

 

(in thousands)

 

2023

 

2024

 

 

3,285

 

2025

 

 

3,258

 

2026

 

 

3,240

 

2027

 

 

3,324

 

2028 and beyond

 

 

52,341

 

Total lease payments

 

$65,448

Less imputed interest

 

 

(45,936)

Total

 

$19,512

 

XML 49 R35.htm IDEA: XBRL DOCUMENT v3.24.1
SHARE BASED COMPENSATION (Tables)
12 Months Ended
Dec. 31, 2023
SHARE BASED COMPENSATION  
Schedule Of Share-based Compensation Expense

 

 

Years Ended

 

 

 

December 31,

 

 

December 31,

 

(in thousands)

 

2023

 

 

2022

 

Cost of goods sold

 

$-

 

 

$-

 

General and administrative expense

 

 

231

 

 

 

564

 

Total share-based compensation

 

$231

 

 

$564

 

Schedule Of Stock Option Activity

 

 

 

 

Weighted-

 

 

Weighted-

Average

 

 

 

 

 

 

 

Average

 

 

Remaining

 

 

Aggregate

 

(in thousands except per share amounts)

 

Stock

Options

 

 

Exercise

Price

 

 

Contractual

Life

 

 

Intrinsic

Value

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Outstanding-December 31, 2022

 

 

1,007

 

 

$4.7

 

 

 

4.6

 

 

 

-

 

Granted

 

 

828

 

 

 

0.3

 

 

 

 

 

 

 

-

 

Expired

 

 

(28)

 

 

20.4

 

 

 

 

 

 

 

-

 

Cancelled

 

 

(354)

 

 

4.6

 

 

 

 

 

 

 

-

 

Outstanding-December 31, 2023

 

 

1,453

 

 

 

1.9

 

 

 

5.3

 

 

 

-

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Exercisable-December 31, 2023

 

 

988

 

 

 

2.09

 

 

 

5.2

 

 

 

-

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Vested and expected to vest-December 31, 2023

 

 

1,453

 

 

 

1.91

 

 

 

5.3

 

 

 

-

 

Schedule Of Restricted Stock Unit Activity

 

 

 

 

Weighted-Average

 

(in thousands except per share amounts)

 

RSUs

 

 

Fair Value

 

 

 

 

 

 

 

 

Outstanding-December 31, 2022

 

 

21

 

 

$1.10

 

Granted

 

 

-

 

 

-

 

Vested

 

(4

)

 

 

-

 

Cancelled

 

 

(17 )

 

 

1.02

 

Outstanding-December 31, 2023

 

 

-

 

 

$-

 

Schedule Of Weighted Average Assumptions

Options

 

Years Ended

 

 

 

December 31,

 

 

December 31,

 

 

 

2023

 

 

2022

 

Expected volatility

 

 

50%

 

 

50%

Dividend yield

 

 

0%

 

 

0%

Risk-free interest rate

 

 

4.12%

 

 

2.48%

Expected term in years

 

 

5.58

 

 

 

3.9

 

XML 50 R36.htm IDEA: XBRL DOCUMENT v3.24.1
INCOME TAXES (Tables)
12 Months Ended
Dec. 31, 2023
INCOME TAXES  
Schedule Of income tax expense

 

 

Years Ended

 

(in thousands)

 

2023

 

 

2022

 

Current

 

 

 

 

 

 

Federal

 

$-

 

 

$-

 

State

 

 

161

 

 

 

191

 

Total Current

 

 

191

 

 

 

191

 

 

 

 

 

 

 

 

 

 

Deferred tax benefit

 

 

 

 

 

 

 

 

Federal

 

 

(1,615 )

 

 

(1,987 )

State

 

 

(3,111 )

 

 

(15,293)

Total deferred tax benefit

 

 

(4,726 )

 

 

(17,280 )

 

 

 

 

 

 

 

 

 

Valuation allowance

 

 

4,726

 

 

 

17,280

 

 

 

 

 

 

 

 

 

 

Income tax expense

 

$161

 

 

$191

 

Schedule Of deferred tax assets and liabilities

 

 

Years Ended

 

(in thousands)

 

2023

 

 

2022

 

Deferred tax assets

 

 

 

 

 

 

Net operating loss carryforwards

 

$23,323

 

 

$17,038

 

Accruals and reserves

 

 

-

 

 

 

-

 

Depreciation

 

 

-

 

 

 

-

 

Other

 

 

-

 

 

 

-

 

Valuation allowance

 

 

(23,323 )

 

 

(17,038 )

Total deferred tax assets

 

 

-

 

 

 

-

 

 

 

 

 

 

 

 

 

 

Accruals and reserves

 

 

-

 

 

 

-

 

Share-based compensation

 

 

-

 

 

 

-

 

Total deferred tax liabilities

 

 

-

 

 

 

-

 

 

 

 

 

 

 

 

 

 

Net deferred tax liabilities

 

$-

 

 

$-

 

XML 51 R37.htm IDEA: XBRL DOCUMENT v3.24.1
NET INCOME (LOSS) PER SHARE (Tables)
12 Months Ended
Dec. 31, 2023
Net loss per share:  
Schedule Of Net Earnings/(loss) Per Share

 

 

Years Ended

 

 

 

December 31,

 

 

December 31,

 

(in thousands except per share amounts)

 

2023

 

 

2022

 

Net loss

 

$(37,342 )

 

$(24,677 )

 

 

 

 

 

 

 

 

 

Net loss per share:

 

 

 

 

 

 

 

 

Basic

 

$(2.71 )

 

$(2.17 )

Diluted

 

$(2.71 )

 

$(2.17 )

Weighted average shares outstanding:

 

 

 

 

 

 

 

 

Basic

 

 

13,790

 

 

 

11,318

 

Diluted

 

 

13,790

 

 

 

11,318

 

 

 

 

 

 

 

 

 

 

Weighted average potentially diluted shares (1):

 

 

 

 

 

 

 

 

Basic shares

 

 

13,790

 

 

 

11,318

 

Options

 

 

-

 

 

 

-

 

Warrants

 

 

-

 

 

 

-

 

Convertible debentures

 

 

-

 

 

 

-

 

Restricted stock units

 

 

-

 

 

 

-

 

Total weighted average potentially diluted shares:

 

 

13,790

 

 

 

11,318

 

XML 52 R38.htm IDEA: XBRL DOCUMENT v3.24.1
GENERAL AND ADMINISTRATIVE EXPENSES (Tables)
12 Months Ended
Dec. 31, 2023
GENERAL AND ADMINISTRATIVE EXPENSES  
Schedule Of General And Administrative Expense

 

 

Years Ended

 

 

 

December 31,

 

 

December 31,

 

(in thousands)

 

2023

 

 

2022

 

Salaries and benefits

 

$3,229

 

 

$5,286

 

Professional fees

 

 

527

 

 

 

465

 

Share-based compensation

 

 

231

 

 

 

564

 

Insurance

 

 

999

 

 

 

1,344

 

Administrative

 

 

2,316

 

 

 

1,894

 

Total general and administrative expenses

 

$7,302

 

 

$9,553

 

XML 53 R39.htm IDEA: XBRL DOCUMENT v3.24.1
BUSINESS, BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details)
12 Months Ended
Dec. 31, 2023
Buildings [Member]  
Estimated useful life 35 years
Office equipment [Member] | Minimum [Member]  
Estimated useful life 3 years
Office equipment [Member] | Maximum [Member]  
Estimated useful life 5 years
Furniture and fixtures [Member] | Minimum [Member]  
Estimated useful life 3 years
Furniture and fixtures [Member] | Maximum [Member]  
Estimated useful life 7 years
Vehicles [Member] | Minimum [Member]  
Estimated useful life 4 years
Vehicles [Member] | Maximum [Member]  
Estimated useful life 5 years
Machinery and equipment [Member] | Minimum [Member]  
Estimated useful life 3 years
Machinery and equipment [Member] | Maximum [Member]  
Estimated useful life 6 years
Leasehold improvements [Member]  
Description of useful life The lesser of the estimated useful life or length of the lease
Construction in Process  
Description of useful life Not depreciated
XML 54 R40.htm IDEA: XBRL DOCUMENT v3.24.1
BUSINESS, BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) - USD ($)
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Feb. 28, 2016
BUSINESS BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES      
Changes in adoption accumulated deficit $ 847,000   $ 847,000
Development costs   $ 78,000  
Cash FDIC Insured Amount $ 1,974,000 $ 360,000  
Straight line basis 15 years    
XML 55 R41.htm IDEA: XBRL DOCUMENT v3.24.1
PREPAID AND OTHER CURRENT ASSETS (Details) - USD ($)
$ in Thousands
Dec. 31, 2023
Dec. 31, 2022
PREPAID AND OTHER CURRENT ASSETS    
Deposits $ 1,134 $ 595
Insurance 237 235
Supplier Advances 26 375
Interest And Taxes 26 69
Licenses and payments 106 146
Royalty Advance 853 0
Other 15 102
Prepaid Expenses And Other Current Assets $ 2,397 $ 1,522
XML 56 R42.htm IDEA: XBRL DOCUMENT v3.24.1
INVENTORY (Details) - USD ($)
$ in Thousands
Dec. 31, 2023
Dec. 31, 2022
INVENTORY    
Raw Materials $ 1,400 $ 7,431
Work In Process 307 940
Finished Goods 3,053 2,408
Inventory $ 4,760 $ 10,779
XML 57 R43.htm IDEA: XBRL DOCUMENT v3.24.1
INVENTORY (Details Narrative) - USD ($)
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
INVENTORY    
Inventory reserve $ 1,780 $ 1,492
Inventory write off $ 2,607  
XML 58 R44.htm IDEA: XBRL DOCUMENT v3.24.1
Other current liabilities (Details) - USD ($)
$ in Thousands
Dec. 31, 2023
Dec. 31, 2022
OTHER CURRENT LIABILITIES    
Excise And Cannabis Tax $ 3 $ 948
Third Party Brand Distribution Accrual 558 17
Insurance And Professional Accrual 287 158
Interest and tax accrual 109 921
Employee Retention Credit financing accrual 441 441
Equipment purchase accrual 0 724
Other 545 445
Total Other Current Liabilities $ 1,943 $ 3,654
XML 59 R45.htm IDEA: XBRL DOCUMENT v3.24.1
Other current liabilities (Details Narrative) - E R C Claim [Member] - On Twenty Six July Two Thousand Twenty Two [Member] - USD ($)
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Purchase of derivative payment rights $ 2,446,000  
Other income   $ 2,014
Accrued other liability   441
Interest Expense   $ 864
XML 60 R46.htm IDEA: XBRL DOCUMENT v3.24.1
PROPERTY AND EQUIPMENT AND RIGHT OF USE ASSETS (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Additions $ 17,203  
Disposal (15,921)  
Remeasurements (4,602)  
Impairments (39,688)  
Property And Equipment Cost, Ending 29,643 $ 72,651
Accumulated Depreciation, Beginning (14,004)  
Depreciation (4,711) (7,022)
Accumulated amortization disposals 441  
Accumulated amortization remeasurement 2,661  
Accumulated amortization impairments 8,396  
Accumulated Depreciation, Ending (7,217)  
Net Book Value 22,426  
Property And Equipment Cost, Beginning 72,651  
Net Book Value 4,099 31,284
Remeasurements 8,632  
Construction in Process    
Additions 0  
Disposal 0  
Impairments 0  
Property And Equipment Cost, Ending 35 35
Accumulated Depreciation, Beginning 0  
Depreciation 0  
Accumulated amortization disposals 0  
Accumulated amortization remeasurement 0  
Accumulated amortization impairments 0  
Accumulated Depreciation, Ending 0  
Property And Equipment Cost, Beginning 35  
Remeasurements 0  
Net Book Value 35  
Remeasurements 0  
Leasehold Improvements    
Additions 29  
Disposal (202)  
Impairments (10,148)  
Property And Equipment Cost, Ending 2,116 12,437
Accumulated Depreciation, Beginning 1,815  
Depreciation (837)  
Accumulated amortization disposals 55  
Accumulated amortization remeasurement 0  
Accumulated amortization impairments 1,516  
Accumulated Depreciation, Ending 1,081  
Property And Equipment Cost, Beginning 12,437  
Remeasurements 0  
Net Book Value 1,035  
Remeasurements 0  
Land And Buildings [Member]    
Additions 0  
Disposal (15,719)  
Impairments 0  
Property And Equipment Cost, Ending 0 15,719
Accumulated Depreciation, Beginning (315)  
Depreciation (71)  
Accumulated amortization disposals 386  
Accumulated amortization remeasurement 0  
Accumulated amortization impairments 0  
Accumulated Depreciation, Ending 0  
Property And Equipment Cost, Beginning 15,719  
Remeasurements 0  
Net Book Value 0  
Remeasurements 0  
Furniture and fixtures [Member]    
Additions 0  
Disposal 0  
Impairments 0  
Property And Equipment Cost, Ending 50 50
Accumulated Depreciation, Beginning (49)  
Depreciation 0  
Accumulated amortization disposals 0  
Accumulated amortization remeasurement 0  
Accumulated amortization impairments 0  
Accumulated Depreciation, Ending 49  
Property And Equipment Cost, Beginning 50  
Net Book Value 1  
Equipment [Member]    
Additions 106  
Disposal 0  
Impairments (1,310)  
Property And Equipment Cost, Ending 5,295 6,499
Accumulated Depreciation, Beginning 1,498  
Depreciation (925)  
Accumulated amortization disposals 0  
Accumulated amortization remeasurement 0  
Accumulated amortization impairments (70)  
Accumulated Depreciation, Ending 2,353  
Property And Equipment Cost, Beginning 6,499  
Remeasurements 0  
Net Book Value 2,942  
Remeasurements 0  
Vehicles [Member]    
Additions 0  
Disposal 0  
Impairments 0  
Property And Equipment Cost, Ending 830 830
Accumulated Depreciation, Beginning (608)  
Depreciation (136)  
Accumulated amortization disposals 0  
Accumulated amortization remeasurement 0  
Accumulated amortization impairments 0  
Accumulated Depreciation, Ending 744  
Property And Equipment Cost, Beginning 830  
Net Book Value 86  
Remeasurements 0  
Right of Use Assets    
Additions 17,068  
Disposal 0  
Impairments (28,230)  
Property And Equipment Cost, Ending 21,317 $ 37,081
Accumulated Depreciation, Beginning 9,719  
Depreciation (2,742)  
Accumulated amortization disposals 0  
Accumulated amortization remeasurement 2,661  
Accumulated amortization impairments 6,810  
Accumulated Depreciation, Ending 2,990  
Property And Equipment Cost, Beginning 37,081  
Remeasurements 4,602  
Net Book Value 18,327  
Remeasurements $ (4,602)  
XML 61 R47.htm IDEA: XBRL DOCUMENT v3.24.1
PROPERTY AND EQUIPMENT AND RIGHT OF USE ASSETS (Details Narrative) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Depreciation $ 4,711 $ 7,022
Leasehold improvements 8,632  
Impairment expense 8,783  
Cost of Goods Sold [Member]    
Depreciation $ 4,613 6,292
Other Income Expense [Member]    
Depreciation   $ 608
XML 62 R48.htm IDEA: XBRL DOCUMENT v3.24.1
INTANGIBLE ASSETS (Details)
12 Months Ended
Dec. 31, 2023
USD ($)
Sale of Brand Assets $ (37,299,000)
Impairment 2,050,000
Definite life intangibles cost, ending 3,416,000
Accumulated amortization, beginning (563,000)
Accumulated amortization impairment 97,000
Amortization (406,000)
Accumulated amortization, ending (872,000)
Net book value, beginning balance 42,202,000
Net book value, ending balance 2,544,000
Amortization 406,000
Definite life intangibles cost, beginning 42,765,000
Impairment (2,050,000)
Definite life intangibles cost, ending (3,416,000)
Brands & Tradenames [Member]  
Sale of Brand Assets (24,053,000)
Impairment 13,654,000
Definite life intangibles cost, ending 0
Accumulated amortization, beginning 0
Amortization 0
Accumulated amortization, ending 0
Net book value, beginning balance 37,707,000
Net book value, ending balance 0
Amortization 0
Definite life intangibles cost, beginning 37,707,000
Impairment (13,654,000)
Definite life intangibles cost, ending 0
Technology/KnowHow  
Impairment 258,000
Definite life intangibles cost, ending (3,000,000)
Accumulated amortization, beginning (535,000)
Accumulated amortization impairment 97,000
Amortization 323,000
Accumulated amortization, ending (761,000)
Net book value, beginning balance 2,723,000
Net book value, ending balance 2,239,000
Amortization (323,000)
Definite life intangibles cost, beginning 3,258,000
Impairment (258,000)
Definite life intangibles cost, ending 3,000,000
Acquired Purchase Rights [Member]  
Impairment 1,384,000
Definite life intangibles cost, ending (416,000)
Accumulated amortization, beginning (28,000)
Accumulated amortization impairment 0
Amortization 83,000
Accumulated amortization, ending (111,000)
Net book value, beginning balance 1,772,000
Net book value, ending balance 305,000
Amortization (83,000)
Definite life intangibles cost, beginning 1,800,000
Impairment (1,384,000)
Definite life intangibles cost, ending $ 416,000
XML 63 R49.htm IDEA: XBRL DOCUMENT v3.24.1
INTANGIBLE ASSETS (Details Narrative) - USD ($)
shares in Millions
9 Months Ended 12 Months Ended
Oct. 06, 2023
Sep. 30, 2021
Dec. 31, 2023
Dec. 31, 2022
Purchase of warrants $ 10,627,483,000      
Descriptions of royalty the Company received a $1 million royalty advance whereby the Company does not have to pay the first $1 million of royalty expense      
Amortization     $ 406,000 $ 354,000
Aggregate principal amount $ 22,157,000      
Cancelled common shares 4,324,845,000      
Impairment of intangible assets $ 13,245,000   $ 2,544,000 $ 42,202,000
Impairment of goodwill   $ 357,000    
Percentage of issued and outstanding shares       15.00%
Subordinate voting shares issued       1
Fair market value of shares       $ 1,800,000
Lowell Brand [Member]        
Descriptions of royalty     Issued shares and royalty advance were recorded at fair value in the amount of $2.03 million or $0.93 million, respectively  
Warrants issued     $ 1,550,000  
Accrued interest     1,490,000  
Intangible assets     24,100,000  
Convertible notes     22,100,000  
Other Intangible Assets [Member]        
Amortization     $ 317,000  
XML 64 R50.htm IDEA: XBRL DOCUMENT v3.24.1
SHAREHOLDERS EQUITY (Details)
shares in Thousands
12 Months Ended
Dec. 31, 2023
shares
Subordinate Voting Share [Member]  
Beginning Balance, Shares 12,177
Issuance Of Vested Restricted Stock Units 4
Issuance of shares in convertible debt conversion 6,843
Ending Balance, Shares 19,024
Super Voting Share [Member]  
Beginning Balance, Shares 20
Ending Balance, Shares 20
XML 65 R51.htm IDEA: XBRL DOCUMENT v3.24.1
SHAREHOLDERS EQUITY (Details 1)
shares in Thousands, $ in Thousands
12 Months Ended
Dec. 31, 2023
USD ($)
shares
SHAREHOLDERS EQUITY  
Warrants, Beginning Balance | shares 17,343
Warrants issued in conjunction with convertible debenture offering | $ $ (15,052)
Warrants expired | $ $ (1,165)
Warrants, Ending Balance | shares 1,126
XML 66 R52.htm IDEA: XBRL DOCUMENT v3.24.1
DEBT (Details) - USD ($)
$ in Thousands
Dec. 31, 2023
Dec. 31, 2022
Total short-term debt $ 3 $ 21,680
Total long-term debt 0 8,716
Total Indebtedness 3 30,396
Convertible Debenture    
Total short-term debt 0 21,398
Total long-term debt 0 0
Vehicle Loans    
Total short-term debt 3 15
Total long-term debt 0 3
Mortgage Payable [Member]    
Total short-term debt 0 257
Total long-term debt 0 8,713
Note Payable    
Total short-term debt $ 0 $ 10
XML 67 R53.htm IDEA: XBRL DOCUMENT v3.24.1
DEBT (Details 1)
$ in Thousands
Dec. 31, 2023
USD ($)
DEBT  
2024 $ 3
Total Debt Obligations $ 3
XML 68 R54.htm IDEA: XBRL DOCUMENT v3.24.1
DEBT (Details Narrative) - USD ($)
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Net Of Deferred Financing Costs     $ 759,000
Vehicle Loans      
Weighted average interest rate 6.40% 6.00%  
Mortgage Payable [Member]      
Weighted average interest rate   12.50%  
Net Of Deferred Financing Costs $ 296,000 $ 296,000  
XML 69 R55.htm IDEA: XBRL DOCUMENT v3.24.1
LEASES (Details)
$ in Thousands
12 Months Ended
Dec. 31, 2023
USD ($)
Lease Liability, Beginning $ 33,999
Sale leaseback addition 17,068
Lease Principal Payments (1,970)
Lease remeasurement (2,064)
Lease Settlement (1,202)
Lease termination (26,319)
Operating lease remeasurement classification 0
Lease Liability, ending 19,512
Operating Leases [Member]  
Lease Liability, Beginning 0
Sale leaseback addition 17,068
Lease Principal Payments (443)
Lease remeasurement (2,064)
Lease Settlement 0
Lease termination 0
Operating lease remeasurement classification 4,841
Lease Liability, ending 19,402
Finance Leases [Member]  
Lease Liability, Beginning 33,999
Sale leaseback addition 0
Lease Principal Payments (1,527)
Lease remeasurement 0
Lease Settlement (1,202)
Lease termination (26,319)
Operating lease remeasurement classification (4,841)
Lease Liability, ending $ 110
XML 70 R56.htm IDEA: XBRL DOCUMENT v3.24.1
LEASES (Details 1) - USD ($)
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
LEASES    
Amortization Of Leased Assets - Finance Leases $ 1,651,000 $ 3,755,000
Interest On Lease Liabilities - Finance Leases 1,651,000 2,219,000
Total - Finance Leases 3,316,000 5,974,000
Amortization Of Leased Assets - Operating Leases 1,091 0
Interest On Lease Liabilities - Operating Leases 1,326 0
Total Operating Lease Amortization $ 2,417 $ 0
XML 71 R57.htm IDEA: XBRL DOCUMENT v3.24.1
LEASES (Details 2)
$ in Thousands
Dec. 31, 2023
USD ($)
LEASES  
2024 $ 3,285
2025 3,258
2026 3,240
2027 3,324
2028 - And Beyond 52,341
Total lease payments 65,448
Less Imputed Interest (45,936)
Total $ 19,512
XML 72 R58.htm IDEA: XBRL DOCUMENT v3.24.1
LEASES (Details Narrative) - USD ($)
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
LEASES      
Lease right of use assets $ 21,423    
Lease obligation 26,319    
Sale of property 19,400,000    
Other Income (expenses) $ 4,896 $ 3,040,000.00  
Weighted Average Remaining Lease Term 8 years 10 months 24 days   14 years 7 months 6 days
Weighted Average Discount Rate 10.00%   6.00%
XML 73 R59.htm IDEA: XBRL DOCUMENT v3.24.1
SHARE BASED COMPENSATION (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Share-based compensation expense $ 231 $ 564
General And Administrative Expense [Member]    
Share-based compensation expense 231 564
Cost of Goods Sold [Member]    
Share-based compensation expense $ 0 $ 0
XML 74 R60.htm IDEA: XBRL DOCUMENT v3.24.1
SHARE BASED COMPENSATION (Details 1)
$ / shares in Units, shares in Thousands, $ in Thousands
12 Months Ended
Dec. 31, 2023
USD ($)
$ / shares
shares
SHARE BASED COMPENSATION  
Stock Options Outstanding, Beginning | shares 1,007
Stock Options, Granted | shares 828
Stock Options, Exercised | shares (28)
Stock Options, Cancelled | shares (354)
Stock Options Outstanding, Ending | shares 1,453
Stock Options Exercisable | shares 988
Stock Options Vested and expected | shares 1,453
Weighted-average Exercise Price Outstanding, Beginning | $ / shares $ 4.7
Weighted-average Exercise Price, Granted | $ / shares 0.3
Weighted-average Exercise Price, Exercised | $ / shares 20.4
Weighted-average Exercise Price, Cancelled | $ / shares 4.6
Weighted-average Exercise Price Outstanding, Ending | $ / shares 1.9
Weighted-average Exercise Price Exercisable | $ / shares 2.09
Weighted-average Exercise Price Vested and expected | $ / shares $ 1.91
Weighted-average Remaining Contactual Life Outstanding, Beginning Balance 4 years 7 months 6 days
Weighted-average Remaining Contactual Life Outstanding, Ending Balance 5 years 3 months 18 days
Weighted-average Remaining Contactual Life, Exercisable 5 years 2 months 12 days
Weighted-average Remaining Contactual Life, Vested And Expected To Vest 5 years 3 months 18 days
Aggregate Intrinsic Value Outstanding, Beginning | $ $ 0
Aggregate Intrinsic Value Outstanding, Ending | $ 0
Aggregate Intrinsic Value, Granted | $ 0
Aggregate Intrinsic Value, Exercised | $ 0
Aggregate Intrinsic Value, Expired | $ 0
Aggregate Intrinsic Value, Cancelled | $ 0
Aggregate Intrinsic Value vested and expected | $ $ 0
XML 75 R61.htm IDEA: XBRL DOCUMENT v3.24.1
SHARE BASED COMPENSATION (Details 2)
shares in Thousands
12 Months Ended
Dec. 31, 2023
$ / shares
shares
SHARE BASED COMPENSATION  
RSUs Outstanding, Beginning Balance | shares 21
RSUs Vested | shares (4)
RSUs Cancelled | shares (17)
Weighted-average Fair Value Outstanding, Beginning Balance $ 1.10
Weighted-average Fair Value Granted 0
Weighted-average Fair Value Vested 0
Weighted-average Fair Value Cancelled 1.02
Weighted-average Fair Value Outstanding, Ending Balance $ 0
XML 76 R62.htm IDEA: XBRL DOCUMENT v3.24.1
SHARE BASED COMPENSATION (Details 3)
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Restricted Stock Units (RSUs) [Member]    
Expected Volatility 0.00% 0.00%
Dividend Yield 0.00% 0.00%
Risk-free Interest Rate 0.00% 0.00%
Expected Term In Years   0 years
Stock Option [Member]    
Expected Volatility 50.00% 50.00%
Dividend Yield 0.00% 0.00%
Risk-free Interest Rate 4.12% 2.48%
Expected Term In Years 5 months 17 days 3 months 27 days
XML 77 R63.htm IDEA: XBRL DOCUMENT v3.24.1
SHARE BASED COMPENSATION (Details Narrative)
$ / shares in Units, $ in Thousands, shares in Millions
12 Months Ended
Dec. 31, 2023
USD ($)
$ / shares
shares
SHARE BASED COMPENSATION  
Proceeds From Issuance Of Stock Options 13.2
Stock Option For Future Grant 3.6
Vesting Period Descriptions The awards granted generally vest in 25% increments over a four-year period and option awards expire 6 years from grant date
Weighted-average Exercise Price Granted | $ / shares $ 0.30
Unrecognized Compensation Cost Related To Nonvested Restricted Stock Units | $ $ 191
Vesting Period 11 months 26 days
XML 78 R64.htm IDEA: XBRL DOCUMENT v3.24.1
INCOME TAXES (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Current      
Federal $ 0   $ 0
State 161   191
Total Current 191   191
Deferred tax benefit      
Federal (1,615)   (1,987)
State (3,111)   (15,293)
Total deferred tax benefit (4,726)   (17,280)
Valuation allowance 4,726   17,280
Income tax expense $ 161 $ 191 $ 191
XML 79 R65.htm IDEA: XBRL DOCUMENT v3.24.1
INCOME TAXES (Details 1) - USD ($)
$ in Thousands
Dec. 31, 2023
Dec. 31, 2022
INCOME TAXES    
Net operating loss carryforwards $ 23,323 $ 17,038
Accruals and reserves 0 0
Depreciation 0 0
Other 0 0
Valuation allowance (23,323) (17,038)
Total deferred tax assets 0 0
Accruals and reserves 0 0
Share-based compensation 0 0
Total deferred tax liabilities 0 0
Net deferred tax liabilities $ 0 $ 0
XML 80 R66.htm IDEA: XBRL DOCUMENT v3.24.1
INCOME TAXES (Details Narrative) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
INCOME TAXES      
Provision For Income Taxes $ 161 $ 191 $ 191
Effective Tax Rate 0.40% 0.80%  
XML 81 R67.htm IDEA: XBRL DOCUMENT v3.24.1
NET INCOME (LOSS) PER SHARE (Details) - USD ($)
$ / shares in Units, shares in Thousands, $ in Thousands
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Net loss per share:    
Net income (loss) $ 37,342 $ (24,677)
Net Loss Per Share:    
Basic $ (2.71) $ (2.17)
Diluted $ (2.71) $ (2.17)
Weighted Average Shares Outstanding:    
Basic 13,790 11,318
Diluted 13,790 11,318
Weighted average potentially diluted shares:    
Basic Shares 13,790 11,318
Total Weighted Average Potentially Diluted Shares 13,790 11,318
XML 82 R68.htm IDEA: XBRL DOCUMENT v3.24.1
COMMITMENTS AND CONTINGENCIES (Details Narrative)
12 Months Ended
Dec. 31, 2022
Due date of commitment 2023
August 2020 [Member]  
Insurance maturity date June 30, 2021
XML 83 R69.htm IDEA: XBRL DOCUMENT v3.24.1
GENERAL AND ADMINISTRATIVE EXPENSES (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
General and administrative $ 7,302 $ 9,553
Salaries And Benefits Member    
General and administrative 3,229 5,286
Professional Fees Member    
General and administrative 527 465
Sharebased Compensation Member    
General and administrative 231 564
Insurance Member    
General and administrative 999 1,344
Administrative Member    
General and administrative $ 2,316 $ 1,894
XML 84 R70.htm IDEA: XBRL DOCUMENT v3.24.1
RELATED PARTY TRANSACTIONS (Details Narrative) - USD ($)
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Related Party Transactions $ 476,000 $ 223,000
Total sales 487,000 274,000
Total payment $ 130,000 10,000
Lease term 12 months  
OMG    
Related Party Transactions $ 0 $ 36
EXCEL 85 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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

,"1)W'MP[WT4K]]3\>9_=Z/?4$L#!!0 ( *%+?%B7BKL

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end XML 86 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 87 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 89 FilingSummary.xml IDEA: XBRL DOCUMENT 3.24.1 html 116 366 1 false 44 0 false 4 false false R1.htm 000001 - Document - Cover Sheet http://f8k.com/role/Cover Cover Cover 1 false false R2.htm 000002 - Statement - CONSOLIDATED BALANCE SHEETS Sheet http://f8k.com/role/ConsolidatedBalanceSheets CONSOLIDATED BALANCE SHEETS Statements 2 false false R3.htm 000003 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical) Sheet http://f8k.com/role/ConsolidatedBalanceSheetsParenthetical CONSOLIDATED BALANCE SHEETS (Parenthetical) Statements 3 false false R4.htm 000004 - Statement - CONSOLIDATED STATEMENTS OF INCOME (LOSS) Sheet http://f8k.com/role/ConsolidatedStatementsOfIncomeLoss CONSOLIDATED STATEMENTS OF INCOME (LOSS) Statements 4 false false R5.htm 000005 - Statement - CONSOLIDATED STATEMENTS OF STOCKHOLDERS EQUITY (DEFICIT) Sheet http://f8k.com/role/ConsolidatedStatementsOfStockholdersEquityDeficit CONSOLIDATED STATEMENTS OF STOCKHOLDERS EQUITY (DEFICIT) Statements 5 false false R6.htm 000006 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS Sheet http://f8k.com/role/ConsolidatedStatementsOfCashFlows CONSOLIDATED STATEMENTS OF CASH FLOWS Statements 6 false false R7.htm 000007 - Disclosure - BUSINESS BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Sheet http://f8k.com/role/BusinessBasisOfPresentationAndSummaryOfSignificantAccountingPolicies BUSINESS BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Notes 7 false false R8.htm 000008 - Disclosure - PREPAID AND OTHER CURRENT ASSETS Sheet http://f8k.com/role/PrepaidAndOtherCurrentAssets PREPAID AND OTHER CURRENT ASSETS Notes 8 false false R9.htm 000009 - Disclosure - INVENTORY Sheet http://f8k.com/role/INVENTORY INVENTORY Notes 9 false false R10.htm 000010 - Disclosure - OTHER CURRENT LIABILITIES Sheet http://f8k.com/role/OtherCurrentLiabilities OTHER CURRENT LIABILITIES Notes 10 false false R11.htm 000011 - Disclosure - PROPERTY AND EQUIPMENT AND RIGHT OF USE ASSETS Sheet http://f8k.com/role/PropertyAndEquipmentAndRightOfUseAssets PROPERTY AND EQUIPMENT AND RIGHT OF USE ASSETS Notes 11 false false R12.htm 000012 - Disclosure - INTANGIBLE ASSETS Sheet http://f8k.com/role/IntangibleAssets INTANGIBLE ASSETS Notes 12 false false R13.htm 000013 - Disclosure - SHAREHOLDERS EQUITY Sheet http://f8k.com/role/ShareholdersEquity SHAREHOLDERS EQUITY Notes 13 false false R14.htm 000014 - Disclosure - DEBT Sheet http://f8k.com/role/DEBT DEBT Notes 14 false false R15.htm 000015 - Disclosure - LEASES Sheet http://f8k.com/role/LEASES LEASES Notes 15 false false R16.htm 000016 - Disclosure - SHARE BASED COMPENSATION Sheet http://f8k.com/role/ShareBasedCompensation SHARE BASED COMPENSATION Notes 16 false false R17.htm 000017 - Disclosure - INCOME TAXES Sheet http://f8k.com/role/IncomeTaxes INCOME TAXES Notes 17 false false R18.htm 000018 - Disclosure - NET INCOME (LOSS) PER SHARE Sheet http://f8k.com/role/NetIncomeLossPerShare NET INCOME (LOSS) PER SHARE Notes 18 false false R19.htm 000019 - Disclosure - FAIR VALUE MEASUREMENTS Sheet http://f8k.com/role/FairValueMeasurements FAIR VALUE MEASUREMENTS Notes 19 false false R20.htm 000020 - Disclosure - COMMITMENTS AND CONTINGENCIES Sheet http://f8k.com/role/CommitmentsAndContingencies COMMITMENTS AND CONTINGENCIES Notes 20 false false R21.htm 000021 - Disclosure - GENERAL AND ADMINISTRATIVE EXPENSES Sheet http://f8k.com/role/GeneralAndAdministrativeExpenses GENERAL AND ADMINISTRATIVE EXPENSES Notes 21 false false R22.htm 000022 - Disclosure - RELATED PARTY TRANSACTIONS Sheet http://f8k.com/role/RelatedPartyTransactions RELATED PARTY TRANSACTIONS Notes 22 false false R23.htm 000023 - Disclosure - SEGMENT INFORMATION Sheet http://f8k.com/role/SegmentInformation SEGMENT INFORMATION Notes 23 false false R24.htm 000024 - Disclosure - SUBSEQUENT EVENTS Sheet http://f8k.com/role/SubsequentEvents SUBSEQUENT EVENTS Notes 24 false false R25.htm 000025 - Disclosure - BUSINESS BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) Sheet http://f8k.com/role/BusinessBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies BUSINESS BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) Policies 25 false false R26.htm 000026 - Disclosure - BUSINESS BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables) Sheet http://f8k.com/role/BusinessBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesTables BUSINESS BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables) Tables http://f8k.com/role/BusinessBasisOfPresentationAndSummaryOfSignificantAccountingPolicies 26 false false R27.htm 000027 - Disclosure - PREPAID AND OTHER CURRENT ASSETS (Tables) Sheet http://f8k.com/role/PrepaidAndOtherCurrentAssetsTables PREPAID AND OTHER CURRENT ASSETS (Tables) Tables http://f8k.com/role/PrepaidAndOtherCurrentAssets 27 false false R28.htm 000028 - Disclosure - INVENTORY (Tables) Sheet http://f8k.com/role/InventoryTables INVENTORY (Tables) Tables http://f8k.com/role/INVENTORY 28 false false R29.htm 000029 - Disclosure - OTHER CURRENT LIABILITIES (Tables) Sheet http://f8k.com/role/OtherCurrentLiabilitiesTables OTHER CURRENT LIABILITIES (Tables) Tables http://f8k.com/role/OtherCurrentLiabilities 29 false false R30.htm 000030 - Disclosure - PROPERTY AND EQUIPMENT AND RIGHT OF USE ASSETS (Tables) Sheet http://f8k.com/role/PropertyAndEquipmentAndRightOfUseAssetsTables PROPERTY AND EQUIPMENT AND RIGHT OF USE ASSETS (Tables) Tables http://f8k.com/role/PropertyAndEquipmentAndRightOfUseAssets 30 false false R31.htm 000031 - Disclosure - INTANGIBLE ASSETS (Tables) Sheet http://f8k.com/role/IntangibleAssetsTables INTANGIBLE ASSETS (Tables) Tables http://f8k.com/role/IntangibleAssets 31 false false R32.htm 000032 - Disclosure - SHAREHOLDERS EQUITY (Tables) Sheet http://f8k.com/role/ShareholdersEquityTables SHAREHOLDERS EQUITY (Tables) Tables http://f8k.com/role/ShareholdersEquity 32 false false R33.htm 000033 - Disclosure - DEBT (Tables) Sheet http://f8k.com/role/DebtTables DEBT (Tables) Tables http://f8k.com/role/DEBT 33 false false R34.htm 000034 - Disclosure - LEASES (Tables) Sheet http://f8k.com/role/LeasesTables LEASES (Tables) Tables http://f8k.com/role/LEASES 34 false false R35.htm 000035 - Disclosure - SHARE BASED COMPENSATION (Tables) Sheet http://f8k.com/role/ShareBasedCompensationTables SHARE BASED COMPENSATION (Tables) Tables http://f8k.com/role/ShareBasedCompensation 35 false false R36.htm 000036 - Disclosure - INCOME TAXES (Tables) Sheet http://f8k.com/role/IncomeTaxesTables INCOME TAXES (Tables) Tables http://f8k.com/role/IncomeTaxes 36 false false R37.htm 000037 - Disclosure - NET INCOME (LOSS) PER SHARE (Tables) Sheet http://f8k.com/role/NetIncomeLossPerShareTables NET INCOME (LOSS) PER SHARE (Tables) Tables http://f8k.com/role/NetIncomeLossPerShare 37 false false R38.htm 000038 - Disclosure - GENERAL AND ADMINISTRATIVE EXPENSES (Tables) Sheet http://f8k.com/role/GeneralAndAdministrativeExpensesTables GENERAL AND ADMINISTRATIVE EXPENSES (Tables) Tables http://f8k.com/role/GeneralAndAdministrativeExpenses 38 false false R39.htm 000039 - Disclosure - BUSINESS, BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) Sheet http://f8k.com/role/BusinessBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetails BUSINESS, BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) Details 39 false false R40.htm 000040 - Disclosure - BUSINESS, BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) Sheet http://f8k.com/role/BusinessBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetailsNarrative BUSINESS, BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) Details 40 false false R41.htm 000041 - Disclosure - PREPAID AND OTHER CURRENT ASSETS (Details) Sheet http://f8k.com/role/PrepaidAndOtherCurrentAssetsDetails PREPAID AND OTHER CURRENT ASSETS (Details) Details http://f8k.com/role/PrepaidAndOtherCurrentAssetsTables 41 false false R42.htm 000042 - Disclosure - INVENTORY (Details) Sheet http://f8k.com/role/InventoryDetails INVENTORY (Details) Details http://f8k.com/role/InventoryTables 42 false false R43.htm 000043 - Disclosure - INVENTORY (Details Narrative) Sheet http://f8k.com/role/InventoryDetailsNarrative INVENTORY (Details Narrative) Details http://f8k.com/role/InventoryTables 43 false false R44.htm 000044 - Disclosure - Other current liabilities (Details) Sheet http://f8k.com/role/OtherCurrentLiabilitiesDetails Other current liabilities (Details) Details 44 false false R45.htm 000045 - Disclosure - Other current liabilities (Details Narrative) Sheet http://f8k.com/role/OtherCurrentLiabilitiesDetailsNarrative Other current liabilities (Details Narrative) Details 45 false false R46.htm 000046 - Disclosure - PROPERTY AND EQUIPMENT AND RIGHT OF USE ASSETS (Details) Sheet http://f8k.com/role/PropertyAndEquipmentAndRightOfUseAssetsDetails PROPERTY AND EQUIPMENT AND RIGHT OF USE ASSETS (Details) Details http://f8k.com/role/PropertyAndEquipmentAndRightOfUseAssetsTables 46 false false R47.htm 000047 - Disclosure - PROPERTY AND EQUIPMENT AND RIGHT OF USE ASSETS (Details Narrative) Sheet http://f8k.com/role/PropertyAndEquipmentAndRightOfUseAssetsDetailsNarrative PROPERTY AND EQUIPMENT AND RIGHT OF USE ASSETS (Details Narrative) Details http://f8k.com/role/PropertyAndEquipmentAndRightOfUseAssetsTables 47 false false R48.htm 000048 - Disclosure - INTANGIBLE ASSETS (Details) Sheet http://f8k.com/role/IntangibleAssetsDetails INTANGIBLE ASSETS (Details) Details http://f8k.com/role/IntangibleAssetsTables 48 false false R49.htm 000049 - Disclosure - INTANGIBLE ASSETS (Details Narrative) Sheet http://f8k.com/role/IntangibleAssetsDetailsNarrative INTANGIBLE ASSETS (Details Narrative) Details http://f8k.com/role/IntangibleAssetsTables 49 false false R50.htm 000050 - Disclosure - SHAREHOLDERS EQUITY (Details) Sheet http://f8k.com/role/ShareholdersEquityDetails SHAREHOLDERS EQUITY (Details) Details http://f8k.com/role/ShareholdersEquityTables 50 false false R51.htm 000051 - Disclosure - SHAREHOLDERS EQUITY (Details 1) Sheet http://f8k.com/role/ShareholdersEquityDetails1 SHAREHOLDERS EQUITY (Details 1) Details http://f8k.com/role/ShareholdersEquityTables 51 false false R52.htm 000052 - Disclosure - DEBT (Details) Sheet http://f8k.com/role/DebtDetails DEBT (Details) Details http://f8k.com/role/DebtTables 52 false false R53.htm 000053 - Disclosure - DEBT (Details 1) Sheet http://f8k.com/role/DebtDetails1 DEBT (Details 1) Details http://f8k.com/role/DebtTables 53 false false R54.htm 000054 - Disclosure - DEBT (Details Narrative) Sheet http://f8k.com/role/DebtDetailsNarrative DEBT (Details Narrative) Details http://f8k.com/role/DebtTables 54 false false R55.htm 000055 - Disclosure - LEASES (Details) Sheet http://f8k.com/role/LeasesDetails LEASES (Details) Details http://f8k.com/role/LeasesTables 55 false false R56.htm 000056 - Disclosure - LEASES (Details 1) Sheet http://f8k.com/role/LeasesDetails1 LEASES (Details 1) Details http://f8k.com/role/LeasesTables 56 false false R57.htm 000057 - Disclosure - LEASES (Details 2) Sheet http://f8k.com/role/LeasesDetails2 LEASES (Details 2) Details http://f8k.com/role/LeasesTables 57 false false R58.htm 000058 - Disclosure - LEASES (Details Narrative) Sheet http://f8k.com/role/LeasesDetailsNarrative LEASES (Details Narrative) Details http://f8k.com/role/LeasesTables 58 false false R59.htm 000059 - Disclosure - SHARE BASED COMPENSATION (Details) Sheet http://f8k.com/role/ShareBasedCompensationDetails SHARE BASED COMPENSATION (Details) Details http://f8k.com/role/ShareBasedCompensationTables 59 false false R60.htm 000060 - Disclosure - SHARE BASED COMPENSATION (Details 1) Sheet http://f8k.com/role/ShareBasedCompensationDetails1 SHARE BASED COMPENSATION (Details 1) Details http://f8k.com/role/ShareBasedCompensationTables 60 false false R61.htm 000061 - Disclosure - SHARE BASED COMPENSATION (Details 2) Sheet http://f8k.com/role/ShareBasedCompensationDetails2 SHARE BASED COMPENSATION (Details 2) Details http://f8k.com/role/ShareBasedCompensationTables 61 false false R62.htm 000062 - Disclosure - SHARE BASED COMPENSATION (Details 3) Sheet http://f8k.com/role/ShareBasedCompensationDetails3 SHARE BASED COMPENSATION (Details 3) Details http://f8k.com/role/ShareBasedCompensationTables 62 false false R63.htm 000063 - Disclosure - SHARE BASED COMPENSATION (Details Narrative) Sheet http://f8k.com/role/ShareBasedCompensationDetailsNarrative SHARE BASED COMPENSATION (Details Narrative) Details http://f8k.com/role/ShareBasedCompensationTables 63 false false R64.htm 000064 - Disclosure - INCOME TAXES (Details) Sheet http://f8k.com/role/IncomeTaxesDetails INCOME TAXES (Details) Details http://f8k.com/role/IncomeTaxesTables 64 false false R65.htm 000065 - Disclosure - INCOME TAXES (Details 1) Sheet http://f8k.com/role/IncomeTaxesDetails1 INCOME TAXES (Details 1) Details http://f8k.com/role/IncomeTaxesTables 65 false false R66.htm 000066 - Disclosure - INCOME TAXES (Details Narrative) Sheet http://f8k.com/role/IncomeTaxesDetailsNarrative INCOME TAXES (Details Narrative) Details http://f8k.com/role/IncomeTaxesTables 66 false false R67.htm 000067 - Disclosure - NET INCOME (LOSS) PER SHARE (Details) Sheet http://f8k.com/role/NetIncomeLossPerShareDetails NET INCOME (LOSS) PER SHARE (Details) Details http://f8k.com/role/NetIncomeLossPerShareTables 67 false false R68.htm 000068 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details Narrative) Sheet http://f8k.com/role/CommitmentsAndContingenciesDetailsNarrative COMMITMENTS AND CONTINGENCIES (Details Narrative) Details http://f8k.com/role/CommitmentsAndContingencies 68 false false R69.htm 000069 - Disclosure - GENERAL AND ADMINISTRATIVE EXPENSES (Details) Sheet http://f8k.com/role/GeneralAndAdministrativeExpensesDetails GENERAL AND ADMINISTRATIVE EXPENSES (Details) Details http://f8k.com/role/GeneralAndAdministrativeExpensesTables 69 false false R70.htm 000070 - Disclosure - RELATED PARTY TRANSACTIONS (Details Narrative) Sheet http://f8k.com/role/RelatedPartyTransactionsDetailsNarrative RELATED PARTY TRANSACTIONS (Details Narrative) Details http://f8k.com/role/RelatedPartyTransactions 70 false false All Reports Book All Reports [dq-60547-EntityTaxIdentificationNumber-Missing] Submission type 10-K should have a non-empty value for EntityTaxIdentificationNumber in the Required Context. lowlf_10k.htm [ix-0514-Hidden-Fact-Eligible-For-Transform] WARN: 17 fact(s) appearing in ix:hidden were eligible for transformation: dei:CurrentFiscalYearEndDate, dei:DocumentFinStmtErrorCorrectionFlag, lowlf:ChangesInAdoptionAccumulatedDeficit, lowlf:DueDateOfCommitment, lowlf:InsuranceMaturityDate, lowlf:ScheduleOfPropertyAndEquipmentEstimatedUsefulLifeTextBlock, us-gaap:DebtInstrumentBasisSpreadOnVariableRate1, us-gaap:GoodwillImpairmentLoss, us-gaap:PaymentsOfFinancingCosts, us-gaap:RelatedPartyTransactionAmountsOfTransaction, us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate, us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate, us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate, us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 - lowlf_10k.htm 1 [DQC.US.0043.9873] The company has reported the concept ProfitLoss as part of the cash flow statement. This income item is being deducted from the value of operating cash flows in the calculation defined by the filer. This implies that the resulting operating cash flow calculation excludes this income item from cash flow from operations. If ProfitLoss represents income from discontinued operations then the element NetCashProvidedByUsedInOperatingActivitiesContinuingOperations should be used as the total rather than the current total element of NetCashProvidedByUsedInOperatingActivities. If the item is an income item and is being deducted because the value is negative then consider changing the sign and weight of the element. - https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd 4602, 9356 - https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd 4602, 9356 lowlf-20231231.xsd lowlf-20231231_cal.xml lowlf-20231231_def.xml lowlf-20231231_lab.xml lowlf-20231231_pre.xml lowlf_10k.htm lowlf_10kimg4.jpg lowlf_10kimg7.jpg http://fasb.org/us-gaap/2023 http://xbrl.sec.gov/dei/2023 true true JSON 92 MetaLinks.json IDEA: XBRL DOCUMENT { "version": "2.2", "instance": { "lowlf_10k.htm": { "nsprefix": "lowlf", "nsuri": "http://f8k.com/20231231", "dts": { "schema": { "local": [ "lowlf-20231231.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd", "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd", "http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd", "https://xbrl.sec.gov/country/2023/country-2023.xsd", "https://xbrl.sec.gov/currency/2023/currency-2023.xsd", "https://xbrl.sec.gov/dei/2023/dei-2023.xsd", "https://xbrl.sec.gov/exch/2023/exch-2023.xsd", "https://xbrl.sec.gov/naics/2023/naics-2023.xsd", "https://xbrl.sec.gov/sic/2023/sic-2023.xsd", "https://xbrl.sec.gov/stpr/2023/stpr-2023.xsd" ] }, "calculationLink": { "local": [ "lowlf-20231231_cal.xml" ] }, "definitionLink": { "local": [ "lowlf-20231231_def.xml" ] }, "labelLink": { "local": [ "lowlf-20231231_lab.xml" ] }, "presentationLink": { "local": [ "lowlf-20231231_pre.xml" ] }, "inline": { "local": [ "lowlf_10k.htm" ] } }, "keyStandard": 264, "keyCustom": 102, "axisStandard": 17, "axisCustom": 0, "memberStandard": 16, "memberCustom": 28, "hidden": { "total": 21, "http://xbrl.sec.gov/dei/2023": 6, "http://fasb.org/us-gaap/2023": 11, "http://f8k.com/20231231": 4 }, "contextCount": 116, "entityCount": 1, "segmentCount": 44, "elementCount": 491, "unitCount": 4, "baseTaxonomies": { "http://fasb.org/us-gaap/2023": 524, "http://xbrl.sec.gov/dei/2023": 35 }, "report": { "R1": { "role": "http://f8k.com/role/Cover", "longName": "000001 - Document - Cover", "shortName": "Cover", "isDefault": "true", "groupType": "document", "subGroupType": "", "menuCat": "Cover", "order": "1", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "dei:EntityRegistrantName", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "strong", "p", "td", "tr", "tbody", "table", "body", "html" ], "reportCount": 1, "baseRef": "lowlf_10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "dei:EntityRegistrantName", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "strong", "p", "td", "tr", "tbody", "table", "body", "html" ], "reportCount": 1, "baseRef": "lowlf_10k.htm", "first": true, "unique": true } }, "R2": { "role": "http://f8k.com/role/ConsolidatedBalanceSheets", "longName": "000002 - Statement - CONSOLIDATED BALANCE SHEETS", "shortName": "CONSOLIDATED BALANCE SHEETS", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "2", "firstAnchor": { "contextRef": "AsOf2023-12-31", "name": "us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "strong", "td", "tr", "tbody", "table", "body", "html" ], "reportCount": 1, "baseRef": "lowlf_10k.htm", "first": true }, "uniqueAnchor": { "contextRef": "AsOf2023-12-31", "name": "us-gaap:AccountsReceivableNetCurrent", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "tbody", "table", "body", "html" ], "reportCount": 1, "baseRef": "lowlf_10k.htm", "unique": true } }, "R3": { "role": "http://f8k.com/role/ConsolidatedBalanceSheetsParenthetical", "longName": "000003 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical)", "shortName": "CONSOLIDATED BALANCE SHEETS (Parenthetical)", "isDefault": "false", "groupType": "statement", "subGroupType": "parenthetical", "menuCat": "Statements", "order": "3", "firstAnchor": { "contextRef": "AsOf2022-12-31", "name": "us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "p", "td", "tr", "tbody", "table", "body", "html" ], "reportCount": 1, "baseRef": "lowlf_10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2022-12-31", "name": "us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "p", "td", "tr", "tbody", "table", "body", "html" ], "reportCount": 1, "baseRef": "lowlf_10k.htm", "first": true, "unique": true } }, "R4": { "role": "http://f8k.com/role/ConsolidatedStatementsOfIncomeLoss", "longName": "000004 - Statement - CONSOLIDATED STATEMENTS OF INCOME (LOSS)", "shortName": "CONSOLIDATED STATEMENTS OF INCOME (LOSS)", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "4", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:Revenues", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "tbody", "table", "body", "html" ], "reportCount": 1, "baseRef": "lowlf_10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:Revenues", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "tbody", "table", "body", "html" ], "reportCount": 1, "baseRef": "lowlf_10k.htm", "first": true, "unique": true } }, "R5": { "role": "http://f8k.com/role/ConsolidatedStatementsOfStockholdersEquityDeficit", "longName": "000005 - Statement - CONSOLIDATED STATEMENTS OF STOCKHOLDERS EQUITY (DEFICIT)", "shortName": "CONSOLIDATED STATEMENTS OF STOCKHOLDERS EQUITY (DEFICIT)", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "5", "firstAnchor": { "contextRef": "AsOf2021-12-31_lowlf_SubordinateVotingSharesMember", "name": "us-gaap:SharesIssued", "unitRef": "Shares", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "tbody", "table", "body", "html" ], "reportCount": 1, "baseRef": "lowlf_10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2021-12-31_lowlf_SubordinateVotingSharesMember", "name": "us-gaap:SharesIssued", "unitRef": "Shares", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "tbody", "table", "body", "html" ], "reportCount": 1, "baseRef": "lowlf_10k.htm", "first": true, "unique": true } }, "R6": { "role": "http://f8k.com/role/ConsolidatedStatementsOfCashFlows", "longName": "000006 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS", "shortName": "CONSOLIDATED STATEMENTS OF CASH FLOWS", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "6", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:ProfitLoss", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "tbody", "table", "body", "html" ], "reportCount": 1, "baseRef": "lowlf_10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:ProfitLoss", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "tbody", "table", "body", "html" ], "reportCount": 1, "baseRef": "lowlf_10k.htm", "first": true, "unique": true } }, "R7": { "role": "http://f8k.com/role/BusinessBasisOfPresentationAndSummaryOfSignificantAccountingPolicies", "longName": "000007 - Disclosure - BUSINESS BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES", "shortName": "BUSINESS BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "7", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "lowlf_10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "lowlf_10k.htm", "first": true, "unique": true } }, "R8": { "role": "http://f8k.com/role/PrepaidAndOtherCurrentAssets", "longName": "000008 - Disclosure - PREPAID AND OTHER CURRENT ASSETS", "shortName": "PREPAID AND OTHER CURRENT ASSETS", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "8", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "lowlf_10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "lowlf_10k.htm", "first": true, "unique": true } }, "R9": { "role": "http://f8k.com/role/INVENTORY", "longName": "000009 - Disclosure - INVENTORY", "shortName": "INVENTORY", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "9", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:InventoryDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "lowlf_10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:InventoryDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "lowlf_10k.htm", "first": true, "unique": true } }, "R10": { "role": "http://f8k.com/role/OtherCurrentLiabilities", "longName": "000010 - Disclosure - OTHER CURRENT LIABILITIES", "shortName": "OTHER CURRENT LIABILITIES", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "10", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:OtherLiabilitiesDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "lowlf_10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:OtherLiabilitiesDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "lowlf_10k.htm", "first": true, "unique": true } }, "R11": { "role": "http://f8k.com/role/PropertyAndEquipmentAndRightOfUseAssets", "longName": "000011 - Disclosure - PROPERTY AND EQUIPMENT AND RIGHT OF USE ASSETS", "shortName": "PROPERTY AND EQUIPMENT AND RIGHT OF USE ASSETS", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "11", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "lowlf_10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "lowlf_10k.htm", "first": true, "unique": true } }, "R12": { "role": "http://f8k.com/role/IntangibleAssets", "longName": "000012 - Disclosure - INTANGIBLE ASSETS", "shortName": "INTANGIBLE ASSETS", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "12", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:IntangibleAssetsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "lowlf_10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:IntangibleAssetsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "lowlf_10k.htm", "first": true, "unique": true } }, "R13": { "role": "http://f8k.com/role/ShareholdersEquity", "longName": "000013 - Disclosure - SHAREHOLDERS EQUITY", "shortName": "SHAREHOLDERS EQUITY", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "13", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "lowlf_10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "lowlf_10k.htm", "first": true, "unique": true } }, "R14": { "role": "http://f8k.com/role/DEBT", "longName": "000014 - Disclosure - DEBT", "shortName": "DEBT", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "14", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:DebtDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "lowlf_10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:DebtDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "lowlf_10k.htm", "first": true, "unique": true } }, "R15": { "role": "http://f8k.com/role/LEASES", "longName": "000015 - Disclosure - LEASES", "shortName": "LEASES", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "15", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:LeasesOfLesseeDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "lowlf_10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:LeasesOfLesseeDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "lowlf_10k.htm", "first": true, "unique": true } }, "R16": { "role": "http://f8k.com/role/ShareBasedCompensation", "longName": "000016 - Disclosure - SHARE BASED COMPENSATION", "shortName": "SHARE BASED COMPENSATION", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "16", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "lowlf_10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "lowlf_10k.htm", "first": true, "unique": true } }, "R17": { "role": "http://f8k.com/role/IncomeTaxes", "longName": "000017 - Disclosure - INCOME TAXES", "shortName": "INCOME TAXES", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "17", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "lowlf_10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "lowlf_10k.htm", "first": true, "unique": true } }, "R18": { "role": "http://f8k.com/role/NetIncomeLossPerShare", "longName": "000018 - Disclosure - NET INCOME (LOSS) PER SHARE", "shortName": "NET INCOME (LOSS) PER SHARE", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "18", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:EarningsPerShareTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "lowlf_10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:EarningsPerShareTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "lowlf_10k.htm", "first": true, "unique": true } }, "R19": { "role": "http://f8k.com/role/FairValueMeasurements", "longName": "000019 - Disclosure - FAIR VALUE MEASUREMENTS", "shortName": "FAIR VALUE MEASUREMENTS", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "19", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:FairValueDisclosuresTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "lowlf_10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:FairValueDisclosuresTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "lowlf_10k.htm", "first": true, "unique": true } }, "R20": { "role": "http://f8k.com/role/CommitmentsAndContingencies", "longName": "000020 - Disclosure - COMMITMENTS AND CONTINGENCIES", "shortName": "COMMITMENTS AND CONTINGENCIES", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "20", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "lowlf_10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "lowlf_10k.htm", "first": true, "unique": true } }, "R21": { "role": "http://f8k.com/role/GeneralAndAdministrativeExpenses", "longName": "000021 - Disclosure - GENERAL AND ADMINISTRATIVE EXPENSES", "shortName": "GENERAL AND ADMINISTRATIVE EXPENSES", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "21", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:OtherOperatingIncomeAndExpenseTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "lowlf_10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:OtherOperatingIncomeAndExpenseTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "lowlf_10k.htm", "first": true, "unique": true } }, "R22": { "role": "http://f8k.com/role/RelatedPartyTransactions", "longName": "000022 - Disclosure - RELATED PARTY TRANSACTIONS", "shortName": "RELATED PARTY TRANSACTIONS", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "22", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "lowlf_10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "lowlf_10k.htm", "first": true, "unique": true } }, "R23": { "role": "http://f8k.com/role/SegmentInformation", "longName": "000023 - Disclosure - SEGMENT INFORMATION", "shortName": "SEGMENT INFORMATION", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "23", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:SegmentReportingDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "lowlf_10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:SegmentReportingDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "lowlf_10k.htm", "first": true, "unique": true } }, "R24": { "role": "http://f8k.com/role/SubsequentEvents", "longName": "000024 - Disclosure - SUBSEQUENT EVENTS", "shortName": "SUBSEQUENT EVENTS", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "24", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:SubsequentEventsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "lowlf_10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:SubsequentEventsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "lowlf_10k.htm", "first": true, "unique": true } }, "R25": { "role": "http://f8k.com/role/BusinessBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies", "longName": "000025 - Disclosure - BUSINESS BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)", "shortName": "BUSINESS BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "policies", "menuCat": "Policies", "order": "25", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "lowlf:BusinessPolicyTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "lowlf_10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "lowlf:BusinessPolicyTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "lowlf_10k.htm", "first": true, "unique": true } }, "R26": { "role": "http://f8k.com/role/BusinessBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesTables", "longName": "000026 - Disclosure - BUSINESS BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)", "shortName": "BUSINESS BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "26", "firstAnchor": null, "uniqueAnchor": null }, "R27": { "role": "http://f8k.com/role/PrepaidAndOtherCurrentAssetsTables", "longName": "000027 - Disclosure - PREPAID AND OTHER CURRENT ASSETS (Tables)", "shortName": "PREPAID AND OTHER CURRENT ASSETS (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "27", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:ScheduleOfOtherCurrentAssetsTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "lowlf_10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:ScheduleOfOtherCurrentAssetsTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "lowlf_10k.htm", "first": true, "unique": true } }, "R28": { "role": "http://f8k.com/role/InventoryTables", "longName": "000028 - Disclosure - INVENTORY (Tables)", "shortName": "INVENTORY (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "28", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:InventoryDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "lowlf_10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:InventoryDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "lowlf_10k.htm", "first": true, "unique": true } }, "R29": { "role": "http://f8k.com/role/OtherCurrentLiabilitiesTables", "longName": "000029 - Disclosure - OTHER CURRENT LIABILITIES (Tables)", "shortName": "OTHER CURRENT LIABILITIES (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "29", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:OtherCurrentLiabilitiesTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:OtherLiabilitiesDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "lowlf_10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:OtherCurrentLiabilitiesTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:OtherLiabilitiesDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "lowlf_10k.htm", "first": true, "unique": true } }, "R30": { "role": "http://f8k.com/role/PropertyAndEquipmentAndRightOfUseAssetsTables", "longName": "000030 - Disclosure - PROPERTY AND EQUIPMENT AND RIGHT OF USE ASSETS (Tables)", "shortName": "PROPERTY AND EQUIPMENT AND RIGHT OF USE ASSETS (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "30", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:PropertyPlantAndEquipmentTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "lowlf_10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:PropertyPlantAndEquipmentTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "lowlf_10k.htm", "first": true, "unique": true } }, "R31": { "role": "http://f8k.com/role/IntangibleAssetsTables", "longName": "000031 - Disclosure - INTANGIBLE ASSETS (Tables)", "shortName": "INTANGIBLE ASSETS (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "31", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:IntangibleAssetsDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "lowlf_10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:IntangibleAssetsDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "lowlf_10k.htm", "first": true, "unique": true } }, "R32": { "role": "http://f8k.com/role/ShareholdersEquityTables", "longName": "000032 - Disclosure - SHAREHOLDERS EQUITY (Tables)", "shortName": "SHAREHOLDERS EQUITY (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "32", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:ScheduleOfCommonStockOutstandingRollForwardTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "lowlf_10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:ScheduleOfCommonStockOutstandingRollForwardTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "lowlf_10k.htm", "first": true, "unique": true } }, "R33": { "role": "http://f8k.com/role/DebtTables", "longName": "000033 - Disclosure - DEBT (Tables)", "shortName": "DEBT (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "33", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:ScheduleOfDebtTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:DebtDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "lowlf_10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:ScheduleOfDebtTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:DebtDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "lowlf_10k.htm", "first": true, "unique": true } }, "R34": { "role": "http://f8k.com/role/LeasesTables", "longName": "000034 - Disclosure - LEASES (Tables)", "shortName": "LEASES (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "34", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "lowlf:ScheduleOfLeaseObligationsTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:LeasesOfLesseeDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "lowlf_10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "lowlf:ScheduleOfLeaseObligationsTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:LeasesOfLesseeDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "lowlf_10k.htm", "first": true, "unique": true } }, "R35": { "role": "http://f8k.com/role/ShareBasedCompensationTables", "longName": "000035 - Disclosure - SHARE BASED COMPENSATION (Tables)", "shortName": "SHARE BASED COMPENSATION (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "35", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:ScheduleOfShareBasedCompensationActivityTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "lowlf_10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:ScheduleOfShareBasedCompensationActivityTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "lowlf_10k.htm", "first": true, "unique": true } }, "R36": { "role": "http://f8k.com/role/IncomeTaxesTables", "longName": "000036 - Disclosure - INCOME TAXES (Tables)", "shortName": "INCOME TAXES (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "36", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "lowlf_10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "lowlf_10k.htm", "first": true, "unique": true } }, "R37": { "role": "http://f8k.com/role/NetIncomeLossPerShareTables", "longName": "000037 - Disclosure - NET INCOME (LOSS) PER SHARE (Tables)", "shortName": "NET INCOME (LOSS) PER SHARE (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "37", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:EarningsPerShareTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "lowlf_10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:EarningsPerShareTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "lowlf_10k.htm", "first": true, "unique": true } }, "R38": { "role": "http://f8k.com/role/GeneralAndAdministrativeExpensesTables", "longName": "000038 - Disclosure - GENERAL AND ADMINISTRATIVE EXPENSES (Tables)", "shortName": "GENERAL AND ADMINISTRATIVE EXPENSES (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "38", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:ScheduleOfOtherOperatingCostAndExpenseByComponentTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:OtherOperatingIncomeAndExpenseTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "lowlf_10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:ScheduleOfOtherOperatingCostAndExpenseByComponentTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:OtherOperatingIncomeAndExpenseTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "lowlf_10k.htm", "first": true, "unique": true } }, "R39": { "role": "http://f8k.com/role/BusinessBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetails", "longName": "000039 - Disclosure - BUSINESS, BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details)", "shortName": "BUSINESS, BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "39", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31_lowlf_BuildingsMember", "name": "lowlf:PropertyPlantAndEquipmentUsefulLifes", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "p", "td", "tr", "tbody", "table", "us-gaap:PropertyPlantAndEquipmentPolicyTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "lowlf_10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31_lowlf_BuildingsMember", "name": "lowlf:PropertyPlantAndEquipmentUsefulLifes", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "p", "td", "tr", "tbody", "table", "us-gaap:PropertyPlantAndEquipmentPolicyTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "lowlf_10k.htm", "first": true, "unique": true } }, "R40": { "role": "http://f8k.com/role/BusinessBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetailsNarrative", "longName": "000040 - Disclosure - BUSINESS, BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)", "shortName": "BUSINESS, BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "40", "firstAnchor": { "contextRef": "AsOf2023-12-31", "name": "lowlf:ChangesInAdoptionAccumulatedDeficit", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "p", "us-gaap:LesseeLeasesPolicyTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "lowlf_10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2023-12-31", "name": "lowlf:ChangesInAdoptionAccumulatedDeficit", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "p", "us-gaap:LesseeLeasesPolicyTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "lowlf_10k.htm", "first": true, "unique": true } }, "R41": { "role": "http://f8k.com/role/PrepaidAndOtherCurrentAssetsDetails", "longName": "000041 - Disclosure - PREPAID AND OTHER CURRENT ASSETS (Details)", "shortName": "PREPAID AND OTHER CURRENT ASSETS (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "41", "firstAnchor": { "contextRef": "AsOf2023-12-31", "name": "us-gaap:DepositsAssetsCurrent", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "tbody", "table", "us-gaap:ScheduleOfOtherCurrentAssetsTableTextBlock", "us-gaap:DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "lowlf_10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2023-12-31", "name": "us-gaap:DepositsAssetsCurrent", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "tbody", "table", "us-gaap:ScheduleOfOtherCurrentAssetsTableTextBlock", "us-gaap:DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "lowlf_10k.htm", "first": true, "unique": true } }, "R42": { "role": "http://f8k.com/role/InventoryDetails", "longName": "000042 - Disclosure - INVENTORY (Details)", "shortName": "INVENTORY (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "42", "firstAnchor": { "contextRef": "AsOf2023-12-31", "name": "us-gaap:InventoryRawMaterials", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "tbody", "table", "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "us-gaap:InventoryDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "lowlf_10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2023-12-31", "name": "us-gaap:InventoryRawMaterials", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "tbody", "table", "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "us-gaap:InventoryDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "lowlf_10k.htm", "first": true, "unique": true } }, "R43": { "role": "http://f8k.com/role/InventoryDetailsNarrative", "longName": "000043 - Disclosure - INVENTORY (Details Narrative)", "shortName": "INVENTORY (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "43", "firstAnchor": { "contextRef": "AsOf2023-12-31", "name": "us-gaap:InventoryValuationReserves", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "us-gaap:InventoryDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "lowlf_10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2023-12-31", "name": "us-gaap:InventoryValuationReserves", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "us-gaap:InventoryDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "lowlf_10k.htm", "first": true, "unique": true } }, "R44": { "role": "http://f8k.com/role/OtherCurrentLiabilitiesDetails", "longName": "000044 - Disclosure - Other current liabilities (Details)", "shortName": "Other current liabilities (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "44", "firstAnchor": { "contextRef": "AsOf2023-12-31", "name": "us-gaap:SalesAndExciseTaxPayableCurrent", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "tbody", "table", "us-gaap:OtherCurrentLiabilitiesTableTextBlock", "us-gaap:OtherLiabilitiesDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "lowlf_10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2023-12-31", "name": "us-gaap:SalesAndExciseTaxPayableCurrent", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "tbody", "table", "us-gaap:OtherCurrentLiabilitiesTableTextBlock", "us-gaap:OtherLiabilitiesDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "lowlf_10k.htm", "first": true, "unique": true } }, "R45": { "role": "http://f8k.com/role/OtherCurrentLiabilitiesDetailsNarrative", "longName": "000045 - Disclosure - Other current liabilities (Details Narrative)", "shortName": "Other current liabilities (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "45", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31_lowlf_ERCClaimMember_lowlf_OnTwentySixJulyTwoThousandTwentyTwoMember", "name": "lowlf:PurchaseOfDerivativePaymentRights", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "p", "us-gaap:OtherLiabilitiesDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "lowlf_10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31_lowlf_ERCClaimMember_lowlf_OnTwentySixJulyTwoThousandTwentyTwoMember", "name": "lowlf:PurchaseOfDerivativePaymentRights", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "p", "us-gaap:OtherLiabilitiesDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "lowlf_10k.htm", "first": true, "unique": true } }, "R46": { "role": "http://f8k.com/role/PropertyAndEquipmentAndRightOfUseAssetsDetails", "longName": "000046 - Disclosure - PROPERTY AND EQUIPMENT AND RIGHT OF USE ASSETS (Details)", "shortName": "PROPERTY AND EQUIPMENT AND RIGHT OF USE ASSETS (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "46", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:PropertyPlantAndEquipmentAdditions", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "tbody", "table", "us-gaap:PropertyPlantAndEquipmentTextBlock", "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "lowlf_10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:PropertyPlantAndEquipmentAdditions", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "tbody", "table", "us-gaap:PropertyPlantAndEquipmentTextBlock", "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "lowlf_10k.htm", "first": true, "unique": true } }, "R47": { "role": "http://f8k.com/role/PropertyAndEquipmentAndRightOfUseAssetsDetailsNarrative", "longName": "000047 - Disclosure - PROPERTY AND EQUIPMENT AND RIGHT OF USE ASSETS (Details Narrative)", "shortName": "PROPERTY AND EQUIPMENT AND RIGHT OF USE ASSETS (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "47", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:Depreciation", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "p", "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "lowlf_10k.htm", "first": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "lowlf:ImpairmentExpense", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "p", "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "lowlf_10k.htm", "unique": true } }, "R48": { "role": "http://f8k.com/role/IntangibleAssetsDetails", "longName": "000048 - Disclosure - INTANGIBLE ASSETS (Details)", "shortName": "INTANGIBLE ASSETS (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "48", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:GainLossOnSaleOfOtherAssets", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "tbody", "table", "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock", "us-gaap:IntangibleAssetsDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "lowlf_10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:GainLossOnSaleOfOtherAssets", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "tbody", "table", "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock", "us-gaap:IntangibleAssetsDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "lowlf_10k.htm", "first": true, "unique": true } }, "R49": { "role": "http://f8k.com/role/IntangibleAssetsDetailsNarrative", "longName": "000049 - Disclosure - INTANGIBLE ASSETS (Details Narrative)", "shortName": "INTANGIBLE ASSETS (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "49", "firstAnchor": { "contextRef": "From2023-10-01to2023-10-06", "name": "lowlf:PurchaseOfWarrants", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "p", "us-gaap:IntangibleAssetsDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "lowlf_10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-10-01to2023-10-06", "name": "lowlf:PurchaseOfWarrants", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "p", "us-gaap:IntangibleAssetsDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "lowlf_10k.htm", "first": true, "unique": true } }, "R50": { "role": "http://f8k.com/role/ShareholdersEquityDetails", "longName": "000050 - Disclosure - SHAREHOLDERS EQUITY (Details)", "shortName": "SHAREHOLDERS EQUITY (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "50", "firstAnchor": { "contextRef": "AsOf2022-12-31_lowlf_SubordinateVotingMember", "name": "us-gaap:SharesOutstanding", "unitRef": "Shares", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "strong", "td", "tr", "tbody", "table", "us-gaap:ScheduleOfCommonStockOutstandingRollForwardTableTextBlock", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "lowlf_10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2022-12-31_lowlf_SubordinateVotingMember", "name": "us-gaap:SharesOutstanding", "unitRef": "Shares", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "strong", "td", "tr", "tbody", "table", "us-gaap:ScheduleOfCommonStockOutstandingRollForwardTableTextBlock", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "lowlf_10k.htm", "first": true, "unique": true } }, "R51": { "role": "http://f8k.com/role/ShareholdersEquityDetails1", "longName": "000051 - Disclosure - SHAREHOLDERS EQUITY (Details 1)", "shortName": "SHAREHOLDERS EQUITY (Details 1)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "51", "firstAnchor": { "contextRef": "AsOf2022-12-31", "name": "lowlf:WarrantsBeginningBalance", "unitRef": "Shares", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "strong", "td", "tr", "tbody", "table", "lowlf:ScheduleOfWarrantsOutstandingTableTextBlock", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "lowlf_10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2022-12-31", "name": "lowlf:WarrantsBeginningBalance", "unitRef": "Shares", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "strong", "td", "tr", "tbody", "table", "lowlf:ScheduleOfWarrantsOutstandingTableTextBlock", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "lowlf_10k.htm", "first": true, "unique": true } }, "R52": { "role": "http://f8k.com/role/DebtDetails", "longName": "000052 - Disclosure - DEBT (Details)", "shortName": "DEBT (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "52", "firstAnchor": { "contextRef": "AsOf2023-12-31", "name": "us-gaap:LongTermDebtCurrent", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "tbody", "table", "us-gaap:ScheduleOfDebtTableTextBlock", "us-gaap:DebtDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "lowlf_10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2023-12-31", "name": "us-gaap:LongTermDebtCurrent", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "tbody", "table", "us-gaap:ScheduleOfDebtTableTextBlock", "us-gaap:DebtDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "lowlf_10k.htm", "first": true, "unique": true } }, "R53": { "role": "http://f8k.com/role/DebtDetails1", "longName": "000053 - Disclosure - DEBT (Details 1)", "shortName": "DEBT (Details 1)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "53", "firstAnchor": { "contextRef": "AsOf2023-12-31", "name": "us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "tbody", "table", "us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "lowlf_10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2023-12-31", "name": "us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "tbody", "table", "us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "lowlf_10k.htm", "first": true, "unique": true } }, "R54": { "role": "http://f8k.com/role/DebtDetailsNarrative", "longName": "000054 - Disclosure - DEBT (Details Narrative)", "shortName": "DEBT (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "54", "firstAnchor": { "contextRef": "From2021-01-01to2021-12-31", "name": "us-gaap:PaymentsOfFinancingCosts", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "em", "p", "td", "tr", "tbody", "table", "us-gaap:DebtDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "lowlf_10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2021-01-01to2021-12-31", "name": "us-gaap:PaymentsOfFinancingCosts", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "em", "p", "td", "tr", "tbody", "table", "us-gaap:DebtDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "lowlf_10k.htm", "first": true, "unique": true } }, "R55": { "role": "http://f8k.com/role/LeasesDetails", "longName": "000055 - Disclosure - LEASES (Details)", "shortName": "LEASES (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "55", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "lowlf:OperatingLeaseLiabilityBeginning", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "strong", "td", "tr", "tbody", "table", "lowlf:ScheduleOfLeaseObligationsTableTextBlock", "us-gaap:LeasesOfLesseeDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "lowlf_10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "lowlf:OperatingLeaseLiabilityBeginning", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "strong", "td", "tr", "tbody", "table", "lowlf:ScheduleOfLeaseObligationsTableTextBlock", "us-gaap:LeasesOfLesseeDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "lowlf_10k.htm", "first": true, "unique": true } }, "R56": { "role": "http://f8k.com/role/LeasesDetails1", "longName": "000056 - Disclosure - LEASES (Details 1)", "shortName": "LEASES (Details 1)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "56", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:AmortizationOfLeasedAsset", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "tbody", "table", "us-gaap:LeaseCostTableTextBlock", "us-gaap:LeasesOfLesseeDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "lowlf_10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:AmortizationOfLeasedAsset", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "tbody", "table", "us-gaap:LeaseCostTableTextBlock", "us-gaap:LeasesOfLesseeDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "lowlf_10k.htm", "first": true, "unique": true } }, "R57": { "role": "http://f8k.com/role/LeasesDetails2", "longName": "000057 - Disclosure - LEASES (Details 2)", "shortName": "LEASES (Details 2)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "57", "firstAnchor": { "contextRef": "AsOf2023-12-31", "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "tbody", "table", "us-gaap:ScheduleOfFutureMinimumLeasePaymentsForCapitalLeasesTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "lowlf_10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2023-12-31", "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "tbody", "table", "us-gaap:ScheduleOfFutureMinimumLeasePaymentsForCapitalLeasesTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "lowlf_10k.htm", "first": true, "unique": true } }, "R58": { "role": "http://f8k.com/role/LeasesDetailsNarrative", "longName": "000058 - Disclosure - LEASES (Details Narrative)", "shortName": "LEASES (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "58", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:FinanceLeaseRightOfUseAssetAmortization", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "us-gaap:LeasesOfLesseeDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "lowlf_10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:FinanceLeaseRightOfUseAssetAmortization", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "us-gaap:LeasesOfLesseeDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "lowlf_10k.htm", "first": true, "unique": true } }, "R59": { "role": "http://f8k.com/role/ShareBasedCompensationDetails", "longName": "000059 - Disclosure - SHARE BASED COMPENSATION (Details)", "shortName": "SHARE BASED COMPENSATION (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "59", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:EmployeeBenefitsAndShareBasedCompensation", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "strong", "td", "tr", "tbody", "table", "us-gaap:ScheduleOfShareBasedCompensationActivityTableTextBlock", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "lowlf_10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:EmployeeBenefitsAndShareBasedCompensation", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "strong", "td", "tr", "tbody", "table", "us-gaap:ScheduleOfShareBasedCompensationActivityTableTextBlock", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "lowlf_10k.htm", "first": true, "unique": true } }, "R60": { "role": "http://f8k.com/role/ShareBasedCompensationDetails1", "longName": "000060 - Disclosure - SHARE BASED COMPENSATION (Details 1)", "shortName": "SHARE BASED COMPENSATION (Details 1)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "60", "firstAnchor": { "contextRef": "AsOf2022-12-31", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "unitRef": "Shares", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "tbody", "table", "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "lowlf_10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2022-12-31", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "unitRef": "Shares", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "tbody", "table", "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "lowlf_10k.htm", "first": true, "unique": true } }, "R61": { "role": "http://f8k.com/role/ShareBasedCompensationDetails2", "longName": "000061 - Disclosure - SHARE BASED COMPENSATION (Details 2)", "shortName": "SHARE BASED COMPENSATION (Details 2)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "61", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "lowlf:RsusOutstandingBeginningBalance", "unitRef": "Shares", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "tbody", "table", "us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "lowlf_10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "lowlf:RsusOutstandingBeginningBalance", "unitRef": "Shares", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "tbody", "table", "us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "lowlf_10k.htm", "first": true, "unique": true } }, "R62": { "role": "http://f8k.com/role/ShareBasedCompensationDetails3", "longName": "000062 - Disclosure - SHARE BASED COMPENSATION (Details 3)", "shortName": "SHARE BASED COMPENSATION (Details 3)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "62", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31_lowlf_StockOptionsMember", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate", "unitRef": "Pure", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "td", "tr", "tbody", "table", "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "lowlf_10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31_lowlf_StockOptionsMember", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate", "unitRef": "Pure", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "td", "tr", "tbody", "table", "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "lowlf_10k.htm", "first": true, "unique": true } }, "R63": { "role": "http://f8k.com/role/ShareBasedCompensationDetailsNarrative", "longName": "000063 - Disclosure - SHARE BASED COMPENSATION (Details Narrative)", "shortName": "SHARE BASED COMPENSATION (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "63", "firstAnchor": { "contextRef": "AsOf2023-12-31", "name": "lowlf:ProceedsFromIssuanceOfStockOptions", "unitRef": "Shares", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "p", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "lowlf_10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2023-12-31", "name": "lowlf:ProceedsFromIssuanceOfStockOptions", "unitRef": "Shares", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "p", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "lowlf_10k.htm", "first": true, "unique": true } }, "R64": { "role": "http://f8k.com/role/IncomeTaxesDetails", "longName": "000064 - Disclosure - INCOME TAXES (Details)", "shortName": "INCOME TAXES (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "64", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:CurrentFederalTaxExpenseBenefit", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "tbody", "table", "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "lowlf_10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:CurrentFederalTaxExpenseBenefit", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "tbody", "table", "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "lowlf_10k.htm", "first": true, "unique": true } }, "R65": { "role": "http://f8k.com/role/IncomeTaxesDetails1", "longName": "000065 - Disclosure - INCOME TAXES (Details 1)", "shortName": "INCOME TAXES (Details 1)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "65", "firstAnchor": { "contextRef": "AsOf2023-12-31", "name": "us-gaap:DeferredTaxAssetsOperatingLossCarryforwards", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "tbody", "table", "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "lowlf_10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2023-12-31", "name": "us-gaap:DeferredTaxAssetsOperatingLossCarryforwards", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "tbody", "table", "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "lowlf_10k.htm", "first": true, "unique": true } }, "R66": { "role": "http://f8k.com/role/IncomeTaxesDetailsNarrative", "longName": "000066 - Disclosure - INCOME TAXES (Details Narrative)", "shortName": "INCOME TAXES (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "66", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:IncomeTaxExpenseBenefit", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "p", "td", "tr", "tbody", "table", "body", "html" ], "reportCount": 1, "baseRef": "lowlf_10k.htm", "first": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:EffectiveIncomeTaxRateContinuingOperations", "unitRef": "Pure", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "p", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "lowlf_10k.htm", "unique": true } }, "R67": { "role": "http://f8k.com/role/NetIncomeLossPerShareDetails", "longName": "000067 - Disclosure - NET INCOME (LOSS) PER SHARE (Details)", "shortName": "NET INCOME (LOSS) PER SHARE (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "67", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "tbody", "table", "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "us-gaap:EarningsPerShareTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "lowlf_10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "tbody", "table", "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "us-gaap:EarningsPerShareTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "lowlf_10k.htm", "first": true, "unique": true } }, "R68": { "role": "http://f8k.com/role/CommitmentsAndContingenciesDetailsNarrative", "longName": "000068 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details Narrative)", "shortName": "COMMITMENTS AND CONTINGENCIES (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "68", "firstAnchor": null, "uniqueAnchor": null }, "R69": { "role": "http://f8k.com/role/GeneralAndAdministrativeExpensesDetails", "longName": "000069 - Disclosure - GENERAL AND ADMINISTRATIVE EXPENSES (Details)", "shortName": "GENERAL AND ADMINISTRATIVE EXPENSES (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "69", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:GeneralAndAdministrativeExpense", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "tbody", "table", "body", "html" ], "reportCount": 1, "baseRef": "lowlf_10k.htm", "first": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31_lowlf_SalariesAndBenefitsMember", "name": "us-gaap:GeneralAndAdministrativeExpense", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "tbody", "table", "us-gaap:ScheduleOfOtherOperatingCostAndExpenseByComponentTextBlock", "us-gaap:OtherOperatingIncomeAndExpenseTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "lowlf_10k.htm", "unique": true } }, "R70": { "role": "http://f8k.com/role/RelatedPartyTransactionsDetailsNarrative", "longName": "000070 - Disclosure - RELATED PARTY TRANSACTIONS (Details Narrative)", "shortName": "RELATED PARTY TRANSACTIONS (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "70", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "lowlf:RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParties", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "p", "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "lowlf_10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "lowlf:RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParties", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "p", "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "lowlf_10k.htm", "first": true, "unique": true } } }, "tag": { "us-gaap_AccountingPoliciesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccountingPoliciesAbstract", "lang": { "en-us": { "role": { "label": "BUSINESS BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES" } } }, "auth_ref": [] }, "lowlf_AccountingStandardsNotYetAdoptedPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://f8k.com/20231231", "localname": "AccountingStandardsNotYetAdoptedPolicyTextBlock", "presentation": [ "http://f8k.com/role/BusinessBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Accounting standards not yet adopted" } } }, "auth_ref": [] }, "us-gaap_AccountsPayableCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccountsPayableCurrent", "crdr": "credit", "calculation": { "http://f8k.com/role/ConsolidatedBalanceSheets": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 11.0 } }, "presentation": [ "http://f8k.com/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Accounts payable", "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)." } } }, "auth_ref": [ "r16", "r620" ] }, "us-gaap_AccountsReceivableNetCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccountsReceivableNetCurrent", "crdr": "debit", "calculation": { "http://f8k.com/role/ConsolidatedBalanceSheets": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://f8k.com/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Accounts Receivable - net of allowance for doubtful accounts of $1,053 and $1,139 at December 31, 2022 and December 31, 2021, respectively", "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current." } } }, "auth_ref": [ "r242", "r243" ] }, "us-gaap_AccruedEmployeeBenefitsCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccruedEmployeeBenefitsCurrent", "crdr": "credit", "calculation": { "http://f8k.com/role/ConsolidatedBalanceSheets": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 12.0 } }, "presentation": [ "http://f8k.com/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Accrued payroll and benefits", "documentation": "Carrying value as of the balance sheet date of obligations, excluding pension and other postretirement benefits, incurred through that date and payable for perquisites provided to employees pertaining to services received from them. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)." } } }, "auth_ref": [ "r20" ] }, "us-gaap_AccruedInsuranceCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccruedInsuranceCurrent", "crdr": "credit", "presentation": [ "http://f8k.com/role/OtherCurrentLiabilitiesDetails" ], "lang": { "en-us": { "role": { "label": "Insurance And Professional Accrual", "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable to insurance entities to mitigate potential loss from various risks or to satisfy a promise to provide certain coverage's to employees. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)." } } }, "auth_ref": [ "r20" ] }, "us-gaap_AccruedMarketingCostsCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccruedMarketingCostsCurrent", "crdr": "credit", "presentation": [ "http://f8k.com/role/OtherCurrentLiabilitiesDetails" ], "lang": { "en-us": { "role": { "label": "Third Party Brand Distribution Accrual", "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for the marketing, trade and selling of the entity's goods and services. Marketing costs would include expenditures for planning and executing the conception, pricing, promotion, and distribution of ideas, goods, and services; costs of public relations and corporate promotions; and obligations incurred and payable for sales discounts, rebates, price protection programs, etc. offered to customers and under government programs. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)." } } }, "auth_ref": [] }, "lowlf_AccumulatedAmortizationBeginning": { "xbrltype": "monetaryItemType", "nsuri": "http://f8k.com/20231231", "localname": "AccumulatedAmortizationBeginning", "crdr": "debit", "presentation": [ "http://f8k.com/role/IntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "periodStartLabel": "Accumulated amortization, beginning", "label": "[Accumulated amortization, beginning]" } } }, "auth_ref": [] }, "lowlf_AccumulatedAmortizationDisposals": { "xbrltype": "monetaryItemType", "nsuri": "http://f8k.com/20231231", "localname": "AccumulatedAmortizationDisposals", "crdr": "debit", "presentation": [ "http://f8k.com/role/PropertyAndEquipmentAndRightOfUseAssetsDetails" ], "lang": { "en-us": { "role": { "label": "Accumulated amortization disposals" } } }, "auth_ref": [] }, "lowlf_AccumulatedAmortizationEnding": { "xbrltype": "monetaryItemType", "nsuri": "http://f8k.com/20231231", "localname": "AccumulatedAmortizationEnding", "crdr": "debit", "presentation": [ "http://f8k.com/role/IntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "periodEndLabel": "Accumulated amortization, ending", "label": "[Accumulated amortization, ending]" } } }, "auth_ref": [] }, "lowlf_AccumulatedAmortizationImpairment": { "xbrltype": "monetaryItemType", "nsuri": "http://f8k.com/20231231", "localname": "AccumulatedAmortizationImpairment", "crdr": "debit", "presentation": [ "http://f8k.com/role/IntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "label": "Accumulated amortization impairment" } } }, "auth_ref": [] }, "lowlf_AccumulatedAmortizationImpairments": { "xbrltype": "monetaryItemType", "nsuri": "http://f8k.com/20231231", "localname": "AccumulatedAmortizationImpairments", "crdr": "debit", "presentation": [ "http://f8k.com/role/PropertyAndEquipmentAndRightOfUseAssetsDetails" ], "lang": { "en-us": { "role": { "label": "Accumulated amortization impairments" } } }, "auth_ref": [] }, "lowlf_AccumulatedAmortizationRemeasurement": { "xbrltype": "monetaryItemType", "nsuri": "http://f8k.com/20231231", "localname": "AccumulatedAmortizationRemeasurement", "crdr": "debit", "presentation": [ "http://f8k.com/role/PropertyAndEquipmentAndRightOfUseAssetsDetails" ], "lang": { "en-us": { "role": { "label": "Accumulated amortization remeasurement" } } }, "auth_ref": [] }, "lowlf_AccumulatedDepreciationBeginning": { "xbrltype": "monetaryItemType", "nsuri": "http://f8k.com/20231231", "localname": "AccumulatedDepreciationBeginning", "crdr": "credit", "presentation": [ "http://f8k.com/role/PropertyAndEquipmentAndRightOfUseAssetsDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Accumulated Depreciation, Beginning", "label": "[Accumulated Depreciation, Beginning]" } } }, "auth_ref": [] }, "lowlf_AccumulatedDepreciationEnding": { "xbrltype": "monetaryItemType", "nsuri": "http://f8k.com/20231231", "localname": "AccumulatedDepreciationEnding", "crdr": "credit", "presentation": [ "http://f8k.com/role/PropertyAndEquipmentAndRightOfUseAssetsDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Accumulated Depreciation, Ending", "label": "[Accumulated Depreciation, Ending]" } } }, "auth_ref": [] }, "lowlf_AcquiredPurchaseRightsMember": { "xbrltype": "domainItemType", "nsuri": "http://f8k.com/20231231", "localname": "AcquiredPurchaseRightsMember", "presentation": [ "http://f8k.com/role/IntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "label": "Acquired Purchase Rights [Member]" } } }, "auth_ref": [] }, "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract", "presentation": [ "http://f8k.com/role/ConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Adjustments to reconcile net loss to net cash used in operating activities:" } } }, "auth_ref": [] }, "lowlf_AdministrativeMember": { "xbrltype": "domainItemType", "nsuri": "http://f8k.com/20231231", "localname": "AdministrativeMember", "presentation": [ "http://f8k.com/role/GeneralAndAdministrativeExpensesDetails" ], "lang": { "en-us": { "role": { "label": "Administrative Member" } } }, "auth_ref": [] }, "us-gaap_AdvanceRoyalties": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AdvanceRoyalties", "crdr": "debit", "presentation": [ "http://f8k.com/role/PrepaidAndOtherCurrentAssetsDetails" ], "lang": { "en-us": { "role": { "label": "Royalty Advance", "documentation": "The amount paid to music publishers, record producers, songwriters, or other artists in advance of their earning royalties from record or music sales. Such an amount is based on contractual terms and is generally nonrefundable." } } }, "auth_ref": [ "r453" ] }, "lowlf_AggregateIntrinsicValueExpired": { "xbrltype": "monetaryItemType", "nsuri": "http://f8k.com/20231231", "localname": "AggregateIntrinsicValueExpired", "crdr": "debit", "presentation": [ "http://f8k.com/role/ShareBasedCompensationDetails1" ], "lang": { "en-us": { "role": { "label": "Aggregate Intrinsic Value, Expired" } } }, "auth_ref": [] }, "lowlf_AggregateIntrinsicValueVestedAndExpected": { "xbrltype": "monetaryItemType", "nsuri": "http://f8k.com/20231231", "localname": "AggregateIntrinsicValueVestedAndExpected", "crdr": "debit", "presentation": [ "http://f8k.com/role/ShareBasedCompensationDetails1" ], "lang": { "en-us": { "role": { "label": "Aggregate Intrinsic Value vested and expected" } } }, "auth_ref": [] }, "lowlf_AggregatePrincipalAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://f8k.com/20231231", "localname": "AggregatePrincipalAmount", "crdr": "debit", "presentation": [ "http://f8k.com/role/IntangibleAssetsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Aggregate principal amount" } } }, "auth_ref": [] }, "us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AllowanceForDoubtfulAccountsReceivableCurrent", "crdr": "credit", "presentation": [ "http://f8k.com/role/ConsolidatedBalanceSheetsParenthetical" ], "lang": { "en-us": { "role": { "label": "Allowance For Doubtful Accounts", "documentation": "Amount of allowance for credit loss on accounts receivable, classified as current." } } }, "auth_ref": [ "r157", "r246", "r251" ] }, "dei_AmendmentFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AmendmentFlag", "presentation": [ "http://f8k.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Amendment Flag", "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission." } } }, "auth_ref": [] }, "lowlf_AmortizationExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://f8k.com/20231231", "localname": "AmortizationExpense", "crdr": "debit", "presentation": [ "http://f8k.com/role/IntangibleAssetsDetailsNarrative" ], "lang": { "en-us": { "role": { "verboseLabel": "Amortization", "label": "[Amortization]" } } }, "auth_ref": [] }, "us-gaap_AmortizationOfFinancingCosts": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AmortizationOfFinancingCosts", "crdr": "debit", "calculation": { "http://f8k.com/role/ConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://f8k.com/role/ConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Amortization of debt issuance costs", "documentation": "Amount of amortization expense attributable to debt issuance costs." } } }, "auth_ref": [ "r80", "r308", "r422", "r651" ] }, "us-gaap_AmortizationOfIntangibleAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AmortizationOfIntangibleAssets", "crdr": "debit", "presentation": [ "http://f8k.com/role/IntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Amortization", "label": "[Amortization of Intangible Assets]", "verboseLabel": "Amortization", "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method." } } }, "auth_ref": [ "r6", "r43", "r48" ] }, "us-gaap_AmortizationOfLeasedAsset": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AmortizationOfLeasedAsset", "crdr": "debit", "presentation": [ "http://f8k.com/role/LeasesDetails1" ], "lang": { "en-us": { "role": { "label": "Amortization Of Leased Assets - Finance Leases", "documentation": "The expense charged against earnings for the periodic recognition of capitalized leases. This element may apply to energy companies that lease mineral producing properties and to other enterprises that capitalize property, plant, or equipment obtained through capital leases." } } }, "auth_ref": [ "r123", "r129" ] }, "lowlf_AmortizationOfLeasedAssetsOperatingLeases": { "xbrltype": "monetaryItemType", "nsuri": "http://f8k.com/20231231", "localname": "AmortizationOfLeasedAssetsOperatingLeases", "crdr": "credit", "presentation": [ "http://f8k.com/role/LeasesDetails1" ], "lang": { "en-us": { "role": { "label": "Amortization Of Leased Assets - Operating Leases" } } }, "auth_ref": [] }, "lowlf_AmortizationsOfIntangibleAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://f8k.com/20231231", "localname": "AmortizationsOfIntangibleAssets", "crdr": "debit", "presentation": [ "http://f8k.com/role/IntangibleAssetsDetailsNarrative" ], "lang": { "en-us": { "role": { "verboseLabel": "Amortization", "label": "[Amortization 1]" } } }, "auth_ref": [] }, "us-gaap_Assets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "Assets", "crdr": "debit", "calculation": { "http://f8k.com/role/ConsolidatedBalanceSheets": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://f8k.com/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "totalLabel": "Total assets", "label": "[Assets]", "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events." } } }, "auth_ref": [ "r110", "r151", "r180", "r220", "r229", "r234", "r248", "r277", "r278", "r279", "r280", "r281", "r282", "r283", "r284", "r285", "r397", "r401", "r414", "r472", "r536", "r620", "r626", "r663", "r664", "r702" ] }, "us-gaap_AssetsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AssetsAbstract", "presentation": [ "http://f8k.com/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "ASSETS" } } }, "auth_ref": [] }, "us-gaap_AssetsCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AssetsCurrent", "crdr": "debit", "calculation": { "http://f8k.com/role/ConsolidatedBalanceSheets": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://f8k.com/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "totalLabel": "Total current assets", "label": "[Assets, Current]", "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events." } } }, "auth_ref": [ "r146", "r160", "r180", "r248", "r277", "r278", "r279", "r280", "r281", "r282", "r283", "r284", "r285", "r397", "r401", "r414", "r620", "r663", "r664", "r702" ] }, "us-gaap_AssetsCurrentAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AssetsCurrentAbstract", "presentation": [ "http://f8k.com/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Current assets:" } } }, "auth_ref": [] }, "dei_AuditorFirmId": { "xbrltype": "nonemptySequenceNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AuditorFirmId", "presentation": [ "http://f8k.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Auditor Firm Id", "documentation": "PCAOB issued Audit Firm Identifier" } } }, "auth_ref": [ "r628", "r629", "r630" ] }, "dei_AuditorLocation": { "xbrltype": "internationalNameItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AuditorLocation", "presentation": [ "http://f8k.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Auditor Location" } } }, "auth_ref": [ "r628", "r629", "r630" ] }, "dei_AuditorName": { "xbrltype": "internationalNameItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AuditorName", "presentation": [ "http://f8k.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Auditor Name" } } }, "auth_ref": [ "r628", "r629", "r630" ] }, "lowlf_AugustTwentyTwentyMember": { "xbrltype": "domainItemType", "nsuri": "http://f8k.com/20231231", "localname": "AugustTwentyTwentyMember", "presentation": [ "http://f8k.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "August 2020 [Member]" } } }, "auth_ref": [] }, "us-gaap_AwardDateAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AwardDateAxis", "presentation": [ "http://f8k.com/role/CommitmentsAndContingenciesDetailsNarrative", "http://f8k.com/role/OtherCurrentLiabilitiesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Award Date [Axis]", "documentation": "Information by date or year award under share-based payment arrangement is granted." } } }, "auth_ref": [ "r666", "r667", "r668", "r669", "r670", "r671", "r672", "r673", "r674", "r675", "r676", "r677", "r678", "r679", "r680", "r681", "r682", "r683", "r684", "r685", "r686", "r687", "r688", "r689", "r690", "r691" ] }, "us-gaap_AwardDateDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AwardDateDomain", "presentation": [ "http://f8k.com/role/CommitmentsAndContingenciesDetailsNarrative", "http://f8k.com/role/OtherCurrentLiabilitiesDetailsNarrative" ], "lang": { "en-us": { "role": { "documentation": "Date or year award under share-based payment arrangement is granted." } } }, "auth_ref": [ "r666", "r667", "r668", "r669", "r670", "r671", "r672", "r673", "r674", "r675", "r676", "r677", "r678", "r679", "r680", "r681", "r682", "r683", "r684", "r685", "r686", "r687", "r688", "r689", "r690", "r691" ] }, "us-gaap_AwardTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AwardTypeAxis", "presentation": [ "http://f8k.com/role/ShareBasedCompensationDetails3" ], "lang": { "en-us": { "role": { "label": "Award Type [Axis]", "documentation": "Information by type of award under share-based payment arrangement." } } }, "auth_ref": [ "r334", "r335", "r336", "r338", "r339", "r340", "r341", "r342", "r343", "r344", "r345", "r346", "r347", "r348", "r349", "r350", "r351", "r352", "r353", "r354", "r355", "r358", "r359", "r360", "r361", "r362" ] }, "lowlf_BasicShares": { "xbrltype": "sharesItemType", "nsuri": "http://f8k.com/20231231", "localname": "BasicShares", "presentation": [ "http://f8k.com/role/NetIncomeLossPerShareDetails" ], "lang": { "en-us": { "role": { "label": "Basic Shares" } } }, "auth_ref": [] }, "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BasisOfAccountingPolicyPolicyTextBlock", "presentation": [ "http://f8k.com/role/BusinessBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Basis Of Presentation", "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS)." } } }, "auth_ref": [] }, "us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BasisOfPresentationAndSignificantAccountingPoliciesTextBlock", "presentation": [ "http://f8k.com/role/BusinessBasisOfPresentationAndSummaryOfSignificantAccountingPolicies" ], "lang": { "en-us": { "role": { "label": "Basis Of Presentation And Summary Of Significant Accounting Policies", "documentation": "The entire disclosure for the basis of presentation and significant accounting policies concepts. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS). Accounting policies describe all significant accounting policies of the reporting entity." } } }, "auth_ref": [ "r92" ] }, "lowlf_BrandedProductsPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://f8k.com/20231231", "localname": "BrandedProductsPolicyTextBlock", "presentation": [ "http://f8k.com/role/BusinessBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Branded Products" } } }, "auth_ref": [] }, "lowlf_BuildingsMember": { "xbrltype": "domainItemType", "nsuri": "http://f8k.com/20231231", "localname": "BuildingsMember", "presentation": [ "http://f8k.com/role/BusinessBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "label": "Buildings [Member]" } } }, "auth_ref": [] }, "us-gaap_BusinessCombinationsPolicy": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessCombinationsPolicy", "presentation": [ "http://f8k.com/role/BusinessBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Business Combinations", "documentation": "Disclosure of accounting policy for completed business combinations (purchase method, acquisition method or combination of entities under common control). This accounting policy may include a general discussion of the purchase method or acquisition method of accounting (including for example, the treatment accorded contingent consideration, the identification of assets and liabilities, the purchase price allocation process, how the fair values of acquired assets and liabilities are determined) and the entity's specific application thereof. An entity that acquires another entity in a leveraged buyout transaction generally discloses the accounting policy followed by the acquiring entity in determining the basis used to value its interest in the acquired entity, and the rationale for that accounting policy." } } }, "auth_ref": [ "r58" ] }, "lowlf_BusinessPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://f8k.com/20231231", "localname": "BusinessPolicyTextBlock", "presentation": [ "http://f8k.com/role/BusinessBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Business" } } }, "auth_ref": [] }, "lowlf_CancelledCommonShares": { "xbrltype": "monetaryItemType", "nsuri": "http://f8k.com/20231231", "localname": "CancelledCommonShares", "crdr": "debit", "presentation": [ "http://f8k.com/role/IntangibleAssetsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Cancelled common shares" } } }, "auth_ref": [] }, "us-gaap_CapitalLeaseObligations": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CapitalLeaseObligations", "crdr": "credit", "presentation": [ "http://f8k.com/role/LeasesDetailsNarrative" ], "lang": { "en-us": { "role": { "verboseLabel": "Lease obligation", "label": "[Capital Lease Obligations]", "documentation": "Amount equal to the present value (the principal) at the beginning of the lease term of minimum lease payments during the lease term (excluding that portion of the payments representing executory costs such as insurance, maintenance, and taxes to be paid by the lessor, together with any profit thereon) net of payments or other amounts applied to the principal through the balance sheet date." } } }, "auth_ref": [ "r121", "r130", "r131" ] }, "us-gaap_CapitalLeaseObligationsCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CapitalLeaseObligationsCurrent", "crdr": "credit", "calculation": { "http://f8k.com/role/ConsolidatedBalanceSheets": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 14.0 } }, "presentation": [ "http://f8k.com/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Lease obligation, current portion", "documentation": "Amount of capital lease obligation due within one year or the normal operating cycle, if longer." } } }, "auth_ref": [ "r120", "r128", "r130" ] }, "us-gaap_CapitalLeaseObligationsNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CapitalLeaseObligationsNoncurrent", "crdr": "credit", "calculation": { "http://f8k.com/role/ConsolidatedBalanceSheets": { "parentTag": "us-gaap_Liabilities", "weight": 1.0, "order": 19.0 } }, "presentation": [ "http://f8k.com/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Lease obligation", "documentation": "Amount equal to the present value (the principal) at the beginning of the lease term of minimum lease payments during the lease term (excluding that portion of the payments representing executory costs such as insurance, maintenance, and taxes to be paid by the lessor, together with any profit thereon) net of payments or other amounts applied to the principal, through the balance sheet date and due to be paid more than one year (or one operating cycle, if longer) after the balance sheet date." } } }, "auth_ref": [ "r122", "r128", "r130" ] }, "us-gaap_CashAndCashEquivalentsPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashAndCashEquivalentsPolicyTextBlock", "presentation": [ "http://f8k.com/role/BusinessBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Cash and Cash Equivalents", "documentation": "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value." } } }, "auth_ref": [ "r30" ] }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "crdr": "debit", "calculation": { "http://f8k.com/role/ConsolidatedBalanceSheets": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://f8k.com/role/ConsolidatedBalanceSheets", "http://f8k.com/role/ConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Cash and cash equivalents", "periodStartLabel": "Cash and cash equivalents-beginning of year", "periodEndLabel": "Cash, cash equivalents-end of period", "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates." } } }, "auth_ref": [ "r29", "r89", "r177" ] }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect", "crdr": "debit", "calculation": { "http://f8k.com/role/ConsolidatedStatementsOfCashFlows": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://f8k.com/role/ConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "totalLabel": "Change in cash and cash equivalents", "label": "[Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect]", "documentation": "Amount of increase (decrease) in cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; excluding effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates." } } }, "auth_ref": [ "r2", "r89" ] }, "us-gaap_CashFDICInsuredAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashFDICInsuredAmount", "crdr": "debit", "presentation": [ "http://f8k.com/role/BusinessBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Cash FDIC Insured Amount", "documentation": "The amount of cash deposited in financial institutions as of the balance sheet date that is insured by the Federal Deposit Insurance Corporation." } } }, "auth_ref": [] }, "lowlf_ChangesInAdoptionAccumulatedDeficit": { "xbrltype": "monetaryItemType", "nsuri": "http://f8k.com/20231231", "localname": "ChangesInAdoptionAccumulatedDeficit", "crdr": "credit", "presentation": [ "http://f8k.com/role/BusinessBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Changes in adoption accumulated deficit" } } }, "auth_ref": [] }, "us-gaap_CharityCareOtherMeasurementBasisAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CharityCareOtherMeasurementBasisAmount", "crdr": "debit", "presentation": [ "http://f8k.com/role/PropertyAndEquipmentAndRightOfUseAssetsDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Remeasurements", "label": "[Charity Care, Other Measurement Basis, Amount]", "negatedLabel": "Remeasurements", "documentation": "The amount of charity care provided during the period on a basis other than the provider's direct and indirect costs of providing charity care services." } } }, "auth_ref": [] }, "dei_CityAreaCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CityAreaCode", "presentation": [ "http://f8k.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "City Area Code", "documentation": "Area code of city" } } }, "auth_ref": [] }, "us-gaap_ClassOfStockDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ClassOfStockDomain", "presentation": [ "http://f8k.com/role/ShareholdersEquityDetails" ], "lang": { "en-us": { "role": { "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock." } } }, "auth_ref": [ "r143", "r154", "r155", "r156", "r180", "r200", "r201", "r206", "r208", "r214", "r215", "r248", "r277", "r279", "r280", "r281", "r284", "r285", "r314", "r315", "r317", "r320", "r326", "r414", "r493", "r494", "r495", "r496", "r503", "r504", "r505", "r506", "r507", "r508", "r509", "r510", "r511", "r512", "r513", "r514", "r524", "r545", "r568", "r584", "r585", "r586", "r587", "r588", "r636", "r652", "r656" ] }, "us-gaap_ClassOfWarrantOrRightAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ClassOfWarrantOrRightAxis", "presentation": [ "http://f8k.com/role/ShareBasedCompensationDetails3" ], "lang": { "en-us": { "role": { "label": "Class of Warrant or Right [Axis]", "documentation": "Information by type of warrant or right issued." } } }, "auth_ref": [ "r52" ] }, "us-gaap_ClassOfWarrantOrRightDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ClassOfWarrantOrRightDomain", "presentation": [ "http://f8k.com/role/ShareBasedCompensationDetails3" ], "lang": { "en-us": { "role": { "documentation": "Name of the class or type of warrant or right outstanding. Warrants and rights represent derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months." } } }, "auth_ref": [] }, "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommitmentsAndContingenciesDisclosureAbstract", "presentation": [ "http://f8k.com/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "verboseLabel": "COMMITMENTS AND CONTINGENCIES" } } }, "auth_ref": [] }, "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommitmentsAndContingenciesDisclosureTextBlock", "presentation": [ "http://f8k.com/role/CommitmentsAndContingencies" ], "lang": { "en-us": { "role": { "label": "Commitments And Contingencies", "documentation": "The entire disclosure for commitments and contingencies." } } }, "auth_ref": [ "r100", "r271", "r272", "r591", "r662" ] }, "us-gaap_CommonStockValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockValue", "crdr": "credit", "calculation": { "http://f8k.com/role/ConsolidatedBalanceSheets": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 22.0 } }, "presentation": [ "http://f8k.com/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Share capital", "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity." } } }, "auth_ref": [ "r69", "r473", "r620" ] }, "us-gaap_ConcentrationRiskBenchmarkDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ConcentrationRiskBenchmarkDomain", "presentation": [ "http://f8k.com/role/PropertyAndEquipmentAndRightOfUseAssetsDetailsNarrative", "http://f8k.com/role/ShareBasedCompensationDetails" ], "lang": { "en-us": { "role": { "documentation": "The denominator in a calculation of a disclosed concentration risk percentage." } } }, "auth_ref": [ "r36", "r37", "r60", "r61", "r241", "r590" ] }, "us-gaap_ConcentrationRiskByBenchmarkAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ConcentrationRiskByBenchmarkAxis", "presentation": [ "http://f8k.com/role/PropertyAndEquipmentAndRightOfUseAssetsDetailsNarrative", "http://f8k.com/role/ShareBasedCompensationDetails" ], "lang": { "en-us": { "role": { "label": "Concentration Risk Benchmark [Axis]", "documentation": "Information by benchmark of concentration risk." } } }, "auth_ref": [ "r36", "r37", "r60", "r61", "r241", "r490", "r590" ] }, "us-gaap_ConstructionInProgressMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ConstructionInProgressMember", "presentation": [ "http://f8k.com/role/BusinessBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetails", "http://f8k.com/role/PropertyAndEquipmentAndRightOfUseAssetsDetails" ], "lang": { "en-us": { "role": { "label": "Construction in Process", "documentation": "Structure or a modification to a structure under construction. Includes recently completed structures or modifications to structures that have not been placed into service." } } }, "auth_ref": [] }, "us-gaap_ConversionOfStockSharesIssued1": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ConversionOfStockSharesIssued1", "presentation": [ "http://f8k.com/role/ShareBasedCompensationDetails2" ], "lang": { "en-us": { "role": { "negatedLabel": "RSUs Vested", "label": "[Conversion of Stock, Shares Issued]", "documentation": "The number of new shares issued in the conversion of stock in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period." } } }, "auth_ref": [ "r32", "r33", "r34" ] }, "us-gaap_ConvertibleDebtCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ConvertibleDebtCurrent", "crdr": "credit", "calculation": { "http://f8k.com/role/ConsolidatedBalanceSheets": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 15.0 } }, "presentation": [ "http://f8k.com/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Convertible debentures", "documentation": "The portion of the carrying value of long-term convertible debt as of the balance sheet date that is scheduled to be repaid within one year or in the normal operating cycle if longer. Convertible debt is a financial instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder." } } }, "auth_ref": [ "r66" ] }, "us-gaap_ConvertibleDebtMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ConvertibleDebtMember", "presentation": [ "http://f8k.com/role/DebtDetails" ], "lang": { "en-us": { "role": { "label": "Convertible Debenture", "documentation": "Borrowing which can be exchanged for a specified number of another security at the option of the issuer or the holder, for example, but not limited to, the entity's common stock." } } }, "auth_ref": [ "r102", "r287", "r288", "r298", "r299", "r300", "r304", "r305", "r306", "r307", "r308", "r609", "r610", "r611", "r612", "r613" ] }, "us-gaap_ConvertibleDebtNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ConvertibleDebtNoncurrent", "crdr": "credit", "calculation": { "http://f8k.com/role/ConsolidatedBalanceSheets": { "parentTag": "us-gaap_Liabilities", "weight": 1.0, "order": 20.0 } }, "presentation": [ "http://f8k.com/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "verboseLabel": "Convertible debentures", "label": "[Convertible Debt, Noncurrent]", "documentation": "Carrying amount of long-term convertible debt as of the balance sheet date, net of the amount due in the next twelve months or greater than the normal operating cycle, if longer. The debt is convertible into another form of financial instrument, typically the entity's common stock." } } }, "auth_ref": [ "r23" ] }, "us-gaap_ConvertibleNotesPayable": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ConvertibleNotesPayable", "crdr": "credit", "presentation": [ "http://f8k.com/role/IntangibleAssetsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Convertible notes", "documentation": "Including the current and noncurrent portions, carrying value as of the balance sheet date of a written promise to pay a note, initially due after one year or beyond the operating cycle if longer, which can be exchanged for a specified amount of one or more securities (typically common stock), at the option of the issuer or the holder." } } }, "auth_ref": [ "r14", "r112", "r710" ] }, "us-gaap_CostOfGoodsAndServicesSold": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CostOfGoodsAndServicesSold", "crdr": "debit", "calculation": { "http://f8k.com/role/ConsolidatedStatementsOfIncomeLoss": { "parentTag": "us-gaap_GrossProfit", "weight": -1.0, "order": 3.0 } }, "presentation": [ "http://f8k.com/role/ConsolidatedStatementsOfIncomeLoss" ], "lang": { "en-us": { "role": { "label": "Cost of goods sold", "documentation": "The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities." } } }, "auth_ref": [ "r82", "r451" ] }, "us-gaap_CostOfGoodsTotalMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CostOfGoodsTotalMember", "presentation": [ "http://f8k.com/role/PropertyAndEquipmentAndRightOfUseAssetsDetailsNarrative", "http://f8k.com/role/ShareBasedCompensationDetails" ], "lang": { "en-us": { "role": { "label": "Cost of Goods Sold [Member]", "documentation": "Cost of product sold and service rendered, when it serves as benchmark in concentration of risk calculation." } } }, "auth_ref": [ "r638" ] }, "dei_CoverAbstract": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CoverAbstract", "lang": { "en-us": { "role": { "label": "Cover [Abstract]", "documentation": "Cover page." } } }, "auth_ref": [] }, "us-gaap_CurrentFederalTaxExpenseBenefit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CurrentFederalTaxExpenseBenefit", "crdr": "debit", "presentation": [ "http://f8k.com/role/IncomeTaxesDetails" ], "lang": { "en-us": { "role": { "label": "Federal", "documentation": "Amount of current federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current national tax expense (benefit) for non-US (United States of America) jurisdiction." } } }, "auth_ref": [ "r640", "r655", "r698" ] }, "dei_CurrentFiscalYearEndDate": { "xbrltype": "gMonthDayItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CurrentFiscalYearEndDate", "presentation": [ "http://f8k.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Current Fiscal Year End Date", "documentation": "End date of current fiscal year in the format --MM-DD." } } }, "auth_ref": [] }, "us-gaap_CurrentIncomeTaxExpenseBenefit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CurrentIncomeTaxExpenseBenefit", "crdr": "debit", "presentation": [ "http://f8k.com/role/IncomeTaxesDetails" ], "lang": { "en-us": { "role": { "label": "Total Current", "documentation": "Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations." } } }, "auth_ref": [ "r108", "r386", "r392", "r655" ] }, "us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract", "presentation": [ "http://f8k.com/role/IncomeTaxesDetails" ], "lang": { "en-us": { "role": { "label": "Current" } } }, "auth_ref": [] }, "us-gaap_CurrentStateAndLocalTaxExpenseBenefit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CurrentStateAndLocalTaxExpenseBenefit", "crdr": "debit", "presentation": [ "http://f8k.com/role/IncomeTaxesDetails" ], "lang": { "en-us": { "role": { "label": "State", "documentation": "Amount of current state and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction." } } }, "auth_ref": [ "r640", "r655", "r698" ] }, "us-gaap_DebtDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtDisclosureAbstract", "lang": { "en-us": { "role": { "label": "DEBT" } } }, "auth_ref": [] }, "us-gaap_DebtDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtDisclosureTextBlock", "presentation": [ "http://f8k.com/role/DEBT" ], "lang": { "en-us": { "role": { "label": "Debt", "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants." } } }, "auth_ref": [ "r101", "r178", "r286", "r292", "r293", "r294", "r295", "r296", "r297", "r302", "r309", "r310", "r311" ] }, "us-gaap_DebtInstrumentAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentAxis", "presentation": [ "http://f8k.com/role/DebtDetails", "http://f8k.com/role/DebtDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Debt Instrument [Axis]", "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities." } } }, "auth_ref": [ "r14", "r66", "r67", "r111", "r112", "r182", "r287", "r288", "r289", "r290", "r291", "r293", "r298", "r299", "r300", "r301", "r303", "r304", "r305", "r306", "r307", "r308", "r423", "r609", "r610", "r611", "r612", "r613", "r653" ] }, "us-gaap_DebtInstrumentBasisSpreadOnVariableRate1": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentBasisSpreadOnVariableRate1", "presentation": [ "http://f8k.com/role/DebtDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Weighted average interest rate", "documentation": "Percentage points added to the reference rate to compute the variable rate on the debt instrument." } } }, "auth_ref": [] }, "us-gaap_DebtInstrumentIncreaseAccruedInterest": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentIncreaseAccruedInterest", "crdr": "credit", "presentation": [ "http://f8k.com/role/IntangibleAssetsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Accrued interest", "documentation": "Increase for accrued, but unpaid interest on the debt instrument for the period." } } }, "auth_ref": [ "r653" ] }, "us-gaap_DebtInstrumentNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentNameDomain", "presentation": [ "http://f8k.com/role/DebtDetails", "http://f8k.com/role/DebtDetailsNarrative" ], "lang": { "en-us": { "role": { "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities." } } }, "auth_ref": [ "r23", "r182", "r287", "r288", "r289", "r290", "r291", "r293", "r298", "r299", "r300", "r301", "r303", "r304", "r305", "r306", "r307", "r308", "r423", "r609", "r610", "r611", "r612", "r613", "r653" ] }, "us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock", "presentation": [ "http://f8k.com/role/PrepaidAndOtherCurrentAssets" ], "lang": { "en-us": { "role": { "label": "Prepaid And Other Current Assets", "documentation": "Tabular disclosure of the amounts paid in advance for capitalized costs that will be expensed with the passage of time or the occurrence of a triggering event, and will be charged against earnings within one year or the normal operating cycle, if longer; the aggregate carrying amount of current assets, not separately presented elsewhere in the balance sheet; and other deferred costs." } } }, "auth_ref": [] }, "us-gaap_DeferredFederalIncomeTaxExpenseBenefit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredFederalIncomeTaxExpenseBenefit", "crdr": "debit", "presentation": [ "http://f8k.com/role/IncomeTaxesDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Federal", "label": "[Deferred Federal Income Tax Expense (Benefit)]", "documentation": "Amount of deferred federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, deferred national tax expense (benefit) for non-US (United States of America) jurisdiction." } } }, "auth_ref": [ "r655", "r697", "r698" ] }, "us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredFederalStateAndLocalTaxExpenseBenefit", "crdr": "debit", "presentation": [ "http://f8k.com/role/IncomeTaxesDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "State", "label": "[Deferred Federal, State and Local, Tax Expense (Benefit)]", "documentation": "Amount of deferred federal, state, and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, deferred national, regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction." } } }, "auth_ref": [ "r693" ] }, "us-gaap_DeferredIncomeTaxExpenseBenefit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredIncomeTaxExpenseBenefit", "crdr": "debit", "presentation": [ "http://f8k.com/role/IncomeTaxesDetails" ], "lang": { "en-us": { "role": { "label": "Total deferred tax benefit", "documentation": "Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations." } } }, "auth_ref": [ "r6", "r108", "r141", "r391", "r392", "r655" ] }, "us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract", "presentation": [ "http://f8k.com/role/IncomeTaxesDetails" ], "lang": { "en-us": { "role": { "label": "Deferred tax benefit" } } }, "auth_ref": [] }, "us-gaap_DeferredTaxAssetsLiabilitiesNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredTaxAssetsLiabilitiesNet", "crdr": "debit", "presentation": [ "http://f8k.com/role/IncomeTaxesDetails1" ], "lang": { "en-us": { "role": { "label": "Net deferred tax liabilities", "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, without jurisdictional netting." } } }, "auth_ref": [ "r695" ] }, "us-gaap_DeferredTaxAssetsNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredTaxAssetsNet", "crdr": "debit", "presentation": [ "http://f8k.com/role/IncomeTaxesDetails1" ], "lang": { "en-us": { "role": { "label": "Total deferred tax assets", "documentation": "Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards." } } }, "auth_ref": [ "r695" ] }, "us-gaap_DeferredTaxAssetsOperatingLossCarryforwards": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredTaxAssetsOperatingLossCarryforwards", "crdr": "debit", "presentation": [ "http://f8k.com/role/IncomeTaxesDetails1" ], "lang": { "en-us": { "role": { "label": "Net operating loss carryforwards", "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards." } } }, "auth_ref": [ "r57", "r696" ] }, "us-gaap_DeferredTaxAssetsOther": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredTaxAssetsOther", "crdr": "debit", "presentation": [ "http://f8k.com/role/IncomeTaxesDetails1" ], "lang": { "en-us": { "role": { "verboseLabel": "Other", "label": "[Deferred Tax Assets, Other]", "documentation": "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences, classified as other." } } }, "auth_ref": [ "r57", "r696" ] }, "lowlf_DeferredTaxAssetsTaxDeferredExpenseDepreciation": { "xbrltype": "monetaryItemType", "nsuri": "http://f8k.com/20231231", "localname": "DeferredTaxAssetsTaxDeferredExpenseDepreciation", "crdr": "debit", "presentation": [ "http://f8k.com/role/IncomeTaxesDetails1" ], "lang": { "en-us": { "role": { "verboseLabel": "Depreciation", "label": "[Depreciation 1]" } } }, "auth_ref": [] }, "us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities", "crdr": "debit", "presentation": [ "http://f8k.com/role/IncomeTaxesDetails1" ], "lang": { "en-us": { "role": { "label": "Accruals and reserves", "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from accrued liabilities." } } }, "auth_ref": [ "r57", "r696" ] }, "us-gaap_DeferredTaxAssetsValuationAllowance": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredTaxAssetsValuationAllowance", "crdr": "credit", "presentation": [ "http://f8k.com/role/IncomeTaxesDetails1" ], "lang": { "en-us": { "role": { "negatedLabel": "Valuation allowance", "label": "[Deferred Tax Assets, Valuation Allowance]", "documentation": "Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized." } } }, "auth_ref": [ "r382" ] }, "us-gaap_DeferredTaxLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredTaxLiabilities", "crdr": "credit", "presentation": [ "http://f8k.com/role/IncomeTaxesDetails1" ], "lang": { "en-us": { "role": { "label": "Total deferred tax liabilities", "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences without jurisdictional netting." } } }, "auth_ref": [ "r56", "r695" ] }, "us-gaap_DeferredTaxLiabilitiesPrepaidExpenses": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredTaxLiabilitiesPrepaidExpenses", "crdr": "credit", "presentation": [ "http://f8k.com/role/IncomeTaxesDetails1" ], "lang": { "en-us": { "role": { "verboseLabel": "Accruals and reserves", "label": "[Deferred Tax Liabilities, Prepaid Expenses]", "documentation": "Amount of deferred tax consequences attributable to taxable temporary differences derived from prepaid expenses." } } }, "auth_ref": [] }, "lowlf_DeferredTaxLiabilitiesShareBasedCompensation": { "xbrltype": "monetaryItemType", "nsuri": "http://f8k.com/20231231", "localname": "DeferredTaxLiabilitiesShareBasedCompensation", "crdr": "credit", "presentation": [ "http://f8k.com/role/IncomeTaxesDetails1" ], "lang": { "en-us": { "role": { "label": "Share-based compensation" } } }, "auth_ref": [] }, "lowlf_DefiniteLivedIntangibleAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://f8k.com/20231231", "localname": "DefiniteLivedIntangibleAssets", "crdr": "debit", "presentation": [ "http://f8k.com/role/IntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Definite life intangibles cost, ending", "label": "[Definite life intangibles cost, ending]", "periodStartLabel": "Definite life intangibles cost, beginning", "periodEndLabel": "Definite life intangibles cost, ending" } } }, "auth_ref": [] }, "us-gaap_DepositsAssetsCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DepositsAssetsCurrent", "crdr": "debit", "presentation": [ "http://f8k.com/role/PrepaidAndOtherCurrentAssetsDetails" ], "lang": { "en-us": { "role": { "label": "Deposits", "documentation": "Carrying value of amounts transferred to third parties for security purposes that are expected to be returned or applied towards payment within one year or during the operating cycle, if shorter." } } }, "auth_ref": [ "r647" ] }, "us-gaap_Depreciation": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "Depreciation", "crdr": "debit", "presentation": [ "http://f8k.com/role/PropertyAndEquipmentAndRightOfUseAssetsDetails", "http://f8k.com/role/PropertyAndEquipmentAndRightOfUseAssetsDetailsNarrative" ], "lang": { "en-us": { "role": { "negatedLabel": "Depreciation", "label": "[Depreciation]", "verboseLabel": "Depreciation", "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation." } } }, "auth_ref": [ "r6", "r50" ] }, "us-gaap_DepreciationAndAmortization": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DepreciationAndAmortization", "crdr": "debit", "calculation": { "http://f8k.com/role/ConsolidatedStatementsOfIncomeLoss": { "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://f8k.com/role/ConsolidatedStatementsOfIncomeLoss" ], "lang": { "en-us": { "role": { "label": "Depreciation and amortization", "documentation": "The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production." } } }, "auth_ref": [ "r6", "r50" ] }, "us-gaap_DepreciationDepletionAndAmortization": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DepreciationDepletionAndAmortization", "crdr": "debit", "calculation": { "http://f8k.com/role/ConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://f8k.com/role/ConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "verboseLabel": "Depreciation and amortization", "label": "[Depreciation, Depletion and Amortization]", "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets." } } }, "auth_ref": [ "r6", "r224" ] }, "lowlf_DescriptionOfUsefulLife": { "xbrltype": "stringItemType", "nsuri": "http://f8k.com/20231231", "localname": "DescriptionOfUsefulLife", "presentation": [ "http://f8k.com/role/BusinessBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "label": "Description of useful life" } } }, "auth_ref": [] }, "lowlf_DescriptionsOfRoyalty": { "xbrltype": "stringItemType", "nsuri": "http://f8k.com/20231231", "localname": "DescriptionsOfRoyalty", "presentation": [ "http://f8k.com/role/IntangibleAssetsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Descriptions of royalty" } } }, "auth_ref": [] }, "us-gaap_DevelopmentCosts": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DevelopmentCosts", "crdr": "debit", "presentation": [ "http://f8k.com/role/BusinessBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Development costs", "documentation": "The capitalized costs incurred during the period (excluded from amortization) to obtain access to proved reserves and to provide facilities for extracting, treating, gathering and storing the oil and gas." } } }, "auth_ref": [ "r455" ] }, "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "presentation": [ "http://f8k.com/role/ShareBasedCompensation" ], "lang": { "en-us": { "role": { "verboseLabel": "SHARE BASED COMPENSATION", "label": "Share-Based Payment Arrangement [Text Block]", "documentation": "The entire disclosure for share-based payment arrangement." } } }, "auth_ref": [ "r332", "r333", "r363", "r364", "r365", "r616" ] }, "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract", "lang": { "en-us": { "role": { "label": "SHARE BASED COMPENSATION" } } }, "auth_ref": [] }, "lowlf_DistributionPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://f8k.com/20231231", "localname": "DistributionPolicyTextBlock", "presentation": [ "http://f8k.com/role/BusinessBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Distribution" } } }, "auth_ref": [] }, "dei_DocumentAnnualReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentAnnualReport", "presentation": [ "http://f8k.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Annual Report", "documentation": "Boolean flag that is true only for a form used as an annual report." } } }, "auth_ref": [ "r628", "r629", "r630" ] }, "dei_DocumentFinStmtErrorCorrectionFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentFinStmtErrorCorrectionFlag", "presentation": [ "http://f8k.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Fin Stmt Error Correction Flag", "documentation": "Indicates whether any of the financial statement period in the filing include a restatement due to error correction." } } }, "auth_ref": [ "r628", "r629", "r630", "r632" ] }, "dei_DocumentFiscalPeriodFocus": { "xbrltype": "fiscalPeriodItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentFiscalPeriodFocus", "presentation": [ "http://f8k.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Fiscal Period Focus", "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY." } } }, "auth_ref": [] }, "dei_DocumentFiscalYearFocus": { "xbrltype": "gYearItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentFiscalYearFocus", "presentation": [ "http://f8k.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Fiscal Year Focus", "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006." } } }, "auth_ref": [] }, "dei_DocumentPeriodEndDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentPeriodEndDate", "presentation": [ "http://f8k.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Period End Date", "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD." } } }, "auth_ref": [] }, "dei_DocumentTransitionReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentTransitionReport", "presentation": [ "http://f8k.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Transition Report", "documentation": "Boolean flag that is true only for a form used as a transition report." } } }, "auth_ref": [ "r631" ] }, "dei_DocumentType": { "xbrltype": "submissionTypeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentType", "presentation": [ "http://f8k.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Type", "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'." } } }, "auth_ref": [] }, "lowlf_DueDateOfCommitment": { "xbrltype": "stringItemType", "nsuri": "http://f8k.com/20231231", "localname": "DueDateOfCommitment", "presentation": [ "http://f8k.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Due date of commitment" } } }, "auth_ref": [] }, "lowlf_ERCClaimMember": { "xbrltype": "domainItemType", "nsuri": "http://f8k.com/20231231", "localname": "ERCClaimMember", "presentation": [ "http://f8k.com/role/OtherCurrentLiabilitiesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "E R C Claim [Member]" } } }, "auth_ref": [] }, "us-gaap_EarningsPerShareAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EarningsPerShareAbstract", "presentation": [ "http://f8k.com/role/ConsolidatedStatementsOfIncomeLoss" ], "lang": { "en-us": { "role": { "label": "Net loss per share:" } } }, "auth_ref": [] }, "us-gaap_EarningsPerShareBasic": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EarningsPerShareBasic", "presentation": [ "http://f8k.com/role/ConsolidatedStatementsOfIncomeLoss", "http://f8k.com/role/NetIncomeLossPerShareDetails" ], "lang": { "en-us": { "role": { "label": "Basic", "verboseLabel": "Basic", "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period." } } }, "auth_ref": [ "r169", "r188", "r189", "r190", "r191", "r192", "r197", "r200", "r206", "r207", "r208", "r212", "r411", "r412", "r468", "r481", "r602" ] }, "us-gaap_EarningsPerShareBasicAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EarningsPerShareBasicAbstract", "presentation": [ "http://f8k.com/role/NetIncomeLossPerShareDetails" ], "lang": { "en-us": { "role": { "label": "Net Loss Per Share:" } } }, "auth_ref": [] }, "us-gaap_EarningsPerShareDiluted": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EarningsPerShareDiluted", "presentation": [ "http://f8k.com/role/ConsolidatedStatementsOfIncomeLoss", "http://f8k.com/role/NetIncomeLossPerShareDetails" ], "lang": { "en-us": { "role": { "label": "Diluted", "verboseLabel": "Diluted", "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period." } } }, "auth_ref": [ "r169", "r188", "r189", "r190", "r191", "r192", "r200", "r206", "r207", "r208", "r212", "r411", "r412", "r468", "r481", "r602" ] }, "us-gaap_EarningsPerShareTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EarningsPerShareTextBlock", "presentation": [ "http://f8k.com/role/NetIncomeLossPerShare" ], "lang": { "en-us": { "role": { "label": "Net Income (loss) Per Share", "documentation": "The entire disclosure for earnings per share." } } }, "auth_ref": [ "r196", "r209", "r210", "r211" ] }, "us-gaap_EffectiveIncomeTaxRateContinuingOperations": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EffectiveIncomeTaxRateContinuingOperations", "presentation": [ "http://f8k.com/role/IncomeTaxesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Effective Tax Rate", "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations." } } }, "auth_ref": [ "r378" ] }, "us-gaap_EmployeeBenefitsAndShareBasedCompensation": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EmployeeBenefitsAndShareBasedCompensation", "crdr": "debit", "presentation": [ "http://f8k.com/role/ShareBasedCompensationDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Share-based compensation expense", "label": "[Employee Benefits and Share-Based Compensation]", "documentation": "Amount of expense for employee benefit and equity-based compensation." } } }, "auth_ref": [] }, "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions", "crdr": "debit", "presentation": [ "http://f8k.com/role/ShareBasedCompensationDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Unrecognized Compensation Cost Related To Nonvested Restricted Stock Units", "documentation": "Amount of cost to be recognized for nonvested award under share-based payment arrangement. Excludes share and unit options." } } }, "auth_ref": [ "r692" ] }, "dei_EntityAddressAddressLine1": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine1", "presentation": [ "http://f8k.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address Address Line 1", "documentation": "Address Line 1 such as Attn, Building Name, Street Name" } } }, "auth_ref": [] }, "dei_EntityAddressCityOrTown": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressCityOrTown", "presentation": [ "http://f8k.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address City Or Town", "documentation": "Name of the City or Town" } } }, "auth_ref": [] }, "dei_EntityAddressPostalZipCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressPostalZipCode", "presentation": [ "http://f8k.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address Postal Zip Code", "documentation": "Code for the postal or zip code" } } }, "auth_ref": [] }, "dei_EntityAddressStateOrProvince": { "xbrltype": "stateOrProvinceItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressStateOrProvince", "presentation": [ "http://f8k.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address State Or Province", "documentation": "Name of the state or province." } } }, "auth_ref": [] }, "dei_EntityCentralIndexKey": { "xbrltype": "centralIndexKeyItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCentralIndexKey", "presentation": [ "http://f8k.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Central Index Key", "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK." } } }, "auth_ref": [ "r627" ] }, "dei_EntityCommonStockSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCommonStockSharesOutstanding", "presentation": [ "http://f8k.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Common Stock Shares Outstanding", "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument." } } }, "auth_ref": [] }, "dei_EntityCurrentReportingStatus": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCurrentReportingStatus", "presentation": [ "http://f8k.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Current Reporting Status", "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [] }, "dei_EntityEmergingGrowthCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityEmergingGrowthCompany", "presentation": [ "http://f8k.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Emerging Growth Company", "documentation": "Indicate if registrant meets the emerging growth company criteria." } } }, "auth_ref": [ "r627" ] }, "dei_EntityExTransitionPeriod": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityExTransitionPeriod", "presentation": [ "http://f8k.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Ex Transition Period", "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards." } } }, "auth_ref": [ "r635" ] }, "dei_EntityFileNumber": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFileNumber", "presentation": [ "http://f8k.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity File Number", "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen." } } }, "auth_ref": [] }, "dei_EntityFilerCategory": { "xbrltype": "filerCategoryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFilerCategory", "presentation": [ "http://f8k.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Filer Category", "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [ "r627" ] }, "dei_EntityIncorporationStateCountryCode": { "xbrltype": "edgarStateCountryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityIncorporationStateCountryCode", "presentation": [ "http://f8k.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Incorporation State Country Code", "documentation": "Two-character EDGAR code representing the state or country of incorporation." } } }, "auth_ref": [] }, "dei_EntityInteractiveDataCurrent": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityInteractiveDataCurrent", "presentation": [ "http://f8k.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Interactive Data Current", "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)." } } }, "auth_ref": [ "r633" ] }, "dei_EntityPublicFloat": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityPublicFloat", "crdr": "credit", "presentation": [ "http://f8k.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Public Float", "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter." } } }, "auth_ref": [] }, "dei_EntityRegistrantName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityRegistrantName", "presentation": [ "http://f8k.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Registrant Name", "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC." } } }, "auth_ref": [ "r627" ] }, "dei_EntityShellCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityShellCompany", "presentation": [ "http://f8k.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Shell Company", "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act." } } }, "auth_ref": [ "r627" ] }, "dei_EntitySmallBusiness": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntitySmallBusiness", "presentation": [ "http://f8k.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Small Business", "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)." } } }, "auth_ref": [ "r627" ] }, "dei_EntityVoluntaryFilers": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityVoluntaryFilers", "presentation": [ "http://f8k.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Voluntary Filers", "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act." } } }, "auth_ref": [] }, "dei_EntityWellKnownSeasonedIssuer": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityWellKnownSeasonedIssuer", "presentation": [ "http://f8k.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Well Known Seasoned Issuer", "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A." } } }, "auth_ref": [ "r634" ] }, "lowlf_EquipmentPurchaseAccrual": { "xbrltype": "monetaryItemType", "nsuri": "http://f8k.com/20231231", "localname": "EquipmentPurchaseAccrual", "crdr": "credit", "presentation": [ "http://f8k.com/role/OtherCurrentLiabilitiesDetails" ], "lang": { "en-us": { "role": { "label": "Equipment purchase accrual" } } }, "auth_ref": [] }, "lowlf_EquipmentsMember": { "xbrltype": "domainItemType", "nsuri": "http://f8k.com/20231231", "localname": "EquipmentsMember", "presentation": [ "http://f8k.com/role/PropertyAndEquipmentAndRightOfUseAssetsDetails" ], "lang": { "en-us": { "role": { "label": "Equipment [Member]" } } }, "auth_ref": [] }, "us-gaap_EquityComponentDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EquityComponentDomain", "presentation": [ "http://f8k.com/role/ConsolidatedStatementsOfStockholdersEquityDeficit" ], "lang": { "en-us": { "role": { "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc." } } }, "auth_ref": [ "r9", "r144", "r164", "r165", "r166", "r183", "r184", "r185", "r187", "r193", "r195", "r213", "r249", "r250", "r328", "r366", "r367", "r368", "r387", "r388", "r403", "r404", "r405", "r406", "r407", "r408", "r410", "r415", "r416", "r417", "r418", "r419", "r420", "r436", "r485", "r486", "r487", "r503", "r568" ] }, "us-gaap_FairValueDisclosuresAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueDisclosuresAbstract", "lang": { "en-us": { "role": { "label": "FAIR VALUE MEASUREMENTS" } } }, "auth_ref": [] }, "us-gaap_FairValueDisclosuresTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueDisclosuresTextBlock", "presentation": [ "http://f8k.com/role/FairValueMeasurements" ], "lang": { "en-us": { "role": { "label": "Fair Value Measurements", "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information." } } }, "auth_ref": [ "r413" ] }, "lowlf_FairValueOfShares": { "xbrltype": "monetaryItemType", "nsuri": "http://f8k.com/20231231", "localname": "FairValueOfShares", "crdr": "credit", "presentation": [ "http://f8k.com/role/IntangibleAssetsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Fair market value of shares" } } }, "auth_ref": [] }, "us-gaap_FinanceLeaseInterestExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FinanceLeaseInterestExpense", "crdr": "debit", "presentation": [ "http://f8k.com/role/LeasesDetails1" ], "lang": { "en-us": { "role": { "label": "Interest On Lease Liabilities - Finance Leases", "documentation": "Amount of interest expense on finance lease liability." } } }, "auth_ref": [ "r426", "r430", "r619" ] }, "us-gaap_FinanceLeasePrincipalPayments": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FinanceLeasePrincipalPayments", "crdr": "credit", "calculation": { "http://f8k.com/role/ConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0, "order": 23.0 } }, "presentation": [ "http://f8k.com/role/ConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Principal payments on finance lease obligations", "label": "[Finance Lease, Principal Payments]", "documentation": "Amount of cash outflow for principal payment on finance lease." } } }, "auth_ref": [ "r427", "r432" ] }, "us-gaap_FinanceLeaseRightOfUseAssetAmortization": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FinanceLeaseRightOfUseAssetAmortization", "crdr": "debit", "presentation": [ "http://f8k.com/role/LeasesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Lease right of use assets", "documentation": "Amount of amortization expense attributable to right-of-use asset from finance lease." } } }, "auth_ref": [ "r426", "r430", "r619" ] }, "lowlf_FinanceLeasesMember": { "xbrltype": "domainItemType", "nsuri": "http://f8k.com/20231231", "localname": "FinanceLeasesMember", "presentation": [ "http://f8k.com/role/LeasesDetails" ], "lang": { "en-us": { "role": { "label": "Finance Leases [Member]" } } }, "auth_ref": [] }, "us-gaap_FinancingReceivableNonaccrualNoAllowance": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FinancingReceivableNonaccrualNoAllowance", "crdr": "debit", "presentation": [ "http://f8k.com/role/OtherCurrentLiabilitiesDetails" ], "lang": { "en-us": { "role": { "label": "Employee Retention Credit financing accrual", "documentation": "Amortized cost of financing receivable on nonaccrual status with no allowance for credit loss. Excludes net investment in lease." } } }, "auth_ref": [ "r253" ] }, "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis", "presentation": [ "http://f8k.com/role/IntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "label": "Finite-Lived Intangible Assets by Major Class [Axis]", "documentation": "Information by major type or class of finite-lived intangible assets." } } }, "auth_ref": [ "r263", "r265", "r266", "r268", "r452", "r454" ] }, "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain", "presentation": [ "http://f8k.com/role/IntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company." } } }, "auth_ref": [ "r44", "r47" ] }, "lowlf_FiniteLivedIntangibleAssetsRemainingAmortizationPeriodOne": { "xbrltype": "durationItemType", "nsuri": "http://f8k.com/20231231", "localname": "FiniteLivedIntangibleAssetsRemainingAmortizationPeriodOne", "presentation": [ "http://f8k.com/role/BusinessBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Straight line basis" } } }, "auth_ref": [] }, "us-gaap_FurnitureAndFixturesMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FurnitureAndFixturesMember", "presentation": [ "http://f8k.com/role/BusinessBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetails", "http://f8k.com/role/PropertyAndEquipmentAndRightOfUseAssetsDetails" ], "lang": { "en-us": { "role": { "label": "Furniture and fixtures [Member]", "verboseLabel": "Furniture and fixtures [Member]", "documentation": "Equipment commonly used in offices and stores that have no permanent connection to the structure of a building or utilities. Examples include, but are not limited to, desks, chairs, tables, and bookcases." } } }, "auth_ref": [] }, "lowlf_GainLossOnLeaseSettlement": { "xbrltype": "monetaryItemType", "nsuri": "http://f8k.com/20231231", "localname": "GainLossOnLeaseSettlement", "crdr": "credit", "calculation": { "http://f8k.com/role/ConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 9.0 } }, "presentation": [ "http://f8k.com/role/ConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Gain on lease settlement", "label": "[Gain on lease settlement]" } } }, "auth_ref": [] }, "us-gaap_GainLossOnSaleOfOtherAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GainLossOnSaleOfOtherAssets", "crdr": "credit", "presentation": [ "http://f8k.com/role/IntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "label": "Sale of Brand Assets", "documentation": "Amount of gain (loss) on sale or disposal of other assets." } } }, "auth_ref": [ "r651" ] }, "us-gaap_GainLossOnSaleOfProperty": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GainLossOnSaleOfProperty", "crdr": "credit", "presentation": [ "http://f8k.com/role/LeasesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Sale of property", "documentation": "Amount of gain (loss) on sale or disposal of oil and gas property or timber property." } } }, "auth_ref": [ "r6" ] }, "us-gaap_GainLossOnTerminationOfLease": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GainLossOnTerminationOfLease", "crdr": "credit", "presentation": [ "http://f8k.com/role/LeasesDetails" ], "lang": { "en-us": { "role": { "label": "Lease termination", "documentation": "Amount of gain (loss) on termination of lease before expiration of lease term." } } }, "auth_ref": [ "r424" ] }, "lowlf_GainOnLeaseTermination": { "xbrltype": "monetaryItemType", "nsuri": "http://f8k.com/20231231", "localname": "GainOnLeaseTermination", "crdr": "credit", "calculation": { "http://f8k.com/role/ConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0, "order": 21.0 } }, "presentation": [ "http://f8k.com/role/ConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Gain on lease termination", "label": "[Gain on lease termination]" } } }, "auth_ref": [] }, "us-gaap_GainsLossesOnSalesOfAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GainsLossesOnSalesOfAssets", "crdr": "credit", "calculation": { "http://f8k.com/role/ConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 7.0 } }, "presentation": [ "http://f8k.com/role/ConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Loss on sale of assets", "label": "[Gain (Loss) on Disposition of Assets for Financial Service Operations]", "documentation": "Amount of gain (loss) on sale or disposal of assets utilized in financial service operations." } } }, "auth_ref": [] }, "us-gaap_GeneralAndAdministrativeExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GeneralAndAdministrativeExpense", "crdr": "debit", "calculation": { "http://f8k.com/role/ConsolidatedStatementsOfIncomeLoss": { "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://f8k.com/role/ConsolidatedStatementsOfIncomeLoss", "http://f8k.com/role/GeneralAndAdministrativeExpensesDetails" ], "lang": { "en-us": { "role": { "label": "General and administrative", "verboseLabel": "General and administrative", "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line." } } }, "auth_ref": [ "r84", "r548" ] }, "us-gaap_GeneralAndAdministrativeExpenseAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GeneralAndAdministrativeExpenseAbstract", "lang": { "en-us": { "role": { "label": "GENERAL AND ADMINISTRATIVE EXPENSES" } } }, "auth_ref": [] }, "us-gaap_GeneralAndAdministrativeExpenseMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GeneralAndAdministrativeExpenseMember", "presentation": [ "http://f8k.com/role/ShareBasedCompensationDetails" ], "lang": { "en-us": { "role": { "label": "General And Administrative Expense [Member]", "documentation": "Primary financial statement caption encompassing general and administrative expense." } } }, "auth_ref": [ "r79" ] }, "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract", "lang": { "en-us": { "role": { "label": "INTANGIBLE ASSETS (Tables)" } } }, "auth_ref": [] }, "us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GoodwillAndIntangibleAssetsDisclosureTextBlock", "lang": { "en-us": { "role": { "label": "INTANGIBLE ASSETS", "documentation": "The entire disclosure for goodwill and intangible assets." } } }, "auth_ref": [ "r94" ] }, "us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GoodwillAndIntangibleAssetsGoodwillPolicy", "presentation": [ "http://f8k.com/role/BusinessBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Goodwill", "documentation": "Disclosure of accounting policy for goodwill. This accounting policy also may address how an entity assesses and measures impairment of goodwill, how reporting units are determined, how goodwill is allocated to such units, and how the fair values of the reporting units are determined." } } }, "auth_ref": [ "r258", "r261", "r608" ] }, "us-gaap_GoodwillImpairmentLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GoodwillImpairmentLoss", "crdr": "debit", "presentation": [ "http://f8k.com/role/IntangibleAssetsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Impairment of goodwill", "documentation": "Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized." } } }, "auth_ref": [ "r6", "r259", "r260", "r261", "r608" ] }, "us-gaap_GrossProfit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GrossProfit", "crdr": "credit", "calculation": { "http://f8k.com/role/ConsolidatedStatementsOfIncomeLoss": { "parentTag": "us-gaap_OperatingIncomeLoss", "weight": 1.0, "order": 7.0 } }, "presentation": [ "http://f8k.com/role/ConsolidatedStatementsOfIncomeLoss" ], "lang": { "en-us": { "role": { "totalLabel": "Gross profit (loss)", "label": "[Gross Profit]", "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity." } } }, "auth_ref": [ "r81", "r180", "r220", "r228", "r233", "r236", "r248", "r277", "r278", "r279", "r280", "r281", "r282", "r283", "r284", "r285", "r414", "r604", "r663" ] }, "dei_IcfrAuditorAttestationFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "IcfrAuditorAttestationFlag", "presentation": [ "http://f8k.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Icfr Auditor Attestation Flag" } } }, "auth_ref": [ "r628", "r629", "r630" ] }, "lowlf_ImpairmentExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://f8k.com/20231231", "localname": "ImpairmentExpense", "crdr": "debit", "presentation": [ "http://f8k.com/role/PropertyAndEquipmentAndRightOfUseAssetsDetailsNarrative" ], "lang": { "en-us": { "role": { "verboseLabel": "Impairment expense", "label": "[Impairment expense]" } } }, "auth_ref": [] }, "us-gaap_ImpairmentOfIntangibleAssetsFinitelived": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ImpairmentOfIntangibleAssetsFinitelived", "crdr": "debit", "calculation": { "http://f8k.com/role/ConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 16.0 } }, "presentation": [ "http://f8k.com/role/ConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Impairment expense", "documentation": "The amount of impairment loss recognized in the period resulting from the write-down of the carrying amount of a finite-lived intangible asset to fair value." } } }, "auth_ref": [ "r651", "r660" ] }, "us-gaap_ImpairmentOfInvestments": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ImpairmentOfInvestments", "crdr": "debit", "calculation": { "http://f8k.com/role/ConsolidatedStatementsOfIncomeLoss": { "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": -1.0, "order": 11.0 } }, "presentation": [ "http://f8k.com/role/ConsolidatedStatementsOfIncomeLoss" ], "lang": { "en-us": { "role": { "label": "Impairment Impairment expense of long-lived assets", "documentation": "The amount by which the fair value of an investment is less than the amortized cost basis or carrying amount of that investment at the balance sheet date and the decline in fair value is deemed to be other than temporary, before considering whether or not such amount is recognized in earnings or other comprehensive income." } } }, "auth_ref": [ "r124" ] }, "us-gaap_ImpairmentOfLeasehold": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ImpairmentOfLeasehold", "crdr": "debit", "presentation": [ "http://f8k.com/role/IntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Impairment", "label": "[Impairment of Leasehold]", "negatedLabel": "Impairment", "documentation": "The adjustment to reduce the value of existing agreements that specify the lessee's rights to use the leased property. This expense is charged when the estimates of future profits generated by the leased property are reduced." } } }, "auth_ref": [ "r6", "r49" ] }, "us-gaap_ImpairmentOfOilAndGasProperties": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ImpairmentOfOilAndGasProperties", "crdr": "debit", "presentation": [ "http://f8k.com/role/PropertyAndEquipmentAndRightOfUseAssetsDetails" ], "lang": { "en-us": { "role": { "label": "Impairments", "documentation": "The expense recorded to reduce the value of oil and gas assets consisting of proved properties and unproved properties as the estimate of future successful production from these properties is reduced." } } }, "auth_ref": [ "r6", "r65", "r98" ] }, "us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock", "presentation": [ "http://f8k.com/role/BusinessBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Impairment of Long-lived Assets", "documentation": "Disclosure of accounting policy for recognizing and measuring the impairment of long-lived assets. An entity also may disclose its accounting policy for long-lived assets to be sold. This policy excludes goodwill and intangible assets." } } }, "auth_ref": [ "r0", "r99" ] }, "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "crdr": "credit", "calculation": { "http://f8k.com/role/ConsolidatedStatementsOfIncomeLoss": { "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0, "order": 15.0 } }, "presentation": [ "http://f8k.com/role/ConsolidatedStatementsOfIncomeLoss" ], "lang": { "en-us": { "role": { "totalLabel": "Loss before provision for income taxes", "label": "[Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest]", "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest." } } }, "auth_ref": [ "r1", "r77", "r114", "r220", "r228", "r233", "r236", "r469", "r478", "r604" ] }, "us-gaap_IncomeStatementAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeStatementAbstract", "lang": { "en-us": { "role": { "label": "CONSOLIDATED STATEMENTS OF INCOME (LOSS)" } } }, "auth_ref": [] }, "us-gaap_IncomeStatementLocationAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeStatementLocationAxis", "presentation": [ "http://f8k.com/role/ShareBasedCompensationDetails" ], "lang": { "en-us": { "role": { "label": "Income Statement Location [Axis]", "documentation": "Information by location in the income statement." } } }, "auth_ref": [ "r269", "r270", "r552" ] }, "us-gaap_IncomeStatementLocationDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeStatementLocationDomain", "presentation": [ "http://f8k.com/role/ShareBasedCompensationDetails" ], "lang": { "en-us": { "role": { "documentation": "Location in the income statement." } } }, "auth_ref": [ "r270", "r552" ] }, "us-gaap_IncomeTaxDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxDisclosureAbstract", "lang": { "en-us": { "role": { "label": "INCOME TAXES" } } }, "auth_ref": [] }, "us-gaap_IncomeTaxDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxDisclosureTextBlock", "presentation": [ "http://f8k.com/role/IncomeTaxes" ], "lang": { "en-us": { "role": { "label": "Income Taxes", "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information." } } }, "auth_ref": [ "r181", "r374", "r379", "r380", "r384", "r389", "r393", "r394", "r395", "r498" ] }, "us-gaap_IncomeTaxExaminationInterestAccrued": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxExaminationInterestAccrued", "crdr": "credit", "presentation": [ "http://f8k.com/role/OtherCurrentLiabilitiesDetails" ], "lang": { "en-us": { "role": { "label": "Interest and tax accrual", "documentation": "The amount of estimated interest accrued as of the balance sheet date arising from income tax examinations." } } }, "auth_ref": [ "r694" ] }, "us-gaap_IncomeTaxExpenseBenefit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxExpenseBenefit", "crdr": "debit", "calculation": { "http://f8k.com/role/ConsolidatedStatementsOfIncomeLoss": { "parentTag": "us-gaap_NetIncomeLoss", "weight": -1.0, "order": 16.0 } }, "presentation": [ "http://f8k.com/role/ConsolidatedStatementsOfIncomeLoss", "http://f8k.com/role/IncomeTaxesDetails", "http://f8k.com/role/IncomeTaxesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Provision for income taxes", "verboseLabel": "Income tax expense", "terseLabel": "Provision For Income Taxes", "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations." } } }, "auth_ref": [ "r132", "r142", "r194", "r195", "r225", "r377", "r390", "r483" ] }, "us-gaap_IncomeTaxPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxPolicyTextBlock", "presentation": [ "http://f8k.com/role/BusinessBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "verboseLabel": "Income Taxes", "label": "Income Tax, Policy [Policy Text Block]", "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements." } } }, "auth_ref": [ "r163", "r375", "r376", "r380", "r381", "r383", "r385", "r492" ] }, "us-gaap_IncomeTaxesPaidNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxesPaidNet", "crdr": "credit", "presentation": [ "http://f8k.com/role/ConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Cash paid during the period for income taxes", "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes." } } }, "auth_ref": [ "r31" ] }, "us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInAccountsPayableAndAccruedLiabilities", "crdr": "debit", "calculation": { "http://f8k.com/role/ConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 15.0 } }, "presentation": [ "http://f8k.com/role/ConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Accounts payable and accrued expenses", "documentation": "The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid." } } }, "auth_ref": [ "r5" ] }, "us-gaap_IncreaseDecreaseInAccountsReceivable": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInAccountsReceivable", "crdr": "credit", "calculation": { "http://f8k.com/role/ConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 11.0 } }, "presentation": [ "http://f8k.com/role/ConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Accounts receivable", "label": "[Increase (Decrease) in Accounts Receivable]", "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services." } } }, "auth_ref": [ "r5" ] }, "us-gaap_IncreaseDecreaseInInventories": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInInventories", "crdr": "credit", "calculation": { "http://f8k.com/role/ConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 12.0 } }, "presentation": [ "http://f8k.com/role/ConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Inventory", "label": "[Increase (Decrease) in Inventories]", "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities." } } }, "auth_ref": [ "r5" ] }, "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInOperatingCapitalAbstract", "presentation": [ "http://f8k.com/role/ConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Changes in operating assets and liabilities:" } } }, "auth_ref": [] }, "us-gaap_IncreaseDecreaseInOperatingLeaseLiability": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInOperatingLeaseLiability", "crdr": "debit", "calculation": { "http://f8k.com/role/ConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 17.0 } }, "presentation": [ "http://f8k.com/role/ConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Operating lease liabilities", "documentation": "Amount of increase (decrease) in obligation for operating lease." } } }, "auth_ref": [ "r639", "r650" ] }, "us-gaap_IncreaseDecreaseInOtherAccruedLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInOtherAccruedLiabilities", "crdr": "debit", "presentation": [ "http://f8k.com/role/OtherCurrentLiabilitiesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Accrued other liability", "documentation": "The increase (decrease) during the reporting period in other expenses incurred but not yet paid." } } }, "auth_ref": [ "r5" ] }, "us-gaap_IncreaseDecreaseInOtherOperatingAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInOtherOperatingAssets", "crdr": "credit", "calculation": { "http://f8k.com/role/ConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 14.0 } }, "presentation": [ "http://f8k.com/role/ConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Other assets", "label": "[Increase (Decrease) in Other Operating Assets]", "documentation": "Amount of increase (decrease) in operating assets classified as other." } } }, "auth_ref": [ "r5" ] }, "us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets", "crdr": "credit", "calculation": { "http://f8k.com/role/ConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 13.0 } }, "presentation": [ "http://f8k.com/role/ConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Prepaid expenses and other current assets", "label": "[Increase (Decrease) in Prepaid Expense and Other Assets]", "documentation": "Amount of increase (decrease) in prepaid expenses, and assets classified as other." } } }, "auth_ref": [ "r5" ] }, "us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncrementalCommonSharesAttributableToConversionOfDebtSecurities", "presentation": [ "http://f8k.com/role/ShareholdersEquityDetails" ], "lang": { "en-us": { "role": { "label": "Issuance of shares in convertible debt conversion", "documentation": "Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of convertible debt securities using the if-converted method." } } }, "auth_ref": [ "r202", "r203", "r208" ] }, "us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IndefiniteLivedIntangibleAssetsByMajorClassAxis", "presentation": [ "http://f8k.com/role/IntangibleAssetsDetails", "http://f8k.com/role/IntangibleAssetsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Indefinite-Lived Intangible Assets [Axis]", "documentation": "Information by type or class of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit." } } }, "auth_ref": [ "r264", "r267" ] }, "us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IndefiniteLivedIntangibleAssetsMajorClassNameDomain", "presentation": [ "http://f8k.com/role/IntangibleAssetsDetails", "http://f8k.com/role/IntangibleAssetsDetailsNarrative" ], "lang": { "en-us": { "role": { "documentation": "The major class of indefinite-lived intangible asset (for example, trade names, etc. but not all-inclusive), excluding goodwill. A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of the company." } } }, "auth_ref": [ "r45", "r95" ] }, "lowlf_InsuranceMaturityDate": { "xbrltype": "stringItemType", "nsuri": "http://f8k.com/20231231", "localname": "InsuranceMaturityDate", "presentation": [ "http://f8k.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Insurance maturity date" } } }, "auth_ref": [] }, "lowlf_InsuranceMember": { "xbrltype": "domainItemType", "nsuri": "http://f8k.com/20231231", "localname": "InsuranceMember", "presentation": [ "http://f8k.com/role/GeneralAndAdministrativeExpensesDetails" ], "lang": { "en-us": { "role": { "label": "Insurance Member" } } }, "auth_ref": [] }, "us-gaap_IntangibleAssetsCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IntangibleAssetsCurrent", "crdr": "debit", "presentation": [ "http://f8k.com/role/IntangibleAssetsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Intangible assets", "documentation": "The current portion of nonphysical assets, excluding financial assets, if these assets are classified into the current and noncurrent portions." } } }, "auth_ref": [ "r3" ] }, "us-gaap_IntangibleAssetsDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IntangibleAssetsDisclosureTextBlock", "presentation": [ "http://f8k.com/role/IntangibleAssets" ], "lang": { "en-us": { "role": { "verboseLabel": "INTANGIBLE ASSETS", "label": "Intangible Assets Disclosure [Text Block]", "documentation": "The entire disclosure for all or part of the information related to intangible assets." } } }, "auth_ref": [ "r262" ] }, "us-gaap_IntangibleAssetsFiniteLivedPolicy": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IntangibleAssetsFiniteLivedPolicy", "presentation": [ "http://f8k.com/role/BusinessBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Intangible Assets", "documentation": "Disclosure of accounting policy for finite-lived intangible assets. This accounting policy also might address: (1) the amortization method used; (2) the useful lives of such assets; and (3) how the entity assesses and measures impairment of such assets." } } }, "auth_ref": [ "r47", "r448", "r449", "r450", "r452", "r599" ] }, "us-gaap_IntangibleAssetsNetExcludingGoodwill": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IntangibleAssetsNetExcludingGoodwill", "crdr": "debit", "presentation": [ "http://f8k.com/role/IntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "periodStartLabel": "Net book value, beginning balance", "label": "[Intangible Assets, Net (Excluding Goodwill)]", "periodEndLabel": "Net book value, ending balance", "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges." } } }, "auth_ref": [ "r42", "r46" ] }, "us-gaap_InterestExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InterestExpense", "crdr": "debit", "presentation": [ "http://f8k.com/role/OtherCurrentLiabilitiesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Interest Expense", "documentation": "Amount of the cost of borrowed funds accounted for as interest expense." } } }, "auth_ref": [ "r63", "r116", "r167", "r223", "r421", "r553", "r624", "r711" ] }, "us-gaap_InterestExpenseOther": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InterestExpenseOther", "crdr": "debit", "calculation": { "http://f8k.com/role/ConsolidatedStatementsOfIncomeLoss": { "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": -1.0, "order": 12.0 } }, "presentation": [ "http://f8k.com/role/ConsolidatedStatementsOfIncomeLoss" ], "lang": { "en-us": { "role": { "negatedLabel": "Interest expense", "label": "[Interest Expense, Other]", "documentation": "Amount of interest expense classified as other." } } }, "auth_ref": [] }, "lowlf_InterestOnLeaseLiabilitiesOperatingLeases": { "xbrltype": "monetaryItemType", "nsuri": "http://f8k.com/20231231", "localname": "InterestOnLeaseLiabilitiesOperatingLeases", "crdr": "credit", "presentation": [ "http://f8k.com/role/LeasesDetails1" ], "lang": { "en-us": { "role": { "label": "Interest On Lease Liabilities - Operating Leases" } } }, "auth_ref": [] }, "us-gaap_InterestPaidNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InterestPaidNet", "crdr": "credit", "presentation": [ "http://f8k.com/role/ConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Cash paid during the period for interest", "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount." } } }, "auth_ref": [ "r172", "r175", "r176" ] }, "us-gaap_InterestReceivable": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InterestReceivable", "crdr": "debit", "presentation": [ "http://f8k.com/role/PrepaidAndOtherCurrentAssetsDetails" ], "lang": { "en-us": { "role": { "label": "Interest And Taxes", "documentation": "Carrying amount as of the balance sheet date of interest earned but not received. Also called accrued interest or accrued interest receivable." } } }, "auth_ref": [ "r641", "r713" ] }, "us-gaap_InterimPeriodCostsNotAllocableDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InterimPeriodCostsNotAllocableDomain", "presentation": [ "http://f8k.com/role/GeneralAndAdministrativeExpensesDetails" ], "lang": { "en-us": { "role": { "documentation": "This element represents the type of costs and expenses incurred during an interim period that cannot be readily identified with the activities or benefits of other interim periods and are charged to the interim period in which incurred." } } }, "auth_ref": [ "r35" ] }, "us-gaap_InventoryDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InventoryDisclosureAbstract", "lang": { "en-us": { "role": { "label": "INVENTORY" } } }, "auth_ref": [] }, "us-gaap_InventoryDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InventoryDisclosureTextBlock", "presentation": [ "http://f8k.com/role/INVENTORY" ], "lang": { "en-us": { "role": { "verboseLabel": "Inventory", "label": "Inventory Disclosure [Text Block]", "documentation": "The entire disclosure for inventory. Includes, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the classes of inventory, and the nature of the cost elements included in inventory." } } }, "auth_ref": [ "r254" ] }, "us-gaap_InventoryFinishedGoods": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InventoryFinishedGoods", "crdr": "debit", "presentation": [ "http://f8k.com/role/InventoryDetails" ], "lang": { "en-us": { "role": { "label": "Finished Goods", "documentation": "Amount before valuation and LIFO reserves of completed merchandise or goods expected to be sold within one year or operating cycle, if longer." } } }, "auth_ref": [ "r642" ] }, "us-gaap_InventoryNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InventoryNet", "crdr": "debit", "calculation": { "http://f8k.com/role/ConsolidatedBalanceSheets": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://f8k.com/role/ConsolidatedBalanceSheets", "http://f8k.com/role/InventoryDetails" ], "lang": { "en-us": { "role": { "label": "Inventory", "verboseLabel": "Inventory", "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer." } } }, "auth_ref": [ "r159", "r596", "r620" ] }, "us-gaap_InventoryPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InventoryPolicyTextBlock", "presentation": [ "http://f8k.com/role/BusinessBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Inventories", "documentation": "Disclosure of inventory accounting policy for inventory classes, including, but not limited to, basis for determining inventory amounts, methods by which amounts are added and removed from inventory classes, loss recognition on impairment of inventories, and situations in which inventories are stated above cost." } } }, "auth_ref": [ "r133", "r148", "r158", "r254", "r255", "r257", "r447", "r600" ] }, "us-gaap_InventoryRawMaterials": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InventoryRawMaterials", "crdr": "debit", "presentation": [ "http://f8k.com/role/InventoryDetails" ], "lang": { "en-us": { "role": { "label": "Raw Materials", "documentation": "Amount before valuation and LIFO reserves of raw materials expected to be sold, or consumed within one year or operating cycle, if longer." } } }, "auth_ref": [ "r644" ] }, "us-gaap_InventoryValuationReserves": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InventoryValuationReserves", "crdr": "credit", "presentation": [ "http://f8k.com/role/InventoryDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Inventory reserve", "documentation": "Amount of valuation reserve for inventory." } } }, "auth_ref": [ "r41", "r645" ] }, "us-gaap_InventoryWorkInProcess": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InventoryWorkInProcess", "crdr": "debit", "presentation": [ "http://f8k.com/role/InventoryDetails" ], "lang": { "en-us": { "role": { "label": "Work In Process", "documentation": "Amount before valuation and LIFO reserves of merchandise or goods in the production process expected to be completed within one year or operating cycle, if longer." } } }, "auth_ref": [ "r643" ] }, "us-gaap_InventoryWriteDown": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InventoryWriteDown", "crdr": "debit", "presentation": [ "http://f8k.com/role/InventoryDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Inventory write off", "documentation": "Amount of loss from reductions in inventory due to subsequent measurement adjustments, including, but not limited to, physical deterioration, obsolescence, or changes in price levels." } } }, "auth_ref": [ "r256" ] }, "lowlf_IssuanceCostsRelatedToSubordinateVotingShareOffering": { "xbrltype": "monetaryItemType", "nsuri": "http://f8k.com/20231231", "localname": "IssuanceCostsRelatedToSubordinateVotingShareOffering", "crdr": "credit", "calculation": { "http://f8k.com/role/ConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0, "order": 26.0 } }, "presentation": [ "http://f8k.com/role/ConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Issuance costs related to subordinate voting share offering" } } }, "auth_ref": [] }, "lowlf_IssuanceOfSubordinateVotingSharesInConvertibleDebentureRepurchase": { "xbrltype": "monetaryItemType", "nsuri": "http://f8k.com/20231231", "localname": "IssuanceOfSubordinateVotingSharesInConvertibleDebentureRepurchase", "crdr": "credit", "presentation": [ "http://f8k.com/role/ConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Issuance of subordinate voting shares in convertible debenture repurchase" } } }, "auth_ref": [] }, "lowlf_IssuanceOfSubordinateVotingSharesToAcquirePurchaseRights": { "xbrltype": "monetaryItemType", "nsuri": "http://f8k.com/20231231", "localname": "IssuanceOfSubordinateVotingSharesToAcquirePurchaseRights", "crdr": "credit", "presentation": [ "http://f8k.com/role/ConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Issuance of subordinate voting shares to acquire purchase rights" } } }, "auth_ref": [] }, "lowlf_IssuanceOfVestedRsusAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://f8k.com/20231231", "localname": "IssuanceOfVestedRsusAmount", "crdr": "debit", "presentation": [ "http://f8k.com/role/ConsolidatedStatementsOfStockholdersEquityDeficit" ], "lang": { "en-us": { "role": { "label": "Issuance of vested RSUs, Amount" } } }, "auth_ref": [] }, "lowlf_IssuanceOfVestedRsusShares": { "xbrltype": "sharesItemType", "nsuri": "http://f8k.com/20231231", "localname": "IssuanceOfVestedRsusShares", "presentation": [ "http://f8k.com/role/ConsolidatedStatementsOfStockholdersEquityDeficit" ], "lang": { "en-us": { "role": { "label": "Issuance of vested RSUs, Shares" } } }, "auth_ref": [] }, "lowlf_LandAndBuildingsMember": { "xbrltype": "domainItemType", "nsuri": "http://f8k.com/20231231", "localname": "LandAndBuildingsMember", "presentation": [ "http://f8k.com/role/PropertyAndEquipmentAndRightOfUseAssetsDetails" ], "lang": { "en-us": { "role": { "label": "Land And Buildings [Member]" } } }, "auth_ref": [] }, "us-gaap_LeaseCostTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LeaseCostTableTextBlock", "presentation": [ "http://f8k.com/role/LeasesTables" ], "lang": { "en-us": { "role": { "label": "Schedule Of Lease Expense", "documentation": "Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income." } } }, "auth_ref": [ "r700" ] }, "lowlf_LeaseRemeasurement": { "xbrltype": "monetaryItemType", "nsuri": "http://f8k.com/20231231", "localname": "LeaseRemeasurement", "crdr": "credit", "presentation": [ "http://f8k.com/role/LeasesDetails" ], "lang": { "en-us": { "role": { "label": "Lease remeasurement" } } }, "auth_ref": [] }, "lowlf_LeaseSettlement": { "xbrltype": "monetaryItemType", "nsuri": "http://f8k.com/20231231", "localname": "LeaseSettlement", "crdr": "credit", "presentation": [ "http://f8k.com/role/LeasesDetails" ], "lang": { "en-us": { "role": { "label": "Lease Settlement" } } }, "auth_ref": [] }, "lowlf_LeaseTerm": { "xbrltype": "durationItemType", "nsuri": "http://f8k.com/20231231", "localname": "LeaseTerm", "presentation": [ "http://f8k.com/role/RelatedPartyTransactionsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Lease term" } } }, "auth_ref": [] }, "us-gaap_LeaseholdImprovementsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LeaseholdImprovementsMember", "presentation": [ "http://f8k.com/role/PropertyAndEquipmentAndRightOfUseAssetsDetails" ], "lang": { "en-us": { "role": { "label": "Leasehold Improvements", "documentation": "Additions or improvements to assets held under a lease arrangement." } } }, "auth_ref": [ "r97" ] }, "lowlf_LeaseholdimprovementsMember": { "xbrltype": "domainItemType", "nsuri": "http://f8k.com/20231231", "localname": "LeaseholdimprovementsMember", "presentation": [ "http://f8k.com/role/BusinessBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "label": "Leasehold improvements [Member]" } } }, "auth_ref": [] }, "us-gaap_LeasesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LeasesAbstract", "lang": { "en-us": { "role": { "label": "LEASES" } } }, "auth_ref": [] }, "us-gaap_LeasesOfLesseeDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LeasesOfLesseeDisclosureTextBlock", "presentation": [ "http://f8k.com/role/LEASES" ], "lang": { "en-us": { "role": { "label": "Leases", "documentation": "The entire disclosure for lessee entity's leasing arrangements including, but not limited to, all of the following: (a.) The basis on which contingent rental payments are determined, (b.) The existence and terms of renewal or purchase options and escalation clauses, (c.) Restrictions imposed by lease agreements, such as those concerning dividends, additional debt, and further leasing." } } }, "auth_ref": [ "r125" ] }, "us-gaap_LesseeLeasesPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LesseeLeasesPolicyTextBlock", "presentation": [ "http://f8k.com/role/BusinessBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Leased Assets", "documentation": "Disclosure of accounting policy for leasing arrangement entered into by lessee." } } }, "auth_ref": [ "r429" ] }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths", "crdr": "credit", "presentation": [ "http://f8k.com/role/LeasesDetails2" ], "lang": { "en-us": { "role": { "verboseLabel": "2024", "label": "[Lessee, Operating Lease, Liability, to be Paid, Year One]", "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r434" ] }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFive", "crdr": "credit", "presentation": [ "http://f8k.com/role/LeasesDetails2" ], "lang": { "en-us": { "role": { "label": "2028 - And Beyond", "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r434" ] }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFour", "crdr": "credit", "presentation": [ "http://f8k.com/role/LeasesDetails2" ], "lang": { "en-us": { "role": { "label": "2027", "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r434" ] }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearThree", "crdr": "credit", "presentation": [ "http://f8k.com/role/LeasesDetails2" ], "lang": { "en-us": { "role": { "label": "2026", "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r434" ] }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearTwo", "crdr": "credit", "presentation": [ "http://f8k.com/role/LeasesDetails2" ], "lang": { "en-us": { "role": { "label": "2025", "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r434" ] }, "us-gaap_Liabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "Liabilities", "crdr": "credit", "calculation": { "http://f8k.com/role/ConsolidatedBalanceSheets": { "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0, "order": 24.0 } }, "presentation": [ "http://f8k.com/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "totalLabel": "Total liabilities", "label": "[Liabilities]", "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future." } } }, "auth_ref": [ "r19", "r180", "r248", "r277", "r278", "r279", "r280", "r281", "r282", "r283", "r284", "r285", "r398", "r401", "r402", "r414", "r523", "r603", "r626", "r663", "r702", "r703" ] }, "us-gaap_LiabilitiesAndStockholdersEquity": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LiabilitiesAndStockholdersEquity", "crdr": "credit", "calculation": { "http://f8k.com/role/ConsolidatedBalanceSheets": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://f8k.com/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "totalLabel": "Total liabilities and stockholders' equity", "label": "[Liabilities and Equity]", "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any." } } }, "auth_ref": [ "r73", "r113", "r475", "r620", "r654", "r658", "r699" ] }, "us-gaap_LiabilitiesAndStockholdersEquityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LiabilitiesAndStockholdersEquityAbstract", "presentation": [ "http://f8k.com/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "LIABILITIES AND STOCKHOLDERS' EQUITY" } } }, "auth_ref": [] }, "us-gaap_LiabilitiesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LiabilitiesCurrent", "crdr": "credit", "calculation": { "http://f8k.com/role/ConsolidatedBalanceSheets": { "parentTag": "us-gaap_Liabilities", "weight": 1.0, "order": 17.0 } }, "presentation": [ "http://f8k.com/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "totalLabel": "Total current liabilities", "label": "[Liabilities, Current]", "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer." } } }, "auth_ref": [ "r22", "r147", "r180", "r248", "r277", "r278", "r279", "r280", "r281", "r282", "r283", "r284", "r285", "r398", "r401", "r402", "r414", "r620", "r663", "r702", "r703" ] }, "us-gaap_LiabilitiesCurrentAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LiabilitiesCurrentAbstract", "presentation": [ "http://f8k.com/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Current liabilities:" } } }, "auth_ref": [] }, "lowlf_LicensesAndPayments": { "xbrltype": "monetaryItemType", "nsuri": "http://f8k.com/20231231", "localname": "LicensesAndPayments", "crdr": "credit", "presentation": [ "http://f8k.com/role/PrepaidAndOtherCurrentAssetsDetails" ], "lang": { "en-us": { "role": { "label": "Licenses and payments" } } }, "auth_ref": [] }, "dei_LocalPhoneNumber": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "LocalPhoneNumber", "presentation": [ "http://f8k.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Local Phone Number", "documentation": "Local phone number for entity." } } }, "auth_ref": [] }, "us-gaap_LongTermDebt": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LongTermDebt", "crdr": "credit", "presentation": [ "http://f8k.com/role/DebtDetails1" ], "lang": { "en-us": { "role": { "label": "Total Debt Obligations", "documentation": "Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt. Excludes lease obligation." } } }, "auth_ref": [ "r14", "r112", "r299", "r312", "r610", "r611", "r710" ] }, "us-gaap_LongTermDebtCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LongTermDebtCurrent", "crdr": "credit", "presentation": [ "http://f8k.com/role/DebtDetails" ], "lang": { "en-us": { "role": { "label": "Total short-term debt", "documentation": "Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt classified as current. Excludes lease obligation." } } }, "auth_ref": [ "r152" ] }, "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths", "crdr": "credit", "presentation": [ "http://f8k.com/role/DebtDetails1" ], "lang": { "en-us": { "role": { "label": "2024", "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r8", "r182", "r304" ] }, "us-gaap_LongTermDebtNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LongTermDebtNoncurrent", "crdr": "credit", "presentation": [ "http://f8k.com/role/DebtDetails" ], "lang": { "en-us": { "role": { "label": "Total long-term debt", "documentation": "Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt classified as noncurrent. Excludes lease obligation." } } }, "auth_ref": [ "r153" ] }, "us-gaap_LongTermNotesPayable": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LongTermNotesPayable", "crdr": "credit", "calculation": { "http://f8k.com/role/ConsolidatedBalanceSheets": { "parentTag": "us-gaap_Liabilities", "weight": 1.0, "order": 18.0 } }, "presentation": [ "http://f8k.com/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Notes payable", "documentation": "Carrying value as of the balance sheet date of notes payable (with maturities initially due after one year or beyond the operating cycle if longer), excluding current portion." } } }, "auth_ref": [ "r23" ] }, "lowlf_LowellBrandMember": { "xbrltype": "domainItemType", "nsuri": "http://f8k.com/20231231", "localname": "LowellBrandMember", "presentation": [ "http://f8k.com/role/IntangibleAssetsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Lowell Brand [Member]" } } }, "auth_ref": [] }, "lowlf_LowellFarmsServicesPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://f8k.com/20231231", "localname": "LowellFarmsServicesPolicyTextBlock", "presentation": [ "http://f8k.com/role/BusinessBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Lowell Farms Services" } } }, "auth_ref": [] }, "us-gaap_MachineryAndEquipmentMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "MachineryAndEquipmentMember", "presentation": [ "http://f8k.com/role/BusinessBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "label": "Machinery and equipment [Member]", "documentation": "Tangible personal property used to produce goods and services, including, but is not limited to, tools, dies and molds, computer and office equipment." } } }, "auth_ref": [] }, "srt_MaximumMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "MaximumMember", "presentation": [ "http://f8k.com/role/BusinessBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "label": "Maximum [Member]" } } }, "auth_ref": [ "r273", "r274", "r275", "r276", "r331", "r446", "r484", "r515", "r516", "r576", "r577", "r578", "r579", "r580", "r593", "r594", "r605", "r614", "r615", "r621", "r665", "r704", "r705", "r706", "r707", "r708", "r709" ] }, "srt_MinimumMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "MinimumMember", "presentation": [ "http://f8k.com/role/BusinessBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "label": "Minimum [Member]" } } }, "auth_ref": [ "r273", "r274", "r275", "r276", "r331", "r446", "r484", "r515", "r516", "r576", "r577", "r578", "r579", "r580", "r593", "r594", "r605", "r614", "r615", "r621", "r665", "r704", "r705", "r706", "r707", "r708", "r709" ] }, "lowlf_MortgagePayableMember": { "xbrltype": "domainItemType", "nsuri": "http://f8k.com/20231231", "localname": "MortgagePayableMember", "presentation": [ "http://f8k.com/role/DebtDetails", "http://f8k.com/role/DebtDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Mortgage Payable [Member]" } } }, "auth_ref": [] }, "us-gaap_NatureOfExpenseAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NatureOfExpenseAxis", "presentation": [ "http://f8k.com/role/GeneralAndAdministrativeExpensesDetails" ], "lang": { "en-us": { "role": { "label": "Nature of Expense [Axis]", "documentation": "Information by type of cost or expense." } } }, "auth_ref": [ "r35" ] }, "lowlf_NetBooksValue": { "xbrltype": "monetaryItemType", "nsuri": "http://f8k.com/20231231", "localname": "NetBooksValue", "crdr": "debit", "presentation": [ "http://f8k.com/role/PropertyAndEquipmentAndRightOfUseAssetsDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Net Book Value", "label": "[Net Book Value]" } } }, "auth_ref": [] }, "us-gaap_NetCashProvidedByUsedInFinancingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInFinancingActivities", "crdr": "debit", "calculation": { "http://f8k.com/role/ConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect", "weight": 1.0, "order": 30.0 } }, "presentation": [ "http://f8k.com/role/ConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "totalLabel": "Net cash provided by financing activities", "label": "[Net Cash Provided by (Used in) Financing Activities]", "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit." } } }, "auth_ref": [ "r174" ] }, "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract", "presentation": [ "http://f8k.com/role/ConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "CASH FLOW FROM FINANCING ACTIVITIES" } } }, "auth_ref": [] }, "us-gaap_NetCashProvidedByUsedInInvestingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInInvestingActivities", "crdr": "debit", "calculation": { "http://f8k.com/role/ConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect", "weight": 1.0, "order": 29.0 } }, "presentation": [ "http://f8k.com/role/ConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "totalLabel": "Net cash used in investing activities", "label": "[Net Cash Provided by (Used in) Investing Activities]", "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets." } } }, "auth_ref": [ "r174" ] }, "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract", "presentation": [ "http://f8k.com/role/ConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "CASH FLOW FROM INVESTING ACTIVITIES" } } }, "auth_ref": [] }, "us-gaap_NetCashProvidedByUsedInOperatingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInOperatingActivities", "calculation": { "http://f8k.com/role/ConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect", "weight": 1.0, "order": 28.0 } }, "presentation": [ "http://f8k.com/role/ConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "totalLabel": "Net cash used in operating activities", "label": "[Net Cash Provided by (Used in) Operating Activities]", "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities." } } }, "auth_ref": [ "r89", "r90", "r91" ] }, "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract", "presentation": [ "http://f8k.com/role/ConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "CASH FLOW FROM OPERATING ACTIVITIES" } } }, "auth_ref": [] }, "us-gaap_NetIncomeLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetIncomeLoss", "crdr": "credit", "calculation": { "http://f8k.com/role/ConsolidatedStatementsOfIncomeLoss": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://f8k.com/role/ConsolidatedStatementsOfIncomeLoss", "http://f8k.com/role/ConsolidatedStatementsOfStockholdersEquityDeficit" ], "lang": { "en-us": { "role": { "totalLabel": "Net loss", "label": "[Net Income (Loss) Attributable to Parent]", "verboseLabel": "Net Loss", "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent." } } }, "auth_ref": [ "r78", "r91", "r115", "r145", "r161", "r162", "r166", "r180", "r186", "r188", "r189", "r190", "r191", "r194", "r195", "r204", "r220", "r228", "r233", "r236", "r248", "r277", "r278", "r279", "r280", "r281", "r282", "r283", "r284", "r285", "r412", "r414", "r480", "r544", "r566", "r567", "r604", "r624", "r663" ] }, "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetIncomeLossAvailableToCommonStockholdersBasic", "crdr": "credit", "presentation": [ "http://f8k.com/role/NetIncomeLossPerShareDetails" ], "lang": { "en-us": { "role": { "label": "Net income (loss)", "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders." } } }, "auth_ref": [ "r171", "r188", "r189", "r190", "r191", "r197", "r198", "r205", "r208", "r220", "r228", "r233", "r236", "r604" ] }, "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock", "presentation": [ "http://f8k.com/role/BusinessBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Recently Adopted Accounting Standards", "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact." } } }, "auth_ref": [] }, "us-gaap_NoncashInvestingAndFinancingItemsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NoncashInvestingAndFinancingItemsAbstract", "presentation": [ "http://f8k.com/role/ConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "OTHER NONCASH INVESTING AND FINANCING ACTIVITIES" } } }, "auth_ref": [] }, "us-gaap_NonoperatingIncomeExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NonoperatingIncomeExpense", "crdr": "credit", "calculation": { "http://f8k.com/role/ConsolidatedStatementsOfIncomeLoss": { "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0, "order": 14.0 } }, "presentation": [ "http://f8k.com/role/ConsolidatedStatementsOfIncomeLoss" ], "lang": { "en-us": { "role": { "totalLabel": "Total other income (expense)", "label": "[Nonoperating Income (Expense)]", "documentation": "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business)." } } }, "auth_ref": [ "r86" ] }, "us-gaap_NonoperatingIncomeExpenseAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NonoperatingIncomeExpenseAbstract", "presentation": [ "http://f8k.com/role/ConsolidatedStatementsOfIncomeLoss" ], "lang": { "en-us": { "role": { "label": "Other income/(expense)" } } }, "auth_ref": [] }, "lowlf_NotePayable2Member": { "xbrltype": "domainItemType", "nsuri": "http://f8k.com/20231231", "localname": "NotePayable2Member", "presentation": [ "http://f8k.com/role/DebtDetails" ], "lang": { "en-us": { "role": { "label": "Note Payable" } } }, "auth_ref": [] }, "us-gaap_NotesPayableCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NotesPayableCurrent", "crdr": "credit", "calculation": { "http://f8k.com/role/ConsolidatedBalanceSheets": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 13.0 } }, "presentation": [ "http://f8k.com/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Notes payable, current portion", "documentation": "Sum of the carrying values as of the balance sheet date of the portions of long-term notes payable due within one year or the operating cycle if longer." } } }, "auth_ref": [ "r18" ] }, "lowlf_OMGMember": { "xbrltype": "domainItemType", "nsuri": "http://f8k.com/20231231", "localname": "OMGMember", "presentation": [ "http://f8k.com/role/RelatedPartyTransactionsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "OMG" } } }, "auth_ref": [] }, "us-gaap_OfficeEquipmentMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OfficeEquipmentMember", "presentation": [ "http://f8k.com/role/BusinessBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "label": "Office equipment [Member]", "documentation": "Tangible personal property used in an office setting. Examples include, but are not limited to, computers, copiers and fax machine." } } }, "auth_ref": [] }, "lowlf_OnTwentySixJulyTwoThousandTwentyTwoMember": { "xbrltype": "domainItemType", "nsuri": "http://f8k.com/20231231", "localname": "OnTwentySixJulyTwoThousandTwentyTwoMember", "presentation": [ "http://f8k.com/role/OtherCurrentLiabilitiesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "On Twenty Six July Two Thousand Twenty Two [Member]" } } }, "auth_ref": [] }, "us-gaap_OperatingExpenses": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingExpenses", "crdr": "debit", "calculation": { "http://f8k.com/role/ConsolidatedStatementsOfIncomeLoss": { "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0, "order": 8.0 } }, "presentation": [ "http://f8k.com/role/ConsolidatedStatementsOfIncomeLoss" ], "lang": { "en-us": { "role": { "totalLabel": "Total operating expenses", "label": "[Operating Expenses]", "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense." } } }, "auth_ref": [] }, "us-gaap_OperatingExpensesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingExpensesAbstract", "presentation": [ "http://f8k.com/role/ConsolidatedStatementsOfIncomeLoss" ], "lang": { "en-us": { "role": { "label": "Operating expenses" } } }, "auth_ref": [] }, "us-gaap_OperatingIncomeLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingIncomeLoss", "crdr": "credit", "calculation": { "http://f8k.com/role/ConsolidatedStatementsOfIncomeLoss": { "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0, "order": 13.0 } }, "presentation": [ "http://f8k.com/role/ConsolidatedStatementsOfIncomeLoss" ], "lang": { "en-us": { "role": { "totalLabel": "Loss from operations", "label": "[Operating Income (Loss)]", "documentation": "The net result for the period of deducting operating expenses from operating revenues." } } }, "auth_ref": [ "r220", "r228", "r233", "r236", "r604" ] }, "lowlf_OperatingLeaseAmortization": { "xbrltype": "monetaryItemType", "nsuri": "http://f8k.com/20231231", "localname": "OperatingLeaseAmortization", "crdr": "credit", "presentation": [ "http://f8k.com/role/LeasesDetails1" ], "lang": { "en-us": { "role": { "label": "Total Operating Lease Amortization" } } }, "auth_ref": [] }, "lowlf_OperatingLeaseLiabilityBeginning": { "xbrltype": "monetaryItemType", "nsuri": "http://f8k.com/20231231", "localname": "OperatingLeaseLiabilityBeginning", "crdr": "credit", "presentation": [ "http://f8k.com/role/LeasesDetails" ], "lang": { "en-us": { "role": { "label": "Lease Liability, Beginning" } } }, "auth_ref": [] }, "lowlf_OperatingLeaseLiabilityEnding": { "xbrltype": "monetaryItemType", "nsuri": "http://f8k.com/20231231", "localname": "OperatingLeaseLiabilityEnding", "crdr": "credit", "presentation": [ "http://f8k.com/role/LeasesDetails" ], "lang": { "en-us": { "role": { "label": "Lease Liability, ending" } } }, "auth_ref": [] }, "us-gaap_OperatingLeasePayments": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLeasePayments", "crdr": "credit", "presentation": [ "http://f8k.com/role/LeasesDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Lease Principal Payments", "label": "[Operating Lease, Payments]", "documentation": "Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use." } } }, "auth_ref": [ "r428", "r432" ] }, "lowlf_OperatingLeaseRemeasurementClassification": { "xbrltype": "monetaryItemType", "nsuri": "http://f8k.com/20231231", "localname": "OperatingLeaseRemeasurementClassification", "crdr": "credit", "presentation": [ "http://f8k.com/role/LeasesDetails" ], "lang": { "en-us": { "role": { "label": "Operating lease remeasurement classification" } } }, "auth_ref": [] }, "us-gaap_OperatingLeaseRightOfUseAsset": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLeaseRightOfUseAsset", "crdr": "debit", "calculation": { "http://f8k.com/role/ConsolidatedBalanceSheets": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 8.0 } }, "presentation": [ "http://f8k.com/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Right of use assets, net", "documentation": "Amount of lessee's right to use underlying asset under operating lease." } } }, "auth_ref": [ "r425" ] }, "us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLeaseWeightedAverageDiscountRatePercent", "presentation": [ "http://f8k.com/role/LeasesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Weighted Average Discount Rate", "documentation": "Weighted average discount rate for operating lease calculated at point in time." } } }, "auth_ref": [ "r433", "r619" ] }, "lowlf_OperatingLeasesMember": { "xbrltype": "domainItemType", "nsuri": "http://f8k.com/20231231", "localname": "OperatingLeasesMember", "presentation": [ "http://f8k.com/role/LeasesDetails" ], "lang": { "en-us": { "role": { "label": "Operating Leases [Member]" } } }, "auth_ref": [] }, "us-gaap_OtherAccruedLiabilitiesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherAccruedLiabilitiesCurrent", "crdr": "credit", "presentation": [ "http://f8k.com/role/OtherCurrentLiabilitiesDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Other", "label": "[Other Accrued Liabilities, Current]", "documentation": "Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer." } } }, "auth_ref": [ "r20" ] }, "us-gaap_OtherAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherAssets", "crdr": "debit", "calculation": { "http://f8k.com/role/ConsolidatedBalanceSheets": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 10.0 } }, "presentation": [ "http://f8k.com/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Other assets", "documentation": "Amount of assets classified as other." } } }, "auth_ref": [ "r109", "r150", "r471", "r626" ] }, "us-gaap_OtherCurrentLiabilitiesTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherCurrentLiabilitiesTableTextBlock", "presentation": [ "http://f8k.com/role/OtherCurrentLiabilitiesTables" ], "lang": { "en-us": { "role": { "label": "Schedule Of Other Current Liabilities", "documentation": "Tabular disclosure of other current liabilities." } } }, "auth_ref": [] }, "us-gaap_OtherExpenses": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherExpenses", "crdr": "debit", "presentation": [ "http://f8k.com/role/LeasesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Other Income (expenses)", "documentation": "Amount of expense classified as other." } } }, "auth_ref": [ "r85" ] }, "us-gaap_OtherIncome": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherIncome", "crdr": "credit", "presentation": [ "http://f8k.com/role/OtherCurrentLiabilitiesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Other income", "documentation": "Amount of revenue and income classified as other." } } }, "auth_ref": [ "r482", "r546", "r581", "r582", "r583" ] }, "lowlf_OtherIncomeExpenseMember": { "xbrltype": "domainItemType", "nsuri": "http://f8k.com/20231231", "localname": "OtherIncomeExpenseMember", "presentation": [ "http://f8k.com/role/PropertyAndEquipmentAndRightOfUseAssetsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Other Income Expense [Member]" } } }, "auth_ref": [] }, "us-gaap_OtherIntangibleAssetsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherIntangibleAssetsMember", "presentation": [ "http://f8k.com/role/IntangibleAssetsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Other Intangible Assets [Member]", "documentation": "Intangible assets classified as other." } } }, "auth_ref": [] }, "us-gaap_OtherIntangibleAssetsNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherIntangibleAssetsNet", "crdr": "debit", "calculation": { "http://f8k.com/role/ConsolidatedBalanceSheets": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 9.0 } }, "presentation": [ "http://f8k.com/role/ConsolidatedBalanceSheets", "http://f8k.com/role/IntangibleAssetsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Other intangibles, net", "verboseLabel": "Impairment of intangible assets", "documentation": "Amount after accumulated amortization of finite-lived and indefinite-lived intangible assets classified as other." } } }, "auth_ref": [] }, "us-gaap_OtherLiabilitiesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherLiabilitiesCurrent", "crdr": "credit", "calculation": { "http://f8k.com/role/ConsolidatedBalanceSheets": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 16.0 } }, "presentation": [ "http://f8k.com/role/ConsolidatedBalanceSheets", "http://f8k.com/role/OtherCurrentLiabilitiesDetails" ], "lang": { "en-us": { "role": { "label": "Other current liabilities", "verboseLabel": "Total Other Current Liabilities", "documentation": "Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer." } } }, "auth_ref": [ "r20", "r620" ] }, "us-gaap_OtherLiabilitiesCurrentAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherLiabilitiesCurrentAbstract", "lang": { "en-us": { "role": { "label": "OTHER CURRENT LIABILITIES" } } }, "auth_ref": [] }, "us-gaap_OtherLiabilitiesDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherLiabilitiesDisclosureTextBlock", "presentation": [ "http://f8k.com/role/OtherCurrentLiabilities" ], "lang": { "en-us": { "role": { "label": "Other Current Liabilities", "documentation": "The entire disclosure for other liabilities." } } }, "auth_ref": [ "r21" ] }, "us-gaap_OtherNonoperatingIncomeExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherNonoperatingIncomeExpense", "crdr": "credit", "calculation": { "http://f8k.com/role/ConsolidatedStatementsOfIncomeLoss": { "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": 1.0, "order": 9.0 } }, "presentation": [ "http://f8k.com/role/ConsolidatedStatementsOfIncomeLoss" ], "lang": { "en-us": { "role": { "label": "Other income (expense)", "documentation": "Amount of income (expense) related to nonoperating activities, classified as other." } } }, "auth_ref": [ "r87" ] }, "us-gaap_OtherOperatingIncomeAndExpenseTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherOperatingIncomeAndExpenseTextBlock", "presentation": [ "http://f8k.com/role/GeneralAndAdministrativeExpenses" ], "lang": { "en-us": { "role": { "label": "General And Administrative Expenses", "documentation": "The entire disclosure for other operating income and other operating expense items." } } }, "auth_ref": [ "r550" ] }, "us-gaap_OtherPrepaidExpenseCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherPrepaidExpenseCurrent", "crdr": "debit", "presentation": [ "http://f8k.com/role/PrepaidAndOtherCurrentAssetsDetails" ], "lang": { "en-us": { "role": { "label": "Other", "documentation": "Amount of asset related to consideration paid in advance for other costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer." } } }, "auth_ref": [ "r646", "r659" ] }, "us-gaap_ParticipatingMortgageLoansMortgageObligationsAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ParticipatingMortgageLoansMortgageObligationsAmount", "crdr": "credit", "calculation": { "http://f8k.com/role/ConsolidatedBalanceSheets": { "parentTag": "us-gaap_Liabilities", "weight": 1.0, "order": 21.0 } }, "presentation": [ "http://f8k.com/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Mortgage obligation", "documentation": "The aggregate amount of the participating mortgage obligation at the end of the accounting period." } } }, "auth_ref": [ "r51" ] }, "us-gaap_PaymentsOfFinancingCosts": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PaymentsOfFinancingCosts", "crdr": "credit", "presentation": [ "http://f8k.com/role/DebtDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Net Of Deferred Financing Costs", "documentation": "The cash outflow for loan and debt issuance costs." } } }, "auth_ref": [ "r27" ] }, "us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PaymentsToAcquireBusinessesNetOfCashAcquired", "crdr": "credit", "calculation": { "http://f8k.com/role/ConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0, "order": 20.0 } }, "presentation": [ "http://f8k.com/role/ConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Acquisition of business assets, net", "documentation": "The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase." } } }, "auth_ref": [ "r25" ] }, "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PaymentsToAcquirePropertyPlantAndEquipment", "crdr": "credit", "calculation": { "http://f8k.com/role/ConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0, "order": 19.0 } }, "presentation": [ "http://f8k.com/role/ConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Purchases of property and equipment", "label": "[Payments to Acquire Property, Plant, and Equipment]", "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets." } } }, "auth_ref": [ "r88" ] }, "lowlf_PercentageIssuedOutstandingShares": { "xbrltype": "percentItemType", "nsuri": "http://f8k.com/20231231", "localname": "PercentageIssuedOutstandingShares", "presentation": [ "http://f8k.com/role/IntangibleAssetsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Percentage of issued and outstanding shares" } } }, "auth_ref": [] }, "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PrepaidExpenseAndOtherAssetsCurrent", "crdr": "debit", "calculation": { "http://f8k.com/role/ConsolidatedBalanceSheets": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://f8k.com/role/ConsolidatedBalanceSheets", "http://f8k.com/role/PrepaidAndOtherCurrentAssetsDetails" ], "lang": { "en-us": { "role": { "label": "Prepaid expenses and other current assets", "verboseLabel": "Prepaid Expenses And Other Current Assets", "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer." } } }, "auth_ref": [ "r648" ] }, "us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PrepaidExpenseAndOtherAssetsCurrentAbstract", "lang": { "en-us": { "role": { "label": "PREPAID AND OTHER CURRENT ASSETS" } } }, "auth_ref": [] }, "us-gaap_PrepaidInsurance": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PrepaidInsurance", "crdr": "debit", "presentation": [ "http://f8k.com/role/PrepaidAndOtherCurrentAssetsDetails" ], "lang": { "en-us": { "role": { "label": "Insurance", "documentation": "Amount of asset related to consideration paid in advance for insurance that provides economic benefits within a future period of one year or the normal operating cycle, if longer." } } }, "auth_ref": [ "r597", "r606", "r659" ] }, "us-gaap_ProceedsFromConvertibleDebt": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProceedsFromConvertibleDebt", "crdr": "debit", "calculation": { "http://f8k.com/role/ConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0, "order": 22.0 } }, "presentation": [ "http://f8k.com/role/ConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Proceeds from convertible notes, net of financing costs", "documentation": "The cash inflow from the issuance of a long-term debt instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder." } } }, "auth_ref": [ "r26" ] }, "lowlf_ProceedsFromIssuanceOfStockOptions": { "xbrltype": "sharesItemType", "nsuri": "http://f8k.com/20231231", "localname": "ProceedsFromIssuanceOfStockOptions", "presentation": [ "http://f8k.com/role/ShareBasedCompensationDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Proceeds From Issuance Of Stock Options" } } }, "auth_ref": [] }, "lowlf_ProceedsFromSaleLeaseback": { "xbrltype": "monetaryItemType", "nsuri": "http://f8k.com/20231231", "localname": "ProceedsFromSaleLeaseback", "crdr": "debit", "calculation": { "http://f8k.com/role/ConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0, "order": 25.0 } }, "presentation": [ "http://f8k.com/role/ConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Proceeds from sale leaseback" } } }, "auth_ref": [] }, "us-gaap_ProceedsFromSalesOfAssetsInvestingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProceedsFromSalesOfAssetsInvestingActivities", "crdr": "debit", "calculation": { "http://f8k.com/role/ConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": 1.0, "order": 18.0 } }, "presentation": [ "http://f8k.com/role/ConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Proceeds from asset sales", "documentation": "Aggregate cash proceeds received from a combination of transactions that are classified as investing activities in which assets, which may include one or more investments, are sold to third-party buyers. This element can be used by entities to aggregate proceeds from all asset sales that are classified as investing activities." } } }, "auth_ref": [ "r637" ] }, "us-gaap_ProceedsFromStockOptionsExercised": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProceedsFromStockOptionsExercised", "crdr": "debit", "calculation": { "http://f8k.com/role/ConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0, "order": 27.0 } }, "presentation": [ "http://f8k.com/role/ConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Proceeds from exercise of warrants and options", "documentation": "Amount of cash inflow from exercise of option under share-based payment arrangement." } } }, "auth_ref": [ "r4", "r12" ] }, "lowlf_ProfessionalFeesMember": { "xbrltype": "domainItemType", "nsuri": "http://f8k.com/20231231", "localname": "ProfessionalFeesMember", "presentation": [ "http://f8k.com/role/GeneralAndAdministrativeExpensesDetails" ], "lang": { "en-us": { "role": { "label": "Professional Fees Member" } } }, "auth_ref": [] }, "us-gaap_ProfitLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProfitLoss", "crdr": "credit", "calculation": { "http://f8k.com/role/ConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://f8k.com/role/ConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Net loss", "label": "[Net Income (Loss), Including Portion Attributable to Noncontrolling Interest]", "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest." } } }, "auth_ref": [ "r145", "r161", "r162", "r173", "r180", "r186", "r194", "r195", "r220", "r228", "r233", "r236", "r248", "r277", "r278", "r279", "r280", "r281", "r282", "r283", "r284", "r285", "r396", "r399", "r400", "r412", "r414", "r469", "r479", "r502", "r544", "r566", "r567", "r604", "r617", "r618", "r625", "r649", "r663" ] }, "us-gaap_PropertyPlantAndEquipmentAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PropertyPlantAndEquipmentAbstract", "lang": { "en-us": { "role": { "label": "PROPERTY AND EQUIPMENT AND RIGHT OF USE ASSETS" } } }, "auth_ref": [] }, "us-gaap_PropertyPlantAndEquipmentAdditions": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PropertyPlantAndEquipmentAdditions", "crdr": "debit", "presentation": [ "http://f8k.com/role/PropertyAndEquipmentAndRightOfUseAssetsDetails" ], "lang": { "en-us": { "role": { "label": "Additions", "documentation": "Amount of acquisition of long-lived, physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment." } } }, "auth_ref": [] }, "us-gaap_PropertyPlantAndEquipmentByTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PropertyPlantAndEquipmentByTypeAxis", "presentation": [ "http://f8k.com/role/BusinessBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetails", "http://f8k.com/role/PropertyAndEquipmentAndRightOfUseAssetsDetails" ], "lang": { "en-us": { "role": { "label": "Long-Lived Tangible Asset [Axis]", "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale." } } }, "auth_ref": [ "r7" ] }, "us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PropertyPlantAndEquipmentDisclosureTextBlock", "presentation": [ "http://f8k.com/role/PropertyAndEquipmentAndRightOfUseAssets" ], "lang": { "en-us": { "role": { "label": "Property And Equipment And Right Of Use Assets", "documentation": "The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections." } } }, "auth_ref": [ "r96", "r136", "r139", "r140" ] }, "lowlf_PropertyPlantAndEquipmentDisposals1": { "xbrltype": "monetaryItemType", "nsuri": "http://f8k.com/20231231", "localname": "PropertyPlantAndEquipmentDisposals1", "crdr": "credit", "presentation": [ "http://f8k.com/role/PropertyAndEquipmentAndRightOfUseAssetsDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Disposal", "label": "[Disposal]" } } }, "auth_ref": [] }, "us-gaap_PropertyPlantAndEquipmentGross": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PropertyPlantAndEquipmentGross", "crdr": "debit", "presentation": [ "http://f8k.com/role/PropertyAndEquipmentAndRightOfUseAssetsDetails" ], "lang": { "en-us": { "role": { "periodEndLabel": "Property And Equipment Cost, Ending", "label": "[Property, Plant and Equipment, Gross]", "periodStartLabel": "Property And Equipment Cost, Beginning", "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures." } } }, "auth_ref": [ "r97", "r149", "r477" ] }, "us-gaap_PropertyPlantAndEquipmentNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PropertyPlantAndEquipmentNet", "crdr": "debit", "calculation": { "http://f8k.com/role/ConsolidatedBalanceSheets": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 7.0 } }, "presentation": [ "http://f8k.com/role/ConsolidatedBalanceSheets", "http://f8k.com/role/PropertyAndEquipmentAndRightOfUseAssetsDetails" ], "lang": { "en-us": { "role": { "label": "Property and equipment, net", "verboseLabel": "Net Book Value", "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures." } } }, "auth_ref": [ "r7", "r470", "r477", "r620" ] }, "us-gaap_PropertyPlantAndEquipmentPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PropertyPlantAndEquipmentPolicyTextBlock", "presentation": [ "http://f8k.com/role/BusinessBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Property and Equipment", "documentation": "Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections." } } }, "auth_ref": [ "r7", "r136", "r139", "r476" ] }, "lowlf_PropertyPlantAndEquipmentRemeasurements": { "xbrltype": "monetaryItemType", "nsuri": "http://f8k.com/20231231", "localname": "PropertyPlantAndEquipmentRemeasurements", "crdr": "debit", "presentation": [ "http://f8k.com/role/PropertyAndEquipmentAndRightOfUseAssetsDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Remeasurements", "label": "[Remeasurements]" } } }, "auth_ref": [] }, "us-gaap_PropertyPlantAndEquipmentTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PropertyPlantAndEquipmentTextBlock", "presentation": [ "http://f8k.com/role/PropertyAndEquipmentAndRightOfUseAssetsTables" ], "lang": { "en-us": { "role": { "label": "Schedule Of Property And Equipment And Right Of Use Assets", "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation." } } }, "auth_ref": [ "r7" ] }, "us-gaap_PropertyPlantAndEquipmentTypeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PropertyPlantAndEquipmentTypeDomain", "presentation": [ "http://f8k.com/role/BusinessBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetails", "http://f8k.com/role/PropertyAndEquipmentAndRightOfUseAssetsDetails" ], "lang": { "en-us": { "role": { "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software." } } }, "auth_ref": [ "r97" ] }, "lowlf_PropertyPlantAndEquipmentUsefulLifes": { "xbrltype": "durationItemType", "nsuri": "http://f8k.com/20231231", "localname": "PropertyPlantAndEquipmentUsefulLifes", "presentation": [ "http://f8k.com/role/BusinessBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "label": "Estimated useful life" } } }, "auth_ref": [] }, "us-gaap_PropertySubjectToOrAvailableForOperatingLeaseAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PropertySubjectToOrAvailableForOperatingLeaseAxis", "presentation": [ "http://f8k.com/role/LeasesDetails" ], "lang": { "en-us": { "role": { "label": "Property Subject to or Available for Operating Lease [Axis]", "documentation": "Information by property that could be leased or is available for lease." } } }, "auth_ref": [ "r127" ] }, "us-gaap_PropertySubjectToOrAvailableForOperatingLeaseDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PropertySubjectToOrAvailableForOperatingLeaseDomain", "presentation": [ "http://f8k.com/role/LeasesDetails" ], "lang": { "en-us": { "role": { "documentation": "A descriptive title of whether the property is subject to or available for operating lease." } } }, "auth_ref": [ "r127" ] }, "us-gaap_ProvisionForDoubtfulAccounts": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProvisionForDoubtfulAccounts", "crdr": "debit", "calculation": { "http://f8k.com/role/ConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://f8k.com/role/ConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Provision for doubtful accounts", "documentation": "Amount of expense (reversal of expense) for expected credit loss on accounts receivable." } } }, "auth_ref": [ "r170", "r252" ] }, "lowlf_PurchaseOfDerivativePaymentRights": { "xbrltype": "monetaryItemType", "nsuri": "http://f8k.com/20231231", "localname": "PurchaseOfDerivativePaymentRights", "crdr": "credit", "presentation": [ "http://f8k.com/role/OtherCurrentLiabilitiesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Purchase of derivative payment rights" } } }, "auth_ref": [] }, "lowlf_PurchaseOfPropertyAndEquipmentNotYetPaid": { "xbrltype": "monetaryItemType", "nsuri": "http://f8k.com/20231231", "localname": "PurchaseOfPropertyAndEquipmentNotYetPaid", "crdr": "credit", "presentation": [ "http://f8k.com/role/ConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Purchase of property and equipment not yet paid for" } } }, "auth_ref": [] }, "lowlf_PurchaseOfWarrants": { "xbrltype": "monetaryItemType", "nsuri": "http://f8k.com/20231231", "localname": "PurchaseOfWarrants", "crdr": "debit", "presentation": [ "http://f8k.com/role/IntangibleAssetsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Purchase of warrants" } } }, "auth_ref": [] }, "srt_RangeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "RangeAxis", "presentation": [ "http://f8k.com/role/BusinessBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "label": "Range [Axis]" } } }, "auth_ref": [ "r273", "r274", "r275", "r276", "r329", "r331", "r359", "r360", "r361", "r445", "r446", "r484", "r515", "r516", "r576", "r577", "r578", "r579", "r580", "r593", "r594", "r605", "r614", "r615", "r621", "r622", "r661", "r665", "r705", "r706", "r707", "r708", "r709" ] }, "srt_RangeMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "RangeMember", "presentation": [ "http://f8k.com/role/BusinessBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetails" ], "auth_ref": [ "r273", "r274", "r275", "r276", "r329", "r331", "r359", "r360", "r361", "r445", "r446", "r484", "r515", "r516", "r576", "r577", "r578", "r579", "r580", "r593", "r594", "r605", "r614", "r615", "r621", "r622", "r661", "r665", "r705", "r706", "r707", "r708", "r709" ] }, "us-gaap_RealEstateImprovements": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RealEstateImprovements", "crdr": "debit", "presentation": [ "http://f8k.com/role/PropertyAndEquipmentAndRightOfUseAssetsDetails", "http://f8k.com/role/PropertyAndEquipmentAndRightOfUseAssetsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Remeasurements", "verboseLabel": "Leasehold improvements", "documentation": "Amount of increase in real estate investments related to improvements for entities with a substantial portion of business acquiring and holding investment real estate." } } }, "auth_ref": [ "r592" ] }, "us-gaap_ReceivableWithImputedInterestDiscount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ReceivableWithImputedInterestDiscount", "crdr": "credit", "presentation": [ "http://f8k.com/role/LeasesDetails2" ], "lang": { "en-us": { "role": { "negatedLabel": "Less Imputed Interest", "label": "[Receivable with Imputed Interest, Discount]", "documentation": "Disclosure of the unamortized amount of the discount on the note or receivable which is deducted from the face amount of the receivable or loan. The discount or premium is the difference between the present value and the face amount." } } }, "auth_ref": [ "r62" ] }, "us-gaap_RelatedPartyDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RelatedPartyDomain", "presentation": [ "http://f8k.com/role/IntangibleAssetsDetailsNarrative", "http://f8k.com/role/RelatedPartyTransactionsDetailsNarrative" ], "lang": { "en-us": { "role": { "documentation": "Related parties include affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests." } } }, "auth_ref": [ "r330", "r440", "r441", "r518", "r519", "r520", "r521", "r522", "r541", "r543", "r575" ] }, "us-gaap_RelatedPartyTransactionAmountsOfTransaction": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RelatedPartyTransactionAmountsOfTransaction", "crdr": "debit", "presentation": [ "http://f8k.com/role/RelatedPartyTransactionsDetailsNarrative" ], "lang": { "en-us": { "role": { "verboseLabel": "Related Party Transactions", "label": "[Related Party Transaction, Amounts of Transaction]", "documentation": "Amount of transactions with related party during the financial reporting period." } } }, "auth_ref": [ "r64", "r440" ] }, "lowlf_RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParties": { "xbrltype": "monetaryItemType", "nsuri": "http://f8k.com/20231231", "localname": "RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParties", "crdr": "credit", "presentation": [ "http://f8k.com/role/RelatedPartyTransactionsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Related Party Transactions" } } }, "auth_ref": [] }, "lowlf_RelatedPartyTransactionSalesToRelatedParty": { "xbrltype": "monetaryItemType", "nsuri": "http://f8k.com/20231231", "localname": "RelatedPartyTransactionSalesToRelatedParty", "crdr": "debit", "presentation": [ "http://f8k.com/role/RelatedPartyTransactionsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Total sales" } } }, "auth_ref": [] }, "us-gaap_RelatedPartyTransactionsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RelatedPartyTransactionsAbstract", "lang": { "en-us": { "role": { "label": "RELATED PARTY TRANSACTIONS" } } }, "auth_ref": [] }, "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RelatedPartyTransactionsByRelatedPartyAxis", "presentation": [ "http://f8k.com/role/IntangibleAssetsDetailsNarrative", "http://f8k.com/role/RelatedPartyTransactionsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Related Party [Axis]", "documentation": "Information by type of related party. Related parties include, but not limited to, affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests." } } }, "auth_ref": [ "r330", "r440", "r441", "r456", "r457", "r458", "r459", "r460", "r461", "r462", "r463", "r464", "r465", "r466", "r467", "r518", "r519", "r520", "r521", "r522", "r541", "r543", "r575", "r701" ] }, "us-gaap_RelatedPartyTransactionsDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RelatedPartyTransactionsDisclosureTextBlock", "presentation": [ "http://f8k.com/role/RelatedPartyTransactions" ], "lang": { "en-us": { "role": { "label": "Related-Party Transactions", "documentation": "The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates." } } }, "auth_ref": [ "r437", "r438", "r439", "r441", "r442", "r499", "r500", "r501", "r549", "r551", "r552", "r572", "r574" ] }, "us-gaap_RepaymentsOfNotesPayable": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RepaymentsOfNotesPayable", "crdr": "credit", "calculation": { "http://f8k.com/role/ConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0, "order": 24.0 } }, "presentation": [ "http://f8k.com/role/ConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Payments on notes payable", "label": "[Repayments of Notes Payable]", "documentation": "The cash outflow for a borrowing supported by a written promise to pay an obligation." } } }, "auth_ref": [ "r28" ] }, "us-gaap_ResearchAndDevelopmentExpensePolicy": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ResearchAndDevelopmentExpensePolicy", "presentation": [ "http://f8k.com/role/BusinessBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Research and Development", "documentation": "Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process." } } }, "auth_ref": [ "r373" ] }, "us-gaap_RestrictedStockUnitsRSUMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RestrictedStockUnitsRSUMember", "presentation": [ "http://f8k.com/role/ShareBasedCompensationDetails3" ], "lang": { "en-us": { "role": { "label": "Restricted Stock Units (RSUs) [Member]", "documentation": "Share instrument which is convertible to stock or an equivalent amount of cash, after a specified period of time or when specified performance conditions are met." } } }, "auth_ref": [] }, "us-gaap_RetainedEarningsAccumulatedDeficit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RetainedEarningsAccumulatedDeficit", "crdr": "credit", "calculation": { "http://f8k.com/role/ConsolidatedBalanceSheets": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 23.0 } }, "presentation": [ "http://f8k.com/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Accumulated deficit", "documentation": "Amount of accumulated undistributed earnings (deficit)." } } }, "auth_ref": [ "r70", "r104", "r474", "r488", "r489", "r497", "r525", "r620" ] }, "us-gaap_RetainedEarningsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RetainedEarningsMember", "presentation": [ "http://f8k.com/role/ConsolidatedStatementsOfStockholdersEquityDeficit" ], "lang": { "en-us": { "role": { "label": "Retained Earnings (Accumulated Deficit)", "documentation": "Accumulated undistributed earnings (deficit)." } } }, "auth_ref": [ "r144", "r183", "r184", "r185", "r187", "r193", "r195", "r249", "r250", "r366", "r367", "r368", "r387", "r388", "r403", "r405", "r406", "r408", "r410", "r485", "r487", "r503", "r712" ] }, "us-gaap_RevenueRecognitionPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RevenueRecognitionPolicyTextBlock", "presentation": [ "http://f8k.com/role/BusinessBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Revenue Recognition", "documentation": "Disclosure of accounting policy for revenue. Includes revenue from contract with customer and from other sources." } } }, "auth_ref": [ "r547", "r595", "r601" ] }, "us-gaap_RevenueRecognitionServicesLicensingFees": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RevenueRecognitionServicesLicensingFees", "presentation": [ "http://f8k.com/role/BusinessBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Licensing", "documentation": "Disclosure of accounting policy for revenue recognition for licensing fees, which is consideration paid to the entity (licensor) by another party for the right to use, but not own, certain of the entity's intangible assets. Licensing arrangements include, but are not limited to, rights to use a patent, copyright, technology, manufacturing process, or trademark." } } }, "auth_ref": [] }, "us-gaap_Revenues": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "Revenues", "crdr": "credit", "calculation": { "http://f8k.com/role/ConsolidatedStatementsOfIncomeLoss": { "parentTag": "us-gaap_GrossProfit", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://f8k.com/role/ConsolidatedStatementsOfIncomeLoss" ], "lang": { "en-us": { "role": { "label": "Net revenue", "documentation": "Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss)." } } }, "auth_ref": [ "r168", "r180", "r221", "r222", "r227", "r231", "r232", "r238", "r240", "r241", "r248", "r277", "r278", "r279", "r280", "r281", "r282", "r283", "r284", "r285", "r414", "r469", "r663" ] }, "lowlf_RightOfUseAssetMember": { "xbrltype": "domainItemType", "nsuri": "http://f8k.com/20231231", "localname": "RightOfUseAssetMember", "presentation": [ "http://f8k.com/role/PropertyAndEquipmentAndRightOfUseAssetsDetails" ], "lang": { "en-us": { "role": { "label": "Right of Use Assets" } } }, "auth_ref": [] }, "lowlf_RsusOutstandingBeginningBalance": { "xbrltype": "sharesItemType", "nsuri": "http://f8k.com/20231231", "localname": "RsusOutstandingBeginningBalance", "presentation": [ "http://f8k.com/role/ShareBasedCompensationDetails2" ], "lang": { "en-us": { "role": { "label": "RSUs Outstanding, Beginning Balance" } } }, "auth_ref": [] }, "lowlf_RsusOutstandingEndingBalance": { "xbrltype": "sharesItemType", "nsuri": "http://f8k.com/20231231", "localname": "RsusOutstandingEndingBalance", "presentation": [ "http://f8k.com/role/ShareBasedCompensationDetails2" ], "lang": { "en-us": { "role": { "label": "RSUs Outstanding, Ending Balance" } } }, "auth_ref": [] }, "lowlf_SalariesAndBenefitsMember": { "xbrltype": "domainItemType", "nsuri": "http://f8k.com/20231231", "localname": "SalariesAndBenefitsMember", "presentation": [ "http://f8k.com/role/GeneralAndAdministrativeExpensesDetails" ], "lang": { "en-us": { "role": { "label": "Salaries And Benefits Member" } } }, "auth_ref": [] }, "us-gaap_SaleAndLeasebackTransactionGainLossNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SaleAndLeasebackTransactionGainLossNet", "crdr": "credit", "calculation": { "http://f8k.com/role/ConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 8.0 } }, "presentation": [ "http://f8k.com/role/ConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Gain on sale leaseback", "label": "[Sale and Leaseback Transaction, Gain (Loss), Net]", "documentation": "Amount of gain (loss) on sale and leaseback transaction from transfer of asset accounted for as sale." } } }, "auth_ref": [ "r431", "r435", "r619" ] }, "us-gaap_SaleLeasebackTransactionRentExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SaleLeasebackTransactionRentExpense", "crdr": "debit", "presentation": [ "http://f8k.com/role/LeasesDetails" ], "lang": { "en-us": { "role": { "label": "Sale leaseback addition", "documentation": "The amount of the current period expense recorded for use of the property in connection with the transaction involving the sale of property to another party and the lease of the property back to the seller." } } }, "auth_ref": [ "r126" ] }, "us-gaap_SaleOfStockNameOfTransactionDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SaleOfStockNameOfTransactionDomain", "presentation": [ "http://f8k.com/role/OtherCurrentLiabilitiesDetailsNarrative" ], "lang": { "en-us": { "role": { "documentation": "Sale of the entity's stock, including, but not limited to, initial public offering (IPO) and private placement." } } }, "auth_ref": [] }, "us-gaap_SalesAndExciseTaxPayableCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SalesAndExciseTaxPayableCurrent", "crdr": "credit", "presentation": [ "http://f8k.com/role/OtherCurrentLiabilitiesDetails" ], "lang": { "en-us": { "role": { "label": "Excise And Cannabis Tax", "documentation": "Carrying value as of the balance sheet date of liabilities incurred through that date and payable for statutory sales and use taxes, including value added tax. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)." } } }, "auth_ref": [ "r16" ] }, "us-gaap_ScheduleOfCommonStockOutstandingRollForwardTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfCommonStockOutstandingRollForwardTableTextBlock", "presentation": [ "http://f8k.com/role/ShareholdersEquityTables" ], "lang": { "en-us": { "role": { "label": "Schedule Of Shares Outstanding", "documentation": "Tabular disclosure of the change in common stock outstanding." } } }, "auth_ref": [] }, "us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock", "presentation": [ "http://f8k.com/role/IncomeTaxesTables" ], "lang": { "en-us": { "role": { "label": "Schedule Of income tax expense", "documentation": "Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years." } } }, "auth_ref": [ "r107" ] }, "us-gaap_ScheduleOfDebtTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfDebtTableTextBlock", "presentation": [ "http://f8k.com/role/DebtTables" ], "lang": { "en-us": { "role": { "label": "Schedule Of Debt", "documentation": "Tabular disclosure of information pertaining to short-term and long-debt instruments or arrangements, including but not limited to identification of terms, features, collateral requirements and other information necessary to a fair presentation." } } }, "auth_ref": [] }, "us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock", "presentation": [ "http://f8k.com/role/IncomeTaxesTables" ], "lang": { "en-us": { "role": { "label": "Schedule Of deferred tax assets and liabilities", "documentation": "Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets." } } }, "auth_ref": [ "r106" ] }, "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "presentation": [ "http://f8k.com/role/NetIncomeLossPerShareTables" ], "lang": { "en-us": { "role": { "label": "Schedule Of Net Earnings/(loss) Per Share", "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations." } } }, "auth_ref": [ "r657" ] }, "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock", "presentation": [ "http://f8k.com/role/IntangibleAssetsTables" ], "lang": { "en-us": { "role": { "label": "Schedule Of Intangible Assets", "documentation": "Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment." } } }, "auth_ref": [ "r44", "r47" ] }, "us-gaap_ScheduleOfFutureMinimumLeasePaymentsForCapitalLeasesTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfFutureMinimumLeasePaymentsForCapitalLeasesTableTextBlock", "presentation": [ "http://f8k.com/role/LeasesTables" ], "lang": { "en-us": { "role": { "label": "Schedule of future lease payments", "documentation": "Tabular disclosure of future minimum lease payments as of the date of the latest balance sheet presented, in aggregate and for each of the five years succeeding fiscal years, with separate deductions from the total for the amount representing executor costs, including any profit thereon, included in the minimum lease payments and for the amount of the imputed interest necessary to reduce the net minimum lease payments to present value." } } }, "auth_ref": [ "r130" ] }, "us-gaap_ScheduleOfInventoryCurrentTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfInventoryCurrentTableTextBlock", "presentation": [ "http://f8k.com/role/InventoryTables" ], "lang": { "en-us": { "role": { "label": "Summary Of Inventory", "documentation": "Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process." } } }, "auth_ref": [ "r15", "r74", "r75", "r76" ] }, "lowlf_ScheduleOfLeaseObligationsTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://f8k.com/20231231", "localname": "ScheduleOfLeaseObligationsTableTextBlock", "presentation": [ "http://f8k.com/role/LeasesTables" ], "lang": { "en-us": { "role": { "label": "Schedule Of Lease Obligations" } } }, "auth_ref": [] }, "us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfMaturitiesOfLongTermDebtTableTextBlock", "presentation": [ "http://f8k.com/role/DebtTables" ], "lang": { "en-us": { "role": { "label": "Schedule Of Maturities Of Debt Obligations", "documentation": "Tabular disclosure of maturity and sinking fund requirement for long-term debt." } } }, "auth_ref": [ "r8" ] }, "us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfOtherCurrentAssetsTableTextBlock", "presentation": [ "http://f8k.com/role/PrepaidAndOtherCurrentAssetsTables" ], "lang": { "en-us": { "role": { "label": "Summary Of Prepaid Expenses And Other Current Assets", "documentation": "Tabular disclosure of the carrying amounts of other current assets." } } }, "auth_ref": [] }, "us-gaap_ScheduleOfOtherOperatingCostAndExpenseByComponentTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfOtherOperatingCostAndExpenseByComponentTextBlock", "presentation": [ "http://f8k.com/role/GeneralAndAdministrativeExpensesTables" ], "lang": { "en-us": { "role": { "label": "Schedule Of General And Administrative Expense", "documentation": "Tabular disclosure of each detailed component of other operating costs and expenses that are applicable to sales and revenues, but not included in the cost of sales in the income statement." } } }, "auth_ref": [ "r83" ] }, "lowlf_ScheduleOfPropertyAndEquipmentEstimatedUsefulLifeTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://f8k.com/20231231", "localname": "ScheduleOfPropertyAndEquipmentEstimatedUsefulLifeTextBlock", "presentation": [ "http://f8k.com/role/BusinessBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesTables" ], "lang": { "en-us": { "role": { "label": "Schedule Of Property and equipment estimated useful life" } } }, "auth_ref": [] }, "us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfShareBasedCompensationActivityTableTextBlock", "presentation": [ "http://f8k.com/role/ShareBasedCompensationTables" ], "lang": { "en-us": { "role": { "label": "Schedule Of Share-based Compensation Expense", "documentation": "Tabular disclosure of activity for award under share-based payment arrangement. Includes, but is not limited to, outstanding award at beginning and end of year, granted, exercised, forfeited, and weighted-average grant date fair value." } } }, "auth_ref": [ "r10", "r11", "r55" ] }, "us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock", "presentation": [ "http://f8k.com/role/ShareBasedCompensationTables" ], "lang": { "en-us": { "role": { "label": "Schedule Of Restricted Stock Unit Activity", "documentation": "Tabular disclosure of the number and weighted-average grant date fair value for restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock units that were granted, vested, or forfeited during the year." } } }, "auth_ref": [ "r54" ] }, "us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "presentation": [ "http://f8k.com/role/ShareBasedCompensationTables" ], "lang": { "en-us": { "role": { "label": "Schedule Of Stock Option Activity", "documentation": "Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value." } } }, "auth_ref": [ "r10", "r11", "r54" ] }, "us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock", "presentation": [ "http://f8k.com/role/ShareBasedCompensationTables" ], "lang": { "en-us": { "role": { "label": "Schedule Of Weighted Average Assumptions", "documentation": "Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions." } } }, "auth_ref": [ "r105" ] }, "lowlf_ScheduleOfWarrantsOutstandingTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://f8k.com/20231231", "localname": "ScheduleOfWarrantsOutstandingTableTextBlock", "presentation": [ "http://f8k.com/role/ShareholdersEquityTables" ], "lang": { "en-us": { "role": { "label": "Schedule Of Warrants Outstanding" } } }, "auth_ref": [] }, "us-gaap_SegmentReportingAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SegmentReportingAbstract", "lang": { "en-us": { "role": { "label": "SEGMENT INFORMATION" } } }, "auth_ref": [] }, "us-gaap_SegmentReportingDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SegmentReportingDisclosureTextBlock", "presentation": [ "http://f8k.com/role/SegmentInformation" ], "lang": { "en-us": { "role": { "label": "Segment Information", "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments." } } }, "auth_ref": [ "r216", "r217", "r218", "r219", "r220", "r226", "r230", "r234", "r235", "r236", "r237", "r238", "r239", "r241" ] }, "us-gaap_SellingAndMarketingExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SellingAndMarketingExpense", "crdr": "debit", "calculation": { "http://f8k.com/role/ConsolidatedStatementsOfIncomeLoss": { "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://f8k.com/role/ConsolidatedStatementsOfIncomeLoss" ], "lang": { "en-us": { "role": { "label": "Sales and marketing", "documentation": "The aggregate total amount of expenses directly related to the marketing or selling of products or services." } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensation": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensation", "crdr": "debit", "calculation": { "http://f8k.com/role/ConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://f8k.com/role/ConsolidatedStatementsOfCashFlows", "http://f8k.com/role/ConsolidatedStatementsOfStockholdersEquityDeficit" ], "lang": { "en-us": { "role": { "label": "Share-based compensation expense Amount", "verboseLabel": "Share-based compensation expense", "documentation": "Amount of noncash expense for share-based payment arrangement." } } }, "auth_ref": [ "r5" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1", "presentation": [ "http://f8k.com/role/ShareBasedCompensationDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Vesting Period", "documentation": "Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition." } } }, "auth_ref": [ "r616" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod", "presentation": [ "http://f8k.com/role/ShareBasedCompensationDetails2" ], "lang": { "en-us": { "role": { "negatedLabel": "RSUs Cancelled", "label": "[Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period]", "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period." } } }, "auth_ref": [ "r351" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue", "presentation": [ "http://f8k.com/role/ShareBasedCompensationDetails2" ], "lang": { "en-us": { "role": { "label": "Weighted-average Fair Value Cancelled", "documentation": "Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event." } } }, "auth_ref": [ "r351" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod", "presentation": [ "http://f8k.com/role/ShareBasedCompensationDetails2" ], "lang": { "en-us": { "role": { "negatedLabel": "RSUs Granted", "label": "[Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period]", "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan)." } } }, "auth_ref": [ "r349" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue", "presentation": [ "http://f8k.com/role/ShareBasedCompensationDetails2" ], "lang": { "en-us": { "role": { "label": "Weighted-average Fair Value Granted", "documentation": "The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan)." } } }, "auth_ref": [ "r349" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue", "presentation": [ "http://f8k.com/role/ShareBasedCompensationDetails2" ], "lang": { "en-us": { "role": { "label": "Weighted-average Fair Value Vested", "documentation": "The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement." } } }, "auth_ref": [ "r350" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate", "presentation": [ "http://f8k.com/role/ShareBasedCompensationDetails3" ], "lang": { "en-us": { "role": { "label": "Dividend Yield", "documentation": "The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term." } } }, "auth_ref": [ "r360" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate", "presentation": [ "http://f8k.com/role/ShareBasedCompensationDetails3" ], "lang": { "en-us": { "role": { "label": "Expected Volatility", "documentation": "The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period." } } }, "auth_ref": [ "r359" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate", "presentation": [ "http://f8k.com/role/ShareBasedCompensationDetails3" ], "lang": { "en-us": { "role": { "label": "Risk-free Interest Rate", "documentation": "The risk-free interest rate assumption that is used in valuing an option on its own shares." } } }, "auth_ref": [ "r361" ] }, "lowlf_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsCancelledInPeriodIntrinsicValue": { "xbrltype": "monetaryItemType", "nsuri": "http://f8k.com/20231231", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsCancelledInPeriodIntrinsicValue", "crdr": "debit", "presentation": [ "http://f8k.com/role/ShareBasedCompensationDetails1" ], "lang": { "en-us": { "role": { "label": "Aggregate Intrinsic Value, Cancelled" } } }, "auth_ref": [] }, "lowlf_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisable": { "xbrltype": "sharesItemType", "nsuri": "http://f8k.com/20231231", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisable", "presentation": [ "http://f8k.com/role/ShareBasedCompensationDetails1" ], "lang": { "en-us": { "role": { "periodEndLabel": "Stock Options Exercisable", "label": "[Stock Options Exercisable]" } } }, "auth_ref": [] }, "lowlf_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedInPeriodIntrinsicValue": { "xbrltype": "monetaryItemType", "nsuri": "http://f8k.com/20231231", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedInPeriodIntrinsicValue", "crdr": "debit", "presentation": [ "http://f8k.com/role/ShareBasedCompensationDetails1" ], "lang": { "en-us": { "role": { "label": "Aggregate Intrinsic Value, Exercised" } } }, "auth_ref": [] }, "lowlf_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedInPeriodIntrinsicValue": { "xbrltype": "monetaryItemType", "nsuri": "http://f8k.com/20231231", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedInPeriodIntrinsicValue", "crdr": "debit", "presentation": [ "http://f8k.com/role/ShareBasedCompensationDetails1" ], "lang": { "en-us": { "role": { "label": "Aggregate Intrinsic Value, Granted" } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross", "presentation": [ "http://f8k.com/role/ShareBasedCompensationDetails1" ], "lang": { "en-us": { "role": { "label": "Stock Options, Granted", "documentation": "Gross number of share options (or share units) granted during the period." } } }, "auth_ref": [ "r342" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue", "crdr": "debit", "presentation": [ "http://f8k.com/role/ShareBasedCompensationDetails1" ], "lang": { "en-us": { "role": { "periodStartLabel": "Aggregate Intrinsic Value Outstanding, Beginning", "label": "[Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value]", "periodEndLabel": "Aggregate Intrinsic Value Outstanding, Ending", "documentation": "Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding." } } }, "auth_ref": [ "r53" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "presentation": [ "http://f8k.com/role/ShareBasedCompensationDetails1" ], "lang": { "en-us": { "role": { "periodStartLabel": "Stock Options Outstanding, Beginning", "label": "[Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number]", "periodEndLabel": "Stock Options Outstanding, Ending", "documentation": "Number of options outstanding, including both vested and non-vested options." } } }, "auth_ref": [ "r338", "r339" ] }, "lowlf_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisable": { "xbrltype": "perShareItemType", "nsuri": "http://f8k.com/20231231", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisable", "presentation": [ "http://f8k.com/role/ShareBasedCompensationDetails1" ], "lang": { "en-us": { "role": { "periodEndLabel": "Weighted-average Exercise Price Exercisable", "label": "[Weighted-average Exercise Price Exercisable]" } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice", "presentation": [ "http://f8k.com/role/ShareBasedCompensationDetails1" ], "lang": { "en-us": { "role": { "periodStartLabel": "Weighted-average Exercise Price Outstanding, Beginning", "label": "[Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price]", "periodEndLabel": "Weighted-average Exercise Price Outstanding, Ending", "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan." } } }, "auth_ref": [ "r338", "r339" ] }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain", "presentation": [ "http://f8k.com/role/ShareBasedCompensationDetails3" ], "lang": { "en-us": { "role": { "documentation": "Award under share-based payment arrangement." } } }, "auth_ref": [ "r334", "r335", "r336", "r338", "r339", "r340", "r341", "r342", "r343", "r344", "r345", "r346", "r347", "r348", "r349", "r350", "r351", "r352", "r353", "r354", "r355", "r358", "r359", "r360", "r361", "r362" ] }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice", "presentation": [ "http://f8k.com/role/ShareBasedCompensationDetails1" ], "lang": { "en-us": { "role": { "label": "Weighted-average Exercise Price, Exercised", "documentation": "Weighted average price at which option holders acquired shares when converting their stock options into shares." } } }, "auth_ref": [ "r343" ] }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice", "presentation": [ "http://f8k.com/role/ShareBasedCompensationDetails1" ], "lang": { "en-us": { "role": { "label": "Weighted-average Exercise Price, Cancelled", "documentation": "Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated." } } }, "auth_ref": [ "r344" ] }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice", "presentation": [ "http://f8k.com/role/ShareBasedCompensationDetails1" ], "lang": { "en-us": { "role": { "label": "Weighted-average Exercise Price, Granted", "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options." } } }, "auth_ref": [ "r342" ] }, "us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationOptionAndIncentivePlansPolicy", "presentation": [ "http://f8k.com/role/BusinessBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Share-Based Compensation", "documentation": "Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost." } } }, "auth_ref": [ "r332", "r337", "r356", "r357", "r358", "r359", "r362", "r369", "r370", "r371", "r372" ] }, "lowlf_ShareRePurchaseAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://f8k.com/20231231", "localname": "ShareRePurchaseAmount", "crdr": "debit", "presentation": [ "http://f8k.com/role/ConsolidatedStatementsOfStockholdersEquityDeficit" ], "lang": { "en-us": { "role": { "label": "Share re-purchase, Amount" } } }, "auth_ref": [] }, "lowlf_ShareRePurchaseShares": { "xbrltype": "sharesItemType", "nsuri": "http://f8k.com/20231231", "localname": "ShareRePurchaseShares", "presentation": [ "http://f8k.com/role/ConsolidatedStatementsOfStockholdersEquityDeficit" ], "lang": { "en-us": { "role": { "label": "Share re-purchase, Shares" } } }, "auth_ref": [] }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1", "presentation": [ "http://f8k.com/role/ShareBasedCompensationDetails3" ], "lang": { "en-us": { "role": { "label": "Expected Term In Years", "documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [ "r358" ] }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1", "presentation": [ "http://f8k.com/role/ShareBasedCompensationDetails1" ], "lang": { "en-us": { "role": { "label": "Weighted-average Remaining Contactual Life, Exercisable", "documentation": "Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [ "r53" ] }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1", "presentation": [ "http://f8k.com/role/ShareBasedCompensationDetails1" ], "lang": { "en-us": { "role": { "label": "Weighted-average Remaining Contactual Life, Vested And Expected To Vest", "documentation": "Weighted average remaining contractual term for fully vested and expected to vest options outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur." } } }, "auth_ref": [ "r354" ] }, "lowlf_SharebasedCompensationMember": { "xbrltype": "domainItemType", "nsuri": "http://f8k.com/20231231", "localname": "SharebasedCompensationMember", "presentation": [ "http://f8k.com/role/GeneralAndAdministrativeExpensesDetails" ], "lang": { "en-us": { "role": { "label": "Sharebased Compensation Member" } } }, "auth_ref": [] }, "lowlf_SharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaveragevestedAndExpected": { "xbrltype": "perShareItemType", "nsuri": "http://f8k.com/20231231", "localname": "SharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaveragevestedAndExpected", "presentation": [ "http://f8k.com/role/ShareBasedCompensationDetails1" ], "lang": { "en-us": { "role": { "periodEndLabel": "Weighted-average Exercise Price Vested and expected", "label": "[Weighted-average Exercise Price Vested and expected]" } } }, "auth_ref": [] }, "lowlf_SharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedAndExpected": { "xbrltype": "sharesItemType", "nsuri": "http://f8k.com/20231231", "localname": "SharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedAndExpected", "presentation": [ "http://f8k.com/role/ShareBasedCompensationDetails1" ], "lang": { "en-us": { "role": { "periodEndLabel": "Stock Options Vested and expected", "label": "[Stock Options Vested and expected]" } } }, "auth_ref": [] }, "lowlf_ShareholdersEquityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://f8k.com/20231231", "localname": "ShareholdersEquityAbstract", "lang": { "en-us": { "role": { "label": "SHAREHOLDERS EQUITY" } } }, "auth_ref": [] }, "lowlf_SharesCapitalMember": { "xbrltype": "domainItemType", "nsuri": "http://f8k.com/20231231", "localname": "SharesCapitalMember", "presentation": [ "http://f8k.com/role/ConsolidatedStatementsOfStockholdersEquityDeficit" ], "lang": { "en-us": { "role": { "label": "Shares Capital [Member]" } } }, "auth_ref": [] }, "us-gaap_SharesIssued": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SharesIssued", "presentation": [ "http://f8k.com/role/ConsolidatedStatementsOfStockholdersEquityDeficit" ], "lang": { "en-us": { "role": { "periodStartLabel": "Balance, shares", "label": "[Shares, Issued]", "periodEndLabel": "Balance, shares", "documentation": "Number of shares of stock issued as of the balance sheet date, including shares that had been issued and were previously outstanding but which are now held in the treasury." } } }, "auth_ref": [ "r9" ] }, "lowlf_SharesIssuedInConnectionWithAssetAcquisitionAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://f8k.com/20231231", "localname": "SharesIssuedInConnectionWithAssetAcquisitionAmount", "crdr": "debit", "presentation": [ "http://f8k.com/role/ConsolidatedStatementsOfStockholdersEquityDeficit" ], "lang": { "en-us": { "role": { "label": "Shares issued in connection with asset acquisition, Amount" } } }, "auth_ref": [] }, "lowlf_SharesIssuedInConnectionWithAssetAcquisitionShares": { "xbrltype": "sharesItemType", "nsuri": "http://f8k.com/20231231", "localname": "SharesIssuedInConnectionWithAssetAcquisitionShares", "presentation": [ "http://f8k.com/role/ConsolidatedStatementsOfStockholdersEquityDeficit" ], "lang": { "en-us": { "role": { "label": "Shares issued in connection with asset acquisition, Shares" } } }, "auth_ref": [] }, "lowlf_SharesIssuedInConnectionWithBrandSaleAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://f8k.com/20231231", "localname": "SharesIssuedInConnectionWithBrandSaleAmount", "crdr": "debit", "presentation": [ "http://f8k.com/role/ConsolidatedStatementsOfStockholdersEquityDeficit" ], "lang": { "en-us": { "role": { "label": "Shares issued in connection with debenture conversion, Amount" } } }, "auth_ref": [] }, "lowlf_SharesIssuedInConnectionWithBrandSaleShares": { "xbrltype": "sharesItemType", "nsuri": "http://f8k.com/20231231", "localname": "SharesIssuedInConnectionWithBrandSaleShares", "presentation": [ "http://f8k.com/role/ConsolidatedStatementsOfStockholdersEquityDeficit" ], "lang": { "en-us": { "role": { "label": "Shares issued in connection with debenture conversion, Shares" } } }, "auth_ref": [] }, "us-gaap_SharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SharesOutstanding", "presentation": [ "http://f8k.com/role/ShareholdersEquityDetails" ], "lang": { "en-us": { "role": { "periodStartLabel": "Beginning Balance, Shares", "label": "[Shares, Outstanding]", "periodEndLabel": "Ending Balance, Shares", "documentation": "Number of shares issued which are neither cancelled nor held in the treasury." } } }, "auth_ref": [] }, "us-gaap_ShortTermDebtTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShortTermDebtTypeAxis", "presentation": [ "http://f8k.com/role/DebtDetails" ], "lang": { "en-us": { "role": { "label": "Short-Term Debt, Type [Axis]", "documentation": "Information by type of short-term debt arrangement." } } }, "auth_ref": [ "r17" ] }, "us-gaap_ShortTermDebtTypeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShortTermDebtTypeDomain", "presentation": [ "http://f8k.com/role/DebtDetails" ], "lang": { "en-us": { "role": { "documentation": "Type of short-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing." } } }, "auth_ref": [ "r16" ] }, "us-gaap_StatementClassOfStockAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementClassOfStockAxis", "presentation": [ "http://f8k.com/role/ShareholdersEquityDetails" ], "lang": { "en-us": { "role": { "label": "Class of Stock [Axis]", "documentation": "Information by the different classes of stock of the entity." } } }, "auth_ref": [ "r143", "r154", "r155", "r156", "r180", "r200", "r201", "r206", "r208", "r214", "r215", "r248", "r277", "r279", "r280", "r281", "r284", "r285", "r314", "r315", "r317", "r320", "r326", "r414", "r493", "r494", "r495", "r496", "r503", "r504", "r505", "r506", "r507", "r508", "r509", "r510", "r511", "r512", "r513", "r514", "r524", "r545", "r568", "r584", "r585", "r586", "r587", "r588", "r636", "r652", "r656" ] }, "us-gaap_StatementEquityComponentsAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementEquityComponentsAxis", "presentation": [ "http://f8k.com/role/ConsolidatedStatementsOfStockholdersEquityDeficit" ], "lang": { "en-us": { "role": { "label": "Equity Components [Axis]", "documentation": "Information by component of equity." } } }, "auth_ref": [ "r9", "r24", "r144", "r164", "r165", "r166", "r183", "r184", "r185", "r187", "r193", "r195", "r213", "r249", "r250", "r328", "r366", "r367", "r368", "r387", "r388", "r403", "r404", "r405", "r406", "r407", "r408", "r410", "r415", "r416", "r417", "r418", "r419", "r420", "r436", "r485", "r486", "r487", "r503", "r568" ] }, "us-gaap_StatementLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementLineItems", "presentation": [ "http://f8k.com/role/BusinessBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetails", "http://f8k.com/role/CommitmentsAndContingenciesDetailsNarrative", "http://f8k.com/role/ConsolidatedStatementsOfStockholdersEquityDeficit", "http://f8k.com/role/DebtDetails", "http://f8k.com/role/DebtDetailsNarrative", "http://f8k.com/role/GeneralAndAdministrativeExpensesDetails", "http://f8k.com/role/IntangibleAssetsDetails", "http://f8k.com/role/IntangibleAssetsDetailsNarrative", "http://f8k.com/role/LeasesDetails", "http://f8k.com/role/OtherCurrentLiabilitiesDetailsNarrative", "http://f8k.com/role/PropertyAndEquipmentAndRightOfUseAssetsDetails", "http://f8k.com/role/PropertyAndEquipmentAndRightOfUseAssetsDetailsNarrative", "http://f8k.com/role/RelatedPartyTransactionsDetailsNarrative", "http://f8k.com/role/ShareBasedCompensationDetails", "http://f8k.com/role/ShareBasedCompensationDetails3", "http://f8k.com/role/ShareholdersEquityDetails" ], "lang": { "en-us": { "role": { "label": "Statement [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r183", "r184", "r185", "r213", "r451", "r491", "r514", "r517", "r518", "r519", "r520", "r521", "r522", "r524", "r527", "r528", "r529", "r530", "r531", "r532", "r533", "r534", "r535", "r537", "r538", "r539", "r540", "r541", "r543", "r547", "r548", "r554", "r555", "r556", "r557", "r558", "r559", "r560", "r561", "r562", "r563", "r564", "r565", "r568", "r623" ] }, "us-gaap_StatementOfCashFlowsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementOfCashFlowsAbstract", "lang": { "en-us": { "role": { "label": "CONSOLIDATED STATEMENTS OF CASH FLOWS" } } }, "auth_ref": [] }, "us-gaap_StatementOfFinancialPositionAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementOfFinancialPositionAbstract", "lang": { "en-us": { "role": { "label": "CONSOLIDATED BALANCE SHEETS" } } }, "auth_ref": [] }, "us-gaap_StatementOfStockholdersEquityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementOfStockholdersEquityAbstract", "lang": { "en-us": { "role": { "label": "CONSOLIDATED STATEMENTS OF STOCKHOLDERS EQUITY (DEFICIT)" } } }, "auth_ref": [] }, "us-gaap_StatementTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementTable", "presentation": [ "http://f8k.com/role/BusinessBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetails", "http://f8k.com/role/CommitmentsAndContingenciesDetailsNarrative", "http://f8k.com/role/ConsolidatedStatementsOfStockholdersEquityDeficit", "http://f8k.com/role/DebtDetails", "http://f8k.com/role/DebtDetailsNarrative", "http://f8k.com/role/GeneralAndAdministrativeExpensesDetails", "http://f8k.com/role/IntangibleAssetsDetails", "http://f8k.com/role/IntangibleAssetsDetailsNarrative", "http://f8k.com/role/LeasesDetails", "http://f8k.com/role/OtherCurrentLiabilitiesDetailsNarrative", "http://f8k.com/role/PropertyAndEquipmentAndRightOfUseAssetsDetails", "http://f8k.com/role/PropertyAndEquipmentAndRightOfUseAssetsDetailsNarrative", "http://f8k.com/role/RelatedPartyTransactionsDetailsNarrative", "http://f8k.com/role/ShareBasedCompensationDetails", "http://f8k.com/role/ShareBasedCompensationDetails3", "http://f8k.com/role/ShareholdersEquityDetails" ], "lang": { "en-us": { "role": { "label": "Statement [Table]", "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed." } } }, "auth_ref": [ "r183", "r184", "r185", "r213", "r451", "r491", "r514", "r517", "r518", "r519", "r520", "r521", "r522", "r524", "r527", "r528", "r529", "r530", "r531", "r532", "r533", "r534", "r535", "r537", "r538", "r539", "r540", "r541", "r543", "r547", "r548", "r554", "r555", "r556", "r557", "r558", "r559", "r560", "r561", "r562", "r563", "r564", "r565", "r568", "r623" ] }, "lowlf_StockIssuedDuringPeriodShareBasedCompensation": { "xbrltype": "sharesItemType", "nsuri": "http://f8k.com/20231231", "localname": "StockIssuedDuringPeriodShareBasedCompensation", "presentation": [ "http://f8k.com/role/ShareholdersEquityDetails" ], "lang": { "en-us": { "role": { "label": "Issuance Of Vested Restricted Stock Units" } } }, "auth_ref": [] }, "us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockIssuedDuringPeriodSharesShareBasedCompensation", "presentation": [ "http://f8k.com/role/ConsolidatedStatementsOfStockholdersEquityDeficit" ], "lang": { "en-us": { "role": { "label": "Share-based compensation expense, Shares", "documentation": "Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP)." } } }, "auth_ref": [ "r9", "r68", "r69", "r104" ] }, "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised", "presentation": [ "http://f8k.com/role/ShareBasedCompensationDetails1" ], "lang": { "en-us": { "role": { "negatedLabel": "Stock Options, Exercised", "label": "[Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period]", "documentation": "Number of share options (or share units) exercised during the current period." } } }, "auth_ref": [ "r9", "r68", "r69", "r104", "r343" ] }, "lowlf_StockOptionForFutureGrant": { "xbrltype": "sharesItemType", "nsuri": "http://f8k.com/20231231", "localname": "StockOptionForFutureGrant", "presentation": [ "http://f8k.com/role/ShareBasedCompensationDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Stock Option For Future Grant" } } }, "auth_ref": [] }, "lowlf_StockOptionsCancelled": { "xbrltype": "sharesItemType", "nsuri": "http://f8k.com/20231231", "localname": "StockOptionsCancelled", "presentation": [ "http://f8k.com/role/ShareBasedCompensationDetails1" ], "lang": { "en-us": { "role": { "label": "Stock Options, Cancelled" } } }, "auth_ref": [] }, "lowlf_StockOptionsMember": { "xbrltype": "domainItemType", "nsuri": "http://f8k.com/20231231", "localname": "StockOptionsMember", "presentation": [ "http://f8k.com/role/ShareBasedCompensationDetails3" ], "lang": { "en-us": { "role": { "label": "Stock Option [Member]" } } }, "auth_ref": [] }, "us-gaap_StockholdersEquity": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockholdersEquity", "crdr": "credit", "calculation": { "http://f8k.com/role/ConsolidatedBalanceSheets": { "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0, "order": 25.0 } }, "presentation": [ "http://f8k.com/role/ConsolidatedBalanceSheets", "http://f8k.com/role/ConsolidatedStatementsOfStockholdersEquityDeficit" ], "lang": { "en-us": { "role": { "totalLabel": "Total stockholders' equity", "label": "[Stockholders' Equity Attributable to Parent]", "periodStartLabel": "Balance, amount", "periodEndLabel": "Balance, amount", "documentation": "Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest." } } }, "auth_ref": [ "r69", "r71", "r72", "r93", "r526", "r542", "r569", "r570", "r620", "r626", "r654", "r658", "r699", "r712" ] }, "us-gaap_StockholdersEquityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockholdersEquityAbstract", "presentation": [ "http://f8k.com/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "STOCKHOLDERS' EQUITY" } } }, "auth_ref": [] }, "us-gaap_StockholdersEquityNoteDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockholdersEquityNoteDisclosureTextBlock", "presentation": [ "http://f8k.com/role/ShareholdersEquity" ], "lang": { "en-us": { "role": { "label": "Shareholders Equity", "documentation": "The entire disclosure for equity." } } }, "auth_ref": [ "r103", "r179", "r313", "r315", "r316", "r317", "r318", "r319", "r320", "r321", "r322", "r323", "r324", "r325", "r328", "r409", "r571", "r573", "r589" ] }, "lowlf_SubordinateVotingMember": { "xbrltype": "domainItemType", "nsuri": "http://f8k.com/20231231", "localname": "SubordinateVotingMember", "presentation": [ "http://f8k.com/role/ShareholdersEquityDetails" ], "lang": { "en-us": { "role": { "label": "Subordinate Voting Share [Member]" } } }, "auth_ref": [] }, "lowlf_SubordinateVotingSharesIssued": { "xbrltype": "sharesItemType", "nsuri": "http://f8k.com/20231231", "localname": "SubordinateVotingSharesIssued", "presentation": [ "http://f8k.com/role/IntangibleAssetsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Subordinate voting shares issued" } } }, "auth_ref": [] }, "lowlf_SubordinateVotingSharesMember": { "xbrltype": "domainItemType", "nsuri": "http://f8k.com/20231231", "localname": "SubordinateVotingSharesMember", "presentation": [ "http://f8k.com/role/ConsolidatedStatementsOfStockholdersEquityDeficit" ], "lang": { "en-us": { "role": { "label": "Subordinate Voting Shares [Member]" } } }, "auth_ref": [] }, "us-gaap_SubsequentEventsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SubsequentEventsAbstract", "lang": { "en-us": { "role": { "label": "SUBSEQUENT EVENTS" } } }, "auth_ref": [] }, "us-gaap_SubsequentEventsTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SubsequentEventsTextBlock", "presentation": [ "http://f8k.com/role/SubsequentEvents" ], "lang": { "en-us": { "role": { "label": "Subsequent Events", "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business." } } }, "auth_ref": [ "r443", "r444" ] }, "us-gaap_SubsidiarySaleOfStockAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SubsidiarySaleOfStockAxis", "presentation": [ "http://f8k.com/role/OtherCurrentLiabilitiesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Sale of Stock [Axis]", "documentation": "Information by type of sale of the entity's stock." } } }, "auth_ref": [] }, "lowlf_SuperVotingMember": { "xbrltype": "domainItemType", "nsuri": "http://f8k.com/20231231", "localname": "SuperVotingMember", "presentation": [ "http://f8k.com/role/ShareholdersEquityDetails" ], "lang": { "en-us": { "role": { "label": "Super Voting Share [Member]" } } }, "auth_ref": [] }, "lowlf_SuperVotingSharesMember": { "xbrltype": "domainItemType", "nsuri": "http://f8k.com/20231231", "localname": "SuperVotingSharesMember", "presentation": [ "http://f8k.com/role/ConsolidatedStatementsOfStockholdersEquityDeficit" ], "lang": { "en-us": { "role": { "label": "Super Voting Shares [Member]" } } }, "auth_ref": [] }, "us-gaap_SupplementalCashFlowInformationAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SupplementalCashFlowInformationAbstract", "presentation": [ "http://f8k.com/role/ConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION" } } }, "auth_ref": [] }, "us-gaap_Supplies": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "Supplies", "crdr": "debit", "presentation": [ "http://f8k.com/role/PrepaidAndOtherCurrentAssetsDetails" ], "lang": { "en-us": { "role": { "label": "Supplier Advances", "documentation": "Amount of consideration paid in advance for supplies that provide economic benefits within a future period of one year or the normal operating cycle, if longer." } } }, "auth_ref": [ "r598", "r607", "r659" ] }, "us-gaap_TechnologyBasedIntangibleAssetsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "TechnologyBasedIntangibleAssetsMember", "presentation": [ "http://f8k.com/role/IntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "label": "Technology/KnowHow", "documentation": "Technology-based intangible assets, including, but not limited to, patented technology, unpatented technology, and developed technology rights." } } }, "auth_ref": [ "r13" ] }, "lowlf_ThirdPartyManufacturedProductsPolicy": { "xbrltype": "textBlockItemType", "nsuri": "http://f8k.com/20231231", "localname": "ThirdPartyManufacturedProductsPolicy", "presentation": [ "http://f8k.com/role/BusinessBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Third Party Manufactured Products" } } }, "auth_ref": [] }, "lowlf_TotalComponentsOfLeaseExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://f8k.com/20231231", "localname": "TotalComponentsOfLeaseExpense", "crdr": "credit", "presentation": [ "http://f8k.com/role/LeasesDetails1" ], "lang": { "en-us": { "role": { "label": "Total - Finance Leases" } } }, "auth_ref": [] }, "lowlf_TotalFutureLeasePayments": { "xbrltype": "monetaryItemType", "nsuri": "http://f8k.com/20231231", "localname": "TotalFutureLeasePayments", "crdr": "credit", "presentation": [ "http://f8k.com/role/LeasesDetails2" ], "lang": { "en-us": { "role": { "verboseLabel": "Total", "label": "[Total]" } } }, "auth_ref": [] }, "lowlf_TotalIndebtness": { "xbrltype": "monetaryItemType", "nsuri": "http://f8k.com/20231231", "localname": "TotalIndebtness", "crdr": "credit", "presentation": [ "http://f8k.com/role/DebtDetails" ], "lang": { "en-us": { "role": { "label": "Total Indebtedness" } } }, "auth_ref": [] }, "lowlf_TotalLeasePayments": { "xbrltype": "monetaryItemType", "nsuri": "http://f8k.com/20231231", "localname": "TotalLeasePayments", "crdr": "debit", "presentation": [ "http://f8k.com/role/LeasesDetails2" ], "lang": { "en-us": { "role": { "label": "Total lease payments" } } }, "auth_ref": [] }, "lowlf_TotalPayment": { "xbrltype": "monetaryItemType", "nsuri": "http://f8k.com/20231231", "localname": "TotalPayment", "crdr": "credit", "presentation": [ "http://f8k.com/role/RelatedPartyTransactionsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Total payment" } } }, "auth_ref": [] }, "us-gaap_TradeAndOtherAccountsReceivablePolicy": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "TradeAndOtherAccountsReceivablePolicy", "presentation": [ "http://f8k.com/role/BusinessBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Accounts Receivable", "documentation": "Disclosure of accounting policy for accounts receivable." } } }, "auth_ref": [ "r117", "r118", "r119", "r244", "r245", "r247" ] }, "us-gaap_TradeNamesMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "TradeNamesMember", "presentation": [ "http://f8k.com/role/IntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "label": "Brands & Tradenames [Member]", "documentation": "Rights acquired through registration of a business name to gain or protect exclusive use thereof." } } }, "auth_ref": [ "r59" ] }, "us-gaap_UnrealizedGainLossOnInvestments": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "UnrealizedGainLossOnInvestments", "crdr": "credit", "calculation": { "http://f8k.com/role/ConsolidatedStatementsOfIncomeLoss": { "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": 1.0, "order": 10.0 }, "http://f8k.com/role/ConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 10.0 } }, "presentation": [ "http://f8k.com/role/ConsolidatedStatementsOfCashFlows", "http://f8k.com/role/ConsolidatedStatementsOfIncomeLoss" ], "lang": { "en-us": { "role": { "label": "Unrealized loss on change in fair value of investment", "negatedLabel": "Unrealized loss (gain) on change in fair value of investments", "documentation": "Amount of unrealized gain (loss) on investment." } } }, "auth_ref": [ "r6" ] }, "us-gaap_UseOfEstimates": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "UseOfEstimates", "presentation": [ "http://f8k.com/role/BusinessBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Use Of Estimates", "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles." } } }, "auth_ref": [ "r38", "r39", "r40", "r134", "r135", "r137", "r138" ] }, "lowlf_ValuationAllowanceDeferredTaxAssetsChangeInAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://f8k.com/20231231", "localname": "ValuationAllowanceDeferredTaxAssetsChangeInAmount", "crdr": "credit", "presentation": [ "http://f8k.com/role/IncomeTaxesDetails" ], "lang": { "en-us": { "role": { "label": "Valuation allowance" } } }, "auth_ref": [] }, "lowlf_VehicleLoansMember": { "xbrltype": "domainItemType", "nsuri": "http://f8k.com/20231231", "localname": "VehicleLoansMember", "presentation": [ "http://f8k.com/role/DebtDetails", "http://f8k.com/role/DebtDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Vehicle Loans" } } }, "auth_ref": [] }, "us-gaap_VehiclesMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "VehiclesMember", "presentation": [ "http://f8k.com/role/BusinessBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetails", "http://f8k.com/role/PropertyAndEquipmentAndRightOfUseAssetsDetails" ], "lang": { "en-us": { "role": { "label": "Vehicles [Member]", "verboseLabel": "Vehicles [Member]", "documentation": "Equipment used primarily for road transportation." } } }, "auth_ref": [] }, "lowlf_VestingPeriodDescriptions": { "xbrltype": "stringItemType", "nsuri": "http://f8k.com/20231231", "localname": "VestingPeriodDescriptions", "presentation": [ "http://f8k.com/role/ShareBasedCompensationDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Vesting Period Descriptions" } } }, "auth_ref": [] }, "us-gaap_WarrantExercisePriceDecrease": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "WarrantExercisePriceDecrease", "presentation": [ "http://f8k.com/role/ShareBasedCompensationDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Weighted-average Exercise Price Granted", "documentation": "Per share decrease in exercise price of warrant. Excludes change due to standard antidilution provision." } } }, "auth_ref": [ "r327" ] }, "lowlf_WarrantsBeginningBalance": { "xbrltype": "sharesItemType", "nsuri": "http://f8k.com/20231231", "localname": "WarrantsBeginningBalance", "presentation": [ "http://f8k.com/role/ShareholdersEquityDetails1" ], "lang": { "en-us": { "role": { "periodStartLabel": "Warrants, Beginning Balance", "label": "[Warrants, Beginning Balance]" } } }, "auth_ref": [] }, "lowlf_WarrantsCancelledWithBrandSaleAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://f8k.com/20231231", "localname": "WarrantsCancelledWithBrandSaleAmount", "crdr": "debit", "presentation": [ "http://f8k.com/role/ConsolidatedStatementsOfStockholdersEquityDeficit" ], "lang": { "en-us": { "role": { "label": "Warrants Cancelled with brand sale" } } }, "auth_ref": [] }, "lowlf_WarrantsEndingBalance": { "xbrltype": "sharesItemType", "nsuri": "http://f8k.com/20231231", "localname": "WarrantsEndingBalance", "presentation": [ "http://f8k.com/role/ShareholdersEquityDetails1" ], "lang": { "en-us": { "role": { "periodEndLabel": "Warrants, Ending Balance", "label": "[Warrants, Ending Balance]" } } }, "auth_ref": [] }, "lowlf_WarrantsExpired": { "xbrltype": "monetaryItemType", "nsuri": "http://f8k.com/20231231", "localname": "WarrantsExpired", "crdr": "credit", "presentation": [ "http://f8k.com/role/ShareholdersEquityDetails1" ], "lang": { "en-us": { "role": { "label": "Warrants expired" } } }, "auth_ref": [] }, "lowlf_WarrantsIssued": { "xbrltype": "monetaryItemType", "nsuri": "http://f8k.com/20231231", "localname": "WarrantsIssued", "crdr": "debit", "presentation": [ "http://f8k.com/role/IntangibleAssetsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Warrants issued" } } }, "auth_ref": [] }, "lowlf_WarrantsIssuedInConjunctionWithConvertibleDebentureOffering": { "xbrltype": "monetaryItemType", "nsuri": "http://f8k.com/20231231", "localname": "WarrantsIssuedInConjunctionWithConvertibleDebentureOffering", "crdr": "credit", "presentation": [ "http://f8k.com/role/ShareholdersEquityDetails1" ], "lang": { "en-us": { "role": { "label": "Warrants issued in conjunction with convertible debenture offering" } } }, "auth_ref": [] }, "lowlf_WeightedAverageFairValueOutstandingBeginningBalance": { "xbrltype": "perShareItemType", "nsuri": "http://f8k.com/20231231", "localname": "WeightedAverageFairValueOutstandingBeginningBalance", "presentation": [ "http://f8k.com/role/ShareBasedCompensationDetails2" ], "lang": { "en-us": { "role": { "label": "Weighted-average Fair Value Outstanding, Beginning Balance" } } }, "auth_ref": [] }, "lowlf_WeightedAverageFairValueOutstandingEndingBalance": { "xbrltype": "perShareItemType", "nsuri": "http://f8k.com/20231231", "localname": "WeightedAverageFairValueOutstandingEndingBalance", "presentation": [ "http://f8k.com/role/ShareBasedCompensationDetails2" ], "lang": { "en-us": { "role": { "label": "Weighted-average Fair Value Outstanding, Ending Balance" } } }, "auth_ref": [] }, "us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "WeightedAverageNumberDilutedSharesOutstandingAdjustment", "presentation": [ "http://f8k.com/role/NetIncomeLossPerShareDetails" ], "lang": { "en-us": { "role": { "label": "Total Weighted Average Potentially Diluted Shares", "documentation": "The sum of dilutive potential common shares or units used in the calculation of the diluted per-share or per-unit computation." } } }, "auth_ref": [ "r657" ] }, "us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract", "presentation": [ "http://f8k.com/role/NetIncomeLossPerShareDetails" ], "lang": { "en-us": { "role": { "label": "Weighted average potentially diluted shares:" } } }, "auth_ref": [] }, "lowlf_WeightedAverageNumberOfDilutedShareOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://f8k.com/20231231", "localname": "WeightedAverageNumberOfDilutedShareOutstanding", "presentation": [ "http://f8k.com/role/NetIncomeLossPerShareDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Diluted", "label": "[Diluted]" } } }, "auth_ref": [] }, "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "WeightedAverageNumberOfDilutedSharesOutstanding", "presentation": [ "http://f8k.com/role/ConsolidatedStatementsOfIncomeLoss" ], "lang": { "en-us": { "role": { "verboseLabel": "Diluted", "label": "[Weighted Average Number of Shares Outstanding, Diluted]", "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period." } } }, "auth_ref": [ "r199", "r208" ] }, "us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "WeightedAverageNumberOfSharesOutstandingAbstract", "presentation": [ "http://f8k.com/role/ConsolidatedStatementsOfIncomeLoss", "http://f8k.com/role/NetIncomeLossPerShareDetails" ], "lang": { "en-us": { "role": { "label": "Weighted average shares outstanding:", "verboseLabel": "Weighted Average Shares Outstanding:" } } }, "auth_ref": [] }, "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "WeightedAverageNumberOfSharesOutstandingBasic", "presentation": [ "http://f8k.com/role/ConsolidatedStatementsOfIncomeLoss", "http://f8k.com/role/NetIncomeLossPerShareDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Basic", "label": "[Weighted Average Number of Shares Outstanding, Basic]", "terseLabel": "Basic", "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period." } } }, "auth_ref": [ "r197", "r208" ] }, "lowlf_WeightedAverageRemainingContactualLifeOutstandingBeginningBalance": { "xbrltype": "durationItemType", "nsuri": "http://f8k.com/20231231", "localname": "WeightedAverageRemainingContactualLifeOutstandingBeginningBalance", "presentation": [ "http://f8k.com/role/ShareBasedCompensationDetails1" ], "lang": { "en-us": { "role": { "label": "Weighted-average Remaining Contactual Life Outstanding, Beginning Balance" } } }, "auth_ref": [] }, "lowlf_WeightedAverageRemainingContactualLifeOutstandingEndingBalance": { "xbrltype": "durationItemType", "nsuri": "http://f8k.com/20231231", "localname": "WeightedAverageRemainingContactualLifeOutstandingEndingBalance", "presentation": [ "http://f8k.com/role/ShareBasedCompensationDetails1" ], "lang": { "en-us": { "role": { "label": "Weighted-average Remaining Contactual Life Outstanding, Ending Balance" } } }, "auth_ref": [] }, "lowlf_WeightedAverageRemainingLeaseTerm": { "xbrltype": "durationItemType", "nsuri": "http://f8k.com/20231231", "localname": "WeightedAverageRemainingLeaseTerm", "presentation": [ "http://f8k.com/role/LeasesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Weighted Average Remaining Lease Term" } } }, "auth_ref": [] } } } }, "std_ref": { "r0": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "05", "Paragraph": "4", "SubTopic": "10", "Topic": "360", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482338/360-10-05-4" }, "r1": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "25", "Paragraph": "1", "SubTopic": "20", "Topic": "940", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481913/940-20-25-1" }, "r2": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "SubTopic": "230", "Topic": "830", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481877/830-230-45-1" }, "r3": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10", "SubTopic": "20", "Topic": "205", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483475/205-20-45-10" }, "r4": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "14", "Subparagraph": "(a)", "SubTopic": "10", "Topic": "230", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-14" }, "r5": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Subparagraph": "(a)", "SubTopic": "10", "Topic": "230", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28" }, "r6": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Subparagraph": "(b)", "SubTopic": "10", "Topic": "230", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28" }, "r7": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "SubTopic": "10", "Topic": "360", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1" }, "r8": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "SubTopic": "10", "Topic": "470", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481544/470-10-50-1" }, "r9": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "SubTopic": "10", "Topic": "505", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-2" }, "r10": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)", "SubTopic": "10", "Topic": "718", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r11": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)", "SubTopic": "10", "Topic": "718", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r12": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2A", "Subparagraph": "(a)", "SubTopic": "10", "Topic": "718", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2A" }, "r13": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "13", "SubTopic": "20", "Topic": "805", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479876/805-20-55-13" }, "r14": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(22))", "SubTopic": "10", "Topic": "210", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r15": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483489/210-10-50-1" }, "r16": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.19(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r17": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.19)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r18": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.19,20)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r19": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.19-26)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r20": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.20)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r21": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.20,24)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r22": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.21)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r23": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.22)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r24": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.29-31)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r25": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "13", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-13" }, "r26": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "14", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-14" }, "r27": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "15", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-15" }, "r28": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "15", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-15" }, "r29": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-4" }, "r30": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-1" }, "r31": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-2" }, "r32": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-3" }, "r33": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-4" }, "r34": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-5" }, "r35": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "270", "SubTopic": "10", "Section": "45", "Paragraph": "8", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482989/270-10-45-8" }, "r36": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "18", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-18" }, "r37": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "20", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-20" }, "r38": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-4" }, "r39": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-8" }, "r40": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-9" }, "r41": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "330", "SubTopic": "10", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB TOPIC 5.BB)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480581/330-10-S99-2" }, "r42": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "350", "SubTopic": "30", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482686/350-30-45-1" }, "r43": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "350", "SubTopic": "30", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482686/350-30-45-2" }, "r44": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "350", "SubTopic": "30", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-1" }, "r45": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "350", "SubTopic": "30", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-1" }, "r46": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "350", "SubTopic": "30", "Section": "50", "Paragraph": "2", "Subparagraph": "((a)(1),(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2" }, "r47": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "350", "SubTopic": "30", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2" }, "r48": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "350", "SubTopic": "30", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2" }, "r49": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "360", "SubTopic": "10", "Section": "45", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482130/360-10-45-4" }, "r50": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "360", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1" }, "r51": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "470", "SubTopic": "30", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481212/470-30-50-1" }, "r52": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-1" }, "r53": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r54": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r55": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r56": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "740", "SubTopic": "10", "Section": "45", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482525/740-10-45-6" }, "r57": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "740", "SubTopic": "10", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-8" }, "r58": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "805", "SubTopic": "10", "Section": "05", "Paragraph": "4", "Subparagraph": "(a)-(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479515/805-10-05-4" }, "r59": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "805", "SubTopic": "20", "Section": "55", "Paragraph": "14", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479876/805-20-55-14" }, "r60": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "825", "SubTopic": "10", "Section": "50", "Paragraph": "20", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-20" }, "r61": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "825", "SubTopic": "10", "Section": "50", "Paragraph": "21", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-21" }, "r62": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "835", "SubTopic": "30", "Section": "45", "Paragraph": "1A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482925/835-30-45-1A" }, "r63": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "835", "SubTopic": "30", "Section": "45", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482925/835-30-45-3" }, "r64": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "850", "SubTopic": "10", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-3" }, "r65": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "932", "SubTopic": "360", "Section": "35", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482450/932-360-35-11" }, "r66": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(19))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r67": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(20))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r68": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(28))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r69": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(29))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r70": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(30)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r71": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(30))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r72": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(31))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r73": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(32))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r74": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(6)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r75": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(6)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r76": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(6)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r77": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(10))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r78": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(20))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r79": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r80": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(8))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r81": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03.1,2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r82": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03.2(a),(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r83": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03.3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r84": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03.4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r85": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03.4,6)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r86": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03.7)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r87": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03.9)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r88": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "13", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-13" }, "r89": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-24" }, "r90": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-25" }, "r91": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28" }, "r92": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "235", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//235/tableOfContent" }, "r93": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB Topic 4.E)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480418/310-10-S99-2" }, "r94": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "350", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//350/tableOfContent" }, "r95": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2" }, "r96": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "360", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//360/tableOfContent" }, "r97": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "360", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1" }, "r98": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "360", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-2" }, "r99": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "360", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB Topic 5.CC)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480091/360-10-S99-2" }, "r100": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "440", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//440/tableOfContent" }, "r101": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "470", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//470/tableOfContent" }, "r102": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "25", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481284/470-20-25-10" }, "r103": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "505", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//505/tableOfContent" }, "r104": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.3-04)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-1" }, "r105": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "718", "SubTopic": "10", "Subparagraph": "(f)(2)", "Name": "Accounting Standards Codification", "Paragraph": "2", "Section": "50", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r106": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Paragraph": "2", "Section": "50", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-2" }, "r107": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Paragraph": "9", "Section": "50", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-9" }, "r108": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 6.I.7)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1" }, "r109": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(10))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r110": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(11))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r111": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(13))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r112": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(16))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r113": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(23))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r114": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(15))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r115": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(22))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r116": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04.9)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r117": { "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11B", "Subparagraph": "(b)", "SubTopic": "10", "Topic": "310", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481962/310-10-50-11B" }, "r118": { "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "15", "Subparagraph": "(d)", "SubTopic": "10", "Topic": "310", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481962/310-10-50-15" }, "r119": { "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "SubTopic": "10", "Topic": "310", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481962/310-10-50-6" }, "r120": { "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(19))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r121": { "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(22))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r122": { "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.22)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r123": { "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28" }, "r124": { "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "8A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481830/320-10-45-8A" }, "r125": { "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef", "Topic": "840", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//840/tableOfContent" }, "r126": { "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef", "Topic": "840", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481501/840-20-50-1" }, "r127": { "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef", "Topic": "840", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481501/840-20-50-4" }, "r128": { "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef", "Topic": "840", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481192/840-30-45-2" }, "r129": { "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef", "Topic": "840", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481192/840-30-45-3" }, "r130": { "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef", "Topic": "840", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481161/840-30-50-1" }, "r131": { "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(16))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r132": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Subparagraph": "(a)", "SubTopic": "20", "Topic": "740", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482659/740-20-45-2" }, "r133": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "6", "Subparagraph": "(a)", "SubTopic": "10", "Topic": "270", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482989/270-10-45-6" }, "r134": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "SubTopic": "10", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-1" }, "r135": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "SubTopic": "10", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-1" }, "r136": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "SubTopic": "360", "Topic": "958", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480321/958-360-50-1" }, "r137": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "SubTopic": "10", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-11" }, "r138": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12", "SubTopic": "10", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-12" }, "r139": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "SubTopic": "360", "Topic": "958", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480321/958-360-50-6" }, "r140": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "SubTopic": "360", "Topic": "958", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480321/958-360-50-7" }, "r141": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Subparagraph": "(b)", "SubTopic": "10", "Topic": "740", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-9" }, "r142": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(h))", "SubTopic": "10", "Topic": "235", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r143": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-K (SK)", "Number": "229", "Section": "1402", "Paragraph": "(a)", "Publisher": "SEC" }, "r144": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "105", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479343/105-10-65-6" }, "r145": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-7" }, "r146": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1" }, "r147": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-5" }, "r148": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483489/210-10-50-1" }, "r149": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(13))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r150": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(17))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r151": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(18))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r152": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(20))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r153": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(22))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r154": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(27)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r155": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(28))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r156": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(29))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r157": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r158": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(6)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r159": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r160": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(9))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r161": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1A", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1A" }, "r162": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1B" }, "r163": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-1" }, "r164": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-4" }, "r165": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-5" }, "r166": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-6" }, "r167": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(210.5-03(11))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r168": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r169": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(25))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r170": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r171": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5", "Subparagraph": "(SAB Topic 6.B)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-5" }, "r172": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "17", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-17" }, "r173": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-2" }, "r174": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-24" }, "r175": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-25" }, "r176": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-2" }, "r177": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-8" }, "r178": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r179": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(e)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r180": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r181": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(h)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r182": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-04(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-3" }, "r183": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "23", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-23" }, "r184": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-24" }, "r185": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-5" }, "r186": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1" }, "r187": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1" }, "r188": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-11" }, "r189": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-11" }, "r190": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-3" }, "r191": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-4" }, "r192": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-7" }, "r193": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-7" }, "r194": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-8" }, "r195": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-9" }, "r196": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//260/tableOfContent" }, "r197": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-10" }, "r198": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-11" }, "r199": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "16", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-16" }, "r200": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-2" }, "r201": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-3" }, "r202": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "40", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-40" }, "r203": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "42", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-42" }, "r204": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "60B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B" }, "r205": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "60B", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B" }, "r206": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "60B", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B" }, "r207": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-7" }, "r208": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1" }, "r209": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1" }, "r210": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-2" }, "r211": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-3" }, "r212": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "15", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482635/260-10-55-15" }, "r213": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "272", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483014/272-10-45-1" }, "r214": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "272", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482987/272-10-50-1" }, "r215": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "272", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482987/272-10-50-3" }, "r216": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//280/tableOfContent" }, "r217": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "15", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-15" }, "r218": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "21", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-21" }, "r219": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "21", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-21" }, "r220": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r221": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r222": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r223": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r224": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r225": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r226": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "26", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-26" }, "r227": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30" }, "r228": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30" }, "r229": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30" }, "r230": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "31", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-31" }, "r231": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32" }, "r232": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32" }, "r233": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32" }, "r234": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32" }, "r235": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32" }, "r236": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32" }, "r237": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "34", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-34" }, "r238": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "40", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-40" }, "r239": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "41", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-41" }, "r240": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "41", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-41" }, "r241": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "42", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-42" }, "r242": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481990/310-10-45-2" }, "r243": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481990/310-10-45-9" }, "r244": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481962/310-10-50-1" }, "r245": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481962/310-10-50-2" }, "r246": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481962/310-10-50-4" }, "r247": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "310", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481569/310-20-50-1" }, "r248": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "323", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3" }, "r249": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "4", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-4" }, "r250": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "5", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-5" }, "r251": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479344/326-20-45-1" }, "r252": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-13" }, "r253": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "16", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-16" }, "r254": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "330", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//330/tableOfContent" }, "r255": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "330", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483080/330-10-50-1" }, "r256": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "330", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483080/330-10-50-2" }, "r257": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "330", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483080/330-10-50-4" }, "r258": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//350-20/tableOfContent" }, "r259": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482598/350-20-45-2" }, "r260": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r261": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-2" }, "r262": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//350-30/tableOfContent" }, "r263": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-1" }, "r264": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-1" }, "r265": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-1" }, "r266": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2" }, "r267": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2" }, "r268": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2" }, "r269": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "360", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-3" }, "r270": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482017/420-10-50-1" }, "r271": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "440", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482648/440-10-50-4" }, "r272": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "440", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482648/440-10-50-4" }, "r273": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-4" }, "r274": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-9" }, "r275": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 5.Y.Q2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480102/450-20-S99-1" }, "r276": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 5.Y.Q4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480102/450-20-S99-1" }, "r277": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r278": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r279": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(iv))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r280": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r281": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r282": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r283": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r284": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iv))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r285": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r286": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r287": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r288": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r289": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r290": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r291": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r292": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r293": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r294": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r295": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1C", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1C" }, "r296": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1C", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1C" }, "r297": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1C", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1C" }, "r298": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1D", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D" }, "r299": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1D", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D" }, "r300": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1D", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D" }, "r301": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1E", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E" }, "r302": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1E", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E" }, "r303": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1E", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E" }, "r304": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1E", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E" }, "r305": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1F", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F" }, "r306": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1F", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F" }, "r307": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1F", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F" }, "r308": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1F", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F" }, "r309": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1I", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1I" }, "r310": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1I", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1I" }, "r311": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1I", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1I" }, "r312": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-4" }, "r313": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r314": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r315": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r316": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r317": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r318": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r319": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "14", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-14" }, "r320": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "14", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-14" }, "r321": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "14", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-14" }, "r322": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "16", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-16" }, "r323": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18" }, "r324": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18" }, "r325": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18" }, "r326": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-2" }, "r327": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-3" }, "r328": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.3-04)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-1" }, "r329": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r330": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(n)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r331": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-5" }, "r332": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//718/tableOfContent" }, "r333": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r334": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r335": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r336": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r337": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r338": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r339": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r340": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r341": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r342": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r343": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(02)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r344": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r345": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(04)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r346": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r347": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r348": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r349": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r350": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(02)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r351": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r352": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r353": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r354": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r355": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r356": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r357": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r358": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r359": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r360": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r361": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r362": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(v)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r363": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(h)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r364": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(h)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r365": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(l)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r366": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "15", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15" }, "r367": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "15", "Subparagraph": "(f)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15" }, "r368": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "15", "Subparagraph": "(f)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15" }, "r369": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 14.C.Q3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479830/718-10-S99-1" }, "r370": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 14.D.1.Q5)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479830/718-10-S99-1" }, "r371": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 14.D.2.Q6)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479830/718-10-S99-1" }, "r372": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 14.D.3.Q2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479830/718-10-S99-1" }, "r373": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "730", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "05", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483044/730-10-05-1" }, "r374": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//740/tableOfContent" }, "r375": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482525/740-10-45-25" }, "r376": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482525/740-10-45-28" }, "r377": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-10" }, "r378": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-12" }, "r379": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "14", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-14" }, "r380": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "17", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-17" }, "r381": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "19", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-19" }, "r382": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-2" }, "r383": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "20", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-20" }, "r384": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "21", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-21" }, "r385": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-9" }, "r386": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-9" }, "r387": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "8", "Subparagraph": "(d)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8" }, "r388": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "8", "Subparagraph": "(d)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8" }, "r389": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB TOPIC 6.I.5.Q1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1" }, "r390": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB TOPIC 6.I.7)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1" }, "r391": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 6.I.Fact.1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1" }, "r392": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 6.I.Fact.2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1" }, "r393": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB Topic 11.C)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-2" }, "r394": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "270", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482526/740-270-50-1" }, "r395": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482603/740-30-50-2" }, "r396": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "19", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-19" }, "r397": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-25" }, "r398": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-25" }, "r399": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A" }, "r400": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A" }, "r401": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(bb)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-3" }, "r402": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-3" }, "r403": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r404": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r405": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r406": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r407": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r408": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(i)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r409": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480237/815-40-50-6" }, "r410": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(e)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1" }, "r411": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(e)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1" }, "r412": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1" }, "r413": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r414": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "28", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-28" }, "r415": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "17", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-17" }, "r416": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20" }, "r417": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20" }, "r418": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20" }, "r419": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20" }, "r420": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481674/830-30-50-1" }, "r421": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "835", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483013/835-20-50-1" }, "r422": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "835", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482925/835-30-45-3" }, "r423": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "835", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482900/835-30-50-1" }, "r424": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "40", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479092/842-20-40-1" }, "r425": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-1" }, "r426": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-4" }, "r427": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-5" }, "r428": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-5" }, "r429": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-1" }, "r430": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4" }, "r431": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4" }, "r432": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(g)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4" }, "r433": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(g)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4" }, "r434": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-6" }, "r435": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479741/842-40-50-2" }, "r436": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "848", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(a)(3)(iii)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483550/848-10-65-2" }, "r437": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//850/tableOfContent" }, "r438": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1" }, "r439": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1" }, "r440": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1" }, "r441": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1" }, "r442": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-6" }, "r443": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "855", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//855/tableOfContent" }, "r444": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "855", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483399/855-10-50-2" }, "r445": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r446": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "910", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482546/910-10-50-6" }, "r447": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "912", "SubTopic": "330", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482105/912-330-50-1" }, "r448": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "920", "SubTopic": "350", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483256/920-350-50-1" }, "r449": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "920", "SubTopic": "350", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483256/920-350-50-1" }, "r450": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "920", "SubTopic": "350", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483256/920-350-50-4" }, "r451": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "924", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 11.L)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479941/924-10-S99-1" }, "r452": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "926", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483154/926-20-50-5" }, "r453": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "928", "SubTopic": "340", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483172/928-340-45-1" }, "r454": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "928", "SubTopic": "340", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483147/928-340-50-1" }, "r455": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-10(c)(7)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479664/932-10-S99-1" }, "r456": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "15", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-15" }, "r457": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "15", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-15" }, "r458": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "20", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-20" }, "r459": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "20", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-20" }, "r460": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "28", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-28" }, "r461": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "28", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-28" }, "r462": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "33", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-33" }, "r463": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "33", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-33" }, "r464": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "35A", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-35A" }, "r465": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "35A", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-35A" }, "r466": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-8" }, "r467": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-8" }, "r468": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(27))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r469": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-05(b)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479557/942-235-S99-1" }, "r470": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480842/942-360-50-1" }, "r471": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(10))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r472": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(12))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r473": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(22))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r474": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r475": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(25))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r476": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(8)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r477": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(8))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r478": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(11))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r479": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(16))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r480": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(18))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r481": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(23))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r482": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r483": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(9))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r484": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7A", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480081/944-40-50-7A" }, "r485": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r486": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(f)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r487": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(f)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r488": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(g)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r489": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(h)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r490": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "825", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479383/944-825-50-1B" }, "r491": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3" }, "r492": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(h)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3" }, "r493": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(i)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3" }, "r494": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(i)(2)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3" }, "r495": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(i)(2)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3" }, "r496": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(i)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3" }, "r497": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-11" }, "r498": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-13" }, "r499": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-2" }, "r500": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-5" }, "r501": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-6" }, "r502": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-3" }, "r503": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-4" }, "r504": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-2" }, "r505": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "27", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-27" }, "r506": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7" }, "r507": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7" }, "r508": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7" }, "r509": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7" }, "r510": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7" }, "r511": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7" }, "r512": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7" }, "r513": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7" }, "r514": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480555/946-210-45-4" }, "r515": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6" }, "r516": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6" }, "r517": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r518": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(12)(b)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r519": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(12)(b)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r520": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(12)(b)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r521": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(13)(a)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r522": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(13)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r523": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(14))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r524": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(16)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r525": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(17))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r526": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(19))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r527": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(2)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r528": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(2)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r529": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(3)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r530": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(3)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r531": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(3)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r532": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r533": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r534": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r535": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(e))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r536": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(8))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r537": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r538": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r539": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r540": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(e))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r541": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.6-05(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-2" }, "r542": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.6-05(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-2" }, "r543": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-3" }, "r544": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-7" }, "r545": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483580/946-220-50-3" }, "r546": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(1)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r547": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r548": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(2)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r549": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(2)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r550": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(2)(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r551": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(2)(e))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r552": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(2)(g)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r553": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r554": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r555": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r556": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r557": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r558": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r559": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r560": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r561": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r562": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r563": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r564": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r565": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r566": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(9))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r567": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(1)(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r568": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(4)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r569": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r570": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r571": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481062/946-235-50-2" }, "r572": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481062/946-235-50-2" }, "r573": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481062/946-235-50-2" }, "r574": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481062/946-235-50-2" }, "r575": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480833/946-310-45-1" }, "r576": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1" }, "r577": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2" }, "r578": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r579": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r580": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6" }, "r581": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column E)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6" }, "r582": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column E)(Footnote 4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6" }, "r583": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column E)(Footnote 6)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6" }, "r584": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-1" }, "r585": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2" }, "r586": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2" }, "r587": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2" }, "r588": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2" }, "r589": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-6" }, "r590": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "954", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481027/954-310-50-2" }, "r591": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "954", "SubTopic": "440", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480327/954-440-50-1" }, "r592": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Footnote 4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1" }, "r593": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "976", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482856/976-310-50-1" }, "r594": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "978", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482707/978-310-50-1" }, "r595": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(e)", "SubTopic": "10", "Topic": "235", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483426/235-10-50-4" }, "r596": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1" }, "r597": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(g)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1" }, "r598": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(g)(7)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1" }, "r599": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483426/235-10-50-4" }, "r600": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483426/235-10-50-4" }, "r601": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483426/235-10-50-4" }, "r602": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "52", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482635/260-10-55-52" }, "r603": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30" }, "r604": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "31", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-31" }, "r605": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "12A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481933/310-10-55-12A" }, "r606": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "340", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "05", "Paragraph": "5", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482955/340-10-05-5" }, "r607": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "340", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "05", "Paragraph": "5", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482955/340-10-05-5" }, "r608": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482548/350-20-55-24" }, "r609": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r610": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "69B", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69B" }, "r611": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "69C", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69C" }, "r612": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "69E", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69E" }, "r613": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "69F", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69F" }, "r614": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r615": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480547/715-80-55-8" }, "r616": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r617": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "4J", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481175/810-10-55-4J" }, "r618": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "4K", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481175/810-10-55-4K" }, "r619": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "53", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479589/842-20-55-53" }, "r620": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "852", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481372/852-10-55-10" }, "r621": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "29F", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480046/944-40-55-29F" }, "r622": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480493/946-210-55-1" }, "r623": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480833/946-310-45-1" }, "r624": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "830", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-10" }, "r625": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "830", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-11" }, "r626": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "830", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-12" }, "r627": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-2" }, "r628": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 10-K", "Number": "249", "Section": "310" }, "r629": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Number": "249", "Section": "220", "Subsection": "f" }, "r630": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Number": "249", "Section": "240", "Subsection": "f" }, "r631": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Section": "13", "Subsection": "a-1" }, "r632": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w" }, "r633": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-T", "Number": "232", "Section": "405" }, "r634": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "405" }, "r635": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "7A", "Section": "B", "Subsection": "2" }, "r636": { "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef", "Topic": "272", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483014/272-10-45-3" }, "r637": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "12", "SubTopic": "10", "Topic": "230", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-12" }, "r638": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "SubTopic": "10", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-18" }, "r639": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(g)(1)", "SubTopic": "20", "Topic": "842", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4" }, "r640": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Subparagraph": "(a)", "SubTopic": "10", "Topic": "740", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-9" }, "r641": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(3)(a)(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r642": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(6)(a)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r643": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(6)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r644": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(6)(a)(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r645": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r646": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r647": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(8))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r648": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(9))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r649": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-6" }, "r650": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28" }, "r651": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28" }, "r652": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r653": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(f))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r654": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r655": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(h)(1)(Note 1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r656": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "55", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-55" }, "r657": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1" }, "r658": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "323", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3" }, "r659": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "340", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483032/340-10-45-1" }, "r660": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-3" }, "r661": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "410", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "10", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481931/410-30-50-10" }, "r662": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "450", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//450/tableOfContent" }, "r663": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r664": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(iii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r665": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r666": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r667": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r668": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r669": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r670": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r671": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r672": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r673": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r674": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(02)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r675": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r676": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(04)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r677": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r678": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r679": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r680": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r681": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(02)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r682": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r683": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r684": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r685": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r686": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r687": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r688": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r689": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r690": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r691": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(v)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r692": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r693": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-10" }, "r694": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "15", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-15" }, "r695": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-2" }, "r696": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-6" }, "r697": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-9" }, "r698": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 6.I.7)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1" }, "r699": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "28", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-28" }, "r700": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4" }, "r701": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-3" }, "r702": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "852", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481404/852-10-50-7" }, "r703": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "852", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481404/852-10-50-7" }, "r704": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r705": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r706": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r707": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4" }, "r708": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4" }, "r709": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4" }, "r710": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(16)(a)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r711": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Subparagraph": "(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-3" }, "r712": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(4)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r713": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480833/946-310-45-1" } } } ZIP 93 0001654954-24-003785-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001654954-24-003785-xbrl.zip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lowlf_10k_htm.xml IDEA: XBRL DOCUMENT 0001838128 2023-01-01 2023-12-31 0001838128 lowlf:OMGMember 2023-01-01 2023-12-31 0001838128 lowlf:OMGMember 2022-01-01 2022-12-31 0001838128 lowlf:SalariesAndBenefitsMember 2022-01-01 2022-12-31 0001838128 lowlf:AdministrativeMember 2022-01-01 2022-12-31 0001838128 lowlf:InsuranceMember 2022-01-01 2022-12-31 0001838128 lowlf:SharebasedCompensationMember 2022-01-01 2022-12-31 0001838128 lowlf:ProfessionalFeesMember 2022-01-01 2022-12-31 0001838128 lowlf:AdministrativeMember 2023-01-01 2023-12-31 0001838128 lowlf:InsuranceMember 2023-01-01 2023-12-31 0001838128 lowlf:SharebasedCompensationMember 2023-01-01 2023-12-31 0001838128 lowlf:ProfessionalFeesMember 2023-01-01 2023-12-31 0001838128 lowlf:SalariesAndBenefitsMember 2023-01-01 2023-12-31 0001838128 lowlf:AugustTwentyTwentyMember 2022-01-01 2022-12-31 0001838128 us-gaap:RestrictedStockUnitsRSUMember 2022-01-01 2022-12-31 0001838128 us-gaap:RestrictedStockUnitsRSUMember 2023-01-01 2023-12-31 0001838128 lowlf:StockOptionsMember 2023-01-01 2023-12-31 0001838128 lowlf:StockOptionsMember 2022-01-01 2022-12-31 0001838128 us-gaap:GeneralAndAdministrativeExpenseMember 2023-01-01 2023-12-31 0001838128 us-gaap:GeneralAndAdministrativeExpenseMember 2022-01-01 2022-12-31 0001838128 lowlf:FinanceLeasesMember 2023-01-01 2023-12-31 0001838128 lowlf:OperatingLeasesMember 2023-01-01 2023-12-31 0001838128 2021-01-01 2021-12-31 0001838128 lowlf:MortgagePayableMember 2023-01-01 2023-12-31 0001838128 lowlf:MortgagePayableMember 2022-01-01 2022-12-31 0001838128 lowlf:VehicleLoansMember 2022-01-01 2022-12-31 0001838128 lowlf:VehicleLoansMember 2023-01-01 2023-12-31 0001838128 lowlf:NotePayable2Member 2023-12-31 0001838128 lowlf:NotePayable2Member 2022-12-31 0001838128 us-gaap:ConvertibleDebtMember 2023-12-31 0001838128 lowlf:MortgagePayableMember 2023-12-31 0001838128 us-gaap:ConvertibleDebtMember 2022-12-31 0001838128 lowlf:MortgagePayableMember 2022-12-31 0001838128 lowlf:VehicleLoansMember 2023-12-31 0001838128 lowlf:VehicleLoansMember 2022-12-31 0001838128 lowlf:SuperVotingMember 2023-12-31 0001838128 lowlf:SuperVotingMember 2022-12-31 0001838128 lowlf:SubordinateVotingMember 2023-12-31 0001838128 lowlf:SubordinateVotingMember 2023-01-01 2023-12-31 0001838128 lowlf:SubordinateVotingMember 2022-12-31 0001838128 us-gaap:OtherIntangibleAssetsMember 2023-01-01 2023-12-31 0001838128 2021-01-01 2021-09-30 0001838128 lowlf:LowellBrandMember 2023-12-31 0001838128 2023-10-06 0001838128 lowlf:LowellBrandMember 2023-01-01 2023-12-31 0001838128 2023-10-01 2023-10-06 0001838128 lowlf:AcquiredPurchaseRightsMember 2023-12-31 0001838128 lowlf:AcquiredPurchaseRightsMember 2023-01-01 2023-12-31 0001838128 lowlf:AcquiredPurchaseRightsMember 2022-12-31 0001838128 us-gaap:TradeNamesMember 2023-12-31 0001838128 us-gaap:TradeNamesMember 2023-01-01 2023-12-31 0001838128 us-gaap:TradeNamesMember 2022-12-31 0001838128 us-gaap:TechnologyBasedIntangibleAssetsMember 2023-12-31 0001838128 us-gaap:TechnologyBasedIntangibleAssetsMember 2022-12-31 0001838128 us-gaap:TechnologyBasedIntangibleAssetsMember 2023-01-01 2023-12-31 0001838128 us-gaap:CostOfGoodsTotalMember 2023-01-01 2023-12-31 0001838128 lowlf:OtherIncomeExpenseMember 2022-01-01 2022-12-31 0001838128 us-gaap:CostOfGoodsTotalMember 2022-01-01 2022-12-31 0001838128 lowlf:RightOfUseAssetMember 2023-12-31 0001838128 lowlf:RightOfUseAssetMember 2023-01-01 2023-12-31 0001838128 lowlf:RightOfUseAssetMember 2022-12-31 0001838128 us-gaap:ConstructionInProgressMember 2023-12-31 0001838128 us-gaap:ConstructionInProgressMember 2022-12-31 0001838128 us-gaap:VehiclesMember 2023-12-31 0001838128 us-gaap:VehiclesMember 2023-01-01 2023-12-31 0001838128 us-gaap:VehiclesMember 2022-12-31 0001838128 lowlf:EquipmentsMember 2023-12-31 0001838128 lowlf:EquipmentsMember 2023-01-01 2023-12-31 0001838128 lowlf:EquipmentsMember 2022-12-31 0001838128 us-gaap:FurnitureAndFixturesMember 2023-12-31 0001838128 us-gaap:FurnitureAndFixturesMember 2023-01-01 2023-12-31 0001838128 us-gaap:FurnitureAndFixturesMember 2022-12-31 0001838128 us-gaap:LeaseholdImprovementsMember 2023-12-31 0001838128 us-gaap:LeaseholdImprovementsMember 2023-01-01 2023-12-31 0001838128 us-gaap:LeaseholdImprovementsMember 2022-12-31 0001838128 lowlf:LandAndBuildingsMember 2023-12-31 0001838128 lowlf:LandAndBuildingsMember 2023-01-01 2023-12-31 0001838128 lowlf:LandAndBuildingsMember 2022-12-31 0001838128 lowlf:OnTwentySixJulyTwoThousandTwentyTwoMember lowlf:ERCClaimMember 2022-01-01 2022-12-31 0001838128 lowlf:OnTwentySixJulyTwoThousandTwentyTwoMember lowlf:ERCClaimMember 2023-01-01 2023-12-31 0001838128 2016-02-28 0001838128 us-gaap:ConstructionInProgressMember 2023-01-01 2023-12-31 0001838128 lowlf:LeaseholdimprovementsMember 2023-01-01 2023-12-31 0001838128 srt:MaximumMember us-gaap:MachineryAndEquipmentMember 2023-01-01 2023-12-31 0001838128 srt:MaximumMember us-gaap:FurnitureAndFixturesMember 2023-01-01 2023-12-31 0001838128 srt:MaximumMember us-gaap:VehiclesMember 2023-01-01 2023-12-31 0001838128 srt:MaximumMember us-gaap:OfficeEquipmentMember 2023-01-01 2023-12-31 0001838128 srt:MinimumMember us-gaap:MachineryAndEquipmentMember 2023-01-01 2023-12-31 0001838128 srt:MinimumMember us-gaap:VehiclesMember 2023-01-01 2023-12-31 0001838128 srt:MinimumMember us-gaap:FurnitureAndFixturesMember 2023-01-01 2023-12-31 0001838128 srt:MinimumMember us-gaap:OfficeEquipmentMember 2023-01-01 2023-12-31 0001838128 lowlf:BuildingsMember 2023-01-01 2023-12-31 0001838128 us-gaap:RetainedEarningsMember 2023-12-31 0001838128 lowlf:SharesCapitalMember 2023-12-31 0001838128 lowlf:SuperVotingSharesMember 2023-12-31 0001838128 lowlf:SubordinateVotingSharesMember 2023-12-31 0001838128 lowlf:SubordinateVotingSharesMember 2023-01-01 2023-12-31 0001838128 us-gaap:RetainedEarningsMember 2023-01-01 2023-12-31 0001838128 lowlf:SharesCapitalMember 2023-01-01 2023-12-31 0001838128 us-gaap:RetainedEarningsMember 2022-12-31 0001838128 lowlf:SharesCapitalMember 2022-12-31 0001838128 lowlf:SuperVotingSharesMember 2022-12-31 0001838128 lowlf:SubordinateVotingSharesMember 2022-12-31 0001838128 lowlf:SubordinateVotingSharesMember 2022-01-01 2022-12-31 0001838128 us-gaap:RetainedEarningsMember 2022-01-01 2022-12-31 0001838128 lowlf:SharesCapitalMember 2022-01-01 2022-12-31 0001838128 us-gaap:RetainedEarningsMember 2021-12-31 0001838128 lowlf:SharesCapitalMember 2021-12-31 0001838128 lowlf:SuperVotingSharesMember 2021-12-31 0001838128 lowlf:SubordinateVotingSharesMember 2021-12-31 0001838128 2022-01-01 2022-12-31 0001838128 2021-12-31 0001838128 2022-12-31 0001838128 2023-12-31 0001838128 2024-03-26 0001838128 2023-06-30 iso4217:USD shares iso4217:USD shares pure 0001838128 false --12-31 FY 2023 false Category Useful LifeLeasehold improvements The lesser of the estimated useful life or length of the lease Office equipment 3-5 yearsFurniture and fixtures 3-7 yearsVehicles 4-5 yearsMachinery and equipment 3-6 yearsBuildings 35 yearsConstruction in progress Not depreciated 847000 357000 0.06 296000 0 0 0 0 0 0 P0Y June 30, 2021 2023 0 10-K true 2023-12-31 false 000-56254 LOWELL FARMS INC. Z4 19 Quail Run Circle - Suite B Salinas CA 93907 831 998-8214 No No Yes Yes Non-accelerated Filer true true false false false 3069255 18130566 6580 GreenGrowth CPAs Los Angeles, California 6580 2311000 1098000 959000 1053000 2620000 4163000 4760000 10779000 2397000 1522000 12088000 17562000 4099000 31284000 18327000 27362000 2544000 42202000 555000 413000 37613000 118823000 4314000 2307000 363000 350000 3000 282000 1990000 2659000 0 21398000 1943000 3654000 8613000 30650000 0 3000 17522000 31340000 0 0 0 8713000 26135000 70706000 192445000 191742000 -180967000 -143625000 11478000 48117000 37613000 118823000 28265000 43535000 35707000 45376000 -7442000 -1841000 7302000 9553000 2397000 5274000 421000 448000 10120000 15275000 -17562000 -17116000 8541000 2455000 -28000 -109000 -24295000 -3240000 3837000 6363000 -19619000 -7257000 -37181000 -24373000 161000 191000 -37342000 -24564000 -2.71 -2.17 -2.71 -2.17 13790000 11318000 13790000 11318000 11181000 20000 189368000 -119061000 70307000 0 -24564000 -24564000 1000000 1800000 0 1800000 -40000 0 0 0 14000 10000 0 10000 22000 564000 0 564000 12177000 20000 191742000 -143625000 48117000 12177000 20000 191742000 -143625000 48117000 0 -37342000 -37342000 6843000 2027000 0 2027000 -1555000 0 -1555000 4000 0 0 0 231000 0 231000 19024000 20000 192445000 -180967000 11478000 37342000 24564000 5117000 7376000 712000 937000 231000 564000 616000 517000 0 -59000 3004000 0 880000 0 -28000 -109000 24295000 3240000 5020000 0 -927000 -3542000 -6019000 -2564000 -2731000 -454000 270000 106000 -443000 0 242000 -1136000 -6041000 -6444000 0 60000 135000 4250000 0 0 -135000 -4190000 0 6552000 1527000 2497000 75000 210000 8991000 0 0 0 0 0 7389000 3845000 1213000 -6789000 1098000 7887000 2311000 1098000 3689000 4215000 87000 171000 7000 819000 0 1800000 2027000 0 <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;"><strong>1. BUSINESS, BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;"><strong><em>Business</em></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; TEXT-INDENT: 33.75pt; text-align:justify;">Lowell Farms Inc. is governed by the laws of British Columbia, Canada. On April 26, 2019, the Company completed a reverse takeover transaction with Indus Holding Company, a Delaware corporation, incorporated in 2014. Effective March 1, 2021, the Company changed its name to Lowell Farms Inc. and is a California-based cannabis company with vertically integrated operations including large scale cultivation, extraction, processing, manufacturing, branding, packaging and wholesale distribution to retail dispensaries. The Company manufactures and distributes proprietary and third-party brands throughout the State of California, the largest cannabis market in the world. The Company also provides manufacturing, extraction and distribution services to third-party cannabis and cannabis branding companies. The Company’s corporate office and principal place of business is located at 19 Quail Run Circle, Salinas, California.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;"><strong><em>Basis of Presentation</em></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; TEXT-INDENT: 33.75pt; text-align:justify;">The consolidated financial statements of Lowell Farms Inc. and its wholly owned subsidiaries (collectively, the “Company,” “we,” “us” or “our”) have been prepared in accordance with generally accepted accounting principles in the United States (“GAAP”). All intercompany transactions and balances have been eliminated in consolidation.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; TEXT-INDENT: 33.75pt; text-align:justify;">All dollar amounts in the consolidated financial statements and notes to consolidated financial statements are expressed in thousands of United States dollars ("$" or "US$"), unless otherwise indicated.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;"><strong><em>Use of Estimates</em></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; TEXT-INDENT: 33.75pt; text-align:justify;">The preparation of financial statements in conformity with generally accepted accounting principles in the United States (“U.S. GAAP”) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Significant estimates in these financial statements include allowance for doubtful accounts and credit losses, carrying value of inventory, revenue recognition, accounting for stock-based compensation expense, and income taxes. Actual results could differ from those estimates.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; TEXT-INDENT: 33.75pt; text-align:justify;">The global COVID-19 pandemic has impacted the operations and purchasing decisions of companies worldwide. It also has created and may continue to create significant uncertainty in the global economy. The Company has undertaken measures to protect its employees, partners, customers, and vendors. In addition, the Company’s personnel are subject to various travel restrictions, which limit the ability of the Company to provide services to customers and affiliates. This impacts the Company's normal operations. To date, the Company has been able to provide uninterrupted access to its products and services, including certain employees that are working remotely, and its pre-existing infrastructure that supports secure access to the Company’s internal systems. If, however, the COVID-19 pandemic has a substantial impact on the productivity of the Company’s employees or its partners’ or customers’ decision to use the Company’s products and services, the results of the Company’s operations and overall financial performance may be adversely impacted. The duration and extent of the impact from the COVID-19 pandemic depends on future developments that cannot be accurately predicted at this time. As of the date of issuance of the financial statements, the Company is not aware of any specific event or circumstance that would require updates to the Company’s estimates and judgments or revisions to the carrying value of its assets or liabilities. These estimates may change, as new events occur and additional information is obtained, and are recognized in the condensed consolidated financial statements as soon as they become known. Actual results could differ from those estimates and any such differences may be material to the financial statements.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;"><strong><em>Significant Accounting Policies </em></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">Cash and Cash Equivalents</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; TEXT-INDENT: 33.75pt; text-align:justify;">Cash and cash equivalents include cash on hand, cash deposits in financial institutions, and other deposits that are readily convertible into cash. The Company considers all short-term, highly liquid investments purchased with maturities of three months or less to be cash equivalents. These investments are carried at cost, which approximates fair value.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; TEXT-INDENT: 33.75pt; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">As of December 31, 2023 and December 31, 2022, the Company’s cash and cash equivalents exceeded FDIC insured limits by $1,974 and $360, respectively.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">Accounts Receivable</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; TEXT-INDENT: 33.75pt; text-align:justify;">Accounts receivables are classified as loans and receivable financial assets. Accounts receivables are recognized initially at fair value and subsequently measured at amortized cost, less any provisions for impairment. When an accounts receivable is uncollectible, it is written off against the provision. Subsequent recoveries of amounts previously written off are credited to the consolidated statements of operations.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">Inventories</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; TEXT-INDENT: 33.75pt; text-align:justify;">Inventories are valued at the lower of cost and net realizable value. Costs related to raw materials and finished goods are determined on the first-in, first-out basis. Specific identification and average cost methods are also used primarily for certain packing materials and operating supplies. The Company reviews inventory for obsolete, redundant and slow-moving goods and any such inventory is written-down to net realizable value.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">Property and Equipment</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; TEXT-INDENT: 33.75pt; text-align:justify;">Property and equipment are stated at cost, net of accumulated depreciation and impairment losses, if any. Depreciation is calculated on a straight-line basis over the estimated useful life of the asset using the following terms and methods:</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><table cellpadding="0" style="border-spacing:0;font-size:10pt;width:100%"><tbody><tr style="height:15px"><td style="BORDER-BOTTOM: 1px solid;width:31%;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">Category</p></td><td style="width:1%;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:46%;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">Useful Life</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="width:31%;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">Leasehold improvements</p></td><td style="width:1%;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p></td><td style="width:46%;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">The lesser of the estimated useful life or length of the lease </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="width:31%;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">Office equipment</p></td><td style="width:1%;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p></td><td style="width:46%;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">3-5 years</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="width:31%;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">Furniture and fixtures</p></td><td style="width:1%;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p></td><td style="width:46%;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">3-7 years</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="width:31%;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">Vehicles</p></td><td style="width:1%;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p></td><td style="width:46%;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">4-5 years</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="width:31%;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">Machinery and equipment</p></td><td style="width:1%;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p></td><td style="width:46%;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">3-6 years</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="width:31%;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">Buildings</p></td><td style="width:1%;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p></td><td style="width:46%;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">35 years</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="width:31%;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">Construction in progress</p></td><td style="width:1%;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p></td><td style="width:46%;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">Not depreciated</p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; TEXT-INDENT: 33.75pt; text-align:justify;">The assets’ residual values, useful lives and methods of depreciation are reviewed at each financial year-end and adjusted prospectively if appropriate. An item of equipment is derecognized upon disposal or when no future economic benefits are expected from its use. Any gain or loss arising on derecognition of the asset (calculated as the difference between the net disposal proceeds and the carrying value of the asset) is included in the consolidated statements of operations in the year the asset is derecognized.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">Goodwill</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; TEXT-INDENT: 33.75pt; text-align:justify;">Goodwill represents the excess of the purchase price paid for the acquisition of an entity over the fair value of the net tangible and intangible assets acquired. Goodwill that has an indefinite useful life is not subject to amortization and is tested annually for impairment, or more frequently if events or changes in circumstances indicate that goodwill might be impaired. Any goodwill impairment loss is recognized in the consolidated statements of operations in the period in which the impairment is identified. Impairment losses on goodwill are not subsequently reversed.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">Intangible Assets</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; TEXT-INDENT: 33.75pt; text-align:justify;">Intangible assets are recorded at cost, less accumulated amortization and impairment losses, if any. Intangible assets acquired in a business combination are measured at fair value at the acquisition date. Intangible assets acquired in an asset purchase are valued at their purchase price. Amortization is recorded on a straight-line basis over their estimated useful lives, which do not exceed the contractual period, if any. The estimated useful lives, residual values, and amortization methods are reviewed at each year-end, and any changes in estimates are accounted for prospectively.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; TEXT-INDENT: 33.75pt; text-align:justify;">Branding rights are measured at fair value at the time of acquisition and are amortized on a straight-line basis over a period of 15 years. In addition, the Company has certain brand and tradenames with indefinite lives, which are evaluated for impairment on an annual basis.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">Impairment of Long-lived Assets</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; TEXT-INDENT: 33.75pt; text-align:justify;">Long-lived assets, including property, plant and equipment and intangible assets are reviewed for impairment at each statement of financial position date or whenever events or changes in circumstances indicate that the carrying amount of an asset exceeds its recoverable amount. For the purpose of impairment testing, assets that cannot be tested individually are grouped together into the smallest group of assets that generates cash inflows from continuing use that are largely independent of the cash inflows of other assets or groups of assets. The recoverable amount of an asset or an asset group is the higher of its fair value, less costs to sell, and its value in use. If the carrying amount of an asset exceeds its recoverable amount, an impairment charge is recognized immediately in profit or loss equal to the amount by which the carrying amount exceeds the recoverable amount. Where an impairment loss subsequently reverses, the carrying amount of the asset is increased to the lesser of the revised estimate of the recoverable amount, and the carrying amount that would have been recorded had no impairment loss been recognized previously.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">Leased Assets</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; TEXT-INDENT: 33.75pt; text-align:justify;">The Company adopted FASB Topic 842, Leases (“Topic 842”) effective January 1, 2019, using the modified retrospective adoption method which allowed it to initially apply the new standard at the adoption date and recognize a cumulative-effect adjustment to the opening balance of accumulated deficit. In connection with the adoption of the lease pronouncement, the Company recorded a charge to accumulated deficit of $847. A lease of property and equipment is classified as a capital lease if it transfers substantially all the risks and rewards incidental to ownership to the Company. Lease right-of-use assets represent the right to use an underlying asset for the lease term, and lease liabilities represent the obligation to make payments arising from the lease agreement. These assets and liabilities are recognized at the commencement of the lease based upon the present value of the future minimum lease payments over the lease term. The lease term reflects the noncancelable period of the lease together with periods covered by an option to extend or terminate the lease when management is reasonably certain that it will exercise such option. Changes in the lease term assumption could impact the right-of-use assets and lease liabilities recognized on the balance sheet. As our leases typically do not contain a readily determinable implicit rate, we determine the present value of the lease liability using our incremental borrowing rate at the lease commencement date based on the lease term on a collateralized basis. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; TEXT-INDENT: 33.75pt; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; TEXT-INDENT: 33.75pt; text-align:justify;">The Company accounts for sales leaseback transactions in accordance with ASC 842-40: Sale and Leaseback Transactions. The Company determines whether the transfer of an asset represents a sale based on requirements from Topic 606, lease classification, and nature of purchase options. If a transfer is deemed a sale and at fair value, the Company derecognizes the asset and records a gain/(loss) in the income statement. If a transfer is deemed a sale and not at fair value, the Company derecognizes the asset and does not recognize a gain/(loss) in the income statement. If a transfer of the asset is not a sale, the Company does not derecognize the asset.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;"> Income Taxes</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; TEXT-INDENT: 33.75pt; text-align:justify;">The Company is a United States C corporation for income tax purposes. Income tax expense consisting of current and deferred tax expense is recognized in the consolidated statements of operations. Current tax expense is the expected tax payable on the taxable income for the year, using tax rates enacted or substantively enacted at year-end, adjusted for amendments to tax payable with regards to previous years. Deferred tax assets and liabilities and the related deferred income tax expense or recovery are recognized for deferred tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using the enacted or substantively enacted tax rates expected to apply when the asset is realized or the liability settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that substantive enactment occurs. A deferred tax asset is recognized to the extent that it is probable that future taxable income will be available against which the asset can be utilized. Deferred tax assets and liabilities are offset when there is a legally enforceable right to set off current tax assets against current tax liabilities and when they relate to income taxes levied by the same taxation authority and the Company intends to settle its current tax assets and liabilities on a net basis.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">Revenue Recognition</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; TEXT-INDENT: 33.75pt; text-align:justify;">Revenue is recognized upon transfer of control of promised products or services to customers in an amount that reflects the consideration the Company expects to receive in exchange for those products or services. The Company enters contracts that can include various combinations of products and services, which are generally capable of being distinct and accounted for as separate performance obligations Revenue is recognized net of allowances for returns and any taxes collected from customers, which are subsequently remitted to governmental authorities.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">Branded Products</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; TEXT-INDENT: 33.75pt; text-align:justify;">For the Company’s branded products, revenue is recognized when it satisfies a performance obligation by transferring a promised cannabis good to a customer. A contract, whether a verbal or written sales order, is established with customers prior to order fulfillment with agreement upon unit prices, delivery dates, and payment terms. The transaction price is based on market pricing while considering the value of the Company’s brand and quality. Transaction price is allocated to each product sold based upon the negotiated unit sales price associated with each product line scheduled for delivery within the order. Performance obligation satisfaction occurs upon delivery to customer premises. These types of revenues accounted for under ASC Topic 606, generally, do not require significant estimates or judgments based on the nature of the Company’s revenue stream. The sales prices, including discounts, are fixed at the point of sale and all consideration from contracts is included in the transaction price. The Company’s contracts do not include multiple performance obligations or material variable consideration.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">Third Party Manufactured Products</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; TEXT-INDENT: 33.75pt; text-align:justify;">The Company has certain licenses to manufacture and distribute third party products to retail dispensaries and deliveries in return for paying royalty payments to the third parties. The Company is a principal in the arrangement, it assumes primary responsibility for fulfilling the customer promise to retail dispensaries and deliveries, and it holds the inventory risk. Revenue is recognized when it satisfies a performance obligation by transferring a promised cannabis good to a retail dispensary or retail delivery. A contract, whether a verbal or written sales order, is established with customers prior to order fulfillment with agreement upon unit prices, delivery dates, and payment terms. The transaction price is based on market pricing while considering the value of the Company’s brand and quality. Transaction price is allocated to each product sold based upon the negotiated unit sales price associated with each product line scheduled for delivery within the order. Performance obligation satisfaction occurs upon delivery to customer premises. These types of revenues accounted for under ASC Topic 606, generally, do not require significant estimates or judgments based on the nature of the Company’s revenue stream. The sales prices, including discounts, are fixed at the point of sale and all consideration from contracts is included in the transaction price. The Company’s contracts do not include multiple performance obligations or material variable consideration.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Licensing</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">The Company has entered into contracts to license the right to utilize the Company’s branding and intellectual property. For all sales utilizing the license, the Company recognizes a percentage based license fee. Revenue is recognized when performance obligations are satisfied by recognizing fees on sales utilizing the licensed property to other companies. Contracts exist that define the property that is licensed, the time period, the fees and payment terms. These types of revenues accounted for under ASC Topic 606, generally, do not require significant estimates or judgments based on the nature of the Company’s revenue stream.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">Distribution</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; TEXT-INDENT: 33.75pt; text-align:justify;">The Company distributes certain third-party brands and bulk flower. The Company is a principal in the arrangement, it assumes primary responsibility for fulfilling the customer promise to retail dispensaries and deliveries and other wholesale customers, and it holds the inventory risk. Revenue is recognized when it satisfies a performance obligation by transferring a promised cannabis good to a customer. A contract, whether a verbal or written sales order, is established with customers prior to order fulfillment with agreement upon unit prices, delivery dates, and payment terms. The transaction price is based on market pricing while considering the value of the Company’s brand and quality. Transaction price is allocated to each product sold based upon the negotiated unit sales price associated with each product line scheduled for delivery within the order. Performance obligation satisfaction occurs upon delivery to customer premises. These types of revenues accounted for under ASC Topic 606, generally, do not require significant estimates or judgments based on the nature of the Company’s revenue stream. The sales prices, including discounts, are fixed at the point of sale and all consideration from contracts is included in the transaction price. The Company’s contracts do not include multiple performance obligations or material variable consideration.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">Lowell Farms Services</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; TEXT-INDENT: 33.75pt; text-align:justify;">The Company performs various processing activities under Lowell Farms Services including drying, bucking, trimming, sorting, grading and packaging operations. Revenue is recognized when it satisfies a performance obligation by completing the agreed upon services that were negotiated with a customer. A contract, whether a verbal or written sales order, is established with customers prior to completing the agreed upon services with the type of services to be performed and with the agreed upon pricing and timing. The transaction price is based on the nature of the services to be performed and market pricing. Performance obligation satisfaction occurs upon completion of the services performed. These types of revenues accounted for under ASC Topic 606, generally, do not require significant estimates or judgments based on the nature of the Company’s revenue stream. The Company’s contracts do not include multiple performance obligations or material variable consideration.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">Research and Development</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; TEXT-INDENT: 33.75pt; text-align:justify;">Research costs are expensed as incurred. For the years ended December 31, 2023 and 2022, research costs are immaterial.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; TEXT-INDENT: 33.75pt; text-align:justify;">For the year ended December 31, 2022, the Company incurred certain development expenditures related to the Lowell 35s product line that launched during the third quarter of the year ended December 31, 2022. Development costs of approximately $78 were expensed during the year ended December 31, 2022 to validate that the product line was commercially and technically feasible and to bring the product to market. Development expenditures are capitalized only if development costs are material, can be measured reliably, future economic benefits are probable, and the Company intends to and has sufficient resources to complete the development to use or sell the asset. To date, no development costs have been capitalized.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">Share-Based Compensation</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; TEXT-INDENT: 33.75pt; text-align:justify;">The Company has a share-based compensation plan. The Company measures equity settled share-based payments based on their fair value at the grant date and recognizes compensation expense over the vesting period based on the Company’s estimate of equity instruments that will eventually vest.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; TEXT-INDENT: 33.75pt; text-align:justify;">For shares granted to non-employees, the compensation expense is measured at the fair value of the goods and services received, except where the fair value cannot be estimated, in which case, it is measured at the fair value of the equity instruments granted. The fair value of share-based compensation to non-employees is periodically re-measured until counterparty performance is complete, and any change therein is recognized over the period and in the same manner as if the Company had paid cash instead of paying with or using equity instruments.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">Business Combinations</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; TEXT-INDENT: 33.75pt; text-align:justify;">A business combination is defined as an acquisition of assets and liabilities that constitute a business. A business consists of inputs, including non-current assets and processes, including operational processes, that when applied to those inputs have the ability to create outputs that provide a return to the Company. Business combinations are accounted for using the acquisition method of accounting. The consideration of each acquisition is measured at the aggregate of the fair values of tangible and intangible assets obtained, liabilities and contingent liabilities incurred or assumed, and equity instruments issued by the Company at the date of acquisition. Key assumptions routinely utilized in allocation of purchase price to intangible assets include projected financial information such as revenue projections for companies acquired. As of the acquisition date, goodwill is measured as the excess of consideration given, generally measured at fair value, and the net of the acquisition date fair values of the identifiable assets acquired and the liabilities assumed.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;"><strong><em>Recently Adopted Accounting Standards </em></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; TEXT-INDENT: 33.75pt; text-align:justify;">In December 2019, the FASB issued ASU 2019-12, Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes. This guidance removes certain exceptions to the general principles in Topic 740 and enhances and simplifies various aspects of the income tax accounting guidance, including requirements such as tax basis step-up in goodwill obtained in a transaction that is not a business combination, ownership changes in investments, and interim-period accounting for enacted changes in tax law. This standard is effective for fiscal years and interim periods within those fiscal years beginning after December 15, 2020. This guidance was effective for the Company in our fiscal year and interim periods beginning on January 1, 2021 and did not have a material impact on our consolidated financial statements.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; TEXT-INDENT: 33.75pt; text-align:justify;">In January 2020, the FASB issued ASU 2020-01 Investments-Equity Securities (Topic 321), Investments-Equity Method and Joint Ventures (Topic 323), and Derivatives and Hedging (Topic 815) - Clarifying the Interactions between Topic 321, Topic 323, and Topic 815. This guidance addresses accounting for the transition into and out of the equity method and provides clarification of the interaction of rules for equity securities, the equity method of accounting, and forward contracts and purchase options on certain types of securities. This standard is effective for fiscal years and interim periods within those fiscal years beginning after December 15, 2020. We evaluated the impact of ASU 2020-01 on our Consolidated Financial Statements, which was effective for the Company in our fiscal year and interim periods beginning on January 1, 2021 and it did not have a material impact on our consolidated financial statements.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; TEXT-INDENT: 33.75pt; text-align:justify;">In August 2020, the FASB issued ASU 2020-06, Debt-Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging-Contracts in Entity’s Own Equity (Subtopic 815-40). This update amends the guidance on convertible instruments and the derivatives scope exception for contracts in an entity's own equity and improves and amends the related EPS guidance for both Subtopics. This standard is effective for fiscal years and interim periods within those fiscal years beginning after December 15, 2021, which means it was effective for our fiscal year beginning January 1, 2022 and did not have a material impact on our consolidated financial statements.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;"><strong><em>Accounting standards not yet adopted </em></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; TEXT-INDENT: 33.75pt; text-align:justify;">In October 2021, the FASB issued ASU 2021-08-Business Combinations (“Topic 805”): Accounting for Contract Assets and Contract Liabilities from Contracts with Customers. The amendments in ASU 2021-08 require that an entity recognizes and measures contract assets and contract liabilities acquired in a business combination in accordance with ASC 606, Revenue from Contracts with Customers (“Topic 606”). At the acquisition date, an acquirer should account for the related revenue contracts in accordance with Topic 606 as if it had originated the contracts. The amendments improve comparability for both the recognition and measurement of acquired revenue contracts with customers at the date of and after a business combination. This standard is effective for fiscal years and interim periods within those fiscal years beginning after December 15, 2022, which means it was effective for our fiscal year beginning January 1, 2023 and did not have a material impact on our consolidated financial statements.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; TEXT-INDENT: 33.75pt; text-align:justify;">No other recently issued accounting pronouncements had or are expected to have a material impact on our consolidated financial statements. </p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; TEXT-INDENT: 33.75pt; text-align:justify;">Lowell Farms Inc. is governed by the laws of British Columbia, Canada. On April 26, 2019, the Company completed a reverse takeover transaction with Indus Holding Company, a Delaware corporation, incorporated in 2014. Effective March 1, 2021, the Company changed its name to Lowell Farms Inc. and is a California-based cannabis company with vertically integrated operations including large scale cultivation, extraction, processing, manufacturing, branding, packaging and wholesale distribution to retail dispensaries. The Company manufactures and distributes proprietary and third-party brands throughout the State of California, the largest cannabis market in the world. The Company also provides manufacturing, extraction and distribution services to third-party cannabis and cannabis branding companies. The Company’s corporate office and principal place of business is located at 19 Quail Run Circle, Salinas, California.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; TEXT-INDENT: 33.75pt; text-align:justify;">The consolidated financial statements of Lowell Farms Inc. and its wholly owned subsidiaries (collectively, the “Company,” “we,” “us” or “our”) have been prepared in accordance with generally accepted accounting principles in the United States (“GAAP”). All intercompany transactions and balances have been eliminated in consolidation.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; TEXT-INDENT: 33.75pt; text-align:justify;">All dollar amounts in the consolidated financial statements and notes to consolidated financial statements are expressed in thousands of United States dollars ("$" or "US$"), unless otherwise indicated.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; TEXT-INDENT: 33.75pt; text-align:justify;">The preparation of financial statements in conformity with generally accepted accounting principles in the United States (“U.S. GAAP”) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Significant estimates in these financial statements include allowance for doubtful accounts and credit losses, carrying value of inventory, revenue recognition, accounting for stock-based compensation expense, and income taxes. Actual results could differ from those estimates.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; TEXT-INDENT: 33.75pt; text-align:justify;">The global COVID-19 pandemic has impacted the operations and purchasing decisions of companies worldwide. It also has created and may continue to create significant uncertainty in the global economy. The Company has undertaken measures to protect its employees, partners, customers, and vendors. In addition, the Company’s personnel are subject to various travel restrictions, which limit the ability of the Company to provide services to customers and affiliates. This impacts the Company's normal operations. To date, the Company has been able to provide uninterrupted access to its products and services, including certain employees that are working remotely, and its pre-existing infrastructure that supports secure access to the Company’s internal systems. If, however, the COVID-19 pandemic has a substantial impact on the productivity of the Company’s employees or its partners’ or customers’ decision to use the Company’s products and services, the results of the Company’s operations and overall financial performance may be adversely impacted. The duration and extent of the impact from the COVID-19 pandemic depends on future developments that cannot be accurately predicted at this time. As of the date of issuance of the financial statements, the Company is not aware of any specific event or circumstance that would require updates to the Company’s estimates and judgments or revisions to the carrying value of its assets or liabilities. These estimates may change, as new events occur and additional information is obtained, and are recognized in the condensed consolidated financial statements as soon as they become known. Actual results could differ from those estimates and any such differences may be material to the financial statements.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; TEXT-INDENT: 33.75pt; text-align:justify;">Cash and cash equivalents include cash on hand, cash deposits in financial institutions, and other deposits that are readily convertible into cash. The Company considers all short-term, highly liquid investments purchased with maturities of three months or less to be cash equivalents. These investments are carried at cost, which approximates fair value.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; TEXT-INDENT: 33.75pt; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">As of December 31, 2023 and December 31, 2022, the Company’s cash and cash equivalents exceeded FDIC insured limits by $1,974 and $360, respectively.</p> 1974000 360000 <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; TEXT-INDENT: 33.75pt; text-align:justify;">Accounts receivables are classified as loans and receivable financial assets. Accounts receivables are recognized initially at fair value and subsequently measured at amortized cost, less any provisions for impairment. When an accounts receivable is uncollectible, it is written off against the provision. Subsequent recoveries of amounts previously written off are credited to the consolidated statements of operations.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; TEXT-INDENT: 33.75pt; text-align:justify;">Inventories are valued at the lower of cost and net realizable value. Costs related to raw materials and finished goods are determined on the first-in, first-out basis. Specific identification and average cost methods are also used primarily for certain packing materials and operating supplies. The Company reviews inventory for obsolete, redundant and slow-moving goods and any such inventory is written-down to net realizable value.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; TEXT-INDENT: 33.75pt; text-align:justify;">Property and equipment are stated at cost, net of accumulated depreciation and impairment losses, if any. Depreciation is calculated on a straight-line basis over the estimated useful life of the asset using the following terms and methods:</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><table cellpadding="0" style="border-spacing:0;font-size:10pt;width:100%"><tbody><tr style="height:15px"><td style="BORDER-BOTTOM: 1px solid;width:31%;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">Category</p></td><td style="width:1%;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:46%;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">Useful Life</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="width:31%;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">Leasehold improvements</p></td><td style="width:1%;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p></td><td style="width:46%;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">The lesser of the estimated useful life or length of the lease </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="width:31%;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">Office equipment</p></td><td style="width:1%;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p></td><td style="width:46%;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">3-5 years</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="width:31%;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">Furniture and fixtures</p></td><td style="width:1%;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p></td><td style="width:46%;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">3-7 years</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="width:31%;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">Vehicles</p></td><td style="width:1%;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p></td><td style="width:46%;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">4-5 years</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="width:31%;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">Machinery and equipment</p></td><td style="width:1%;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p></td><td style="width:46%;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">3-6 years</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="width:31%;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">Buildings</p></td><td style="width:1%;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p></td><td style="width:46%;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">35 years</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="width:31%;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">Construction in progress</p></td><td style="width:1%;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p></td><td style="width:46%;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">Not depreciated</p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; TEXT-INDENT: 33.75pt; text-align:justify;">The assets’ residual values, useful lives and methods of depreciation are reviewed at each financial year-end and adjusted prospectively if appropriate. An item of equipment is derecognized upon disposal or when no future economic benefits are expected from its use. Any gain or loss arising on derecognition of the asset (calculated as the difference between the net disposal proceeds and the carrying value of the asset) is included in the consolidated statements of operations in the year the asset is derecognized.</p> The lesser of the estimated useful life or length of the lease P3Y P5Y P3Y P7Y P4Y P5Y P3Y P6Y P35Y Not depreciated <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; TEXT-INDENT: 33.75pt; text-align:justify;">Goodwill represents the excess of the purchase price paid for the acquisition of an entity over the fair value of the net tangible and intangible assets acquired. Goodwill that has an indefinite useful life is not subject to amortization and is tested annually for impairment, or more frequently if events or changes in circumstances indicate that goodwill might be impaired. Any goodwill impairment loss is recognized in the consolidated statements of operations in the period in which the impairment is identified. Impairment losses on goodwill are not subsequently reversed.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; TEXT-INDENT: 33.75pt; text-align:justify;">Intangible assets are recorded at cost, less accumulated amortization and impairment losses, if any. Intangible assets acquired in a business combination are measured at fair value at the acquisition date. Intangible assets acquired in an asset purchase are valued at their purchase price. Amortization is recorded on a straight-line basis over their estimated useful lives, which do not exceed the contractual period, if any. The estimated useful lives, residual values, and amortization methods are reviewed at each year-end, and any changes in estimates are accounted for prospectively.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; TEXT-INDENT: 33.75pt; text-align:justify;">Branding rights are measured at fair value at the time of acquisition and are amortized on a straight-line basis over a period of 15 years. In addition, the Company has certain brand and tradenames with indefinite lives, which are evaluated for impairment on an annual basis.</p> P15Y <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; TEXT-INDENT: 33.75pt; text-align:justify;">Long-lived assets, including property, plant and equipment and intangible assets are reviewed for impairment at each statement of financial position date or whenever events or changes in circumstances indicate that the carrying amount of an asset exceeds its recoverable amount. For the purpose of impairment testing, assets that cannot be tested individually are grouped together into the smallest group of assets that generates cash inflows from continuing use that are largely independent of the cash inflows of other assets or groups of assets. The recoverable amount of an asset or an asset group is the higher of its fair value, less costs to sell, and its value in use. If the carrying amount of an asset exceeds its recoverable amount, an impairment charge is recognized immediately in profit or loss equal to the amount by which the carrying amount exceeds the recoverable amount. Where an impairment loss subsequently reverses, the carrying amount of the asset is increased to the lesser of the revised estimate of the recoverable amount, and the carrying amount that would have been recorded had no impairment loss been recognized previously.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; TEXT-INDENT: 33.75pt; text-align:justify;">The Company adopted FASB Topic 842, Leases (“Topic 842”) effective January 1, 2019, using the modified retrospective adoption method which allowed it to initially apply the new standard at the adoption date and recognize a cumulative-effect adjustment to the opening balance of accumulated deficit. In connection with the adoption of the lease pronouncement, the Company recorded a charge to accumulated deficit of $847. A lease of property and equipment is classified as a capital lease if it transfers substantially all the risks and rewards incidental to ownership to the Company. Lease right-of-use assets represent the right to use an underlying asset for the lease term, and lease liabilities represent the obligation to make payments arising from the lease agreement. These assets and liabilities are recognized at the commencement of the lease based upon the present value of the future minimum lease payments over the lease term. The lease term reflects the noncancelable period of the lease together with periods covered by an option to extend or terminate the lease when management is reasonably certain that it will exercise such option. Changes in the lease term assumption could impact the right-of-use assets and lease liabilities recognized on the balance sheet. As our leases typically do not contain a readily determinable implicit rate, we determine the present value of the lease liability using our incremental borrowing rate at the lease commencement date based on the lease term on a collateralized basis. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; TEXT-INDENT: 33.75pt; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; TEXT-INDENT: 33.75pt; text-align:justify;">The Company accounts for sales leaseback transactions in accordance with ASC 842-40: Sale and Leaseback Transactions. The Company determines whether the transfer of an asset represents a sale based on requirements from Topic 606, lease classification, and nature of purchase options. If a transfer is deemed a sale and at fair value, the Company derecognizes the asset and records a gain/(loss) in the income statement. If a transfer is deemed a sale and not at fair value, the Company derecognizes the asset and does not recognize a gain/(loss) in the income statement. If a transfer of the asset is not a sale, the Company does not derecognize the asset.</p> 847000 <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; TEXT-INDENT: 33.75pt; text-align:justify;">The Company is a United States C corporation for income tax purposes. Income tax expense consisting of current and deferred tax expense is recognized in the consolidated statements of operations. Current tax expense is the expected tax payable on the taxable income for the year, using tax rates enacted or substantively enacted at year-end, adjusted for amendments to tax payable with regards to previous years. Deferred tax assets and liabilities and the related deferred income tax expense or recovery are recognized for deferred tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using the enacted or substantively enacted tax rates expected to apply when the asset is realized or the liability settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that substantive enactment occurs. A deferred tax asset is recognized to the extent that it is probable that future taxable income will be available against which the asset can be utilized. Deferred tax assets and liabilities are offset when there is a legally enforceable right to set off current tax assets against current tax liabilities and when they relate to income taxes levied by the same taxation authority and the Company intends to settle its current tax assets and liabilities on a net basis.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; TEXT-INDENT: 33.75pt; text-align:justify;">Revenue is recognized upon transfer of control of promised products or services to customers in an amount that reflects the consideration the Company expects to receive in exchange for those products or services. The Company enters contracts that can include various combinations of products and services, which are generally capable of being distinct and accounted for as separate performance obligations Revenue is recognized net of allowances for returns and any taxes collected from customers, which are subsequently remitted to governmental authorities.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; TEXT-INDENT: 33.75pt; text-align:justify;">For the Company’s branded products, revenue is recognized when it satisfies a performance obligation by transferring a promised cannabis good to a customer. A contract, whether a verbal or written sales order, is established with customers prior to order fulfillment with agreement upon unit prices, delivery dates, and payment terms. The transaction price is based on market pricing while considering the value of the Company’s brand and quality. Transaction price is allocated to each product sold based upon the negotiated unit sales price associated with each product line scheduled for delivery within the order. Performance obligation satisfaction occurs upon delivery to customer premises. These types of revenues accounted for under ASC Topic 606, generally, do not require significant estimates or judgments based on the nature of the Company’s revenue stream. The sales prices, including discounts, are fixed at the point of sale and all consideration from contracts is included in the transaction price. The Company’s contracts do not include multiple performance obligations or material variable consideration.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; TEXT-INDENT: 33.75pt; text-align:justify;">The Company has certain licenses to manufacture and distribute third party products to retail dispensaries and deliveries in return for paying royalty payments to the third parties. The Company is a principal in the arrangement, it assumes primary responsibility for fulfilling the customer promise to retail dispensaries and deliveries, and it holds the inventory risk. Revenue is recognized when it satisfies a performance obligation by transferring a promised cannabis good to a retail dispensary or retail delivery. A contract, whether a verbal or written sales order, is established with customers prior to order fulfillment with agreement upon unit prices, delivery dates, and payment terms. The transaction price is based on market pricing while considering the value of the Company’s brand and quality. Transaction price is allocated to each product sold based upon the negotiated unit sales price associated with each product line scheduled for delivery within the order. Performance obligation satisfaction occurs upon delivery to customer premises. These types of revenues accounted for under ASC Topic 606, generally, do not require significant estimates or judgments based on the nature of the Company’s revenue stream. The sales prices, including discounts, are fixed at the point of sale and all consideration from contracts is included in the transaction price. The Company’s contracts do not include multiple performance obligations or material variable consideration.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">The Company has entered into contracts to license the right to utilize the Company’s branding and intellectual property. For all sales utilizing the license, the Company recognizes a percentage based license fee. Revenue is recognized when performance obligations are satisfied by recognizing fees on sales utilizing the licensed property to other companies. Contracts exist that define the property that is licensed, the time period, the fees and payment terms. These types of revenues accounted for under ASC Topic 606, generally, do not require significant estimates or judgments based on the nature of the Company’s revenue stream.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; TEXT-INDENT: 33.75pt; text-align:justify;">The Company distributes certain third-party brands and bulk flower. The Company is a principal in the arrangement, it assumes primary responsibility for fulfilling the customer promise to retail dispensaries and deliveries and other wholesale customers, and it holds the inventory risk. Revenue is recognized when it satisfies a performance obligation by transferring a promised cannabis good to a customer. A contract, whether a verbal or written sales order, is established with customers prior to order fulfillment with agreement upon unit prices, delivery dates, and payment terms. The transaction price is based on market pricing while considering the value of the Company’s brand and quality. Transaction price is allocated to each product sold based upon the negotiated unit sales price associated with each product line scheduled for delivery within the order. Performance obligation satisfaction occurs upon delivery to customer premises. These types of revenues accounted for under ASC Topic 606, generally, do not require significant estimates or judgments based on the nature of the Company’s revenue stream. The sales prices, including discounts, are fixed at the point of sale and all consideration from contracts is included in the transaction price. The Company’s contracts do not include multiple performance obligations or material variable consideration.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; TEXT-INDENT: 33.75pt; text-align:justify;">The Company performs various processing activities under Lowell Farms Services including drying, bucking, trimming, sorting, grading and packaging operations. Revenue is recognized when it satisfies a performance obligation by completing the agreed upon services that were negotiated with a customer. A contract, whether a verbal or written sales order, is established with customers prior to completing the agreed upon services with the type of services to be performed and with the agreed upon pricing and timing. The transaction price is based on the nature of the services to be performed and market pricing. Performance obligation satisfaction occurs upon completion of the services performed. These types of revenues accounted for under ASC Topic 606, generally, do not require significant estimates or judgments based on the nature of the Company’s revenue stream. The Company’s contracts do not include multiple performance obligations or material variable consideration.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; TEXT-INDENT: 33.75pt; text-align:justify;">Research costs are expensed as incurred. For the years ended December 31, 2023 and 2022, research costs are immaterial.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; TEXT-INDENT: 33.75pt; text-align:justify;">For the year ended December 31, 2022, the Company incurred certain development expenditures related to the Lowell 35s product line that launched during the third quarter of the year ended December 31, 2022. Development costs of approximately $78 were expensed during the year ended December 31, 2022 to validate that the product line was commercially and technically feasible and to bring the product to market. Development expenditures are capitalized only if development costs are material, can be measured reliably, future economic benefits are probable, and the Company intends to and has sufficient resources to complete the development to use or sell the asset. To date, no development costs have been capitalized.</p> 78000 <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; TEXT-INDENT: 33.75pt; text-align:justify;">The Company has a share-based compensation plan. The Company measures equity settled share-based payments based on their fair value at the grant date and recognizes compensation expense over the vesting period based on the Company’s estimate of equity instruments that will eventually vest.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; TEXT-INDENT: 33.75pt; text-align:justify;">For shares granted to non-employees, the compensation expense is measured at the fair value of the goods and services received, except where the fair value cannot be estimated, in which case, it is measured at the fair value of the equity instruments granted. The fair value of share-based compensation to non-employees is periodically re-measured until counterparty performance is complete, and any change therein is recognized over the period and in the same manner as if the Company had paid cash instead of paying with or using equity instruments.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; TEXT-INDENT: 33.75pt; text-align:justify;">A business combination is defined as an acquisition of assets and liabilities that constitute a business. A business consists of inputs, including non-current assets and processes, including operational processes, that when applied to those inputs have the ability to create outputs that provide a return to the Company. Business combinations are accounted for using the acquisition method of accounting. The consideration of each acquisition is measured at the aggregate of the fair values of tangible and intangible assets obtained, liabilities and contingent liabilities incurred or assumed, and equity instruments issued by the Company at the date of acquisition. Key assumptions routinely utilized in allocation of purchase price to intangible assets include projected financial information such as revenue projections for companies acquired. As of the acquisition date, goodwill is measured as the excess of consideration given, generally measured at fair value, and the net of the acquisition date fair values of the identifiable assets acquired and the liabilities assumed.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; TEXT-INDENT: 33.75pt; text-align:justify;">In December 2019, the FASB issued ASU 2019-12, Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes. This guidance removes certain exceptions to the general principles in Topic 740 and enhances and simplifies various aspects of the income tax accounting guidance, including requirements such as tax basis step-up in goodwill obtained in a transaction that is not a business combination, ownership changes in investments, and interim-period accounting for enacted changes in tax law. This standard is effective for fiscal years and interim periods within those fiscal years beginning after December 15, 2020. This guidance was effective for the Company in our fiscal year and interim periods beginning on January 1, 2021 and did not have a material impact on our consolidated financial statements.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; TEXT-INDENT: 33.75pt; text-align:justify;">In January 2020, the FASB issued ASU 2020-01 Investments-Equity Securities (Topic 321), Investments-Equity Method and Joint Ventures (Topic 323), and Derivatives and Hedging (Topic 815) - Clarifying the Interactions between Topic 321, Topic 323, and Topic 815. This guidance addresses accounting for the transition into and out of the equity method and provides clarification of the interaction of rules for equity securities, the equity method of accounting, and forward contracts and purchase options on certain types of securities. This standard is effective for fiscal years and interim periods within those fiscal years beginning after December 15, 2020. We evaluated the impact of ASU 2020-01 on our Consolidated Financial Statements, which was effective for the Company in our fiscal year and interim periods beginning on January 1, 2021 and it did not have a material impact on our consolidated financial statements.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; TEXT-INDENT: 33.75pt; text-align:justify;">In August 2020, the FASB issued ASU 2020-06, Debt-Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging-Contracts in Entity’s Own Equity (Subtopic 815-40). This update amends the guidance on convertible instruments and the derivatives scope exception for contracts in an entity's own equity and improves and amends the related EPS guidance for both Subtopics. This standard is effective for fiscal years and interim periods within those fiscal years beginning after December 15, 2021, which means it was effective for our fiscal year beginning January 1, 2022 and did not have a material impact on our consolidated financial statements.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; TEXT-INDENT: 33.75pt; text-align:justify;">In October 2021, the FASB issued ASU 2021-08-Business Combinations (“Topic 805”): Accounting for Contract Assets and Contract Liabilities from Contracts with Customers. The amendments in ASU 2021-08 require that an entity recognizes and measures contract assets and contract liabilities acquired in a business combination in accordance with ASC 606, Revenue from Contracts with Customers (“Topic 606”). At the acquisition date, an acquirer should account for the related revenue contracts in accordance with Topic 606 as if it had originated the contracts. The amendments improve comparability for both the recognition and measurement of acquired revenue contracts with customers at the date of and after a business combination. This standard is effective for fiscal years and interim periods within those fiscal years beginning after December 15, 2022, which means it was effective for our fiscal year beginning January 1, 2023 and did not have a material impact on our consolidated financial statements.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; TEXT-INDENT: 33.75pt; text-align:justify;">No other recently issued accounting pronouncements had or are expected to have a material impact on our consolidated financial statements. </p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;"><strong>2. PREPAID AND OTHER CURRENT ASSETS</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; TEXT-INDENT: 33.75pt; text-align:justify;">Prepaid and other current assets were comprised of the following items:</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>December 31,</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>December 31,</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">(in thousands)</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>2023</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>2022</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Deposits</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1,134</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">595</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Insurance</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">237</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">235</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Supplier advances</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">26</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">375</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Interest and taxes</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">26</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">69</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Licenses and payments</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">106</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">146</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Royalty Advance</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">853</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Other</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">15</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">102</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in"><strong>Total prepaid and other current assets</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><strong>2,397</strong></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><strong>1,522</strong></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table> <table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>December 31,</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>December 31,</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">(in thousands)</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>2023</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>2022</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Deposits</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1,134</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">595</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Insurance</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">237</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">235</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Supplier advances</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">26</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">375</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Interest and taxes</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">26</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">69</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Licenses and payments</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">106</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">146</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Royalty Advance</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">853</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Other</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">15</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">102</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in"><strong>Total prepaid and other current assets</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><strong>2,397</strong></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><strong>1,522</strong></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table> 1134000 595000 237000 235000 26000 375000 26000 69000 106000 146000 853000 0 15000 102000 2397000 1522000 <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;"><strong>3. INVENTORY</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; TEXT-INDENT: 33.75pt; text-align:justify;">Inventory, net was comprised of the following items:</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>December 31,</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>December 31,</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">(in thousands)</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>2023</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>2022</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Raw materials</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1,400</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">7,431</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Work in process</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">307</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">940</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Finished goods</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">3,053</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">2,408</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in"><strong>Total inventory</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><strong>4,760</strong></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><strong>10,779</strong></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table><p style="font-size:10pt;font-family:times new roman;margin:0px">  </p><p style="font-size:10pt;font-family:times new roman;margin:0px">As a result of the Zabala lease termination, the Company wrote off $2,607 of plant inventory that was in the facility as of the end of the year, which was recorded in cost of goods sold. </p><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company recorded an inventory reserve of $1,780 and $1,492 for the year ended December 31, 2023 and 2022, respectively.</p> <table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>December 31,</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>December 31,</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">(in thousands)</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>2023</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>2022</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Raw materials</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1,400</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">7,431</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Work in process</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">307</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">940</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Finished goods</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">3,053</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">2,408</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in"><strong>Total inventory</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><strong>4,760</strong></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><strong>10,779</strong></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table> 1400000 7431000 307000 940000 3053000 2408000 4760000 10779000 2607 1780 1492 <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;"><strong>4. OTHER CURRENT LIABILITIES</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; TEXT-INDENT: 33.75pt; text-align:justify;">Other current liabilities were comprised of the following items:</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>December 31,</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>December 31,</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">(in thousands)</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>2023</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>2022</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Excise and cannabis tax</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">3</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">948</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Third party brand distribution accrual</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">558</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">17</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Insurance and professional fee accrual</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">287</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">158</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Interest and tax accrual</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">109</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">921</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Employee Retention Credit financing accrual</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">441</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">441</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Equipment purchase accrual</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">724</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Other</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">545</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">445</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in"><strong>Total other current liabilities</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><strong>1,943</strong></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><strong>3,654</strong></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; TEXT-INDENT: 33.75pt; text-align:justify;">On July 26, 2022, subsidiaries of the Company entered into an agreement with an institutional investor pursuant to which the investor purchased a participation ("Transferred Interests") in all rights to payment from the United States IRS in respect of the Company’s employee retention credits for the first and second quarters of 2021 (the “ERC Claim”). The purchase price paid for the derivative payment rights was $2,446, which was paid in immediately available funds. For the year ended December 31, 2022, the Company recorded net other income of $2,014 and an accrued other liability of $441 to be paid to facilitate the sale of the ERC Claim. Included in interest expense is $864 of financing related charges.</p> <table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>December 31,</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>December 31,</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">(in thousands)</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>2023</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>2022</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Excise and cannabis tax</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">3</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">948</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Third party brand distribution accrual</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">558</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">17</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Insurance and professional fee accrual</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">287</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">158</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Interest and tax accrual</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">109</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">921</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Employee Retention Credit financing accrual</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">441</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">441</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Equipment purchase accrual</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">724</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Other</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">545</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">445</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in"><strong>Total other current liabilities</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><strong>1,943</strong></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><strong>3,654</strong></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table> 3000 948000 558000 17000 287000 158000 109000 921000 441000 441000 0 724000 545000 445000 1943000 3654000 2446000 2014 441 864 <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;"><strong>5. PROPERTY AND EQUIPMENT AND RIGHT OF USE ASSETS </strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 33.75pt; text-align:justify;">A reconciliation of the beginning and ending balances of property and equipment, right of use assets and accumulated depreciation during the years ended December 31, 2023 and 2022, and property and equipment, net and right of use assets, net as of for the same years are as follows:</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="width:6%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>Land and</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="width:6%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>Leasehold</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="width:6%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>Furniture </strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>and</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="width:6%;"></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="width:6%;"></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="width:6%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>Construction</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="width:6%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>Right of</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="width:6%;"></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">(in thousands)</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:6%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>Buildings</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:6%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>Improvements</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:6%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>Fixtures</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:6%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>Equipment</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:6%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>Vehicles</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:6%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>in Process</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:6%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>Use Assets</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:6%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>Total</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in"><strong>Costs</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in"><strong>Balance-December 31, 2022</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;"><strong>15,719</strong></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;"><strong>12,437</strong></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;"><strong>50</strong></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;"><strong>6,499</strong></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;"><strong>830</strong></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;"><strong>35</strong></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;"><strong>37,081</strong></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;"><strong>72,651</strong></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 11.25pt">Additions</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">29</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">106</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">17,068</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">17,203</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 11.25pt">Disposals</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">(15,719 </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">(202 </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">(15,921</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">) </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 11.25pt">Remeasurements</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">(4,602 </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">(4,602</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 11.25pt">Impairments </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:6%;vertical-align:bottom;text-align:right;">-</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:6%;vertical-align:bottom;text-align:right;">(10,148 </td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:6%;vertical-align:bottom;text-align:right;">-</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:6%;vertical-align:bottom;text-align:right;">(1,310 </td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:6%;vertical-align:bottom;text-align:right;">-</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:6%;vertical-align:bottom;text-align:right;">-</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:6%;vertical-align:bottom;text-align:right;">(28,230 </td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:6%;vertical-align:bottom;text-align:right;">(39,688</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in"><strong>Balance-December 31, 2023</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:6%;vertical-align:bottom;text-align:right;"><strong>-</strong></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:6%;vertical-align:bottom;text-align:right;"><strong>2,116</strong></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:6%;vertical-align:bottom;text-align:right;"><strong>50</strong></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:6%;vertical-align:bottom;text-align:right;"><strong>5,295</strong></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:6%;vertical-align:bottom;text-align:right;"><strong>830</strong></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:6%;vertical-align:bottom;text-align:right;"><strong>35</strong></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:6%;vertical-align:bottom;text-align:right;"><strong>21,317</strong></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:6%;vertical-align:bottom;text-align:right;"><strong>29,643</strong></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in"><strong>Accumulated Depreciation</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in"><strong>Balance-December 31, 2022</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;"><strong>(315 </strong></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;"><strong>)</strong></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;"><strong>(1,815 </strong></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;"><strong>)</strong></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;"><strong>(49 </strong></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;"><strong>)</strong></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;"><strong>(1,498 </strong></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;"><strong>)</strong></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;"><strong>(608 </strong></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;"><strong>)</strong></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;"><strong>-</strong></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;"><strong>(9,719 </strong></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;"><strong>)</strong></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;"><strong>(14,004</strong></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">) </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 11.25pt">Depreciation</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">(71 </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">(837 </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:right;">- </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">(925 </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">(136 </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">(2,742 </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">(4,711</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">) </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 11.25pt">Disposals</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">386</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">55</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">441</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 11.25pt">Remeasurement</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">2,661</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">2,661</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 11.25pt">Impairments</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:6%;vertical-align:bottom;text-align:right;">-</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:6%;vertical-align:bottom;text-align:right;">1,516</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:6%;vertical-align:bottom;text-align:right;">-</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:6%;vertical-align:bottom;text-align:right;">70 </td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:6%;vertical-align:bottom;text-align:right;">-</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:6%;vertical-align:bottom;text-align:right;">-</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:6%;vertical-align:bottom;text-align:right;">6,810</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:6%;vertical-align:bottom;text-align:right;">8,396</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in"><strong>Balance-December 31, 2023</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 1px solid;">$</td><td style="BORDER-BOTTOM: black 1px solid;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;"> <strong>- </strong></p></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:6%;vertical-align:bottom;text-align:right;"><strong>(1,081 </strong></td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;"><strong>)</strong></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:6%;vertical-align:bottom;text-align:right;"><strong>(49 </strong></td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;"><strong>)</strong></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:6%;vertical-align:bottom;text-align:right;"><strong>(2,353 </strong></td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;"><strong>)</strong></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:6%;vertical-align:bottom;text-align:right;"><strong>(744 </strong></td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;"><strong>)</strong></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:6%;vertical-align:bottom;text-align:right;"><strong>-</strong></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:6%;vertical-align:bottom;text-align:right;"><strong>(2,990 </strong></td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;"><strong>)</strong></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:6%;vertical-align:bottom;text-align:right;"><strong>(7,217</strong></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">) </p></td></tr><tr style="height:15px;background-color:#ffffff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in"><strong>Net Book Value-December 31, 2023</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:6%;vertical-align:bottom;text-align:right;"><strong>-</strong></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:6%;vertical-align:bottom;text-align:right;"><strong>1,035</strong></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:6%;vertical-align:bottom;text-align:right;"><strong>1</strong></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:6%;vertical-align:bottom;text-align:right;"><strong>2,942</strong></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:6%;vertical-align:bottom;text-align:right;"><strong>86</strong></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:6%;vertical-align:bottom;text-align:right;"><strong>35</strong></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:6%;vertical-align:bottom;text-align:right;"><strong>18,327</strong></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:6%;vertical-align:bottom;text-align:right;"><strong>22,426</strong></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; TEXT-INDENT: 33.75pt; text-align:justify;">Construction in process represents assets under construction related to cultivation, manufacturing, and distribution facilities not yet completed or otherwise not placed in service.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; TEXT-INDENT: 33.75pt; text-align:justify;">Depreciation expense of $4,711, and $7,022, were recorded for the years ended December 31, 2023 and 2022 respectively, of which $4,613 and $6,292, respectively, were included in cost of goods sold. Depreciation expense of $608 was also recorded in other expense for the year ended December 31, 2022.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; TEXT-INDENT: 33.75pt; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">As a result of the Zabala lease termination, the Company wrote off $8,632 of leasehold improvements and $151 of equipment resulting in an impairment expense of $8,783, which was recorded in other income and expense.</p> <table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="width:6%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>Land and</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="width:6%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>Leasehold</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="width:6%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>Furniture </strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>and</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="width:6%;"></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="width:6%;"></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="width:6%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>Construction</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="width:6%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>Right of</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="width:6%;"></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">(in thousands)</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:6%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>Buildings</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:6%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>Improvements</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:6%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>Fixtures</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:6%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>Equipment</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:6%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>Vehicles</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:6%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>in Process</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:6%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>Use Assets</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:6%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>Total</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in"><strong>Costs</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in"><strong>Balance-December 31, 2022</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;"><strong>15,719</strong></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;"><strong>12,437</strong></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;"><strong>50</strong></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;"><strong>6,499</strong></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;"><strong>830</strong></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;"><strong>35</strong></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;"><strong>37,081</strong></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;"><strong>72,651</strong></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 11.25pt">Additions</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">29</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">106</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">17,068</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">17,203</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 11.25pt">Disposals</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">(15,719 </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">(202 </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">(15,921</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">) </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 11.25pt">Remeasurements</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">(4,602 </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">(4,602</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 11.25pt">Impairments </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:6%;vertical-align:bottom;text-align:right;">-</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:6%;vertical-align:bottom;text-align:right;">(10,148 </td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:6%;vertical-align:bottom;text-align:right;">-</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:6%;vertical-align:bottom;text-align:right;">(1,310 </td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:6%;vertical-align:bottom;text-align:right;">-</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:6%;vertical-align:bottom;text-align:right;">-</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:6%;vertical-align:bottom;text-align:right;">(28,230 </td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:6%;vertical-align:bottom;text-align:right;">(39,688</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in"><strong>Balance-December 31, 2023</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:6%;vertical-align:bottom;text-align:right;"><strong>-</strong></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:6%;vertical-align:bottom;text-align:right;"><strong>2,116</strong></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:6%;vertical-align:bottom;text-align:right;"><strong>50</strong></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:6%;vertical-align:bottom;text-align:right;"><strong>5,295</strong></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:6%;vertical-align:bottom;text-align:right;"><strong>830</strong></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:6%;vertical-align:bottom;text-align:right;"><strong>35</strong></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:6%;vertical-align:bottom;text-align:right;"><strong>21,317</strong></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:6%;vertical-align:bottom;text-align:right;"><strong>29,643</strong></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in"><strong>Accumulated Depreciation</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in"><strong>Balance-December 31, 2022</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;"><strong>(315 </strong></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;"><strong>)</strong></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;"><strong>(1,815 </strong></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;"><strong>)</strong></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;"><strong>(49 </strong></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;"><strong>)</strong></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;"><strong>(1,498 </strong></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;"><strong>)</strong></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;"><strong>(608 </strong></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;"><strong>)</strong></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;"><strong>-</strong></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;"><strong>(9,719 </strong></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;"><strong>)</strong></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;"><strong>(14,004</strong></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">) </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 11.25pt">Depreciation</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">(71 </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">(837 </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:right;">- </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">(925 </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">(136 </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">(2,742 </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">(4,711</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">) </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 11.25pt">Disposals</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">386</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">55</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">441</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 11.25pt">Remeasurement</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">2,661</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">2,661</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 11.25pt">Impairments</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:6%;vertical-align:bottom;text-align:right;">-</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:6%;vertical-align:bottom;text-align:right;">1,516</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:6%;vertical-align:bottom;text-align:right;">-</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:6%;vertical-align:bottom;text-align:right;">70 </td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:6%;vertical-align:bottom;text-align:right;">-</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:6%;vertical-align:bottom;text-align:right;">-</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:6%;vertical-align:bottom;text-align:right;">6,810</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:6%;vertical-align:bottom;text-align:right;">8,396</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in"><strong>Balance-December 31, 2023</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 1px solid;">$</td><td style="BORDER-BOTTOM: black 1px solid;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;"> <strong>- </strong></p></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:6%;vertical-align:bottom;text-align:right;"><strong>(1,081 </strong></td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;"><strong>)</strong></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:6%;vertical-align:bottom;text-align:right;"><strong>(49 </strong></td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;"><strong>)</strong></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:6%;vertical-align:bottom;text-align:right;"><strong>(2,353 </strong></td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;"><strong>)</strong></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:6%;vertical-align:bottom;text-align:right;"><strong>(744 </strong></td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;"><strong>)</strong></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:6%;vertical-align:bottom;text-align:right;"><strong>-</strong></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:6%;vertical-align:bottom;text-align:right;"><strong>(2,990 </strong></td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;"><strong>)</strong></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:6%;vertical-align:bottom;text-align:right;"><strong>(7,217</strong></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">) </p></td></tr><tr style="height:15px;background-color:#ffffff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in"><strong>Net Book Value-December 31, 2023</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:6%;vertical-align:bottom;text-align:right;"><strong>-</strong></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:6%;vertical-align:bottom;text-align:right;"><strong>1,035</strong></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:6%;vertical-align:bottom;text-align:right;"><strong>1</strong></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:6%;vertical-align:bottom;text-align:right;"><strong>2,942</strong></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:6%;vertical-align:bottom;text-align:right;"><strong>86</strong></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:6%;vertical-align:bottom;text-align:right;"><strong>35</strong></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:6%;vertical-align:bottom;text-align:right;"><strong>18,327</strong></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:6%;vertical-align:bottom;text-align:right;"><strong>22,426</strong></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table> 15719000 12437000 50000 6499000 830000 35000 37081000 72651000 0 29000 0 106000 0 0 17068000 17203000 15719000 202000 0 0 0 0 0 15921000 0 0 0 0 0 4602000 4602000 0 -10148000 0 -1310000 0 0 -28230000 -39688000 0 2116000 50000 5295000 830000 35000 21317000 29643000 315000 -1815000 49000 -1498000 608000 0 -9719000 14004000 71000 837000 0 925000 136000 0 2742000 4711000 386000 55000 0 0 0 0 0 441000 0 0 0 0 0 0 2661000 2661000 0 1516000 0 -70000 0 0 6810000 8396000 0 -1081000 -49000 -2353000 -744000 0 -2990000 7217000 0 1035000 1000 2942000 86000 35000 18327000 22426000 4711000 7022000 4613000 6292000 608000 8632000 8783000 <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; TEXT-INDENT: 33.75pt; text-align:left;"><strong>6. INTANGIBLE ASSETS</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; TEXT-INDENT: 33.75pt; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">A reconciliation of the beginning and ending balances of intangible assets and accumulated amortization during the years ended December 31, 2023 and 2022 are as follows:</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="6" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>Definite Life Intangibles</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>Indefinite Life </strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="width:9%;"></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>Technology/</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>Acquired </strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>Purchase </strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>Intangibles </strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>Brands &amp;</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="width:9%;"></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">(in thousands)</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>Know How</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>Rights</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>Tradenames</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>Total</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in"><strong>Costs</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in"><strong>Balance-December 31, 2022</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><strong>3,258</strong></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><strong>1,800</strong></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><strong>37,707</strong></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><strong>42,765</strong></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 11.25pt">Sale of Brand Assets</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(24,053 </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(37,299 </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 11.25pt">Impairment </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(258 </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(1,384</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">)</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(13,654</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">) </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(2,050</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">) </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in"><strong>Balance-December 31, 2023</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><strong>3,000</strong></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><strong>416</strong></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><strong>-</strong></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><strong>3,416</strong></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in"><strong>Accumulated Amortization</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in"><strong>Balance-December 31, 2022</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><strong>(535 </strong></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;"><strong>)</strong></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><strong>(28 </strong></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;"><strong>)</strong></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><strong>-</strong></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><strong>(563 </strong></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;"><strong>)</strong></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 11.25pt">Amortization</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(323 </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(83 </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(406 </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">     Impairment </p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;"> 97</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;"> -</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;"> 97</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in"><strong>Balance-December 31, 2023</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><strong>(761 </strong></td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;"><strong>)</strong></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><strong>(111 </strong></td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;"><strong>)</strong></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><strong>-</strong></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><strong>(872 </strong></td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;"><strong>)</strong></td></tr><tr style="height:15px;background-color:#cceeff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in"><strong>Net Book Value</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in"><strong>December 31, 2022</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><strong>2,723</strong></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><strong>1,772</strong></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><strong>37,707</strong></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><strong>42,202</strong></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in"><strong>Net Book Value</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in"><strong>December 31, 2023</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><strong>2,239</strong></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><strong>305</strong></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><strong>-</strong></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><strong>2,544</strong></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; TEXT-INDENT: 33.75pt; text-align:justify;">Intangible assets with finite lives are amortized over their estimated useful lives. Amortization periods of assets with finite lives are based on management's estimates at the date of acquisition. The Company recorded amortization expense of $406, and $354 for the years ended December 31, 2023, and 2022, respectively. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; TEXT-INDENT: 33.75pt; text-align:justify;">During the year ended December 31, 2022, the Company acquired rights to purchase additional manufacturing equipment related to the Lowell 35s automated pre-roll line. Per the terms of the purchase agreement, the Company acquired the rights to acquire eight pre-roll machines and one packaging machine and received 15% of the issued and outstanding shares of the selling company, which have a fair market value of $nil. For the year ended December 31, 2022, one pre-roll machine and the packaging machine were received and in use and the acquired purchase rights are being amortized over the five year useful life of the machines. As consideration for the purchase of the acquisition rights, the Company paid for deposits on a portion of the machines, which are reflected as additions within <em>Property and Equipment</em> and issued 1 million subordinate voting shares with a fair market value of  $1,800 on the issuance date. The Company impaired the remaining purchase rights on the unpurchased machines in the period ending December 31, 2023.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">On October 6th, 2023 the Company repurchased all of the $22,157 aggregate principal amount of outstanding Senior Secured Convertible Debentures (“Debentures”) together with the related warrants to purchase 10,627,483 subordinate voting shares of the Company and 4,324,845 common shares of Indus which have been cancelled. Share amounts reflect the 1 for 10 reverse stock split effective August 31, 2023. A total of 6,849,572 shares of the Company were issued to holders based on the proportion of the outstanding Debentures held by such holder, of (x) membership interests in LF Brandco LLC (“Brandco”), an entity formed to hold the Company’s intellectual property relating to its “Lowell Smokes” and “Lowell Herb Co.” brands (including trademarks, logos and additional identifying marks, domain names and social media accounts). During the year ended December 31, 2023, and as result of the transaction, the Company recognized $13,245 of impairment on the intangible brand assets.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;"> In addition, the Company has entered into a license agreement with Brandco for the “Lowell” trademarks, logos, and related intellectual property on an exclusive basis in the State of California for a five-year license term, with up to three five-year extensions. The Company’s exercise of the extension terms is subject to mutual agreement on certain sales performance criteria for each extension term. In addition, the Company received a $1 million royalty advance whereby the Company does not have to pay the first $1 million of royalty expense.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">The transaction is considered to be a “related party transaction” because insiders of the Company hold Debentures and Warrants.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="font-size:10pt;font-family:times new roman;margin:0px"> As a result of the transaction, the Company derecognized Lowell brand name intangible ($24.1) million, convertible notes ($22.1) million, accrued interest ($1.49) million and warrants ($1.55) million. Issued shares and royalty advance were recorded at fair value in the amount of $2.03 million or $0.93 million, respectively.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; TEXT-INDENT: 33.75pt; text-align:justify;">The Company estimates that amortization expense for our existing other intangible assets will average approximately $317 annually for the next seven and a half fiscal years. Actual amortization expense to be reported in future periods could differ from these estimates as a result of new intangible asset acquisitions, changes in useful lives or other relevant factors or changes.</p> <table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="6" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>Definite Life Intangibles</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>Indefinite Life </strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="width:9%;"></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>Technology/</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>Acquired </strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>Purchase </strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>Intangibles </strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>Brands &amp;</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="width:9%;"></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">(in thousands)</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>Know How</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>Rights</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>Tradenames</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>Total</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in"><strong>Costs</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in"><strong>Balance-December 31, 2022</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><strong>3,258</strong></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><strong>1,800</strong></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><strong>37,707</strong></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><strong>42,765</strong></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 11.25pt">Sale of Brand Assets</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(24,053 </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(37,299 </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 11.25pt">Impairment </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(258 </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(1,384</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">)</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(13,654</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">) </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(2,050</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">) </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in"><strong>Balance-December 31, 2023</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><strong>3,000</strong></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><strong>416</strong></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><strong>-</strong></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><strong>3,416</strong></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in"><strong>Accumulated Amortization</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in"><strong>Balance-December 31, 2022</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><strong>(535 </strong></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;"><strong>)</strong></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><strong>(28 </strong></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;"><strong>)</strong></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><strong>-</strong></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><strong>(563 </strong></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;"><strong>)</strong></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 11.25pt">Amortization</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(323 </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(83 </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(406 </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">     Impairment </p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;"> 97</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;"> -</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;"> 97</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in"><strong>Balance-December 31, 2023</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><strong>(761 </strong></td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;"><strong>)</strong></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><strong>(111 </strong></td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;"><strong>)</strong></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><strong>-</strong></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><strong>(872 </strong></td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;"><strong>)</strong></td></tr><tr style="height:15px;background-color:#cceeff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in"><strong>Net Book Value</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in"><strong>December 31, 2022</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><strong>2,723</strong></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><strong>1,772</strong></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><strong>37,707</strong></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><strong>42,202</strong></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in"><strong>Net Book Value</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in"><strong>December 31, 2023</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><strong>2,239</strong></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><strong>305</strong></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><strong>-</strong></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><strong>2,544</strong></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table> 3258000 1800000 37707000 42765000 -24053000 -37299000 258000 1384000 13654000 2050000 3000000 416000 0 -3416000 -535000 -28000 0 -563000 -323000 -83000 0 406000 97000 0 97000 -761000 -111000 0 -872000 2723000 1772000 37707000 42202000 2239000 305000 0 2544000 406000 354000 0.15 1000000 1800000 22157000 10627483000 4324845000 13245000 the Company received a $1 million royalty advance whereby the Company does not have to pay the first $1 million of royalty expense 24100000 22100000 1490000 1550000 Issued shares and royalty advance were recorded at fair value in the amount of $2.03 million or $0.93 million, respectively 317000 <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;"><strong>7. SHAREHOLDERS’ EQUITY</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;"><strong><span style="text-decoration:underline">Shares Outstanding</span></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; TEXT-INDENT: 33.75pt; text-align:justify;">The table below details the change in Company shares outstanding by class during year ended December 31, 2023:</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>Subordinate</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>Super</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">(in thousands)</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>Voting Shares</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>Voting Shares</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in"><strong>Balance-December 31, 2022</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><strong>12,177</strong></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><strong>20</strong></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Issuance of vested restricted stock units</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">4</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Issuance of shares in convertible debt conversion</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">6,843</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in"><strong>Balance-December 31, 2023</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><strong>19,024</strong></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><strong>20</strong></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;"><strong><span style="text-decoration:underline">Warrants </span></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; TEXT-INDENT: 33.75pt; text-align:justify;">A reconciliation of the beginning and ending balances of warrants outstanding is as follows: </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td style="BORDER-BOTTOM: 1px solid;vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">(in thousands)</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in"><strong>Balance-December 31, 2022</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><strong>17,343</strong></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Warrants canceled in conjunction with convertible debt conversion</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(15,052</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Warrants expired </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">(1,165 </td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in"><strong>Balance-December 31, 2023</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><strong>1,126</strong></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p> <table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>Subordinate</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>Super</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">(in thousands)</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>Voting Shares</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>Voting Shares</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in"><strong>Balance-December 31, 2022</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><strong>12,177</strong></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><strong>20</strong></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Issuance of vested restricted stock units</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">4</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Issuance of shares in convertible debt conversion</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">6,843</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in"><strong>Balance-December 31, 2023</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><strong>19,024</strong></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><strong>20</strong></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table> 12177000 20000 4000 6843000 19024000 20000 <table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td style="BORDER-BOTTOM: 1px solid;vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">(in thousands)</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in"><strong>Balance-December 31, 2022</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><strong>17,343</strong></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Warrants canceled in conjunction with convertible debt conversion</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(15,052</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Warrants expired </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">(1,165 </td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in"><strong>Balance-December 31, 2023</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><strong>1,126</strong></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table> 17343000 -15052000 -1165000 1126000 <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;"><strong>8. DEBT</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; TEXT-INDENT: 33.75pt; text-align:justify;">Debt at December 31, 2023 and 2022, was comprised of the following:</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>December 31,</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>December 31,</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">(in thousands)</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>2023</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>2022</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in"><strong>Current portion of long-term debt</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Vehicle loans<sup style="vertical-align:super">(1)</sup></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">3</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">15</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Mortgage payable<sup style="vertical-align:super">(2)</sup></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">257</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Note payable</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">10</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Convertible debt<sup style="vertical-align:super">(3)</sup></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">-</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">21,398</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 11.25pt">Total short-term debt</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">3</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">21,680</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in"><strong>Long-term debt, net</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Vehicle loans<sup style="vertical-align:super">(1)</sup></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">3</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Mortgage payable<sup style="vertical-align:super">(2)</sup></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">8,713</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Convertible debenture<sup style="vertical-align:super">(3)</sup></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">-</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">-</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 11.25pt">Total long-term debt</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">-</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">8,716</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in"><strong>Total Indebtedness</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><strong>3</strong></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><strong>30,396</strong></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">_____________</p><table cellpadding="0" style="border-spacing:0;font-size:10pt;width:100%"><tbody><tr style="height:15px"><td style="width:4%;vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in"><em><sup style="vertical-align:super">(1) </sup></em></p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;"><em>Primarily fixed term loans on transportation vehicles. Weighted average interest rate at December 31, 2023 and December 31, 2022 was 6.4%</em><em>.</em></p></td></tr><tr style="height:15px"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;"><em><sup style="vertical-align:super">(2) </sup></em></p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;"><em>Mortgage payable associated with the acquired processing facility. Weighted average interest rate at December 31, 2022 was 12.5%. Net of deferred financing costs as December 31, 2022 of $296.As part of sale leaseback transaction, the Company sold the property, and the buyer assumed the mortgage. Refer to Note “Leases” for more information</em></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">       </p></td></tr><tr style="height:15px"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;"><em><sup style="vertical-align:super">(3) </sup></em></p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;"><em>Net of deferred financing costs at December 31, 2022 of $759.During the year, the Company repurchased the Convertible Notes. Refer to Note “Intangible Assets” for more information.</em></p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">Stated maturities of debt obligations are as follows as of December 31, 2023:</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>December 31,</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">(in thousands)</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>2023</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">2024</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">3</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Total debt obligations</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><strong>3</strong></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table> <table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>December 31,</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>December 31,</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">(in thousands)</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>2023</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>2022</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in"><strong>Current portion of long-term debt</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Vehicle loans<sup style="vertical-align:super">(1)</sup></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">3</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">15</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Mortgage payable<sup style="vertical-align:super">(2)</sup></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">257</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Note payable</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">10</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Convertible debt<sup style="vertical-align:super">(3)</sup></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">-</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">21,398</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 11.25pt">Total short-term debt</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">3</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">21,680</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in"><strong>Long-term debt, net</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Vehicle loans<sup style="vertical-align:super">(1)</sup></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">3</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Mortgage payable<sup style="vertical-align:super">(2)</sup></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">8,713</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Convertible debenture<sup style="vertical-align:super">(3)</sup></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">-</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">-</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 11.25pt">Total long-term debt</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">-</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">8,716</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in"><strong>Total Indebtedness</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><strong>3</strong></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><strong>30,396</strong></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table> 3000 15000 0 257000 0 10000 0 21398000 3000 21680000 0 3000 0 8713000 0 0 0 8716000 3000 30396000 0.064 0.125 296000 759000 <table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>December 31,</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">(in thousands)</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>2023</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">2024</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">3</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Total debt obligations</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><strong>3</strong></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table> 3000 3000 <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;"><strong>9. LEASES </strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; TEXT-INDENT: 33.75pt; text-align:justify;">A reconciliation of lease obligations for the years ended December 31, 2023 and 2022, is as follows:</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td style="vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px">(in thousands)</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="width:9%;"></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="width:9%;"></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="width:9%;"></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px"><td style="vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Lease obligation</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: #000000 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong> Operating Leases</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: #000000 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Finance Leases </strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: #000000 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Total</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>December 31, 2022</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><strong>-</strong></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><strong>33,999</strong></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><strong>33,999</strong></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Sale leaseback addition</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">17,068</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">17,068</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Lease principal payments</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:right;">(443</td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:right;">(1,527</td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:right;">(1,970</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">) </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Lease remeasurement</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">(2,064</td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(2,064</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Lease settlement</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:right;">-</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:right;">(1,202</td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:right;">(1,202</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">) </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Lease termination</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:right;">- </td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:9%;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;"> (26,319</p></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">)</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:right;">(26,319</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">)</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Operating lease remeasurement classification</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:right;">4,841</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:right;">(4,841</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">) </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:right;">-</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>December 31, 2023</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:right;"><strong>19,402</strong></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:right;"><strong>110</strong></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:right;"><strong>19,512</strong></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">As a result of the Zabala lease termination, The Company derecognized the right of use asset in the amount of $21,423 and lease obligation of $26,319, which resulted in a gain on termination of $4,896, which was recorded in Other Income/(expense). </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">During the year, the Company entered into a sale and leaseback transaction for its Spence Road facility. As part of the transaction, the Company sold the property for $19.4 million including assumption of the underlying mortgage. The Company leased back the facility for a ten-year period with 2 ten-year extension options. The Company accounted for the transaction as a sale recorded a gain of $3.04 million in Other income (expense). The lease back was classified as an operating lease. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; TEXT-INDENT: 33.75pt; text-align:justify;">All extension options that are reasonably certain to be exercised have been included in the measurement of lease obligations. The Company reassesses the likelihood of extension option exercise if there is a significant event or change in circumstances within its control.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; TEXT-INDENT: 33.75pt; text-align:justify;">The components of lease expense for the years ended December 31, 2023, and 2022, are as follows:</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="6" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>Years Ended </strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Finance Leases</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>December 31,</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>December 31,</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">(in thousands)</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>2023</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>2022</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Amortization of leased assets <sup style="vertical-align:super">(1)</sup></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1,651</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">3,755</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Interest on lease liabilities <sup style="vertical-align:super">(2)</sup></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">1,651</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">2,219</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in"><strong>Total</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><strong>3,316</strong></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><strong>5,974</strong></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">____________</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;"><em>(1) Included in cost of goods sold, general and administrative expenses and other expenses in the consolidated statement of operations. </em></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;"><em>(2) Included in interest expense in the consolidated statement of operations. </em></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;"> </p><table cellpadding="0" style="border-spacing:0;font-size:10pt;width:100%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td colspan="6" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Years Ended </strong></p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Operating Leases</strong></p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td colspan="2" style="width:9%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>December 31,</strong></p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td colspan="2" style="width:9%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>December 31,</strong></p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px">(in thousands)</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2023</strong></p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2022</strong></p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Amortization of leased assets <sup style="vertical-align:super">(1)</sup></p></td><td style="width:1%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px">$</p></td><td style="width:9%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">1,091</p></td><td style="width:1%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px">$</p></td><td style="width:9%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">-</p></td><td style="width:1%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Interest on lease liabilities <sup style="vertical-align:super">(1)</sup></p></td><td style="width:1%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">1,326</p></td><td style="width:1%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">-</p></td><td style="width:1%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Total</strong></p></td><td style="width:1%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>$</strong></p></td><td style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;"><strong>2,417</strong></p></td><td style="width:1%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>$</strong></p></td><td style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;"><strong>-</strong></p></td><td style="width:1%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">____________</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><em>(1) Included in cost of goods sold, general and administrative expenses and other expenses in the consolidated statement of operations. </em></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; TEXT-INDENT: 33.75pt; text-align:justify;">The key assumptions used in accounting for leases as of December 31, 2023, were a weighted average remaining lease term of 8.9 years and a weighted average discount rate of 10%. The key assumptions used in accounting for leases as of December 31, 2022 were a weighted average remaining lease term of 14.6 years and a weighted average discount rate of 6%. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; TEXT-INDENT: 33.75pt; text-align:justify;">The future lease payments with initial remaining terms in excess of one year as of December 31, 2023 were as follows:</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>December 31,</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">(in thousands)</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>2023</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">2024</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">3,285</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">2025</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">3,258</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">2026</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">3,240</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">2027</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">3,324</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">2028 and beyond</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">52,341</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in"><strong>Total lease payments</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">65,448</td><td style="width:1%;white-space: nowrap;"></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Less imputed interest</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(45,936</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in"><strong>Total</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">19,512</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table> <table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td style="vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px">(in thousands)</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="width:9%;"></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="width:9%;"></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="width:9%;"></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px"><td style="vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Lease obligation</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: #000000 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong> Operating Leases</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: #000000 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Finance Leases </strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: #000000 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Total</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>December 31, 2022</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><strong>-</strong></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><strong>33,999</strong></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><strong>33,999</strong></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Sale leaseback addition</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">17,068</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">17,068</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Lease principal payments</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:right;">(443</td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:right;">(1,527</td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:right;">(1,970</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">) </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Lease remeasurement</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">(2,064</td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(2,064</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Lease settlement</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:right;">-</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:right;">(1,202</td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:right;">(1,202</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">) </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Lease termination</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:right;">- </td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:9%;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;"> (26,319</p></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">)</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:right;">(26,319</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">)</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Operating lease remeasurement classification</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:right;">4,841</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:right;">(4,841</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">) </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:right;">-</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>December 31, 2023</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:right;"><strong>19,402</strong></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:right;"><strong>110</strong></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:right;"><strong>19,512</strong></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table> 0 33999000 33999000 17068000 0 17068000 443000 1527000 1970000 -2064000 0 -2064000 0 -1202000 -1202000 0 -26319000 -26319000 4841000 -4841000 0 19402000 110000 19512000 21423 26319 4896 19400000 3040000.00 <table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="6" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>Years Ended </strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Finance Leases</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>December 31,</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>December 31,</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">(in thousands)</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>2023</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>2022</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Amortization of leased assets <sup style="vertical-align:super">(1)</sup></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1,651</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">3,755</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Interest on lease liabilities <sup style="vertical-align:super">(2)</sup></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">1,651</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">2,219</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in"><strong>Total</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><strong>3,316</strong></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><strong>5,974</strong></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table><table cellpadding="0" style="border-spacing:0;font-size:10pt;width:100%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td colspan="6" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Years Ended </strong></p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Operating Leases</strong></p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td colspan="2" style="width:9%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>December 31,</strong></p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td colspan="2" style="width:9%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>December 31,</strong></p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px">(in thousands)</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2023</strong></p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2022</strong></p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Amortization of leased assets <sup style="vertical-align:super">(1)</sup></p></td><td style="width:1%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px">$</p></td><td style="width:9%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">1,091</p></td><td style="width:1%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px">$</p></td><td style="width:9%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">-</p></td><td style="width:1%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Interest on lease liabilities <sup style="vertical-align:super">(1)</sup></p></td><td style="width:1%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">1,326</p></td><td style="width:1%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">-</p></td><td style="width:1%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Total</strong></p></td><td style="width:1%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>$</strong></p></td><td style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;"><strong>2,417</strong></p></td><td style="width:1%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>$</strong></p></td><td style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;"><strong>-</strong></p></td><td style="width:1%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">____________</p> 1651000 3755000 1651000 2219000 3316000 5974000 1091 0 1326 0 2417 0 P8Y10M24D 0.10 P14Y7M6D 0.06 <table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>December 31,</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">(in thousands)</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>2023</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">2024</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">3,285</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">2025</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">3,258</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">2026</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">3,240</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">2027</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">3,324</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">2028 and beyond</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">52,341</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in"><strong>Total lease payments</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">65,448</td><td style="width:1%;white-space: nowrap;"></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Less imputed interest</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(45,936</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in"><strong>Total</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">19,512</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table> 3285000 3258000 3240000 3324000 52341000 65448000 45936000 19512000 <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;"> <strong>10. SHARE-BASED COMPENSATION </strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; TEXT-INDENT: 33.75pt; text-align:justify;">During 2019, the Company’s Board of Directors adopted the 2019 Stock and Incentive Plan (the “Plan”), which was amended in April 2020 and March 2021. The Plan permits the issuance of stock options, stock appreciation rights, stock awards, share units, performance shares, performance units and other stock-based awards, and, as of December 31, 2022, 13.2 million shares have been authorized to be issued under the Plan and 3.6 million are available for future grant. The Plan provides for the grant of options as either non-statutory stock options or incentive stock options and restricted stock units to employees, officers, directors, and consultants of the Company to attract and retain persons of ability to perform services for the Company and to reward such individuals who contribute to the achievement by the Company of its economic objectives. The awards granted generally vest in 25% increments over a four-year period and option awards expire 6 years from grant date. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; TEXT-INDENT: 33.75pt; text-align:justify;">The Plan is administered by the Board or a committee appointed by the Board, which determines the persons to whom the awards will be granted, the type of awards to be granted, the number of awards to be granted, and the specific terms of each grant, including the vesting thereof, subject to the provisions of the Plan.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; TEXT-INDENT: 33.75pt; text-align:justify;">During the years December 31, 2023 and 2022, the Company granted shares to certain employees as compensation for services. These shares were accounted for in accordance with ASC 718 - Compensation - Stock Compensation. The Company amortizes awards over the service period and until awards are fully vested.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; TEXT-INDENT: 33.75pt; text-align:justify;">For the years ended December 31, 2023, and 2022 share-based compensation expense was as follows:</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="6" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>Years Ended </strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>December 31,</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>December 31,</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">(in thousands)</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>2023</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>2022</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Cost of goods sold</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">General and administrative expense</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">231</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">564</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in"><strong>Total share-based compensation</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><strong>231</strong></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><strong>564</strong></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; TEXT-INDENT: 33.75pt; text-align:justify;">The following table summarizes the status of stock option grants and unvested awards at and for the year ended December 31, 2023:</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="width:9%;"></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>Weighted-</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>Weighted-</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>Average</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="width:9%;"></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="width:9%;"></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>Average</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>Remaining</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>Aggregate </strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">(in thousands except per share amounts)</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>Stock</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>Options</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>Exercise </strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>Price</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>Contractual </strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>Life</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>Intrinsic </strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>Value</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in"><strong>Outstanding-December 31, 2022</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1,007</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">4.7</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">4.6</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 11.25pt">Granted</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">828</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.3</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 11.25pt">Expired</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(28</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">) </td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">20.4</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 11.25pt">Cancelled</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">(354</td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">) </td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">4.6</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Outstanding-December 31, 2023</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1,453</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1.9</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">5.3</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Exercisable-December 31, 2023</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">988</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">2.09</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">5.2</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Vested and expected to vest-December 31, 2023</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1,453</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1.91</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">5.3</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; TEXT-INDENT: 33.75pt; text-align:justify;">The weighted-average fair value of options granted during the year ended December 31, 2023, estimated as of the grant date was $0.30. As of December 31, 2023, there was $191 of total unrecognized compensation cost related to non-vested options, which is expected to be recognized over a remaining weighted-average vesting period of 0.99 years.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; TEXT-INDENT: 33.75pt; text-align:justify;">The following table summarizes the status of restricted stock unit (“RSU”) grants and unvested awards at and for the year ended December 31, 2023:</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="width:9%;"></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>Weighted-Average</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">(in thousands except per share amounts)</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>RSUs</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>Fair Value</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in"><strong>Outstanding-December 31, 2022</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">21</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1.10</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 11.25pt">Granted</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">- </td><td style="width:1%;white-space: nowrap;"></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 11.25pt">Vested</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:right;">(4</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">)</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 11.25pt">Cancelled</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">(17 </td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1.02</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in"><strong>Outstanding-December 31, 2023</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; TEXT-INDENT: 33.75pt; text-align:justify;">As of December 31, 2023, there was no unrecognized compensation cost related to non-vested restricted stock units.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; TEXT-INDENT: 33.75pt; text-align:justify;">The fair value of the stock options and RSUs granted were determined using the Black-Scholes option-pricing model with the following weighted average assumptions at the time of grant. No RSUs were granted for the years ended December 31, 2023 and 2022.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in"><strong>Options</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="6" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>Years Ended </strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>December 31,</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>December 31,</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>2023</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>2022</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Expected volatility</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">50</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">%</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">50</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">%</td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Dividend yield</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">%</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">%</td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Risk-free interest rate</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">4.12</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">%</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">2.48</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">%</td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Expected term in years</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">5.58</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">3.9</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p> 13200000 3600000 The awards granted generally vest in 25% increments over a four-year period and option awards expire 6 years from grant date <table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="6" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>Years Ended </strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>December 31,</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>December 31,</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">(in thousands)</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>2023</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>2022</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Cost of goods sold</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">General and administrative expense</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">231</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">564</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in"><strong>Total share-based compensation</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><strong>231</strong></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><strong>564</strong></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table> 0 0 231000 564000 231000 564000 <table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="width:9%;"></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>Weighted-</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>Weighted-</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>Average</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="width:9%;"></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="width:9%;"></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>Average</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>Remaining</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>Aggregate </strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">(in thousands except per share amounts)</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>Stock</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>Options</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>Exercise </strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>Price</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>Contractual </strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>Life</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>Intrinsic </strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>Value</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in"><strong>Outstanding-December 31, 2022</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1,007</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">4.7</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">4.6</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 11.25pt">Granted</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">828</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.3</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 11.25pt">Expired</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(28</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">) </td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">20.4</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 11.25pt">Cancelled</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">(354</td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">) </td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">4.6</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Outstanding-December 31, 2023</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1,453</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1.9</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">5.3</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Exercisable-December 31, 2023</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">988</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">2.09</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">5.2</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Vested and expected to vest-December 31, 2023</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1,453</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1.91</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">5.3</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table> 1007000 4.7 4.6 0 828000 0.3 0 28000 20.4 0 -354000 P4Y7M6D 0 1453000 1.9 P5Y3M18D 0 988000 2.09 P5Y2M12D 0 1453000 1.91 P5Y3M18D 0 0.30 191000 P0Y11M26D <table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="width:9%;"></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>Weighted-Average</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">(in thousands except per share amounts)</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>RSUs</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>Fair Value</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in"><strong>Outstanding-December 31, 2022</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">21</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1.10</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 11.25pt">Granted</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">- </td><td style="width:1%;white-space: nowrap;"></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 11.25pt">Vested</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:right;">(4</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">)</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 11.25pt">Cancelled</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">(17 </td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1.02</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in"><strong>Outstanding-December 31, 2023</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table> 21000 1.10 0 4000 0 17000 1.02 0 <table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in"><strong>Options</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="6" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>Years Ended </strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>December 31,</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>December 31,</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>2023</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>2022</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Expected volatility</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">50</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">%</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">50</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">%</td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Dividend yield</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">%</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">%</td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Risk-free interest rate</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">4.12</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">%</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">2.48</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">%</td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Expected term in years</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">5.58</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">3.9</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table> 0.50 0.50 0 0 0.0412 0.0248 P5M17D P3M27D <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;"><strong>11. INCOME TAXES </strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;"><span style="text-decoration:underline">Coronavirus Aid, Relief and Economic Security Act</span></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; TEXT-INDENT: 33.75pt; text-align:justify;">On March 27, 2020, the Coronavirus Aid, Relief, and Economic Security Act (the “CARES Act”) was enacted and signed into law in response to the market volatility and instability resulting from the COVID-19 pandemic. It includes a significant number of tax provisions and lifts certain deduction limitations originally imposed by the Tax Cuts and Jobs Act of 2017 (the “2017 Act”). The changes mainly related to: (1) the business interest expense disallowance rules for 2019 and 2020; (2) net operating loss rules; (3) charitable contribution limitations; (4) employee retention credit; and (5) the realization of corporate alternative minimum tax credits.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; TEXT-INDENT: 33.75pt; text-align:justify;">The Company continues to assess the impact and future implication of these provisions; however, it does not anticipate any amounts that could give rise to a material impact to the overall consolidated financial statements.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; TEXT-INDENT: 33.75pt; text-align:justify;">The provision for income tax expense for the year ended December 31, 2023, was $161, representing an effective tax rate of (0.4)%, compared to an income tax expense of 191 for the year ended December 31, 2022, representing an effective tax rate of (0.8)%. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; TEXT-INDENT: 33.75pt; text-align:justify;">The provision for income tax expense for the years ended December 31, 2023 and 2022, consisted of the following:</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="6" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>Years Ended </strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">(in thousands)</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>2023</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>2022</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in"><strong>Current</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 11.25pt">Federal</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 11.25pt">State</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">161</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">191</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in"><strong>Total Current</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><strong>191</strong></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><strong>191</strong></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in"><strong>Deferred tax benefit</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 11.25pt">Federal</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(1,615 </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(1,987 </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 11.25pt">State</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">(3,111 </td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">(15,293</td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in"><strong>Total deferred tax benefit</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><strong>(4,726 </strong></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;"><strong>)</strong></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><strong>(17,280 </strong></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;"><strong>)</strong></td></tr><tr style="height:15px;background-color:#cceeff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Valuation allowance</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">4,726</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">17,280</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in"><strong>Income tax expense</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><strong>161</strong></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><strong>191</strong></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; TEXT-INDENT: 33.75pt; text-align:justify;">As the Company operates in the cannabis industry, it is subject to the limitations of IRC Section 280E, under which the Company is only allowed to deduct expenses directly related to sales of product. This results in permanent differences between ordinary and necessary business expenses deemed non-allowable under IRC Section 280E. Therefore, the effective tax rate can be highly variable and may not necessarily correlate with pre-tax income or loss.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; TEXT-INDENT: 33.75pt; text-align:justify;">In December 2017, the United States (“U.S.”) Congress passed and the President signed into law what is referred to as the 2017 Tax Act, which contains many significant changes to the U.S. tax laws, including, but not limited to, reducing the U.S. federal corporate tax rate from 35% to 21% and utilization limitations of net operating loss carryforwards created in tax years beginning after December 31, 2017 to 80% of taxable income with an indefinite carryforward period. As the Company has a full valuation allowance against its U.S. deferred tax assets, the revaluation of net deferred tax assets resulting from the reduction in the U.S. federal corporate income tax rate did not impact the Company’s effective tax rate. Additional guidance may be issued by the U.S. Treasury Department, the IRS, or other standard-setting bodies, which may result in adjustments to the amounts recorded, </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">including the valuation allowance. The Company is being audited by the IRS for years 2019 and 2020. Significant components of the Company’s deferred tax assets and liabilities at December 31, 2023 and 2022, are as follows:</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="6" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>Years Ended </strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">(in thousands)</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>2023</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>2022</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in"><strong>Deferred tax assets</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 11.25pt">Net operating loss carryforwards </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">23,323</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">17,038</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 11.25pt">Accruals and reserves</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 11.25pt">Depreciation</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 11.25pt">Other</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 11.25pt">Valuation allowance</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">(23,323 </td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">(17,038 </td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in"><strong>Total deferred tax assets</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 11.25pt">Accruals and reserves</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 11.25pt">Share-based compensation</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">-</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">-</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in"><strong>Total deferred tax liabilities</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><strong>-</strong></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><strong>-</strong></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in"><strong>Net deferred tax liabilities</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><strong>-</strong></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><strong>-</strong></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table> 161000 0.004 191000 0.008 <table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="6" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>Years Ended </strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">(in thousands)</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>2023</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>2022</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in"><strong>Current</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 11.25pt">Federal</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 11.25pt">State</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">161</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">191</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in"><strong>Total Current</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><strong>191</strong></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><strong>191</strong></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in"><strong>Deferred tax benefit</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 11.25pt">Federal</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(1,615 </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(1,987 </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 11.25pt">State</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">(3,111 </td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">(15,293</td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in"><strong>Total deferred tax benefit</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><strong>(4,726 </strong></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;"><strong>)</strong></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><strong>(17,280 </strong></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;"><strong>)</strong></td></tr><tr style="height:15px;background-color:#cceeff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Valuation allowance</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">4,726</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">17,280</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in"><strong>Income tax expense</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><strong>161</strong></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><strong>191</strong></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table> 0 0 161000 191000 191000 191000 -1615000 -1987000 -3111000 -15293000 -4726000 -17280000 4726000 17280000 161000 191000 <table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="6" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>Years Ended </strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">(in thousands)</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>2023</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>2022</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in"><strong>Deferred tax assets</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 11.25pt">Net operating loss carryforwards </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">23,323</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">17,038</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 11.25pt">Accruals and reserves</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 11.25pt">Depreciation</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 11.25pt">Other</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 11.25pt">Valuation allowance</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">(23,323 </td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">(17,038 </td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in"><strong>Total deferred tax assets</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 11.25pt">Accruals and reserves</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 11.25pt">Share-based compensation</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">-</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">-</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in"><strong>Total deferred tax liabilities</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><strong>-</strong></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><strong>-</strong></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in"><strong>Net deferred tax liabilities</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><strong>-</strong></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><strong>-</strong></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table> 23323000 17038000 0 0 0 0 0 0 23323000 17038000 0 0 0 0 0 0 0 0 0 0 <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;"><strong>12. NET INCOME (LOSS) PER SHARE</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; TEXT-INDENT: 33.75pt; text-align:justify;">Net loss per share represents the net earnings/loss attributable to shareholders divided by the weighted average number of shares outstanding during the period on an as converted basis.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="6" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>Years Ended </strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>December 31,</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>December 31,</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">(in thousands except per share amounts)</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>2023</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>2022</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Net loss</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(37,342 </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(24,677 </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#ffffff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Net loss per share: </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Basic</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">(2.71 </td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">(2.17 </td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Diluted </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">(2.71 </td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">(2.17 </td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Weighted average shares outstanding: </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Basic</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">13,790</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">11,318</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Diluted </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">13,790</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">11,318</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Weighted average potentially diluted shares (1):</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Basic shares</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">13,790</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">11,318</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Options</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Warrants</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Convertible debentures</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Restricted stock units</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">-</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">-</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Total weighted average potentially diluted shares:</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">13,790</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">11,318</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;"><em>________________</em></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;"><em>(1) For the above periods, the inclusion of options, warrants, convertible debentures and restricted stock units in the calculation of diluted earnings per share would be anti-dilutive, and accordingly, were excluded from the diluted loss per share calculation.</em></p> <table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="6" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>Years Ended </strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>December 31,</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>December 31,</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">(in thousands except per share amounts)</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>2023</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>2022</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Net loss</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(37,342 </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(24,677 </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#ffffff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Net loss per share: </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Basic</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">(2.71 </td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">(2.17 </td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Diluted </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">(2.71 </td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">(2.17 </td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Weighted average shares outstanding: </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Basic</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">13,790</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">11,318</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Diluted </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">13,790</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">11,318</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Weighted average potentially diluted shares (1):</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Basic shares</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">13,790</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">11,318</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Options</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Warrants</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Convertible debentures</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Restricted stock units</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">-</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">-</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Total weighted average potentially diluted shares:</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">13,790</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">11,318</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table> 37342000 -24677000 -2.71 -2.17 -2.71 -2.17 13790000 11318000 13790000 11318000 13790000 11318000 13790000 11318000 <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;"><strong>13. FAIR VALUE MEASUREMENTS</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; TEXT-INDENT: 33.75pt; text-align:justify;">Accounting standards define fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. The fair value hierarchy prioritizes the inputs to valuation techniques used to measure fair value. An asset’s or liability’s level is based on the lowest level of input that is significant to the fair value measurement. Assets and liabilities carried at fair value are valued and disclosed in one of the following three levels of the valuation hierarchy:</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; TEXT-INDENT: 33.75pt; text-align:justify;">Level 1: Quoted market prices in active markets for identical assets or liabilities.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; TEXT-INDENT: 33.75pt; text-align:justify;">Level 2: Observable market-based inputs or unobservable inputs that are corroborated by market data. Level 3: Unobservable inputs reflecting the reporting entity’s own assumptions.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; TEXT-INDENT: 33.75pt; text-align:justify;">At December 31, 2023 and December 31, 2022 the carrying value of cash and cash equivalents, accounts receivable, prepaid expense and other current assets, accounts payable and other current liabilities approximate fair value due to the short-term nature of such instruments.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; TEXT-INDENT: 33.75pt; text-align:justify;">The carrying value of the Company's debt approximates fair value based on current market rates (Level 2).</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;"><strong>Nonrecurring fair value measurements</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; TEXT-INDENT: 33.75pt; text-align:justify;">The Company uses fair value measures when determining assets and liabilities acquired in an acquisition as described above in the Notes to Consolidated Financial Statements, which are considered a Level 3 measurement.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;"><strong>14. COMMITMENTS AND CONTINGENCIES </strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;"><strong><span style="text-decoration:underline">Contingencies</span></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; TEXT-INDENT: 33.75pt; text-align:justify;">The Company’s operations are subject to a variety of local and state regulation. Failure to comply with one or more of those regulations could result in fines, restrictions on its operations, or losses of permits that could result in the Company ceasing operations. While management of the Company believes that the Company is in compliance with applicable local and state regulation as of December 31, 2023, cannabis regulations continue to evolve and are subject to differing interpretations. As a result, the Company may be subject to regulatory fines, penalties or restrictions in the future. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; TEXT-INDENT: 33.75pt; text-align:justify;">The Company is being audited by the IRS for years 2019 and 2020 and may be subject to additional taxes, penalties and interest.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;"><strong><span style="text-decoration:underline">Litigation and Claims</span></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; TEXT-INDENT: 33.75pt; text-align:justify;">From time to time, the Company may be involved in litigation relating to claims arising out of operations in the normal course of business.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; TEXT-INDENT: 33.75pt; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">On January 12, 2024, Cypress Holding Company, LLC (“Cypress”), a wholly owned subsidiary of the Company, surrendered possession of approximately 10 acres of real property at 139 Zabala Road, Salinas, California (the “Zabala Road Property”) leased by Cypress pursuant to a Lease Agreement dated April 1, 2017 (the “Zabala Road Lease”) with Tinhouse, LLC, dba Tinhouse Partners, LLC, as landlord (the “Landlord”). Prior to vacating the premises on January 12, 2024, the Company had operated a cultivation facility, which includes four greenhouses totaling approximately 255,000 square feet, on the Zabala Road Property.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">In January 2023, the Company’s Board of Directors formed a strategic alternatives special committee of independent directors to explore, review and evaluate strategic and financial alternatives. As part of these efforts, the Company entered into negotiations with the Landlord to restructure the terms of the Zabala Road Lease, which provided for an expiry date of December 31, 2027, subject to five 5-year extension options exercisable by Cypress.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">In 2023, the Company and the Landlord reached a settlement amending the terms of the Zabala Road Lease and reaching agreement on all rent-related issues. The Landlord terminated the Zabala Road Lease via a letter, which was served by its counsel on the Company in 2023. In 2023, the Company filed a lawsuit for breach of contract and specific performance against the Landlord to enforce the settlement terms. The Landlord filed counterclaims and an unlawful detainer action against the Company, claiming damages of more than $36 million, which the Landlord claims are based on an analysis of accelerated rent due through the end of the term of the Zabala Road Lease, along with attorney’s fees, improvements, and other undefined costs.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">The Company intends to vigorously defend itself against the claims made by the Landlord. However, no assurance can be provided as to whether or not the Company will prevail, and it may be required to pay significant monetary damages. It is difficult to evaluate the likely outcome of a trial at such an early stage and with competing claims and cross-claims. In addition, due to the early nature of the case, an estimate on a loss cannot be made.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">A punitive class action was filed on behalf of all California consumers who purchased products made by Lowell Farms, Inc. in California. The case alleges that Lowell failed to accurately label its products with the THC% identified by its testing laboratories, and that California consumers were thereby deceived into paying higher prices for Lowell’s products than they otherwise would have. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="font-size:10pt;font-family:times new roman;margin:0px">No trial has been scheduled in this matter. The parties are presently engaged in the process by which Plaintiff will bring a motion seeking certification of a class. If class certification is denied, then Plaintiff will be relegated to his own damages, which is likely just a few hundred dollars, and the case will likely end. If class certification is granted, then the parties will engage in fact discovery and the Court will set a trial date. The class certification motion is scheduled to be heard on August 26, 2024. Plaintiff has served discovery requests limited to class certification issues, but the parties have not engaged in any merits discovery. It is difficult to evaluate any potential outcome at such an early stage of the case where there has been no merits discovery. The Company is prepared to vigorously defend itself at the trial if a class is certified and a settlement is not reached. It is difficult to evaluate the likely outcome of a trial because Plaintiff has not articulated a theory of damages. In addition, due to the early nature of the case, an estimate of a loss cannot be made.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;"><strong>15. GENERAL AND ADMINISTRATIVE EXPENSES</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; TEXT-INDENT: 33.75pt; text-align:justify;">For the years ended December 31, 2023 and 2022, general and administrative expenses were comprised of:</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="6" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>Years Ended </strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>December 31,</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>December 31,</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">(in thousands)</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>2023</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>2022</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Salaries and benefits</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">3,229</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">5,286</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Professional fees</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">527</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">465</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Share-based compensation</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">231</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">564</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Insurance</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">999</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1,344</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Administrative</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">2,316</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">1,894</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in"><strong>Total general and administrative expenses</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><strong>7,302</strong></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><strong>9,553</strong></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table> <table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="6" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>Years Ended </strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>December 31,</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>December 31,</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">(in thousands)</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>2023</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>2022</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Salaries and benefits</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">3,229</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">5,286</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Professional fees</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">527</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">465</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Share-based compensation</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">231</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">564</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Insurance</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">999</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1,344</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Administrative</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">2,316</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">1,894</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in"><strong>Total general and administrative expenses</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><strong>7,302</strong></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><strong>9,553</strong></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table> 3229000 5286000 527000 465000 231000 564000 999000 1344000 2316000 1894000 7302000 9553000 <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;"><strong>16. RELATED-PARTY TRANSACTIONS</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; TEXT-INDENT: 33.75pt; text-align:justify;">Transactions with related parties are entered into in the normal course of business and are measured at the amount established and agreed to by the parties.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; TEXT-INDENT: 33.75pt; text-align:justify;">In April 2015, Lowell entered into a services agreement with Olympic Management Group (“OMG”), for advisory and technology support services, including the access and use of software licensed to OMG to perform certain data processing and enterprise resource planning (ERP) operational services. OMG is owned by one of the Company’s co-founders. The agreement provides for the dollar-for-dollar reimbursement of expenses incurred by OMG in performance of its services. Amounts paid to OMG for the years ended December 31, 2023 and 2022, were $nil and $36, respectively.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; TEXT-INDENT: 33.75pt; text-align:justify;">During October 2022, Cannaco Research Corporation, an existing customer, became a related party when Ms. Lawrence, a new member joined the Board of Directors. Total sales recognized for Cannaco Research Corporation for the years ended December 31, 2023 and 2022 were $487 and $274, respectively. For the years ended December 31, 2023 and 2022, cash collected from Cannaco Research Corporation was $476 and $223, respectively. In December, 2022, the Company entered into an agreement with Cannaco Research Corporation to lease approximately 2,000 square feet of warehouse space in Los Angeles to facilitate distribution services in the area. The lease was a 12 month storage agreement for the warehouse space. Total payments to Cannaco Research Corporation for the lease were $130 and $10 in the years ended December 31, 2023 and December 31,2022, respectively.</p> 36 487000 274000 476000 223000 P12M 130000 10000 <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;"><strong>17. SEGMENT INFORMATION</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; TEXT-INDENT: 33.75pt; text-align:justify;">The Company's operations are comprised of a single reporting operating segment engaged in the production and sale of cannabis products in the United States. As the operations comprise a single reporting segment, amounts disclosed in the financial statements also represent a single reporting segment.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;"><strong>18. SUBSEQUENT EVENTS</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;"> </p><p style="font-size:10pt;font-family:times new roman;margin:0px">On January 12, 2024, Cypress Holding Company, LLC (“Cypress”), a wholly owned subsidiary of the Company, surrendered possession of approximately 10 acres of real property at 139 Zabala Road, Salinas, California (the “Zabala Road Property”) leased by Cypress pursuant to a Lease Agreement dated April 1, 2017 (the “Zabala Road Lease”) with Tinhouse, LLC, dba Tinhouse Partners, LLC, as landlord (the “Landlord”). Prior to vacating the premises on January 12, 2024, the Company had operated a cultivation facility, which includes four greenhouses totaling approximately 255,000 square feet, on the Zabala Road Property. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 36pt; text-align:justify;">As previously announced, in January 2023, the Company’s Board of Directors formed a strategic alternatives special committee of independent directors to explore, review and evaluate strategic and financial alternatives. As part of these efforts, the Company entered into negotiations with the Landlord to restructure the terms of the Zabala Road Lease, which provided for an expiry date of December 31, 2027, subject to five 5-year extension options exercisable by Cypress.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 36pt; text-align:justify;">In September 2023, the Company and the Landlord reached a settlement amending the terms of the Zabala Road Lease and reaching agreement on all rent-related issues. The Landlord terminated the Zabala Road Lease via a letter dated October 6, 2023, which was served by its counsel on the Company on October 10, 2023. In October 2023, the Company filed a lawsuit for breach of contract and specific performance against the Landlord to enforce the settlement terms. The Landlord filed counterclaims and an unlawful detainer action against the Company, claiming damages of more than $36 million, which the Landlord claims are based on an analysis of accelerated rent due through the end of the term of the Zabala Road Lease, along with attorney’s fees, improvements, and other undefined costs.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; TEXT-INDENT: 33.75pt; text-align:justify;">The Company has evaluated subsequent events through March 26, 2024, the date the financial statements were available to be issued.</p>